{"subject_id":"10789227","hadm_id":"27763533","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nmorphine / Keflex\n \nAttending: ___.\n \nChief Complaint:\nFall, hyponatremia\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ y/o F w/ h/o ckd, not on blood thinners, in assisted living, \nhere after witnessed mechanical fall around 8p. Pt bending over \nto adjust fan, fell, hit right side of head and right hip. No \nLOC, N/V, vision changes, altered mental status, or amnesia. Pt \ncurrently c/o right sided headache, and right hip pain. \n\nIn the ED, initial vitals:  97.8\n72 183/74 18 100% RA\nLabs were significant for  hyponatremia (118), ___ (cr 1.3 from \n1, has been as high as 1.7 in past), mild luekocytosis (13.4), \npositive U/A\nImaging showed\nCT head and cspine neg, plain films hip neg\nAble to range right hip well\nCspine clinically cleared  \nIn the ED, she received tylenol, oxycodone 5 mg X 3 over 8 \nhours, fluoxetine, gabapentin, synthroid\n\nShe was fluid restricted for hyponaremia of 118, which improved \nto 122 and Cr to 1.2.\n\nVitals prior to transfer: 98.2 65 140/77 16 96% RA \n\nOn floor patient reports no complaints. She has been eating and \ndrinking okay the past few days and has not felt fatigued, and \nhas had no change in bladder or bowel habits. She does report \nhowever that she has had been drinking more tea and water \nrecently. She is very pleasant and is AOX3; is a former ___. \n\n \nPast Medical History:\n- CKD\n- Osteoporosis\n- Anemia\n- Dysphagia\n- Cervical radiculopathy\n- Polyneuropathy\n- Frequent falls\n- Hx Basal cell carcinoma\n- Hx Lentigo maligna\n- Hx Squamous cell carcinoma of skin\n- Hx Ankle fracture\n- Hx Humerus fracture, proximal w/ shoulder arthroplasty ___\n \nSocial History:\n___\nFamily History:\nMother with facial cancer. Didn't know her father. Sister \nhealthy.\n\n \nPhysical Exam:\nON ADMISSION\n\nVS:  T 98.3 145/66 HR 62 RR 18 98 % RA\n GEN: Alert, lying in bed, no acute distress  \n HEENT: dry MM, no cervical LAD, anisocoria noted \n NECK: Supple without LAD\n PULM: Generally CTA over anterior chest   \n COR: RRR (+)S1/S2 no m/r/g  \n ABD: Soft, non-tender,slight distension, midline scar ___ prior \nhysterectomy\n EXTREM: Warm, well-perfused, no edema  \n NEURO: CN II-XII grossly intact, motor function grossly normal \n\nON DISCHARGE\n\nPHYSICAL EXAM:  \nVS:  BP 144/66 HR 59 RR 18 97 RA\n GEN: Alert, lying in bed, no acute distress  \n HEENT: moist mucous membranes \n NECK: Supple without LAD\n PULM: Generally CTA over anterior chest   \n COR: RRR (+)S1/S2 no m/r/g  \n ABD: Soft, non-tender,slight distension, midline scar ___ prior \nhysterectomy\n EXTREM: Warm, well-perfused, skin tender to touch. LEft lateral \nhip tenderness \n NEURO: CN II-XII grossly intact, motor function grossly normal\n\n \nPertinent Results:\nON ADMISSION\n======================\n\n___ 07:30PM   GLUCOSE-137* UREA N-11 CREAT-1.3* SODIUM-121* \nPOTASSIUM-4.7 CHLORIDE-89* TOTAL CO2-24 ANION GAP-13\n___ 10:13AM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 10:55PM   WBC-13.4* RBC-3.93 HGB-11.9 HCT-34.3 MCV-87 \nMCH-30.3 MCHC-34.7 RDW-12.5 RDWSD-40.0\n\nON DISCHARGE\n======================\n\n___ 06:05AM BLOOD WBC-9.1 RBC-3.29* Hgb-9.8* Hct-30.3* \nMCV-92 MCH-29.8 MCHC-32.3 RDW-12.7 RDWSD-42.0 Plt ___\n___ 06:05AM BLOOD Glucose-90 UreaN-23* Creat-1.2* ___ \nK-4.6 Cl-94* HCO3-27 AnGap-12\n___ 06:05AM BLOOD Calcium-9.2 Phos-4.2 Mg-1.9\n___ 06:54AM BLOOD TSH-12*\n___ 06:54AM BLOOD Free T4-1.0\n\nIMAGING\n================================\nHIP XRAY\n\nFinal Report\nINDICATION:  ___ with mechanical fall, fell onto right side, \nwith right hip\npain  // fracture\n \nCOMPARISON:  Prior exam dated ___.\n \nFINDINGS: \n \nAP pelvis and two views of the right hip were provided.  There \nis left hip\narthroplasty partially imaged which appears aligns normally and \nwithout signs\nof hardware failure.  Chronic deformities involving the inferior \npubic rami\nare again noted.  Right hip aligns normally.  Vascular \ncalcification noted. \nBony pelvic ring appears intact.  SI joints are symmetric and \nnormal.\n \nIMPRESSION: \n \nNo acute findings.\n\nEXAMINATION:  CT C-SPINE W/O CONTRAST\n \nINDICATION:  ___ with mechanical fall witnessed onto right side, \nwith right\nsided hematoma, no LOC, not on blood thinners\n \nTECHNIQUE:  Non-contrast helical multidetector CT was performed. \nSoft tissue\nand bone algorithm images were generated.  Coronal and sagittal \nreformations\nwere then constructed.\n \nDOSE:  Total DLP (Body) = 625 mGy-cm.\n\nCT SPINE\n\nCOMPARISON:  CT cervical spine ___.\n \nFINDINGS: \n \nMild anterolisthesis of C4 on C5 and retrolisthesis of C6 on C7 \nis chronic. \nNo acute fractures are identified.  Multilevel degenerative \nchanges with\nanterior osteophytes and disc space narrowing are present and \nunchanged. \nThere is no prevertebral soft tissue swelling.There is no \ncervical\nlymphadenopathy by size criteria.  The visualized thyroid gland \nis\nunremarkable.  Prominent biapical pleural-parenchymal scarring \nand\ncalcifications are unchanged from prior exam.  The visualized \naerodigestive\ntract is grossly unremarkable.  Prominent atherosclerotic \ncalcification of the\nbilateral carotid bifurcations are noted.\n \nIMPRESSION:\n \n \n1. No acute fracture or traumatic malalignment.\n2. Multilevel degenerative changes, unchanged from prior exam.\n\nCT HEAD\n\nFinal Report\nEXAMINATION:  CT HEAD W/O CONTRAST\n \nINDICATION:  ___ with mechanical fall witnessed onto right side, \nwith right\nsided hematoma, no LOC, not on blood thinners\n \nTECHNIQUE:  Contiguous axial images of the brain were obtained \nwithout\ncontrast.\n \nDOSE:  Total DLP (Head) = 803 mGy-cm.\n \nCOMPARISON:  Head CT ___.\n \nFINDINGS: \n \nThere is no evidence of acute large territorial infarction, \nhemorrhage, edema,\nor mass effect. Ventricles and sulci are prominent, consistent \nwith\nage-related involutional changes.  Periventricular subcortical \nwhite matter\nhypodensities are nonspecific but compatible with chronic small \nvessel\nischemic changes and unchanged from prior exam.\nThere is no evidence of fracture.  Extensive calcification of \ncarotid siphons\nis present.  Partial opacification of right mastoid air cells is \nnoted.  The\nvisualized portion of the paranasal sinuses,left mastoid air \ncells, and middle\near cavities are clear.  Mild right temporal scalp hematoma is \nidentified\nwithout underlying skull fracture.\n \nIMPRESSION:\n \n \n1. No acute intracranial abnormality on noncontrast head CT.  \nSpecifically no\nintracranial hemorrhage.\n\nCXR \n\nEXAMINATION:\nChest:  Frontal and lateral views\n \nINDICATION:  ___ year old woman with fall found to have elevated \nWBC.  // Eval\nfor cardiopulmonary process\n \nTECHNIQUE:  Chest:  Frontal and Lateral\n \nCOMPARISON:  ___\n \nFINDINGS: \n \nThe patient is somewhat rotated.  The lungs remain \nhyperinflated.  Biapical\npleural thickening is noted.  No new focal consolidation is \nseen.  No pleural\neffusion or pneumothorax is seen. The cardiac and mediastinal \nsilhouettes are\nstable.  Partially imaged bilateral humeral prostheses noted.\n \nIMPRESSION: \n \nNo acute cardiopulmonary process.\n\nMICRIOBIOLOGY\n========================\n\nAllergies: morphine / Keflex\nResident: ___ ___ Intern: ___ ___\nCode Status: Do not resuscitate (DNR/DNI) molst in chart\nMicrobiology Results(last 7 days) ___\n__________________________________________________________\n___ 10:13 am URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n \n\n \nBrief Hospital Course:\n___ pleasant year old female s/p recent left hip revision \nhemiarthoplasty presents from nursing home with mechanical fall, \nfound to have profound hyponatremia (118) and likely UTI, and \n___. It was determined patient likely had prerenal ___ prior to \nadmission, and during hospital stay while hyponatremika improved \nfrom 118 to 128 source of hypoantremia remained unclear, with \nbelief being patient may have suffered from SIADH vs reset \nosmostat. Patient discharged on 1 L fluid restriction with plans \nfor close PCP followup, and her home SSRi was stopped.  \n\nHOSPITAL COURSE BY ISSUE\n==================\n#Hyponatremia: Likely chronic in setting of poor po intake, \npossible volume down, and confusion from UTI. initially patient \nwas fluid restricted for concern siadh. Patient was given 500 cc \nboluses but now with ___ improvement 118 on admission to 129, \nleading team to believe hypovolemic hyponatremia in setting of \npoor po intake after recent hip surgery as cause. However, \npatient then subseqeutnly had drop in ___, with urine osmolality \nshowed ~ 400. AS a result, patient was fluid restricted, with ___ \nhovering around ~140, with resolution ___ below. Ultimately it \nwas determined as despite fluid boluses and fluid restriction \nand given lack of symptoms, patient may have had a reset \nosmostat as well. Her home fluoxetine was stopped, and TSH was \nchecked at 12 (FT4 1.0); home synthroid was uptitrated to 75 mcg \nfrom 50mcg as a result.   \n\n# UTI, leukocytosis: CXR clear. WBC 13.4 on admision, ~ 7 on \n___ after treating uti. Patient was on bactrim ___t \n___ for unclear reason, switched to cipro in house. patient \nafebrile, has some hesitancy symptoms, mild positive u/a. \nLeukocytosis now improving. Urince cultures were negative but \ngiven fact patient came in on bactrim and improvement in WBC \ncontinued cipro /17, d7 = ___ given improvement since starting \nantibx\n\n___: Cr 1.4 from 1.0 baseline, likely pre renal. It was \nbelieved she ahd a prerenal ATN immediately prior to admission \nas while giving her fluidis initially during her stay helped her \n___ it worsened her Cr. However, by discharge, Cr had started to \ndowntrend to 1.2. \n\n# Hypertension: Home lisinopril was held due to ___ above. She \nwas intermittently hypertensive overnight in the setting of \npain. She recieved oxycodone prn as below.  \n\n#Trauma workup s/p mechanical fall: Hip x-rays Negative, no \nfractures. Patient s/o ___ left hip hemiarthoplasty (left \nhip s/p hip replacement ___ years prior) Pain control with \noxycodone. \n\n# Hx depression: Continued hoem fluoxetine, then stopped ___ \npossible SIADH above \n\n# Hypothyroid: Continued home synthroid. TSH in house was 12; \nhowever free T4 was wnl. ___ hypothyroidism as possible \netiology of hypoantremia above, patient was uptitrated to 75 mcg \nsynthroid on d/c. \n\n# Osteoporosis: Continued calcium, vitamin D \n\n# Pain control: Continued home meds save for hydromorphone; \nswitched to oxycodone prn, can switch back on d/c. \n\nTRANSITIONAL ISSUES\n==============================\n-Patient to end ciprofloxacin on ___\n-Please check ___, Cr at next PCP appointment, ___ on d/c 128, \n1.2\n-Patient used short term oxycodone in house; she can resume her \nprior pain regimen thereafter. Rx short course to last until PCP \nfollowup as patient feared ALF would require rx to fill.  \n-Patient's home lisinopril discontinued, if Cr returns to normal \non d/c woul restart\n-Home synthroid increased to 75 mcg from 50 mcg given TSH of 12 \n(elevated) and hyponatremia above (however free T4 1). Given \njust subclinical hypothyroidism on labs; would recheck TSH and \nFree T4 in 3 weeks; if patient hyperthyroid decrease synthroid \nback to 50 mcg. \n-Patient's home SSRI stopped due to hyponatremia above. \n-Patient discharged on 1 L fluid restriction; if patient appears \ndry on F/U appointment and ___ improving, would liberalize \nrestriction. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Calcium Carbonate 600 mg PO DAILY \n2. Docusate Sodium 100 mg PO BID \n3. Gabapentin 600 mg PO TID \n4. Levothyroxine Sodium 50 mcg PO DAILY \n5. Lisinopril 2.5 mg PO DAILY \n6. Lorazepam 1 mg PO BID:PRN anxiety \n7. Multivitamins 1 TAB PO DAILY \n8. Omeprazole 20 mg PO DAILY \n9. Senna 8.6 mg PO BID:PRN constipation \n10. TraZODone 100 mg PO QHS \n11. Vitamin D ___ UNIT PO DAILY \n12. Acetaminophen 1000 mg PO Q8H \n13. Denosumab (Prolia) 60 mg SC Q6MONTHS \n14. Fluoxetine 20 mg PO DAILY \n15. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \n16. Fiber (calcium polycarbophil) (calcium polycarbophil) 625 mg \noral DAILY \n17. Ferrous Sulfate 325 mg PO DAILY \n18. Voltaren (diclofenac sodium) 1 % topical BID \n19. Sulfameth/Trimethoprim DS 1 TAB PO BID \n20. Hydrocodone-Acetaminophen (5mg-325mg) 1 TAB PO DAILY:PRN \npain \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nHypovolemic Hyponatremia\nUTI\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou came to the hospital because you fell. At the hospital, it \nwas determined that you had no fractures but your sodium was \nvery low, and our medical team felt you were dehydrated. In the \nhospital we gave your IV fluids and your sodium improved. We ask \nthat you follow up with your primary care physician to monitor \nyour sodium level and kidney function. We also also discharging \nyou with a short taper of oxycodone for pain in your hip; after \nthis you should go back on the pain regimen your assisted living \nfacility is giving you. Lastly, we are giving you an antiobiotic \nfor a possible UTI (you were taking another antibitotic at home \nwhich we changed). This antibiiotic is called ciprofloxacin, and \nyou will take it until ___.  \n\nWe wish you all the best!\n-You ___ Care Team\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13839476","hadm_id":"27356429","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \n___\n \nAttending: ___.\n \nChief Complaint:\nshortness of breath\n \nMajor Surgical or Invasive Procedure:\nAnterior Thoracentesis ___\nDrainage of Posterior Left Pleurex Catheter ___\n\n \nHistory of Present Illness:\n___ with metastatic thyroid cancer and hx of pleural effusion, \nwho presented with dyspnea. She has had a mild non-productive \ncough since the pigtail catheter was placed, but has noted that \nover the last 2 days she has had increasing dyspena, and feels \nfatigued. She denies fevers, chills, chest pain, pain with deep \nbreathing. Overall it appears that there has been a decline in \nthe output of her pleurex ___ three times weekly).  \n.  \nPatient recently stopped sorafenib as she has had disease \nprogression and there are no plans for futher treatment \n(chemotherapy might be a future option). CT chest ___ reveals \nmoderate sized, left-sided, loculated pleural effusion. Patient \nhad thoracentesis ___ with minimal relief. On ___ she saw \nher pulmonologists who put TPA into the pleural space via the \npleurx catheter with 150 ml out.  \n\n \nPast Medical History:\nMetastatic papillary thyroid cancer s/p thyroidectomy, RAI\nHypoparathyroidism with hypocalcemia\nidiopathic dilated cardiomyopathy (now resolved)\nh/o LV thrombus\nAfib s/p DCCV\nHiatal hernia\nErosive gastritis\ns/p varicose vein stripping\ns/p tonsillectomy\n\n \nSocial History:\n___\nFamily History:\nNon-contributory\n \nPhysical Exam:\nVitals: T:95.7 BP:109/47 P: R:20 O2: 92% on RA  \nGeneral: Alert, oriented, no acute distress.  \nHEENT: Sclera anicteric, MMM, oropharynx clear.  \nNeck: supple, JVP not elevated.  \nLungs: Decreased/No breath sounds left lung, right lung clear. \nLeft pleurex catheter without surrounding erythema.  \nCV: Regular rate and rhythm, no murmurs.  \nAbdomen: soft, non-tender, non-distended, bowel sounds positive. \n \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n\n \nPertinent Results:\n___ 01:20PM BLOOD WBC-12.3*# RBC-3.74* Hgb-11.3*# Hct-34.2* \nMCV-92 MCH-30.2 MCHC-33.0 RDW-14.7 Plt ___\n___ 01:20PM BLOOD Neuts-83.3* Lymphs-6.7* Monos-6.9 Eos-2.8 \nBaso-0.2\n___ 01:58PM BLOOD ___ PTT-24.7 ___\n___ 01:20PM BLOOD Glucose-108* UreaN-22* Creat-1.0 Na-141 \nK-4.7 Cl-101 HCO3-27 AnGap-18\n___ 01:20PM BLOOD Calcium-7.7* Phos-3.9 Mg-2.1\n___ 04:50PM PLEURAL WBC-120* ___ Polys-40* \nLymphs-10* Monos-17* Eos-23* Meso-1* Macro-9*\n___ 04:50PM PLEURAL TotProt-4.2 Glucose-57 Creat-0.8 \nLD(LDH)-939 Amylase-71 Albumin-2.5\nCXR:\nAP PORTABLE CHEST ___ AT 12:58 P.M. \n  \nHISTORY: Dyspnea with left-sided chest tube. \n  \nCOMPARISON: Multiple priors, the most recent dated ___. \n  \nFINDINGS: Compared to the ___ PET-CT, there has been \nprogressive enlargement of the effusion and progressive \nrightward mediastinal shift on all successive radiographs \nincluding today's. There is near complete opacification of the \nleft hemithorax with only a small residual aerated lung noted \nlaterally in the lower aspects of the hemithorax in the region \nof the indwelling pleural drain. The right lung is largely \nclear. The mediastinum cannot be adequately assessed. The \nosseous structures are grossly unremarkable. \n  \nIMPRESSION: Massive left pleural effusion with near-complete \nopacification of the left lung as above. \nCT Chest:\nCOMPUTED TOMOGRAPHY OF THE THORAX \n  \nINDICATION: Worsening malignant effusion, potential loculations. \n\n  \nTECHNIQUE: Volumetric thin section CT over the entire thorax in \ninspiration, \nno administration of contrast material, multiplanar \nreconstructions. \n  \nCOMPARISON: PET-CT of ___. \n  \nFINDINGS: The pre-existing left-sided fluid collection has \nincreased in \nextent. It now occupies most of the volume of the left \nhemithorax. In the \nbasal dorsal regions of the fluid collection, a single septation \nis seen. \nOtherwise, no septations or loculations can be visualized. The \nfluid is \ncontained in a sac of thickened and hypodense pleura. At the \nbasolateral \nparts of this pleural site, a laterally positioned drain is \nvisualized. The pleural sac displaces the mediastinum to the \nright. Several high density and enlarged lymph nodes are seen, \nnotably at the ventral circumference of the pleural sac, at the \nlevel of the aortic arch and in the aortopulmonary window. \nSimilar structures are also seen in the subcarinal region. Mild \npericardial effusion, small hiatal hernia. In the right lung, a \nsmall subpleural nodules has newly occurred (3,17). No other \nlung lesions are seen. \n  \nIMPRESSION: Increase of the left fluid collection that shows a \nsingle \nloculation in the dorsal basal area. Massively thickened nodular \npleura. \nExtensive mediastinal and perilesional lymphadenopathy. Massive \ndisplacement of the mediastinum. Newly appeared right lung \nnodules. \n\n \nBrief Hospital Course:\nIn the ED, initial vs were: T 97, HR 100, BP 142/66, RR 16, Sat \n99% ra. U/S with effusion. CXR with L whiteout. CT chest with \nnew anterior effusion. Patient was discussed with IP who said \nthey would see the patient on the floor. Patient remained stable \non room air.  \n.  \n \n.\n# Dyspnea: Given imaging, likely ___ lung collapse from \nworsening malignant pleural effusion. The effusion appears to \nhave an anterior and posterior compartment. The posterior \ncompartment is being drained by her pleurex which is working \nappropriately. On arrival the the floor the patient was seen by \n___. They noted that her posterior pigtail was draining well. \nThey did an anterior thoracentesis and drained 1.1L of \nserosanguinous fluid.  IP was concerned for bleeding into her \npleural cavity, but thoracentesis is serosangionous so more \nlikely malignant effusion. No fever, chills or leukocytosis \nconcerning for infection.  The patient's repeat CXR \npost-thoracentesis showed mild improvement in aeration and \nmediastinal shift.  The follow up CXR from day after \nthoracentesis showed reaccumulation of the fluid.  The patient \nhad no 02 requirement and 02 sat ranged 93-100%.  \n-will f/u with IP the week of discharge for likely drain \nplacement. \n.  \n# Thyroid Cancer: Spoke to patient's outpatient oncologist and \nthe patient has failed sorafenib, her only future option would \nbe chemo. However, per her outpatient PCP notes, the patient is \nnot interested in future chemo.  \n-outpatient ONC follow up.  \n.  \n# Hypoparathyroidism with hypocalcemia:  Patient continued on \nhome calcitriol and calcium.  Calcium 7.7 on DOA.\n.\n#Paroxysmal Atrial Fibrillation: Patient not anticoagulated as \noutpatient.  She was continued on 200 amiodarone daily and \nmetoprolol.  \n.  \n# Hypothyroidism:  Patient continued on levothyroxine. \n.  \n# Anemia: Patient's HCT decreased by 6 overnight.  CXR was \nrepeated and did not show evidence of hemothrorax.  Repeat HCT \nincreased so likely lab error and dilutional effect of IVF.  \nAlso, patient had some mild bleeding with thoracentesis.\n \nMedications on Admission:\nAmiodarone 200 mg alternating with 100 mg daily,  \nCalcitriol 0.25 mcg daily,  \nLevothyroxine 0.125 mg tablets  \nMetoprolol 25 mg b.i.d.  \nProchlorperazine 10 mg every four hours as needed for nausea,  \nCalcium 3 g daily,  \nLoperamide as needed  \n\n \nDischarge Medications:\n1. Levothyroxine 125 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n2. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).  \n3. Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO \nQ6H (every 6 hours) as needed for nausea/vomiting.  \n4. Calcitriol 0.25 mcg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n5. Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Calcium Carbonate 500 mg Tablet, Chewable Sig: Two (2) \nTablet, Chewable PO TID (3 times a day).  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nMalignany Left Pleural Effusion\nParoxysmal atrial fibrillation  \ntachycardia-mediated cardiomyopathy (now resolved)  \nMetastatic papillary thyroid cancer \nHypoparathyroidism with hypocalcemia  \n\n \nDischarge Condition:\nStable on room air, not short of breath, decreased/no breath \nsounds on left, \n\n \nDischarge Instructions:\nYou came to the hospital with shortness of breath.  We found \nthat your left lung was collapsed from fluid builing up.  Our \ninterventional pulmonologists drained the fluid from your lung \nand you remained stable.  We would like you to follow up with \nyour pulmonologists very closely for management.\n.\nWe made NO changes to your medications.\n.\nPlease follow up with your doctors as below.  The pulmonary \ndoctors ___ on ___ to schedule your follow up \nappointment.  If you do not hear from them, please call the \npulmonary clinic on ___.\n.\nIf you have worsening shortness of breath, fever, chills, chest \npain, blood in your sputum, back pain, nausea, vomiting or any \nother symptoms that are concerning to you please call your \ndoctor or come to the emergency room.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10442795","hadm_id":"25135363","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain, BRBPR, nausea/vomiting\n \nMajor Surgical or Invasive Procedure:\nEGD ___\nColonoscopy ___\n\n \nHistory of Present Illness:\nHPI(4): Ms. ___ is a ___ female with a history of\nCrohn's colitis s/p terminal ileum resection ___ and colectomy\nin ___ who presented with abdominal pain and BRBPR.\n\nAbout 2 days ago on ___, she started to have dark-colored\nstools, which are very unusual for her, and then BRBPR (drops of\nblood in the toilet and blood on the toilet paper). At baseline,\nshe normally has ___ stools a day, but sometimes it goes up to\n___. She feels like her frequency of stooling is slightly \nabove\nbaseline and greater than 10 per day. At the same time that she\ndeveloped the bloody stools, she started to have LLQ pain as \nwell\nas rectal pain. The pain is both aching and sharp, constant, and\nnon-radiating. It does feel like her Crohn's. Nothing makes it\nsignificantly better or worse. The pain has been associated with\nnausea and vomiting. She has had a few bouts of emesis with\nbright red blood. Her last PO intake was a shake on ___\nafternoon. On ___ she was able to eat a meatball and some\ncarrots. \nShe woke up sweaty and hot on ___ night. She did not take\nher temperature.\n\nHer frequency of stooling has been at her baseline of ___ stools\nper day. She also started to have LLQ pain associated with\nnausea, vomiting, and coffee-ground emesis. She has only been\nable to take in Pedialyte for the past 2 days. She has been\nhaving subjective fevers at home.\n\nSince arrival in the ED, her pain is unchanged. She feels a\nlittle less nauseated since receiving antiemetics and pain meds. \n\n\nShe denies lightheadedness, dizziness, chest pain, shortness of\nbreath, or palpitations. No coughing. No dysuria. No rashes or\nskin changes. No lower extremity edema. She has been walking\naround without issues.\n\nFor her Crohn's, she is followed by Dr. ___ at the\n___. She last saw her about 6 months ago and had a\nsigmoidoscopy which appeared normal. \nCurrently she takes nutraceutical supplements for her Crohn's.\nThe last time she was on therapy for her Crohn's was ___ years\nago when she was on Remicaide. It worked well for her Crohn's \nbut\nshe developed sinus infections so discontinued it. Her Crohn's\nhas been in remission since then.\nPrior to Remicaide she was on ___, and prior to that she was on\nPentasa. \n\nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative.\n\nED COURSE:\nVS: Tmax 98.6, HR ___, BP ___, RR ___, SpO2\n96-100% on RA\nExam: Exam notable for significant LLQ TTP w/o R/G.\nLabs: CBC wnl, chem7 wnl, AST 98 otherwise LFTs wnl, lipase 61,\nCRP 1, UA bland\nImaging: CT abd/pelvis with contrast: s/p total colectomy, no\nbowel obstruction\nInterventions:\n - morphine 4 mg IV x2\n - ondansetron 4 mg IV x2\n - normal saline 1L x2\n - hydromorphone 0.5 mg IV x3\n - paroxetine 40 mg PO x1\n - pantoprazole 40 mg IV x1\n - Lorazepam 0.5 mg IV x1\nConsultants: GI - initial recommendations:\n -Please send CRP \n -IV PPI\n -If clinical concern for SBO would have low threshold to place\nNGT to Low intermittent suction especially given report of\nemesis.\n -NPO for now, IVF\n \nPast Medical History:\nCrohn's s/p terminal ileum resection ___ and colectomy in ___\nDepression and anxiety\n \nSocial History:\n___\nFamily History:\nReviewed and found to be not relevant to this illness/reason for \nhospitalization.\n \nPhysical Exam:\nADMISSION EXAM(8)\nVITALS: T 98.4, HR 94, BP 112/69, RR 16, SpO2 96% on RA\nGENERAL: Alert, NAD, appears comfortable laying in bed\nEYES: Anicteric, PERRL\nENT: mmm, OP clear\nCV: NR/RR, no m/r/g\nRESP: CTAB, no wheezes, crackles, or rhonchi\nABD/GI: Soft, ND, TTP in LLQ without guarding or rebound\ntenderness, normoactive bowel sounds\nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nVASC/EXT: No ___ edema, 2+ DP pulses\nSKIN: No rashes or lesions noted on visible skin\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nmoves all limbs \nPSYCH: pleasant, appropriate affect\n\nDISCHARGE EXAM:\n98.8 PO 115 / 77 76 18 97 RA \nGENERAL: Alert, NAD, appears comfortable laying in bed\nEYES: Anicteric, PERRL\nENT: mmm, OP clear\nCV: NR/RR, no m/r/g\nRESP: CTAB, no wheezes, crackles, or rhonchi\nABD/GI: Soft, ND, mild TTP in LLQ without guarding or rebound \ntenderness, normoactive bowel sounds\nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nVASC/EXT: No ___ edema, 2+ DP pulses\nSKIN: No rashes or lesions noted on visible skin\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nmoves all limbs \nPSYCH: pleasant, appropriate affect\n \nPertinent Results:\nADMISSION LABS:\n___ 02:45AM BLOOD WBC-6.3 RBC-4.14 Hgb-13.2 Hct-40.0 MCV-97 \nMCH-31.9 MCHC-33.0 RDW-13.6 RDWSD-48.2* Plt ___\n___:45AM BLOOD Glucose-84 UreaN-14 Creat-0.8 Na-135 \nK-6.7* Cl-100 HCO3-24 AnGap-11\n___ 02:45AM BLOOD ALT-30 AST-98* AlkPhos-80 TotBili-0.2\n___ 02:45AM BLOOD Albumin-4.7\n\nIMAGING:\nCT ABD/PELVIS:\n1. No findings to explain the patient's symptoms.  Specifically, \nno bowel obstruction.\n2. Status post total colectomy.\n\nEGD: Mild gastritis likely due to NSAID use. \n\nColonoscopy: Mild stable ulcer in the rectum previously biopsied \nwith outpatient GI provider. No other findings. \n\nDISCAHRGE LABS: \n___ 06:55AM BLOOD WBC-4.5 RBC-3.37* Hgb-10.7* Hct-33.2* \nMCV-99* MCH-31.8 MCHC-32.2 RDW-13.5 RDWSD-48.6* Plt ___\n___ 06:45AM BLOOD Glucose-83 UreaN-8 Creat-0.7 Na-142 K-3.9 \nCl-106 HCO3-29 AnGap-7*\n \nBrief Hospital Course:\n___ female with a history of Crohn's colitis s/p \nterminal ileum resection ___ and colectomy\nin ___ who presented with abdominal pain and BRBPR.\n\n# Crohn's colitis\n# LLQ abdominal pain\n# BRBPR\n# Nausea/vomiting, ?hematemesis \nUnclear etiology of abdominal pain, BRBPR, and nausea/vomiting. \nThe patient has had recent work up at ___ without clear \netiology. CRP is 1. CT abd/pelvis was unrevealing for etiology \nof the patient's pain and symptoms. GI consulted and \nEGD/Colonosocppy was negative unremarkable. She was tapered off \nopiate pain medication given lack of source for pain. She was \noffered non-narcotic pain control with acetaminophen, bentyl, \nsimethicone, and gabapentin. She reported continued nausea and \npain at tme of discharge but was hemodynamically stable and able \nto tolerate PO and maintain hydration without need for IV \nfluids. She reported nausea but no vomiting. \n\nCHRONIC/STABLE PROBLEMS:\n# Anxiety/depression - Continued home mirtazapine and paroxetine \n\n\nGreater than 30 minutes was spent in care coordination and \ncounseling on the day of discharge. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Mirtazapine 15 mg PO QHS \n2. PARoxetine 40 mg PO DAILY \n3. VSL#3 (Lactobac #2-Bifido #1-S. therm) 112.5 billion cell \noral DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO TID \nRX *acetaminophen 500 mg 2 tablet(s) by mouth three times a day \nDisp #*50 Tablet Refills:*0 \n2.  DICYCLOMine 10 mg PO TID \nRX *dicyclomine 10 mg 1 tablet(s) by mouth three times a day \nDisp #*30 Capsule Refills:*0 \n3.  Gabapentin 300 mg PO TID \nRX *gabapentin 300 mg 1 capsule(s) by mouth three times a day \nDisp #*60 Capsule Refills:*0 \n4.  Omeprazole 20 mg PO DAILY \nRX *omeprazole 20 mg 1 capsule(s) by mouth once a day Disp #*28 \nCapsule Refills:*0 \n5.  Ondansetron ODT 4 mg PO Q8H:PRN Nausea/Vomiting - First Line \n\n  Reason for PRN duplicate override: Alternating agents for \nsimilar severity\nRX *ondansetron 4 mg 1 tablet(s) by mouth Every 8 hours as \nneeded Disp #*10 Tablet Refills:*0 \n6.  Mirtazapine 15 mg PO QHS  \n7.  PARoxetine 40 mg PO DAILY  \n8.  VSL#3 (Lactobac #2-Bifido #1-S. therm) 112.5 billion cell \noral DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAbdominal Pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs ___, \n\nIt was a pleasure taking care of you while you were in the \nhospital. You were admitted with abdominal pain and underwent an \nevaluation for the cause. You underwent an EGD and Colonoscopy \nto evaluate the cause. This did not show a cause of your pain \nthat would need intervention. You were tapered off of the \nnarcotic pain medication and started on several other \nmedications for your pain. \n\nPlease take you medications as directed and follow up as noted \nbelow. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"19710506","hadm_id":"24974443","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nback pain x 1 week\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ y/o male with prostate ca, DM II, and spinal stenosis who was \nin his usual state of health until last month.  He states that \nhe was ambulatory and able to enjoy activities such as golf just \nover a month ago, but that his back pain started to become worse \nsuch that he had difficulty ambulating, leading to an epidural \ninjection on ___.  The pain was ___, sharp, constant, over \nhis back and down his right leg, and not positional.  He does \nnote that his pain improves with resting.  Per pt, the last time \nhe received an epidural injection was over ___ yrs ago.  He has \ndenied significant back pain until this recent episode.  Pt \ndenies recent trauma, fevers, chills, night sweats.  Pt was seen \nat ___ and transferred for spine evaluation.  \n.\nIn the ED, vitals: 97.2, 85, 157/48, 16, 96 RA.  MRI spine was \nunchanged from prior ___ exam.  Abd U/S done to evaluate aorta \nwhich was normal.  Pt also had HCT at ___ which was normal, \ndue to some question of confusion/AMS.\n.\nOn the medical floor, VSS and patient reporting only mild back \npain.\n \nPast Medical History:\n-HTN \n-HLD\n-DM\n-Carotid stenosis\n-h/o TIA\n-prostate cancer s/p resection\n-___ colonoscopy \"lymphocytic colitis\"\n \nSocial History:\n___\nFamily History:\nmother was \"anemic\" and had heart disease. His father died of \nbladder cancer. Brother died of pancreatic cancer.\n \nPhysical Exam:\nVITALS: T 97.6, HR 70, BP 154-159/68-71, RR 20, ___ 98 RA  \nGeneral: elderly gentleman, pale, in no significant distress; \nspeaking and moving comfortably, alert to name and place not \ntime \nHEENT: MMD, OP clear\nNeck: no LAD \nChest: CTAB\nHeart: RRR, nl S1S2, no m/r/g\nAbdomen: soft, nt, nd, NABS\nExtremities: thin, no c/c/e, warm\nBack: minimally tender over paraspinal muscles near L4/L5\nNeuro: oriented to name and place but not time, 4+/5 strength \nRLE, ___ strength LLE, upper extremities ___ strength, normal \nsensation, downgoing babinski, neg straight leg test\nRectal: normal rectal tone\n \nPertinent Results:\nSodium on discharge was 130\nCr on discharge was 0.7\n.\nMRI FINDINGS: Alignment of the lumbar spine is normal. Bone \nmarrow signal in the vertebral bodies is homogeneous except L5, \nwhere there is an area of T2 hyperintensity/T1 hypointensity \nseen on the previous study that may possibly represent \nhemangioma. The distal spinal cord and conus medullaris appear \nnormal. The conus terminates at the T11/T12 level. No intradural \nabnormalities are seen nor are any fluid collections seen in the \nepidural space.\n.\nL2-L3: There is intervertebral disc desiccation without \nherniation. There is no spinal stenosis or neural foraminal \nnarrowing. The facet joints are noted to be hypertrophic. \n.\nL3-L4: Desiccation of the intervertebral disc without protrusion \nis noted. There is no spinal stenosis or neural foraminal \nnarrowing. The facet joint are hypertrophy. \n.\nL4-L5: There is intervertebral disc desiccation with mild \nposterior disc \nprotrusion causing mild spinal canal stenosis, thickening of the \nligamentum flavum is also contributing. The articular facet \njoints are hypertrophied, causing mild bilateral neural \nforaminal narrowing. \n.\nL5-S1: There is intervertebral disc desiccation with mild \nbulging and \nposteriorly causing mild spinal stenosis along with a thickened \nligamentum flavum. The facet joints are hypertrophied and there \nis mild bilateral neural foraminal narrowing.\n. \nRETROPERITONEUM: The aorta and vena there are normal appearing. \nThe kidneys are grossly normal appearing. \n.\nThere is no abnormal enhancement after contrast administration. \nThe SI joints are normal. \n.\nIMPRESSION: \n.\nMultilevel degenerative changes with mild spinal stenosis at \nL4-L5 and L5-S1, stable hemangioma at L5, no significant change \nfrom previous study. No new fluid collections. \n.\n___ 07:55AM   GLUCOSE-184* UREA N-45* CREAT-1.1 SODIUM-129* \nPOTASSIUM-5.0 CHLORIDE-100 TOTAL CO2-23 ANION GAP-11\n___ 07:55AM   estGFR-Using this\n___ 07:55AM   WBC-6.1 RBC-3.42* HGB-11.0* HCT-31.6* MCV-93 \nMCH-32.0 MCHC-34.7 RDW-13.7\n___ 07:55AM   NEUTS-64.5 ___ MONOS-5.1 EOS-0.3 \nBASOS-0.4\n___ 07:55AM   PLT COUNT-211\n___ 07:55AM   ___ PTT-28.5 ___ y/o male with hx of spinal stenosis, who was without back \npain until ___, who now presents with acute back pain x 1 \nweek after epidural injection on ___.\n.\n1. Back pain - without red flags such as bowel \nincontinence/saddle anesthesia and with normal rectal tone. DDX \nincluded infection such as abscess, diskitis or osteomyelitis \nfrom potential seeding after his epidural injection (though less \nlikely with unchanged MRI and physical exam). Less likely items \non the differential included cauda equina (unlikely in this pt \nwithout saddle anesthesia, bilateral sciatica, leg weakness, \nnegative MRI, normal rectal tone).  Of note, we considered \nrecurrent prostate cancer on the DDX; however, patient has been \nbiochemically disease free following his hormonal therapy, as \nper heme/onc notes in ___. Most likely etiology was felt \nto be progression of patient's spinal stenosis, despite \nunchanged MRI findings.  Initially attempted pain control with \ntylenol, but patient's pain adequately controlled on ultram 50 \nmg q4 hours and ibuprofen 600 mg q6 hours prn with lidocaine \npatch.  Patient will be discharged on this regimen, and will \nhave close follow-up with his primary care doctor.\n.\n2. ?Mental status changes/confusion - during initial exam, pt \noriented to person and place, but not time but otherwise able to \ncarry on appropriate conversation.  Had HCT at ___ for \nsimilar sx, which was read as no acute intracranial abnormality. \n No hx of baseline dementia.  Hyponatremia may have been \npossible contributor, as his mental status improved throughout \nhospitalization.  After initial exam, patient did not exhibit \nany disorientation for the remainder of his hospitalization.  We \nalso avoided narcotics in this patient who has had prior AMS \nwith narcotics.\n.\n3. Hyponatremia - Na 129 on admission.  Pt initially fluid \nchallenged for suspected dehydration, without Na correction and \ndownward trend.  Urine lytes were much more consistent with a \nSIADH picture (high Uosm, high UNa).  With salt tablets and free \nwater restriction to 1500 mL/day, pt's sodium corrected.  \nDischarge Na 130.  Pain may have contributed to part of the \nSIADH picture, although pain was adequately controlled for past \nseveral days prior to d/c.  Hypervolemic conditions (including \ncirrhosis, nephrotic dz, cardiac dz) leading to low Na much less \nlikely given physical exam and laboratory values.\n.\n4. HTN - stable and well controlled at home on current regimen.  \nPt was continued on amlodipine, atenolol, hydralazine, \nlisinopril, valsartan at home doses (pt on ACEi and ___ as per \nnephrology).\n.\n5. DM - stable, last A1c 6.9 per my records.  Pt was continued \non home dose insulin lantus 12U at night with qid accuchecks and \nISS.\n.\n6. Hypothyroidism - stable, last TSH 0.71 as per my records.  \nSynthroid was continued as per home dose.\n.\n7. h/o TIAs - stable, without active issues.  Aggrenox and \naspirin were continued as per neurology.\n.\n8. HLD - last LDL 54 as per my records.  Simvastatin 80 mg was \ncontinued (home regimen).\n.\n9. h/o \"lymphocytic colitis\" - as seen on colonoscopy, denies \nconcerns.  Mesalamine continued at home regimen dose.\n.\n10. h/o prostate cancer s/p resection - no evidence of \nbiochemical disease, as per most recent heme/onc note in ___.  To be followed-up by PCP and heme/onc.\n \nMedications on Admission:\n-amlodipine 10 mg Tablet - 1 Tablet(s) by mouth once a day\n-atenolol - 25 mg Tablet - 0.5 Tablet(s) by mouth once a day\n-aggrenox - 25 mg-200 mg Cap, Multiphasic\nRelease 12 hr - 1 Cap(s) by mouth twice a day\n-hydralazine 25 mg Tablet - 3 Tablet(s) by mouth three times a\n-INSULIN GLARGINE - 12 units at bedtime, per pt\n-INSULIN LISPRO [HUMALOG] -  (Prescribed by Other Provider: Dr\n___ - 100 unit/mL Solution - TID as directed\n-synthroid - 88 mcg Tablet - 1 Tablet(s) by mouth\nonce a day\n-lisinopril - 40 mg Tablet - 1 Tablet(s) by mouth once a day\n-mesalamine - 400 mg tablet, 4 tabs by mouth, twice a day\n- simvastatin - 80 mg Tablet - 1 Tablet(s) by mouth at bedtime\n-valsartan - 160 mg Tablet - 1 Tablet(s) by mouth twice a day\n-aspirin - 81 mg po qday\n \nDischarge Medications:\n1. Atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n2. Tramadol 50 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 \nhours) as needed for back pain.\nDisp:*30 Tablet(s)* Refills:*0*\n3. Valsartan 160 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n5. Mesalamine 400 mg Tablet, Delayed Release (E.C.) Sig: Four \n(4) Tablet, Delayed Release (E.C.) PO BID (2 times a day).  \n6. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n7. Levothyroxine 88 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n8. Dipyridamole-Aspirin 200-25 mg Cap, Multiphasic Release 12 hr \nSig: One (1) Cap PO BID (2 times a day).  \n9. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  \n\n10. Hydralazine 25 mg Tablet Sig: One (1) Tablet PO every six \n(6) hours.\nDisp:*120 Tablet(s)* Refills:*0*\n11. Insulin Glargine 100 unit/mL Solution Sig: 12 units at \nbedtime units Subcutaneous once a day.  \n12. Sodium Chloride 1 gram Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).\nDisp:*20 Tablet(s)* Refills:*0*\n13. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily).\nDisp:*30 Adhesive Patch, Medicated(s)* Refills:*2*\n14. Insulin Glargine 100 unit/mL Solution Sig: Twelve (12) units \nSubcutaneous at bedtime.  \n15. Insulin Lispro 100 unit/mL Solution Sig: per sliding scale  \nSubcutaneous four times a day.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___:\nPrimary:\nSpinal stenosis\nHyponatremia\nHypertension\n.\nSecondary:\nDiabetes\nHistory of Prostate cancer \n\n \nDischarge Condition:\ngood, ambulating with some support, home ___ services\n\n \nDischarge Instructions:\nYou were admitted to the hospital for acute back pain.  Repeat \nMRI was similar to your prior one from ___, showing spinal \nstenosis, without evidence of infection or nerve compression.  \nYour back pain was felt to be related to your spinal stenosis, \nwithout other contributing factors.  You were placed on ultram \nand ibuprofen for pain control.  \n.\nYour sodium level was low while in the hospital.  We believe \nthis is likely related to the effect of your back pain hormones \nreleased from the brain that regulate body fluid balance. After \nrestricting your fluid intake, giving you salt tabs, and \ncontrolling your back pain your sodium has improved.\n.\nNEW MEDICATIONS:\n--Sodium Chloride 1 gram by mouth twice a day\n--Ultram 50 mg: this is a pain medication. avoid driving or \noperating heavy machinery while using this medication.\n--Lidocaine patch: apply for no longer than 12 hours per day\n.\nMEDICATION CHANGES:\n--Atenolol increased to 25mg daily\n--Hydralazine changed to 25 mg four times per day\n.\n***Please drink no more than 1.5 liters of fluid per day****\n.\nWhile you were admitted, physical therapy worked with your \nambulation and back pain.  Upon discharge, you were ambulating \nwith some assistance, and you will be discharged home with ___ \nservices. We also recommend that you have outpatient physical \ntherapy.\n.\nIf you experience fevers, chills, night sweats, dizziness, \nfalls, chest pain or shortness of breath please contact your \nprimary care physician or go to the emergency department for \nevaluation.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19880882","hadm_id":"25252749","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nMajor Surgical or Invasive Procedure:\nNone\n\nattach\n \nPertinent Results:\nLabs:\n___ 08:50PM BLOOD WBC-4.1 RBC-4.21 Hgb-12.3 Hct-38.4 MCV-91 \nMCH-29.2 MCHC-32.0 RDW-13.1 RDWSD-43.3 Plt ___\n___ 08:50PM BLOOD Glucose-101* UreaN-15 Creat-0.8 Na-142 \nK-3.9 Cl-105 HCO3-25 AnGap-12\n___ 12:00AM BLOOD Triglyc-78 HDL-56 CHOL/HD-2.8 LDLcalc-84\n \nBrief Hospital Course:\nMs. ___ is a ___ ___ woman with HLD presenting\nwith chest pain that radiated from left shoulder pain that has \nbeen going on for 2 weeks. She underwent a stress ECHO test that \ndid not show any wall motion abnormalities and was an otherwise \nnormal test. She will be discharged with PCP follow up for \nshoulder pain, which possibly represents underlying impingement \nsyndrome. \n\nTRANSITIONAL ISSUES:\n===================\n[ ] Continued management and workup of left shoulder pain.\n\n=============== \nACTIVE ISSUES: \n=============== \n#Atypical Chest pain\n#Concerns for unstable angina\nPatient is presenting with chest pain over the past 2.5 weeks\nthat has occurred both at rest and with exertion, but radiates\nfrom left shoulder around to center part of chest. Negative\nbiomarkers and lateral TWI that are stable from priors. Risk\nfactors include HLD. She was admitted and underwent stress ECHO \ntest which showed good exercise capacity and the echo did not \nshow any evidence of wall motion abnormalities. She will be \ndischarged with close PCP ___ for further management of \nher shoulder pain.\n\n#HLD\nContinue atorvastatin to 20mg daily\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atorvastatin 20 mg PO QPM \n\n \nDischarge Medications:\n1.  Atorvastatin 20 mg PO QPM  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary\nChest Pain\nShoulder impingement syndrome\n\nSecondary\nHyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n  \n___ was a pleasure caring of you at ___.  \n\nWHY WAS I IN THE HOSPITAL?  \n- You were admitted for chest and shoulder pain\n\nWHAT HAPPENED TO ME IN THE HOSPITAL?  \n- You had a stress test which was normal\n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  \n- Continue to take over the counter acetaminophen and/or \nibuprofen as needed for left shoulder pain. Can also consider \ntopical medications such as lidocaine. \n- Continue to take all your medicines and keep your \nappointments.  \n\nWe wish you the best!  \n\nSincerely,  \n\nYour ___ Team\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10031470","hadm_id":"28522103","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Latex\n \nAttending: ___.\n \nChief Complaint:\nAbd pain\n \nMajor Surgical or Invasive Procedure:\nEGD\n \nHistory of Present Illness:\nPer admitting resident: ___ is a ___ y/o woman who \nhad an open roux-en-y gastric bypass for extrmee morbid obesity \n(preop BMI 94.9) and partial liver resection in ___ with Dr. \n___. She has been well since surgery. During her ___ \nfollow-up visit, she was noted to have some increased \nnausea/heartburn noted but an EGD done on ___ was normal. \nShe reports that she tolerated her regular dinner last night, \nbut was woken from sleep at ~0200 with severe epigastric \npain/burning, nausea, feeling the urge to vomit but no emesis, \nand she reported feeling dizzy and weak while climbing stairs at \nhome. The epigastric burning lasted ~6 hours, at which point she \ncalled the ___ service and was advised to go to her local \nemergency room. At an OSH ED, she had a CT abd that was negative \nfor free air, free fluid in the abdomen, CBC and chem-10 within \nnormal limits and a negative troponin x1, and her symptoms \nresolved. At ~1500, she had some crackers and ginger ale, at \nwhich point her symptoms returned and she was transferred to \n___ for further evaluation. \n\n \n\n \nPast Medical History:\nPast Medical History:\n1.  History of hepatic adenoma.\n2.  Polycystic ovary disease.\n3.  Hypothyroid for which she is on Synthroid.\n4.  Hyperlipidemia, resolved.\n5.  Obstructive sleep apnea, resolved.\n6.  Urinary tract infection.  This is actually the incidence of \n    these have decreased since her weight loss.\n7.  Hypertension, resolved.\n8.  Gastroesophageal reflux.  This predated her weight loss \n    operation, but has recurred recently to a mild extent.\n9.  Incisional hernia.\n\nPast Surgical History:\n1.  Wisdom teeth extraction in ___.\n2.  Tonsillectomy and adenoidectomy in ___.\n3.  Open Roux-en-Y gastric bypass, cholecystectomy and left\nhepatectomy for adenoma in ___.\n4.  Right liver resection in ___ at ___.\n\n \nSocial History:\n___\nFamily History:\nFamily history is noted for father deceased had hyperlipidemia \nand obesity; mother living age ___ with obesity; grandfather \ndeceased with heart disease; grandmother living age ___ with \narthritis and other grandmother with lupus.\n\n \nPhysical Exam:\nVSS\nConstitutional: NAD\nNeuro: Alert and oriented x 3\nCardiac: RRR, NL S1, S2\nResp: CTA B\nAbd: Soft, non-tender, non-distended, no rebound tenderness or \nguarding\nWounds: Abd lap sites CDI\nExt: No edema\n\n \nPertinent Results:\n___ 07:40PM BLOOD WBC-8.0 RBC-4.46 Hgb-12.1 Hct-37.0 MCV-83 \nMCH-27.1 MCHC-32.7 RDW-12.8 Plt ___\n___ 07:40PM BLOOD Neuts-58.5 ___ Monos-3.7 Eos-3.6 \nBaso-0.7\n___ 07:40PM BLOOD Glucose-90 UreaN-7 Creat-0.5 Na-139 K-3.9 \nCl-104 HCO3-26 AnGap-13\n___ 07:40PM BLOOD ALT-25 AST-26 AlkPhos-66 TotBili-0.5\n___ 07:40PM BLOOD Lipase-36\n___ 07:40PM BLOOD Albumin-4.0\n___ 09:50PM BLOOD Lactate-1.5\n\nEGD: \nNormal mucosa in the esophagus\nEvidence of a previous Roux-en-y Gastric bypass surgery was \nseen. The GE junction was at 40 cm and the GJ at 45 cm. The \nmucosa of the stomach pouch appeared normal. There was slight \nnarrowing at the GJ junction to 13 mm but the scope could easily \ntraverse. There was some nodularity at the GJ junction. No ulcer \nnoted. The blind limb appeared normal. (biopsy)\nNormal mucosa in the duodenum Otherwise normal EGD to jejunum \nand blind limb\n \nBrief Hospital Course:\nMs. ___ is a ___ year-old female with a history of \nroux-en-Y gastric bypass with history of a marginal ulcer \nadmitted to the hospital on ___ due to new onset \nepigastric pain in setting of known smoking.  Upon arrival, she \nwas placed on bowel rest with intravenous fluids and antiacids.  \nPo's were trialed on HD2 due to resolution of pain, however, the \npatient's pain returned.  She subsequently underwent an EGD on \nHD3, which did not show a marginal ulcer, therefore, her pain \nwas attributed to a possible ulcer in the remnant stomach.  \nPost-procedure, as she remained hemodynamically stable with \nimproved pain and tolerance to a stage 3 diet, she was \ndischarged to home on omeprazole.  She will follow-up with Dr. \n___ in clinic within the next few weeks.  \n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. Multivitamins W/minerals 1 TAB PO BID \n3. Omeprazole 40 mg PO BID \n4. Calcium Carbonate 500 mg PO DAILY \n5. Citalopram 10 mg PO DAILY \n6. Levothyroxine Sodium 50 mcg PO DAILY \n7. biotin 2,500 mcg oral daily \n8. Cyanocobalamin 500 mcg PO 1X/WEEK (___) \n9. Vitamin D ___ UNIT PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. biotin 2,500 mcg oral daily \n3. Calcium Carbonate 500 mg PO DAILY \n4. Citalopram 10 mg PO DAILY \n5. Cyanocobalamin 500 mcg PO 1X/WEEK (___) \n6. Levothyroxine Sodium 50 mcg PO DAILY \n7. Multivitamins W/minerals 1 TAB PO BID \n8. Omeprazole 40 mg PO BID \n9. Vitamin D ___ UNIT PO DAILY \n10. Sucralfate 1 gm PO QID \nRX *sucralfate 1 gram/10 mL 10 ML by mouth four times a day \nRefills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis: \npresumed remnant stomach ulcer\n\nSecondary diagnosis: history of morbid obesity, post Roux-en-Y \ngastric bypass\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were seen at the ___ due to \nstomach pain caused by a presumed ulcer, which has occured as \nthe result of smoking. We monitored your blood counts and labs \nwhile you were admitted and have determined that your symptoms \nare unlikely due to a bleeding ulcer. We are sending you home at \nthis time.  Please continue to take your antiacid, twice daily.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12785458","hadm_id":"27935584","text":" \nName:  ___.                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nlisinopril / chlorthalidone / spironolactone\n \nAttending: ___.\n \nChief Complaint:\nElevated blood pressure\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ F w/ hx of DMII, CKDIII, nephrotic syndrome, significant \nfamily history of renal and hypertensive disease, and personal \nhistory of refractory HTN (with prior seizures i/s/o \nhypertensive emergency) initially presented for hypertensive \nepisodes.\nPatient has had a history of hypertensive emergency episodes in \nthe past, including one this past ___ when her co-worker help \nher to the emergency room during a time when she experienced a \ngrand-mal seizure. Patient states that she was recently taken \noff of chlorthalidone and her amlodipine was decreased on ___ \nfrom 10 mg daily to 5 mg daily due to complaint regarding \nincreasing leg swelling. Patient noted she had felt \"crummy\" for \nthe past two weeks, and along with this she notes that her blood \npressures at home have risen from on average a systolic of 150s \nto systolics of 180s or higher during the past two weeks. Today \nshe was at work (works at ___), had her BP taken \nand found it to be very elevated so came in for evaluation. \nPatient currently on clonidine patch, labetalol, amlodipine, and \nvalsartan.\nPatient notes she has a doctor at ___ who \nhas been directing most of her renal and hypertensive workup, \nand that the doctor planned at one point to do a CT \nabdomen/pelvis to look for an adrenal mass, but this has not \nbeen done yet. Previous Renal US consistent with CKD. Prior \nserologic workup for systemic renal disease negative. Patient's \nstudies were only noteably for a reported elevated serum \ndopamine.\nIn the ED initial vitals were: 98.5 94 ___ RA\nPhysical exam: JVP about 10cm, 2+ pitting edema Abd benign. \nLungs CTA.\nLabs/studies notable for: Trop 0.09, ___: 16336, Cr2.0, \nproteinuria\nEKG: NSR, poor R wave progression\nCXR: Low lung volumes with patchy opacities in the lung bases \nwhich could reflect atelectasis, but aspiration or infection \ncannot be excluded. No pulmonary edema.\nTTE revealed new depressed EF to 40-45%, RV/LV hypertrophy, \nmoderate diastolic dysfunction and moderate pulmonary \nhypertension\nPatient was given:\n___ 22:35 IV Labetalol 10 mg\n___ 00:19 IV Labetalol 10 mg\n___ 03:48 IV Labetalol 10 mg\n___ 06:03 PO/NG Labetalol 300 mg\n___ 06:03 PO/NG amLODIPine 5 mg\n___ 06:57 IV Furosemide 40 mg\n___ 11:11 SC Insulin 15\n___ 12:03 PO/NG Labetalol 300 mg\n___ 12:03 PO/NG amLODIPine 5 mg\n___ 14:49 PO/NG HydrALAZINE 25 mg\n___ 18:10 PO/NG Labetalol 300 mg\n___ 18:18 SC Insulin 8 Units\nVitals on transfer:98.0 88 160/100 19 99% RA\nOn the floor patient is comfortable, claims she wants to get to \nthe bottom of this high blood pressure as she is worried about \nher long term health. Reports disease is \"taking its toll.\"\nREVIEW OF SYSTEMS:\nPositive per HPI. Additionally reports some DOE, PND, orthopnea, \nankle edema. Reports a cough 2 days ago in the setting of \nincreased sensation of fluid.\nCardiac review of systems is notable for absence of chest pain, \n, palpitations, syncope, or presyncope.\nOn further review of systems, denies fevers or chills. Denies \nany prior history of stroke, TIA, deep venous thrombosis, \npulmonary embolism, bleeding at the time of surgery, myalgias, \njoint pains, hemoptysis, black stools or red stools. Denies \nexertional buttock or calf pain. All of the other review of \nsystems were negative.\n \nPast Medical History:\nPAST MEDICAL HISTORY:\n1. CARDIAC RISK FACTORS\n- Diabetes\n- Hypertension\n- Nephrotic range Proteinuria\n2. CARDIAC HISTORY\n- unknown\n- EF 40-45%,\n- NSR,\n3. OTHER PAST MEDICAL HISTORY\nASTHMA\nDEPRESSION\nANEMIA\nFIBROID UTERUS status post hysterectomy in ___.\nALPHA THALLASSEMIA TRAIT\nANEMIA\nNEPHROTIC SYNDROME\nSEIZURE DISORDER\n \nSocial History:\n___\nFamily History:\nFather had DM, HTN, ESRD s/p temporary HD, renal transplant\nMother DM and HTN\nMultiple maternal aunts HTN DM and renal disease\n \nPhysical Exam:\nADMISSION PHYSICAL\n=================\nVS: 156/117 94\nGENERAL: Well developed, well nourished woman in NAD. Oriented \nx3. Mood, affect appropriate.\nHEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. \nConjunctiva were pink. No pallor or cyanosis of the oral mucosa. \nNo xanthelasma.\nNECK: Supple. JVP of 10 cm.\nCARDIAC: PMI located in ___ intercostal space, midclavicular \nline. Regular rate and rhythm. Loud S4.\nLUNGS: No chest wall deformities or tenderness. Respiration is \nunlabored with no accessory muscle use. No crackles, wheezes or \nrhonchi.\nABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No \nsplenomegaly. No CVA tenderness.\nEXTREMITIES: Marked tense edema bilaterally in lower extremities \n2+ up to knee.\nSKIN: No significant skin lesions or rashes.\nPULSES: Distal pulses palpable and symmetric.\n\nDISCHARGE PHYSICAL\n=================\nVS: 98.6 ___ 18 98-100%RA\nWeight: 92.9kg -\u003e 92.9kg -\u003e 92.5kg -\u003e 92.1-\u003e 90.6 -\u003e 91.9kg -\u003e \n89.4kg -\u003e 88.9kg   \nI/O: ___\nGENERAL: Pleasant, NAD \nHEENT: Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No \npallor or cyanosis of the oral mucosa. No xanthelasma.  \nNECK: Supple. JVP 6-8cm at 90degrees, improving EJ distension.  \nCARDIAC:  Regular rate and rhythm.  S1, S2.  No S4.  No murmurs. \n \nLUNGS: No chest wall deformities or tenderness. Respiration is \nunlabored with no accessory muscle use. No crackles, wheezes or \nrhonchi.  \nABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No \nsplenomegaly. No CVA tenderness.  \nEXTREMITIES: WWP. compression stockings, edema bilaterally in \nlower extremities 1+ up to knee.  \nSKIN: No significant skin lesions or rashes.  \nPULSES: Distal pulses palpable and symmetric.\n \nPertinent Results:\nADMISSION LABS\n=============\n___ 09:07PM BLOOD WBC-6.5 RBC-5.39* Hgb-10.1* Hct-32.7* \nMCV-61* MCH-18.7* MCHC-30.9* RDW-19.3* RDWSD-37.9 Plt ___\n___ 09:07PM BLOOD Neuts-68.2 ___ Monos-9.6 Eos-1.5 \nBaso-0.5 Im ___ AbsNeut-4.42 AbsLymp-1.29 AbsMono-0.62 \nAbsEos-0.10 AbsBaso-0.03\n___ 09:07PM BLOOD Plt ___\n___ 09:07PM BLOOD Glucose-372* UreaN-29* Creat-1.9* Na-136 \nK-4.4 Cl-98 HCO3-22 AnGap-20\n___ 09:07PM BLOOD ___\n___ 09:07PM BLOOD Calcium-8.1* Phos-5.1* Mg-2.1\n___ 08:30PM URINE Color-Straw Appear-Hazy Sp ___\n___ 08:30PM URINE Blood-SM  Nitrite-NEG Protein-600 \nGlucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG\n___ 08:30PM URINE RBC-2 WBC-2 Bacteri-FEW Yeast-NONE Epi-3\n___ 08:30PM URINE Hours-RANDOM UreaN-352 Creat-63 Na-35 \nTotProt-675 Prot/Cr-10.7* Albumin-408.2 Alb/Cre-6479.4*\n___ 08:30PM URINE UCG-NEGATIVE Osmolal-333\n\nPERTINENT LABS\n=============\n___ 03:30PM BLOOD CK-MB-10 cTropnT-0.08*\n___ 07:46AM BLOOD cTropnT-0.09*\n___ 09:07PM BLOOD cTropnT-0.09*\n___ 09:07PM BLOOD ___\n___ 08:30PM URINE Blood-SM  Nitrite-NEG Protein-600 \nGlucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG\n___ 08:30PM URINE Hours-RANDOM UreaN-352 Creat-63 Na-35 \nTotProt-675 Prot/Cr-10.7* Albumin-408.2 Alb/Cre-6479.4*\n\nMICRO\n=====\nNONE\n\nSTUDIES/IMAGING\n==============\nCXR ___\nFINDINGS: \nLung volumes are low.  This accentuates the size of the cardiac \nsilhouette\nwhich appears mildly enlarged.  Mediastinal and hilar contours \nare\nunremarkable.  Crowding of bronchovascular structures is present \nwithout overt\npulmonary edema.  Patchy opacities within the lung bases may \nreflect\natelectasis, but infection or aspiration are not excluded.  No \nlarge pleural\neffusion or pneumothorax is seen.  There are no acute osseous \nabnormalities.\nIMPRESSION: \nLow lung volumes with patchy opacities in the lung bases which \ncould reflect\natelectasis, but aspiration or infection cannot be excluded.  No \npulmonary\nedema.\n\nTTE ___\nThe left atrium is moderately dilated. The estimated right \natrial pressure is ___ mmHg. There is mild symmetric left \nventricular hypertrophy with normal cavity size. There is mild \nregional left ventricular systolic dysfunction with focal \nhypokinesis of the basal to mid inferoseptum. The remaining \nsegments contract normally. Overall left ventricular systolic \nfunction is mildly depressed (LVEF= 40-45 %). Moderate diastolic \ndysfunction. Right ventricular chamber size and free wall motion \nare normal. The right ventricular free wall is hypertrophied. \nThe diameters of aorta at the sinus, ascending and arch levels \nare normal. The aortic valve leaflets (3) appear structurally \nnormal with good leaflet excursion and no aortic stenosis or \naortic regurgitation. The mitral valve leaflets are structurally \nnormal. There is no mitral valve prolapse. Mild (1+) mitral \nregurgitation is seen. There is moderate pulmonary artery \nsystolic hypertension. There is a small pericardial effusion. \nThe effusion appears circumferential. There are no \nechocardiographic signs of tamponade. There is brief right \natrial diastolic collapse. \nIMPRESSION: Mild symmetric left ventricular hypertrophy with \nmild regional systolic dysfunction c/w possible CAD. Moderate \ndiastolic dysfunction with elevated PCWP. Right ventricular \nhypertrophy with normal right ventricular cavity size and \nsystolic function. At least moderate pulmonary hypertension. \nMild mitral regurgitation. Small circumferential pericardial \neffusion with no signs of tamponade. \n\nDISCHARGE LABS\n=============\n\n___ 07:35AM BLOOD WBC-4.0 RBC-4.79 Hgb-9.0* Hct-29.4* \nMCV-61* MCH-18.8* MCHC-30.6* RDW-19.1* RDWSD-38.5 Plt ___\n___ 01:05PM BLOOD Glucose-271* UreaN-30* Creat-1.9* Na-139 \nK-4.0 Cl-100 HCO3-27 AnGap-16\n___ 01:05PM BLOOD Calcium-8.5 Phos-6.1* Mg-2.1\n \nBrief Hospital Course:\nPatient is a ___ with CKDIII, nephrotic syndrome, DMII, and \nuncontrolled HTN who presented with hypertensive urgency, \nadmitted for newly found HFrEF. \n\n# Acute Systolic/Diastolic Heart Failure: TTE on admission \nrevealed depressed EF 40-45% associated with hypertrophy of \nleft/right ventricles as well as moderate pulmonary \nhypertension. Most likely ___ to uncontrolled hypertension. \n___ elevated to 16,000s, troponinemia (trops peaked at .09) \nlikely Type 2 NSTEMI, patient appeared volume overloaded on \nexam, severe ___ in setting of nephrotic syndrome. She received \nlasix 80mg IV boluses with good UOP. Given severe hypertension \n(\u003e230 SBPs on admission), afterload reduction was uptitrated \nslowly so as to prevent acute, relative hypotension. Blood \npressures had decreased to systolic 150-160s by time of \ndischarge. Afterload reduction regimen at time of discharge: \nClonidine Patch 0.3mg/24hr, Amlodipine 10 daily, Valsartan 160mg \nBID, Imdur 30 Daily, Hydralazine 10 TID. \n\n# Hypertensive Urgency: New heart failure as above, also CKD. \nPatient presented with SBPs \u003e230. Regimen at time of discharge: \nClonidine Patch 0.3mg/24hr, Amlodipine 10 daily, Valsartan 160mg \nBID, Imdur 30 Daily, Hydralazine 10 TID, carvedilol 25mg BID, \nHydralazine 10 TID.\n\n# Troponinemia: Elevated on presentation in the setting of stage \nIII CKD, likely Type II NSTEMI. Trops peaked at .09.\n\n# ___ \n# Nephrotic Syndrome: Cr on presentation elevated to 2.0 from \nrecent baseline of 1.4-1.5, FeNa 0.8%, suggesting prerenal cause \n(e.g. cardiorenal syndrome from HTN-induced CHF). She likely has \nCKD in setting of hypertension and DM. Renal was consulted and \nhelped to tailor anti-HTN regimen as above. They recommended \noutpatient renal biopsy.\n\nTRANSITIONAL ISSUES\n=================\nMEDICATIONS CHANGED, STOPPED, STARTED: \n[] Amlodipine 10mg Daily CHANGED from 5mg daily \n[] Torsemide 100mg Daily, CHANGED from 10mg daily \n[] Valsartan 160mg BID, CHANGED from 320mg Daily \n[] Carvedilol 25 mg BID, CHANGED from Labetolol 300mg QID\n[] Chlorthalidone 25mg Daily STARTED \n[] Hydralazine 10mg PO TID, STARTED for BP control \n[] Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY, \nSTARTED\n[] Spironolactone 25mg Daily, STARTED \n[] Labetolol 300mg QID STOPPED and replaced with Carvedilol 25 \nmg \n\n- Discharge weight: 86.4 kg \n- Discharge Cr: 2.0 (uptrending from 1.8) \n\nITEMS THAT REQUIRE FOLLOW-UP: \n[] Patient will need a kidney biopsy as an outpatient once her \nblood pressures are adequately controlled. She will be followed \nby Dr. ___ as an outpatient. \n[] Consider up-titration of the Hydralazine and Imdur for better \nblood pressure control as patient is able to tolerate. \n[] Patient will need electrolyte levels drawn 5 to 7 days after \ndischarge. Would also suggest drawing CMP at next PCP \n___. \n[] Patient will likely require further titration of torsemide. \nShe will follow with heart failure team. \n[] Patient will be recording her own weights and urinary output \nat home. She has refused ___ services. \n\n==============\n- Code Status: Full\n- Contact: ___ ___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Valsartan 320 mg PO DAILY \n2. Labetalol 300 mg PO QID \n3. Clonidine Patch 0.3 mg/24 hr 1 PTCH TD QTHUR \n4. amLODIPine 5 mg PO DAILY \n5. Glargine 15 Units Breakfast\nGlargine 10 Units Dinner\n6. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB \n7. Torsemide 10 mg PO BID was taking TID at home \n8. MetFORMIN XR (Glucophage XR) 1000 mg PO DAILY \n\n \nDischarge Medications:\n1.  Carvedilol 25 mg PO BID \nRX *carvedilol 25 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*0 \n2.  Chlorthalidone 25 mg PO DAILY \nRX *chlorthalidone 25 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0 \n3.  HydrALAZINE 10 mg PO TID \nRX *hydralazine 10 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*90 Tablet Refills:*0 \n4.  Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY \nRX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0 \n5.  Spironolactone 25 mg PO DAILY \nRX *spironolactone 25 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0 \n6.  amLODIPine 10 mg PO DAILY \nRX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n7.  Glargine 15 Units Breakfast\nGlargine 10 Units Dinner \n8.  Torsemide 100 mg PO DAILY \nRX *torsemide 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n9.  Valsartan 160 mg PO BID \nRX *valsartan 160 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*0 \n10.  Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB  \n11.  Clonidine Patch 0.3 mg/24 hr 1 PTCH TD QTHUR  \n12.  MetFORMIN XR (Glucophage XR) 1000 mg PO DAILY  \n13.Outpatient Lab Work\nI50.9 \nPlease obtain complete metabolic panel ___\nFax results to: Dr. ___\n___\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnoses\n==============\nHypertension\nAcute on chronic systolic/diastolic congestive heart failure \nexacerbation\n\nSecondary Diagnoses\n================\nNephrotic Syndrome\nType II Diabetes Mellitus\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital because your blood pressure \nwas severely elevated, causing injury to both your kidneys and \nheart.  You had an ultrasound of your heart which showed that \nthe pumping function is decreased (congestive heart failure).  \nThis is most likely due to longstanding elevated blood \npressures.  \n\nYou received intravenous diuretics to help remove excess fluid \nvia urination.  Your blood pressure medications were changed so \nas to best keep it at a normal level. \n\nThe kidney doctors came to ___ you and suggested that you have a \nkidney biopsy as an outpatient.\n\nIt is important that you take your medicines as prescribed and \nfollow-up with your doctors as listed below.\n\nIt was a pleasure taking care of you!\n\nSincerely,\n\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18801336","hadm_id":"21035666","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\ns/p MVC\n \nMajor Surgical or Invasive Procedure:\n___:  Traction pin placement\n___:  ORIF of right both-column acetabular fracture via a \nStoppa window and an ilioinguinal exposure.\n\n \nHistory of Present Illness:\nMr. ___ is a ___ year old man who was involved in a MVC.  He was \ntaken to ___ and found to have a right \nacetabular fracture and a right scapula fracture.  He was then \ntransferred to the ___ for further evaluation and care.\n \nPast Medical History:\ns/p open appy at ___ of age\n \nSocial History:\n___\nFamily History:\nn/a\n \nPhysical Exam:\nUpon admission:\n\nAlert\n\nCardiac:  Regular rate rhythm\nChest:  Lungs clear\nAbdomen:  Distended, FAST negative\nExtremities:  RUE unable to move R shoulder, tender to \npalpatation, +pulses/sensation.  RLE slightly shortned, + \npulses, sensation.\n \nPertinent Results:\n___ 07:20PM BLOOD WBC-19.2* RBC-4.86 Hgb-14.2 Hct-40.6 \nMCV-84 MCH-29.2 MCHC-35.0 RDW-13.7 Plt ___\n___ 12:55PM BLOOD Hct-38.8*\n___ 08:00AM BLOOD WBC-14.1* RBC-4.14* Hgb-12.1* Hct-34.5* \nMCV-83 MCH-29.1 MCHC-35.0 RDW-13.3 Plt ___\n___ 07:15AM BLOOD WBC-10.3 RBC-3.74* Hgb-11.0* Hct-31.5* \nMCV-84 MCH-29.4 MCHC-34.9 RDW-13.2 Plt ___\n___ 03:16PM BLOOD WBC-15.1* RBC-3.76* Hgb-11.0* Hct-31.1* \nMCV-83 MCH-29.2 MCHC-35.3* RDW-13.5 Plt ___\n___ 07:25AM BLOOD WBC-13.3* RBC-3.76* Hgb-11.1* Hct-30.9* \nMCV-82 MCH-29.6 MCHC-35.9* RDW-13.6 Plt ___\n___ 07:20AM BLOOD Hct-27.5*\n___ 08:55AM BLOOD WBC-9.8 RBC-2.97* Hgb-8.7* Hct-25.5* \nMCV-86 MCH-29.3 MCHC-34.2 RDW-13.5 Plt ___\n___ 07:20AM BLOOD Hct-27.8*\n___ 07:20PM BLOOD ___ PTT-21.5* ___\n___ 07:15AM BLOOD ___ PTT-31.6 ___\n___ 07:15AM BLOOD Glucose-413* UreaN-10 Creat-0.7 Na-131* \nK-5.3* Cl-99 HCO3-25 AnGap-12\n___ 03:16PM BLOOD Glucose-156* UreaN-11 Creat-0.6 Na-137 \nK-4.1 Cl-104 HCO3-25 AnGap-12\n___ 07:25AM BLOOD Glucose-145* UreaN-11 Creat-0.6 Na-136 \nK-4.2 Cl-100 HCO3-24 AnGap-16\n___ 08:55AM BLOOD Glucose-167* UreaN-17 Creat-0.6 Na-136 \nK-3.7 Cl-99 HCO3-27 AnGap-14\n___ 07:20PM BLOOD Lipase-37\n___ 03:16PM BLOOD Calcium-7.5*\n___ 07:25AM BLOOD Calcium-8.1* Phos-2.6* Mg-1.8\n___ 07:20AM BLOOD Phos-1.8* Mg-2.0\n\n___ CT Head:\nIMPRESSION: No acute intracranial pathology including no \nhemorrhage.\n\n___ CT Torso:\nIMPRESSION: \n1. No acute solid organ pathology is noted within the chest, \nabdomen, and \npelvis. \n2. Comminuted fracture of the right scapula and the comminuted \nfracture of \nthe right acetabulum with extension into the ilium, ischium and \nright superior pubic ramus. \n3. Multiple sub 5 mm nodules of the right lung. 6 months follow \nup with chest CT is recommended.\n\nAP Pelvis Xrays:\nThere is a complex fracture involving the right acetabulum with \nmild \ndisplacement of the fracture fragments. The fracture also \nextends to the \nsuperior aspect of the acetabular roof. Minimally displaced \nfractures of the right superior and inferior pubic rami are \nidentified.\n\nKUB ___:\nIMPRESSION: Dilated loops of small and large bowel with moderate \ngastric \ndistension consistent with ileus.\n\nKUB ___:\nIMPRESSION: \n1. Interval resolution of gastric distension. \n2. Persistent ileus. \n\n \nBrief Hospital Course:\nMr. ___ presented to the ___ on ___ via transfer from \n___.  He was evaluated by the trauma and \northopaedic surgery services.  He was found to have a right \nacetabular and right scapular fracture.  A traction pin was \nplaced in the emergency department, and he was admitted to the \northopaedic surgery service.  On ___ he was noted to have \nabdominal pain and distension.  An NGT was placed by surgery and \nhe was made NPO and placed on IVF. His abdominal pain and \ndistention resolved on ___ and the NGT was left in place for \nprecautionary measures.\n\nHe was taken to the OR for ORIF of his right acetabulum on ___. \nThe traction pin apparatus was removed in the OR. He tolerated \nthe procedure well, recovered in the PACU without events, and \nreturned to the floor in stable condition.\n\nHis NGT was removed on POD 1 and he began tolerating a regular \ndiet shortly thereafter.\n\nacute blood loss anemia - the patient was transfused 1 unit of \nPRBCs on ___ and again on ___ for acute anemia. His HCT was \nstable prior to discharge.\n\n___ - the patient was seen and evaluated by ___\n\nHis pain was well controlled with IV and then PO pain \nmedication. He was tolerating a regular diet prior to discharge.\n\nHe was discharged to .... on ___.\n \nMedications on Admission:\ndenies\n \nDischarge Medications:\n1. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every \n6 hours).  \n2. Lovenox 30 mg/0.3 mL Syringe Sig: One (1) inj Subcutaneous \nevery twelve (12) hours for 4 weeks.\nDisp:*56 syringes* Refills:*0*\n3. Oxycodone 5 mg Capsule Sig: ___ Capsules PO every four (4) \nhours as needed for pain.\nDisp:*90 Capsule(s)* Refills:*0*\n4. Valium 5 mg Tablet Sig: ___ Tablets PO every ___ hours as \nneeded for muscle spasms.\nDisp:*30 Tablet(s)* Refills:*0\n5. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \n6. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*0*\n7. Senna 8.6 mg Capsule Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.  \n8. Zolpidem 5 mg Tablet Sig: ___ Tablets PO HS (at bedtime) as \nneeded for sleep.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\ns/p MVC\nRight both column acetabular fracture\nRight scapular fracture\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nDo not bear weight through your right arm until after follow up.\nYou may lightly touch down your right foot, but do not bear \nweight.\n\nPlease call your doctor or return to the ER for any of the \nfollowing:\n* You experience new chest pain, pressure, squeezing or \ntightness.\n* New or worsening cough or wheezing.\n* If you are vomiting and cannot keep in fluids or your \nmedications.\n* You are getting dehydrated due to continued vomiting, \ndiarrhea or other reasons. Signs of dehydration include dry \nmouth, rapid heartbeat or feeling dizzy or faint when standing.\n* You see blood or dark/black material when you vomit or have a \nbowel movement.\n* Your pain is not improving within ___ hours or not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or is changing location or moving to your chest or \n\nback.\n* You have shaking chills, or a fever greater than 101.5 (F) \ndegrees or 38(C) degrees.\n* Any serious change in your symptoms, or any new symptoms that \nconcern you.\nPhysical Therapy:\nRUE NWB\nRLE TDWB\nTreatments Frequency:\ndry sterile dressings to incisions as needed\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16069489","hadm_id":"26722361","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \ntramadol / fentanyl / Compazine / Macrobid / Neo-Synephrine \n(phenylephrine) / prochlorperazine / Sulfa (Sulfonamide \nAntibiotics) / trimethoprim / phenylephrine\n \nAttending: ___.\n \nChief Complaint:\nRight lower extremity rest pain\n \nMajor Surgical or Invasive Procedure:\nR leg angiogram, plasty of R popliteal artery on ___, and a \nrepeat R leg angiogram, re-plasty of R popliteal artery, \nstenting of R popliteal artery on ___\n\n \nHistory of Present Illness:\n___ is a ___ woman\nwho presents to our service as an inpatient consult for right\nfoot rest pain and discoloration consistent with dependent\nrubor.  She was therefore offered a CTA, which revealed\nheavily calcified iliac vessels with it being unclear if these\nwere deep patent, as well as the suggestion of a right distal\nSFA/popliteal occlusion.  She was therefore offered right\nlower extremity angiogram with possible intervention.\n \nPast Medical History:\nPAD, atrial fibrillation (previously treated with Eliquis\nwhich was d/c'd after a recent head CT was c/f small bleed),\nGERD, hypertension, CHF, HLD, HTN, hypothyroidism, polymyalgia \non\nlong term prednisone, spinal stenosis, vaginal pessary, iron\ndeficiency anemia, DM2, SBO\n \nSocial History:\n___\nFamily History:\nFH: Father died at the age of ___ from heart disease.  Mother \ndied\nat the age of ___ from heart disease.\n \nPhysical Exam:\nADMISSION EXAM:\nGen: NAD, A\u0026Ox2, some confusion\nPulm: Non-labored breathing, on RA\nCV: RRR\nAbd: Soft, NT, ND, BS+, no guard/rebound\nExt: Warm bilaterally, mild RLE edema/erythema, R: P///D faint, \nL:P//D/D\nmotor/sensation intact\n\nDISCHARGE EXAM:\nGen: NAD, A\u0026Ox2, some confusion\nPulm: Non-labored breathing, on RA\nCV: RRR\nAbd: Soft, NT, ND, BS+, no guard/rebound\nExt: Warm bilaterally, mild RLE edema/erythema, R: P///D, \nL:P//D/D\nmotor/sensation intact\n \nPertinent Results:\nLAB:\n\n___ 05:55AM BLOOD Hct-33.2*\n___ 06:30AM BLOOD WBC-14.3*# RBC-4.30 Hgb-11.2 Hct-37.0 \nMCV-86 MCH-26.0 MCHC-30.3* RDW-15.8* RDWSD-49.4* Plt ___\n___ 05:00AM BLOOD Hct-32.6*\n___ 05:40AM BLOOD WBC-10.4* RBC-3.95 Hgb-10.1* Hct-33.4* \nMCV-85 MCH-25.6* MCHC-30.2* RDW-15.9* RDWSD-48.3* Plt ___\n___ 06:30AM BLOOD ___ PTT-25.7 ___\n___ 05:00AM BLOOD ___ PTT-25.4 ___\n___ 05:55AM BLOOD Creat-0.8 K-4.0\n___ 06:30AM BLOOD Glucose-129* UreaN-29* Creat-0.8 Na-144 \nK-3.6 Cl-102 HCO3-27 AnGap-15\n___ 05:00AM BLOOD Glucose-106* UreaN-25* Creat-0.7 Na-142 \nK-4.3 Cl-106 HCO3-24 AnGap-12\n___ 05:40AM BLOOD Glucose-114* UreaN-26* Creat-0.8 Na-139 \nK-3.9 Cl-101 HCO3-26 AnGap-12\n___ 06:30AM BLOOD Calcium-9.0 Phos-3.4 Mg-1.7\n___ 05:00AM BLOOD Calcium-8.1* Phos-2.6* Mg-2.7*\n___ 05:40AM BLOOD Calcium-8.4 Phos-2.6* Mg-2.3\n\nIMAGING:\nArt Ext (Rest Only) ___:\nFINDINGS:  \n  \nOn the right side, triphasic Doppler waveforms are seen in the \nright femoral artery.  A monophasic waveform is seen within the \npopliteal artery.  No waveform is identified within the \nposterior tibial artery.  A monophasic waveform is identified \nwithin the dorsalis pedis artery. \nThe right ABI was 0. \n  \nOn the left side, triphasic Doppler waveforms are seen at the \nleft femoral and popliteal arteries.  The posterior tibial \nartery waveform is absent.  There is a monophasic waveform \nwithin the dorsalis pedis artery. \nThe left ABI was 0.30. \n  \nIMPRESSION:  \n  \nSevere arterial insufficiency of the bilateral lower extremities \nbelow the \nknee. \n\nArterial Duplex RLE ___:\nFINDINGS:  \n  \nThere is moderate to severe right common femoral artery plaque. \n  \nPeak systolic velocities are as follows: \nCommon femoral artery waveform is triphasic. Peak systolic \nvelocity is 137 \ncm/sec. Proximal superficial femoral artery waveform is \ntriphasic. Peak systolic velocity is 70 cm/sec \nMid superficial femoral artery waveform is biphasic. Peak \nsystolic velocity is 34 cm/sec \nDistal superficial femoral artery waveform is biphasic. Peak \nsystolic velocity is 36 cm/sec \nThe proximal popliteal artery is occluded.  There is distal \nreconstitution by collaterals. \nPosterior tibial and peroneal arteries are not visualized, in \nkeeping with CTA finding of probable proximal occlusion. \nRight dorsalis pedis artery is patent.  Peak systolic velocity \nis 46 cm/sec. \n\nIMPRESSION:  \nSevere atherosclerotic disease of the right lower extremity, as \ndescribed.  \nThere is probable severe stenosis involving the right \nsuperficial femoral \nartery.  The proximal right popliteal artery is occluded with \ndistal \nreconstitution by collaterals.  Additionally, the right \nposterior tibial and peroneal arteries are not visualized, in \nkeeping with CTA finding of probable  proximal occlusion.  The \nright dorsalis pedis artery is patent, compatible with finding \nof one-vessel runoff to the right foot. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year old female with  Right lower extremity \nrest pain who was admitted to the ___ \n___ on ___. The patient was taken to the endovascular \nsuite and underwent Right lower extremity angiogram and \nSelective catheterization of the right anterior tibial\nartery, a third-order vessel. For details of the procedure, \nplease see the surgeon's operative note. The patient tolerated \nthe procedure well without complications and was brought to the \npost-anesthesia care unit in stable condition. In the PACU, her \nright lower extremity pulses were difficult to Doppler, and ABIs \nwere performed, wherein she was found to have an occluded right \npopliteal artery. She was taken back to the OR on ___ for  \nright lower extremity angiogram and selective catheterization of \nthe right popliteal artery as well as Percutaneous transluminal \nangioplasty and stenting of the\nright popliteal artery. She was transferred to the PACU in \nstable condition, and then to the vascular surgery floor.\n\nPost-operatively, she did well without any groin swelling. She \nwas able to tolerate a regular diet, get out of bed and ambulate \nwithout assistance, void without issues, and pain was controlled \non oral medications alone. She was deemed ready for discharge, \nand was given the appropriate discharge and follow-up \ninstructions.\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Atorvastatin 40 mg PO QPM \n2. Esomeprazole 20 mg Other DAILY \n3. Furosemide 20 mg PO DAILY \n4. Levothyroxine Sodium 88 mcg PO DAILY \n5. nebivolol 5 mg oral DAILY \n6. PredniSONE 3 mg PO DAILY \n7. Sertraline 50 mg PO DAILY \n\n \nDischarge Medications:\n1.  Aspirin 81 mg PO DAILY  \n2.  Clopidogrel 75 mg PO DAILY \nRX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0 \n3.  Atorvastatin 40 mg PO QPM  \n4.  Esomeprazole 20 mg Other DAILY  \n5.  Furosemide 20 mg PO DAILY  \n6.  Levothyroxine Sodium 88 mcg PO DAILY  \n7.  nebivolol 5 mg oral DAILY  \n8.  PredniSONE 3 mg PO DAILY  \n9.  Sertraline 50 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight lower extremity rest pain with threatened leg.\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ and underwent R leg angiogram, plasty \nof R popliteal artery on ___, and a repeat R leg angiogram, \nre-plasty of R popliteal artery, stenting of R popliteal artery \non ___. You are now stable for discharge home.\n\nMEDICATION:\n Take Aspirin 81mg once daily\n If instructed, take Plavix (Clopidogrel) 75mg once daily\n Continue all other medications you were taking before surgery, \nunless otherwise directed\n You make take Tylenol or prescribed pain medications for any \npost procedure pain or discomfort\nWHAT TO EXPECT:\nIt is normal to have slight swelling of the legs:\n Elevate your leg above the level of your heart with pillows \nevery ___ hours throughout the day and night\n Avoid prolonged periods of standing or sitting without your \nlegs elevated\n It is normal to feel tired and have a decreased appetite, your \nappetite will return with time \n Drink plenty of fluids and eat small frequent meals\n It is important to eat nutritious food options (high fiber, \nlean meats, vegetables/fruits, low fat, low cholesterol) to \nmaintain your strength and assist in wound healing\n To avoid constipation: eat a high fiber diet and use stool \nsoftener while taking pain medication\n\nACTIVITIES:\n When you go home, you may walk and use stairs\n You may shower (let the soapy water run over groin incision, \nrinse and pat dry)\n Your incision may be left uncovered, unless you have small \namounts of drainage from the wound, then place a dry dressing or \nband aid over the area \n No heavy lifting, pushing or pulling (greater than 5 lbs) for \n1 week (to allow groin puncture to heal)\n After 1 week, you may resume sexual activity\n After 1 week, gradually increase your activities and distance \nwalked as you can tolerate\n No driving until you are no longer taking pain medications\n\nCALL THE OFFICE FOR: ___\n Numbness, coldness or pain in lower extremities \n Temperature greater than 101.5F for 24 hours\n New or increased drainage from incision or white, yellow or \ngreen drainage from incisions\n Bleeding from groin puncture site\n\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)\n Lie down, keep leg straight and have someone apply firm \npressure to area for 10 minutes. If bleeding stops, call \nvascular office ___. If bleeding does not stop, call \n___ for transfer to closest Emergency Room. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18223363","hadm_id":"21196505","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \ngluten / honey nut cheerios\n \nAttending: ___.\n \nChief Complaint:\nGastric mass\n \nMajor Surgical or Invasive Procedure:\n___:\n1. Laparoscopic exploration of the stomach.\n2. Laparoscopic intraoperative ultrasound.\n3. Distal gastrectomy with looped gastrojejunostomy.\n4. Placement of fiducials for possible CyberKnife therapy.\n5. Peritoneal washings.\n\n \nHistory of Present Illness:\nThe patient is a lovely ___ year old woman with a history of \nceliac disease and diverticulosis who has recently been having \nincreased abdominal pain and some weight loss. Initially, an \nabdominal CT was uninformative, so an EGD was done\non ___, which revealed atrophic and inflamed appearing antral \nmucosa with a raised, soft erythematous 1.5cm area of mucosa in \nthe antrum along the lesser curvature. Biopsies of this area \nshowed superficial portions of gastric mucosa displaying \nintestinal metaplasia and at least intramucosal carcinoma. This\nlesion was not seen on prior ___ in ___, although no \ngastric biopsies were taken due to the patient not tolerating \nthe procedure. \nOn ___ she underwent an EUS (Dr. ___. Findings included \nerythema and erosions in the antrum and a nodule in the gastric \nantrum, 1.7 cm X 0.5 cm in size with well-demarcated walls with \nhypoechoic and heterogeneous echotecture. The lesion appeared to \narise from the deep mucosal layer, with intact muscularis. No \nadjacent lymph adenopathy was found. Biopsy of the antrum nodule\nwhich was read as extensive high grade displasia, with foci \nsuspicious for invasion. The patient was evaluated by Dr. ___ \nin her ___ ___ clinic for possible resection. After \nall risks, benefits and possible outcomes were discussed with \nthe patient, she was scheduled for elective laparoscopic gastric \nresection on ___.\n\n \nPast Medical History:\nPMHx: ___ disease, celiac disease which is controlled \nwith diet, anxiety, hypothyroidism, diverticulosis, colon \npolyps, osteoporosis, and hyperlipidemia\n\nPSHx: appendectomy and tonsillectomy as a child, and \narthroscopic knee surgery and cataract extraction as an adult.\n \nSocial History:\n___\nFamily History:\nFamily history is significant for achalasia in one of her \ndaughters. \n\n \nPhysical Exam:\nPrior Discharge:\nVS: 98.1, 70, 122/52, 18, 97% RA\nGEN: Pleasant with NAD\nCV: RRR, no m/r/g\nPULM: CTAB\nABD: Laparoscopic incisions open to air with dermabond and \nc/d/i. Abdomen soft, NT/ND.\nEXTR: Thin, warm, no c/c/e\n \nPertinent Results:\n___ 11:00AM BLOOD WBC-8.4 RBC-3.32* Hgb-10.4* Hct-30.7* \nMCV-93 MCH-31.2 MCHC-33.8 RDW-13.5 Plt ___\n___ 06:52AM BLOOD Glucose-89 UreaN-10 Creat-0.5 Na-140 \nK-3.9 Cl-103 HCO3-27 AnGap-14\n___ 06:52AM BLOOD Calcium-9.2 Phos-4.0 Mg-1.9\n \nBrief Hospital Course:\nThe patient with gastric mass was admitted to the Surgical \nOncology Service for elective resection. On ___, the \npatient underwent laparoscopic exploration of the stomach, \ndistal gastrectomy with looped gastrojejunostomy and peritoneal \nwashing, which went well without complication (please see the \nOperative Note for details). After a brief, uneventful stay in \nthe PACU, the patient arrived on the floor NPO, on IV fluids and \nantibiotics, with a foley catheter, and Morphine PCA for pain \ncontrol.  The patient was hemodynamically stable.\nPsych: Patient has a history of early ___ and anxiety. \nShe was found to have visual hallucinations and agitated on POD \n1 and Geriatric Service was called in order to help managing \npatient acute post op delirium. Geriatric's recommendations were \nfollowed, opioids were minimized, patient was given Zyprexa and \nAtivan for agitations. Patient's mental status started to \nimprove on POD 4 and gradually returned to her baseline prior \ndischarge. \nNeuro: The patient received Morphine PCA immediately post op. \nShe was unable to use PCA and was started on Morphine prn. \nOpioids were minimized for treatment of delirium, IV Tylenol and \nLidocaine patch were provided for pain control. When tolerating \nPO patient was started on Tramadol for pain control with good \neffect.\nCV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored.\nPulmonary: The patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirrometry were \nencouraged throughout hospitalization.\nGI: Post-operatively, the patient was made NPO/NGT with IV \nfluids. NGT was removed on POD 2. Diet was advanced when \nappropriate to regular post gastrectomy diet on POD 9. Nutrition \nservice followed the patient and education about diet \nmodification was provided to the patient and her family. \nPatient's intake and output were closely monitored, and IV fluid \nwas adjusted when necessary.  Electrolytes were routinely \nfollowed, and repleted when necessary.\nID: The patient's white blood count and fever curves were \nclosely watched for signs of infection. Wound was evaluated \ndaily and no signs or symptoms of infection were noticed.\nEndocrine: No issues\nHematology: The patient's complete blood count was examined \nroutinely; no transfusions were required.\nProphylaxis: The patient received subcutaneous heparin and \nvenodyne boots were used during this stay; was encouraged to get \nup and ambulate as early as possible.\nAt the time of discharge, the patient was doing well, afebrile \nwith stable vital signs.  The patient was tolerating a regular \npost gastrectomy diet, ambulating, voiding without assistance, \nand pain was well controlled.  The patient received discharge \nteaching and follow-up instructions with understanding \nverbalized and agreement with the discharge plan.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Carbidopa-Levodopa (___) 1 TAB PO TID \n2. Desipramine 10 mg PO DAILY \n3. Levothyroxine Sodium 125 mcg PO DAILY \n4. Lorazepam 1 mg PO PRN anxiety \n5. Lovastatin 10 mg oral daily \n6. Ranitidine 150 mg PO BID \n7. Sertraline 50 mg PO DAILY \n8. melatonin 3 mg oral prn insomnia \n\n \nDischarge Medications:\n1. Carbidopa-Levodopa (___) 1 TAB PO TID \n2. Desipramine 10 mg PO DAILY \n3. Levothyroxine Sodium 125 mcg PO DAILY \n4. Lorazepam 1 mg PO PRN anxiety \n5. melatonin 3 mg oral prn insomnia \n6. Sertraline 50 mg PO DAILY \n7. Acetaminophen 650 mg PO Q6H \n8. Docusate Sodium 100 mg PO BID \n9. Lidocaine 5% Patch 1 PTCH TD QAM \nRX *lidocaine [Lidoderm] 5 % (700 mg/patch) 1 patch QAM Disp \n#*10 Patch Refills:*0\n10. Pantoprazole 40 mg PO Q12H \nRX *pantoprazole 40 mg 1 tablet(s) by mouth every twelve (12) \nhours Disp #*60 Tablet Refills:*5\n11. Senna 8.6 mg PO BID \n12. TraMADOL (Ultram) 50 mg PO TID:PRN pain \nRX *tramadol 50 mg 1 tablet(s) by mouth three times a day Disp \n#*50 Tablet Refills:*0\n13. Lovastatin 10 mg oral daily \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n1. Gastric mass (pathology pending)\n2. Delirium\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the surgery service at ___ for surgical \nresection of your gastric mass. Your recovery was complicated by \npost operative delirium, which resolved. You are now safe to \nreturn home to complete your recovery with the following \ninstructions:\n.\nPlease call Dr. ___ office at ___ if you have any \nquestions or concerns..\n.\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication.  Also, please take \nany new medications as prescribed.\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids.  Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon, who will instruct you further regarding activity \nrestrictions.\nAvoid driving or operating heavy machinery while taking pain \nmedications.\nPlease follow-up with your surgeon and Primary Care Provider \n(PCP) as advised.\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with a mild soap \nand warm water.  Gently pat the area dry.\n*If you have steri-strips, they will fall off on their own.  \nPlease remove any remaining strips ___ days after surgery.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18175344","hadm_id":"26963008","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nBcg (Bacillus ___) / Influenza Virus Vaccine\n \nAttending: ___\n \nChief Complaint:\nAnemia\n \nMajor Surgical or Invasive Procedure:\nCABG, MVR\n \nHistory of Present Illness:\n___ y/o woman with PMHx significant for CAD s/p CABG ___ \n(occluded SVG to OM and SVG to PDA grafts, occluded LIMA to LAD, \noccluded RCA and occluded LCx stent), PCI ___, sCHF (EF 35%), \nNSTEMI ___ and multiple GIBs requiring transfusions who was \nadmitted to ___ ___ for scheduled CABG and MVR who was found \nto have an LV aneurysm and HCT 16. She was taken off the OR \ntable and sent to the VICU, where she was transfused 4U pRBCs \nwith appropriate response. She was recently discharged from \n___ ___ for CHF exacerbation and has been in her USOH. \nShe denies recent CP/SOB/N/V/D/BRBPR, hematemesis or hemoptysis. \nShe has had melanotic stools, though she notes these are chronic \nand likely related to her FeSO4 supplementation. EGD on ___ \nshowed non bleeding varicies of the esophagus and fundus and \ngastritis. Colonoscopy from the same day showed multiple benign \npolyps and cecal AVMs, one of which was biopsied. \n.  \nOn arrival to the floor, patient denies CP/SOB/N/V, \nlightheadedness or palpitations. No e/o active or ongoing \nbleeding.\n \nPast Medical History:\nPAST MEDICAL HISTORY:  \n1. CARDIAC RISK FACTORS: Hypertension  \n2. CARDIAC HISTORY:  \n-CABG:  CAD s/p CABG ___ (occluded SVG to OM and SVG to PDA \ngrafts, occluded LIMA to LAD, occluded RCA and occluded LCx \nstent)\n-PERCUTANEOUS CORONARY INTERVENTIONS: PCI ___ to LCx c/b in \nstent thrombosis s/p baloon angioplasty\n-PACING/ICD: None \n3. OTHER PAST MEDICAL HISTORY:  \n-NSTEMI ___\n-GI bleeds with multiple prior transfusions in past year\n-s/p chole with hernia at incision site\n-Anemia\n-Hypothyroidism\n-Depression.\n-GERD.\n-TB exposure.\n-Depression.\n\n \nSocial History:\n___\nFamily History:\nPatient does not know her family history.\nParents died when she was young.  \n \nPhysical Exam:\nAdmission Exam: \nVS: T 98 BP 110/80 HR 70 RR 20 O2 Sat 95% RA\nGENERAL: WDWN woman in NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa. \nNECK: Supple, unable to asses JVP ___ R IJ TLC\nCARDIAC: RR, normal S1, S2. II/VI non radiating systolic murmur \nbest heart at the RUSB. No thrills, lifts. No S3 or S4. PMI \nlocated in ___ intercostal space, midclavicular line.  \nLUNGS: CTAB,crackles at the bases, no wheezes or rhonchi. No \nchest wall deformities, scoliosis or kyphosis. Resp were \nunlabored, no accessory muscle use.  \nABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not \nenlarged by palpation. No abdominal bruits.  \nEXTREMITIES: WWP, trace BLE edema  \nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  \nPULSES:  \nRight: Carotid 2+ DP 2+ ___ 2+  \nLeft: Carotid 2+ DP 2+ ___ 2+  \nNEURO: A/Ox3, CN II-XII intact, non focal.\n.\nDischarge Exam:\nWt 67.4-\u003e65.6-\u003e65.8-\u003e66.1-\u003e64.7\nTele: No events\nVS: T ___ BP 99-121/50s-60s HR ___ RR 18 O2 Sat 96% RA\nGEN: NAD, pleasant   \nHEENT: NCAT. MMM. \nNECK: Supple, unable to asses JVP ___ R IJ TLC\nCARDIAC: RR, normal S1, S2. II/VI non radiating systolic murmur \nbest heart at the RUSB, heard throughout the precordium, rads to \naxilla. No thrills, lifts. No S3 or S4. \nLUNGS: CTAB, no wheezes, rales or rhonchi. No increased WOB\nABDOMEN: Soft, NTND. No HSM or tenderness. \nEXTREMITIES: WWP, no c/c/e.  \nNEURO: A/Ox3, CN II-XII intact, non focal. \n\n \nPertinent Results:\nAdmission Labs:\n\n___ 09:48AM BLOOD WBC-5.1# RBC-2.64* Hgb-8.3* Hct-25.8* \nMCV-98 MCH-31.4 MCHC-32.2 RDW-18.5* Plt ___\n___ 09:48AM BLOOD Neuts-75.4* ___ Monos-4.4 Eos-1.3 \nBaso-0.5\n___ 09:48AM BLOOD ___ PTT-27.6 ___\n___ 02:09PM BLOOD Ret Aut-4.4*\n___ 09:48AM BLOOD Glucose-128* UreaN-51* Creat-1.1 Na-136 \nK-4.1 Cl-103 HCO3-25 AnGap-12\n___ 09:48AM BLOOD ALT-31 AST-44* AlkPhos-144* TotBili-0.6\n___ 09:48AM BLOOD Albumin-3.1* Calcium-8.2* Phos-5.6* \nMg-2.2\n___ 06:30AM BLOOD calTIBC-467 VitB12-491 Folate-GREATER TH \nFerritn-47 TRF-359\n___ 07:38AM BLOOD Type-ART pO2-395* pCO2-38 pH-7.42 \ncalTCO2-25 Base XS-0 Intubat-INTUBATED Vent-CONTROLLED\n___ 07:38AM BLOOD Glucose-115* Lactate-2.2* Na-134 K-3.5 \nCl-102\n___ 07:38AM BLOOD Hgb-5.4* calcHCT-16\n___ 07:46AM BLOOD Hgb-5.4* calcHCT-16\n___ 07:38AM BLOOD freeCa-1.08*\n.\nDischarge Labs:\n\n___ 05:13AM BLOOD WBC-3.6* RBC-2.70* Hgb-8.4* Hct-26.0* \nMCV-96 MCH-31.0 MCHC-32.3 RDW-16.5* Plt ___\n___ 05:13AM BLOOD Glucose-94 UreaN-29* Creat-1.0 Na-138 \nK-4.0 Cl-100 HCO3-32 AnGap-10\n.\nTTE (___):\nThere is a left ventricular aneurysm involving the basal \ninferior, posterior, and lateral walls. NO thrombus seen on \ncontrast imaging with Optison. LV systolic function appears \nseverely depressed (see report of ___ for details). \nThe mitral valve leaflets are mildly thickened. An eccentric, \nposteriorly directed jet of severe (4+) mitral regurgitation is \nseen.  \n.\nCardiac MRI (___): Read Pending\n.\nKUB (___): \nFINDINGS: A single frontal view of the abdomen shows a round \nradiopaque \ndensity in the lower mid abdomen, which is likely the capsule in \nor close to the rectosigmoid junction. There are surgical clips \nin the right upper \nquadrant. There is a nonobstructive gas pattern. There are \nvascular \ncalcifications. \n  \nIMPRESSION: Capsule present around the rectosigmoid junction. \n\n \nBrief Hospital Course:\nPrimary Reason for Admission: ___ y/o woman with PMHx significant \nfor CAD s/p CABG ___ (occluded SVG to OM and SVG to PDA grafts, \noccluded LIMA to LAD, occluded RCA and occluded LCx stent), PCI \n___, ___ (EF 35-40%), NSTEMI ___ and multiple GIBs requiring \ntransfusions who was admitted to ___ ___ for scheduled CABG \nand MVR who was found to have an LV aneurysm and HCT 16 now \nadmitted to ___ for workup of anemia and further eval of LV \naneurysm.\n.\nActive Problems:\n.\n# Anemia: Pt was found to have HCT of 16 on pre-op ABG. Given \nextensive h/o GIBs requiring transfusion and the acuity of her \nHCT drop, GIB is the most likely cause of her anemia. She was \ntransfused 4U pRBCs with appropriate repsonse and admitted to \n___. The pt was guiac negative and denied BRBPR, hematemesis or \nhemoptysis. She did endorse melana, though she takes oral FeSO4 \nsupplementation. On ___ pt had a melanotic BM that was \nguiac positive. GI was consulted and recommended capsule \nendoscopy to r/o small bowel source. Capsule study was \nunremarkable, but of poor quality. Push enteroscopy was then \nperformed and showed angioectasias in the proximal jejunum and \nmid jejunum (thermal therapy), as well as esophageal/gastric \nvaricies and gastritis (no active bleeding). Fe, folate, B12, \nhaptoglobin and reticulocyte count were all appropriate and the \npt's HCT remained stable throughout the remainder of her course. \nUltimately, her anemia was felt to be ___ GIB, though we were \nunable to find an actively bleeding source. Given her HCT \nremained stable after her initial presentation, this is \ncompatible with a self-limited GIB. She was discharged home. \n.\n# CAD: Pt remained CP free througout her course and her \nmedications were continued. She was discharged home with \ninstructions to return to the hosptial next week for elective \nCABG. \n.\n# LV Aneurysm: Pt was noted to have an LV aneurysm on pre-op \nTEE. TTE was performed on ___ that conformed presence of \naneurysm and was negative for mural thrombus. On ___, \nCardiac MRI was preformed; final read was pending at the time of \ndischarge. \n.\n# CHF: Pt with EF 25%. She received a large osmotic load with 4U \npRBCs and was diuresed with Lasix 20mg IV x2 upon arrival to the \nfloor. She responded well to the lasix and was euvolemic s/p \ndiuresis. She remained comfortable on RA throughout her course, \nand there was no clinical evidence of CHF exacerbation during \nher stay. \n.\nChronic Problems:\n.\n# MR: Pt with known, severe MR. ___ the setting of EF 25%, she \nwould benefit from MVR to improve forward flow and quality of \nlife. This is planned to coincide with CABG. \n.\n# Cirrhosis: Pt with known Primary Biliary Cirrhosis; her \nursodiol 500mg po bid \nwas continued throughout her course. \n.\n# Hypothyroidism: Her levothyroxine was continued throughout her \ncourse. \n.\nTransitional Issues: Pt remained stable througout her course. \nShe was d/c'ed home with plan for elective CABG next week. She \nhas cards/GI follow up. \n \nMedications on Admission:\nallopurinol ___ mg BID\ndigoxin 125 mcg\nfolic acid 1 mg\nvicodin prn\nlevothyroxine 150 mcg\nlisinopril 2.5 mg\nlorazepam 0.5 mg BID\nmetoprolol succinate 25 mg daily\nNitroglycerin PRN\nZoloft 50 mg daily\ntorsemide 20 mg, 30 mg for the past few days\ncolace 100 mg BID\nferrous sulfate 325 mg daily\nsulcralfate 1 g bid \naspirin 325 mg daily\nursodiol 500 mg twice a day\npravastatin 20 mg daily\npantoprazole 40 mg BID\n\n \nDischarge Medications:\n1. allopurinol ___ mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n2. digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n3. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n4. levothyroxine 75 mcg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n5. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for anxiety.  \n6. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: \nOne (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n7. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain: \nas previously prescribed.  call md or 911 if take them.  \n8. sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n9. torsemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n10. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.  \n11. ferrous sulfate 300  mg (60 mg iron) Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n12. sucralfate 1 gram Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n13. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n14. ursodiol 250 mg Tablet Sig: Two (2) Tablet PO BID (2 times a \nday).  \n15. pravastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).\nDisp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*2*\n17. lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPriamry: \nCoronary Arteries Disease\nSecondary:\nGI Bleed\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms ___, \n\nIt was a pleasure caring for you at the ___ \n___. You were admitted to have an operation on your \nheart. Immediately before your surgery, the surgeons noticed \nthat your blood counts were low and that the aneurysm in your \nheart was enlarged. As such, you were admitted to the hospital \nfor ongoing management of these issues.\n\nWe performed a thorough workup of your anemia including \nenteroscopy and capsule imaging and found no evidence of ongoing \nbleeding. You had an endoscopy that showed small malformations \nin your small bowel that were not bleeding.  The \ngastroenterologists felt that you were safe to have your \nsurgery.  We also performed an MRI of your heart to further \nevaluate your ventricular aneurysm.    You are being discharged \nhome to come back next week for your bypass surgery.\n\nDuring this admission, we made no changes to your medications. \n\nWeigh yourself every morning, call MD if weight goes up more \nthan 3 lbs.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15597359","hadm_id":"22459205","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nLisinopril / Feldene / Keflex\n \nAttending: ___.\n \nChief Complaint:\ndiarrhea\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ y.o.f. with peripheral neuropathy, constipation, and \nmetastatic breast cancer to the liver who received C2D8 of \nnavelbine/avastin on ___, although the navelbine was held \nd/t neutropenia, who presents with diarrhea for 4 days PTA. The \npatient has had issues with chronic constipation that has \nworsened on new chemotherapy, and she was taking senna daily. \nShe added miralax to this on ___ and then added MOM to this on \n___ so that she was taking 3 agent for constipation. She then \ndeveloped loose stool on ___ and ___ BMs by ___ that \ncontinued ___ and today. She stopped the stool medications \nyesterday. + chills, no fevers to her knowledge. Stool is brown, \nno melena, no hematochezia. Mild stomach cramping, not \nassociated with food. No nausea or emesis. Unable to keep up \nwith POs due to lack of appetite. No LH, dizziness. . Two days \nof lethargy.\n.\nIn the ED, vitals 97.7, 133, 152/84, 20, 100% RA. Received 1L NS \nand oral potassium. UA sent but contaminated. BCX, UCX sent.\n \nPast Medical History:\nMetastatic breast cancer - ER/PR positive, HER-2/neu negative \ninvolving the liver. She was initially diagnosed with a T1c N0 \ncancer, found to be recurret in ___ involving the \nliver. She is status post 4 cycles of single agent Taxotere, \nwhich she completed on ___. She had disease progression \ninvolving her liver and therefore she was initiated on Navelbine \ncombined with Avastin on ___, and she has completed two \ncycles of therapy.\n# Peripheral neuropathy\n# Constipation\n# right thyroid lobectomy performed ___ by Dr. ___ \n___ a follicular adenoma\n# Hypercholesteremia\n# GERD\n# CAD ___ cardiac cath with subtotal stenosis of the \nproximal LAD with subsequent angioplasty and stent placement. \nThe patient had a normal MIBI on ___.\n# SVT\n \nSocial History:\n___\nFamily History:\nThe patient's maternal aunt had breast cancer in her ___ or \n___ and died of this. Mother developed colon cancer at the age \nof ___\n \nPhysical Exam:\nVITAL SIGNS: 97.3, 150/80, 80, 16, 97% RA.\nGENERAL: Pleasant, NAD, easily arousable.\nHEENT: Bald, anicteric sclerae. EOMI. OP clear, MM dry,\nNECK: Supple without any cervical or supraclavicular adenopathy.\nLeft sided port site appears to be clean, dry, and intact.\nCARDIAC: Regular rate, S1, S2, no murmurs, rubs, or gallops.\nLUNGS: CTAB, no W/R/C.\nABDOMEN: Soft, nontender, nondistended. + BS.\nEXTREMITIES: No C/C/E\n \nPertinent Results:\n___ 06:24AM BLOOD WBC-3.5* RBC-3.45* Hgb-9.3* Hct-29.4* \nMCV-85 MCH-26.9* MCHC-31.6 RDW-20.6* Plt ___\n___ 02:00PM BLOOD WBC-2.7* RBC-3.90* Hgb-10.3* Hct-31.8* \nMCV-81* MCH-26.4* MCHC-32.4 RDW-22.2* Plt ___\n___ 06:25AM BLOOD ___ PTT-28.1 ___\n___ 06:24AM BLOOD UreaN-15 Creat-0.6 Na-140 K-3.9 Cl-107 \nHCO3-26 AnGap-11\n___ 02:00PM BLOOD Glucose-140* UreaN-13 Creat-0.7 Na-141 \nK-3.1* Cl-105 HCO3-27 AnGap-12\n___ 06:25AM BLOOD CK(CPK)-71\n___ 02:00PM BLOOD ALT-28 AST-57* AlkPhos-77 TotBili-1.1\n___ 06:24AM BLOOD Mg-1.9\n___ 07:50AM BLOOD Lactate-2.4*\n___ 02:03PM BLOOD Lactate-3.4*\n___ 04:00PM URINE Color-Straw Appear-Clear Sp ___\n___ 04:00PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-TR\n___ 04:00PM URINE ___ Bacteri-OCC Yeast-NONE \n___\n\n___ 3:47 am SWAB     Site: RECTAL      Source: Rectal swab. \n\n\n   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Preliminary): \n      No Virus isolated so far. \n\n___ 5:08 pm STOOL     CONSISTENCY: WATERY      Source: \nStool. \n\n                            **FINAL REPORT ___\n\n   CLOSTRIDIUM DIFFICILE TOXIN ASSAY (Final ___: \n      FECES NEGATIVE FOR C. DIFFICILE TOXIN BY EIA. \n           (Reference Range-Negative). \n\nBlood culture negative at time of discharge. Urine culture - \ncontaminated. \n\nPA AND LATERAL VIEWS OF THE CHEST.\n\nINDICATION: ___ female with metastatic breast cancer to \nthe liver, presenting with weakness, diarrhea. Assess for \ninfiltrate.\n\nCOMPARISONS: CT dated ___.\n\nFINDINGS: The left-sided central venous port is in place with \ntip at the cavoatrial junction. The cardiomediastinal silhouette \nis stable. A small right pleural effusion appears unchanged \ncompared to the CT examination of ___. The lungs are clear, \nwithout focal evidence of consolidation. There are mild \ndegenerative changes involving the right acromioclavicular \njoint. A few hyperdense foci project over the right upper \nquadrant of the abdomen and likely correlate to gallstones seen \non the previous CT examination. The soft tissues and osseous \nstructures are otherwise grossly unremarkable.\n\nIMPRESSION: Stable small right pleural effusion compared to CT \nof ___. No acute cardiopulmonary process.\n\nCardiology ReportECGStudy Date of ___  8:04:40 ___\n \nEctopic atrial tachycardia. Compared to the previous tracing of \n___ the\nischemic appearing anterior ST segment changes have improved. \nOtherwise,\nno diagnostic interim change.\nTRACING #2\n\nCardiology ReportECGStudy Date of ___  2:35:00 ___\n \nEctopic atrial tachycardia is new as compared with prior tracing \nof ___.\nAtrial ectopy is no longer recorded and there are new ischemic \nappearing\nST segment changes in leads V2-V4 in the context of increase in \nrate and\nchange in atrial morphology. Followup and clinical correlation \nare suggested.\nTRACING #___iarrhea from laxatives likely. Infectious work up negative. \nDiarrhea resolved on day 2 of admission. \nHypovolemia - resolved with IV fluids. \n\nH/o supra ventricular tachycardia, ectopy - noted on telemetry. \nKnown history of SVT and patient followed by Dr ___ \ncardiology. \n\nHistory of metastatic breast cancer - follow up with Dr ___ \n___ ongoing chemotherapy. \n\nHistory of hypertension - well controlled on home regimen. \n\nNeutropenia - likely from chemotherapy. Stable. Patient \nafebrile. \n\nAnemia - stable. \n \nMedications on Admission:\nAmlodipine 5 mg daily\nHCTZ 25 mg daily\nMetoprolol 50 mg BID\nMorphine SR 7.5 mg QAM, 15 mg QPM\nProtonix 40 mg daily\nCompazine 10 mg PO Q8H prn\nAspirin 81 mg PO daily\nMOM prn\n___ TID\nMiralax\n \nDischarge Medications:\n1. Morphine 15 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO QHS (once a day (at bedtime)).  \n2. Morphine 15 mg Tablet Sustained Release Sig: 0.5 Tablet \nSustained Release PO QAM (once a day (in the morning)).  \n3. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).  \n4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n5. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n6. Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once \na day.  \n7. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \n8. Compazine 10 mg Tablet Sig: One (1) Tablet PO every eight (8) \nhours as needed for nausea.  \n9. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO twice \na day.\nDisp:*60 Capsule(s)* Refills:*0*\n10. Senna 8.6 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nDiarrhea from laxatives\nHypovolemia\nH/o supra ventricular tachycardia, ectopy\nHistory of metastatic breast cancer\nHistory of hypertension \nNeutropenia\nAnemia\n\n \nDischarge Condition:\nstable\n\n \nDischarge Instructions:\nReturn to the hospital if you have new diarhea, abdominal pain \npr any other symptoms of concern to you. \n\nKeep your appointments. \n\nYou had diarrhea likely from the laxative. No soucce of \ninfection was found. \n\nIf you get constipatied, use medications as prescribed with prn \nuse meds. Discuss this further with your primary care doctor. \n\nYour heart rate increased with walking. Please discuss this as \nwell with your primary care doctor. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"12576401","hadm_id":"21366082","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nfever\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPCP:\nName: ___. \nAddress: ___, ___ \nPhone: ___ \nFax: ___ \n\n___ with poorly differentiated adenocarcinoma of the distal \nesophagus (T3, N1, M0) status post stenting and possible \nalcohol-related liver disease, recently hospitalized for \ninitiation of chemo (cisplatin, fluorouracil), and radiation, \npresents with fever, chest pain, dyspnea, and cough.  Symptoms \nbegan a few days ago since discharge.  He reports clear sputum.  \nHis pain is midsternal, tighness, and pleuritic.  He denies \nradiation to arm, numbness, abd pain.  He has been undergoing \nradiation and not tolerating well.  He reports his companion had \na \"cold\" recently.  He also reports anorexia and n/v with food.  \nHe denies diarrhea, bloody/black stool, or dysuria.\n\nIn the ED, he was found to have asymmetric BP in arms (lower on \nleft).  CXR negative, but CTA chest suggestive of bilateral PNA, \nas well as left subclavian stenosis/occlusion.  He was given \nVanco/Cefepime/Flagyl and vascular surgery was consulted.\n\n10 point review of systems otherwise negative\n \nPast Medical History:\nPAST ONCOLOGIC HISTORY:  \nPoorly differentiated adenocarcinoma of the distal esophagus \n(T3, N1, M0) status post stenting\nChemo/XRT initiated ___:\n(cisplatin day 1/fluorouracil days ___, 28-day \ncycle) and radiation (50.4 Gy in 28 fractions over 5.5 weeks)\n\nPAST MEDICAL HISTORY:  \nProbable alcohol-related liver disease (patient denies)\nGastric ulcer\nChronic left knee injury\n\n \nSocial History:\n___\nFamily History:\nFather died at ___ years old of a CVA. Mother died at ___ years \nold of a pulmonary embolism.\n\n \nPhysical Exam:\nT 97.1, HR 71, BP 156/49R 96/67L, RR 22, 100%RA\ncachectic, tired appearing in NAD\nanicteric sclera, MMM, OP clear, PERRL\nsupple, thin neck, no LAD\nRRR nl S12, no mrg.  diminshed radial pulse L arm\nBibasilar crackles with triggered coughing, scattered wheeze.  \nsymmetric\nabd soft with upper abd tenderness to palpation, +BS no rebound\nExt warm, with venous stasis change and varicosities.  clean \nbased L plantar ulcer without drainage\nBack without lesions or midline tenderness\nno rashes or bruising\nalert and oriented.  CN II-XII intact\n \nPertinent Results:\n___ 11:00AM URINE  HOURS-RANDOM\n___ 11:00AM URINE  UHOLD-HOLD\n___ 11:00AM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 11:00AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-70 KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 08:54AM   LACTATE-2.0\n___ 08:40AM   GLUCOSE-101* UREA N-7 CREAT-0.7 SODIUM-135 \nPOTASSIUM-3.1* CHLORIDE-98 TOTAL CO2-24 ANION GAP-16\n___ 08:40AM   estGFR-Using this\n___ 08:40AM   ALT(SGPT)-10 AST(SGOT)-18 ALK PHOS-106 TOT \nBILI-1.0\n___ 08:40AM   cTropnT-\u003c0.01\n___ 08:40AM   ALBUMIN-3.1* CALCIUM-8.4 PHOSPHATE-2.1* \nMAGNESIUM-1.7\n___ 08:40AM   WBC-2.8* RBC-3.41* HGB-12.7* HCT-34.6* \nMCV-102* MCH-37.1* MCHC-36.5* RDW-14.5\n___ 08:40AM   NEUTS-23* BANDS-6* ___ MONOS-37* EOS-0 \nBASOS-0 ATYPS-3* ___ MYELOS-0\n___ 08:40AM   HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-NORMAL \nMACROCYT-2+ MICROCYT-NORMAL POLYCHROM-NORMAL\n___ 08:40AM   PLT SMR-NORMAL PLT COUNT-256#\n___ 08:40AM   ___ PTT-27.4 ___\n\nBlood/Urine cx: NGTD\n\nCXR:\nFINDINGS: \nThe lungs are well expanded, without focal opacities.  \nCardiomediastinal and hilar contours are unremarkable. There is \nno pleural effusion or pneumothorax. Interval removal of right \nsided PICC. Known esophageal stent barely seen. \n  \nIMPRESSION: No evidence of pneumonia. \n\nCTA CHEST:\n1. Complete occlusion of the left subclavian artery by a large \ncalcified \natherosclerotic plaque at its origin is incompletely evaluated \nin this exam but raises concern for subclavian steal syndrome. \nEvaluation of differential upper extremity blood pressure should \nbe performed. Dense calcification was also seen at the level of \nocclusion in the non enhanced chest CT from ___, \nsuggesting chronicity. \n2. No evidence of pulmonary embolism or acute aortic syndrome. \n3. No esophageal extravasation of contrast or penumomediastinum \nidentified.  However, this supine study is limited for \nassessment of esophageal perforation and an upper GI study \nshould be performed if there is further clinical concern. \n4. Bibasilar ground-glass opacities with nodular components, \nmore prominent in the right base, are slightly worsened than in \nthe previous exam. Given short term progression this likely \nrepresents infection versus aspiration.  However, continued \nfollow up after treatment is recommended to assess for \nresolution of nodular component in this patient with history of \nesophageal cancer. \n\nCarotid US:\nIMPRESSION:  Diffuse distal common carotid and carotid \nbifurcation plaque with no significant stenosis.  Reversal of \nflow is seen in the left vertebral artery consistent with a \nknown subclavian occlusion. \n\nFOOT X RAY:\nTHREE VIEWS, LEFT FOOT: \nThere is an ulceration measuring approximately 2.2 cm on the \nplantar aspect of the left foot at the level of the \ntarsometatarsal joints.  There is a somewhat chronic-appearing \nerosion at the base of the first metatarsal medially.  If this \ncorresponds to the site of the ulcer, this could reflect \nosteomyelitis.  Otherwise, this represents a nonspecific erosion \nwhich could be seen in the setting of an inflammatory \narthropathy or gout.  There are mild degenerative changes of the \nleft foot.  A moderate-sized plantar calcaneal spur is noted. \n\nBlood, Urine cx, Legionella: Negative\n \nBrief Hospital Course:\n___ with esophageal carcinoma recently hospitalized and started \non chemo/XRT, now neutropenic, presents with fever, cough, \ndyspnea, and chest pain, CT findings suggestive of PNA as well \nas incidental left subclavian artery occlusion/stenosis, new \natrial fibrillation, and chronic foot ulcer.\n\nPresumed infectious/bacterial PNA: Based on new symptoms of \ncough, fever, dyspnea, and chest pain.  Neutropenic so high risk \nfor bacterial infection, and also high risk for resistance given \nrecent prolonged hospitalization.  Was initially given \nVanco/Cefepime/Levofloxacin with rapid improvement.  He was then \nweaned to Levofloxacin alone with continued benefit.  Cultures \nwere negative.  He was discharged to complete a full course with \nLevofloxacin.\n\nSubclavian artery stenosis/occlusion: Asymptomatic but clear BP \ndifference on exam.  Findings suggest chronicity.  Diminished \nradial pulse.  Carotid/Vertebral ultrasound demonstrated \nexpected reversal of flow.  Vascular surgery was consulted and \nfelt he had subclavian steal, but no syndrome given he was \nasymptomatic.  They recommended 3 month follow up.\n\nNeutropenia: Likely chemo induced.  Counts improved prior to \ndischarge\n\nEsophageal carcinoma: Poorly differentiated.  s/p stenting, \nchemo, xrt.  XRT was continued in house and will continue as \noutpatient.  Appointment with Dr. ___ was to be rescheduled.\n\nNew Atrial Fibrillation: Noted on admission EKG.  Asymptomatic \nand controlled.  CHADS2 = 0.  This was discussed with patient.  \nAspirin 81mg daily was initiated on discharge.\n\nChronic foot ulcer: Wound care and podiatry were consulted.  \nXray was performed showing erosion but no clear osteomyelitis.  \nPodiatry recommended WTD dressings daily, CAM boot, and close \nfollow up\n\nPUD: PPI continued\n\nCode: FULL, confirmed\n\n \nMedications on Admission:\nOmeprazole 20 mg PO BID \nSucralfate 2 gm PO BID \nOndansetron 8 mg PO Q8H:PRN nausea \nProchlorperazine 10 mg PO Q6H:PRN nausea \nAlleve prn, last dose yesterday\n \nDischarge Medications:\n1. Levofloxacin 750 mg PO DAILY Duration: 5 Doses \nRX *levofloxacin 750 mg 1 tablet(s) by mouth once a day Disp #*2 \nTablet Refills:*0\n2. Neutra-Phos 1 PKT PO DAILY \nRX *potassium \u0026 sodium phosphates [Phos-NaK] 280 mg-160 mg-250 \nmg 1 powder(s) by mouth once a day Disp #*30 Packet Refills:*0\n3. Omeprazole 20 mg PO BID \n4. Ondansetron 8 mg PO Q8H:PRN nausea \n5. Prochlorperazine 10 mg PO Q6H:PRN nausea \n6. Sucralfate 1 gm PO BID \ndo not take with antibiotic \n7. Aspirin 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet,chewable(s) by mouth once a day Disp \n#*90 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nBacterial Pneumonia\nNeutropenia\nAtrial fibrillation, new\nEsophageal cancer\nLeft subclavian artery occlusion, chronic\nLeft foot ulcer\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted with fever, cough, shortness of breath.  You \nwere diagnosed with a pneumonia.  With antibiotics your symptoms \nimproved.  You will need to complete a full course of therapy.  \nIn addition, your blood counts were found to be recovering from \nyour recent chemotherapy.  You will need to follow up with Dr. \n___ continue your radiation treatments.\n\nAdditionally, you were found to have an old occlusion of your \nleft subclavian artery.  Please follow up with vascular surgery \nto monitor this.  Also, please wear your CAM boot to protect \nyour ulcer, and see a Podiatrist.\n\nFinally, you were also found to have atrial fibrillation, a \nheart rhythm which can increase your risk of stroke.  Given your \nrisk factors, you will be started on a daily aspirin.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10247690","hadm_id":"24858476","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: CARDIOTHORACIC\n \nAllergies: \nNeosporin / atorvastatin / aspirin / Zetia\n \nAttending: ___\n \nChief Complaint:\nShortness of breath and chest pain\n \nMajor Surgical or Invasive Procedure:\n___ CABG\nUrgent coronary artery bypass graft x4:  Left internal mammary \nartery to left anterior descending artery, and saphenous vein \ngrafts to the diagonal, obtuse marginal,and distal right \ncoronary arteries. Endoscopic harvesting of the long saphenous \nvein.\n\n \nHistory of Present Illness:\nThis is a ___ year old woman with history of prior NSTEMI in the \nsetting of demand ischemia from anemia, no known prior cath. \nLVEF 40%. Has had intermittent chest pain x one\n\nweek with variable relief with nitro. She presented with \nconstant chest pain since this morning. Took 2 SL nitroglycerin \nwithout relief. Chest pain with exertion, associated with SOB, \nno rest pain. Came in to ER where EKG with ST Elevation. Pain \n___ initially. +  Mild dyspnea. Given asa x 4 and IV morphine \nwith a decrease in pain. Heparin started. Transferred to ___ \nfor cath. Cath today revealed multivessel disease including \ndistal left main, CTO of RCA, and diffuse LAD. A balloon pump \nwas placed via right femoral artery for refractory angina with \nresolution of chest pain and improvement in ECG changes. ___ \nconsulted for emergent CABG\n\n \nPast Medical History:\nHypertension\n\nHyperlipidemia\n\nCAD/NSTEMI in ___ in setting of anemia- LVEF 40-45% ___ MR\n\n___ bleed admit in ___ with HCT of 19-transfused 4 units. \n\n\n+ Guaiac stool, C- scope and EGD did not show any obvious source\n\nof GIB\n\nCapsule endoscopy no active bleeding in small bowel.\n\n___: PE on CTA\n\nPeripheral vascular disease, s/p left common ilaiac artery  \n\nangioplasty/? stent in ___ at ___  \n\nIDDM\n\nCarotid disease - refused CEA in past\n\n? Esophageal stricture - work up in progress\n\nPast Surgical History\n\nAppy\n\nTonsillectomy\n\n___: Actinic keratosis/other papule right calf, excisional\n\nbiopsy\n\n \nSocial History:\n___\nFamily History:\nPremature coronary artery disease\n \nPhysical Exam:\nGeneral Appearance: Well nourished\nEyes / Conjunctiva: PERRL\nHead, Ears, Nose, Throat: Normocephalic\nCardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)\nPeripheral Vascular: (Right radial pulse: Not assessed), (Left \nradial pulse: Not assessed), (Right DP pulse: Not assessed), \n(Left DP pulse: Not assessed)\nRespiratory / Chest: (Expansion: Symmetric), (Percussion: \nResonant : ), (Breath Sounds: Clear : )\nAbdominal: Soft, Non-tender, Bowel sounds present, Distended\nExtremities: Right lower extremity edema: Absent, Left lower \nextremity edema: Absent\nSkin:  Not assessed\nNeurologic: Responds to: Not assessed, Movement: Not assessed, \nTone: Not assessed\n \nPertinent Results:\nADMISSION LABS:\n---------------\n___ 01:44PM BLOOD WBC-10.0 RBC-3.73* Hgb-11.6 Hct-35.3 \nMCV-95# MCH-31.1# MCHC-32.9 RDW-13.2 RDWSD-45.9 Plt ___\n___ 06:30PM BLOOD Neuts-64.7 ___ Monos-6.1 Eos-1.2 \nBaso-0.3 Im ___ AbsNeut-7.17* AbsLymp-3.01 AbsMono-0.68 \nAbsEos-0.13 AbsBaso-0.03\n___ 06:30PM BLOOD ___ PTT-29.1 ___\n___ 01:44PM BLOOD Glucose-150* UreaN-14 Creat-0.9 Na-138 \nK-4.3 Cl-104 HCO3-25 AnGap-13\n___ 12:30PM BLOOD cTropnT-\u003c0.01\n___ 01:44PM BLOOD Calcium-9.0 Phos-3.5 Mg-2.2\n___ 01:55PM BLOOD ___ pH-7.33* Comment-GREEN TOP\n___ 03:21PM BLOOD Type-ART pO2-381* pCO2-44 pH-7.36 \ncalTCO2-26 Base XS-0 Intubat-INTUBATED Vent-CONTROLLED\n___ 03:21PM BLOOD Glucose-138* Lactate-1.0 Na-136 K-4.2 \nCl-108\n___ 03:21PM BLOOD Hgb-11.5* calcHCT-35\n___ 01:55PM BLOOD freeCa-1.11*\n___ 02:06PM URINE Color-Yellow Appear-Clear Sp ___\n___ 02:06PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\n___ 02:06PM URINE RBC-1 WBC-1 Bacteri-NONE Yeast-NONE Epi-1\n\n___ \n\n___ ECHOCARDIOGRAPHY REPORT\n\n___       ___ MRN:   ___       TEE \n(Complete) Done ___ at 4:11:49 ___      FINAL  \nReferring Physician      ___   \n___ of Cardiothoracic Surg\n___  Status: Inpatient DOB: ___ \nAge (years): ___ F  Hgt (in):  \nBP (mm Hg): /  Wgt (lb):  \nHR (bpm):  BSA (m2):  \nIndication: Intraoperative TEE for Emergent CABG with \nintra-aortic balloon pump.  \nDiagnosis: I35.9, I34.0, I36.8 \n___ Information   \nDate/Time: ___ at 16:11    ___ MD: ___, MD \n___ Type: TEE (Complete) Sonographer: ___, MD \nDoppler: Full Doppler and color Doppler ___ Location: \nAnesthesia West OR cardiac \nContrast: None Tech Quality: Suboptimal \nTape #:  Machine: ___ ___ \nEchocardiographic Measurements   \n\nResults  \n\nMeasurements  \n\nNormal Range  \n\nLeft Ventricle - Inferolateral Thickness:   *1.5 cm   0.6 - 1.1 \ncm   \nLeft Ventricle - Diastolic Dimension:   5.2 cm   \u003c= 5.6 cm   \nLeft Ventricle - Ejection Fraction:   30% to 35%   \u003e= 55%   \nAorta - Annulus:   2.2 cm   \u003c= 3.0 cm   \nAorta - Sinus Level:   3.3 cm   \u003c= 3.6 cm   \nAorta - Ascending:   3.1 cm   \u003c= 3.4 cm   \nAorta - Descending Thoracic:   2.1 cm   \u003c= 2.5 cm   \nAortic Valve - Peak Velocity:   1.3 m/sec   \u003c= 2.0 m/sec   \nAortic Valve - Peak Gradient:   7 mm Hg   \u003c 20 mm Hg   \nAortic Valve - Mean Gradient:   3 mm Hg       \nAortic Valve - LVOT diam:   1.9 cm       \n  \nFindings   \nLEFT ATRIUM: No spontaneous echo contrast or thrombus in the \n___ or the RA/RAA. Good (\u003e20 cm/s) ___ ejection velocity. \n\nRIGHT ATRIUM/INTERATRIAL SEPTUM: A catheter or pacing wire is \nseen in the RA and extending into the RV. Left-to-right shunt \nacross the interatrial septum at rest. \n\nLEFT VENTRICLE: Moderate symmetric LVH. Normal LV cavity size. \nModerate-severe regional left ventricular systolic dysfunction. \n\nRIGHT VENTRICLE: Normal RV systolic function. \n\nAORTA: Normal aortic diameter at the sinus level. Focal \ncalcifications in aortic root. Normal ascending aorta diameter. \nSimple atheroma in ascending aorta. Focal calcifications in \nascending aorta. Simple atheroma in aortic arch. Normal \ndescending aorta diameter. Simple atheroma in descending aorta. \n\nAORTIC VALVE: Mildly thickened aortic valve leaflets (3). No AS. \nTrace AR. \n\nMITRAL VALVE: Mildly thickened mitral valve leaflets. Mild \nmitral annular calcification. Mild to moderate (___) MR. \n\n___ VALVE: Mildly thickened tricuspid valve leaflets. Mild \nto moderate [___] TR. \n\nPULMONIC VALVE/PULMONARY ARTERY: Thickened pulmonic valve \nleaflets. Mild PR. \n\nPERICARDIUM: No pericardial effusion. \n\nGENERAL COMMENTS: Informed consent was obtained. A TEE was \nperformed in the location listed above. I certify I was present \nin compliance with ___ regulations. The ___ was under \ngeneral anesthesia throughout the procedure. No TEE related \ncomplications. Image quality was suboptimald - poor esophageal \ncontact. The ___ appears to be in sinus rhythm. Results were \npersonally reviewed with the MD caring for the ___.   \nConclusions   \nPRE BYPASS No spontaneous echo contrast or thrombus is seen in \nthe body of the left atrium/left atrial appendage or the body of \nthe right atrium/right atrial appendage. A PFO with \nleft-to-right shunt across the interatrial septum is seen at \nrest. There is moderate symmetric left ventricular hypertrophy. \nThe left ventricular cavity size is normal. There is moderate to \nsevere regional left ventricular systolic dysfunction with \nsevere hypokinesis of the inferior wall with extension \ninferoseptally and inferolaterally is seen in the setting of \nmoderate global hypokinesis. The right ventricle displays normal \nfree wall contractility. There are simple atheroma in the \nascending aorta. There are simple atheroma in the aortic arch. \nThere are simple atheroma in the descending thoracic aorta. An \nintra-aortic balloon pump is seen in the descending thoracic \naorta. Its tip is about 2 cm below the distal arch. The aortic \nvalve leaflets (3) are mildly thickened but aortic stenosis is \nnot present. Trace aortic regurgitation is seen. The mitral \nvalve leaflets are mildly thickened. Mild to moderate (___) \nmitral regurgitation is seen. The tricuspid valve leaflets are \nmildly thickened. There is mild to moderate tricuspid \nregurgitation. The pulmonic valve leaflets are thickened. There \nis no pericardial effusion. Dr. ___ was notified in \nperson of the results in the operating room at the time of the \nstudy.\n\n POST BYPASS The ___ is atrially paced. The ___ is \nreceiving epinephrine by IV infusion. There is normal right \nventricular systolic function. The left ventricle displays \ncontinued severe inferior hypokinesis with extension laterally \nand septally but all other wall segments show improved function. \nThe left ventricular ejection fraction is about 40 to 45%. The \nmitral regurgitation ___ initially in the moderate to severe \nrange after separation from bypass but improved over time and \nwas eventually back in the mild to moderate range. The tricuspid \nregurgitation was also worsened to the moderate range. The rest \nof valvular function was unchanged. The thoracic aorta was \nintact after decannulation with the IABP still in place.    \n   I certify that I was present for this procedure in compliance \nwith ___ regulations.\n\nElectronically signed by ___, MD, Interpreting physician \n___ ___ 18:31   \n    \n\n ___ ___. All rights reserved.\n\n___ 05:02AM BLOOD WBC-12.7* RBC-2.37* Hgb-7.4* Hct-23.1* \nMCV-98 MCH-31.2 MCHC-32.0 RDW-14.0 RDWSD-49.3* Plt ___\n___ 04:50AM BLOOD ___\n___ 05:02AM BLOOD Glucose-171* UreaN-48* Creat-1.2* Na-136 \nK-4.6 Cl-96 HCO3-29 AnGap-16\n \nBrief Hospital Course:\n###Medical Course###\n___ year old woman with history of prior NSTEMI in the setting of \ndemand ischemia from anemia, no known prior cath. LVEF 40%. Has \nhad intermittent chest pain x one week with variable relief with \nnitro. found to have distal LM significant lesion with a chronic \nocclusion of the RCA. The ___ was placed on an IABP for \nrefractory chest pain that improved with the AIBP, admitted \ninitiation to the CCU for monitoring and c.surg eval.\n\n# Acute ST elevation MI: s/p cath with LM and chronic RCA lesion \nwhich is equivalent to 3VD. the ___ has chest pain off of \nthe IABP which indicate ongoing ischemia. She is a good surgical \ncandidate given the good baseline physical and lack of \nsignificant comorbidities. She was quickly taken for CABG with \nC-surg after arrival.\n\n# Hypertension: Her home antihypertensives were held in the \nsetting of possible CABG\n\n# Hyperlipidemia: Was continued on home statins\n\n# Anemia/and history of GI bleed: CBC was stable on admission.\n\n# Peripheral vascular disease: Continued on statin and ASA \ntomorrow. \n\n# IDDM: managed on home insulin.\n\n###Cardiac Surgery Course###\nOn ___ ___ was taken urgently to the operating room \nand underwent\n1. Urgent coronary artery bypass graft x4:  Left internal \nmammary artery to left anterior descending artery, and saphenous \nvein grafts to the diagonal, obtuse marginal,and distal right \ncoronary arteries. 2. Endoscopic harvesting of the long \nsaphenous vein. Please see operative report for further surgical \ndetails. She tolerated the procedure well and was transferred to \nthe CVICU for recovery and invasive monitoring. She was kept \nintubated and the Intraaoric balloon was kept in over night. The \nfollowing morning she awoke neurologically intact and was weaned \nto extubate. The IABP was discontinued without incident. She \nweaned off of pressor support and Beta-blocker/ASA/Statin and \ndiuresis were initiated. She had postop atrial flutter/ \nfibrillation. She was placed on Amiodarone and beta-blocker \noptimized. Chest tubes and pacing wires were discontinued per \nprotocol without incident. She was transferred to the step down \nunit for further management. Physical Therapy was consulted for \nevaluation of strength and mobility. The remainder of her \nhospital course was essentially uneventful. By  the time of pod# \n6 she was ambulating with assistance, pain controlled, and \nwounds healing. She was discharged to ___ \n___. All follow up appointmenst were advised.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Metoprolol Succinate XL 100 mg PO DAILY \n2. Losartan Potassium 25 mg PO DAILY \n3. Simvastatin 40 mg PO QPM \n4. Insulin SC \n      Sliding Scale\nInsulin SC Sliding Scale using HUM Insulin\n5. Isosorbide Dinitrate 15 mg PO DAILY \n6. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n7. Glucosamine Chondroitin MaxStr (glucosamine-chondroit-vit \nC-Mn) 500-400 mg oral DAILY \n8. Fish Oil (Omega 3) 1200 mg PO DAILY \n9. Ascorbic Acid ___ mg PO BID \n10. Vitamin D 1000 UNIT PO DAILY \n11. Cyanocobalamin 1000 mcg PO DAILY \n12. Co Q-10 (coenzyme Q10) 200 mg oral DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO/PR Q4H:PRN pain or temperature \u003e38.0 \n \n2.  Amiodarone 200 mg PO BID Duration: 7 Days \nthen decrease to 200 mg daily until reevaluated by Cardiologist  \n\n3.  Aspirin EC 81 mg PO DAILY  \n4.  Dextrose 50% 12.5 gm IV PRN glucose  \u003c 60  \n5.  Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol  \n6.  Docusate Sodium 100 mg PO BID  \n7.  Furosemide 40 mg PO DAILY  \n8.  Heparin 5000 UNIT SC BID  \n9.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H  \n10.  Metoprolol Tartrate 12.5 mg PO Q8H  \n11.  Ranitidine 150 mg PO DAILY  \n12.  TraMADol 25 mg PO Q4H:PRN Pain - Moderate  \n13.  70/30 24 Units Breakfast\n70/30 24 Units Dinner\nInsulin SC Sliding Scale using HUM Insulin \n14.  Simvastatin 10 mg PO QPM  \n15.  Ascorbic Acid ___ mg PO BID  \n16.  Co Q-10 (coenzyme Q10) 200 mg oral DAILY  \n17.  Cyanocobalamin 1000 mcg PO DAILY  \n18.  Fish Oil (Omega 3) 1200 mg PO DAILY  \n19.  Glucosamine Chondroitin MaxStr (glucosamine-chondroit-vit \nC-Mn) 500-400 mg oral DAILY  \n20.  Vitamin D 1000 UNIT PO DAILY  \n21. HELD- Losartan Potassium 25 mg PO DAILY  This medication was \nheld. Do not restart Losartan Potassium until reevaluated by \nCardiologist\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nCoronary artery disease\n\n \nDischarge Condition:\nAlert and oriented x3 nonfocal\nAmbulating, gait steady\nSternal pain managed with oral analgesics\nSternal Incision - healing well, no erythema or drainage\nTrace Edema\n\n \nDischarge Instructions:\nPlease shower daily including washing incisions gently with mild \nsoap, no baths or swimming, and look at your incisions\n Please NO lotions, cream, powder, or ointments to incisions\n Each morning you should weigh yourself and then in the evening \ntake your temperature, these should be written down on the chart\n No driving for approximately one month and while taking \nnarcotics, will be discussed at follow up appointment with \nsurgeon when you will be able to drive\n No lifting more than 10 pounds for 10 weeks\n Please call with any questions or concerns ___\n **Please call cardiac surgery office with any questions or \nconcerns ___. Answering service will contact on call \nperson during off hours**\n Females: Please wear bra to reduce pulling on incision, avoid \nrubbing on lower edge\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"14766421","hadm_id":"21453457","text":" \nName:  ___.                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nLipitor / Lisinopril / Iodine / Paper Tape\n \nAttending: ___\n \nChief Complaint:\nshortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with a cardiac history significant for 4 vessel CABG, CHF \nwith an EF of 20%, HTN, DM and dyslipidemia admitted for further \nmanagement of her CHF. She had been recently discharged after \nadmission for CHF exacerbation. She was placed on Furosemide 120 \nmg BID which seemed to be doing well for her, but over the last \n2 days or so, she has had increasing SOB and DOE. She has been \nunable to walk more than a few steps before she gets very short \nof breath. She also has noted some increased ___ swelling as well \nas increase in the size of her neck veins. She denies any \ndietary indiscretion, and states that she has been eating all \nlow salt things. She denies any CP, fevers, chills, cough, \ndiarrhea, constipation, dysuria, or hematuria. She says her \nurination amount has been about stable. She has no other \ncomplaints.  \n.  \nShe went to see her PCP, and was very dyspneic so was referred \nto the ED for further management. In the ED, her vitals were \n96.3, 77, 104/61, 20, 98% 2L. She was given 80 mg IV lasix with \nsome UOP. She was then admitted to ___ for further management \nof her CHF. CXR was reportedly unchanged from prior.  \n.  \nOn review of systems, she denies any prior history of stroke, \nTIA, deep venous thrombosis, pulmonary embolism, bleeding at the \ntime of surgery, myalgias, hemoptysis, black stools or red \nstools. She denies recent fevers, chills or rigors. She denies \nexertional buttock or calf pain. All of the other review of \nsystems were negative.  \n.  \nCardiac review of systems is notable for absence of chest pain, \nparoxysmal nocturnal dyspnea, orthopnea, palpitations, syncope \nor presyncope.  \n\n \nPast Medical History:\n1. CAD s/p 4v CABG in ___ with LIMA-LAD, SVG-Diag (known\noccluded), SVG-OM1, and SVG-RCA; non-sustained VT on tele s/p\nCABG, had intervention to the LIMA-LAD anastamosis in ___ with\nCypher stent at the anastomosis; cath'd most recently in ___\nwith instent restenosis of LIMA-LAD prior Cypher stent that was \nsuccessfully treated with Taxus stent.\n2. DM2 since ___\n3. Hypercholesterolemia\n4. Osteoarthritis: b/l shoulder, knee arthritis with\nintermittent effusions, RF +; also DJD of both knees and L\nthumb, s/p TKR of L knee ___. Dyspnea on exertion x years, followed by cardiology and\npulmonology, thought to be most likely related to ischemic\ncardiomyopathy and CAD\n6. CHF (EF ___. 1+ MR, 1+TR. Small atrial secundum\ndefect\n7. Hypertension\n8. Asthma\n9. Uterine fibroids, has had ___ spotting, received\nHRT\n10. History of occult blood positive stool\n11. Myelodysplastic syndrome\n12. Cataracts\n13. ICD\n.\n1. CARDIAC RISK FACTORS: Diabetes, Dyslipidemia, Hypertension\n.\n2. CARDIAC HISTORY:\n-CABG: ___ with LIMA-LAD, SVG-Diag (known occluded), SVG-OM1, \nand SVG-RCA\n-PERCUTANEOUS CORONARY INTERVENTIONS: ___ - Instent restenosis \nof LIMA-LAD stent successfully treated with re-stenting;\n___ - Successful PTCA and stenting of the mid LAD immediately \nafter the insertion of the LIMA.\n- ICD: placed ___ \n \nSocial History:\n___\nFamily History:\nMother had DM and CAD, but died at ___ from lung CA. Father died \nof an accidental death, but had a h/o CAD.\n \nPhysical Exam:\nVS: 96.2 103/70 78 18 96%2L  \nGENERAL: Well-appearing, NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  \n\nNECK: Supple with JVP to ears bilaterally  \nCARDIAC: PMI located in ___ intercostal space, midclavicular \nline. RR, normal S1, S2. II/VI systolic murmur heard best at \nleft upper sternal border. No thrills, lifts. + S4.  \nLUNGS: No chest wall deformities, scoliosis or kyphosis. Resp \nwere unlabored, no accessory muscle use. CTAB, mild expiratory \nwheezes bilaterally. minimal crackles at bases  \nABDOMEN: Soft, NTND. No HSM or tenderness.  \nEXTREMITIES: 2+ BLE edema.  \nSKIN: + stasis dermatitis. No ulcers or xanthomas.  \nPULSES:  \nRight: DP 2+  \nLeft: DP 2+  \n\n \nPertinent Results:\n___ U/S: IMPRESSION: No evidence of deep vein thrombosis in the \nright leg.\nCXR: Stable moderate cardiomegaly without evidence of acute \nintrathoracic process. \n\nIMPRESSION: Stable moderate cardiomegaly without evidence of \nacute \nintrathoracic process \n\nEKG: Unchanged from baseline, RBBB with left ant fascicular \nblock, old ant infarct and ST depressions in the precordial \nleads, NSR\n\nCBC:\n___ 06:10PM BLOOD WBC-3.7* RBC-UNABLE TO  Hgb-10.5* \nHct-34.0* MCV-UNABLE TO  MCH-UNABLE TO  MCHC-33.4 RDW-UNABLE TO  \nPlt ___\n___ 05:25AM BLOOD WBC-2.3* RBC-UNABLE TO  Hgb-8.8* \nHct-30.5* MCV-UNABLE TO  MCH-UNABLE TO  MCHC-34.0 RDW-UNABLE TO  \nPlt ___\n___ 06:10PM BLOOD Neuts-37* Bands-2 ___ Monos-19* \nEos-0 Baso-0 ___ Metas-2* Myelos-0 Promyel-1* Blasts-9* \nNRBC-280*\n\nchemistries:\n___ 06:10PM BLOOD Glucose-192* UreaN-64* Creat-2.2* Na-135 \nK-3.7 Cl-96 HCO3-22 AnGap-21*\n___ 05:25AM BLOOD Glucose-156* UreaN-73* Creat-2.1* Na-134 \nK-3.3 Cl-94* HCO3-24 AnGap-19\n\n___ 06:10PM BLOOD Calcium-9.0 Phos-3.3 Mg-2.5\n___ 05:25AM BLOOD Mg-2.0\n\ncardiac enzymes:\n___ 06:10PM BLOOD CK(CPK)-45\n___ 05:25AM BLOOD CK(CPK)-52\n___ 05:00PM BLOOD CK(CPK)-100\n___ 01:25AM BLOOD CK(CPK)-65\n___ 05:20AM BLOOD CK(CPK)-63\n___ 06:14AM BLOOD CK(CPK)-35\n\n___ 06:10PM BLOOD cTropnT-0.07*\n___ 05:25AM BLOOD CK-MB-NotDone cTropnT-0.20*\n___ 05:00PM BLOOD CK-MB-13* MB Indx-13.0* cTropnT-0.65*\n___ 01:25AM BLOOD CK-MB-NotDone cTropnT-0.75*\n___ 05:20AM BLOOD CK-MB-NotDone cTropnT-0.68*\n___ 06:14AM BLOOD CK-MB-NotDone cTropnT-0.45*\n\nLipid Panel:\n___ 05:25AM BLOOD Triglyc-139 HDL-10 CHOL/HD-14.0 \nLDLcalc-102\n\nDigoxin Levels:\n___ 05:25AM BLOOD Digoxin-1.4\n___ 06:08AM BLOOD Digoxin-1.3\n___ 05:20AM BLOOD Digoxin-1.0\n___ 05:25AM BLOOD Digoxin-0.8*\n \nBrief Hospital Course:\n# SOB: Has chronic systolic heart failure (EF 20%) Likely due to \nCHF exacerbation which patient has been admitted for multiple \ntimes. Precipitating factor likely nutrional and fluid \nrestriction non-compliance (see disposition at end of discharge \n___. Unlikely ischemia as had no EKG changes, no arrythmias \non telemetry, and no evidence of infection such as UTI or PNA. \nHypervolemic on exam. Patient was diuresed with a lasix gtt drip \nand was negative ___ L and down ___ kg in weight prior to \ndisscharge. Her beta blocker was continued and imdur was added.\nHer digoxin was discontinued after supratherapeutic digoxin \nlevel was discovered, and was restarted on discharge on a \n___ schedule. Nutriton consult was obtained \nand patient was given information on sodium and fluid restricted \ndiets. Kept daily weights, kept on sodium and fluid restricted \ndiet and strict Is and Os. Discharged on torsamide 40 mg PO BID. \nOn discharge, she was no orthopnic or SOB and satting well on \nroom air.\n\n# CAD: Denies chest pain. Unlikely ACS, as she no significant \nEKG changes from previous. Her cardiac enzymes were likely \nelevated in the setting of CHF resulting in mild demand ischem \nand chronic renal failure. Patient has had similar tropnin \nelevation on previous admissions for CHF exacerbations. She was \ncontinued on ASA, beta blocker, imdur, and plavix. She has an \nallergy to lipitor, but her lipid panel showed \nhypertriglyceridemia and LDL not at goal and so she was started \non pravastatin, which she tolerated well.   \n\n#. Hypotension - pt runs in SBPs of ___, likely in setting of \nher chronic systolic heart failure. continued BB, ACEI, imdur \nwith lower BP hold parameters.  \n \n# Myelofibrosis: Patient had elevated nucleated RBCs on her \nblood smear. Heme-onc followed patient while in house. Her \ndanazol was stopped during this hospital admission. Patient also \nhad some issues with bleeding from heparin SQ and some \nassociated mild thrombocytopenia (platelets 120s =\u003e 100s), so it \nwas discontinued and she was switched to pneumoboots. Receives \nAranesp 25 mcg qweekly, last dose ___. She will follow in \noutpatient ___ clinic for her Aranesp injections  \n\n# Lower extremity edema: R \u003e L lower leg edema, likely chronic \nin setting of SVG removal from R leg. No recent travel. No \nevidence of DVT on LENIS.  \n\n#. Asthma - continued albuterol and fluticasone and tiotroprium. \n \n\n#. Hyperlipidemia - started on pravastatin which was tolerated \nwell.\n\n#. Diabetes - diet controlled with diabetic/cardiac diet. HISS \nnot required for this patient.\n\n# Disposition: Patient was discharged to home with many \nmedication changes, including medications directed towards \nimproving her CHF treatment (imdur, torsamide, digoxin regimen \nchange) and had follow up with multiple providers. When nursing \nwas doing discharge preparations for the patient in the \nafternoon, patient was reportedly angry that she could not be \ndischarged at the time she was seen by the medical team in the \nmorning, even though it was repeatedly explained to her that her \ndischarge paperwork and medications needed to be organized and \nthat this would require some time. Per RN report, patients's \nhusband demanded that she remove the IV. RN removed IV with \nstrict instructions for patient to remain in room so she could \nreturn with medications and discharge instructions. RN returned \nto room 15 minutes later to find that patient and family had \nleft without discharge instructions or prescriptions for her \nmedications. RN informed discharging MD immediately who called \npatient multiple times at her home phone number at that time and \nthe day after discharge, instructing her on the answering \nmachine to return to the hospital for her discharge \ninstructions. MD's calls were not returned. Her prescriptions \nwere called into her ___ pharmacy listed in OMR, and this \nwas relayed to patient through phone messages at her home phone. \nThe sudden departure of the patient from the hospital without \ndischarge instructions lends credence to the fact that her \nmultiple admissions CHF exacerbations may be due in part to \nmedical non-compliance. In patient RN and MD staff made multiple \nattempts to contact patient and have been unsuccessful to date \nat the time of signing of this discharge summary. Patient does \nhave ___ at home, but should follow up with her outpatient \ncardiologist for medical reconciliation as soon as possible to \nprevent future hospitalizations.\n \nMedications on Admission:\nalbuterol 2 puffs q4h prn  \nplavix 75mg daily  \ndanazol 200mg 2 capsules BID  \nepoetin  \nfluticasone 110mcg 2puffs BID  \nfurosemide 120mg BID  \nmetoprolol succinate 25mg daily  \nnitro 0.3mg prn  \naspirin 325mg daily  \nMVI  \ntrazodone 25mg qhs  \ndigoxin 125 mcg qod  \nspiriva 18mcg capsule i inh daily  \ndocusate sodium 100mg bid  \n\n \nDischarge Medications:\n1. Digoxin 125 mcg Tablet Sig: One (1) Tablet PO ___, \n___.  \n2. Torsemide 20 mg Tablet Sig: Two (2) Tablet PO twice a day.\nDisp:*120 Tablet(s)* Refills:*2*\n3. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  \n4. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n5. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n7. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).  \n8. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n9. Pravastatin 40 mg Tablet Sig: One (1) Tablet PO at bedtime.\nDisp:*30 Tablet(s)* Refills:*2*\n10. Albuterol 90 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation Q4H (every 4 hours) as needed for wheezing.  \n11. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n12. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual every 5 minutes for three doses as needed for chest \npain.  \n13. Trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as \nneeded for insomnia.  \n14. Epoetin Alfa  Injection\n15. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO twice \na day as needed.  \n16. Aranesp SureClick -Polysorbate 25 mcg/0.42 mL Pen Injector \nSig: ___ (25) mcg Subcutaneous once a week: administered \nby your outpatient hematologist.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n1' diagnosis \nShortness of Breath \n \n2' diagnosis \nChronic Systolic and Diastolic Heart Failure \nCoronary Artery Disease \nHypertension \nDiabetes Mellitus \n\n \nDischarge Condition:\nafebrile, chest pain free, and hemodynamically stable on \ndischarge\n\n \nDischarge Instructions:\nWeigh yourself every morning, call MD if weight \u003e 3 lbs.\nAdhere to 2 gm sodium diet\nFluid Restriction: \u003c 1000 ml per day\n\nYou were admitted with a diagnosis of congestive heart failure \nexacerbation. You were diuresed with Lasix and Diuril. Your \nfluid status improved, and you were discharged in good health.\n\nThe following changes were made in your medications:\nSTOP: Lasix 120 mg by mouth twice a day\nSTART: Torsamide 40 mg by mouth twice a day\nCHANGE: Digoxin 125 mcg by mouth every other day TO\n        Digoxin 125 mcg by mouth ___\nSTART: Pravastatin 40 mg by mouth daily\nSTART: Imdur 30 mg by mouth daily\nSTOP: Danazol 200 mg by mouth twice a day\nSTART: Aranesp injections per your outpatient hematologist\n\nPlease return to the emergency department or call your primary \ncare physician or cardiologist if you experience any of the \nfollowing symptoms: chest pain, increasing shortness of breath, \nnausea, vomiting, sweating, light headedness, loss of \nconsciousness, falls with injury, increased swelling in your \nlegs, or any other symptoms not listed here that are concerning \nenough to warrant physician ___.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19142211","hadm_id":"24651320","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nBactrim DS / Ceclor / Percodan / Mushroom Flavor / peppers / \nPercocet / clams\n \nAttending: ___.\n \nChief Complaint:\nDyspnea \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ hx tobacco abuse (no hx COPD, no PFTs in system), recent \nviral URI, p/w dyspnea at rest w/o CP. \n\nHistory taken from patient who reports that she had diarrhea \nlast ___ briefly, since resolved. Felt well ___ but on \n___ had symptoms of a cold coming on, including sore throat, \ngeneral malaise and diffuse aches of her muscles and joints. \nThese symptoms lingered for several days until yesterday when \nshe left work early for feeling unwell. Overnight she couldn't \nsleep because she couldn't catch her breath. She never \nexperienced chest pain, her cough was only productive of clear \nphlegm, and there was never any wheeze. No fevers, only chills. \nShe came to the ED today for evaluation. \n\nIn the ED, initial VS were: 97.9 105 187/90 20 93% RA.\n \nED physical exam was recorded as:\nPeak flow 150\nFaint expiratory wheezes with decreased breath sounds \nbilaterally\nsomewhat tachycardic rate with no r/m/g\nNo abdominal distension, NT, no rebound/guarding\nDry mucus membranes\n\nED labs were notable for: WBC 10.2 with left shift, no bandemia. \nChem10 essentially normal. UA with Lg Leuk, 6 WBC, Tr Blood.\n\nImaging showed:\n___ CXR: IMPRESSION:    \nNo radiographic evidence of pneumonia. \n\nEKG showed: baseline artifact, NSR w/o ischemic change.\n\nPatient was given:\n___ 01:50 PO Benzonatate 100 mg \n___ 01:50 PO/NG Guaifenesin-Dextromethorphan 5 mL\n___ 01:50 PO/NG PredniSONE 40 mg \n___ 01:50 PO/NG Azithromycin 500 mg \n___ 01:56 IH Ipratropium Bromide Neb 1 NEB \n___ 01:56 IH Albuterol 0.083% Neb Soln 1 NEB \n___ 05:52 PO/NG Levothyroxine Sodium 150 mcg \n___ 08:18 IH Albuterol 0.083% Neb Soln 1 Neb \n___ 08:18 IH Ipratropium Bromide Neb 1 Neb \n___ 10:08 PO Benzonatate 100 mg \nShe also received 1L IVF.\n\nED subsequently documented that the patient failed an ambulatory \nsat, and so were admitted for presumed COPD exacerbation. @ 0630 \n- 92% on 3L NC (new O2 requirement). \n\nTransfer VS were: 97.8 79 138/75 18 95% Nasal Cannula. \n\nWhen seen on the floor, patient is feeling pretty well from the \nbreathing treatments she had in the ED. She does not feel short \nof breath with the supplemental oxygen on. There is no chest \ncongestion nor sinus congestion now (though the nebs apparently \npartially alleviated this latter symptom). No leg swelling. No \nrecent travel or sick contacts that she can think of. \n \nREVIEW OF SYSTEMS: \nA ten point ROS was conducted and was negative except as above \nin the HPI.\n\n \nPast Medical History:\nTobacco Abuse (no hx COPD, no PFTs in system)\nHypothyroidism\nHLD\nOA\nRheumatoid Arthritis\n \nSocial History:\n___\nFamily History:\nMother had breast ___.\nFather had lymphoma.\nBrother had testicular ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: 98.1 128/77 94 18 93%3L\nGen: Pleasant elder female sitting on bed, speaking complete \nsentences, no acute distress\nEyes: Anicteric sclera\nENT: Hearing normal, no rhinitis, no sinus pressure, clear OP\nCardiac: RRR, no r/g/m\nResp: Distant breath sounds all lung fields but no focal \nadventitial breath sounds, no w/r/r, no accessory muscle use\nGI: Soft NT ND +BS\nMSK: No effusions, mild kyphosis\nSkin: Warm, no rashes\nNeuro: AAOx3 face symmetric moving all limbs normally\nPsych: Normal\n\nDISCHARGE PHYSICAL EXAM:\nVitals: 97.2 103 / 63 74 14 94%RA\nGen: Pleasant elder female sitting on bed, speaking complete \nsentences, no acute distress\nEyes: Anicteric sclera\nENT: Hearing normal, no rhinitis, no sinus pressure, clear OP\nCardiac: RRR, no r/g/m\nResp: Distant breath sounds all lung fields but no focal \nadventitial breath sounds, no w/r/r, no accessory muscle use\nGI: Soft NT ND +BS\nMSK: No effusions, mild kyphosis\nSkin: Warm, no rashes\nNeuro: AAOx3 face symmetric moving all limbs normally\nPsych: Normal\n \nPertinent Results:\nADMISSION LABS:\n___ 01:05AM BLOOD WBC-10.2* RBC-5.06 Hgb-14.5 Hct-44.8 \nMCV-89 MCH-28.7 MCHC-32.4 RDW-13.3 RDWSD-43.0 Plt ___\n___ 01:05AM BLOOD Neuts-80.6* Lymphs-8.7* Monos-8.2 Eos-1.5 \nBaso-0.6 Im ___ AbsNeut-8.20* AbsLymp-0.88* AbsMono-0.83* \nAbsEos-0.15 AbsBaso-0.06\n___ 01:05AM BLOOD Glucose-119* UreaN-9 Creat-0.6 Na-142 \nK-4.1 Cl-104 HCO3-27 AnGap-15\n___ 01:05AM BLOOD Calcium-9.3 Phos-3.8 Mg-2.1\n___ 06:00AM URINE Color-Yellow Appear-Clear Sp ___\n___ 06:00AM URINE Blood-TR Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-LG\n___ 06:00AM URINE RBC-\u003c1 WBC-6* Bacteri-NONE Yeast-NONE \nEpi-\u003c1 TransE-\u003c1\n___ 06:00AM URINE CastHy-1*\n\n___ CXR: IMPRESSION:    \nNo radiographic evidence of pneumonia.\n\nDISCHARGE LABS:\n___ 07:20AM BLOOD WBC-7.8 RBC-4.61 Hgb-13.3 Hct-40.6 MCV-88 \nMCH-28.9 MCHC-32.8 RDW-13.4 RDWSD-43.1 Plt ___\n___ 07:20AM BLOOD Glucose-97 UreaN-13 Creat-0.6 Na-144 \nK-4.3 Cl-105 HCO3-28 AnGap-15\n___ 07:20AM BLOOD Calcium-8.9 Phos-3.4 Mg-2.___ hx tobacco abuse (no hx COPD, no PFTs in system), recent \nviral URI, p/w dyspnea at rest w/o CP, with hypoxia, likely \nfirst COPD flare triggered by viral URI.\n\n# Hypoxia\n# Tobacco Abuse\n# Likely COPD Flare from Viral URI\nCould be first presentation of COPD triggered by viral URI, \nsupported by initial symptomology, distant breath sounds on exam \nand long smoking history. No evidence of acute processes by \ncardiac markers or CTA Chest. Discharged on inhalers, \nazithromycin, prednisone burst and Guaifenesin for comfort. \nCould consider PFTs and Pulmonary consultation as an outpatient.\n\n# HLD: Continued home statin\n# Hypothyroidism: Continued home levothyroxine.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atorvastatin 20 mg PO QPM \n2. Levothyroxine Sodium 75 mcg PO 3X/WEEK (___) \n3. Levothyroxine Sodium 150 mcg PO 4X/WEEK (___) \n\n \nDischarge Medications:\n1.  Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath, \nwheeze \nUse as needed in addition to your ipratroprium-albuterol \ninhaler. \nRX *albuterol sulfate [ProAir HFA] 90 mcg 2 puff IH every four \n(4) hours Disp #*1 Inhaler Refills:*0 \n2.  Azithromycin 250 mg PO Q24H Duration: 4 Days \nFinish ___. OK to dispense Zpac.  \nRX *azithromycin 250 mg 1 tablet(s) by mouth once a day Disp #*3 \nTablet Refills:*0 \n3.  Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough \nRX *codeine-guaifenesin 10 mg-100 mg/5 mL 5 mL by mouth every \nsix (6) hours Refills:*0 \n4.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN shortness of \nbreath, wheeze \nUse this inhaler first if feeling short of breath, no more than \n4 times a day. \nRX *ipratropium-albuterol [Combivent Respimat] 20 mcg-100 \nmcg/actuation 1 puff IH every six (6) hours Disp #*1 Inhaler \nRefills:*0 \n5.  Nicotine Patch 14 mg TD DAILY \nRX *nicotine 14 mg/24 hour apply to arm daily Disp #*14 Patch \nRefills:*0 \n6.  PredniSONE 40 mg PO DAILY Duration: 4 Days \nTo finish ___ \nRX *prednisone 20 mg 2 tablet(s) by mouth once a day Disp #*3 \nTablet Refills:*0 \n7.  Atorvastatin 20 mg PO QPM  \n8.  Levothyroxine Sodium 75 mcg PO 3X/WEEK (___)  \n9.  Levothyroxine Sodium 150 mcg PO 4X/WEEK (___)  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHypoxia, likely acute COPD exacerbation. \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms ___,\n\nYou were admitted for low oxygen saturations which is likely a \nfirst manifestation of COPD triggered by a viral upper \nrespiratory infection. Fortunately, you had no evidence of heart \ndamage or lung clots. You recovered rapidly. Please take the \nmedications prescribed below and follow-up with your primary \ncare physician to discuss pulmonary function testing and \npotential referral to a Pulmonologist.\n\nWe wish you all the ___,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"17250375","hadm_id":"27065643","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Zithromax\n \nAttending: ___\n \nChief Complaint:\nFever and hypotension\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old history of COPD not on home O2, OSA, schizophrenia, \nhypertension, hyperlipidemia, who was admitted from \n___ after being diagnosed with ESBL, who presents \nfrom ___ nursing facility after experiencing fever and \nhypotension.  \n During prior hospitalization, patient was started on \npiperacillin-tazobactam for ESBL but was subsequently narrowed \nto TMP-SMX when sensitivities returned. During hospitalization \nfoley catheter was exchanged.  \n At ___ nursing facility, patient had a fever to ___ with \nSBP between ___ leading to referral to ___ ED.  \n In the ED, initial vitals: 98.2, 98, 98/44, 18, 94% on 2L.  \n - Labs notable for: WBC 20.3 (4.6 at last discharge), H/H \n11.5/38.0, platelets 307. Chemsitry panel was unremarkable. \nLactate 2.0. FluA/FluB negative. UA showed 46 RBC, 3 WBC, few \nbacteria.  \n - Imaging notable for: patchy opacity in the left base \nconcerning for infection or aspiration with small left pleural \neffusion.  \n - Pt given: ceftriaxone 1 gram IV x 1, 2L normal saline, \nacetaminophen 650 mg x 1, levofloxacin 750 mg IV x 1, vancomycin \n1000 mg IV x 1.  \n On arrival to the floor, pt reports that he has had significant \ndiarrhea since starting the antibiotics. He has had abdominal \npain. Acknowledges fever today but denies any cough, chest pain, \nchest pressure, chest palpitations.  \n \nPast Medical History:\nCOPD not on home O2\nsleep apnea\nschizophrenia\nhypertension\nGERD\nanxiety\ndepression\nBPH\nobesity\nhyperlipidemia\nhypothyroidism\n \nSocial History:\n___\nFamily History:\nUnknown per patient\n \nPhysical Exam:\nPHYSICAL EXAMINATION ON ADMISSION:\n==================================\nVitals: 100.4, 107/63, 75, 18, 95% on 1L.  \nGENERAL: AOx2, NAD\nHEENT: Normocephalic, atraumatic.  EOMI.  MMM\nCARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops.  \nLUNGS: CTAB, no wheezes, ronchi, rales, crackles\nABDOMEN:  PEG in place, hyperactive bowel sounds, slightly \ndistended, no rebound or guarding, mild diffuse tenderness to \npalpation\nEXTREMITIES: No clubbing, cyanosis or edema. Strength ___ in \nupper extremity. Proximal lower extremity strength ___, distal \nlower extremity strength ___. \nSKIN: No new rashes, lesions or bruises  \n\nPHYSICAL EXAMINATION ON DISCHARGE:\n==================================\nVITALS: 98.3 ___ 92-96RA. BM: 2 small BM \n(loose/watery)\nGENERAL: Laying in bed, making great eye contact, able to \ninitiate and participate in conversation \nHEENT: Dry mucous membranes. No OP lesions  \nLungs: CTAB, no R/R/W\nCV: RRR, S1 and S2 present, no M/R/G\nAbdomen: soft, BS+, minimal tenderness, PEG tube in place with \nno drainage.  \nExtremities: No lower extremity edema appreciated.  \nNeurological: Appears to have left facial droop but really \nprefers to keep his tongue there, left hand squeeze weaker than \nright hand squeeze, ___ strength in upper extremities \notherwise  \n\n \nPertinent Results:\nAdmission labs:\n===========\n___ 12:10PM BLOOD WBC-20.3*# RBC-3.84* Hgb-11.5* Hct-38.0* \nMCV-99* MCH-29.9 MCHC-30.3* RDW-16.7* RDWSD-60.0* Plt ___\n___ 12:10PM BLOOD Neuts-80.0* Lymphs-11.6* Monos-7.0 \nEos-0.0* Baso-0.5 NRBC-0.1* Im ___ AbsNeut-16.23*# \nAbsLymp-2.36 AbsMono-1.42* AbsEos-0.00* AbsBaso-0.10*\n___ 12:10PM BLOOD Plt ___\n___ 06:18AM BLOOD ___ PTT-30.5 ___\n___ 12:10PM BLOOD Glucose-103* UreaN-49* Creat-0.7 Na-141 \nK-4.7 Cl-99 HCO3-23 AnGap-24*\n___ 06:18AM BLOOD ALT-18 AST-12 LD(LDH)-162 AlkPhos-64 \nTotBili-0.3\n___ 12:10PM BLOOD CK-MB-\u003c1 cTropnT-0.09*\n___ 06:10PM BLOOD CK-MB-\u003c1 cTropnT-0.02*\n___ 06:18AM BLOOD CK-MB-\u003c1 cTropnT-0.04*\n___ 06:18AM BLOOD Calcium-7.9* Phos-2.3* Mg-2.3\n___ 07:55AM BLOOD Hapto-420*\n___ 06:55AM BLOOD Triglyc-152* HDL-13 CHOL/HD-7.6 \nLDLcalc-56\n___ 07:10AM BLOOD TSH-2.4\n___ 07:10AM BLOOD Free T4-1.3\n___ 08:22AM BLOOD Cortsol-12.5\n___ 05:31PM BLOOD ___ pO2-140* pCO2-60* pH-7.37 \ncalTCO2-36* Base XS-7\n___ 01:01AM BLOOD ___ pO2-215* pCO2-59* pH-7.40 \ncalTCO2-38* Base XS-9 Comment-GREEN TOP\n\nMICROBIOLOGY:\n=============\nMRSA screen positive\nNegative blood cultures throughout admission\nNegative urine culture throughout admission\nNegative c.diff\n\nIMAGING:\n==========\n___ ECHO\nFOCUSED STUDY/LIMITED VIEWS: Overall left ventricular systolic \nfunction is normal (LVEF\u003e55%). The right ventricular cavity is \nmildly dilated with normal free wall contractility. The aortic \nvalve leaflets (3) are mildly thickened. No masses or \nvegetations are seen on the aortic valve. No aortic \nregurgitation is seen. The mitral valve leaflets are \nstructurally normal. There is no mitral valve prolapse. No mass \nor vegetation is seen on the mitral valve. Physiologic mitral \nregurgitation is seen (within normal limits). \n\nCompared with the prior study (images reviewed) of ___, \nthe comparable findings are similar. \n\n___ CXR\nFINDINGS: Increasing right basilar opacity, may represent \ndeveloping pneumonia.  Stable retrocardiac consolidation.  There \nmay be small right pleural effusion.  No pneumothorax.  Normal \nheart size.  No edema.\nIMPRESSION: Increasing right basilar opacity, may represent \npneumonia.\n\n___ CT ABD + PELVIS\nIMPRESSION:\n1. Improving left and worsening right basilar opacities \nworrisome for\naspiration pneumonia.\n2. Persistent bronchial wall thickening and mucous plugging at \nthe lung bases.\nBackground of moderate to severe centrilobular emphysema.\n3. Mild mediastinal and hilar lymphadenopathy is unchanged, \nlikely reactive.\n4. Interval resolution of previous upper mediastinal mass, most \ncompatible\nwith resolved hematoma.\n5. No acute abnormality in the abdomen or pelvis. Sigmoid \ndiverticulosis\nwithout diverticulitis.\n\n___ CT CHEST\nIMPRESSION:\n 1. Improving left and worsening right basilar opacities \nworrisome for\naspiration pneumonia.\n2. Persistent bronchial wall thickening and mucous plugging at \nthe lung bases.\nBackground of moderate to severe centrilobular emphysema.\n3. Mild mediastinal and hilar lymphadenopathy is unchanged, \nlikely reactive.\n4. Interval resolution of previous upper mediastinal mass, most \ncompatible\nwith resolved hematoma.\n5. No acute abnormality in the abdomen or pelvis. Sigmoid \ndiverticulosis\nwithout diverticulitis.\n\n___ CHEST X RAY\nIMPRESSION: \nModerate cardiomegaly and tortuous aorta are stable.  Mild \nvascular congestion has improved.  Bilateral pleural effusions \nassociated atelectasis have minimally improved.  Right IJ \ncatheter tip is in the lower SVC.  There is no evident \npneumothorax\n\nDISCHARGE LABS\n===============\n___ 05:45AM BLOOD WBC-9.8 RBC-2.78* Hgb-8.3* Hct-26.7* \nMCV-96 MCH-29.9 MCHC-31.1* RDW-16.9* RDWSD-58.8* Plt ___\n___ 05:45AM BLOOD Neuts-73* Bands-3 Lymphs-12* Monos-8 \nEos-1 Baso-0 Atyps-1* Metas-1* Myelos-1* AbsNeut-7.45* \nAbsLymp-1.27 AbsMono-0.78 AbsEos-0.10 AbsBaso-0.00*\n___ 05:45AM BLOOD Hypochr-1+ Anisocy-2+ Poiklo-NORMAL \nMacrocy-1+ Microcy-1+ Polychr-1+\n___ 05:45AM BLOOD Glucose-73 UreaN-11 Creat-0.3* Na-142 \nK-4.0 Cl-102 HCO3-28 AnGap-16\n___ 05:45AM BLOOD Calcium-9.3 Phos-5.0* Mg-1.___ year old history of COPD not on home O2, OSA, schizophrenia, \nhypertension, hyperlipidemia, who was admitted from \n___ after being diagnosed with ESBL, who presents \nfrom ___ facility after experiencing fever and \nhypotension, treated for HCAP. Course had been complicated by \nworsening AMS and increased oxygen requirement, now resolved.  \n\n# HCAP: Patient initially presented with high fevers and \nhypotension. Investigation for infectious source revealed \nconsolidation on CXR consistent with pneumonia. Treated with \nvancomycin and zosyn, but he still continued to have fevers, \npersistent leukocytosis and worsening oxygen requirement, \nneeding a non-rebreather at one point. Tobramycin and \ndoxycycline were added on ___ and ID was consulted. Patient \nimproved significantly after addition of tobramycin/doxycycline, \nwith mental status back to baseline. Tobramycin and doxycycline \nwere discontinued on ___, given that ID felt that the \npercentage of GNRs not covered by zosyn is small, and he may \nsimply require a longer duration of treatment with zosyn (i.e. \nhe has not necessarily failed zosyn treatment). Additionally it \nwas thought he may have been occasionally aspirating causing \nfevers and hypoxia. Patient has continued to do well with \nresolution of his leukocytosis and his last documented fever \noccurred on ___. Given that his MRSA screen returned \npositive, he will continue on Zosyn and Vancomycin through \n___. \n\n# Toxic metabolic encephalopathy: Etiology appears to be \nsecondary to infection as patient's mental status improved on \nantibitoics. CTA negative and EEG negative as well.\n\n# Anemia: No evidence of bleeding and patient has remained \nhemodynamically stable with regards to his anemia. Anemia likely \nsecondary to bone marrow suppression in the setting of sepsis. \nHe did require one unit of RBC transfusion on ___. \n\n# Abdominal pain and diarrhea. Patient with history of chronic \nabdominal pain and diarrhea. He has been C.diff negative. \nSymptoms improved on loperamide as recommended by his PCP. \nThyroid function tests were also within normal limits. \n\n# Schizophrenia/Depression: Paroxetine was discontinued. \nValproic acid dosing was decreased FROM 750 mg BID to ___ mg \nBID. Risperidone 1 mg BID was continued.\n\n# Essential Hypertension: Home amlodipine and clonidine were \ninitially held in the setting of hypotension on presentation. \nHome amlodipine was restarted prior to discharge.\n\n# Goals of care. Guardian ___ wishes to make the patient CMO as \nit is inevitable he will continue to aspirate and have PNA with \nMDR bacteria. ___ at this time does not have the authority to \ndo so and he is working on getting authorization.  \n\n# Urinary tract infection. Diagnosed in last hospitalization \nwith end date of therapy being ___. Treatment completed and \ncovered with HCAP treatment as above.\n\nCHRONIC AND STABLE ISSUES\n# COPD: Continue albuterol inhaler 1 puff Q6H:PRN, \niptraropium-albuterol neb Q4H:PRN, and fluticasone-salmeterol \n250/50 1 IH BID.  \n\n# CAD prevention: Continue Aspirin 81 mg PO daily\n  \n# HLD: Continue atorvastatin 20mg po qHS  \n\n# Hypothyroidism: Continue levothyroxine 25 mcg daily.  \n\n# Dysphagia: During prior admission, patient had been made NPO \ngiven aspiration risk. He was started on tube feeds at that time \nwith a plan to consider EGD in the future. Currently has a PEG \ntube in place.  \n \n# Mediastinal mass: CT chest on ___ showed interval \nresolution of previous upper mediastinal mass, most compatible \nwith resolved hematoma. \n\nTRANSITIONAL ISSUES FROM PRIOR HOSPITALIZATION \n================================================= \n[ ] Patient's home amlodipine was restarted prior to discharge \non ___. Held off on restarting his clonidine patch, consider \nrestarting as BP allows for goal BP \u003c140\n[ ] Follow up with PCP for thyroid ultrasound in ___ to \nensure resolution. Para-thyroid mass likely hematoma from spinal \nsurgery as it was not there 1 mo prior to surgery (___). No \nbiopsy. \n[ ] Consider mobility with wheelchair to improve quality of life \n \n[ ] Follow up on etiology of patient's anemia, patient needs \nfurther workup  \n- Per facility, patient has foley exchanged every month. Given \ndiagnosis of UTI, foley exchanged in hospital on ___  \n- If abdominal symptoms/diarrhea recurs, please have patient \nfollow up with a gastroenterologist. Patient has been treated \nwith Loperamide and Metamucil  \n[ ] Monitor for somnolence, and consider CPAP at night for sleep \napnea\n- Psychiatry made the following changes to the medications: \nStopped paroxetine, reduced dose of valproic acid from 750 mg \nBID to ___ mg BID, and kept risperidone unchanged\n[ ] Monitor for depression and consider referral to psychiatry\n[ ] Re-address code status: pt is currently full-code but \nguardian is trying to get ability to change code status as he \nbelieves this is not in the patient's best interest\n\nNEW MEDICATION:\nImodium\nMetamucil\nVancomycin (through ___\nZosyn (through ___\n\nCHANGED MEDICATION:\nDecreased dose of valproic acid from 750 mg BID to ___ mg BID\n\nSTOPPED MEDICATION:\nParoxetine 20 mg\nClonidine patch discontinued\n\n- Code: Full \n- Contact: ___ ___ ___\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild \n2. Acetylcysteine 20% ___ mL NEB Q6H:PRN mucus  \n3. Albuterol Inhaler 1 PUFF IH Q6H:PRN SOB \n4. Aspirin 81 mg PO/NG DAILY \n5. Atorvastatin 20 mg PO/NG QPM \n6. Bisacodyl ___AILY:PRN constipation \n7. Clonidine Patch 0.2 mg/24 hr 1 PTCH TD QTUES \n8. Fleet Enema ___AILY:PRN Constipation \n9. Fluticasone Propionate NASAL 1 SPRY NU DAILY \n10. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n11. FoLIC Acid 1 mg PO/NG DAILY \n12. GuaiFENesin ___ mL PO/NG Q4H secretions requiring \nsuctioning \n13. Heparin 5000 UNIT SC BID \n14. Ipratropium-Albuterol Neb 1 NEB NEB Q4H:PRN dyspnea \n15. Levothyroxine Sodium 25 mcg PO/NG DAILY \n16. Ondansetron ODT 4 mg PO Q8H:PRN Nausea \n17. PARoxetine 20 mg PO/NG DAILY \n18. RisperiDONE 2 mg NG BID \n19. Simethicone 80 mg PO/NG QID:PRN indigestion \n20. Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush \n21. valproic acid (as sodium salt) 250mg/5mL 15mL PEG tube BID \n22. Acidophilus (Lactobacillus acidophilus) 1 tab oral DAILY \n23. amLODIPine 10 mg PO DAILY \n24. Ferrous Sulfate (Liquid) 300 mg PO/NG DAILY \n25. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation \ninhalation BID \n26. Vitamin D ___ UNIT PO ONCE PER MONTH \n27. Sulfameth/Trimethoprim DS 1 TAB PO BID \n\n \nDischarge Medications:\n1.  LOPERamide 4 mg PO QID diarrhea \nRX *loperamide [Anti-Diarrhea] 2 mg 2 tablet by mouth four times \na day Disp #*112 Tablet Refills:*2 \n2.  Piperacillin-Tazobactam 4.5 g IV Q8H Duration: 4 Days \nRX *piperacillin-tazobactam 4.5 gram 1 vial IV every eight (8) \nhours Disp #*13 Vial Refills:*0 \n3.  Psyllium Powder 1 PKT PO BID \nRX *psyllium husk (aspartame) [Metamucil MultiHealth Fiber] 3.4 \ngram/5.8 gram 1 powder(s) by mouth twice a day Refills:*0 \n4.  Vancomycin 1250 mg IV Q 12H \nRX *vancomycin 750 mg 1 vial IV every twelve (12) hours Disp #*9 \nVial Refills:*0\nRX *vancomycin 500 mg 1 vial IV every twelve (12) hours Disp #*9 \nVial Refills:*0 \n5.  valproic acid (as sodium salt) 500 mg PO BID \nRX *valproic acid (as sodium salt) 500 mg/10 mL (10 mL) 10 ml by \nmouth twice a day Disp #*600 Milliliter Milliliter Refills:*2 \n6.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild  \n7.  Acetylcysteine 20% ___ mL NEB Q6H:PRN mucus   \n8.  Acidophilus (Lactobacillus acidophilus) 1 tab oral DAILY  \n9.  Albuterol Inhaler 1 PUFF IH Q6H:PRN SOB  \n10.  amLODIPine 10 mg PO DAILY  \n11.  Aspirin 81 mg PO DAILY  \n12.  Atorvastatin 20 mg PO QPM  \n13.  Bisacodyl ___AILY:PRN constipation  \n14.  Ferrous Sulfate (Liquid) 300 mg PO DAILY  \n15.  Fleet Enema ___AILY:PRN Constipation  \n16.  Fluticasone Propionate NASAL 1 SPRY NU DAILY  \n17.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID  \n18.  FoLIC Acid 1 mg PO DAILY  \n19.  GuaiFENesin ___ mL PO Q4H secretions requiring suctioning  \n\n20.  Heparin 5000 UNIT SC BID  \n21.  Ipratropium-Albuterol Neb 1 NEB NEB Q4H:PRN dyspnea  \n22.  Levothyroxine Sodium 25 mcg PO DAILY  \n23.  Ondansetron ODT 4 mg PO Q8H:PRN Nausea  \n24.  RisperiDONE 2 mg PO BID  \n25.  Simethicone 80 mg PO QID:PRN indigestion  \n26.  Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush  \n27.  Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation \ninhalation BID  \n28.  Vitamin D ___ UNIT PO ONCE PER MONTH  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nPRIMARTY DIAGNOSIS:\nHospital acquired pneumonia\n\nSECONDARY DIAGNOSES:\nDepression\nChronic diarrhea\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou came to the hospital because you were experiencing fever and \nlow blood pressure. You were found to have a pneumonia.\n\nWhat happened to you during your hospital stay?\n- We treated the pneumonia with antibiotics through the veins \nand you significantly improved\n- You were found to be very somnolent during your hospital stay; \nhead imaging was negative for any head bleed and your somnolence \nresolved without any intervention\n- We consulted psychiatry to help us with the management of your \ndepression, so we made some changes to your medications\n- You were also experiencing severe diarrhea; we ruled out \ninfectious causes and contacted your outpatient \ngastroenterologist who confirmed that this is a chronic issue\n- For the diarrhea, we made changes to your tube feeds and \nstarted you on an anti-diarrhea medication called Imodium. You \nhave also been started on Metamucil to bulk up your stools.\n\nWhat should you do when you leave the hospital?\n- You will go back to a facility. Make sure to take all your \nmedications as prescribed and follow up with your doctors as \n___\n\nWe wish you all the best,\nYour ___ team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11459120","hadm_id":"24783889","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCeclor / Grass ___ Blue, Standard / Ragweed\n \nAttending: ___\n \nChief Complaint:\nhypotension/fall weakness\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ yo F with HTN, hypothyroid presents s/p fall at home. She \nreported fall occured in the setting of 'weakness'. She \napparently hit her head and was transferred to ED. Per ED note \npatient was febrile at home (unclear how high).  \nIn the ED, patient had a CT head that was negative. She also had \na CXR that showed a LLL opacity, possibly PNA. Patient was given \na dose of levofloxacin and was being prepared for transfer to \nfloor when it was noted that her systolic pressure was in the \n70's. She had a lactate drawn that came back at 2.4. Patient was \nmentating. A central line was placed, she was gicev 2L of IVF \nand a dose of ceftriaxone. Her SBPs increased only to the 80's, \ntherefore levophed was started. repeat lactate was down to 0.9.  \n\nLast set of vitals per ED resident BP 83/47, HR 70, O2 sat 96% \non 2L/RA (NC comes off). Patient mentating well, has foley in \nplace with good UOP.  \nAdmitted to ICU for further management. \n.. \n___ y.o. W with HTN, hypothyroid who initially presented to the \nED s/p fall at home in the setting of 'weakness' and fever. In \nthe ED patient had negative head CT, was found to have a PNA, \nand was admitted to the ICU for hypotension to the 70's and \nlactate of 2.4.  \nNow improved, on multiple antibiotics for influenza pna with \nsuspected bacterial superinfection.  \n\n \nPast Medical History:\nHypertension  \nAsthma  \nHypothyroidism.  \nBilateral total knee replacements  \nleft thumb CMC joint arthritis  \n\n \nSocial History:\n___\nFamily History:\nnon contributory vis a vis current issues\n \nPhysical Exam:\nVS: 99.4 148/90 96 24 94% on 3 L by face mask  \nGEN: NAD  \nHEENT: AT, NC, no conjuctival injection, anicteric, think \nbrownish coating on tongue, MMM, neck supple  \nCV: RRR, nl s1, s2, no m/r/g  \nPULM: coarse ronchi ___, L \u003e R, fairly good air movement \nthroughout  \nABD: soft, obese, NT, ND, + BS  \nEXT: warm, dry, +2 distal pulses ___  \nNEURO: alert \u0026 oriented, CN II-XII grossly intact  \nPSYCH: appropriate affect  \n\n \nPertinent Results:\nAdmit labs:\n\n___ 01:45AM   WBC-12.9*# RBC-4.26 HGB-13.3 HCT-39.1 MCV-92 \nMCH-31.2 MCHC-34.0 RDW-14.4\n___ 01:45AM   NEUTS-87.7* LYMPHS-7.5* MONOS-4.5 EOS-0.2 \nBASOS-0.1\n___ 01:45AM   PLT COUNT-185\n___ 01:45AM   GLUCOSE-119* UREA N-25* CREAT-1.3* SODIUM-138 \nPOTASSIUM-4.2 CHLORIDE-100 TOTAL CO2-26 ANION GAP-16\n___ 01:45AM   LD(LDH)-267*\nCHEST (PA \u0026 LAT)\n\nReason: r/o PNA \n\nUNDERLYING MEDICAL CONDITION:\n___ year old woman with fevers and cough \nREASON FOR THIS EXAMINATION:\nr/o PNA \nINDICATION: ___ female with fevers and cough. Rule out \npneumonia.\n\nCOMPARISON: ___.\n\nPA AND LATERAL VIEWS OF THE CHEST: The heart size is normal. \nMediastinal and hilar contours are unchanged and unremarkable. \nAortic arch calcifications are noted. Within the left lung base \nin the anterior left lower lobe, there is opacity, which could \nrepresent pneumonia. Given its somewhat linear appearance, \natelectasis is an alternative etiology. The overlying soft \ntissue obscures detailed evaluation of this region.\n\nThere are no pleural effusions and there is no pneumothorax.\n\nIMPRESSION: Left lower lobe opacity, probably representing \npneumonia. However, given linear configuration, atelectasis is \nan alternative explanation.\nCT HEAD W/O CONTRAST\n\nReason: S/P FALL\n\nUNDERLYING MEDICAL CONDITION:\n___ year old woman s/p fall. + hit head. no loc \nREASON FOR THIS EXAMINATION:\nr/o bleed \nCONTRAINDICATIONS for IV CONTRAST: None.\n\nINDICATION: ___ female status post fall. Rule out bleed.\n\nNo comparison studies.\n\nTECHNIQUE: Non-contrast CT of the head.\n\nFINDINGS: There is no intracranial hemorrhage, mass effect, or \nshift of normally midline structures. Gray-white matter \ndifferentiation is preserved. The ventricles are prominent, \nlikely due to central atrophy. There is moderate diffuse white \nmatter hypodensity most likely representing chronic \nmicrovascular disease. There is no evidence of acute major \nvascular territorial infarction.\n\nThe visualized paranasal sinuses demonstrate moderate ethmoid \nsinus mucosal thickening and mild bilateral right greater than \nleft maxillary sinus mucosal thickening. There is no evidence of \nfracture. The surrounding soft tissue structures are \nunremarkable. Cataract surgical changes of the globes are seen \nbilaterally.\n\nIMPRESSION: No acute intracranial abnormalities. Extensive \nmicroangiopathic changes and central atrophy\n============================================================\nCHEST (PA \u0026 LAT)  ___ 10:16 AM\n\nCHEST (PA \u0026 LAT)\n\nReason: ? interval change \n\nUNDERLYING MEDICAL CONDITION:\n___ year old woman with asthma, pneumonia, flu \nREASON FOR THIS EXAMINATION:\n? interval change \nFRONTAL AND LATERAL CHEST RADIOGRAPH\n\nINDICATION: Asthma, pneumonia, flu. Evaluate interval change.\n\nCOMPARISON: ___.\n\nFINDINGS:\nThere is an air-fluid level at the lower mediastinum compatible \nwith a hiatal hernia. There is no significant pulmonary \nconsolidation. There is some minimal left basilar atelectasis. \nNote is made of a left shoulder hemiarthroplasty. There is \nthoracic spinal degenerative discogenic disease.\n\nIMPRESSION: Basilar atelectasis. Hiatal hernia.\n=====================================================\nECG:\nSinus rhythm \nBorderline first degree A-V delay \nLeft atrial abnormality \nModest nonspecific ST-T wave changes \nSince previous tracing of ___, probably no significant \nchange \nDischarge labs:\n\n  \n\n \nBrief Hospital Course:\nPatient admitted to ICU on ___. In ICU patient patient requiring \n___ oxygen, started on levaquin for pneumonia, given \naggressive fluids for hypotension likely from \ndehydration/infection.  Levaquin changed to vancomycin and \naztreonam on ___ with continued fever spikes and continued \nsignificant oxygen requirment.\nPatient started on prednisone taper, nebulizers.  Slowly \nimproved with stabilization of pulm status, hemodynamics, oxygen \nto 3l requirement and bp's improved from 70's to 100's by \ntransfer to floor on ___.\n\nOn the floor from ___ on.  Completed 8day course of vancomycin \nand aztreonam for possible hospital acquired pneumonia.  \nMaintained on prednisone, nebs, humidified O2, chest ___. \n\nDespite aggressive Rx for above issues, patient still appeared \nvery dyspneic and hence CTA chest was done that revealed \nbilateral PE's. In further w/u, pt was also found to have \nbilateral DVT's. Started on IV heparin and coumadin to target \nINR ___. \n\nPatient is advised to have age appropriate ca screening. She has \nnever had a colonoscopy and mammogram was ___ years back. Given \nnew VTE, should have testing for hidden / occult malignancy. \n\nECHO showed Diastolic CHF, chronic - stable. On ASA, statin, \nlisinopril, metoprolol.\n\nIncidental finding of pulmonary nodules see on CT chest - needs \nfollow up. (pt informed). CT abd/pelvis as part of malignancy \nw/u with non specific LAD.  Radiology recommends repeat CT torso \nin approx 6 weeks ___ to d/w PCP regarding ___ \n___ CT's. \n\nHypothyroidism - is on levothyroxine. TSH significantly elevated \nand FT4 is low. Increased dose of levothyroxine to 125 \nmicrogram/day. Recheck in ___ weeks recommended. \n\nHypertension - HCTZ, lisinopril, metoprolol continued after \nhypotension resolved. \n\nHyperlipidemia - on statin\n\nDepression - on zoloft. Mood stable.\n\nDispo - eventually home with ___ after clinical improvement.\n \nMedications on Admission:\n(per OMR):  \nLevothyroxine [Synthroid] 112 mcg 1 Tablet(s) by mouth once a \nday  \nLisinopril-Hydrochlorothiazide  \n20 mg-12.5 mg Tablet by mouth once a day  \nMetoprolol Succinate [Toprol XL]  \nSertraline 50 mg Tablet 1 Tablet(s) by mouth QD (once a day)  \nSimvastatin [Zocor]  \nAscorbic Acid [Vitamin C]  \nAspirin [Ecotrin] 325 mg Tablet  \nCalcium-Cholecalciferol (D3) [Os-Cal 500 + D]  \nFerrous Sulfate  \nMultivitamin with Iron-Mineral [Centrum]  \nOmeprazole 20 mg Capsule  \nVitamin E \n..\n..\nHeparin 5000 UNIT SC Q8H  \nAcetaminophen ___ mg PO Q6H:PRN  \nHeparin Flush CVL (100 units/ml) 1 ml IV DAILY:PRN  \nAlbuterol ___ PUFF IH Q4H SOB  \nAlbuterol 0.083% Neb Soln 1 NEB IH Q6H  \nIpratropium Bromide Neb 1 NEB IH Q6H  \nAspirin EC 325 mg PO DAILY  \nLevothyroxine Sodium 112 mcg PO DAILY  \nAztreonam 1000 mg IV Q8H  \nMultivitamins 1 CAP PO DAILY  \nBenzonatate 100 mg PO TID  \nPantoprazole 40 mg PO Q24H  \nBisacodyl 10 mg PO/PR DAILY:PRN constipation  \nPredniSONE 40 mg PO DAILY Duration: 5 Doses  \nCaptopril 6.25 mg PO TID  \nSertraline 50 mg PO DAILY  \nDocusate Sodium 100 mg PO BID  \nSimvastatin 40 mg PO DAILY  \nGuaifenesin ___ mL PO Q6H  \nVancomycin 1000 mg IV Q 12H  \nHeparin Flush CVL (100 units/ml) 1 ml IV DAILY:PRN  \n10ml NS followed by 1ml of 100 units/ml heparin (100 units \nheparin) each lumen QD and PRN. Inspect site every shift  \n \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\n1. Acute Respiratory Failure\n2. Influenza\n3. Bacterial pneumonia\n4. Asthma with acute exacerbation\n5. Pulmonary embolism and deep vein thrombosis, legs\n6. Hypotension\n7. Pulmonary nodules\nSecondary:\n1 Hypertension\n2. Hypothryoidism\n3. Hyperlipidemia\n4. Depression.\n\n \nDischarge Condition:\nStable, afebrile, satting mid 90's on room air, ambulating, good \nPO intake.\n\n \nDischarge Instructions:\nFollow up as below.\n\nAll medications as prescribed.\nYou will be given enough prednisone to take one pill a day until \n___, when you see Dr. ___.  If Dr. ___ is \nconcerned about your breathing, he might ask that you continue \nprednisone, and will need to give you a prescription for that. \nUse your inhalers as directed. New inhalers have been added. \nTake vitamin D and calcium.\n\nIf you have fevers, chills, worsening shortness of breath, chest \npain or any other new concerning symptoms, contact your doctor.\n\nSince you were diagnosed with clots in your legs and lungs, you \nwill take blood thinners for at least 6 months. It is important \nto have your blood tests closely monitored during this time. \n\nYou are advised to discuss with your doctor about the following \nissues: \n- you have some spots seen on the lung scan and in the abdomen \nas we discussed. You will need to have a CT scan of the chest \nand abdomen repeated in about 3 months. \n- Discuss with your doctor about scheduling a mammogram, pap \nsmear and colonoscopy. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"13955824","hadm_id":"29652095","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCiprofloxacin / OxyContin / Celebrex / Lamictal / Vicodin / \ntramadol / venlafaxine\n \nAttending: ___.\n \nChief Complaint:\nAltered Mental Status\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with a PMH of HTN, HLD, DCIS, chronic back pain who \npresented to the ED with fever and ? of brief confusion. The \npatient is a ___ at ___.  Her assistant had felt her \nforehead  and thought she felt warm so took her tempearture.  \nShe was also noted to be confused- talking about swallowing a \npicture in ___.  \n\nThe patient's main complaint is back pain.  She has a history of \nspinal stenosis and has previously had spine surgery for her \npain.  She went to see her Spine doctor this week as her pain \nwas getting so bad.  She started using Voltaren cream on her \nback.  She has had no problems walking, no weakness or numbness \nin her legs.  She notes that she is chronically incontinent of \nurine and that this is not a new problem.  She has not had any \nburning, frequency or hematuria.  She denies having cough or \nSOB.  She has had no headaches, N/V.  No diarrhea or abdominal \npain.  \n\nInitial vitals in the ED: 101.2 90 144/62 18 96%. UA with few \nBact, sm Leuk est, 18 WBCs. nl Chem 7. Nl Lactate. nl CBC. nl \nLFTs. CXR showed no acute cardiopulmonary process. UCx pending. \nPt was treated with CTX for presumed UTI. \n\nOn the floor, the patient was pleasant, oriented to person, \nplace and time without any evidence of inattention or confusion. \n She denies lightheadedness or dizziness and again complains \nabout her back pain.  The only other symptoms she notes is a \nsore throat when swallowing but she cannot say how long this has \nbeen going on for.\n \nPast Medical History:\nDCIS s/p resection\nHTN\nHYPERLIPIDEMIA\nDEPRESSION\nSpinal Stenosis\nChronic Low Back Pain\nhysterectomy for fibroids\nBilateral Total Knee Replacement\nBilateral Total Hip Replacement\n \nSocial History:\n___\nFamily History:\nmother diabetes cad\nfather lung ca\nbrother leukemia\nbrother throat ca\nsister died of copd, htn, cad\n\n \nPhysical Exam:\nADMISSION EXAM:\n==================================\nVitals-  97.9  99/59  63  20  95%RA\nGeneral:  pleasant female, NAD, appears stated age\nHEENT: Anicteric, EOMI, MMM, O/P clear\nNeck: supple\nCV: RRR, no m/r/g\nLungs: faint crackles at left base, otherwise clear \nAbdomen: Soft, nontender, nondistended.  Patient notes urge to \nurinate with suprapubic palpation\nGU: no Foley\nExt: Trace edema, warm, well perfused \nNeuro: A\u0026Ox3, CN II-XII grossly intact, ___ strength bilateral \nlower and upper extremities.  \nSkin:  no rashes or lesions noted, midline lumbar scar well \nhealed\n\nDISCHARGE EXAM:\n==================================\nVitals-  99.3  147/54 (99-172/54-65) 64  18  96%RA\n8hr I/0 O/800 + large BM\nGeneral:  pleasant female, NAD, appears stated age, sleeping \ncomfortably\nHEENT: Anicteric, EOMI, MMM, O/P with mild hyperemia\nNeck: supple, no LAD or masses appreciated\nCV: RRR, no m/r/g\nLungs: CTAB, no w/r/r\nAbdomen: + NABS, soft, mild ttp at suprapubic area, nondistended\nGU: no Foley\nExt: Trace edema, warm, well perfused \nNeuro: A\u0026Ox3, CN II-XII grossly intact, ___ strength bilateral \nlower and upper extremities.  \nSkin:  no rashes or lesions noted, midline lumbar scar well \nhealed\n\n \nPertinent Results:\nADMISSION LABS:\n==================================\n___ 02:20AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 \nGLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-SM \n\n___ 02:20AM URINE  RBC-3* WBC-18* BACTERIA-FEW YEAST-NONE \nEPI-0\n___ 02:20AM URINE  HYALINE-7*\n___ 02:20AM URINE  MUCOUS-OCC\n___ 01:12AM   LACTATE-1.1\n___ 01:00AM   GLUCOSE-116* UREA N-13 CREAT-1.1 SODIUM-137 \nPOTASSIUM-3.9 CHLORIDE-102 TOTAL CO2-22 ANION GAP-17\n___ 01:00AM   ALT(SGPT)-13 AST(SGOT)-25 ALK PHOS-69 TOT \nBILI-0.3\n___ 01:00AM   LIPASE-15\n___ 01:00AM   ALBUMIN-4.2\n___ 01:00AM   WBC-6.2 RBC-3.97* HGB-12.6 HCT-39.0 MCV-98 \nMCH-31.8 MCHC-32.4 RDW-12.2\n___ 01:00AM   NEUTS-67.1 ___ MONOS-5.8 EOS-0.6 \nBASOS-0.6\n___ 01:00AM   PLT COUNT-155\n___ 01:00AM   ___ PTT-30.6 ___\n\nDISCHARGE LABS:\n==================================\n___ 05:26AM BLOOD WBC-3.6* RBC-3.80* Hgb-12.1 Hct-37.6 \nMCV-99* MCH-31.8 MCHC-32.1 RDW-12.2 Plt ___\n___ 05:26AM BLOOD Glucose-77 UreaN-13 Creat-1.0 Na-140 \nK-3.9 Cl-106 HCO3-23 AnGap-15\n\nMICROBIOLOGY:\n===================================\n URINE CULTURE (Preliminary): \n      GRAM NEGATIVE ROD(S).    \u003e100,000 ORGANISMS/ML.. \n R/O Beta Strep Group A (Final ___: \n      NO BETA STREPTOCOCCUS GROUP A FOUND. \n\nIMAGING:\n====================================\nCXR ___ \nFRONTAL AND LATERAL VIEWS OF THE CHEST:  The lungs are clear \nwithout focal opacity, pulmonary edema, pleural effusion or \npneumothorax.  The aortic knob is calcified.  The heart size is \ntop normal. \nIMPRESSION:  No acute cardiopulmonary process. \n\n \nBrief Hospital Course:\nMs. ___ is an ___ with HTN/HLD presents with brief episode \nof altered mental status, UA equivocally concerning for UTI. \n\nACTIVE ISSUES:\n==============================\n# Altered Mental Status:  Thought to be delirium in setting of \ninfection (see below).  Patient has no history of seizures and \nno new medication changes that might predispose her to seizure \nand did not appear to be post ictal.  Low concern for TIA given \npt without weakness or slurred speech.  On arrival to the ED and \non the floor, patient's mental status had returned to baseline \n(a\u0026ox3) and remained at baseline for the entirety of the \nadmission and on discharge.  She had additionally noted sore \nthroat and rapid strep was sent which was subsequently negative. \n Urine culture preliminarily grew GNRs and patient was \nempirically treated for UTI.  \n\n# Hypotension: mild, resolved with fluids.  \n\n# Urinary Tract Infection: Patient with fever on admission with \nvery nonfocal symptoms.  Incontinence is baseline, UA was \nequivocal but patient did note suprapubic tenderness on exam.  \nShe was empirically started on Ceftriaxone in the ED and \nsubsequently transitioned to oral Bactrim on the floor.  She \nadditionally was given fluids as above.  Urine culture was sent \nand preliminarily growing GNRs.  \n\n# Sore throat:  Patient noted some symptoms concerning for a \npharyngitis, had cough, hyperemia on exam without exudates or \nsignificant lymphadenopathy.  Given febrile illness at \npresentation and patient's altered mental status, throat swab \nwas sent to rule out Group A strep which was negative.  Thought \nto be viral pharyngitis and no further treatment was needed. \n\nCHRONIC ISSUES:\n================================\n# HTN: Hypotension on admission which resolved after fluid \nresuscitation.  She was restarted on her home dose of \nLisinopril.\n\n# HLD: Continued home fish oil, simvastatin.\n\n# Spinal Stenosis/Chronic low back pain:  Patient on Gabapentin \nas outpatient, was dosed renally in house for concern that it \nwas contributing to her confusion.  She was discharged on \nrenally dosed Gabapentin.  \n\n# Anxiety: Ativan held throughout admission given altered mental \nstatus. \n\nTRANSITIONAL ISSUES:\n================================\n- Per patient's renal function, renally dosed Gabapentin is \n300mg q12hrs, if patient is not tolerating well can uptitrate \nback to TID.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Gabapentin 300 mg PO TID \n2. Lisinopril 40 mg PO DAILY \n3. Lorazepam 1 mg PO TID \n4. Omeprazole 20 mg PO DAILY \n5. Simvastatin 20 mg PO DAILY \n6. Acetaminophen 650 mg PO Q6H:PRN pain \n7. Aspirin 81 mg PO DAILY \n8. Cyanocobalamin ___ mcg PO DAILY \n9. Docusate Sodium 100 mg PO BID \n10. Fish Oil (Omega 3) 1000 mg PO DAILY \n11. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. Aspirin 81 mg PO DAILY \n3. Cyanocobalamin ___ mcg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n5. Fish Oil (Omega 3) 1000 mg PO DAILY \n6. Gabapentin 300 mg PO Q12H \n7. Lisinopril 40 mg PO DAILY \n8. Multivitamins 1 TAB PO DAILY \n9. Omeprazole 20 mg PO DAILY \n10. Simvastatin 20 mg PO DAILY \n11. Lorazepam 1 mg PO TID \n12. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 3 Days \n\n \nRX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by \nmouth twice a day Disp #*4 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: UTI\nSecondary: HTN \n           \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure participating in your care at ___ \n___.  You were admitted because you had \nfevers and were confused.  A urine sample showed that you had an \ninfection in your bladder which was likely the cause of your \nfever and confusion.  Please continue to take the antibiotics as \nprescribed to end on the evening of ___.  \n\nWe recommend that you follow up with your PCP ___ \n___ weeks of leaving the hospital as well as the appointments \nlisted below.\n\nWe wish you the best.\n\nSincerely, \nYour ___ Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13513470","hadm_id":"26950517","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nTrauma: bicyclist versus pole\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMr. ___ is a ___ year-old male with no significant ___ \ntransferred from OSH after crashing into a pole while speed \nbicycling. Patient reports he was bicycling at approximately 25 \nmph when he swerved to avoid a pole but ended up crashing into \nit with the right side of his body. He received 1 liter fluid at \nOSH. OSH CT scan showed a grade IV liver laceration and he was \ntransferred to ___ for further care. At ___ ED, a FAST exam \nwas negative and his Hct was 43. He received an additional 1 \nliter of fluid. On arrival to ___, patient is alert and has no \ncomplaints. His Hct on arrival to ___ was 41 and BP 110/70s \nwith HR ___. He was also told he has a minor right sided rib \nfracture and has some moderate pain with deep inspiration. \n \nPast Medical History:\nnone \n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\n General: Well nourished young male in no acute distress  \n HEENT: PERRLA. Normocephalic, atraumatic  \n Neck: No lymphadenopathy. Normal ROM  \n CV: RRR  \n Lungs: CTABL  \n Abdomen: Soft, nondistended, nontender to palpation  \n GU: deferred  \n Ext: wwp, 2+ distal pulses  \n Neuro: No focal deficits  \n Skin: Small abrasion on right forearm  \n\n \nPertinent Results:\n___ 08:55PM BLOOD WBC-17.2* RBC-4.77 Hgb-14.0 Hct-43.5 \nMCV-91 MCH-29.4 MCHC-32.2 RDW-14.3 RDWSD-48.0* Plt ___\n___ 11:09PM BLOOD WBC-12.7* RBC-4.60 Hgb-13.4* Hct-41.6 \nMCV-90 MCH-29.1 MCHC-32.2 RDW-14.3 RDWSD-47.6* Plt ___\n___ 01:40AM BLOOD WBC-10.3* RBC-4.53* Hgb-13.4* Hct-41.1 \nMCV-91 MCH-29.6 MCHC-32.6 RDW-14.5 RDWSD-47.8* Plt ___\n___ 06:05AM BLOOD WBC-9.3 RBC-4.49* Hgb-13.5* Hct-40.9 \nMCV-91 MCH-30.1 MCHC-33.0 RDW-15.2 RDWSD-50.0* Plt ___\n\nCXR ___: \nIMPRESSION:  \n  \nNo comparison.  The lung volumes are normal.  Normal size of the \ncardiac \nsilhouette.  Normal hilar and mediastinal contours.  No \npneumonia, no \npulmonary edema.  Radiographically, there is no convincing \nevidence for the \npresence of a right rib fracture.  No right-sided pneumothorax. \n\n \nBrief Hospital Course:\n___ transferred from OSH with grade IV liver laceration after \nbicycle accident on ___.  Admitted to ICU for serial \nhematocrit checks. Hct was stable overnight and he was feeling \nwell. His tertiary survey was negative and he was transferred to \nthe floor on ___. \n\nPatient had minimal pain throughout his hospitalization. He \ntolerated a regular diet, voided spontaneously, and was able to \nambulate independently without difficulty. He was discharged \nhome on ___ with instructions to follow-up in ___ clinic in \n3 weeks. \n\n \nMedications on Admission:\nNo meds \n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild \nDo not exceed 4000 mg daily.   \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nGrade ___ liver laceration. no other injuries\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nNo contact sports for 4 months\nNo sports for 4 weeks\n\nACTIVITY:  \n o Do not drive until you have stopped taking pain medicine and \nfeel you could respond in an emergency.  \n o You may climb stairs.  \n o You may go outside, but avoid traveling long distances until \nyou see your surgeon at your next visit.  \n o Don't lift more than ___ lbs for 4 weeks. (This is about \nthe weight of a briefcase or a bag of groceries.) This applies \nto lifting children, but they may sit on your lap.    \n \n HOW YOU MAY FEEL:  \n o You may feel weak or \"washed out\" for a couple of weeks. You \nmight want to nap often. Simple tasks may exhaust you.  \n o You might have trouble concentrating or difficulty sleeping. \nYou might feel somewhat depressed.  \n o You could have a poor appetite for a while. Food may seem \nunappealing.  \n o All of these feelings and reactions are normal and should go \naway in a short time. If they do not, tell your surgeon.    \n YOUR BOWELS:  \n o Constipation is a common side effect of narcotic pain \nmedications. If needed, you may take a stool softener (such as \nColace, one capsule) or gentle laxative (such as milk of \nmagnesia, 1 tbs) twice a day. You can get both of these \nmedicines without a prescription.  \n o If you go 48 hours without a bowel movement, or have pain \nmoving the bowels, call your surgeon.  \n PAIN MANAGEMENT:  \n o It is normal to feel some discomfort/pain following abdominal \nsurgery. This pain is often described as \"soreness\".  \n o Your pain should get better day by day. If you find the pain \nis getting worse instead of better, please contact your surgeon. \n \n o You will receive a prescription for pain medicine to take by \nmouth. It is important to take this medicine as directed. o Do \nnot take it more frequently than prescribed. Do not take more \nmedicine at one time than prescribed.  \n o Your pain medicine will work better if you take it before \nyour pain gets too severe.  \n o Talk with your surgeon about how long you will need to take \nprescription pain medicine. Please don't take any other pain \nmedicine, including non-prescription pain medicine, unless your \nsurgeon has said its okay.  \n o If you are experiencing no pain, it is okay to skip a dose of \npain medicine.  \n o Remember to use your \"cough pillow\" for splinting when you \ncough or when you are doing your deep breathing exercises.  \n If you experience any of the following, please contact your \nsurgeon:  \n - sharp pain or any severe pain that lasts several hours  \n - pain that is getting worse over time  \n - pain accompanied by fever of more than 101  \n - a drastic change in nature or quality of your pain  \n MEDICATIONS:  \n Take all the medicines you were on before the operation just as \nyou did before, unless you have been told differently.  \n If you have any questions about what medicine to take or not to \ntake, please call your surgeon.  \n \nFollowup Instructions:\n___\n"}
{"subject_id":"19429978","hadm_id":"27034681","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: CARDIOTHORACIC\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nChest Pain\n \nMajor Surgical or Invasive Procedure:\n___ Coronary Artery Bypass Graft x 4 (LIMA to LAD, SVG to \nDiag, SVG to Ramus, SVG to PDA)\n \nHistory of Present Illness:\n___ y/o male with known history of coronary artery disease s/p \nstenting in ___ and VF arrest in ___ presented c/o chest pain. \nAdmitted in ___ where he underwent a cardiac cath which \nrevealed instent restenosis in Ramus, RCA occlusion and LAD \ndisease. Referred for surgical revascularization.\n \nPast Medical History:\nCoronary Artery Disease s/p Percutaneous Coronary Intervention \nwith stenting ___, VF arrest ___ s/p AICD placement, Diabetes \nMellitus, Hypertension, Hypercholesterolemia\n \nSocial History:\n___\nFamily History:\nThere is no family history of premature coronary artery disease \nor sudden death.\n \nPhysical Exam:\nVS: 70 14 118/52 72\" 190#\nGen: Well-developed, well-nourished male in no acute distess\nSkin: Warm and dry\nHEENT: Unremarkable\nNeck: Supple, Full range of motion\nChest: Clear to auscultation\nHeart: Regular, rate and rhythm, -murmur\nAbd: Soft, non-tender, non-distended, +bowel sounds\nExt: Warm, well-perfused, -edema\nNeuro: Alert and oriented x 3, grossly intact\n\nAt Discharge:\nVS:T:98.7/98.5, BP:101/50,p:62,RR 20, 98% R/A O2SAT, \nFSBS:192-203\nGen: A\u0026O x3,NAD\nHEENT:WNL\n___\nLungs:CTA\nAbd: benign\nExt:(R)open harvest site C/D/I, (L)EVH site C/D/I\nNeuro: grossly intact\n \nPertinent Results:\n___ Echo: Pre-CPB: Wires from an ICD are seen. No \nspontaneous echo contrast is seen in the left atrial appendage. \nLeft ventricular wall thicknesses and cavity size are normal. \nRight ventricular chamber size and free wall motion are normal. \nThere are simple atheroma in the descending thoracic aorta. The \naortic valve leaflets (3) appear structurally normal with good \nleaflet excursion and no aortic regurgitation. The mitral valve \nleaflets are mildly thickened. Trivial mitral regurgitation is \nseen. There is no pericardial effusion. Post-CPB: The patient is \nA-Paced, on low dose Phenylephrine. Normal biventricular \nsystolic fxn. No AI. Trace MR ___ TR. ___ intact\n\n___ ___ M  ___  ___ \nRadiology Report CHEST (PA \u0026 LAT) Study Date of ___ 9:53 AM \n\nUNDERLYING MEDICAL CONDITION: \n   ___ year old man s/p CABG  \nREASON FOR THIS EXAMINATION:   eval for pleural effusions  \nFinal Report \nREASON FOR EXAMINATION: Followup of pleural effusion in a \npatient after CABG. \nPA and lateral upright chest radiograph was compared to ___. \nHeart size is stable. The post-sternotomy wires appears intact. \nThe \npacemaker defibrillator lead tip is in the right ventricle. \nThe lungs are clear. There is small pleural effusion, bilateral, \nappears to be unchanged compared to the most recent study. No \nevidence of failure is present. Minimal atelectasis seen in the \nlingula. Small left apical \npneumothorax is seen unchanged. \n___. ___\n\n___ 05:33AM BLOOD WBC-4.9 RBC-2.67* Hgb-8.7* Hct-24.6* \nMCV-92 MCH-32.6* MCHC-35.4* RDW-13.2 Plt ___\n___ 12:13PM BLOOD WBC-5.8 RBC-2.83*# Hgb-9.2*# Hct-25.5*# \nMCV-90 MCH-32.4* MCHC-36.0* RDW-13.2 Plt ___\n___ 01:42PM BLOOD ___ PTT-35.8* ___\n___ 12:13PM BLOOD ___ PTT-27.9 ___\n___ 05:33AM BLOOD Glucose-140* UreaN-13 Creat-0.9 Na-137 \nCl-102 HCO3-33*\n    \n\n___ 05:23AM BLOOD WBC-5.3 RBC-2.69* Hgb-8.6* Hct-24.5* \nMCV-91 MCH-31.9 MCHC-35.0 RDW-13.2 Plt ___\n___ 05:23AM BLOOD Plt ___\n___ 01:42PM BLOOD ___ PTT-35.8* ___\n___ 05:23AM BLOOD Glucose-127* UreaN-10 Creat-0.8 Na-136 \nK-4.6 Cl-99 HCO___* AnGap-9\n \nBrief Hospital Course:\nMr. ___ was a same day admit and on ___ he was brought to \nthe operating room where he underwent a coronary artery bypass \ngraft x 4. Please see operative report for surgical details. In \nsummary he had CABG x4 with LIMA-LAD, SVG-Diag, SVG-Ramus, \nSVG-PDA. He tolerated the operation well and following surgery \nhe was transferred to the CVICU for invasive monitoring in \nstable condition. He did well in the immediate post-op period \nand was was weaned from sedation, awoke neurologically intact \nand extubated. On post-op day one he was started on \nbeta-blockers and diuretics. He remained hemodynamically stable \nand was transferred to the telemetry floor for further care. \nChest tubes and epicardial pacing wires were removed per \nprotocol. He continued to progress and on POD 4 he was \ndischarged to home with visiting nurses. ___ follow up \nappointments were advised.\n\n \nMedications on Admission:\nSimvastatin 20mg qd, Amlodipine 5mg qd, Ramipril 10mg qd, Toprol \nXL 50mg qd, Niacin 250mg qd, Byetta 5mg bid, Prandin 2mg bid, \nLevemir 15 units qhs, Aspirin 81mg qd, Flovent, Testim 1% patch \nqd, Imdur, Omeprazole 20mg qd\n \nDischarge Medications:\n1. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).\nDisp:*60 Tablet(s)* Refills:*2*\n2. Potassium Chloride 10 mEq Tablet Sustained Release Sig: Two \n(2) Tablet Sustained Release PO once a day for 2 weeks.\nDisp:*28 Tablet Sustained Release(s)* Refills:*0*\n3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n4. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).\nDisp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*2*\n5. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every \n4 hours) as needed.  \n6. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n7. Testosterone 5 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily).  \n8. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).\nDisp:*1 inhaler* Refills:*2*\n9. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO once a day.  \n10. Repaglinide 2 mg Tablet Sig: One (1) Tablet PO twice a day.  \n\n11. Hydromorphone 2 mg Tablet Sig: ___ Tablets PO every ___ \nhours as needed for pain.\nDisp:*50 Tablet(s)* Refills:*0*\n12. Furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day \nfor 2 weeks.\nDisp:*14 Tablet(s)* Refills:*0*\n13. Byetta 5 mcg/0.02 mL Pen Injector Sig: resume preop schedule \n Subcutaneous twice a day.  \n14. Levemir 100 unit/mL Solution Sig: resume pre-oop schedule  \nSubcutaneous at bedtime.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nCoronary Artery Disease s/p Coronary Artery Bypass Graft x 4\nPMH: s/p Percutaneous Coronary Intervention with stenting ___, \nVF arrest ___ s/p AICD placement, Diabetes Mellitus, \nHypertension, Hypercholesterolemia\n \nDischarge Condition:\nGood\n \nDischarge Instructions:\nPlease shower daily including washing incisions, no baths or \nswimming \nMonitor wounds for infection - redness, drainage, or increased \npain \nReport any fever greater than 101 \nReport any weight gain of greater than 2 pounds in 24 hours or 5 \npounds in a week \nNo creams, lotions, powders, or ointments to incisions \nNo driving for approximately one month \nNo lifting more than 10 pounds for 10 weeks \nPlease call with any questions or concerns ___\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12980551","hadm_id":"20540758","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nLisinopril\n \nAttending: ___.\n \nChief Complaint:\nChest Pain\n \nMajor Surgical or Invasive Procedure:\nCardiac catheterization ___\n\n \nHistory of Present Illness:\n___ M with hx CAD s/p CABG (LIMA-LAD, SVG-OM, SVG-diag, SVG-PDA\n___, inferior MI in ___, stent of LCx and ___ RCA in ___\n(cath showed occluded SVG-Diag and RPDA at that time), ESRD on\nHD, pAfib, HTN, and HLD who presented with chest pain and EKG\nchanges concerning for diffuse ischemia. \n\nHe described substernal chest pain that started at rest around 9\npm on ___ with radiation to the left shoulder and throat with\nassociated nausea/vomiting, diaphoresis, and SOB. He took 5 SL\nnitros and full dose aspirin with improvement of symptoms and\nproceeded to the ED. In the ED, he was initially CP free but\nafter having a bowel movement developed sudden onset chest pain\nwith nausea and vomiting with dynamic EKG changes. Given Zofran\nand IV nitro. BI dialysis group emailed.\n\nIn the ED,  \n- Initial vitals were: T 98.1, HR 76, BP 131/47, RR 18, PO2 97%\nRA \n- Exam notable for: systolic murmur noted throughout precordium,\nlungs clear bilaterally, extremities warm; left upper arm \nfistula\n- Labs notable for:  \n  - Trop-T: 0.06, 3, hgb 9.4, Cr 6.2, WBK 4.8, \n- Studies notable for:\n  - ECG at time of pain: ST elevation in aVR, ST depression in\naVR, V3-V6 resolved on repeat ECG (hyperacute T waves without\npain)\n- Patient was given:  \nIV Ondansetron 4 mg\nIV DRIP Nitroglycerin 0.5 mcg/kg/min \n- Cardiology and ophthalmology was consulted: optho on their way\nto evaluate the eye to decide on risk of starting heparin gtt \niso\npossible retinal hemorrhage. ED physician dilated eyes before\nsending up. Optho with no contraindication to heparin so will\nstart before sending up. \n \nOn arrival to the CCU, patient reports no chest pain. Says that\nfor the last ___ months patient has been experiencing similar\nsymptoms ___ when going to bed or taking a shower. With\nsuch minimal exertion, he will experience a wave of nausea\nfollowed by substernal chest tightness. He would vomit and have\nthe pressure radiate to his left shoulder. After sublingual \nnitro\nx2 and rest, the pain usually resolved. Improved with more\naggressive UF removal with HD. Last night patient had the same\nthing happen when getting into bed. Nausea, ran to the bathroom\nand had the substernal chest pressure, followed by vomiting.\nAfter 2 sublingual nitro the pain did not resolve so patient\ncalled EMS. He eventually ended up taking 5 SL and 4 baby ASA,\nafter which he experienced some relief. \n\nPatient otherwise denies fevers, chills, abd pain, diarrhea,\ndysuria, changes to diet/habits, new medication changes, stress.\nHaving stable sputum production with no new cough.  \n \n \nPast Medical History:\nHTN\nHyperdipidemia\nCoronary artery disease\nGastroesophageal reflux disease\nChronic kidney diseas - Wegener's granulomatosis\nDepression, currently working with counselor bimonthly\nAppendectomy \nHernia  repair in his 20s.\nLeg cramps\nAnemia\n\n \nSocial History:\n___\nFamily History:\nMom: died at ___ of old age\nFather, sister: died from lung CA\nMGM: DM \n \nPhysical Exam:\nADMISSION PHYSICAL:\n====================\nVS:  reviewed in metavision\nGENERAL: Well developed, well nourished in NAD. Oriented x3.\nMood, affect appropriate.  \nHEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. \n\n\nNECK: Supple. JVP 10cm at 45 degrees.  \nCARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or\ngallops.  \nLUNGS: Respiration is unlabored with no accessory muscle use. No\nwheezes, rales, crackles\nABDOMEN: Soft, non-tender, non-distended. +BS\nEXTREMITIES: Warm, well perfused. No peripheral edema.  \nSKIN: No significant lesions or rashes.  \nPULSES: Distal pulses palpable and symmetric.  \n\nDISCHARGE PHYSICAL:\n===================\nVS:  reviewed in metavision\nGENERAL: Well developed, well nourished in NAD. Oriented x3.\nMood, affect appropriate.  \nHEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. \n\nNECK: Supple. JVP 10cm at 45 degrees.  \nCARDIAC: Normal rate, regular rhythm. continuous murmur. No \nrubs,\nor gallops.  \nLUNGS: Respiration is unlabored with no accessory muscle use. No\nwheezes, rales, crackles\nABDOMEN: Soft, non-tender, non-distended. +BS\nEXTREMITIES: Warm, well perfused. No peripheral edema.  \nSKIN: No significant lesions or rashes.  \nPULSES: Distal pulses palpable and symmetric.  \n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 03:01AM BLOOD WBC-7.4 RBC-2.90* Hgb-9.4* Hct-29.0* \nMCV-100* MCH-32.4* MCHC-32.4 RDW-13.5 RDWSD-49.0* Plt ___\n___ 06:25AM BLOOD ___ PTT-28.8 ___\n___ 03:01AM BLOOD Glucose-97 UreaN-61* Creat-6.2* Na-141 \nK-5.0 Cl-102 HCO3-24 AnGap-15\n___ 06:25AM BLOOD ___ PTT-28.8 ___\n___ 03:01AM BLOOD Glucose-97 UreaN-61* Creat-6.2* Na-141 \nK-5.0 Cl-102 HCO3-24 AnGap-15\n\nINTERVAL LABS:\n==================\n___ 03:01AM BLOOD CK-MB-3 cTropnT-0.06*\n___ 08:44AM BLOOD CK-MB-3 cTropnT-0.08*\n___ 05:10AM BLOOD CK-MB-7 cTropnT-0.23*\n___ 01:08PM BLOOD CK-MB-7 cTropnT-0.29*\n\nIMAGING:\n===========\nCardiac Catheterization ___:\nCoronary Description\nThe coronary circulation is right dominant.\nLM: The Left Main, arising from the left cusp, is a large \ncaliber vessel. This vessel bifurcates into the\nLeft Anterior Descending and Left Circumflex systems.\nLAD: The Left Anterior Descending artery, which arises from the \nLM, is a large caliber vessel. There is\na 50% stenosis in the proximal segment. There is a 70% stenosis \nin the proximal segment.\nThe ___ Diagonal, arising from the proximal segment, is a medium \ncaliber vessel.\nThe Septal Perforator, arising from the mid segment, is a small \ncaliber vessel.\nThe ___ Diagonal, arising from the mid segment, is a medium \ncaliber vessel.\nCx: The Circumflex artery, which arises from the LM, is a large \ncaliber vessel.\nThe ___ Obtuse Marginal, arising from the proximal segment, is a \nmedium caliber vessel.\nThe ___ Obtuse Marginal, arising from the mid segment, is a \nmedium caliber vessel. There is a 100%\nstenosis in the proximal and mid segments. There is a 90% \nstenosis in the mid segment.\nThe Superior lateral of the 2ndOM, arising from the distal \nsegment, is a medium caliber vessel. There is\na 40% stenosis in the ostium and proximal segment.\nRCA: The Right Coronary Artery, arising from the right cusp, is \na large caliber vessel. There is a 30%\nstenosis in the proximal segment. There is a stent in the \nproximal and mid segments. There is a 50%\nstenosis in the mid segment.\nThe SinoAtrial, arising from the proximal segment, is a small \ncaliber vessel.\nThe Right Posterolateral Artery, arising from the distal \nsegment, is a medium caliber vessel.\nThe Right Posterior Descending Artery, arising from the distal \nsegment, is a medium caliber vessel.\nName: MRN: Study Date: ___ 10:26:00 p. ___\nBypass Grafts:\nLIMA: A medium caliber arterial LIMA graft connects to the mid \nsegment of the LAD. This graft is\npatent.\nSVG: A medium caliber saphenous vein graft connects to the mid \nsegment of the ___ Diag. There is a\n100% stenosis in the proximal segment.\nSVG: A medium caliber saphenous vein graft connects to the mid \nsegment of the ___ OM. There is a\n30% stenosis in the proximal segment.\n\n___ ECHO:\nThe left atrial volume index is SEVERELY increased. The right \natrium is moderately enlarged. There is mild symmetric left \nventricular hypertrophy with a normal cavity size. There is mild \nglobal left\nventricular hypokinesis. The visually estimated left ventricular \nejection fraction is 45%. There is no resting left ventricular \noutflow tract gradient. The right ventricular free wall is \nhypertrophied.\nModerately dilated right ventricular cavity with moderate global \nfree wall hypokinesis. The aortic valve leaflets (3) are mildly \nthickened. There is no aortic valve stenosis. There is no aortic \nregurgitation. The mitral valve leaflets are mildly thickened. \nThere is no mitral valve stenosis. There is an eccentric, \ninferolateral directed jet of moderate to severe [3+] mitral \nregurgitation. There is significant pulmonic regurgitation. The \ntricuspid valve leaflets appear structurally normal. There is \nmoderate [2+] tricuspid\nregurgitation. There is SEVERE pulmonary artery systolic \nhypertension. The end-diastolic PR velocity is elevated \nsuggesting pulmonary artery diastolic hypertension. Compared \nwith the prior TTE ___, left ventricular systolic \nfunction is reduced, mitral regurgitation is increased, and \nsevere pulmonary hypertension is now present.\n\nMICROBIOLOGY:\n==============\nNone to report\n\nDISCHARGE LABS:\n===============\n___ 12:19AM BLOOD WBC-6.8 RBC-2.69* Hgb-8.9* Hct-27.1* \nMCV-101* MCH-33.1* MCHC-32.8 RDW-13.5 RDWSD-49.6* Plt ___\n___ 12:19AM BLOOD Glucose-80 UreaN-55* Creat-6.1*# Na-138 \nK-5.5* Cl-97 HCO3-28 AnGap-13\n___ 12:19AM BLOOD Calcium-8.9 Phos-4.8* Mg-2.0\n \nBrief Hospital Course:\nPatient Summary for Admission:\n===============================\n___ M with hx CAD s/p CABG (LIMA-LAD, SVG-OM, SVG-diag, SVG-PDA \n___, inferior MI in ___, stent of LCx and ___ RCA in \n___ showed occluded SVG-Diag and RPDA at that time), ESRD \non HD, pAfib, HTN, and HLD who presented with chest pain and EKG \nchanges concerning for diffuse ischemia, now s/p DES to SVG-OM \nanastomosis from prior vein graft on ___. \n\n#CORONARIES: LIMA-LAD, SVG-OM, SVG-diag, SVG-PDA ___, inferior\nMI in ___, stent of LCx and ___ RCA in ___ (cath showed\noccluded SVG-Diag and RPDA at that time), DES to SVG-OM ___\n#PUMP: EF 45%\n#RHYTHM: NSR \n\nACUTE ISSUES: \n============= \n# Chest pain\n# CAD s/p CABG (LIMA-LAD, SVG-OM, SVG-diag, SVG-PDA ___,\ninferior MI in ___, stent of LCx and ___ RCA in ___ (cath\nshowed occluded SVG-Diag and RPDA at that time): Presented with \nunstable angina, with ischemic ST depressions on presenting EKG. \nTroponins trended and peaked at 0.29. Patient underwent \ncatheterization ___ now s/p DES to SVG-OM anastomosis from \nprior veingraft, complicated by post-cath recurrent angina with \nEKG changes\nconcerning that culprit lesion was not intervened upon and need\nfor re-look, however patient's chest pain then resolved and he \ndid not require repeat catheterization during this \nhospitalization. He was continued on Aspirin and Plavix post \nprocedurally and Imdur 120mg daily. He also underwent ECHO on \n___ notable for \"in comparison to prior ECHO ___, left \nventricular systolic function is reduced, mitral regurgitation \nis increased, and severe pulmonary hypertension is now present.\"\n\n# HTN: 150s/50s: Continued home Amlodipine, Imdur and Metoprolol \nwhich was fractionated while inpatient.\n\n# Concern for retinal hemorrhage: \nPatient with concern for vasculitis (Wegener's) and concern for \nstarting systemic heparin with risk for retinal hemorrhage (as \nper outpatient ophthalmologist). Patient evaluated by Optho who \ndid not indicate contraindication to heparin. \n\n# ESRD on HD (___), not anuric: Last dialysis ___. \nContinued dialysis ___. \n\nCHRONIC ISSUES: \n=============== \n# HLD: continue statin, atorva 80 mg\n\n# Paroxysmal atrial fibrillation: Continued Metoprolol for rate \ncontrol.\n\n# Depression: Continued Escitalopram\n\n# Anemia: Hgb 9.4, at baseline. Likely depressed iso ESRD. No \nsigns of bleeding during admission.\n\nTransitional Issues:\n====================\n[] Patient should follow up with PCP ___ AT 3:00 \n___ \n[] Cardiology follow up pending at discharge, patient will be \ncalled for follow up.\n[] If patient experiences changes in his vision, new floaters \nshould have Optho follow up scheduled as outpatient.\n[] Severe pulmonary HTN noted on ___ ECHO, recommend \noutpatient follow up.\n\nMedication Changes:\n====================\nNew Medications: None\nChanged medications: Atorvastatin increased to 80mg daily from \n40 mg\nStopped Medications: None\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Nephrocaps 1 CAP PO DAILY \n2. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n3. Cinacalcet 60 mg PO DAILY \n4. Calcium Carbonate 500 mg PO QID \n5. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild \n6. amLODIPine 5 mg PO DAILY \n7. Aspirin 81 mg PO DAILY \n8. Minoxidil 2.5 mg PO DAILY \n9. Metoprolol Succinate XL 100 mg PO DAILY \n10. Atorvastatin 40 mg PO QPM \n11. Clopidogrel 75 mg PO DAILY \n12. Escitalopram Oxalate 5 mg PO DAILY \n13. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n\n \nDischarge Medications:\n1.  Atorvastatin 80 mg PO QPM \nRX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0 \n2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \n3.  amLODIPine 5 mg PO DAILY  \n4.  Aspirin 81 mg PO DAILY  \n5.  Calcium Carbonate 500 mg PO QID  \n6.  Cinacalcet 60 mg PO DAILY  \n7.  Clopidogrel 75 mg PO DAILY  \n8.  Escitalopram Oxalate 5 mg PO DAILY  \n9.  Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY  \n10.  Metoprolol Succinate XL 100 mg PO DAILY  \n11.  Minoxidil 2.5 mg PO DAILY  \n12.  Nephrocaps 1 CAP PO DAILY  \n13.  Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n==================\nNon ST elevation Myocardial Infarction\nESRD on HD\nConcern for retinal hemorrhage\n\nSecondary Diagnosis:\n====================\nAnemia\nDepression\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nWhy was I admitted to the hospital?\nYou were admitted to the hospital because of chest pain.\n\nWhat was done for me while I was in the hospital?\nYou underwent a catheterization procedure in which a vessel of \nyour heart was opened. We changed some of your medications as \ndetailed below in order to optimize your heart function. Once \nyour chest pain was well managed you were felt safe to go home.\n\nWhat should I do when I leave the hospital?\nPlease continue all of your medications as prescribed. You need \nto follow up with your PCP and your cardiologist within the next \n2 weeks which is scheduled below. If you notice that your chest \npain returns please return to the hospital. It is very important \nthat you take your Aspirin and Plavix every day.\n\nWe wish you the best!\nYour ___ treatment team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13825681","hadm_id":"29140289","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nadhesive tape / Phenergan\n \nAttending: ___\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ female with past medical history\nsignificant for depression, anxiety, Child's A ETOH cirrhosis, \nand chronic calcific pancreatitis with recent diagnosis of PD\ndilation and stones (MRCP ___. She underwent ERCP on\n___ which revealed a dilated PD at a maximum diameter of\napproximately 6mm with multiple filling defects consistent with\nstones. A stricture was noted in the neck of the pancreas. The\nstricture was successfully dilated and a ___ x 10cm plastic PD\nstent was placed. She was discharge to home and reported doing\nreasonably well for several days, but still taking opioids -\ndilaudid was prescribed on discharge, but made her too tired, so\nshe restarted oxycodone, which she usually takes. At the time of\ndischarge, the plan was to return to ___ on ___ for\npancreatic stone lithotripsy, to be performed by Dr. ___.\n\n3 days prior to admission, she had worsening epigastric\ndiscomfort, which she describes as like a \"hot poker\" under her\nribs, with radiation to the back; the pain usually comes and\ngoes, but now has became constant, and she feels it is worse \nthan\nit has ever been. She report generalized nausea, and emesis x 1,\nacute on chronic diarrhea. She has intermittent headache, but\ndenies CP, SOB, blood in stool, joint pain, rash, sweats, she \nhas\neaten minimally in the last several days.\n\nROS: Pertinent positives and negatives as noted in the HPI, ROS\notherwise negative. \n \nPast Medical History:\n- Child' A ETOH Cirrhosis\n- Chronic calcific pancreatitis\n- Depression/Anxiety  \n- S/P appendectomy  \n- Mumps encephalitis as young child \n \nSocial History:\n___\nFamily History:\n- Father DM, CAD, HTN\n- Mother died of \"bone\" cancer\n\n \nPhysical Exam:\nADMISSION EXAM\nVITALS:  Afebrile and vital signs stable (see eFlowsheet)\nGENERAL: Uncomfortable appearing, but non-toxic\nEYES: Anicteric and without injection.\nCV: Regular, S1 and S2, no murmurs or gallops.\nRESP: Lungs clear to auscultation bilaterally without rales,\nrhonchi, or wheezes.\nGI: Abdomen soft, non-distended, mild tenderness to palpation in\nmid epigastrum; no rebound or guarding, BS +\nMSK: BLE warm, without cyanosis or edema.\nSKIN: Warm and well perfused, no excoriations, lesions,  rashes,\nor ulcerations noted.\nNEURO: Alert and oriented x 3, normal attention, speech is\nfluent, verbal comprehension is intact. Face symmetric, gaze\nconjugate and EOMI, gross motor function intact and symmetric in\nall four extremities.\n\nDISCHARGE EXAM\nVITALS:  Afebrile and vital signs stable (see eFlowsheet)\nGENERAL: Comfortable, NAD\nEYES: Anicteric and without injection.\nCV: Regular, S1 and S2, no murmurs or gallops.\nRESP: Lungs clear to auscultation bilaterally without rales,\nrhonchi, or wheezes.\nGI: Abdomen soft, non-distended, no tenderness; no rebound or \nguarding, BS +\nMSK: BLE warm, without cyanosis or edema.\nSKIN: Warm and well perfused, no excoriations, lesions,  rashes,\nor ulcerations noted.\nNEURO: Alert and oriented x 3, normal attention, speech is\nfluent, verbal comprehension is intact. Face symmetric, gaze\nconjugate and EOMI, gross motor function intact and symmetric in\nall four extremities.\n \nPertinent Results:\nADMISSION RESULTS\n___ 11:10AM BLOOD WBC-4.5 RBC-3.83* Hgb-12.4 Hct-35.8 \nMCV-94 MCH-32.4* MCHC-34.6 RDW-12.8 RDWSD-43.7 Plt ___\n___ 11:10AM BLOOD ___ PTT-30.7 ___\n___ 11:10AM BLOOD Glucose-86 UreaN-7 Creat-0.7 Na-143 K-4.1 \nCl-107 HCO3-25 AnGap-11\n___ 11:10AM BLOOD ALT-9 AST-16 AlkPhos-61 TotBili-0.4\n___ 11:10AM BLOOD Lipase-12\n___ 10:10AM BLOOD cTropnT-\u003c0.01\n___ 11:10AM BLOOD Albumin-3.7 Calcium-8.6 Phos-4.5 Mg-1.9\nCXR nil acute\n\nPERTINENT INTERVAL RESULTS\n___ 07:15AM BLOOD Glucose-82 UreaN-6 Creat-0.7 Na-147 \nK-6.0* Cl-108 HCO3-28 AnGap-11\n___ 10:10AM BLOOD Glucose-85 UreaN-5* Creat-0.6 Na-144 \nK-5.3* Cl-106 HCO3-30 AnGap-8*\n___ 10:10AM BLOOD cTropnT-\u003c0.01\n___ 06:50AM BLOOD Cortsol-0.9*\n___ 07:05AM BLOOD Cortsol-14.9\n___ 07:35AM BLOOD Cortsol-17.6\n___ 01:20PM BLOOD ALDOSTERONE-Test      \n___ 01:20PM BLOOD RENIN - FROZEN-PND\n___ 10:45AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG\n___ 10:45AM URINE Color-Yellow Appear-Hazy* Sp ___\n___ mixed gram positive bacteria\n\nMRCP\nIMPRESSION: \n \n1.  Chronic pancreatitis with signal and enhancement changes and \nmild residual\nduct dilation, markedly improved from the prior study.  2.  \nRecanalized\nparaumbilical vein.  3.  Multiple transient hepatic intensity \ndifferences.  4.\nMinimal atelectasis in the right lung base.\n\nDISCHARGE RESULTS\n\n___ 06:50AM BLOOD WBC-4.7 RBC-3.68* Hgb-11.8 Hct-33.6* \nMCV-91 MCH-32.1* MCHC-35.1 RDW-12.4 RDWSD-41.2 Plt ___\n___ 06:50AM BLOOD Glucose-131* UreaN-8 Creat-0.7 Na-144 \nK-5.1 Cl-103 HCO3-27 AnGap-___ w chronic calcific pancreatitis, etoh cirrhosis (c/b \nascites), depression, recent ERCP with PD dilatation and stones \nwho presents with abdominal pain potentially c/f pancreatitis. \nAlso with hyperkalemia ___ adrenal insufficiency. \n\n# pancreatitis: patient reports this pain is a bit different \nthan previous pain, but no other clear cause as CXR neg, EKG \nneg, troponin neg, no rash, UA neg, LFTs wnl. Likely related to \nknown PD duct stones and dilatation. Notably lipase neg, but \npatient reports this is frequently the case. PUD possible but \nalready on PPI. Note that adrenal insufficiency can cause \nabdominal pain and may  in fact be the etiology of her current \npain episode. MRCP with greatly improved pancreatic ductal \ndilatation. Per ERCP, no endoscopic intervention indicated. \nTolerated PO quite well. She will see Dr. ___ as an \noutpatient for outpatient lithotripsy. Patient was given a \nscript for pain meds to get her to her upcoming primary care \nappointment; non-opiate options insufficient. PMP checked. QHS \ntemazepam discontinued given heavy opiate use. \n\n# hyperkalemia and hypoglycemia: on admission, noted to have \nunexpected hyperkalemia to 6.0 with EKG changes (very subtle T \nwave peaks). Received insulin 10, dextrose and calcium. \nUnexpectedly this led to severe and persistent hypoglycemia \nthroughout the day requiring multiple doses of glucose despite \nfunctioning kidneys. Repeat lab check and EKG findings rule out \npseudohyperkalemia. Spironolactone could have contributed but \nsince has been on long-term this seemed unlikely to be primary \nfactor. No renal failure or acidosis to explain. As such, her \nadrenal insufficiency diagnosis makes sense. She was started on \nlow K diet, spironolactone was held. No events on telemetry. \nDischarge K=5.1. \n\n# adrenal insufficiency: Unclear etiology and timeline for \nadrenal insufficiency. Has been\non opiates, but not for a long period of time. No evidence of \nadrenal crisis or significant illness, so no need for stress \ndosing. This does explain both unexplained lab abnormalities \n(hyperkalemia and hypoglycemia). Orthostatics checked and \nnegative. Was started on dexamethasone 0.5mg po qd, ___ stim \nshowed retained adrenal function, consistent with secondary \nadrenal insufficiency. Renin and ___ pending. She received \nextensive verbal and written adrenal insufficiency instructions. \nShe was discharged with prednisone 10mg po qd and a PRN \ndexamethasone IM injection. \n\n# etoh cirrhosis: no longer drinking, c/b ascites which has been \nin remission. No evidence of encephalopathy, has never had \nvarices, no bleeding. No evidence of ascites at this time. \nSpironolactone held as above given hyperkalemia.\n\n# night sweats: patient reports long-standing night sweats. No \nweight loss, up to date on cancer screening. No culprit meds. \nThis may in fact represent menopause given timing. Other \npossibility includes effect of adrenal insufficiency. \n\nCHRONIC/STABLE PROBLEMS:\n# Depression/Anxiety: Continue clonazepam, mirtazapine, and\nfluoxetine.\n# GERD: Continue BID PPI\n\n\u003e30 minutes spent on patient care and coordination on day of \ndischarge. \n\nTRANSITIONAL ISSUES\n- spironolactone held as above, may need another diuretic in its \nplace\n- continue to monitor K\n- consider estrogen therapy as an outpatient versus other workup \nof night sweats, including due for next mammogram and can \nconsider HIV and TSH as outpatient \n- cont to wean opioids, can consider resuming temazepam qhs if \nopiates stopped\n- patient will require removal of previously placed pancreatic \nstent early ___, as previously\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. ClonazePAM 1 mg PO QAM \n2. ClonazePAM 2 mg PO QHS \n3. Creon 12 3 CAP PO TID W/MEALS \n4. FLUoxetine 5 mg PO DAILY \n5. Mirtazapine 30 mg PO QHS \n6. Omeprazole 40 mg PO BID \n7. Spironolactone 150 mg PO DAILY \n8. Temazepam 60 mg PO QHS \n9. Ondansetron 4 mg PO Q8H:PRN nausea \n10. Magnesium Oxide 400 mg PO BID \n11. HYDROmorphone (Dilaudid) 2 mg PO Q6H:PRN Pain - Moderate \n12. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \n\n \nDischarge Medications:\n1.  Dexamethasone 4 mg IM DAILY:PRN shock \nRX *dexamethasone sodium phosphate 4 mg/mL 1 injection IM DAILY \nDisp #*3 Vial Refills:*0 \n2.  Naloxone 0.04 mg IM DAILY:PRN overdose \nRX *naloxone [Evzio] 0.4 mg/0.4 mL 1 injection IM DAILY \nRefills:*0 \n3.  PredniSONE 10 mg PO DAILY \nRX *prednisone 10 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet \nRefills:*0 \n4.  OxyCODONE (Immediate Release) ___ mg PO Q8H:PRN Pain - \nModerate \nhold if sedation, RR\u003c12\n \nRX *oxycodone 5 mg ___ tablet(s) by mouth every eight (8) hours \nDisp #*42 Tablet Refills:*0 \n5.  ClonazePAM 1 mg PO QAM  \n6.  ClonazePAM 2 mg PO QHS  \n7.  Creon 12 3 CAP PO TID W/MEALS  \n8.  FLUoxetine 5 mg PO DAILY  \n9.  Magnesium Oxide 400 mg PO BID  \n10.  Mirtazapine 30 mg PO QHS  \n11.  Omeprazole 40 mg PO BID  \n12.  Ondansetron 4 mg PO Q8H:PRN nausea  \n13. HELD- Spironolactone 150 mg PO DAILY  This medication was \nheld. Do not restart Spironolactone until instructed by your \ndoctors\n\n \n___:\nHome\n \nDischarge Diagnosis:\nabdominal pain\npancreatic duct stones\nadrenal insufficiency\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure caring for you. You were admitted for \nabdominal pain. We believe this is related to your pancreatic \nduct stones. We did an MRCP which showed that you did not need \nan ERCP or stent, which is good.\n\n******\n\nWe also found you to have a condition called \"adrenal \ninsufficiency\". It is not totally clear why you have this, and \nyou will need further workup as an outpatient to find out more. \nWe started you on a steroid (prednisone) to replace the hormone \nyour body is not making. \n\nMedicines\nAdrenal insufficiency is treated with medicines every day. \nMedicines can be taken in pill form or by injection, depending \non your need. Glucocorticoids: One type of medicine you must \ntake every day is type of steroid called a glucocorticoid. This \ntype of steroid (different from the body building steroids) is \nnecessary for allowing the body to metabolize fuel, although it \nalso helps regulate inflammation, stabilize blood pressure and \nhas many other effects in the body. Your medicines may be \nordered as:\n___ hydrocortisone\n___ cortisone acetate\n___ prednisone, or\n___ dexamethasone, also known by the brand name ___\n\n___ crisis can happen when your body's need for cortisol \nchanges and the amount you take is not enough. Signs of an \nadrenal crisis are: Nausea and vomiting Abdominal pain Severe \nweakness or collapse Headache, dizziness or fainting Change in \nalertness or confusion Fever and chills Low blood pressure Fast \nheart rates, or going into shock\nTreatment for Adrenal Crisis\nIf you have one or more of these signs, Dexamethasone can save \nyour life, so carry doses with you at all times. You should have \n2 or 3 prefilled syringes of dexamethasone. Have one at home, \none at work, and one you carry with you all the time. Keep the \nmedicine at room temperature. Avoid hot or very cold \ntemperatures, and keep it away from sunlight, and water. Refill \nyour prescription when you use a dose, after the expiration date \nor one year after having the medicine filled, or if the medicine \nis cloudy or colored .\n\nIf your fever is 100.4F or higher, then double your dose.\n If your fever is 102F or higher, then triple your dose.\n If you experience vomiting and/or diarrhea, then double or \ntriple your dose depending on severity. Take a double dose for \nmild to moderate symptoms and a triple dose for severe symptoms.\no If you vomit, wait half an hour, and repeat the dose. If you \nare vomiting and cannot keep the medicine down (vomiting less \nthan one hour after the dose), you need to administer injectable \nhydrocortisone (Solu-Cortef) or dexamethasone, and contact your \nphysician. Do not delay the injection; give the medicine first, \nand then call your doctor to discuss when you need to be seen. \nDrink small amounts of clear sugar-containing liquids \nfrequently.\n\nFor your safety, you should get and wear a medical alert \nbracelet or necklace that states you have Adrenal Insufficiency. \nApply for a medical alert bracelet or necklace. Wear your \nmedical alert jewelry at all times. Carry with you a wallet card \nthat has your doctors name, phone numbers, medicines you take \nand how to help you in an emergency. If you have one or more \nsigns of adrenal crisis, or feel sick, take a dexamethasone \ninjection, and call your doctor right away. Tell your coworkers, \nfamily and friends about how to help you if you have adrenal \ncrisis. If someone finds you unconscious, have them give you \ndexamethasone right away. Then call ___ for help.\n\n********\nYou are currently off of your spironolactone because your \npotassium is a little elevated and this medicine can worsen \nthat. You may be able to resume this soon after clearance by \nyour doctors. \n\n******\nYou are on opioids and benzodiazepines. We would recommend \ntapering one or both of these medications, as they are \npotentially very risky together for overdose. We are sending you \nwith a script for an opioid reversal agent if needed in case of \naccidental overdose. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13588863","hadm_id":"23072772","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nErythromycin Base / Azithromycin / Levofloxacin\n \nAttending: ___.\n \nChief Complaint:\nDyspnea\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ lady with a history of lung cancer s/p \ncyberknife to RLL lesion, \u003e100 pack year smoking history, COPD \non 2L NC at home, and prior COPD exacerbations who presented to \nthe ED for SOB c/f COPD exacerbation\n\nAs some background, she has a \u003e 100 pack year smoking history \nand has had numerous prior COPD exacerbations treated with \nsteroids. \n\nHad PFTs in ___ which showed severe obstructive disease. \nTTE was normal at the time. CT Chest showed no change in right \nlower lobe lung mass. \n\nHome COPD regimen includes albuterol nebs, albuterol inhaler, \nadvair, and incruse inhalation. She uses 2L oxygen at home by \nnasal cannula. She also attends pulmonary rehab at ___ \n___. She is followed by Dr. ___ pulmonologist. \n\nShe recently saw her PCP and endorsed significant DOE even while \nwearing oxygen. She received prednisone course at the time.\n\nThis presentation:\nPatient has had 1 week worsening SOB, and also felt like she had \na cold that was worsening. \n\nIn the ED, initial vitals: 98.3, 165/83, RR 45, O2 78% on 2L NC. \nShe triggered for tachypnea and hypoxia. She was noted to be \nworking very hard to breath. She was started on stacked nebs and \nthen continuous nebs, also given methylpred 125 mg IV x1, \nazithromycin 500 mg, Zofran (as she gets nauseous with azithro). \nVitals improved to HR 111, BP 127/63, RR 24, and O2 94% 2L (home \nO2 requirement is 2L). \n\nOther labs: WBC 9.1, Cr 0.5, Mg 1.8, Trop \u003c 0.01, VBG 7.36/70. \n\nCXR showed no acute pulmonary process\n\n \nPast Medical History:\n-COPD with frequent exacerbations, 2L NC home O2 used PRN less \nthan daily. Climbs 4 stairs before requiring rest at baseline. \nBaseline PF ~ 150.  \n-H/o breast CA in ___, T2, N2 intraductal carcinoma, ER Pos, \nHER-2 Neg. s/p chemo/radiation, no evidence of recurrence  \nh/o arterial clot in right great toe \"years ago\", treated with \ncoumadin  \n-Smoking history; quit smoking 1 week ago\n \nSocial History:\n___\nFamily History:\nFather died at age ___ of emphysema and coronary artery disease, \nhad first MI in ___. Mother died of emphysema at age ___. \nSister who died of breast cancer. Brother who died of lymphoma \nat ___.\n \nPhysical Exam:\nVS: 98.4 PO 105/50 R Lying 82 20 94 2L NC \nGEN: mild resp distress (after getting to bed from commode),\nmildly cachectic, otherwise appropriate, pleasant, interactive. \nEYES: PERRL, EOMI, conjunctiva clear, anicteric\nENT: moist mucous membranes, no exudates \nNECK: supple \nCV: tachycardic, distant s1s2 nl, no m/r/g\nPULM: CTA, minimal breath sounds, prolonged exp phase, no r/r/w \nGI: normal BS, NT/ND, no HSM  \nEXT: warm, no c/c, 1+ PE to knees bil \nSKIN: no rashes \nNEURO: alert, oriented x 3, answers ? appropriately, follows\ncommands, non focal\nPSYCH: appropriate\nACCESS: PIV\nFOLEY: absent\n \nPertinent Results:\nADMISSION\n=========\n___ 04:18PM BLOOD WBC-9.1 RBC-4.35 Hgb-13.0 Hct-41.5 MCV-95 \nMCH-29.9 MCHC-31.3* RDW-12.6 RDWSD-44.6 Plt ___\n___ 06:07AM BLOOD WBC-4.5# RBC-4.39 Hgb-13.4 Hct-41.8 \nMCV-95 MCH-30.5 MCHC-32.1 RDW-12.2 RDWSD-42.6 Plt ___\n___ 06:31AM BLOOD WBC-5.7 RBC-3.68* Hgb-11.3 Hct-34.6 \nMCV-94 MCH-30.7 MCHC-32.7 RDW-12.6 RDWSD-44.0 Plt ___\n___ 04:18PM BLOOD Glucose-99 UreaN-9 Creat-0.5 Na-139 K-4.4 \nCl-93* HCO3-35* AnGap-11\n___ 06:07AM BLOOD Glucose-121* UreaN-8 Creat-0.5 Na-137 \nK-5.6* Cl-97 HCO3-31 AnGap-9*\n___ 06:31AM BLOOD Glucose-78 UreaN-15 Creat-0.5 Na-141 \nK-4.0 Cl-94* HCO3-38* AnGap-9*\n___ 04:18PM BLOOD Calcium-9.7 Phos-4.7* Mg-1.8\n___ 06:07AM BLOOD Calcium-8.4 Phos-4.3 Mg-1.8\n___ 06:31AM BLOOD Calcium-8.8 Phos-3.6 Mg-1.8\n___ 04:18PM BLOOD proBNP-220\n___ 04:18PM BLOOD cTropnT-\u003c0.01\n___ 04:28PM BLOOD ___ pO2-74* pCO2-70* pH-7.36 \ncalTCO2-41* Base XS-10\n___ 07:06AM BLOOD ___ pO2-245* pCO2-70* pH-7.37 \ncalTCO2-42* Base XS-12 Comment-GREEN TOP\n\nDISCHARGE\n=========\n\n___ 07:43AM BLOOD WBC-5.1 RBC-3.84* Hgb-11.8 Hct-36.3 \nMCV-95 MCH-30.7 MCHC-32.5 RDW-12.6 RDWSD-43.6 Plt ___\n___ 07:43AM BLOOD Glucose-72 UreaN-12 Creat-0.6 Na-143 \nK-4.1 Cl-96 HCO3-40* AnGap-7*\n___ 07:43AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0\n___ 07:06AM BLOOD ___ pO2-245* pCO2-70* pH-7.37 \ncalTCO2-42* Base XS-12 Comment-GREEN TOP\n \nBrief Hospital Course:\nMs. ___ is a ___ h/o COPD on 2L NC at home (\u003e100 pack year tob \nuse), mult prior COPD exacerbation, lung CA /p cyberknife to RLL \nlesion, who presented to the ED for SOB c/f COPD exacerbation. \nShe reports having 1 wk worsening SOB in setting of possible \nviral URI and stopping tob use (~ 1 wk prior to admission).  In \nthe ED, initial vitals: 98.3, 165/83, RR 45, O2 78% on 2L NC. \nShe triggered for tachypnea and hypoxia - noted to be \nsignificantly dyspneic.\n   She was started on stacked nebs and then continuous nebs, \nalso given methylpred 125 mg IV x1, azithromycin 500 mg, Zofran \n(as she gets nauseous with azithro). Vitals improved to HR 111, \nBP 127/63, RR 24, and O2 94% 2L (home O2 requirement is 2L).  \nShe was transferred to ___ for further mgmt.  In the FICU, her \nrespiratory status stabilized and was back to her baseline home \nO2.  She desaturated with ambulation (70-80%) and was markedly \ndyspneic with minimal exertion.  However, while at rest, O2 \nsats\u003e90% on 2L NC.  No need for BiPAP/CPAP during the ICU stay. \nFlu test returned negative.  Due to stable situation, she is \nbeing transferred to the floor.\n   On transfer, she notes significant dyspnea with minimal \nexertion.  Close to her baseline.  Has sensation of sputum in \nchest, but has difficulty coughing it up.  Notes chest tightness \n(EKG, trop neg).   \n   The following day, she reported improvement. She worked with \n___ and had no acute ___ needs. She initially felt ready to go \nhome, then felt like she still wasn't back to her baseline and \nneeded another day in the hospital. She will go home on home \ninhalers, home oxygen, finish course of prednisone and \nazithromycin. She is no longer interested in bupropion or \nnicotine but says she does not plan to continue smoking. Follow \nup with PCP's office scheduled next week.\n\nCHRONIC ISSUES  \n# Mood\n- Continued venlafaxine 75 mg PO daily\n#Insomnia\n-Continued home trazadone QHS PRN\n# HLD\n- Continued home simvastatin 20 mg PO daily\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n2. Incruse Ellipta (umeclidinium) 62.5 mcg/actuation inhalation \nDAILY \n3. Simvastatin 20 mg PO QPM \n4. TraZODone 150 mg PO QHS:PRN insomnia \n5. Venlafaxine 75 mg PO DAILY \n6. albuterol sulfate 90 mcg INHALATION Q6H:PRN Shortness of \nbreath \n\n \nDischarge Medications:\n1.  Azithromycin 250 mg PO Q24H Duration: 1 Dose \nRX *azithromycin 250 mg 1 tablet(s) by mouth daily Disp #*1 \nTablet Refills:*0 \n2.  PredniSONE 60 mg PO DAILY Duration: 1 Dose \nRX *prednisone 20 mg 3 tablet(s) by mouth daily Disp #*6 Tablet \nRefills:*0 \n3.  albuterol sulfate 90 mcg INHALATION Q6H:PRN Shortness of \nbreath \nRX *albuterol sulfate [ProAir HFA] 90 mcg 1 INH every 6 hours as \nneeded Disp #*1 Inhaler Refills:*0 \n4.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \nRX *fluticasone-salmeterol [Advair Diskus] 250 mcg-50 mcg/dose 1 \nINH twice daily Disp #*1 Disk Refills:*0 \n5.  Incruse Ellipta (umeclidinium) 62.5 mcg/actuation inhalation \nDAILY \nRX *umeclidinium [Incruse Ellipta] 62.5 mcg/actuation 1 INH \ndaily Disp #*1 Disk Refills:*0 \n6.  Simvastatin 20 mg PO QPM  \n7.  TraZODone 150 mg PO QHS:PRN insomnia  \n8.  Venlafaxine 75 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nChronic obstructive pulmonary disease exacerbation\nViral upper respiratory infection\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms ___,\nYou were admitted to the hospital for an exacerbation of your \nCOPD, likely triggered by a viral illness. You were initially \nadmitted to the intensive care unit and treated with nebulizers, \nsteroids, and antibiotics to decrease inflammation. You improved \nand were moved to the medical floor, where you continued to \nimprove back to your baseline level of breathing.\n\nPlease continue the 5-day course of steroids and azithromycin as \nprescribed and follow up with your outpatient providers.\n\nIt was a pleasure taking care of you!\n\nSincerely,\nYour ___ team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15230999","hadm_id":"24547387","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Sulfonamides / Amiodarone / Prilosec / \nSpironolactone / Epinephrine / Shellfish Derived / Valium\n \nAttending: ___.\n \nChief Complaint:\nChest pain\n \nMajor Surgical or Invasive Procedure:\nExercise MIBI\n\n \nHistory of Present Illness:\nMs. ___ is a ___ woman with a history of CA s/p CABG, \nuncontrolled GERD, HTN and HL presents with chest pain. Patient \nreports 4 days of a burning sensation throughout her chest with \noccasional pinpoint sharp sensation over her L breast. Pt \nreports ___ pain is persistent, non-exertional and burning \nradiated to her upper neck, back, and bilateral arms. Patient \nreported little palliation on home lansoprazole, a full dose ASA \n325 mg ___ x1, and SL nitroglycerin. Her pain is worse with \nmeals. She denies any n/v/diaphoresis, syncope, SOB, abdominal \npain, diarrhea, or ___. No hemetemesis or tarry stools. She \ntolerated the pain for 4 days, and then decided to come in for \nevaluation b/c she felt that she could no longer attribute it to \njust her chronic reflux esophagitis. Her anginal equivalent is a \nchest heaviness that is worsened by exertion and relieved by \nrest; this current pain is not like her anginal equivalent, but \nworse than her chronic reflux symptoms. She had a negative \nETT-MIBI in ___, and reports she is due for a stress test at \nthe end of ___. She is followed at ___ by GI Dr. ___ \n___ -- she had 2 EGDs in ___ and ___ which were both under \nlocal anesthetic due to the patient's concerns for multiple \nallergies. First EGD in ___ revealed a hiateal hernia; ___ EGD \npatient was unable to tolerate. Recent Upper GI in ___ \nshowed no evidence of reflux. Also states that she has had \ndifficulty coping with her husband's death ___ year ago, and may \nhave some associated anxiety.     \n.\nIn the ED VS were 96.7 52 163/90 18 100% on 2 L NC. Patient \nreceived lansoprazole 30 mg ___ x1.  She declined a GI cocktail. \nCXR was negative for acute intracardiac processes. EKG with \nsinus bradycardia, no ischemic ST segment changes. Cardiac \nenzymes were negative x1. She was admitted to medicine for a \nrule-out MI.\n \nPast Medical History:\nCAD s/p CABG ___. Last stress ___ - ETT-MIBI negative.\nHTN\nHigh cholesterol\nGERD w/ hiatal hernia, frequent symptoms\nEsophagitis\nS/p CCY, s/p appy, s/p hysterectomy\ns/p 0.4 cm grade I invasive ductal carcinoma. ER+, PR+, \nHER-2/neu -ve in ___.\nS/p breast bx for precancerous lesion in ___\nChronic LBP\nThyroid nodule\n2 lung nodules  \nRecent diagnosis of macular degeneration\n \nSocial History:\n___\nFamily History:\nTwo sisters with breast cancer, two sisters with MIs in ___, \ngrandfather with prostate cancer\n \nPhysical Exam:\nVitals: T: 98.3 BP: 132/79 P: 57 R: 20 O2: 98% RA  \nGeneral: Alert, oriented, pleasant and talkative, tearful when \nspeaking about her husband.  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, mild TTP in the epigastric area, non-distended, \nbowel sounds present, no rebound tenderness or guarding, no \norganomegaly  \nGU: no foley  \nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n \nPertinent Results:\nAdmission labs:\n___ 07:50AM   WBC-4.7 RBC-4.34 HGB-13.0 HCT-37.8 MCV-87 \nMCH-30.1 MCHC-34.5 RDW-13.5\n___ 07:50AM   NEUTS-61.7 ___ MONOS-6.4 EOS-4.0 \nBASOS-1.0\n___ 07:50AM   PLT COUNT-211\n___ 07:50AM   GLUCOSE-121* UREA N-18 CREAT-0.9 SODIUM-138 \nPOTASSIUM-3.6 CHLORIDE-103 TOTAL CO2-23 ANION GAP-16\n___ 07:50AM   CK(CPK)-53\n___ 07:50AM   CK-MB-NotDone cTropnT-\u003c0.01\n___ 07:34PM   CK(CPK)-53\n___ 07:34PM   CK-MB-NotDone cTropnT-\u003c0.01\n\nETT: IMPRESSION: Average exercise tolerance. Ischemic ST segment \nchanges and\nnonspecific diffuse T wave inversion noted post-exercise with \natypical\nanginal symptoms. Hypertensive at rest with blunted blood \npressure\nresponse to exercise. Occasional to frequent VEA noted during \nprocedure.\nNuclear report sent separately.\n\nMIBI: Normal myocardial perfusion. Preserved systolic function \nwith LVEF of 73%.\n\nCXR:  No acute cardiopulmonary process.\n\nAbdominal U/S: IMPRESSION:\n1. Mildly ectatic extrahepatic common bile duct which may be \nage-related but in the setting of epigastric pain, further \nevaluation could be considered. The patient is status post \ncholecystectomy.\n2. Echogenic liver consistent with fatty infiltration. Other \nforms of liver\ndisease and more advanced liver disease including significant \nhepatic fibrosis/cirrhosis cannot be excluded on this study.\n3. Stable small pancreatic tail cyst. The previously imaged \nuncinate process cyst could not be identified on today's \nultrasound. \n\nMRCP: IMPRESSION:\n1. Increase in the size, with roughly doubled volume, of the \ncystic lesion in the uncinate process of pancreas. This is \nlikely IPMN and there are\nseptations but no definite nodules. The other two cystic lesions \nwithin the\npancreas are stable. Followup MRCP is recommended in six months.\n2. More than 50% stenosis of the proximal right renal artery, \npossibly high\ngrade.\n3. No intra- or extra-hepatic bile duct dilatation. The \npancreatic duct is\nunremarkable.\n \nBrief Hospital Course:\nMrs. ___ is a ___ yo F with CAD s/p CABG and chronic reflux \nesophagitis who presents with chest pain x4 days.\n.\n# Chest pain: She ruled out for an acute infarction.  Her ETT \nwas troubling that with exertion she has ischemic changes.  \nHowever, her MIBI showed symmetric uptake.  She does not need an \nurgent catheterization, but given her symptoms suggestive of \nstable angina, she may benefit from outpatient catheterization.  \nShe can follow-up with her cardiologist, Dr. ___.  She was \ncontinued on her ASA, BB, ACEI.  She has had allergic reactions \nto multiple statins, so we did not treat her elevated lipids at \nthis time.  Her pain may have been coming from GERD, so her \nlansoprazole was increased to 30mg TID and simethicone for \nsymptomatic relief.  H.Pylori was negative.\n.  \n# HTN: well controlled.  She was continued on atenolol, \ntriamterine/HCTZ, and her ACEI.\n.\n# Abnormal U/S: The patient was seen inpatient by her \ngastroenterologist, Dr. ___.  She was concerned that \nthe band-like pain she had across her abdomen was a passed \nstone.  An U/S showed an ectactic CBD extra-hepatically, which \ncould be concerning for a malignancy.  She also has two \npancreatic cysts which are being followed.  An MRCP was done.  \nAt the time of discharge, the initial wet-read suggested mild \nincrease in the size of one of her cysts, suggested follow-up in \n___ year.  The final read of the MRI suggests possible IPMN and \nsuggests repeat MRCP in 6 months.  This should be ordered by Dr. \n___ gastroenterologist or her PCP.\n\n \nMedications on Admission:\n- Lansoprazole 15mg TID\n- irbesartan 37.5mg BID\n- aspirin 81mg daily\n- Vitamin D 1200mg daily\n- Serax 5mg BID if needed\n- triamterene/HCTZ ___ tab BID\n- Atenolol 75/75/50mg daily\n- KCl 10mg daily\n- Probiotic acidophilus 2 capsules daily \n \nDischarge Medications:\n1. Lansoprazole 30 mg Tablet,Rapid Dissolve, ___ Sig: One (1) \nTablet,Rapid Dissolve, ___ ___ (3 times a day).\nDisp:*90 Tablet,Rapid Dissolve, ___ Refills:*2*\n2. Irbesartan 75 mg Tablet Sig: 0.5 Tablet ___ once a day.  \n3. Aspirin 81 mg Tablet Sig: One (1) Tablet ___ once a day.  \n4. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Three (3) \nTablet ___ DAILY (Daily). Tablet(s) \n5. Oxazepam 10 mg Capsule Sig: 0.5 Capsule ___ BID (2 times a \nday) as needed for anxiety.  \n6. Triamterene-Hydrochlorothiazid 37.5-25 mg Tablet Sig: 0.5 \nTablet ___ twice a day.  \n7. Atenolol 50 mg Tablet Sig: 1.5 Tablets ___ BID (2 times a \nday): Take at breakfast and dinner.  \n8. Atenolol 50 mg Tablet Sig: One (1) Tablet ___ QHS (once a day \n(at bedtime)).  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis: chest pain\n\nSecondary diagnoses: coronary artery disease, hypertension, GERD\n \nDischarge Condition:\nMental Status: Clear and coherent\nLevel of Consciousness: Alert and interactive\nActivity Status: Ambulatory - Independent\n \nDischarge Instructions:\nYou were admitted with burning chest pain. Blood tests and an \nEKG showed no signs of a heart attack.  Because you are at high \nrisk for heart disease, you had an exercise stress test. The EKG \nportion of the exam showed concerning changes, but the images \nwere normal.  You should follow-up with Dr. ___ to decide \nwhat to do with these results.  There was concern that your pain \nmay be coming from a gall stone, so you had an ultrasound done.  \nThe ultrasound had changes that could have been from a cancer, \nbut there were no changes seen on your MRI.\n.\nOne change was made to your medications: please increase your \nlansoprazole dose to 30mg three times a day.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18559699","hadm_id":"29403017","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nTape ___ / Anusol-HC\n \nAttending: ___.\n \nChief Complaint:\nRight Lower Extremity Hematoma\n \nMajor Surgical or Invasive Procedure:\n___: I/D RLE hematoma\n\n \nHistory of Present Illness:\nThe pt is a ___ y/o female who presented initially in ___ with \na traumatic right lateral calf hematoma. She had been followed \nat ___ clinic and managed conservatively. The hematoma was \ncomplicated by surrounding cellulitis and she was treated \nwithout resolution. Given the prolonged course and failure of \nthe hematoma to resolve, the decision was made to bring the \npatient to the operating room for an incision and drainage.  \n \nPast Medical History:\nPMH:  \n- Paroxysmal afib on coum\n- CAD\n- HTN\n- Spontaneous pelvic fracture related to severe osteoporosis\n- Depression\n- Chronic renal insufficiency\n- Trace aortic regurgitation and 2+ tricuspid regurgitation  \n- Osteoarthritis  \n- Colon polyp  \n- Diverticulosis  \n- IBS  \n- Asthma  \n- Macular degeneration  \n- Umbilical hernia s/p repair\n\nPSH:  \n- Right total hip replacement (___)  \n- Periprosthetic hip fracture and repair (___)  \n- Partial Colectomy for Diverticultis c/b anastomotic leak \n- Ileostomy (___) and repair (___)  \n- Cataract repair\n- T\u0026A as child  \n\n \nSocial History:\n___\nFamily History:\nNo history of stroke. Father died of CHF complicated by atrial  \nfibrillation.  \n\n \nPhysical Exam:\nPhysical Exam:\nAlert and oriented x 3 \nVS:BP 139/82   HR 100   RR 18 98% (RA)\nCV: RRR\nResp: Lungs clear\nAbd: Soft, non tender\nExt: Right calf wound packed. Dressing c/d/i. Surrounding \ncellulitis improved. \n \nPertinent Results:\nOR Culture: no growth to date\n \nBrief Hospital Course:\nOn ___, the patient underwent incision/debridement of her \nright calf hematoma. The wound was drained and cultures from the \noperating room sent. The patient tolerated the procedure well \nand was admitted to the floor. While on the floor, the patient \nunderwent WTD dressing changes. She was continued on Augmentin. \nThe patient was discharged on a 14 day course of augmentin on \nPOD1. ___ was set up to place a wound VAC at home the day \nfollowing discharge. She will follow-up in clinic in 14 days. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amiodarone 200 mg PO TID \n2. Metoprolol Succinate XL 25 mg PO DAILY \n3. Venlafaxine XR 150 mg PO DAILY \n4. Amlodipine 2.5 mg PO DAILY \n5. Warfarin 2 mg PO DAILY16 \n\n \nDischarge Medications:\n1. Amiodarone 200 mg PO TID \n2. Amlodipine 2.5 mg PO DAILY \n3. Metoprolol Succinate XL 25 mg PO DAILY \n4. Venlafaxine XR 150 mg PO DAILY \n5. Warfarin 2 mg PO DAILY16 \n6. Amoxicillin-Clavulanic Acid ___ mg PO Q12H \nRX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by \nmouth every twelve (12) hours Disp #*28 Tablet Refills:*0\n7. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*20 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight Lower Leg Hematoma\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n___ will come to your home to manage the wound VAC. Please call \nthe office at ___ if you notice increased drainage, \nswelling, or redness around the wound. Please also call the \noffice if you develope a fever greater than 101.5 degrees. \n\nPlease take the prescribed antibiotic twice a day for two weeks. \nTake all other home medications as prescribed. For pain, take \ntylenol or aspirin. Take 1 tab oxycodone every 4 hours for more \nsevere pain. Do not drive while taking narcotic pain \nmedications. \n\nPlease follow-up with your PCP for management of your Coumadin. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"17267281","hadm_id":"21335568","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nZonegran / Sulfa (Sulfonamide Antibiotics)\n \nAttending: ___\n \nChief Complaint:\nReason for Consultation: epilepsy admission for medication\noptimization\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ is a ___ year old female, patient of Dr. ___ has medically and surgically refractory epilepsy who\npresented at recommendation of her epileptologist given \nincreased\nseizure frequency in the setting of recent Fycompa wean and\nintolerable side effects of rescue therapy at home who was sent\nin by Dr. ___ medication optimization. \n\nWith regards to her epilepsy history, she had seizure onset at\nage ___, second at age ___ years (identical twin had seizures\nat age ___ and ___, also, remained on phenobarbital until teen \nyears,\nbut had no further events), and refractory since. She had\nanterior corpus callosotomy at ___\nin ___, and VNS implanted in ___ then subsequently explanted\nprior to participation in DBS research trial which was also\nremoved due to inefficiency. \n\nShe has two types of events:\na.  Subtle onset of hands shaking, various flexion movements of\nher arms, seeming altered awareness with dazed eyes, lasts for a\nfew seconds. Frequency ___ times per day. \nb.  \"Big seizures\" consisting of body stiffening, dazed eyes and\nhyperventilation. No big seizures since ___. \n\nHer current medications are Felbamate 600 mg QID, Banzel 1000 mg\nBID and Epidiolex 1.5 ml per day. She was started on Epidiolex\naround ___. At that time she was on Fycompa but was having\nsignificant mood issues. Therefore this was decreased from 4 mg\ndaily to 2 mg daily on ___. Several days after this decrease\n(___), she had a flurry of seizures (over 100 in one day). At\nhome, her increased seizure frequency was treated with Ativan.\nHer mother estimates she received Ativan 1 mg ___ times. This\nhelped her seizures and she returned to a baseline of ___ per\nday. \n\nThen on ___, Fycompa was weaned completely off. Several days\nlater ___, ___ again had a flurry of seizures. She again\nutilized Ativan as rescue. She also utilized PHT rescue with the\nhelp of her epileptologist. Her mother estimates she received 24\ntablets (100 mg each) over a 24 hour period. She became\nincreasingly dizzy with increased tremor throughout the day and\neven fell, striking her right eye. However, her seizures \nreturned\nto baseline which continued over through the next weekend.\n\nThen on ___, she again had a flurry of seizures at which time\nPHT rescue was utilized. Her mother estimates 12 tablets were\nused from ___ to ___. On ___ she was more dizzy \non\nand off and again fell with head strike. Her PHT level was\nchecked and was 26. Her seizures had returned to baseline. On\n___ she continued to feel quite dizzy on and off and\ncould not walk and at times was talking like \"a drunken sailor\".\nShe had dysarthria at times and worsening of her baseline \ntremor.\nNo PHT or Ativan was given ___ or ___ given the\ndizziness, slurred speech and return of her baseline seizure\nfrequency. Given ongoing dizziness, speech changes and tenuous\nstatus, she was sent in to the ED for evaluation and admission\nfor medication optimization.\n\nShe currently does not have dizziness. She thinks her tremor is\nsomewhat worse. She endorses some slowed thinking and difficulty\nspeaking at times since taking PHT. She otherwise denies recent\nfevers, chills, cough, diarrhea, abdominal pain, or other\ninfectious symptoms. \n\nPast medication trials per OMR:  \nPhenytoin - ineffective in childhood, has some transient\nimprovement in seizures post hospitalization in ___\nPhenobarbital - effective in childhood\nGabapentin - ineffective\nValproate - ineffective\nZonisamide - ___ reaction\nLamotrigine - ineffective\nTopiramate - ineffective, ___ difficulties\nCarbamazepine - ineffective, osteoporosis\nLacosamide - ineffective and to cause ___ toxicity with\neach increase\nClobazam - possible depression\nRufinamide - current\nfelbamate - current\nBreviact - increased seizures\nFycompa (perampanel) - stopped most recently due to mood issues\n\n \nPast Medical History:\n1. Epilepsy as above \n2. Systemic Lupus/lupus nephritis:  stable, weaned off of oral\nprednisone; currently on hydroxychloroquine, followed by Dr.\n___ for lupus and Dr. ___ for nephrology\n3. Hypercholesterolemia:  taking pravastatin 20 mg per day \n4. Osteoporosis:  taking vitamin D, Tums/calcium\n5. Hypothyroidism\n6. Mood disorder:  followed in the CNU by Dr. ___\n\n___: \n1. Anterior corpus callosal sectioning at ___ in ___\n2. Vagal nerve stimulator placed in ___\n \nSocial History:\n___\nFamily History:\nIdentical twin sister, and one younger sister.  There is no \nfamily history of seizures otherwise. Father had mild heart \nattack.\n\n \nPhysical Exam:\nON ADMISSION:\n==================\nVITALS: 98.0 88 18 123/89 MAP: 100.3 98 Room Air\n\nGeneral: Awake, cooperative\nHEENT: NC/AT, no scleral icterus noted\nPulmonary: no increased wob\nCardiac: RRR\nAbdomen: soft, NT/ND\nExtremities: No ___ edema\nSkin: no rashes or lesions noted\n\nNeurologic:\n**of note, I witnessed a seizure while doing the exam. She had\npronounced increased in her baseline action tremor, then right\nand left arm cross body brief flexion movements with blank stare\nand dazed look. Resolved after several seconds. There was\nassociated tachypnea on tele.\n\n-Mental Status: Alert, oriented to \"Beginning of ___ ___. She is able to relate her history. She is slow with ___\nbackwards, made 2 errors, one of which she corrected. Speech is\nfluent with only rare stutter. There is no dysarthria. \nRepetition\nand comprehension intact. She names high and low ___ objects. \nAble to follow both midline and appendicular commands.  There \nwas\nno evidence of apraxia or neglect.\n\n-Cranial Nerves:\n II, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without\nnystagmus. VFF to confrontation.\n V: Facial sensation intact to light touch.\n VII: No facial droop, facial musculature symmetric. Rare right\nfacial twitch and mouth twitch.\n VIII: Hearing intact to ___ bilaterally.\n IX, X: Palate elevates symmetrically.\n XI: ___ strength in trapezii and SCM bilaterally.\n XII: Tongue protrudes in midline with full excursions.\n\n-Motor: Normal bulk, tone throughout. No pronator drift\nbilaterally. L\u003eR marked intention tremor and postural tremor ___\nmm and present 100% of the time.\n   Delt Bic Tri WrE FFl FE  IP Quad Ham TA Gastroc \n L  5    ___   ___   5    5  5     5    \n R  5    ___   ___   5    5  5     5    \n\n-Sensory: No deficits to light touch, pinprick, proprioception\nthroughout. No extinction to DSS.\n\n-DTRs:\n   Bi Tri ___ Pat Ach\n L  2  2    2    2   0\n R  2  2    2    2   0\n Plantar response was flexor bilaterally.\n\n-Coordination: L\u003eR intention tremor. Diminished RAM bl. \nDysmetria\non L\u003eR FnF. \n-Gait: did not assess \n\nON DISCHARGE:\n================\n24 HR Data (last updated ___ @ 452)\n    Temp: 98.0 (Tm 98.5), BP: 101/65 (___), HR: 69 \n(___), RR: 18 (___), O2 sat: 97% (___), O2 delivery: RA  \n\nGeneral: Awake, cooperative\nHEENT: NC/AT, no scleral icterus noted\nPulmonary: no increased wob\nCardiac: RRR\nAbdomen: soft, NT/ND\nExtremities: No ___ edema\nSkin: no rashes or lesions noted\n\nNeurologic: \n-Mental Status: Alert, eyes open, oriented to ___, ___. Repetition and comprehension intact. \n\nAble to follow both midline and appendicular commands.  There \nwas\nno evidence of apraxia or neglect.\n\n-Cranial Nerves:\n II, III, IV, VI:  PERRL 4to 2mm and brisk. EOMI without\nnystagmus though with some saccadic intrusions. \n V: Facial sensation intact to light touch.\n VII: No facial droop, facial musculature symmetric.\n VIII: Hearing intact to ___ bilaterally.\n IX, X: Palate elevates symmetrically.\n XI: ___ strength in trapezii and SCM bilaterally.\n XII: Tongue protrudes in midline with full excursions.\n\n-Motor: Normal bulk, tone throughout. No pronator drift\nbilaterally. L\u003eR marked intention tremor and postural tremor ___\nmm. Has full strength throughout upper and lower extremities.\n\n-Sensory: No deficits to light touch. No extinction to DSS.\n-DTRs: ___: L\u003eR ataxia on FNF ___ \n-Gait: Narrow based steady gait with normal arm swing.\n\n \nPertinent Results:\nON ADMISSION:\n=================\n-WBC: 8.6 RBC: 4.22 Hgb: 12.8 Hct: 40.4 MCV: 96 MCH: 30.3 MCHC: \n31.7* RDW: 14.0 RDWSD: 49.1* Plt Ct: 341 \n\n-Neuts: 75.2* Lymphs: 14.7* Monos: 7.7 Eos: 1.3 Baso: 0.8 Im \n___: 0.3 AbsNeut: 6.45* AbsLymp: 1.26 AbsMono:0.66 AbsEos: 0.11 \nAbsBaso: 0.07 \n\n-Glucose: 104* UreaN: 17 Creat: 0.6 Na: 139 K: 4.2 Cl: 105 HCO3: \n19* AnGap: 15 Albumin: 4.0 Calcium: 9.4 Phos: 4.6* Mg:\n\nURINE Blood: NEG Nitrite: NEG Protein: 30*\nGlucose: NEG Ketone: NEG Bilirub: NEG Urobiln: NEG pH: 6.0 \nLeuks:\nMOD* RBC: 4* WBC: 6* Bacteri: NONE Yeast: NONE Epi: 9 \n\nENDOCRINOLOGY/RHEUMATOLOGY:\n============================\n-TSH: 2.5 \n-___\n\nAED LEVELS:\n============\nPHENYTOIN                     20.6* \nRUFINAMIDE                    16.0  \nFELBAMATE                     PND\n\nIMAGING:\n===========\n___: ___ CT of Head: no acute process\n\n \nBrief Hospital Course:\n___ year old woman with SLE, HLD, hypothyroidism, unspecified \nmood\ndisorder, and intractable epilepsy s/p anterior corpus\ncallosotomy at ___ in ___,  s/p VNS\n(implanted in ___ then subsequently explanted), s/p DBS\n(explanted) admitted for increased seizure frequency in setting\nof Fycompa wean and toxicity from rescue phenytoin (dizziness).\nFycompa wean was initiated due to concern for mood instability.\nIn the hospital her home AEDs were continued without change. She \nwas started on Ativan 0.5 mg q8h with minimal to modest \nimprovement in EEG and clinical events, so ativan was increased \nto 1mg q8h. She had clinical improvement on Ativan leading to a \nretrial of onfi (previously reported depression on this \nmedication). Ativan was tapered off and onfi 5 mg BID was \ninitiated. She has 2 days of 0.5 mg Ativan daily to complete \ntaper upon discharge. Patient reported return to baseline number \nof daily seizures (___) and cvEEG was discontinued. She denied \nany side effects so far to Onfi. \n\nOf note, AED levels on admission included a phenytoin of 20.6, \nBanzel of 16. Felbamate level still pending at time of \ndischarge. There was discussion about modified ___ diet and \nnutrition was consulted. Patient and family received education, \npatient unsure if she would like to try this diet because some \nof her favorite foods are not within the diet. If interested, \nshe would likely require referral to ___ Admission \nfor initiation of ketogenic diet.\n\nTRANSITIONAL ISSUES:\n=======================\n[] Neurology\n- Started Onfi 5 mg BID. Room to increase.\n- Continue Ativan 0.5 mg taper for 2 more days\n- Ketogenic diet initiation discussion ongoing, would likely \nneed to be initiated at ___\n[] PCP\n- ___ of elevated ___. Recheck with only mildly elevated \ntiters 1:40.\n[] She was seen by ___ who recommended outpatient ___, script \nprovided\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Aspirin 81 mg PO DAILY \n2. Epidiolex (cannabidiol (CBD) extract) 1.5 ml oral BID \n3. Escitalopram Oxalate 10 mg PO DAILY \n4. Felbamate 600 mg PO QID \n5. Hydrocortisone Cream 1% 1 Appl TP QID apply to wrist \n6. Hydroxychloroquine Sulfate 300 mg PO DAILY \n7. Levothyroxine Sodium 150 mcg PO DAILY \n8. Multivitamins 1 TAB PO DAILY \n9. Pravastatin 20 mg PO QPM \n10. rufinamide 1000 mg oral BID \n11. Vitamin D ___ UNIT PO DAILY \n\n \nDischarge Medications:\n1.  Clobazam 5 mg PO BID \nRX *clobazam 10 mg 0.5 (One half) tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*3 \n2.  LORazepam 0.5 mg PO DAILY \nRX *lorazepam 0.5 mg 1 tablet(s) by mouth once a day Disp #*2 \nTablet Refills:*0 \n3.  Aspirin 81 mg PO DAILY  \n4.  Epidiolex (cannabidiol (CBD) extract) 1.5 ml oral BID  \n5.  Escitalopram Oxalate 10 mg PO DAILY  \n6.  Felbamate 600 mg PO QID  \n7.  Hydrocortisone Cream 1% 1 Appl TP QID apply to wrist  \n8.  Hydroxychloroquine Sulfate 300 mg PO DAILY  \n9.  Levothyroxine Sodium 150 mcg PO DAILY  \n10.  Multivitamins 1 TAB PO DAILY  \n11.  Pravastatin 20 mg PO QPM  \n12.  rufinamide 1000 mg oral BID  \n13.  Vitamin D ___ UNIT PO DAILY  \n14.Outpatient Physical Therapy\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nEpilepsy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___\nYou were admitted to ___ for management of increased seizure \nfrequency in setting of Fycompa wean. We started you on ONFI \nwith improvement in your clinical events. \nPlease take your medication as prescribed. We added ONFI 5mg \ntwice daily. We also started you on ativan which we will slowly \nwean. \nYou will take ativan 0.5mg twice daily for 2 more days ___ and \n___, followed by ativan 0.5mg daily for 3 days ( ___. \n\nPlease follow up with neurology as below.\n\nPer MA law you can't drive until 6 months seizure freedom. \nPlease avoid height, swimming in open water or taking baths \nunsupervised. \n\nYour ___ Care Team!\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11934692","hadm_id":"20528831","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ntraumatic brain injury\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMr. ___ is a ___ y.o. homeless male who reportedly did not return \nto the homeless shelter last night. On the morning of ___, he \nreturned to the shelter and was intoxicated; he then had a \ngeneralized tonic clonic seizure and was taken to an OSH.  He \nwas intubated at the OSH for airway protection because he was \nvomiting.  Head CT revealed a severe traumatic brain injury and \nhe was transferred to ___ for further evaluation. \n\n \nPast Medical History:\nETOH Abuse\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nAdmission PHYSICAL EXAMINATION ___:\nConstitutional: Intubated, sedated\nHEENT: Abrasion\nETT in place\nChest: Clear to auscultation\nCardiovascular: Regular Rate and Rhythm\nAbdominal: Soft, Nontender\nExtr/Back: No cyanosis, clubbing or edema\nSkin: No rash\nNeuro: GCS 3T\n\n \nDischarge PHYSICAL EXAMINATION ___:\nConstitutional: A/O x3\nHEENT: Abrasion, healing\nChest: Clear to auscultation\nCardiovascular: Regular Rate and Rhythm\nAbdominal: Soft, Nontender\nExtr/Back: No cyanosis, clubbing or edema\nSkin: No rash\nNeuro: GCS 3T\n\n \nPertinent Results:\n___ 09:52PM   GLUCOSE-128* LACTATE-1.2 NA+-128* K+-4.0 \nCL--94* TCO2-24\n___ 11:21PM   LACTATE-1.3\n___ 09:45PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 09:45PM   LIPASE-18\n___ 09:45PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 09:45PM   WBC-9.6 RBC-4.02* HGB-13.1* HCT-36.1* MCV-90 \nMCH-32.5* MCHC-36.2* RDW-13.5\n___ 09:45PM   PLT COUNT-157\n___ 09:45PM   ___ PTT-26.0 ___\n___ 09:45PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 09:45PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-TR \nGLUCOSE-70 KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG\n___ 09:45PM URINE  RBC-0 WBC-0 BACTERIA-NONE YEAST-NONE \nEPI-0\n___ 09:45PM URINE  MUCOUS-RARE\n___ 04:21AM BLOOD WBC-8.9 RBC-3.76* Hgb-11.8* Hct-34.4* \nMCV-92 MCH-31.4 MCHC-34.2 RDW-13.6 Plt ___\n___ 04:21AM BLOOD Glucose-91 UreaN-7 Creat-0.6 Na-136 K-3.5 \nCl-103 HCO3-26 AnGap-11\n___ 04:21AM BLOOD Albumin-3.4* Calcium-7.9* Phos-2.9 Mg-2.1\n\n___: CXR: 1.  Endotracheal and nasogastric tubes appear in \nappropriate position.  \n2.  Low lung volumes accentuate the bronchovascular markings.  \nSubtle hazy opacity over the right upper lung may be due to low \nlung volumes, although underlying pulmonary contusion is not \nexcluded.  Lateral third right rib fracture. \n\n___: CT ABD/Pelvis: \n1.  No evidence of vascular or solid organ injury in the abdomen \nor pelvis. \n2.  Mild loss of vertebral body height at the T10 and T11 levels \nis of \nindeterminate age, with no evidence of retropulsion. \n3.  Hepatic steatosis. \n4.  Cholelithiasis. \n\n___: CT C-Spine: 1.  No evidence of acute fracture or \ndislocation in the cervical spine. \n2.  Intracranial findings are better assessed on concurrently \nobtained CT of the head. \n3.  Right clavicle fracture, right T1 and T2 transverse process \nfractures, and posterior right non-displaced rib fractures are \nbetter assessed on prior outside CT of the chest. \n\n \n \nBrief Hospital Course:\nMr. ___ is a ___ year old homeless man with a history of alcohol \nabuse who presented to an OSH s/p tonic clonic seizure at his \nshelter.  He was intubated for airway protection at the OSH and \nHead CT revealed a small epidural hematoma, as well as areas of \nsubarachnoid hemorrhage.  He was transfered to ___ on ___ for \nfurther management.  His injuries include, L parietal SAH, R \ntemportal SDH, L frontal and B temporal contusions, right \ntemporal-parietal skull fracture, right scapular spine fracture, \nright medial clavical fracture, burst fracture of T1-T2, \nmultiple rib fracture ___, non-displaced. Per patient report \nonce extubated, on the day prior to admission he fell off his \nbike and struck the right side of his head, unhelmeted. He \ndenies LOC at this time and did not return to the shelter until \nthe morning of the seizure. \n\nFrom the ED he was transferred to the ICU where he remained \nhemodynamically stable. On ___, he was extubated and his neuro \nexam remained intact. He is primarily ___ speaking.  He is \nalert and oriented and MAE to command. PERRL.  He was loaded \nwith Dilantin and will be discharged with a total 7 day course \nfor seizure prophylaxis.  His pain was well controlled with \noxycodone and Tylenol. He was able to deep breathe and remained \noff oxygen. He was afebrile and his WBC was normal.  His diet \nwas advanced to regular and he tolerated this without nausea or \nvomitting.  Occupational therapy evaluated the patient and he \nwill follow up with at ___ for outpatient cognitive therapy.  \nPhysical Therapy evaluated him and cleared him for outpatient \ntherapy.  He is non-weight bearing to his Right arm, which \nshould remain in a sling. He will follow up with orthopedic \nsurgery in 2 weeks with x-ray evaluation.\n \nMedications on Admission:\nnone\n \nDischarge Medications:\n1. Docusate Sodium 100 mg PO BID \n2. Acetaminophen 500 mg PO Q4H \n3. Phenytoin Infatab 100 mg PO TID \n4. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain Duration: \n14 Days \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\npolytrauma\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to ___ following a witness seizure and with \nmultiple injuries including bilateral frontal contusions, rib \nfractures, a right clavicle fracture, and spinal fractures.  You \nare now ready to return home to recover. \n* Your injury caused rib fractures which can cause severe pain \nand subsequently cause you to take shallow breaths because of \nthe pain.\n \n* You should take your pain medication as directed to stay ahead \nof the pain otherwise you won't be able to take deep breaths. If \nthe pain medication is too sedating take half the dose and \nnotify your physician.\n \n* Pneumonia is a complication of rib fractures.  In order to \ndecrease your risk you must use your incentive spirometer 4 \ntimes every hour while awake.  This will help expand the small \nairways in your lungs and assist in coughing up secretions that \npool in the lungs.\n \n* You will be more comfortable if you use a cough pillow to hold \nagainst your chest and guard your rib cage while coughing and \ndeep breathing.\n \n* Symptomatic relief with ice packs or heating pads for short \nperiods may ease the pain.\n \n* Narcotic pain medication can cause constipation therefore you \nshould take a stool softener twice daily and increase your fluid \nand fiber intake if possible.\n \n* Do NOT smoke\n \n* If your doctor allows, non-steroidal ___ drugs \nare very effective in controlling pain ( ie, Ibuprofen, Motrin, \nAdvil, Aleve, Naprosyn) but they have their own set of side \neffects so make sure your doctor approves.\n \n* Return to the Emergency Room right away for any acute \nshortness of breath, increased pain or crackling sensation \naround your ribs (crepitus).\n\n \n \nFollowup Instructions:\n___\n"}
{"subject_id":"18615329","hadm_id":"29965009","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nVancomycin / Penicillins / Iodine-Iodine Containing\n \nAttending: ___.\n \nChief Complaint:\nAMS, fevers\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ YOM with alcoholic cirrhosis c/b encephalopathy, mesenteric \nand portal vein thrombosis, prior variceal bleeding, frequent \nfalls and gait imbalance, possible current alcohol use and \nrecent admission for fall with discharge on ___ presents to ED \nwith AMS, weakness and fevers. Patient's wife said (via the \ntelephone) that he hasn't been acting like him self for sometime \nbut that it has gotten worse int he last two to three days. She \nsays that he has been behving oddly and making ___ requests. \nTwo nights prior to admission he had shaking chills but no \nfever. On the morning of admission he was unable to get out of \nbed and was shaking uncontrollably. His wife called an \nambulance. \n\nOn arrival to the ___ ED he was febrile to 104.8. His CXR \nshowed a large right sided effusion and his UA was positive for \ninfection. Lactate was 4.2, WBC was 1.4 and he was tachycardic. \nGiven his allergies to vancomycin and penicillin he was given \nlevofloxacin and cefepime, 1 g of tylenol and 4 L of NS and \ntransferred to the ICU. The ED resident performed an ultrasound \nof his belly and could not identify any tappable ascites. \n\nOn arrival he is dyspnic but alert and cooperative. He endorsed \nthe above history. He reports cough but that this is long \nstanding and unchanged from baseline. His wife corroborates \nthis. He denies headache, photophobia, neck pain, nausea, \nvommiting or diarrhea. \n.\nOn arrival to the ICU a central line was placed and a \nthoracetesis was performed where 1400cc of straw colored fluid \nwas drained off and sent for studies. An A line was attempted \nbut was unable to be placed. \n.\n.\n.\nReview of systems:  \n(+) Per HPI  \n\n \nPast Medical History:\n- Alcoholic cirrhosis diagnosed ___ years ago: Dr. ___\n- H/o esophageal variceal bleed ___ years ago during alcohol \nbinge\n- H/o alcohol abuse, most recently known to be drinking in ___\n- Ascites\n- Anemia\n- Atrial fibrillation, diagnosed ___\n- Hyperlipidemia\n- Essential hypertension in the past\n- Depression\n- H/o Small bowel resection for possible diverticulitis\n- H/o BPH\n- Depression\n- Sensorineural hearing \n- H/o Crohn's disease\n- History of right sided effusions in the past\n \nSocial History:\n___\nFamily History:\nFather had prostate cancer, died of an MI after a CVA at age ___. \n\nMother died at age ___ of \"old age.\"  \n\n \nPhysical Exam:\nAdmission Physical Exam:   \nGeneral- Elderly frail gentleman in moderate distress, \ntachypneic \nHEENT- MMM NC AT \nNeck- Supple, no JVD \nCV- RRR no MRG \nLungs- CTA on the left dullness with barely audible breath \nsounds on the right. No rhonchi, rales or wheezes \nAbdomen- Distended, + BS, non-tender, No shifting dullness, \nrectal exam guian negative brown stool\nGU- foley in place \nExt- WWp no edema or erythema\nNeuro- AAOX3 with no astrixes  \n\nDISCHARGE PHYSICAL EXAM\nVitals: 98.2 90/58 77 20 95% RA\nGEN: chronically ill-appearing man in NAD, sunken eyes and \ncachectic\nHEENT- MMM NC AT  \nNeck- Supple, no JVD  \nCV- normal rate, regular rhythm, no MRG  \nLungs- Breath sounds still diminished at right base but \nimproved.  Left clear to auscultation.\nAbdomen- mildly distended, + BS, non-tender, no shifting \ndullness   \nExt- WWP; no edema  \nNeuro- AAOX3 with no asterixis \n\n \nPertinent Results:\nAdmission Labs: \n___ 02:40PM BLOOD WBC-1.5*# RBC-4.53* Hgb-14.0 Hct-43.0 \nMCV-95 MCH-30.8 MCHC-32.5 RDW-20.4* Plt Ct-78*\n___ 02:40PM BLOOD Neuts-79.3* Lymphs-7.9* Monos-11.8* \nEos-0.3 Baso-0.7\n___ 02:40PM BLOOD ___ PTT-33.4 ___\n___ 02:40PM BLOOD Glucose-56* UreaN-17 Creat-1.2 Na-131* \nK-3.9 Cl-101 HCO3-20* AnGap-14\n___ 02:40PM BLOOD ALT-42* AST-79* AlkPhos-96 TotBili-3.6*\n___ 02:40PM BLOOD cTropnT-\u003c0.01\n___ 02:40PM BLOOD Albumin-3.1* Calcium-8.4 Phos-1.1* Mg-1.7\n___ 05:59PM BLOOD TotProt-4.3* Albumin-2.1* Globuln-2.2 \nCalcium-7.4* Phos-0.7* Mg-1.6\n___ 05:59PM BLOOD Ethanol-NEG\n___ 10:20PM BLOOD Type-MIX Temp-36.8 O2 Flow-5 pO2-39* \npCO2-27* pH-7.35 calTCO2-16* Base XS--8 Intubat-NOT INTUBA \nComment-NASAL ___\n___ 02:52PM BLOOD Lactate-4.2*\n\nPertinent Interval Labs: \n___ 05:59PM BLOOD WBC-7.3# RBC-3.56* Hgb-11.4* Hct-33.4* \nMCV-94 MCH-32.0 MCHC-34.1 RDW-21.0* Plt Ct-56*\n___ 05:59PM BLOOD Neuts-74* Bands-21* Lymphs-2* Monos-1* \nEos-0 Baso-0 Atyps-2* ___ Myelos-0\n___ 04:01AM BLOOD ___ PTT-47.9* ___\n___ 04:01AM BLOOD ___\n___ 04:01AM BLOOD Glucose-97 UreaN-15 Creat-1.0 Na-132* \nK-3.6 Cl-104 HCO3-18* AnGap-14\n___ 06:15PM BLOOD Lactate-3.8*\n___ 10:20PM BLOOD Lactate-4.4*\n___ 04:20AM BLOOD Lactate-2.5*\n\nReports: \nCXR ___\nIMPRESSION: \n1.  Moderate right and small left pleural effusions, which are \nsignificantly worse than two days ago. \n2.  Bilateral lower lobe atelectasis.  Infection in the lower \nlobes cannot be excluded. \n\nLabs prior to discharge:\n\n___ 05:54AM BLOOD WBC-6.7 RBC-3.74* Hgb-11.6* Hct-34.9* \nMCV-93 MCH-31.0 MCHC-33.2 RDW-20.8* Plt ___\n___ 05:54AM BLOOD ___\n___ 05:54AM BLOOD Glucose-96 UreaN-15 Creat-0.8 Na-132* \nK-3.9 Cl-100 HCO3-24 AnGap-12\n___ 05:54AM BLOOD ALT-43* AST-53* AlkPhos-74 TotBili-1.8*\n___ 05:54AM BLOOD Albumin-2.8* Calcium-8.2* Phos-2.3* \nMg-1.8\n\nMICROBIOLOGY\n___ 3:30 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      PROTEUS MIRABILIS.    10,000-100,000 ORGANISMS/ML.. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             PROTEUS MIRABILIS\n                             |   \nAMPICILLIN------------   \u003c=2 S\nAMPICILLIN/SULBACTAM--   \u003c=2 S\nCEFEPIME--------------   \u003c=1 S\nCEFTAZIDIME-----------   \u003c=1 S\nCEFTRIAXONE-----------   \u003c=1 S\nCIPROFLOXACIN---------\u003c=0.25 S\nGENTAMICIN------------   \u003c=1 S\nMEROPENEM-------------\u003c=0.25 S\nPIPERACILLIN/TAZO-----   \u003c=4 S\nTOBRAMYCIN------------   \u003c=1 S\nTRIMETHOPRIM/SULFA----   \u003c=1 S\n\n___ 4:31 pm PLEURAL FLUID      PLEURAL FLUID. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      2+   ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n\n___ 8:29 pm PLEURAL FLUID      PLEURAL FLUID. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      3+  ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n\n \nBrief Hospital Course:\n___ YOM with alcoholic cirrhosis c/b encephalopathy, mesenteric \nand portal vein thrombosis, prior variceal bleeding, frequent \nfalls and gait imbalance admitted to the MICU with sepsis, found \nto have UTI and recurrent hepatic hydrothorax.\n\n# Sepsis (with urinary source). Patient febrile, tachycardic and \nleukopenic on arrival with urinary vs pulmonary source and \nlactate of 4 and 20% bands on repeat Diff. His blood pressure \nwas close to his base line.  Initially broad differential was \nentertained and he was treated with broad spectrum Linezolid and \nMeropenam given his allergy history.  Patient received 3L IVF in \nED and 1L albumin upon arrival to the MICU. Patient had a \ncentral line and a thoracentesis upon arrival to the MICU.  \nPleural fluid demonstrated transudative per Lytes Criteria.  He \nwas subsequently found to have Proteus UTI.  Linezolid \ndiscontinued, meropenem continued until sensitivities came back \non Proteus, then switched to ciprofloxacin.  No further \nhypotension; in review of outpatient records, SBPs in ___ are \nnormal for him. He was treated with 7 day course of antibiotics. \nBlood cultures were negative. CXR initially showed no PNA; \nsubsequent study read as a new LUL density that could be \naspiration or PNA; however, pt remained afebrile, without cough, \nno CP, no leukocytosis, and 2 thoracentesis specimens both \nwithout evidence of infection, so it was thought unlikely that \nthe patient has a true pneumonia an dhe was not treated for \nthis.  Home midodrine for known orthostasis at increased dose of \n7.5mg TID was continued.\n.  \n# Right Pleural Effusion: During this hospitalization had \nthoracentesis x2 both showing transudative fluid, likely \nrecurrent hepatic hydrothorax as no evidence of focal \nconsolidation to raise suspicion for paraPNA as transudate via \nlights. Effusion re-accumulated after initial thoracentesis \ndespite titrating up diuretics.  After second thoracentesis, \nremained small but stable.  Fluid cultures remained negative.  \nBy definition at this time, his effusion is not refractory given \nit had re-accumulated in setting of holding diuretidcs.  If \neffusion persists/becomes by definition refractory, options \ninclude repeated thoracentesis, transjugular intrahepatic \nportosystemic shunt placement, pleurodesis, and surgical repair \nof defects in the diaphragm.  Continued furosemide 40mg and \nspironolactone 100mg daily.\n\n# Cirrhosis: No evidence of decompensation during this admission \nas LFTs at recent baseline and patient without encephalopathy.  \nContinued 40mg PO Lasix, plus 100mg spironolactone,rifaximin, \nlactulose.\n  \n# Normocytic Anemia. No evidence of GI source in the MICU with \nguaiac negative stool on presentation. Hct had dropped from high \n___ to 31 initially, likely dilutional in the setting of IVF \nresusciation + bone marrow suppression in setting of concurrent \ninfection.  Hemolysis labs with normal LDH, no haptoglobin \navailable, Tbili within recent baseline.  Hct improved from 31 \nto 38 and has been stable.\n\n# Atrial fibrillation. CHADS20/CHADS2VAS1. Currently patient in \nAF with rates in 60-70s. No anticoagulation in setting of \ncomorbidities and frequent falls.\n\n# Hyponatremia. Stable and at recent baseline; likely due to \ncirrhosis with vasodilation and low perceived circulating volume \nto kidneys, leading to release of ADH. Free water restriction to \n2L. \n.  \n# Protein calorie malnutrition: Evaluated by nutrition and found \nnot to be taking in enough calories. Dobhoff in place and the \npatient is tolerating tube feeds well, now at goal.  ___ was \nkept in the stomach (not post-pyloric) due to repeated \nplacements of the tube without success in post-pyloric \nplacement.  Given he was tolerating well, kept in stomach.  He \nwas monitored closely for signs of re-feeding syndrome. \n\n# Alcohol abuse: Last drink 2 days prior to admission.  \nInitially on CIWA but did not score.  Maintained on MVI, \nThiamine, Folate.   \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Citalopram 20 mg PO DAILY \n2. Midodrine 5 mg PO TID \n3. Rifaximin 550 mg PO BID \n4. FoLIC Acid 1 mg PO DAILY \n5. Multivitamins W/minerals 1 TAB PO DAILY \n6. Thiamine 100 mg PO DAILY \n7. AndroGel *NF* (testosterone) 1 % (25 mg/2.5 g) Transdermal \ndaily \n8. Klor-Con M20 *NF* (potassium chloride) 20 mEq Oral daily \n\n \nDischarge Medications:\n1. Citalopram 20 mg PO DAILY \n2. FoLIC Acid 1 mg PO DAILY \n3. Midodrine 7.5 mg PO TID \n4. Multivitamins W/minerals 1 TAB PO DAILY \n5. Rifaximin 550 mg PO BID \n6. Thiamine 100 mg PO DAILY \n7. Furosemide 40 mg PO DAILY \n8. Lactulose 30 mL PO TID \n9. Spironolactone 100 mg PO DAILY \n10. AndroGel *NF* (testosterone) 1 % (25 mg/2.5 g) Transdermal \ndaily \n11. Klor-Con M20 *NF* (potassium chloride) 20 mEq Oral daily \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n1. Sepsis with urinary source\n2. Right sided pleural effusion due to hepatic hydrothorax\n3. Protein calorie malnutrition\n4. Alcoholic cirrhosis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nMr. ___,\n\nIt truly was a pleasure taking care of you while you were \nadmitted at ___.  You were admitted due to feveres and were \nfound to have a urinary tract infection which was treated with \nantibiotics.  The rest of your infectious workup was negative.  \nYou also were found to have fluid around your right lung.  This \nwas drained twice and is likely due to translocation of the \nfluid in your abdomen coming up into your chest.  Your diuretics \nwere also increased to help decrease the fluid in the chest.  \nYou were started on tube feeds because it was found that you \nhave not been getting enough nutrition, and a feeding tube was \nplaced.  You are being discharged to go to a ___ \n___ to help you get stronger after your hospitalization.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11076033","hadm_id":"27402458","text":" \nName:  ___                        Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nred dye / Coumadin / any medication with coating\n \nAttending: ___.\n \nChief Complaint:\nFever, Dyspnea\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ man with a history of \nmyelodysplastic/myeloproliferative disease, paroxysmal afib s/p \nabalation, and dCHF presenting from clinic with fever, and \nshortenss of breath. The patient presented to clinic to today \nfor C1D2 of Dacogen. Prior to initationof chemo therapy he was \nnoted to have a temp of 102.8 and on repeat 102.3. He complained \nof increasing shortness of breath and lethargy. While he was in \nclinic his sats were noted to be 80% on room air with no acute \nrespiratory distress. His sats improved to 91% on 4L NC. He was \ngiven 500 cc fluid and 2g of cefepime. He was then referred to \nthe ED for evaluation. \n.\nPer his daughter's report the patient ___ had generalized \nfatigue and weakness  over the past 1.5 months, no acute \nworsening in his fatigue over the past few days. He does endorse \nchronic cough and shortness of breath. The cough is \nintermittently productive of white phelgm. With regards to his \nSOB, worse when laying flat, but only first thing in the \nmorning. Per his daughter  furosemide was recently discontinued \nin ___ by his cardiologist over concern that it may make him \nmore dehydrated when receving chemo, but that he could take it \nprn if having ___ swelling, weight gain, or when receving blood \ntransfusion. He ___ not taken any since. He ___ not had any \nfevers, sweats, chills, diarrhea CP, or abdominal pain in the \nfew days preceeding his admission. Decreased PO intake over the \nlast several days\n.\nIn terms of his MDS history, per OMR, he received a cycle of \nazacitidine in ___, which was discontinued on C2D2 where he \nsimilarly had a fever to 100.8 and hypoxia to 89% on RA, with \n___. His infectious work up at that time was negative, and abx \nwere discontinued after 48 hrs of neg culture data. It was \nthought that he fevers were drug related and his treatment was \nchanged to decitabine.  \n.\nIn the ED initial vitals were T 99 P 70 RR 21 BP 101/45 O2 sat \n94% on 4L NC. Labs notable for WBC notable for a WBC of 13.2, \nhct 22.8, Cr 1.4 (baseline ___, normal lactate. CXR notable \nfor moderate to severe pulmonary edema with small bilateral \neffusions. The ED was also concerned about possible PNA and gave \nhim 1gm VAnc and another 500ccs NS bolus. \n.\nOn arrival to the MICU,the patient reports just feeling tired, \nstill with intermittent cough., but no increased SOB  \n.\nReview of systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denies cough, shortness of breath, or wheezing. \nDenies chest pain, chest pressure, palpitations, or weakness. \nDenies nausea, vomiting, diarrhea, constipation, abdominal pain, \nor changes in bowel habits. Denies dysuria, frequency, or \nurgency. Denies arthralgias or myalgias. Denies rashes or skin \nchanges.  \n \nPast Medical History:\nPAST ONCOLOGIC HISTORY:\n# MYELODYSPLASTIC SYNDROME, BEST CLASSIFIED AS REFRACTORY \nCYTOPENIA WITH MULTILINEAGE DYSPLASIA\n- BM Biopsy ___ showed moderately hypercellular marrow (20% \nfat). Inadequate response to Aranesp (started ___ and \nNeupogen (300mcg), stopped ___.\n- BM biopsy on ___ showed MYELODYSPLASTIC SYNDROME, BEST \nCLASSIFIED AS REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA. \nIPSS score 0, low risk group. Completed cycle 1 Vidaza, started \n___.\n- ___: Bone Marrow Biopsy: HYPERCELLULAR, MARKEDLY \nMYELOID-DOMINANT BONE MARROW WITH ERYTHROID AND MEGAKARYOCYTIC \nDYSPLASIA\n- ___ one cycle of azacitdine - poorly tolerated\n- ___ bone marrow biopsy: HYPERCELLULAR BONE MARROW FOR AGE \nWITH MORPHOLOGIC FEATURES CONSISTENT WITH MYELOPROLIFERATIVE \nNEOPLASM/MYELOPROLIFERATIVE DISORDER.  \n- ___ KARYOTYPE: 49,XY,+8,+13,+19[9]/46,XY[7] \nINTERPRETATION: Of 16 metaphase cells available for study, nine \ncomprised an ABNORMAL clone with trisomy 8, trisomy 13 and \ntrisomy 19. This result is consistent with myeloid disease, most \nlikely AML. \n-___ C1D1 Azacitidine \n-___ C2D1 Azacitidine\n-___ C1D1 Decitabine\n.\nPAST MEDICAL/SURGICAL HISTORY:  \n# Atrial fibrillation s/p ablation in ___ unable to \nachieve therapeutic levels of warfarin, currently not on \nanticoagulation\n# Diastolic CHF, EF 60%\n# Gastritis/GI bleed, s/p rx for H. pylori\n \nSocial History:\n___\nFamily History:\nBrother with colon ca in ___ no blood ds.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: T 97.9 BP 105/51 HR 58 RR 12 99% 2L\nGeneral:comofortable, in NAD\nHEENT:   Mucous membs moist,no ulcers\nNeck: JVP at the earlobe at 45 deg\nCV:  nl S1/S2 Regular Rate and Rhythm, no murmurs/gallops \nappreciated\nLungs: crackles bilaterally at the bases \nAbdomen: mild TTP mid-epigastrium, soft normactive  BS\nGU: no foley \nExt:  Warm no peripheral edema\nNeuro: AO x 3 MAE\nSkin. pethciae, but no cellulitic rashes\n\nDISCHARGE PHYSICAL EXAM:\nVitals: T 97.8 BP 101/52 HR 103 RR 16 97%RA\nGeneral: NAD, cachetic, appears comfortable, interactive\nHEENT:   dry MM, no oral lesions, PERRL\nNeck: no LAD\nCV:  RRR, normal S1/S2\nLungs: Clear to auscultation bilaterally\nAbdomen: soft, nontender, nondistended, normal BS\nExt:  Warm, well-perfused\nNeuro: Alert, difficult to assess given language barrier, exam \ngrossly intact\n\n \nPertinent Results:\nADMISSION LABS:\n___ 03:30PM BLOOD WBC-14.4* RBC-2.77*# Hgb-8.4*# Hct-24.5*# \nMCV-89 MCH-30.4 MCHC-34.3 RDW-16.1* Plt Ct-35*\n___ 03:30PM BLOOD Neuts-46* Bands-1 ___ Monos-6 Eos-3 \nBaso-1 ___ Metas-5* Myelos-3* Promyel-4* Blasts-12* NRBC-3*\n___ 03:30PM BLOOD Glucose-110* UreaN-21* Creat-1.5* Na-133 \nK-4.5 Cl-103 HCO3-22 AnGap-13\n___ 02:00PM BLOOD Albumin-3.3* Calcium-7.2* Phos-4.3 Mg-2.2\n___ 05:15PM BLOOD Hapto-83\n___ 03:30PM BLOOD ALT-23 AST-39 LD(LDH)-715* AlkPhos-68 \nTotBili-1.7*\n___ 05:25PM BLOOD Lactate-0.5\n\nDISCHARGE LABS:\n___ 07:30AM BLOOD WBC-4.8 RBC-2.80* Hgb-8.8* Hct-25.3* \nMCV-90 MCH-31.3 MCHC-34.8 RDW-15.1 Plt Ct-32*\n___ 07:30AM BLOOD Neuts-67 Bands-0 ___ Monos-6 Eos-0 \nBaso-0 ___ Metas-5* Myelos-1* Plasma-1*\n___ 07:30AM BLOOD Glucose-88 UreaN-22* Creat-1.0 Na-135 \nK-4.3 Cl-101 HCO3-28 AnGap-10\n___ 07:30AM BLOOD ALT-17 AST-13 LD(___)-280* AlkPhos-52 \nTotBili-0.9\n___ 07:30AM BLOOD Albumin-3.1* Calcium-7.2* Phos-4.0 Mg-2.0\n___ 07:30AM BLOOD ___ PTT-27.2 ___\n\nOTHER RELEVANT LABS:\n___ 05:21AM BLOOD WBC-11.1* RBC-2.49* Hgb-8.0* Hct-22.0* \nMCV-88 MCH-32.0 MCHC-36.2* RDW-15.8* Plt Ct-30*\n___ 05:21AM BLOOD ALT-21 AST-29 LD(LDH)-591* AlkPhos-58 \nTotBili-1.6*\n___ 11:55AM URINE Hours-RANDOM UreaN-638 Creat-84 Na-106 \nK-40 Cl-121\n___ 11:55AM URINE Blood-TR Nitrite-NEG Protein-30 \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG\n___ 07:45AM BLOOD ___ PTT-36.8* ___\n___ 07:45AM BLOOD Glucose-109* UreaN-17 Creat-1.0 Na-132* \nK-3.7 Cl-103 HCO3-22 AnGap-11\n___ 07:45AM BLOOD ALT-23 AST-26 LD(LDH)-552* AlkPhos-56 \nTotBili-1.7*\n___ 07:45AM BLOOD Albumin-3.0* Calcium-7.1* Phos-2.9 Mg-2.1\n___ 07:00AM BLOOD WBC-9.6 RBC-2.57* Hgb-8.0* Hct-22.7* \nMCV-88 MCH-30.9 MCHC-35.0 RDW-15.3 Plt Ct-37*\n___ 07:00AM BLOOD Albumin-3.0* Calcium-7.5* Phos-2.6* \nMg-2.0\n___ 07:00AM BLOOD ALT-20 AST-22 LD(LDH)-460* AlkPhos-54 \nTotBili-1.5\n___ 05:50AM BLOOD ___ PTT-36.4 ___\n___ 05:50AM BLOOD Glucose-102* UreaN-19 Creat-1.2 Na-134 \nK-4.3 Cl-103 HCO3-24 AnGap-11\n___ 06:55AM BLOOD WBC-8.7 RBC-3.09*# Hgb-9.7*# Hct-27.5*# \nMCV-89 MCH-31.2 MCHC-35.1* RDW-14.9 Plt Ct-32*\n___ 07:10AM BLOOD Glucose-127* UreaN-23* Creat-1.1 Na-132* \nK-4.0 Cl-100 HCO3-25 AnGap-11\n\nMICRO:\nRapid Respiratory Viral Screen \u0026 Culture Negative\nC diff Negative\nBlood Cx Negativex2\nUrine cx no growth\n\nIMAGING:\nCXR ___\nAP upright portable chest radiograph was provided.  The heart \nremains \nmoderately enlarged.  There is moderate to severe pulmonary \nedema with small bilateral effusions.  Aorta is calcified and \nunfolded.  No pneumothorax.   \n  \nIMPRESSION:  \nFindings compatible with congestive heart failure.\n\nECG ___\nEctopic atrial rhythm. \n\nCXR ___\nFINDINGS:  In comparison with the study of ___, the pulmonary \nedema ___ \nsubstantially decreased.  There is continued enlargement of the \ncardiac \nsilhouette with bilateral pleural effusions and compressive \natelectasis. \n  \nImpression to the right of the lower cervical trachea raises the \npossibility of a thyroid mass. \n \nBrief Hospital Course:\n___ year old ___ speaking male with MDS/myeloproliferative dz \n(w/ poor cytogenetics) s/p Azacitidine x2, h/o pAfib s/p \nablation and currently not on anticoagulation, dCHF (EF 60%) \npresenting with fever and hypoxia. \n\n# Hypoxia: Initially admitted to ICU but transferred to the ___ \nfloor within 24 hours. H/o dCHF. Initial presentation c/w CHF \nand volume overload. Elevated JVD, CXR with pulmonary edema, and \nresponsive to Lasix - easily weaned off oxygen with diuresis. \nUnclear etiology of decompensation, no c/o chest pain. EKG \nwithout evidence of ACS/ischemia, ectopic atrial rhythm s/p \nablation. Likely 2/t weekly transfusions/chemo hydration as well \nas having Lasix held given concern of decreased PO intake with \nchemo tx. Another consideration was PNA given fever, but cough \nwas at baseline, non productive - given recent chemo, pt was \nstarted on Vanco, Cefepime, Azitrhomycin on admission. PE was \nalso considered but pt responded to diuresis while in the ICU. \nAntibiotics d/c ___ given no growth on cxs and no fevers \nduring admission, was saturating well on RA at the time. Did not \ndevelop a fever after discontinuation of antibiotics. Home Lasix \n10mg PO QD was restarted after IV diuresis. Dry weight appears \nto be ~118 pounds. NOTE: O2 saturations should be taken from \nforehead.\n\n# MDS/Myeloproliferative Dz: Poor cytogenetics with persistent \nblasts and transfusion reqs after Azacytidine. Recently started \non Decitabine but only recieved 1 of 5 days. Anemia and \nthrombocytopenia likely 2/t this marrow process. Currently with \n6% blasts. No clear evidence of hemolysis given normal \nhaptoglobin, but pt does have elevated t bili, mostly indirect. \nCould be 2/t ineffective erythropoiesis from underlying MDS. ___ \n___ in the past after chemo. Coags only slightly elevated. \nTransfusions scales were in place (hct \u003c21, plts \u003c10). Acyclovir \nppx continued. Given no infectious source (antibiotics stopped) \nand afebrile x72 hours, decision was made to give a full 5 day \ncycle of Decitabine under direct observation (with preceding \nsteroids to avoid a febrile reaction) - c1d1 ___. Pt \ntolerated the cycle well ???\n\n# Fever: Occurred after one day of Dectibaine. Initially thought \nto be reaction to chemo or PNA given hypoxia. Fatigue was the \nmain localizing symptom (cough was at baseline, dry). CXR did \nnot show obvious consolidation but was c/w pulmonary edema 2/t \nCHF. Repeat CXR after diuresis did not show evidence of PNA but \nresolving pulmonary edema. Pt does have a h/o febrile reaction \nto Azacitidne, admitted a month ago, no source of infection \nfound at that time. Pt was afebrile x72 hours, cultures were \nunrevealing (flu swab negative), and leukocytosis resolved. \nAntibiotics were stopped on ___id not develop a \nfever after discontinuation. As a result, reaction was likely \ndue to chemo and Decitabine was restarted with pre-ceding \nsteroids to avoid a febrile reaction.\n\n# Hyperbilirubinemia: T bili 1. 7 (mostly indirect), however, it \n___ been elevated in the past, specificaly after chemo. \nPotentially drug related as deciatbine is known to cause \nhyperbilirubinemia. Hemolysis is also a consideration but \nhaptoglobin was wnl, LDH was elevated. Could be from underlying \nMD, ineffective erythropoesis. No abd pain to suggest \ngallbladder process. Slowly improved during admission without \nmajor intervention, similar to when pt recieved chemo a month \nago.\n\n# dCHF: On Metoprolol and Lasix at home. Lasix was being held \ndue to concern for dehydration while recieving chemo. \nPresentation c/w HCF decompensation as described above. \nResponded to diuresis as above. Restarted home PO Lasix and \nMetoprolol once HD stable.\n\n# Acute renal failure: Cr of 1.4 on admission with baseline \n(0.9-1.2). Recieved fluids in ED. FeNa did not suggest pre-renal \nazotemia. Cr back at baseline after diuresis. Likely reflective \nof poor forward flow in the settin gof heart failure.\n\n# Paroxsymal atrial fibrillation: Patient is s/p ablation in \n___ and not on systemic anticoagulation given inability to \ncontrol INR levels. EKG difficult to intrepret but read as \nectopic atrial rhythm. Monitored on tele ___ hours and d/c \nafterno events. Restarted home metoprolol.\n\n#Gastritis: Chronic. S/p h pylori rx. Continued omeprazole.\n\nTransitional Issues:\nCODE: Full (confirmed)\nEMERGENCY CONTACT:\nName of health care proxy: ___: Son\nPhone number: ___\nCell phone: ___\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acyclovir 400 mg PO Q12H \n2. Docusate Sodium 100 mg PO BID \n3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS \n4. Metoprolol Tartrate 12.5 mg PO BID \n5. Omeprazole 20 mg PO DAILY \n6. Ondansetron 8 mg PO Q8H:PRN nausea \n7. Prochlorperazine 10 mg PO Q6H:PRN nausea \n8. Furosemide 10 mg PO DAILY \n\n \nDischarge Medications:\n1. Nystatin Oral Suspension 5 mL PO QID \nSwish medication in mouth, then swallow. Continue for at least \n48 hours after symptoms resolve \nRX *nystatin 100,000 unit/mL 5 ml by mouth four times a day Disp \n#*1 Bottle Refills:*0\n2. Acyclovir 400 mg PO Q12H \n3. Docusate Sodium 100 mg PO BID \n4. Furosemide 10 mg PO DAILY \n5. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS \n6. Metoprolol Tartrate 12.5 mg PO BID \n7. Omeprazole 20 mg PO DAILY \n8. Ondansetron 8 mg PO Q8H:PRN nausea \n9. Prochlorperazine 10 mg PO Q6H:PRN nausea \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: Fever, Acute exacerbation of chronic diastolic heart \nfailure, MDS/Myeloproliferative disease\nSecondary: Chronic gastritis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\nIt was a pleasure taking care of you during your stay at ___. \nYou were admitted for reports of low oxygen levels and a fever. \nYou were in the ICU where they thought you had fluid around your \nlungs consistent with congestive heart failure. You were given \nmedications to remove the excess fluid and you improved. In \nterms of the fever, we thought that it may have been a reaction \nto the chemotherapy (given that it ___ occurred in the past with \nAzacitidine). As a result, we decided to give you Decitabine \nagain under direct observation preceded with steroid in order to \navoid a febrile reaction. You received 5 doses of Decitabine and \none blood transfusion with no further complications.  It is also \npossible the reaction you had was to the blood transfusion, and \nnot to the chemotherapy.\n\nWeigh yourself every morning, call MD if weight goes up more \nthan 3 lbs.\n\nPlease keep the follow-up appointments made for you.\n\nIt was a pleasure taking care of you, \n\nYour ___ doctors\n \n___ Instructions:\n___\n"}
{"subject_id":"12230961","hadm_id":"22849197","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nLipitor / Niacin Preparations / fenofibrate nanocrystallized / \ngemcitabine / lisinopril\n \nAttending: ___.\n \nChief Complaint:\nRight thigh wound\n \nMajor Surgical or Invasive Procedure:\nRight thigh I\u0026D and VAC placement (___)\nRight thigh I\u0026D, closure, and incisional VAC placement \n(___)\nR hip ___ guided aspiration (___)\n\n \nHistory of Present Illness:\nThis is a ___ year old male w/bladder CA (receiving BCG bladder \ninfusions), THR ___ ago at ___ who presents with several months \nof persistent RLE wound. He was recently admitted in ___ \nwith pan-negative cultures and negative workup. He presents \ntoday complaining of worsening wound which has now opened and is \ndraining mucoid material. His PCP reports that ___ single outside \nculture has grown mycobacteria (?BCG) and has referred him for \nID and orthopedic involvement.\n\n \nPast Medical History:\n- Bladder cancer, on active chemo\n- Prostate cancer\n- Atrial fibrillation on xarelto\n- NIDDM \n- Hypertension\n- Chronic renal insufficiency \n- Hyperlipidemia \n- GERD\n- Cholecystectomy\n- R-THR @ NEB ___ ago\n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nAdmission exam\nIn general, the patient is a well appearing male who is AOx3 and \nwhose appearance is consistent with stated age.\nVitals: Temp:98.2 HR:89 BP:141/48 RR:17 Sat:99% RA\n\nRight upper extremity:\nSkin intact\nSoft, non-tender arm and forearm\nFull, painless AROM/PROM of shoulder, elbow, wrist, and digits\n+EPL/FPL/DIO (index) fire\n+SILT axillary/radial/median/ulnar nerve distributions\n+Radial pulse\n\nLeft upper extremity:\nSkin intact\nSoft, non-tender arm and forearm\nFull, painless AROM/PROM of shoulder, elbow, wrist, and digits\n+EPL/FPL/DIO (index) fire\n+SILT axillary/radial/median/ulnar nerve distributions\n+Radial pulse\n\nRight lower extremity:\n6x2.5cm erythemetous fluctuant, tender, indurated region on \nlateral thigh inferior to trochanteric head. The wound has a \nslight tissue defect and is draining white, creamy mucoid \nnon-foul smelling material that may be purulent in nature.\nOtherwise soft, non-tender thigh and leg\nFull, painless AROM/PROM of hip, knee, and ankle\n___ fire\n+SILT SPN/DPN/TN/saphenous/sural distributions\n___ pulses, foot warm and well-perfused\n\nLeft lower extremity:\nSkin intact\nSoft, non-tender thigh and leg\nFull, painless AROM/PROM of hip, knee, and ankle\n___ fire\n+SILT SPN/DPN/TN/saphenous/sural distributions\n___ pulses, foot warm and well-perfused\n\nDischarge exam:\nAFVSS\nGen: NAD, A+Ox3\nRLE:\nIncision c/d/i\nMotor intact ___, TA, GSC\nSILT S/S/SP/DP/T\nWWP toes, 2+ DP\nFull ROM at R hip and knee\n \nPertinent Results:\n___ 05:10AM BLOOD WBC-11.7* RBC-4.62 Hgb-13.0* Hct-40.1 \nMCV-87 MCH-28.1 MCHC-32.5 RDW-15.2 Plt ___\n___ 01:55PM BLOOD Neuts-74.3* Lymphs-13.5* Monos-9.3 \nEos-2.2 Baso-0.6\n___ 05:10AM BLOOD Plt ___\n___ 05:10AM BLOOD Glucose-156* UreaN-13 Creat-1.0 Na-132* \nK-4.5 Cl-100 HCO3-26 AnGap-11\n___ 05:10AM BLOOD ALT-25 AST-28 AlkPhos-240*\n___ 05:10AM BLOOD Calcium-8.4 Phos-3.1 Mg-1.2*\n___ 01:55PM BLOOD CRP-53.2*\n___ 12:45PM BLOOD HIV Ab-NEGATIVE\n\n___ 12:45PM BLOOD HCV Ab-NEGATIVE\n___ 02:02PM BLOOD Lactate-1.6\n \nBrief Hospital Course:\nThe patient presented to the emergency department and was \nevaluated by the orthopedic surgery team. The patient was found \nto have a recurent right thigh wound and was admitted to the \northopedic surgery service.  The patient was taken to the \noperating room on ___ for I\u0026D and VAC placement, which the \npatient tolerated well (for full details please see the \nseparately dictated operative report). The patient was taken \nfrom the OR to the PACU in stable condition and after recovery \nfrom anesthesia was transferred to the floor.  The patient was \ninitially given IV fluids and IV pain medications, and \nprogressed to a regular diet and oral medications by POD#1. The \npatient was started on IV antibiotics per Infection Disease \nservice recommendations.  \n\nThe patient was taken to the operating room on ___ for \nrepeat I\u0026D, wound closure, and incisional VAC placement, which \nthe patient tolerated well (for full details please see the \nseparately dictated operative report). The patient was taken \nfrom the OR to the PACU in stable condition and after recovery \nfrom anesthesia was transferred to the floor.  The patient was \ninitially given IV fluids and IV pain medications, and \nprogressed to a regular diet and oral medications by POD#1. The \npatient was continued on his antibiotics until ___ at which \ntime Infectious Disease Service recommended stopping antibioics \nand obtaining a R hip aspiration to evaluate for septic \narthritis. Gram stain of the hip aspiration fluid showed no \nleukocytes and no microorganisms. Preliminary culture results \nshowed no growth to date. \n  \nThe patient's home medications, including Xarelto, were \ncontinued throughout this hospitalization.  The patient worked \nwith ___ who determined that discharge to rehab was appropriate. \nThe ___ hospital course was otherwise unremarkable. His \nincisional VAC was dicontinued at the time of his discharge. \n\nAt the time of discharge the patient was afebrile with stable \nvital signs that were within normal limits, pain was well \ncontrolled with oral medications, incisions were \nclean/dry/intact, and the patient was voiding/moving bowels \nspontaneously. The patient is weight bearing as tolerated in the \nright lower extremity, and will be discharged on his home \nxarelto for DVT prophylaxis.  The patient will follow up in two \nweeks per routine. A thorough discussion was had with the \npatient regarding the diagnosis and expected post-discharge \ncourse, and all questions were answered prior to discharge.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN pain \n\n2. Fluoxetine 20 mg PO DAILY \n3. Rivaroxaban 15 mg PO DAILY \n4. Ondansetron 8 mg PO Q8H:PRN nausea \n5. Docusate Sodium 100 mg PO BID \n6. Metoprolol Succinate XL 50 mg PO DAILY \n7. Omeprazole 20 mg PO DAILY \n8. Vitamin D ___ UNIT PO DAILY \n9. Sodium Bicarbonate 1300 mg PO THE NIGHT BEFORE AND THE \nMORNING AFTER CHEMOTHERAPY \n10. Oxybutynin 5 mg PO HS \n\n \nDischarge Medications:\n1. Docusate Sodium 100 mg PO BID \n2. Fluoxetine 20 mg PO DAILY \n3. Metoprolol Succinate XL 50 mg PO DAILY \n4. Omeprazole 20 mg PO DAILY \n5. Rivaroxaban 15 mg PO DAILY \n6. Vitamin D ___ UNIT PO DAILY \n7. Acetaminophen 650 mg PO Q6H:PRN Pain \n8. Ondansetron 8 mg PO Q8H:PRN nausea \n9. Oxybutynin 5 mg PO HS \n10. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN \npain \n11. Sodium Bicarbonate 1300 mg PO THE NIGHT BEFORE AND THE \nMORNING AFTER CHEMOTHERAPY \n12. MetFORMIN (Glucophage) 500 mg PO BID \n13. Insulin SC \n      Sliding Scale\n\nFingerstick QACHS\nInsulin SC Sliding Scale using REG Insulin\n14. Nystatin Oral Suspension 5 mL PO QID \n15. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN Pain \nRX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours \nDisp #*80 Tablet Refills:*0\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight thigh wound\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nMEDICATIONS:\n- Please take all medications as prescribed by your physicians \nat discharge.\n- Continue all home medications unless specifically instructed \nto stop by your surgeon.\n- Do not drink alcohol, drive a motor vehicle, or operate \nmachinery while taking narcotic pain relievers.\n- Narcotic pain relievers can cause constipation, so you should \ndrink eight 8oz glasses of water daily and take a stool softener \n(colace) to prevent this side effect.\n\nANTICOAGULATION:\n- Please continue taking your home dose of Xarelto to prevent \nthe formation of blood clots. \n\nWOUND CARE:\n- You may shower. No baths or swimming for at least 4 weeks.\n- Any stitches or staples that need to be removed will be taken \nout at your 2-week follow up appointment.\n- No dressing is needed if wound continues to be non-draining.\n\nACTIVITY AND WEIGHT BEARING:\n- Weight bearing as tolerated in right leg\n\nPhysical Therapy:\nWBAT in RLE\nROMAT in R hip and knee\nTreatments Frequency:\nPlease change dressings daily as needed for drainage.\nSutures will be removed at follow up clinic visit in 2 weeks.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18528468","hadm_id":"28536545","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nLevaquin\n \nAttending: ___.\n \nChief Complaint:\nTransfer from ___ with severe acute blood loss anemia due \nto bleeding duodenal polyp\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old male with a recent history of CAD s/p MI and PCI \nwith placement of 3 drug eluting stents in the LAD 1 month prior \nto admission presenting to OSH with syncopal episode 3 days \nprior to transfer to ___. Patient was at his third cardiac \nrehab session, and had felt fine after running on the treadmill. \nHe sat down and was talking with a nurse when he syncopized. Per \nreport, episode lasted for less than one minute. He had no \nprodromal symtpoms, no chest pain, no SOB, no blurry vision, no \nHA, no unilateral weakness, no localizing symptoms. He was not \npost-ictal when he regained consciousness.\n\nHis work up at the ___ was notable for Hct drop from 39 on ___ \nto 26 on ___ with melena. An EGD 1 day prior to transfer showed \na 2cm duodenal polyp with ulcer on the medial side wall. This \nwas not able to be bicapped or injected with epi due to its \nmobility. 2 clips were successfully placed and patient was \ntransferred to the ICU for monitoring out of concern that he may \nre-bleed as his plavix and aspirin could not be stopped. He is \ntransferred here for observation and possible repeat endoscopy. \nHe had received a total of 3 units pRBC, 2 the day prior to \ntransfer and one the morning of transfer.\n\nReview of systems: \n(+) Per HPI\n(-) Denies fever, chills, headache, cough, shortness of breath, \nchest pain, chest pressure, abdominal pain.\n \nPast Medical History:\n- Hemochromatosis\n- s/p MI with PCI DES ___\n- h/o nephrolithiasis\n- Multinodular thyroid followed since ___\n- h/o basal cell carcinoma nasal skin resection\n \nSocial History:\n___\nFamily History:\nNo family history of premature HA. Family history of HTN and \nelevated lipids. Mother died of AAA at ___ and father healthy and \nalive now at ___. Brother with prostate cancer and melanoma.\n \nPhysical Exam:\nVSS AF Stable\nGEN: NAD\nHEENT: EOMI, MMM, - OP Lesions\nPUL: CTA B/L\nCOR: RRR, S1/S2, - MRG\nABD: NT/ND, +BS, - CVAT, - rebound, - guarding, Stool GAUIAC (-) \non discharge\nEXT: - CCE\nNEURO: CAOx3, Non-Focal\n \nPertinent Results:\nLabs on Admission: \n___ 08:04PM BLOOD WBC-9.7 RBC-3.79* Hgb-11.2* Hct-31.5* \nMCV-83 MCH-29.6 MCHC-35.6* RDW-16.1* Plt ___\n___ 08:04PM BLOOD ___ PTT-24.2 ___\n___ 08:04PM BLOOD Glucose-84 UreaN-14 Creat-1.0 Na-142 \nK-4.2 Cl-106 HCO3-23 AnGap-17\n___ 08:04PM BLOOD Calcium-9.5 Phos-3.7 Mg-2.1\n\nLabs on Discharge:\n\n___ 07:55AM BLOOD WBC-10.2 RBC-3.99* Hgb-11.4* Hct-34.0* \nMCV-85 MCH-28.7 MCHC-33.6 RDW-16.4* Plt ___\n___ 08:35AM BLOOD ___ PTT-26.3 ___\n___ 07:55AM BLOOD Glucose-103* UreaN-10 Creat-1.1 Na-143 \nK-4.0 Cl-106 HCO3-27 AnGap-14\n___ 07:55AM BLOOD Calcium-9.2 Phos-4.1 Mg-2.___ yo M hx of CAD s/p MI and PCI with placement of 3 DES in LAD \n1 month ago presenting to OSH with syncopal episode 3 days ago \nand found to have bleeding duodenal polyp s/p clipping x2.\n\n1. Acute blood loss anemia due to GI Bleeding due to Duodenal \npolyp: \nAcute blood loss is the etiology of patient's syncopal episode \nupon presentation. The patient was transfused a total 2 units \npRBCs on presentation.  IV PPI was started, PIVx2 and active \ntype and screen were maintained. The patient underwent EGD with \npolyp clipping x2 at OSH. Following the procedure, the patient \nwas admitted to ICU and monitored closely for signs of re-bleed \nif polyp becomes necrotic given the continuation of patient's \naspirin/plavix. Hct was monitored closely and remained stable, \nrequiring no further transfusions. The patient remained free of \nsymptoms. Diet was advanced as tolerated to regular.  \nAntihypertensives and heparin SC were transiently held on \nadmission in the setting of potentional GI Bleed and re-started \nupon discharge. Plavix/ASA were continued throughout given \nrecent placement of DES.  IV PPI has been switched to PO PPI bid \nprior to discharge.  The patient will follow-up with his PCP and \n___ within 1 week of discharge.\n\n2. Syncope. \nGI Bleeding causing anemia is likely etiology of patient's \ninitial syncope.  Patient was ruled out for MI at OSH. He was \nmonitored on telemetry throughout this admission and had no \nfurther syncopal episodes. \n\n3. CAD Native Vessle, Recent MI s/p PCI Drug Eluting Stents x3. \nAnticoagulation needed to maintain patency of recently placed \nstents per extensive discussion with OSH cardiologist. With \nstrong cardiology recommendation to continue aspirin/plavix, we \ncontinued the patient's anticoagulation and monitored him \nclosely throughout this admission.\n\n4. Hemochromatosis. \nPer OSH records, most recent ferritin is 106 from ___. He is homozygous for the 863D gene.\n\n \nMedications on Admission:\n- Tylenol ___ PO q4hr prn\n- Aspirin 325mg PO Daily\n- Plavix 75mg PO Daily\n- Fish oil 2000mg PO Daily\n- Lisinopril 10mg PO Daily\n- Toprol XL 50mg PO Daily\n- Nitroglycerin SL prn\n- Simvastatin 40mg PO Daily\n \nDischarge Medications:\n1. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n2. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n3. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n4. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n5. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr \nSig: Two (2) Tablet Sustained Release 24 hr PO DAILY (Daily).  \n6. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n7. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual PRN as needed for chest pain.  \n8. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO twice a day.\nDisp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*1*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: Gastrointestinal bleeding from a bleeding duodenal \nulcer\n\nSecondary: Coronary Artery Disease\n\n \nDischarge Condition:\nMental Status:Clear and coherent\nLevel of Consciousness:Alert and interactive\nActivity Status:Ambulatory - Independent\n\n \nDischarge Instructions:\nYou were admitted to the hospital because you collapsed.  You \nwere found to have a low red blood cell count and given 3 units \nof red blood cells.  Endoscopy was performed.  Because you were \non Aspirin and Plavix, you were transferred to ___ Intensive \nCare Unit for close monitoring.  Your red blood cell counts have \nremained stable and you remained free of symptoms.  You are \nbeing discharged home.\n\nYou may continue to eat normal heart healthy diet.\n\nWe prescribed you omeprazole 40mg twice a day.  Please makes \nsure to take this medication carefully.\n\nYou should continue to take all your other medications as \nprescribed.\n\nYou need to follow up with your primary care doctor and GI \ndoctor ___ below).\n\nIt is critical that you call your GI doctor immediately or \npresent to the Emergency Department right away if you develop \nany of the signs or symptoms of GI bleed: dizziness, \nlightheadedness, changes in vision, red, black/tarry stools, or \nany other symptoms that concern you.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15938562","hadm_id":"24996768","text":" \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nIodine-Iodine Containing / Shellfish / Lactose-Free Food / \nlisinopril\n \nAttending: ___\n \nChief Complaint:\nPelvic pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo G0 with h/o CHF, HTN s/p TLH in ___ presenting to\nED with acute right lower quadrant pain that started last night.\nPain came on gradually, felt like cramping, around 2300. She was\nable to fall asleep and then woke up with a more intense achey\ndull pain in her right lower quadrant ___. Took tylenol without\nrelief. Pain is connstant but with some aggravation with certain\npositions. Denies fever, chills. Some nausea, no vomiting. Had\nmultiple episodes of diarrhea yesterday, has resolved. Thinks\nthis was related to some food that she ate. Max T at home was\n99.3. \n.\nHas been followed for right ovarian cyst. Was supposed to start\nprogestin only pill for suppresion, has filled rx but has not\nstarted.\n \nPast Medical History:\nGYN Hx: \n- open myomectomy x 2, hysteroscopic myomectomy, total\nlaparoscopic hysterectomy with extensive LOA for fibroid uterus\n___\n- remote h/o chlamydia, PID\n- condyloma\n- vulvar ___\n- admission ___ for pelvic abscess s/p IV abx, did not require\ndrainage\n\nPMH: idiopathic dilated cardiomyopathy, hypertension, anemia,\nasthma, eczema\n\nPSH: TLH ___, open MMY x 2, hysteoscopy MMY, lumpectomy\n \nSocial History:\n___\nFamily History:\nCHF of unknown etiology in several immediate family members, \nalso IDDM, CAD. \n \nPhysical Exam:\nDischarge Physical Exam\nAfebrile, VSS\nNAD, comfortable\nAbdomen soft, non-tender, no rebound/guarding\nLower extremities non-erythematous, no swelling\n \nPertinent Results:\n___ 03:10PM BLOOD WBC-18.3*# RBC-4.02* Hgb-13.2 Hct-37.4 \nMCV-93 MCH-32.9* MCHC-35.4* RDW-14.5 Plt ___\n___ 03:10PM BLOOD Neuts-89.9* Lymphs-6.2* Monos-2.9 Eos-0.9 \nBaso-0.2\n___ 06:05AM BLOOD WBC-17.9* RBC-3.56* Hgb-11.8* Hct-33.4* \nMCV-94 MCH-33.1* MCHC-35.2* RDW-14.3 Plt ___\n___ 06:05AM BLOOD Neuts-82.6* Lymphs-10.8* Monos-4.4 \nEos-1.9 Baso-0.4\n___ 06:10AM BLOOD WBC-13.3* RBC-3.60* Hgb-11.6* Hct-33.5* \nMCV-93 MCH-32.3* MCHC-34.7 RDW-14.2 Plt ___\n___ 06:10AM BLOOD Neuts-80.9* Lymphs-12.7* Monos-4.0 \nEos-1.9 Baso-0.5\n___ 03:10PM BLOOD Glucose-153* UreaN-19 Creat-0.8 Na-135 \nK-3.9 Cl-95* HCO3-28 AnGap-16\n___ 03:17PM BLOOD Lactate-2.5*\n___ 03:10PM URINE Color-Straw Appear-Clear Sp ___\n___ 03:10PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 03:10PM URINE RBC-\u003c1 WBC-\u003c1 Bacteri-FEW Yeast-NONE \nEpi-\u003c1\n___ 03:10PM URINE CastHy-2*\n___ 03:10PM URINE UCG-NEGATIVE\n \nBrief Hospital Course:\nOn ___, Ms. ___ was admitted to the gynecology service \nfor monitoring and evaluation of her right lower quadrant pain \nand leukocytosis given concern for ovarian torsion. \n.\nShe underwent a CT, which showed no evidence of appendicitis and \na right adnexal cystic structure measuring up to 4.7cm; torsion \ncould not be excluded. A pelvic ultrasound showed a \nheterogeneous structure in the right adnexa measuring 4.1 x 4.0 \nx 4.1 cm without clear visualization of the right ovary, \npossibly suggestive of ovarian torsion. She then underwent MRI, \nwhich showed a 4.4cm hemorrhagic right ovarian cyst, no evidence \nof torsion, multiple foci concerning for endometriosis, and no \nabscess or ___. Her pain was attributed to the ruptured cyst.\n. \nHer pain was controlled with oral percoset, with IV dilaudid for \nbreakthrough pain. Her leukocytosis improved over the course of \nadmission; she did not receive antibiotics during her admission. \n\n.\nShe was maintained on her home medications for her hypertension \nand cardiomyopathy.\n. \nBy hospital day 2, her pain was controlled with oral pain \nmedications, she remained afebrile throughout her \nhospitalization, and her physical exam was reassuring. She was \ndischarged home in stable condition with outpatient follow up \nscheduled.\n \nMedications on Admission:\nALBUTEROL SULFATE - albuterol sulfate HFA 90 mcg/actuation\naerosol inhaler. ___ puffs(s) by mouth every four (4)  to six \n(6)\nhours as needed for cough/wheezing\nALLOPURINOL - allopurinol ___ mg tablet. 1 tablet(s) by mouth\nonce a day\nCARVEDILOL - carvedilol 25 mg tablet. 0.5 (One half) tablet(s) \nby\nmouth twice a day\nCLOBETASOL - clobetasol 0.05 % topical ointment. 1 Ointment(s)\ntwice a day\nCOLCHICINE [COLCRYS] - Colcrys 0.6 mg tablet. 1 tablet(s) by\nmouth twice a day\nEPINEPHRINE [EPIPEN 2-PAK] - EpiPen 2-Pak 0.3 mg/0.3 mL \n(1:1,000)\ninjection,auto-injector. use IN CASE OF SEVERE REACTION AND CALL\n___ (USE ONLY ONCE)\nERGOCALCIFEROL (VITAMIN D2) - ergocalciferol (vitamin D2) 50,000\nunit capsule. 1 capsule(s) by mouth twice weekly\nFLUTICASONE [FLOVENT HFA] - Flovent HFA 220 mcg/actuation \naerosol\ninhaler. 2 puffs twice a day\nLISINOPRIL - lisinopril 20 mg tablet. 1 tablet(s) by mouth daily\nNORETHINDRONE (CONTRACEPTIVE) [NOR-QD] - Nor-QD 0.35 mg tablet.\none tablet(s) by mouth daily\nONDANSETRON HCL - ondansetron HCl 4 mg tablet. 1 tablet(s) by\nmouth Every 8 hours as needed for nausea\nOXYCODONE-ACETAMINOPHEN - oxycodone-acetaminophen 5 mg-325 mg\ntablet. 1 tablet(s) by mouth every six (6) hours as needed for\npain\nPOTASSIUM CHLORIDE - potassium chloride ER 10 mEq\ncapsule,extended release. 3 capsule(s) by mouth once a day\nPREDNISONE - prednisone 5 mg tablet. 1 Tablet(s) by mouth once a\nday take one tab with 10 mg tab total of 15 mg\nPREDNISONE - prednisone 10 mg tablet. 1 tablet(s) by mouth once \na\nday\nRANITIDINE HCL - ranitidine 150 mg capsule. 1 Capsule(s) by \nmouth\ntwice a day\nSPIRONOLACTONE - spironolactone 50 mg tablet. 1 tablet(s) by\nmouth daily\nTORSEMIDE - torsemide 20 mg tablet. ___ tablet(s) by mouth daily\ntitrate to wt change\nTRIAMCINOLONE ACETONIDE - triamcinolone acetonide 0.1 % topical\ncream. 1 Cream(s) three times a day\n \nMedications - OTC\nCALCIUM CARBONATE-VITAMIN D3 [CALTRATE-600 PLUS VITAMIN D3] -\nCaltrate-600 Plus Vitamin D3 600 mg (1,500 mg)-400 unit tablet. \n1\nTablet(s) by mouth twice a day\nMAGNESIUM CHLORIDE [MAG 64] - Mag 64 64 mg tablet,extended\nrelease. take 2 tablets by mouth four times a day\n \nDischarge Medications:\n1. Albuterol Inhaler ___ PUFF IH Q4H:PRN sob \n2. Carvedilol 12.5 mg PO BID \n3. Lisinopril 20 mg PO DAILY \n4. Torsemide 80 mg PO DAILY \n5. Spironolactone 50 mg PO DAILY \n6. norethindrone (contraceptive) 0.35 mg oral DAILY ovulation \nsuppression \n7. PredniSONE 15 mg PO DAILY \n8. Ranitidine 150 mg PO DAILY \n9. Senna 8.6 mg PO BID:PRN constipation \ntake while using narcotic pain medications \nRX *sennosides [senna] 8.6 mg 1 by mouth twice a day Disp #*50 \nTablet Refills:*0\n10. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain \ndo not drink alcohol or drive while taking. do not take more \nthan 4000mg acetaminophen in 24 hours. \nRX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth \nevery ___ hours Disp #*50 Tablet Refills:*0\n11. Docusate Sodium 100 mg PO BID constipation \ntake while using narcotic pain medications \nRX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp \n#*50 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nRuptured ovarian cyst\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the gynecology service for monitoring of  \nyour pain. You have recovered well and the team believes you are \nready to be discharged home. Please call Dr. ___ \noffice with any questions or concerns. Please follow the \ninstructions below.\n\nGeneral instructions:\n* Take your medications as prescribed.\n* Do not drive while taking narcotics.\n* Take a stool softener such as colace while taking narcotics to \nprevent constipation.\n* Do not combine narcotic and sedative medications or alcohol.\n* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs.\n\nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15991007","hadm_id":"24658800","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAneurysm\n \nMajor Surgical or Invasive Procedure:\n___ Pipeline embolization of Left ICA aneurysm\n\n \nHistory of Present Illness:\nShe is a delightful ___ woman at home and has one\ndaughter.  She has a family history of a mother with an aneurysm\nand a grandmother with aneurysm. An MRI approximately three \nmonths ago demonstrates what appears to be a right paraclinoid \ninternal carotid artery/common carotid artery aneurysm.  The \naneurysm is irregular in shape with two separate lobules to it.  \n in widest diameter.  I had a long discussion with\nher husband regarding the natural history of aneurysms.  We also\ndiscussed the potential treatment options. She presents today \nfor Pipeline embolization of Left ICA aneurysm. \n \nPast Medical History:\nremote history of hypertension , no meds at this time\n \nSocial History:\n___\nFamily History:\nMother and grandmother with hx aneurysm\n \nPhysical Exam:\nOn discharge:\nNeurologically intact, groin site c/d/i\n \nPertinent Results:\n___ Pipeline embolization:\nPipeline embolization of right paraophthalmic internal carotid \nartery \naneurysm. \n\n \nBrief Hospital Course:\nOn ___ Mrs. ___ was admitted to the neurosurgical \nservice. She had a successful Pipeline embolization of her Left \nICA aneurysm. She was extubated, right groin angiosealed and \ntransferred to PACU in stale condition and neurologically \nintact. She was transferred to the ___ for further monitoring \nand care and remained stable overnight into ___.\n\nOn ___ she was doing well neurologically and was deemed fit for \ndischarge to home without services. She was given instructions \nfor followup, prescriptions for required medications, and all \nquestions were answered prior to discharge. \n \nMedications on Admission:\nVit D ___ units q week\nBrilinta 90 mg BID\nASA 81 mg qd\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q6H:PRN fever or pain  \n2.  Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0 \n3.  Ondansetron 4 mg PO Q8H:PRN nausea \nRX *ondansetron HCl 4 mg 1 tablet(s) by mouth q8hours Disp #*20 \nTablet Refills:*0 \n4.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth q6hours Disp #*20 Tablet \nRefills:*0 \n5.  Aspirin 81 mg PO DAILY  \n6.  TiCAGRELOR 90 mg PO BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLeft ICA aneurysm\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nActivity\nYou may gradually return to your normal activities, but we \nrecommend you take it easy for the next ___ hours to avoid \nbleeding from your groin.\nHeavy lifting, running, climbing, or other strenuous exercise \nshould be avoided for ten (10) days. This is to prevent bleeding \nfrom your groin.\nYou make take leisurely walks and slowly increase your \nactivity at your own pace. ___ try to do too much all at once.\nDo not go swimming or submerge yourself in water for five (5) \ndays after your procedure.\nYou make take a shower.\nMedications\nResume your normal medications and begin new medications as \ndirected.\nYou have been instructed by your doctor to take one ___ a \nday and Brilinta. If so, do not take any other products that \nhave aspirin in them. If you are unsure of what products contain \nAspirin, as your pharmacist or call our office.\nYou may use Acetaminophen (Tylenol) for minor discomfort if \nyou are not otherwise restricted from taking this medication.\nIf you take Metformin (Glucophage) you may start it again \nthree (3) days after your procedure.\nCare of the Puncture Site\nYou will have a small bandage over the site.\nRemove the bandage in 24 hours by soaking it with water and \ngently peeling it off.\nKeep the site clean with soap and water and dry it carefully.\nYou may use a band-aid if you wish.\n\nWhat You ___ Experience:\nMild tenderness and bruising at the puncture site (groin).\nSoreness in your arms from the intravenous lines.\nMild to moderate headaches that last several days to a few \nweeks.\nFatigue is very normal\nConstipation is common. Be sure to drink plenty of fluids and \neat a high-fiber diet. If you are taking narcotics (prescription \npain medications), try an over-the-counter stool softener.\nWhen to Call Your Doctor at ___ for:\nSevere pain, swelling, redness or drainage from the puncture \nsite. \nFever greater than 101.5 degrees Fahrenheit\nConstipation\nBlood in your stool or urine\nNausea and/or vomiting\nExtreme sleepiness and not being able to stay awake\nSevere headaches not relieved by pain relievers\nSeizures\nAny new problems with your vision or ability to speak\nWeakness or changes in sensation in your face, arms, or leg\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11893689","hadm_id":"25454982","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nhematuria\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ year old male with PMH significant for \nmetastatic colon ___ currently undergoing palliative \nchemotherapy with Erbitux + Irinotecan, HTN, HLD, and b/l \nureteral stents who presents with 3 day history of hematuria, \ndysuria, and left flank pain. He reports that the dysuria \nstarted about 1 week ago and the hematuria started 3 days ago. \nAt first it was pinkish urine which then progressed to frank \nblood.  \nIn the ED, initial vs were:4 97.9 90 137/75 16 96% RA Labs were \nremarkable for WBC 8.7, H/H 10.8/32.0, Lactate:1.1 UA showed \nmoderate Leuk, large Blood, WBC 121, WBC \u003e182, 100 protein, few \nbacteria. Urology saw patient in ED and recommended IV abx and \ndid not think imaging was necessary at this time. Patient was \ngiven 1.5g IV Unasyn and IVF. Vitals on Transfer:0 97.4 77 \n154/82 18 99% RA  \nOn the floor patient reports that he has dysuria, abdominal \npain, and back pain. He reports the abdominal and back pain are \nchronic and are worse because he did not have his home pain \nmedications. He has continued dyuria with low urine volumes and \nhematuria. He denies any fevers, chills, or night sweats.  \n \nReview of sytems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denies cough, shortness of breath. Denies chest pain \nor tightness, palpitations. Denies nausea, vomiting, diarrhea, \nconstipation. Denies arthralgias or myalgias. Ten point review \nof systems is otherwise negative.  \n\n \nPast Medical History:\nPAST ONCOLOGIC HISTORY: \n- ___: screening colonoscopy: polyp in the cecum, polyp in the\ntransverse colon, polyp in the sigmoid colon; all of them were\nresected at the time and the pathology report for all of them \nwas\nadenoma\n- ___ colonoscopy: a single sessile 2.5-cm polyp of \nlobulated\nappearance with significant vascularity was found in the sigmoid\ncolon.  A piece-meal polypectomy was performed and the polyp was\ncompletely removed.  The pathology report ulcerated granulation\ntissue and colonic mucosa with reactive changes consistent with\ninflammatory pseudopolyp\n___: CT scan of the abdomen showed sigmoid colon tumor with\nlarge extraluminal component inseparable from the cecum and\nseveral small bowel loops, bilateral pulmonary metastasis and an\nundetermined lesion within the right lobe of the liver\n- ___ colonoscopy showed a mass in the distal sigmoid\ncolon at 18 cm, another mass in the proximal sigmoid colon at 25\ncm, a polyp in the hepatic flexure.  The pathology report showed\nfragments of invasive adenocarcinoma moderately-to-poorly\ndifferentiated with extensive necrosis in the mass at 25 cm. \nRegarding the mass at 18 cm, it showed invasive adenocarcinoma\nmoderately-to-poorly differentiated with lymphovascular space\ninvolvement\n- ___ CT CHEST: Multiple lung nodules consistent with\nmetastases. Some of which appear more prominent than on prior\nstudy.\n-___ left lower lobe VATS. Adenocarcinoma, consistent \nwith\nmetastasis of colon cancer, positive for CK7, CK20, and CDX2 and\nnegative for ___ start chemotherapy with FOLFOX+Avastin\n-___ CT torso after 2 cycles showed significant disease\nresponse.\n- ___ CT scan after 4 cycles showed stable disease\n- ___ L subclavian and axillary vein thrombosis\n- ___ the patient developed allergic reaction to the\ninfusion of Oxaliplatin, the ___ cycle was given with ___\nalone.\n- ___ start maintenance therapy with ___\n- ___ CT torso stable disease\n- ___ PET-CT showed a 2.5 cm central abdominal mass\nsimilar in size to prior scan, highly FDG avid (SUV max 10.0)\n- ___ CT abdomen stable disease\n- ___ CT torso slight increase in size of the soft tissue\nmass in the mesenteric root\n- ___ palliative XRT to the pelvic mass\n- ___  CT torso shows disease progression\n- ___  start chemotherapy with FOLFIRI\n- ___ CT torso shows stable disease\n- ___ CT torso shows stable disease and new left\nhydronephrosis\n- ___ admission for small bowel obstruction\n- ___ admission due to diarrhea\n- ___ admission due to diarrhea, dehydration, ___,\npartial SBO\n- ___ CT torso: disease progression\n--___ start Irinotecan+Cetuximab\n\nOTHER PAST MEDICAL HISTORY:\n-Hypertension \n-Hypercholesterolemia\n-GERD\n-Anxiety\n\n \nSocial History:\n___\nFamily History:\nHis father died at age ___ of diabetes complications.  His mother \nis ___, alive and healthy. He has 12 siblings and he is not aware \nof any of them having cancer.\n\n \nPhysical Exam:\nADMISSION EXAM:\nVitals-99.3 147/70 76 18 100%RA  \nGeneral- Alert, orientedx3, in no acute distress  \nHEENT- Sclera anicteric, MMM, oropharynx clear  \nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV- Regular rate and rhythm, normal S1, S2, no murmurs, rubs, \ngallops, left chest port c/d/i  \nAbdomen- soft, mild tenderness over surgical scar, \nnon-distended, bowel sounds present, no rebound tenderness or \nguarding,  \nBack: left CVA tenderness  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro- CNs2-12 intact, motor function grossly normal  \n\nDischarge Exam:\nVitals-  99.3/98.5  ___   ___   18   100%RA\nGeneral- Alert, oriented, no acute distress  \nHEENT- Sclera anicteric, MMM, oropharynx clear\nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV- Regular rate and rhythm, normal S1 + S2, no \nmurmurs/rubs/gallops  \nAbdomen- soft, tender on deep palp, non-distended, bowel sounds \npresent, no rebound tenderness or guarding, no organomegaly; \nnotable arterial bruit bilaterally  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing/cyanosis/edema. \n\nNeuro- AAOx3. Follows commands.  Good attention.  CNs2-12 \nintact, UE, ___ ___ strength.  No intention or resting tremors. \nNo dysdiadochokinesis.\n \nPertinent Results:\nPertinant Labs:\n___ 02:50PM BLOOD WBC-8.7 RBC-4.15* Hgb-10.8* Hct-32.0* \nMCV-77* MCH-26.1* MCHC-33.9 RDW-17.6* Plt ___\n___ 02:50PM BLOOD Glucose-114* UreaN-14 Creat-1.2 Na-140 \nK-3.9 Cl-102 HCO3-29 AnGap-13\n___ 02:50PM BLOOD ALT-9 AST-13 CK(CPK)-30* TotBili-0.2\n___ 02:50PM BLOOD Lipase-28\n\n___ 07:00PM URINE RBC-\u003e182* WBC-121* Bacteri-FEW Yeast-NONE \nEpi-0\n\nMICROBIOLOGY:\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n \nBrief Hospital Course:\nMr. ___ is a ___ year old male with PMH significant for \nmetastatic colon cancer currently undergoing palliative \nchemotherapy with Erbitux + Irinotecan, HTN, HLD, and b/l \nureteral stents who presents 1 week history of dysuria and \npink-hued urine progressing to hematuria for the last 3 days, \nand associated right flank pain concerning for complicated \nUTI/pyelonephritis.  \n\n# Urinary Tract Infection: patient presented with new hematuria \n(no signs of urinary obstruction) and positive UA.  Was treated \ninitially with Zosyn though this was quickly transitioned to PO \ncipro.  Cultures did not grow bacteria, though may have been \ncollected post abx so treated for a 7 day total course.\n \n# Metastatic Colon Cancer: Postponed next cycle by a month ___ \ncomplaints of weight loss and dehydration.  He is currently on \nCycle 2 of  Irinotecan + Cetuximab and is followed by Dr. \n___ seen on ___.  He was continued on his home \npain medications.  \n\n# Hypertension: Continued home medications-Amlodipine, \nLisinopril, Metoprolol \n\n# GERD: Stable, continued Omeprazole 40 mg PO BID \n \n# HLD: continued Simvastatin 20 mg PO DAILY  \n\nTransitional Issues:\n-none\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amlodipine 10 mg PO DAILY \n2. Gabapentin 300 mg PO BID \n3. Lisinopril 40 mg PO DAILY \n4. Metoprolol Tartrate 25 mg PO BID \n5. Omeprazole 40 mg PO BID \n6. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n7. OxyCODONE SR (OxyconTIN) 40 mg PO Q12H \n8. Simvastatin 20 mg PO DAILY \n\n \nDischarge Medications:\n1. Amlodipine 10 mg PO DAILY \n2. Gabapentin 300 mg PO BID \n3. Lisinopril 40 mg PO DAILY \n4. Metoprolol Tartrate 25 mg PO BID \n5. Omeprazole 40 mg PO BID \n6. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n7. OxyCODONE SR (OxyconTIN) 40 mg PO Q12H \n8. Simvastatin 20 mg PO DAILY \n9. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days \nRX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice daily Disp \n#*13 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nUrinary tract infection with hematuria\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr. ___ you were admitted to the hospital with blood in your \nurine and treated for a urinary tract infection.  Your symptoms \nimproved and you were discharged home to complete a 7 day course \nof antibiotics.  If your symptoms reoccur please contact your \nprimary care doctor for evaluation.  You will see you urologist \nin a week's time.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11807150","hadm_id":"26828964","text":" \nName:  ___            Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamides) / Tomato / Fish Product Derivatives / Peach \n/ Citrus Derived / Egg\n \nAttending: ___.\n \nChief Complaint:\nfever, tachycardia \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y/o male s/p recent drainage of subdural empyema and \nethmoidectomy who was d/c'd to rehab yesterday from neurosurgery \nservice. He was discharged on ___ after complicated hospital \ncourse (see below) but returned to ___ ED on ___ when he was \nfelt to be unarousable. Upon return to ED, he was easily \narousable and at baseline mental status per Neurosurgical \nevaluation. In the ED, he received a CT head which was felt to \nbe unchanged. After discussion with his rehab and overnight \nmonitoring, he was discharged back to rehab on ___. However, \nupon arrival, he was noted to have a fever to 101 and was felt \nto have altered mental status as compared to earlier in the day. \nAs a result, he was again sent back to ED for evaluation. In \nedition, he was now felt to have a faint maculopapular rash \nwhich is reportedly new.  \n.  \nPatient was admitted to ___ ___ to neurosurgery \nservice with complicated course requiring ICU admission from \n___. He was initially transferred from ___ where \nhe was brought after being found down in his office bathroom. He \nwas intially thought to have a stroke based on ___ and \nleft sided hemiparesis. MRI done here after transfer showed a \nfrontal sinusitis with resulting empyema along the falx cerebri \nand along the lateral right frontal lobe. On ___ he underwent 3 \nright sided craniotimies for drainage of subdural empyema. \nSubsequently, cultures from sinus tissue samples grew \nstreptococcus ___. Unfortunatley the patient continued to \nremain unwell with fevers to 102 and tachypnea to the 40's. On \n___ a repeat head CT showed \"significant interval progression \nof right cerebral subdural collections, now extending along the \nanterior falx and into the middle cranial fossa\". There was also \nnoted \"significant associated mass effect including leftward \nshift of normally midline structures as well as subfalcine and \nuncal herniation.\" An MRV at that time showed no evidence of a \nvenous thrombus in the brain. On ___, the patient went back to \nthe OR for a sterotactic drainage of the abscess and an \nadditional 40cc of purulent fluid was drained. He was also \nplaced on seizure prophylaxis with Keppra. On ___ the patient \nwas taken to the OR for evacuation of remaining abscess fluid. \nTransferred to the floor on ___ and subsequently discharged to \n___ on ___. Plan at that time was to complete a 4 \nweek course of antibiotics with IV Vanco/CTX. In addition, he \nwas being treated for cdiff infection with Po Vanco/IV flagyl.  \n.  \nOf note, course was also complicated by the finding of an \nocclusive thrombus in the right lesser saphenous vein. However \nby ultrasound there was no evidence of thrombosis in the deep \nvenous structures. No anticoagulation given other than heparin \nprophylaxis.  \n.  \nIn ___ ED today, T 101, BP 107/64, HR 105, RR 26, O2 96% RA. \nCXR was negative. Blood cultures were sent. His labs were \nnotable for the absence of a leukocytosis but eosinophils of 10% \nand a negative U/A for infection. Given his new rash, the case \nwas discussed with ID (who followed previously) given concern \nfor an allergic reaction and he received cipro 400mg IV in place \nof his ceftriaxone. He also received 2L of NS. Neurosurgery was \nreconsulted. Once again, patient was felt to be at baseline \nmental status. His head CT was again unchanged. He was admitted \nto medicine for further work-up.  \n.  \nUpon arrival to the floor, patient is without complaint. He does \nnot know why he was sent back to the hospital. When asked, he \nstates he is in \"used real estate in ___. He denies fevers, \nchills, cough, SOB, abdominal pain, HA, numbness, weakness, \ndizziness, or changes in his vision.  \n\n \nPast Medical History:\n# htn  \n# sinusitis  \n# s/p Bilateral frontal sinus trephine  \n# s/p Left external ethmoidectomy  \n# s/p Left endoscopic maxillary antrostomy  \n\n \nSocial History:\n___\nFamily History:\nFamily Hx: father died age ___, mother died ___ w/ CHF,\ngrandfather died of brain tumor\n\n \nPhysical Exam:\nT: 97.3 BP: 115/78 HR: 98 RR: 20 O2 98% RA  \nGen: Flat affect, laying in bed, breathing comfortably, NAD  \nHEENT: Healing surgical incisions on frontal bone. MMM. OP \nclear.  \nNECK: Supple, No LAD. No JVD  \nCV: RRR. nl S1, S2. No murmurs, rubs ___  \nLUNGS: CTAB  \nABD: NABS. Soft, NT, ND. No HSM  \nEXT: WWP, NO CCE. 2+ DP pulses ___. R PICC CDI  \nSKIN: fine ___ rash over trunk and extremities  \nNEURO: A\u0026Ox2 (to person and year. does not know month or place). \nPleasant and cooperative w/ exam. Able to follow commands. \nAffect flat. CN ___ intact. Preserved sensation throughout to \nlight touch. ___nd RLE. 4+/5 strength in LUE. \n3+/5 in LLE.Gait assessment deferred  \n.\nECG: Sinus tach @100. LAD. LAFB. No ST/TW changes. Compared w/ \nECG ___, HR is faster but no other significant change.  \n\n \nPertinent Results:\nLabs on admission:\n___ 11:50PM BLOOD WBC-9.2 RBC-3.09* Hgb-10.1* Hct-29.8* \nMCV-96 MCH-32.7* MCHC-34.0 RDW-15.7* Plt ___\n___ 11:50PM BLOOD Neuts-66.6 Lymphs-15.4* Monos-7.9 \nEos-10.0* Baso-0.2\n___ 11:50PM BLOOD ___ PTT-24.2 ___\n___ 01:15AM BLOOD Glucose-120* UreaN-13 Creat-0.9 Na-130* \nK-3.9 Cl-97 HCO3-24 AnGap-13\n___ 01:15AM BLOOD ALT-27 AlkPhos-70 Amylase-76 TotBili-0.4\n___ 01:15AM BLOOD Lipase-56\n___ 01:15AM BLOOD Albumin-2.8* Calcium-8.3* Phos-3.3 Mg-2.0\n___ 08:45AM BLOOD Vanco-6.5*\n___ 12:07AM BLOOD Lactate-1.6\n.\nCT HEAD W/ \u0026 W/O CONTRAST  ___ 1:33 AM: \n1. No significant change in the appearance of extensive subdural \nempyemas and leptomeningeal enhancement and edema in the right \ncerebral hemisphere compared to CT head study done one day \nprior.\n2. Stable bifrontal edema.\n3. Sinus disease, as described above, unchanged.\n.\nCTA CHEST W\u0026W/O C\u0026RECONS, NON-CORONARY  ___ 1:29 ___\n1. Evidence of pulmonary embolism within multiple segmental and \nsubsegmental branches of the pulmonary arteries including left \nupper and left lower lobes. There is a questionable filling \ndefect within the periphery of the right upper lobe segmental \npulmonary artery.\n2. Enlarged lymph nodes are identified within the mediastinum \nmeasuring up to 13 mm in short axis dimension in the prevascular \nspace. Scattered subcentimeter lymph nodes are also identified \nwithin the right paratracheal distribution.\n3. Evaluation of the pulmonary parenchyma reveals evidence of \nbibasilar opacities, which are hyperattenuating to suggest \nbilateral aspiration.\n.\n___ DUP EXTEXT BIL (MAP/DVT)  ___ 10:35 AM:\nDVT seen in the right posterior tibial veins, and also in the \nleft popliteal, posterior tibial and peroneal veins.\n.\nRENAL U.S.  ___ 1:16 ___ Unremarkable renal ultrasound \nexamination\n \nBrief Hospital Course:\n___ year old male status post recent drainage of subdural empyema \nand ethmoidectomy during prolonged hospitalization complicated \nby persistent empyema requiring broad spectrum antibiotics and \nsubsequent C diff, who now returns with fever, tachypnea, and \ntachycardia.  \n.  \n# DVT/PE:  Patient underwent lower extremity ultrasound on ___ \nto evaluate for DVT given presentation of fever and tachycardia, \nalso report of tachypnea prior to presentation, although was not \ntachypnic at presentation.  Low suspicion at time, as patient \nwas not complaining of lower extremity pain, no respiratory \ncomplaints, vital signs remained stable.  U/S returned positive \nfor DVT in R post tibial veins and L popliteal, post tibial, and \nperoneal veins.  Follow up CTA chest demonstrated multiple PEs \nin segmental and subsegmental branches of pulm arteries, \nincluding left upper lobe and left lower lobe.  Neurosurgery was \ncurbsided regarding whether it was ok to use anticoagulation \ngiven recent neurosurgical procedures, and they said this was ok \nwith lower PTT threshold (45-60).  He was therefore treated with \nheparin drip bridge to coumadin. He was continued on heparin for \n24 hours after his INR was \u003e2 and was then discontinued. He was \ncontinued on coumadin. \n.\n# Eosinophilia: Patient noted to have mild eosinophilia of ~900 \non admission.  Given fevers and rash, and having just recently \nbeen started on ceftriaxone, this was felt to be related to drug \nreaction.  Ceftriaxone was discontinued, and eosinophil count \ntrended down.  He continued to have mild eosinophilia throughout \nadmission but was otherwise asymptomatic. This should be \nfollowed up as an outpatient. \n.  \n# Altered mental status:  Was informed from rehab that patient \nhad altered mental status.  His mental status on presentation \nwas at baseline per neurosurgery and infectious disease doctors, \nwho had seen the patient on his previous admission.  His \nbaseline is somewhat alert, oriented to self and to year (___), \nand to who is president, but not oriented to month (thought it \nwas ___ or to place.  He is also quite slow in his responses. \n Head CT on admission, as above, unchanged.  Infectious work up \nas above.  Otherwise, neurological exam remained stable.  \nPatient's mental status remained at his most recent baseline \nthroughout admission and did show some mild improvement by the \ntime of discharge.\n.  \n# Subdural Empyema: Infected with strep milleri, status post \nnumerous repeat drainages on previous hospital course.  Head CT \non admission showed no progression of infection.  The patient \nwas being treated with IV vancomycin, ceftriaxone and flagyl for \nthis infection.  As above, given presumed allergic reaction to \nceftriaxone, this was discontinued, as was the IV flagyl, and IV \nmeropenem (at CNS dosing) was started instead.  He was also \nmaintained on his keppra for seizure prophylaxis. He will \nrequire prolonged therapy as detailed in his discharge \ninstructions.  His vanco started being dosed by level (dose for \nlevel \u003c20) following his acute renal failure. He should have \ndaily vanco levels checked until renal function improves.  He \nmay require an increase in his vancomycin dose with resolution \nof his renal failure. \n.  \n# C diff: Developed during previous hospital course, presumably \nsecondary to broad spectrum antibiotics for empyema.  Patient \nwas continued on PO Vancomycin, to continue for 2 weeks after \ncompleted course of antibiotics for empyema above. \n.  \n# Anemia: Hct 29 on presentation, which is at baseline - \nconsistent with anemia of chronic disease. He anemia slightly \nimproved over the course of admission but remained stable \nthroughout. \n.\n# Acute renal failure: Patient developed elevated Cr to 1.5 from \nbaseline of 0.___fter episode of low \nblood pressure. However, this was also ~ 2 days following \ncontrast administration for his CTA. He was treated with IVF and \ndiscontinuation of his lisinopril.  His Cr peaked at 1.7 and \nimproved to 1.3 by the time of discharge. Renal ultrasounds was \nunremarkable; urine and serum electrophoreses were pending at \ndischarge.  He continued to make excellent urine throughout \nwithout evidence of volume overload or electrolyte \nabnormalities. \n.\n# Urinary incontinence: He was incontinent of urine after \nremoval of foley catheter prior to discharge. He had no evidence \nof lower extremity paresthesia, acute weakness, or back pain; \nthis should be monitored for improvement.\n.  \n# Hypertension:  Patient on metoprolol and lisinopril on \nadmission.  Lisinopril was held due to acute renal failure as \nmentioned above.  This was held at the time of discharge, but it \nshould be restarted once his Cr returns to baseline.\n.  \n# FEN: regular (please note allergies to tomatoes, fish \nproducts, peaches, citrus, and eggs)\n.  \n# CODE: FULL  \n.  \n# COMMUNICATION: sister ___ at ___    \n \nMedications on Admission:\nMetronidazole 500 mg IV Q8H: stop on ___ then change dose to \nPO.  \nAcetaminophen 325 mg q6prn  \nInsulin Regular QID prn  \nPolyvinyl Alcohol-Povidone: ___ Drops Ophth prn  \nOxycodone-Acetaminophen ___ q4prn  \nFamotidine 20 mg PO BID  \nHeparin (Porcine) 5,000 unit BID  \nVancomycin 125 mg PO Q6H through ___ then change to Q8 then \nstop on ___.  \nMetoprolol Tartrate 50 mg PO TID  \nLevetiracetam 1500mg PO BID  \nCeftriaxone 2 gram IV BID  \nVancomycin 1,000 mg IV BID: Titrate to trough of 20 will \ncontinue to ___  \nLisinopril 10 mg BID  \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed.  \n2. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 \nhours) as needed.  \n3. Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 \nhours).  \n4. Vancomycin 125 mg Capsule Sig: One (1) Capsule PO every ___ \nhours: Please give q 6 hours through ___, then change to q8 \nhours from ___ through ___, then discontinue.  \n5. Levetiracetam 500 mg Tablet Sig: Three (3) Tablet PO BID (2 \ntimes a day).  \n6. Vancomycin in Dextrose 1 gram/200 mL Piggyback Sig: One (1) \ngram Intravenous every ___ hours: Please continue \nthrough ___, then discontinue.\n\nPlease dose by level, with goal of ___.  \n7. Meropenem 1 gram Recon Soln Sig: Two (2) grams Intravenous \nQ8H (every 8 hours): Please continue through ___, then \ndiscontinue.  \n8. Metoprolol Tartrate 25 mg Tablet Sig: Three (3) Tablet PO TID \n(3 times a day).  \n9. Warfarin 2 mg Tablet Sig: One (1) Tablet PO HS (at bedtime): \nPlease titrate to INR 2.0-3.0.  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis:\nPresumed allergic reaction to ceftriaxone\nDVT bilateraly\nDiffuse Pulmonary embolism\n\nSecondary diagnosis:\nSubdural empyema\nhtn  \nsinusitis  \ns/p Bilateral frontal sinus trephine  \ns/p Left external ethmoidectomy  \ns/p Left endoscopic maxillary antrostomy  \n\n \nDischarge Condition:\nGood.  Patient afebrile, heart rate under better control.\n\n \nDischarge Instructions:\nYou were admitted with fevers and elevated heart rate.  \nInfectious work up including a repeat scan of your head, blood \ncultures and urine test were unchanged from previously.  You \nwere found to have a rash and an elevated eosinophil count which \nwas consistent with an allergic reaction, like to ceftriaxone.  \nThis was therefore discontinued and you were changed to \nmeropenem instead.  You were also found to have diffuse DVT in \nboth lower extremities and PEs.  This was treated with heparin \nbridge to coumadin.\n.\nPlease take medications as directed.\n.\nPlease follow up with appointments as directed.\n.\nPlease contact physician if develop worsening fevers, chills, \nany other concerns.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11869197","hadm_id":"27194536","text":" \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: PLASTIC\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nleft hand lacerations\n \nMajor Surgical or Invasive Procedure:\nORIF distal phalanx of middle finger, extensor tendon repair of \nmiddle finger, repair of middle finger laceration, repair of \nindex and thumb with full thickness skin graft to thumb (donor \nsite from middle finger)\n \nHistory of Present Illness:\n___, RHD, dental resident who presents s/p accident with\nblender at 9 ___.  Her blender top malfunctioned and exposed the\nblades of the machine which lacerated several fingers on the \nleft\nhand.  She was given tetanus and Ancef in the ED. \n \nPast Medical History:\nPMH: none\nPSH: gastric sleeve, ___ in ___\n \nSocial History:\n___\nFamily History:\nnoncontributory.\n \nPhysical Exam:\nOn Admission: \nVitals: AFVSS\nGeneral: A\u0026Ox3, NAD\nCAM/MINICOG: Negative\nHeart: Regular rate and rhythm peripherally\nLungs: Breathing comfortably on room air. \n \nLeft upper extremity:\n- Multiple superficial abrasions on multiple fingers.  Large\ndorsal laceration over the DIP of the MF with extensor tendon\ninvolvement.  Obvious fracture within the area of the \nlaceration.\n- Soft, non-tender arm and forearm\n- Full, painless active/passive ROM of shoulder, elbow, wrist,\nand digits--the MF is unable to be extended and has limited\nflexion ___ pain\n- EPL/FPL/DIO (index) fire\n- Sensation intact to light touch in \naxillary/radial/median/ulnar\nnerve distributions\n- 2+ radial pulse, fingers warm and well perfused\n\nOn Discharger:\nVitals: AFVSS\nGeneral: A\u0026Ox3, NAD\nHeart: Regular rate and rhythm peripherally\nLungs: Breathing comfortably on room air. \n \nLeft upper extremity: in splint, RF and SF exposed, cap refill \u003c \n2 seconds, sensation intact. pain in control, in NAD.dressing \nc/d/i.\n\n \nPertinent Results:\n___ 05:24AM URINE  UCG-NEGATIVE\n___ 05:24AM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 12:51AM   WBC-7.4 RBC-4.01 HGB-11.8 HCT-36.0 MCV-90 \nMCH-29.4 MCHC-32.8 RDW-11.9 RDWSD-38.4\n___ 12:51AM   NEUTS-72.7* ___ MONOS-5.3 EOS-2.0 \nBASOS-0.5 IM ___ AbsNeut-5.39 AbsLymp-1.42 AbsMono-0.39 \nAbsEos-0.15 AbsBaso-0.04\n___ 12:51AM   PLT COUNT-281\n___ 12:51AM   PLT COUNT-281\n \nBrief Hospital Course:\nShe was admitted to the floor from the ED overnight for pain \ncontrol and abx after her lacerations were washed in the ED. The \nnext morning, she went to the operating room to have her \nlacerations repaired, extensor tendon repaired, and phalangeal \nfracture repaired. She had a block, and pain was well controlled \novernight. By the next morning after surgery, she was tolerating \na diet, ambulating, pain was well controlled, and she had return \nof function of the hand as the block had weared off. All \ndischarge instructions were conveyed and questions answered.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. This patient is not taking any preadmission medications\n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H  \n2.  cefaDROXil 500 mg/5 mL oral Q12H  \n3.  OxyCODONE (Immediate Release) ___ mg PO Q3H:PRN Pain - \nModerate  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nextensor tendon laceration and phalangeal fractures\n \nDischarge Condition:\nstable, AOx3, ambulatory independently. \nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nplease follow up with Dr. ___ as instructed. Call his office \nto make an appointment. Pls call ___ to make follow up \nappointment. Keep splint on and dry and follow Dr. ___ \n___ instructions. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"14441286","hadm_id":"26346796","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nChest pain \n \nMajor Surgical or Invasive Procedure:\nNone. \n\n \nHistory of Present Illness:\n___ with a h/o hypertension, HLD who presents for chest pain and \ntachycardia. Her husband was just discharged from ___ ___ \nmorning, and she was at home making him dinner when she had a \nsudden onset at 6pm of chest pressure radiating to both \nshoulders, along with palpitations and lightheadedness. She had \nno nausea, vomiting, fevers, chills, or shortness of breath. She \ndenies dysuria, hematuria, discharge. She denies edema, \northopnea, or PND. She denies fall or syncope.  \n\nEMS found her heart rate to be in 230s to 240s. They gave her 6 \nmg of adenosine with no response, then 15 mg of diltiazem with \nimprovement to 140s. She subsequently felt better and was \nbrought to ___ ED.  \n In the ED initial vitals were: HR 147, 149/91, RR 18, 97% RA, \ntemp 98.2  \n Labs/studies notable for: Trop negative, K 3.2, Bicarb 19, BUN \n32, Glucose 203  \n Patient was given:  \n IV Diltiazem 20 mg x3  \n 2L NS  \n 325mg Aspirin  \n Dilt drip subsequently started at 5/hr  \n On the floor, pt felt much better than before. No longer having \nchest pain.  \n REVIEW OF SYSTEMS:  \n Positive per HPI.  \n Cardiac review of systems is notable for absence of dyspnea on \nexertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, \nsyncope.  \n On further review of systems, denies fevers or chills. Denies \nany prior history of stroke, TIA, deep venous thrombosis, \npulmonary embolism, bleeding at the time of surgery, myalgias, \ncough, hemoptysis, black stools or red stools. Denies exertional \nbuttock or calf pain. All of the other review of systems were \nnegative.  \n\n \nPast Medical History:\nHTN  \nHLD  \nMacular Degeneration  \nOsteoarthritis  \nTrigeminal neuralgia  \nCataracts  \n\n \nSocial History:\n___\nFamily History:\nDenies history of A-Fib or Valve Disease  \n Father - MI, T2DM  \n Aunt - breast cancer  \n Mother - PE/DVT  \n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n===========================\nVS: temp 97.2, HR 135, 135/66, RR 18, 99% RA  \nGENERAL: Very well appearing, pleasant, NAD  \nHEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. \nConjunctiva were pink. No pallor or cyanosis of the oral mucosa. \nNo xanthelasma.  \nNECK: Supple. JVP of 8-9 cm. No thyromegaly.  \nCARDIAC: Irregularly irregular and tachycardic. No murmurs.  \nLUNGS: Respiration is unlabored with no accessory muscle use. No \ncrackles, wheezes or rhonchi.  \nABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No \nsplenomegaly.  \nEXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or \nperipheral edema.  SKIN: No significant skin lesions or rashes.  \n\nPULSES: Distal pulses palpable and symmetric. \n\nDISCHARGE PHYSICAL EXAM:\n===========================\nVS: temp 98.7, 155/82 (103-155/61-82), HR 74-84, RR 18, 95% RA \nWeight: 62.4\u003c-61.7\u003c-62.6kg\nAdmission weight: 62.6kg \nGENERAL: Very well appearing, pleasant, NAD  \nHEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. \nConjunctiva were pink. No pallor or cyanosis of the oral mucosa. \nNo xanthelasma.  \nNECK: Supple. No thyromegaly. JVP 8cm at 45 degrees.  \nCARDIAC: Irregularly irregular and tachycardic. No murmurs.  \nLUNGS: Respiration is unlabored with no accessory muscle use. \nSlight crackles at b/l bases. No wheezes or rhonchi.  \nABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No \nsplenomegaly.  \nEXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or \nperipheral edema. 2+ radial/DP pulses. \nSKIN: No significant skin lesions or rashes. \n \nPertinent Results:\nADMISSION LABS:\n=========================\n___ 07:30PM URINE  HOURS-RANDOM\n___ 07:30PM URINE  UHOLD-HOLD\n___ 07:30PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 07:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-MOD\n___ 07:30PM URINE  RBC-1 WBC-20* BACTERIA-FEW YEAST-NONE \nEPI-4\n___ 07:30PM URINE  MUCOUS-RARE\n___ 06:33PM   GLUCOSE-203* UREA N-32* CREAT-1.0 SODIUM-141 \nPOTASSIUM-3.2* CHLORIDE-101 TOTAL CO2-19* ANION GAP-24*\n___ 06:33PM   estGFR-Using this\n___ 06:33PM   ALT(SGPT)-28 AST(SGOT)-34 ALK PHOS-44 TOT \nBILI-1.1\n___ 06:33PM   cTropnT-\u003c0.01\n___ 06:33PM   proBNP-195\n___ 06:33PM   CHOLEST-181\n___ 06:33PM   %HbA1c-5.4 eAG-108\n___ 06:33PM   TRIGLYCER-137 HDL CHOL-90 CHOL/HDL-2.0 \nLDL(CALC)-64 ___\n___ 06:33PM   TSH-2.2\n___ 06:33PM   WBC-8.6# RBC-4.56 HGB-15.0 HCT-46.1* MCV-101* \nMCH-32.9* MCHC-32.5 RDW-12.3 RDWSD-45.9\n___ 06:33PM   NEUTS-51.1 ___ MONOS-6.0 EOS-1.4 \nBASOS-0.6 IM ___ AbsNeut-4.39 AbsLymp-3.50 AbsMono-0.52 \nAbsEos-0.12 AbsBaso-0.05\n___ 06:33PM   PLT COUNT-265\n___ 06:33PM   ___ PTT-29.8 ___\n\nMICROBIOLOGY:\n=========================\nUrine cx (___): negative\nBlood cx (___): negative\n\nIMAGING:\n=========================\nCXR (___): FINDINGS:  \nMild enlargement of the cardiac silhouette is re- demonstrated.  \nThe aorta is mildly tortuous with atherosclerotic calcifications \nnoted at the aortic knob.  Mild pulmonary vascular congestion is \npresent without frank pulmonary edema.  Patchy atelectasis is \nseen in the lung bases, but no focal consolidation.  No pleural \neffusion or pneumothorax is identified.  Though there are no \nacute osseous abnormalities detected. \n  \nIMPRESSION:  \nPatchy bibasilar atelectasis.  Mild pulmonary vascular \ncongestion without \npulmonary edema \n\nCARDIAC STUDIES:\n=========================\n\nEKG:\nEKG (___): NSR  \nEKG (___): A-Fib with RVR, no ischemic changes  \n\n2D ECHOCARDIOGRAM:\nTTE (___): pending read\n\nDISCHARGE AND PERTINENT LABS:\n================================\n___ 06:10AM BLOOD WBC-6.7 RBC-3.76* Hgb-12.5 Hct-39.1 \nMCV-104* MCH-33.2* MCHC-32.0 RDW-12.3 RDWSD-47.6* Plt ___\n___ 06:10AM BLOOD Plt ___\n___ 06:10AM BLOOD Glucose-92 UreaN-21* Creat-0.8 Na-143 \nK-3.9 Cl-109* HCO3-24 AnGap-14\n___ 06:10AM BLOOD Calcium-8.3* Phos-2.3* Mg-2.___ y/o F with a h/o HTN, recent stress iso husband's \nhospitalization, who presents with chest pain and palpitations, \nfound to have new onset Atrial Fibrillation with HRs in 230s.  \n\n# New onset Atrial Fibrillation with RVR: Patient presented with \nabrupt onset of symptomatic A-Fib at 6pm on ___ (while on \nhome atenolol). Her CHADS2-VASC is 4 (HTN, female, age \u003e___). She \nwas initially quite tachycardic (HRs 230s), and required a \ndiltiazem drip (titrated to HR\u003c130) for rate control after \nmultiple IV dilt boluses and 2L IVF failed to result in \nsustained rate control. Initial differential included valve \ndisease (no murmur), ischemic heart disease (trops \n\u003c0.01-\u003e0.03-\u003e0.02, CKMB 11-\u003e10), CHF (proBNP 195), thyroid \ndisease (TSH wnl), infection (afebrile, but endorses URI sx, \nUcx/Blood cx negative), hypokalemia (K 3.2).In addition, patient \nhas been under severe stress in the context of her husband's \nrecent hospitalization, which could also be a trigger. Dilt drip \nultimately led to NSR, but with HRs in the ___. Given high HRs, \nopted to pursue rhythm control w/amiodarone (LFTs wnl, TSH wnl, \nb/l CXR obtained and w/o acute cardiopulmonary process). Patient \nwas transitioned from dilt drip to amiodarone 400mg BID on ___ \nand she maintained NSR with HRs in ___. Amiodarone was converted \nto 200mg BID on ___, with a plan to continue this on discharge. \nFor additional rate control, patient was also converted from \nhome atenolol to metoprolol tartrate 12.5mg BID, which was \ntransitioned to metoprolol succinate XL 25mg daily prior to \ndischarge. Patient continued to maintain NSR with HRs in ___ \nat time of discharge. Given CHADS-VaSc score, pt is a candidate \nfor anticoagulation. Following discussion with patient and her \ndaughter, decision was made to initiate NOAC. Patient was \nstarted on apixaban 5mg BID, but given insurance constraints, \nthis was changed to rivaroxaban 15mg daily, to be started on \n___ at 8PM with a meal following discharge. Patient also \nreceived TTE on ___, with read pending at time of discharge. \n\n\n# Hypokalemia: Patient's K was 3.2 on admission in the setting \nof being on home HCTZ. Her HCTZ was discontinued. She was \nrepleted with PO and IV K and her repeat K was 3.9, and stable \nat 3.9 at time of discharge. HCTZ was not restarted.   \n\n# Pyuria: UA w/20 WBC. Patient denied any dysuria, increased \nurinary frequency. She was afebrile and had no leukocytosis. Did \nnot initiate antibiotic treatment. Urine and blood cx were \nnegative.  \n\n# Anion gap acidosis: Patient had an anion gap of 21 on \nadmission. She appeared hypovolemic on exam, and also had a \nmildly elevated BUN/Cr. Lactate 1.4. Received 2L IVF in the ED, \nwith repeat AG 16. AG 14 at time of discharge.  \n\n# HTN: SBPs in the 140s-150s on admission. Patient was continued \non home losartan 100mg daily. Her home HCTZ was discontinued in \nthe setting of hypokalemia as above. Her home atenolol was \ndiscontinued, and she was initiated on metoprolol tartrate \n12.5mg BID, which was transitioned to metoprolol succinate XL \n25mg daily on prior to discharge. Her SBPs were 110s-130s at the \ntime of discharge.  \n  \n# HLD: Obtained lipids which showed Triglyc: 137, HDL: 90, \nCHOL/HD: 2.0, LDLcalc: 64. Discontinued patient's home \nsimvastatin 5mg given drug-drug interaction with Diltiazem and \ninitiated Atorvastatin 20mg daily on ___, to be continued \nfollowing discharge.  \n \n# Primary Prevention: HbA1c 5.4% on ___. Continued home ASA \n81mg.   \n\n# Hypovitaminosis D: Continued home cholecalciferol daily.  \n \n=================================\nTRANSITIONAL:\n=================================\n- Patient was started on rivaroxaban 15mg daily. She should take \nthe first dose of this medication on the same day of discharge, \n___, at 8PM with dinner.\n- Patient was started on amiodarone 200mg BID.  \n- Patient's home atenolol and hydrochlorothiazide were \ndiscontinued. Metoprolol succinate XL 25mg daily was initiated. \n- Patient's home simvastatin 5mg daily was replaced with \natorvastatin 20mg daily. \n- Patient should be monitored for amiodarone-related \ncomplications, with repeat LFTs, TFTs, CXR in six months.\n\nDischarge Weight: 62.4kg\nDischarge Creatinine: 0.8\n\n#CODE: full  \n#CONTACT: Daughter ___ ___  \n \n\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Vitamin D 1000 UNIT PO DAILY \n2. Simvastatin 5 mg PO QPM \n3. Atenolol 50 mg PO DAILY \n4. Hydrochlorothiazide 25 mg PO DAILY \n5. Losartan Potassium 100 mg PO DAILY \n6. Aspirin 81 mg PO DAILY \n7. Ascorbic Acid ___ mg PO DAILY \n8. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1.  Amiodarone 200 mg PO BID \nRX *amiodarone 200 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*0 \n2.  amLODIPine 2.5 mg PO DAILY \nRX *amlodipine 2.5 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0 \n3.  Atorvastatin 20 mg PO QPM \nRX *atorvastatin 20 mg 1 tablet(s) by mouth daily (in the \nevening) Disp #*30 Tablet Refills:*0 \n4.  Metoprolol Succinate XL 25 mg PO DAILY \nRX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0 \n5.  Rivaroxaban 15 mg PO DINNER \nRX *rivaroxaban [Xarelto] 15 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0 \n6.  Ascorbic Acid ___ mg PO DAILY  \n7.  Aspirin 81 mg PO DAILY  \n8.  Losartan Potassium 100 mg PO DAILY  \n9.  Multivitamins 1 TAB PO DAILY  \n10.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES:\n=======================\nAtrial fibrillation \nHypokalemia\nHypertension\n\nSECONDARY DIAGNOSIS:\n=======================\nHyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \nIt was a pleasure taking care of you! You were admitted with \nchest discomfort and palpitations. We found that this was \nbecause you have an abnormal heart rhythm called atrial \nfibrillation. With this condition, the upper chambers of the \nblood do not pump effectively, and there is also a propensity to \nform clots in those chambers. We started you on medication to \ncontrol your heart rhythm and you improved. We also started you \non a medication to prevent clots from forming. \n\nPlease take your first dose of rivaroxaban 15mg daily today, \n___, at 8PM with a meal. \n\nPlease take all other medications as directed and try your best \nto keep your scheduled medical appointments. \n\nWe wish you the best of health!\nYour ___ Cardiology Care Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16575437","hadm_id":"28253750","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nZocor / ibuprofen / sulfamethoxazole\n \nAttending: ___.\n \nChief Complaint:\nNonhealing right first toe amputation site\n \nMajor Surgical or Invasive Procedure:\n___: RLE Angiogram with SFA stent placement via L groin \naccess site (vascular surgery)\nPROCEDURES PERFORMED:\n1.  Real-time ultrasound-guided access to left common femoral\nartery and placement of ___ sheath.\n2.  Selective catheterization of the superficial femoral\nartery a third order vessel.\n3.  Right lower extremity angiogram.\n4.  A 6 x ___ Innova stent placed in the superficial femoral\nartery.\n5.  AngioSeal.\n\n___: Right first metatarsal head resection (podiatry)\n\n \nHistory of Present Illness:\nThis is an ___ male who had previously undergone a \ntibioperoneal trunk angioplasty and an SFA popliteal angioplasty \nin ___ when he presented with\ngangrene of his right first toe.  He subsequently underwent \namputation and he has continued to have ulceration at the distal \nportion of the amputation site.  He had noninvasive that showed \na 2.5 step-up ion the SFA and a step-up at the TP trunk.\n \nPast Medical History:\n1.  Atrial fibrillation, on Coumadin.\n2.  GERD.\n3.  ___ MI status post PCI in ___.\n4.  Hypertension.\n5.  Hyperlipidemia.\n6.  Iron deficient anemia.\n7.  BPH.\n8.  Type 2 DM\n\nPast Surgical History:\n___ R hallux amp revision (pods)  \n___ RLE angiogram, PTA distal SFA, TP trunk, and ___  \n___ right first toe amp open  \n \n \nSocial History:\n___\nFamily History:\nNoncontributory for type 2 diabetes. \nReportedly, his father had high blood pressure and coronary \nartery disease.\n \nPhysical Exam:\nPhysical Exam on Discharge:\nVitals:WNL\nGEN: WD, WN in NAD\nHEENT: NCAT\nCV: RRR \nPULM:  no respiratory distress\nABD: soft, NT, ND\nEXT: WWP \nRight lower extremity: s/p right ___ MT head resection; healing \nappropriately\nPulse Exam: L //D/D, R //D/D \n \nPertinent Results:\nCOAGULATION LABS\n___ 05:15AM BLOOD ___ PTT-32.0 ___\n___ 04:50AM BLOOD ___ PTT-31.6 ___\n___ 10:45AM BLOOD ___ PTT-31.6 ___\n\nOTHER LABS\n___ 05:15AM BLOOD WBC-7.6 RBC-3.13* Hgb-7.9* Hct-26.3* \nMCV-84 MCH-25.2* MCHC-30.0* RDW-17.7* RDWSD-54.2* Plt ___\n___ 05:15AM BLOOD Glucose-327* UreaN-26* Creat-1.2 Na-142 \nK-4.5 Cl-106 HCO3-24 AnGap-12\n___ 04:50AM BLOOD Glucose-258* UreaN-23* Creat-1.1 Na-143 \nK-4.7 Cl-106 HCO3-27 AnGap-10\n___ 06:56AM BLOOD Glucose-212* UreaN-32* Creat-1.1 Na-140 \nK-4.6 Cl-104 HCO3-25 AnGap-11\n___ 05:15AM BLOOD Calcium-8.1* Phos-2.3* Mg-1.7\n\nIMAGING\n___ FOOT XR:\nFINDINGS: There has been further amputation of the great toe \nthrough the mid first metatarsal.  Overlying bandage, soft \ntissue swelling and soft tissue gas reflects postop status.  \nThere has been prior resection of the second ray through the \nproximal phalangeal midshaft.  No bony destructive changes. \nIMPRESSION: As above.\n\nMICROBIOLOGY\n___ 1:00 pm TISSUE      RIGHT FOOT FIRST METATARSAL HEAD. \n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   TISSUE (Preliminary):    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. \n \nBrief Hospital Course:\nMr. ___ presented to ___ to address his non-healing right \nfirst toe amputation site. On ___, he underwent a right lower \nextremity angiogram with superficial femoral artery stent \nplacement via a left groin access site. The procedure was \nuncomplicated; please see the operative note by Dr. ___ \nfull details. He tolerated the procedure well and was brought to \nthe PACU in good condition and subsequently transferred to the \nsurgical floor. He then went to the operating room with the \npodiatry team on the following day, ___, for resection of the \nnonhealing area of the right first metatarsal head. \nPost-operative foot x-ray, microbiology, and labs were \nreassuring. He again tolerated this procedure well and was \nbrought to the surgical floor in good condition. His Coumadin \nwas restarted on ___ and Plavix for his lower extremity stent \nwas begun on ___. Other home medications were continued through \nhis hospital course. On ___, he was evaluated by physical \ntherapy and recommended for rehab placement given the continued \nneed for teaching on use of the heel weightbearing surgical \nshoe. Initially, Mr. ___ adamantly declined to go to a \nrehab facility and stated that he would only be willing to go \nhome. In light of this, the vascular surgery team came to the \nbedside in the early afternoon of ___ to help determine his \ncapacity to decline rehab. At that time he did not appear to \nhave capacity to fully understand his treatment instructions and \nconsequences of declining rehabilitation, and was felt to be \nmaking some comments that exhibited poor understanding (for \ninstance, stating that his surgical team was \"not very good \nengineers\") and perseverating on lost items which were later \nclarified by family members to have been lost during a previous \nadmission several months ago. At this time the patient \nrepeatedly insisted he was planning to leave the hospital, \nincluding potentially by himself, and would not discuss his \nplans to get home with the surgical team in any detail. The \nsurgical team then spoke with family members to ask for \nassistance in discussing treatment options with the patient, and \npsychiatry was consulted for a formal evaluation of the \npatient's capacity to leave against medical advice and decline \ndischarge to a ___ facility. Later in the afternoon, \nthe patient changed his mind and at the time of psychiatric \nevaluation was no longer asking to leave against medical advice. \nHis family arrived at bedside and with their encouragement on \nthe evening of ___ he agreed to be discharged to a \nrehabilitation facility.\n\nOn ___, discharge to rehabilitation was arranged. The patient \nremained hemodynamically stable and afebrile. He was able to \ntolerate a regular diet, pain was well-controlled on oral \nmedications, and foot dressing and heel weightbearing surgical \nshoe were in place. Discharge instructions were discussed with \nthe patient prior to discharge.\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Metoprolol Succinate XL 125 mg PO DAILY \n2. Warfarin 5 mg PO 2X/WEEK (MO,TH) \n3. Rosuvastatin Calcium 5 mg PO QPM \n4. Glargine 10 Units Bedtime\nHumalog 5 Units Breakfast\nHumalog 6 Units Lunch\nHumalog 5 Units Dinner\n5. Aspirin 81 mg PO DAILY \n6. Warfarin 2.5 mg PO 5X/WEEK (___) \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO TID pain  \n2.  Clopidogrel 75 mg PO DAILY Duration: 30 Days \nRX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0 \n3.  TraMADol 25 mg PO Q6H:PRN pain \nRX *tramadol 50 mg 0.5 (One half) tablet(s) by mouth every six \n(6) hours Disp #*6 Tablet Refills:*0 \n4.  Glargine 10 Units Bedtime\nHumalog 5 Units Breakfast\nHumalog 6 Units Lunch\nHumalog 5 Units Dinner \n5.  Aspirin 81 mg PO DAILY  \n6.  Metoprolol Succinate XL 125 mg PO DAILY  \n7.  Rosuvastatin Calcium 5 mg PO QPM  \n8.  Warfarin 2.5 mg PO 5X/WEEK (___)  \n9.  Warfarin 5 mg PO 2X/WEEK (MO,TH)  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nNonhealing first toe amputation site ulcer\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires heel weight-bearing \nsurgical shoe\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure taking care of you at ___ \n___.  During your hospitalization, you had an \nangiogram and stent placement to improve blood flow to your \nright leg as well as surgery to remove unhealthy tissue at the \nprevious amputation site on your lower extremity.  You tolerated \nthe procedure well and are now ready to be discharged from the \nhospital and go to rehab to continue regaining strength and \ncompleting teaching on how to use your post-surgical heel \nweightbearing shoe.  Please follow the recommendations below to \nensure a speedy and uneventful recovery.\n\nDISCHARGE INSTRUCTIONS\nGROIN PUNCTURE SITE CARE\nFor one week:\nDo not take a tub bath, go swimming or use a Jacuzzi or hot \ntub.\nUse only mild soap and water to gently clean the area around \nthe puncture site. \nGently pat the puncture site dry after showering. \nDo not use powders, lotions, or ointments in the area of the \npuncture site. \nYou may remove the bandage and shower the day after the \nprocedure.  You may leave the bandage off. \nYou may have a small bruise around the puncture site.  This is \nnormal and will go away in one-two weeks. \n\nACTIVITY \nYou should keep your surgical site elevated. This will prevent \nswelling of the tissue.\nIt is very important that you put no weight or pressure on \nyour first toe and metatarsal region with activity or at rest to \nallow the wound to heal properly. \nYou may use the opposite foot for transfers and pivots, if \napplicable.  It will take time to learn to use the heel \nweightbearing shoe. \nBecause of your groin puncture site, for the first week:\nDo not lift, push , pull or carry anything heavier than 10 \npounds\nDo not do any exercises or activity that causes you to hold \nyour breath or bear down with abdominal muscles.   Take care not \nto put strain on your abdominal muscles when coughing, sneezing, \nor moving your bowels.\n\nMEDICATION\nBefore you leave the hospital, you will be given a list of all \nthe medicine you should take at home.  If a medication that you \nnormally take is not on the list or a medication that you do not \ntake is on the list please discuss it with the team!  \nYou may be prescribed narcotic pain medication on discharge \nwhich  can be very constipating.  If you take narcotics,  please \nalso take a stool softener such as Colace.   If constipation \nbecomes a problem, your pharmacist can suggest an additional \nover the counter laxative. \n\nYou should take Tylenol ___ every 6 hours, as needed for \npain.  If this is not enough, take your prescription narcotic \npain medication.  You should require less pain medication each \nday.  Do not take more than a daily total of 3000mg of Tylenol.  \nTylenol is used as an ingredient in some other over-the-counter \nand prescription medications.  Be aware of how much Tylenol you \nare taking in a day.\n\nBATHING/SHOWERING: \nYou may shower when you feel strong enough but no tub baths or \npools until you have permission from your surgeon and the \nincision is fully healed.\nAfter your shower, gently dry the incision well.   Do not rub \nthe area. \n\nWOUND CARE:\nPlease keep the wound clean and dry. It is very important that \nthere is no pressure on wound.    If there is no drainage, you \nmay leave the incision open to air.  \nAny staples or sutures that require removal will be removed by \nyour podiatrist at your follow-up appointment. \n\nCALL THE OFFICE FOR: ___\nOpening, bleeding or drainage or odor from your toe surgical \nsite\nRedness, swelling or warmth in your foot\nFever greater than 101 degrees, chills, or worsening \nincisional/surgical site pain\nCall ___ in an emergency such as:\nSudden, brisk bleeding or swelling at the groin puncture site \nthat does not stop after applying pressure for ___ minutes\nBleeding that is associated with nausea, weakness, or \nfainting.\nCall the vascular surgery office (___) right away if \nyou have any of the following. (Please note that someone is \navailable 24 hours a day, 7 days a week)\nSwelling, bleeding, drainage, or discomfort at the puncture \nsite that is new or increasing since discharge from the hospital\nAny change in sensation or temperature in your legs\nFever of 101 or greater\nAny questions or concerns about recovery from your angiogram \n\nIt was our pleasure taking care of you and we wish you a speedy \nrecovery!\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18374665","hadm_id":"28231997","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nvancomycin / Iodinated Contrast Media - IV Dye\n \nAttending: ___\n \nChief Complaint:\nUterine leiomyosarcoma for chemotherapy\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ hx of Leiomyosarcoma metastatic to liver, lung and bone s/p \nchemotherapy with limited response who is admitted for C3 of \nAdriamycin \u0026 Iphosphamide.  Patient denies any fevers, cough, \nchest pain or dyspnea. She does note some bloating and passing \nof gas. Last BM was yesterday, and was described as \"soft.\" She \nhas chronic LUQ abdominal pain which is tolerated without \nmedication.\n\nReview of Systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies blurry vision, diplopia, loss of vision, \nphotophobia. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denies chest pain or tightness, palpitations, lower \nextremity edema. Denies cough, shortness of breath, or wheezes. \nDenies nausea, vomiting, diarrhea, constipation, abdominal pain, \nmelena, hematemesis, hematochezia. Denies dysuria, stool or \nurine incontinence. Denies arthralgias or myalgias. Denies \nrashes or skin breakdown. No numbness/tingling in extremities. \nAll other systems negative.  \n\n \nPast Medical History:\n \nPAST ONCOLOGIC HISTORY:\n___: Presented with pelvic pain and heavy bleeding to PCP; US \n\nshowed possible fibroid, started on low dose OCP.\n___: Continued to have uterine bleeding for 2 months.\n___: Saw Dr. ___ US showed significant growth in \nuterine mass.  MRI performed, referred to Dr ___ \nmalignant concern, surgery planned for ___: Developed worsening pain, presented to ER at ___.  CT \nshowed growth in mass with surrounding fluid.\n___: Radical hysterectomy\n___: CT showed lung lesions (3, less than 5mm) and liver \nlesion 1.8x1.8cm.  Biopsy confirmed liver lesion as metastatic \ndisease.\n___: Further imaging showed right breast along with new \npulmonary and liver lesion; MRI showed pelvic and right iliac \nbone disease.\n___: Cycle #1 gemcitabine/docetaxel.\n___: Cycle #3 gemcitabine/docetaxel; complicated by ICU \nstay for neutropenic fevers and hypotension.\n___: Cycle #4 gemcitabine/docetaxel.\n___: CT scan showed progression of disease.\n___: Cycle #1 doxorubicin/ifosfamide/mesna.\n___: Cycle #2 doxorubicin/ifosfamide/mesna.\n\nPAST MEDICAL HISTORY:\nLeiomyosarcoma as per onc hx; metastatic\nIrritable bowel syndrome\nMild depression\n \nSocial History:\n___\nFamily History:\nOne healthy brother.  Father died at age ___ from leukemia.The \npaternal side of the family has significant history of \ncolorectal cancer, and a paternal grandmother had pancreatic \ncancer.  Her first cousin was diagnosed with breast cancer in \nher early ___.\n\n \nPhysical Exam:\nADMISSION:\nVitals - 98.0  98/68  HR 60  sat 99% on RA\nGEN: NAD, thin\nHEENT: clear OP\nNeck: Supple, no JVD, no thyromegaly.\nLymph nodes: No cervical, supraclavicular LAD.\nCV: NR, RR, no murmur \nRESP: Good air movement bilaterally, no rhonchi or wheezing.\nABD: Soft, non-tender, non-distended, + bowel sounds; small \nepigastric mildly mobile mass \nEXTR: No lower leg edema, no clubbing or cyanosis\nDERM: No rash\nNeuro: A\u0026O, no gross deficit\nPSYCH: Appropriate \n\nDISCHARGE:\nVitals - afebrile 97.4- 98/64-56-16-100RA\nGEN: NAD, thin\nHEENT: clear OP\nNeck: Supple, no JVD, no thyromegaly.\nLymph nodes: No cervical, supraclavicular LAD.\nCV: NR, RR, no murmur \nRESP: Good air movement bilaterally, no rhonchi or wheezing.\nABD: Soft, non-tender, non-distended, + bowel sounds; small \nepigastric mildly mobile mass \nEXTR: No lower leg edema, no clubbing or cyanosis\nDERM: No rash\nNeuro: A\u0026O, no gross deficit\nPSYCH: Appropriate \n\n \nPertinent Results:\nLABS:\n___ 05:51AM BLOOD WBC-4.5 RBC-2.80* Hgb-9.4* Hct-26.7* \nMCV-95 MCH-33.7* MCHC-35.4* RDW-19.2* Plt ___\n___ 10:07AM BLOOD WBC-5.0# RBC-3.19* Hgb-9.7* Hct-29.5* \nMCV-93# MCH-30.5 MCHC-33.0 RDW-19.5* Plt ___\n___ 10:07AM BLOOD Neuts-69.4 ___ Monos-8.1 Eos-0.4 \nBaso-0.6\n___ 05:51AM BLOOD Glucose-72 UreaN-7 Creat-0.6 Na-141 K-3.7 \nCl-111* HCO3-26 AnGap-8\n___ 10:07AM BLOOD Glucose-70 UreaN-11 Creat-0.7 Na-139 \nK-3.3 Cl-103 HCO3-29 AnGap-10\n___ 05:51AM BLOOD ALT-18 AST-15 AlkPhos-35 TotBili-0.4\n___ 10:07AM BLOOD ALT-16 AST-20 LD(LDH)-218 AlkPhos-44 \nTotBili-0.3\n___ 05:51AM BLOOD Calcium-8.7 Phos-3.2 Mg-2.0\n___ 10:07AM BLOOD Albumin-4.5 Calcium-9.6 Phos-2.8 Mg-2.1\n\nCT Torso w/ contrast ___: IMPRESSION: \n1. Multiple hepatic metastases, overall not significantly \nchanged compared to the prior CT from ___. \n2. Interval increase in size of nodular enhancing lesions within \nthe pelvis, a fully described above. \n3. No significant change in size of anterior abdominal soft \ntissue nodule compared to the most recent CT from ___. \n\n4. Unchanged tiny sub 4 mm pulmonary nodules within the right \nlung. \n5. Unchanged dilatation of the ___ through ___ portions of the \nduodenum with narrowing of the ___ portion of the duodenum as it \npasses between the superior mesenteric artery and aorta, \nsuggestive of SMA syndrome in the appropriate clinical setting, \nespecially given the less than normal angle between the superior \nmesenteric artery and the aorta. \n\n \nBrief Hospital Course:\n___ hx of Leiomyosarcoma metastatic to liver, lung and bone s/p \nchemotherapy with limited response who was admitted for C3 of \nAdriamycin \u0026 Iphosphamide.\n\n# Uterine Leiomyosarcoma: Imaging studies show that her disease \nis metastatic with involvement of the liver, lungs, right iliac \nbone, pelvis and possibly the right breast. She is s/p a radical \nhysterectomy on ___ @ ___ hosptial, now s/p four \ncycles of gemcitabine and taxotere. Started C3 of Adriamycin and \nIphosphamide ___ per outpatient Oncologist, Dr. ___. \nWill need Neulasta on ___.\n\n# Irritible Bowel Syndrome / Bloating: Simethicone 80mg QID.\n\n# Depression: Continued home Zoloft.\n \nCODE: FULL-confirmed\nEMERGENCY CONTACT: ___ (Partner/HCP): ___ \n(h) ___ (c)\nDISPO: OMED to Home\n\n### TRANSITIONAL ISSUES ###:\n-Will need Neulasta on ___.\n-f/u w/ Hem/Onc\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Sertraline 75 mg PO DAILY \n2. Lorazepam 0.5 mg PO HS:PRN insomnia \n3. Cyanocobalamin Dose is Unknown  PO DAILY \n\n \nDischarge Medications:\n1. Cyanocobalamin 100 mcg PO DAILY \n2. Lorazepam 0.5 mg PO HS:PRN insomnia \n3. Sertraline 75 mg PO DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\n1)Leiomyosarcoma\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms ___,\n\nYou were admitted to our hospital for Chemotherapy. You \ntolerated it well. You are being discharged home. \nPlease make sure to go to ___ Oncology to receive your \nNeulasta shot on ___. \n\nIt has been a pleasure to take care of you here at ___. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"16934035","hadm_id":"20354034","text":" \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nErythromycin Base / Morphine\n \nAttending: ___.\n \nChief Complaint:\nC6 da-EPOCH level 1\n \nMajor Surgical or Invasive Procedure:\nPICC placement and removal prior to d/c\n\n \nHistory of Present Illness:\n___ male dx with high-grade B-cell lymphoma in ___. The patient noted a R chest wall mass in ___, CT\nshowed a mass 4.5x7.2x10.9cm mass arising from R serratus\nanterior muscle. This mass was biopsied on ___. PET/CT\nrevealed extensive disease, including bilateral axilla,\nmediastinum, porta hepatis, L pelvic sidewall, liver, R adrenal,\nT11, L1, L4, prostate.\n\nAs part of the workup prior to receiving rituxan, he was tested\nfor HIV, hepatitis B, and hepatitis C. HIV was positive, and he\nhas a log10 vL of 5.06. CD4 is 280. Hepatitis B sAb is positive.\nHe was started on HAART on ___, and follows with Dr ___.\n\nHe is here for his sixth cycle of chemotherapy with da-EPOCH-R.\nHe had IT MTX prior to admission on ___.\n\n \nPast Medical History:\nPast Medical History:\nPast Hematologic History:\nhigh-grade B cell lymphoma dx ___, stage IV\nC1 EPOCH-R dose level 1 ___ with IT MTX\nC2 EPOCH-R dose level 1 ___ with IT MTX\nC3 EPOCH-R dose level 1 ___ with IT MTX\n\nPMH:\nHIV dx ___\nHepatitis B sAb pos\nCORONARY ARTERY DISEASE                                         \nDEPRESSION                                                      \nType 2 DM                                             \nHYPERLIPIDEMIA                                                  \nPSORIASIS\nH/O GASTROESOPHAGEAL REFLUX \nSCC/BCC  \nBurkitt's-like high grade B cell lymphoma as above\n\n \nSocial History:\n___\nFamily History:\nMother deceased at ___ from APL. \nFather is alive at ___ with coronary artery disease.  He has no\nfull siblings.  He is of ___ and ___ descent.\n\n \nPhysical Exam:\nGEN:  NAD\nVS:  T 97.4 BP 116/62 HR 67 RR 20 P2 99%\nHEENT:  MMM, no OP lesions, no cervical, supraclavicular, or\naxillary LAD\nCV:  Regular, normal S1 and S2 no S3, S4, or murmurs\nPULM:  Clear to auscultation bilaterally\nABD:  BS+, soft, non-tender, non-distended, no masses, no\nhepatosplenomegaly\nLIMBS:  +2 pitting edema b/l-consistent\nSKIN:  No rashes or skin breakdown, chronic dry skin\nNEURO:  Grossly nonfocal, alert and oriented \n\n \nPertinent Results:\n___ 12:00AM BLOOD WBC-1.7* RBC-2.68* Hgb-8.0* Hct-23.8* \nMCV-89 MCH-29.9 MCHC-33.7 RDW-18.1* Plt ___\n___ 12:00PM BLOOD WBC-6.1# RBC-2.57* Hgb-7.9* Hct-23.7* \nMCV-92 MCH-30.9 MCHC-33.6 RDW-19.5* Plt ___\n___ 12:00AM BLOOD Neuts-88.4* Lymphs-8.2* Monos-1.4* \nEos-1.8 Baso-0.1\n___ 12:00PM BLOOD Neuts-79* Bands-0 Lymphs-8* Monos-7 Eos-0 \nBaso-0 ___ Metas-4* Myelos-2* NRBC-4*\n___ 12:00AM BLOOD Glucose-201* UreaN-23* Creat-0.5 Na-132* \nK-3.6 Cl-97 HCO3-23 AnGap-16\n___ 12:00PM BLOOD UreaN-9 Creat-0.8 Na-136 K-4.2 Cl-100 \nHCO3-26 AnGap-14\n___ 12:00AM BLOOD ALT-21 AST-16 LD(LDH)-173 AlkPhos-89 \nTotBili-0.3\n___ 12:00PM BLOOD ALT-16 AST-22 LD(LDH)-216 AlkPhos-122 \nTotBili-0.3\n___ 12:00AM BLOOD Albumin-3.7 Calcium-8.5 Phos-3.2 Mg-2.1\n___ 12:00PM BLOOD Calcium-9.0 Phos-3.7 Mg-1.___ year old male with HIV associated Burkitt's like DLBCL, GC\ntype, admitted for cycle 5 of da-EPOCH-R, dose level 1. PET/CT \nprior to first cycle shows extensive involvement in axilla, \nmediastinum, porta hepatis, L pelvic sidewall, liver, R adrenal,\nT11, L1, L4, prostate. PET CT prior to ___ cycles shows CR,\nrepeat PET prior to ___ cycle shows no new FDG avid areas.\n\nC6D6\n\n# HIV assoc DLBCL: chemotherapy as follows (dose level 1).  \n- Etoposide D1-4 \n- Doxorubicin D1-4\n- Vincristine D1-4 \n- Cyclophosphamide D5. \n- Rixuan will be given in clinic outpatient on ___\n- IT Ara-C (has had 6 doses IT MTX) done prior to admit ___\n- neupogen to start at home D6\n\n#Anemia: secondary to marrow suppression s/p 6C of chemo.\n- 1 unit RBCs ___\n\n# FVO: continue compression stocking and monitor. strict I/Os,\ndiurese prn\n\n# HIV:\n- genotyping: wild type, no R' pattern\n- Truvada (2 NRTI) and dolutegravir (integrase inhibitor) \nstarted ___ with improvement in vL, repeat testing stable\n- f/u with Dr ___\n\n# hep B surface Ab positivity: \n- Truvada should provide adequate coverage per Dr ___\n\n# hypertensive heart disease without heart failure or evidence \nof CKD.  CAD PTCA in ___ and ___. \n-holding ASA \n-Continue HCTZ, CCB, ACEI (now at lower dose) with parameters. \n-PRN TNG, has not used in the past\n-Stress testing last performed in ___.\n-hold hyperlipidemia agents while admitted\n\n# CAD s/p PTCA ___ \u0026 ___: see above\n\n# DM type 2 without known target organ damage:\n-resume metformin/glipizide at home\n-A1C is at goal at 6.9%\n-SSI inhouse, ___ if needed\n\n# anxiety: on buspar, prn trazodone for sleep\n\n# psoriasis: not currently using home topical regimens, held\ninpatient per patients preference.\n\n# GERD: remains on ppi. \n\n# L2 compression fracture: continue tylenol, heat, lidoderm\n\n# nausea: Supportive antiemetics with Prednisone D 1,2,3,4,5,\nprochlorperazine, ativan and ondansetron\n\n# peripheral neuropathy: given the risk of constipation with\nvincristine, will schedule bowel regimen. \n\n# DVT prophylaxis: heparin\n# Prophylaxis: acyclovir and bactrim, start cipro at home \n\n# F/E/N: prn electrolytes. drinking well, IVF per protocol.\n\n# Access: L PICC\n# code status: Full\n# dispo: home post chemo\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acyclovir 400 mg PO Q8H \n2. Atorvastatin 10 mg PO QPM \n3. BusPIRone 5 mg PO TID \n4. Ciprofloxacin HCl 500 mg PO Q12H \n5. Cyclobenzaprine 5 mg PO TID:PRN muscle spasms \n6. Dolutegravir 50 mg PO DAILY \n7. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n8. fenofibrate 150 mg oral daily \n9. Filgrastim 480 mcg SC Q24H \n10. Fluocinonide 0.05% Ointment 1 Appl TP BID:PRN skin \nirritation \n11. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN \nallergies/congestion \n12. GlipiZIDE 5 mg PO QAM \n13. Hydrochlorothiazide 25 mg PO DAILY \n14. HydrOXYzine 25 mg PO Q6H:PRN pruritus \n15. Lisinopril 5 mg PO DAILY \n16. Lorazepam 0.5-1 mg PO Q4H:PRN nausea anxiety insomnia \n17. MetFORMIN (Glucophage) 500 mg PO TID \n18. Nitroglycerin SL 0.4 mg SL PRN CP \n19. Omeprazole 20 mg PO DAILY \n20. Ondansetron 8 mg PO Q8H:PRN nausea \n21. Potassium Chloride 10 mEq PO BID \n22. Prochlorperazine 10 mg PO Q6H:PRN nausea \n23. Viagra (sildenafil) 100 mg oral prn \n24. Phosphorus 250 mg PO BID \n25. Sulfameth/Trimethoprim SS 1 TAB PO DAILY \n26. TraZODone 25 mg PO QHS:PRN insomnia \n27. Verapamil SR 240 mg PO Q24H \n28. Calcium Carbonate 500 mg PO BID \n29. Vitamin D 400 UNIT PO DAILY \n30. Cyanocobalamin 250 mcg PO DAILY \n31. Docusate Sodium 100 mg PO BID \n32. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n33. Senna 8.6 mg PO BID \n34. Simethicone 40-80 mg PO QID:PRN flatulence \n\n \nDischarge Medications:\n1. Acyclovir 400 mg PO Q8H \n2. BusPIRone 5 mg PO TID \n3. Cyanocobalamin 250 mcg PO DAILY \n4. Cyclobenzaprine 5 mg PO TID:PRN muscle spasms \n5. Docusate Sodium 100 mg PO BID \n6. Dolutegravir 50 mg PO DAILY \n7. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n8. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN \nallergies/congestion \n9. Hydrochlorothiazide 25 mg PO DAILY \n10. Lisinopril 5 mg PO DAILY \n11. Lorazepam 0.5-1 mg PO Q4H:PRN nausea anxiety insomnia \n12. Omeprazole 20 mg PO DAILY \n13. Phosphorus 250 mg PO BID \n14. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n15. Potassium Chloride 10 mEq PO BID \nHold for K \u003e5 \n16. Prochlorperazine 10 mg PO Q6H:PRN nausea \n17. Senna 8.6 mg PO BID \n18. Simethicone 40-80 mg PO QID:PRN flatulence \n19. Sulfameth/Trimethoprim SS 1 TAB PO DAILY \n20. TraZODone 25 mg PO QHS:PRN insomnia \n21. Vitamin D 400 UNIT PO DAILY \n22. Atorvastatin 10 mg PO QPM \n23. Calcium Carbonate 500 mg PO BID \n24. Ciprofloxacin HCl 500 mg PO Q12H \n25. fenofibrate 150 mg oral daily \n26. Filgrastim 480 mcg SC Q24H \n27. Fluocinonide 0.05% Ointment 1 Appl TP BID:PRN skin \nirritation \n28. GlipiZIDE 5 mg PO QAM \n29. HydrOXYzine 25 mg PO Q6H:PRN pruritus \n30. MetFORMIN (Glucophage) 500 mg PO TID \n31. Nitroglycerin SL 0.4 mg SL PRN CP \n32. Ondansetron 8 mg PO Q8H:PRN nausea \n33. Verapamil SR 240 mg PO Q24H \n34. Viagra (sildenafil) 100 mg ORAL PRN ED \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nlymphoma\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___:\n\nYou were admitted to receive chemotherapy for your lymphoma. You \ntolerated this very well. \n \nYou gained fluid weight due to the chemotherapy, which improved \nwith \nadditional lasix.  \n\nYou will inject neupogen daily starting ___, continue until \nyou are told to stop. \n\nYou will continue to take medications to prevent infection: \nacyclovir, bactrim. You will restart ciprofloxacin as well while \nyour blood counts are low. \n\nYour nausea medications are as follows:\n1 zofran\n2 ativan\n3 compazine\n\nPlease continue to take colace and senna for the next two weeks \nas ordered. If your stools become frequent, you may decrease the \nsenna to once daily. If you become constipated despite the \ncolace/senna, please purchase miralax over the counter and use \nthis daily. If you remain constipated despite these medications, \nplease call us.\n\nPlease drink enough fluids so that your urine is close to clear \n(this is usually between 48-64 oz of fluid per day).\n\nYou will follow up in the outpatient clinic as stated below. \nPlease do not hesitate to call in the meantime with any \nquestions or concerns.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16657198","hadm_id":"28573897","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nLisinopril / Celebrex / Tramadol / Pollen Extracts / Cat/Feline \nProduct Derivatives\n \nAttending: ___.\n \nChief Complaint:\nL hip pain\n \nMajor Surgical or Invasive Procedure:\nsacroiliac joint injection\ngreater trochanteric bursa injection\nepidural injection\n \nHistory of Present Illness:\n___ MEDICINE ATTENDING ADMISSION NOTE .\n\nPCP: Name: ___ \nLocation: HEALTHCARE ASSOCIATES\n___ \nAddress: ___/CC-6, ___ \nPhone: ___ \nFax: ___ \nEmail: ___ \nconfirmed with OMR , last saw  PCP ___ ___\n.\nRheumatologist Dr. ___ at ___\n.\nPatient is a ___ yo woman with PMHx sig. for rheumatoid arthritis \non Remicade q 4 weeks who presents with L hip pain and lower \nback pain.  She was due for remicade 2 day ptp and over the \ncourse of the last week she has noticed increased b/l hip pain. \nShe received remicaide on ___ with good effect of her \npain. She went home and awoke the next morning with pain in L \nhip. Pain worsened over the day ___.  She ran out of \nhydrocodone and drove to the pharmacy to get the ppx refilled. \nDespite taking the hydrocodone her pain worsened. She couldn't \nsleep ___ pain. Pain alleviated somewhat by heat packs but \nslowly continued to worsen. She called her PCP's office the \nevening PTP. PCP office advised her to go to the ED. Hip pain \nthen progressed twoards her lower back. No h/o lower back pain. \nShe usually has neck pain. No f/c. No recent falls since last \n___ during which she fractured her shoulder. No \nincontinence of stool or urine. No focal weakness. \nShe also noticed rectal bleeding ___ tsp on the toilet paper \nover the past month. She was given steroid suppositories by Dr. \n___.\n.\nIn the ED, initial VS were:  97.4 86 156/98 18 98%.  Exam was \nnotable for L paraspinal tenderness, writhing in pain.  L hip \nxray showed no hip fracture.  The patient received dilaudid, \nibuprofen, percocet, valium, and omeprazole.  She is being \nadmitted for pain control. Pain in hip worse with weight \nbearing.\n.\nIn ER: (\nMeds Given: Oxycodone-Acetaminophen 5mg/325mg Tablet [class 2] 1 \n___ \n___ 11:49 Diazepam 5 mg Tab [class 4] 1 ___ \n___ 13:40 Oxycodone-Acetaminophen 5mg/325mg Tablet [class 2] 2 \n___ \n___ 13:40 Ibuprofen 400mg Tablet 2 ___ \n___ 13:46 Omeprazole 20mg Cap 2 ___ \n___ 15:31 HYDROmorphone (Dilaudid) 1mg/1mL Syringe [class 2] 1 \n___ \n___ 17:47 HYDROmorphone (Dilaudid) 1mg/1mL Syringe [class 2] 1 \n___ \n___ 18:25 Diazepam 10mg/2mL Syringe [class 4] \n\n Fluids given: 1L NS\nRadiology Studies: Hip X ray- no formal read but per my read no \novert fx but marked degeneration of b/l acetabulae R \u003eL\nconsults called: none\n\n.\n\nPAIN SCALE: ___ pain in L hip. \n________________________________________________________________\nREVIEW OF SYSTEMS:\nCONSTITUTIONAL:        [] All Normal\n[-] Fever  [- ] Chills   [ ] Sweats  [ ] Fatigue   [ ] Malaise   \n[ ]Anorexia  [ ]Night sweats\n[ ?] weight  loss but she suspects that the bedscale in the \nhospital is incorrect \n\nHEENT:          [X] All Normal\n[ ] Blurred vision   [ ] Blindness  [ ] Photophobia\n[ ] Decreased acuity [ ] Dry mouth  [ ] Bleeding gums\n[ ] Oral ulcers  [ ] Sore throat    [ ] Epistaxis  [ ] Tinnitus\n[ ] Decreased hearing    [ ]Tinnitus [ ] Other:\n\nRESPIRATORY:    [] All Normal\n[ ] SOB     [+] DOE- no worse chronic x years    [+] Can't walk \n2 flights     [ ] Cough\n[ ] Wheeze  [ ] Purulent sputum    [ ] Hemoptysis   [ ]Pleuritic \npain \n[ ] Other:\n\nCARDIAC:        [X]  All Normal\n[ ] Angina    [ ] Palpitations   [ ] Edema   [ ] PND\n[] Orthopnea    [ ] Chest Pain [ ] Other:\n\nGI:             [] All Normal\n[ ] Blood in stool     [ ] Hematemesis     [ ] Odynophagia\n[ ] Dysphagia:   [ ] Solids    [ ] Liquids [+]Blood on toilet \npaper\n[ ] Anorexia    [-] Nausea  [-] Vomiting   [ ] Reflux\n[+] Diarrhea  but now   [+] Constipation- mild ___ opiods  []  \nAbd pain  [ ] Other:\n\nGU:             [X] All Normal\n[ ] Dysuria      [ ] Frequency    [ ] Hematuria  []Discharge \n[]Menorrhagia  \n\nSKIN:           [X] All Normal\n[ ] Rash        [ ] Pruritus\n\nMS:             [X] All Normal\n[ ] Joint pain    [ ] Jt swelling   [ ] Back pain  [ ] Bony pain\n\nNEURO:          [X] All Normal\n[ ] Headache    [ ] Visual changes   [ ] Sensory change [ \n]Confusion [ ]Numbness of extremities\n[ ] Seizures   [ ] Weakness [ ] Dizziness/Lightheaded [ ]Vertigo \n[ ] Headache\n\nENDOCRINE:     [X] All Normal\n[ ] Skin changes  [ ] Hair changes   [ ] Temp subjectivity\n\nHEME/LYMPH:    [X] All Normal\n[ ] Easy bruising   [ ] Easy bleeding    [ ] Adenopathy\n\nPSYCH:         [X] All Normal\n[ ] Mood change        []Suicidal Ideation  [ ] Other:  \n\n \n\n[x]all other systems negative except as noted above \n\n \nPast Medical History:\nHypertension\nAllergic rhinitis\nAshtma\nRheumatoid arthritis\nSleep apnea\nOsteoarthritis\nSteatohepatitis\nSeasonal affective disorder\nOsteoporosis\nHemorrhoids\nUlcerative proctitis\nNoctural myoclonus\nShingles on L side in ___\n \nSocial History:\n___\nFamily History:\nMother died of leukemia at age ___. Father died of MI at age ___. \nGF died age ___ of stroke after hernia. Grand uncle also died \nyoung a stroke.GM died after having several strokes and MI. \n \nPhysical Exam:\nGen: NAD, EOMI, MMM, sclera anicteric, not injected\nNeck: no LAD, no JVD\nCardiovascular: RRR normal s1, s2, no murmurs appreciated\nRespiratory: Clear to auscultation bilaterally, no wheezes, \nrales or rhonchi  \nAbd: normoactive bowel sounds, soft, non-tender, obesely \ndistended Extremities: No edema, 2+ DP pulses\nL upper extremity with mulitple ecchymoses. \nBack: No pinpoint tenderness along spine\nRectal: external hemorrhoids. No bleeding. Vault empty of stool\n? slightly diminished tone\nNo saddle anesthesia\n+ L SLR. \nNeurological: CN II-XII intact, normal attention, sensation \nnormal, speech fluent, DTR's 2+ patellar, achilles, biceps, \nNEURO: EOMI, face symmetric, no tongue deviation\nIntegument: Warm, moist, no rash or ulceration  \nPsychiatric: appropriate, pleasant, not anxious  \n \nPertinent Results:\nAdmission labs:  \n___ 11:35PM   CRP-6.4*\n___ 11:35PM   SED RATE-17\n.\nImaging:\nHip xray ___:\nIMPRESSION: No fracture or dislocation.\n.\nLumbar MRI ___:\nIMPRESSION: \n1. Lumbar spondylosis described above worst at L4-L5 with a \nlarge disc \nprotrusion at L4-L5 with superior migration, resulting in \nsignificant spinal canal narrowing. The left lateral recess at \nthe level of L4 is most severely affected. Please see level by \nlevel description in OMR.\n2. Minimal grade 1 retrolisthesis of L2 on L3. \n3. No abnormal enhancement on the ___ images.\n.\nDischarge labs:\n ___ 06:20AM BLOOD WBC-15.9* RBC-3.59* Hgb-11.5* Hct-35.2* \nMCV-98 MCH-32.1* MCHC-32.7 RDW-17.7* Plt ___\n___ 06:20AM BLOOD Glucose-90 UreaN-19 Creat-0.8 Na-136 \nK-4.2 Cl-96 HCO3-30 AnGap-14\n___ 06:20AM BLOOD ___\n \nBrief Hospital Course:\nMs. ___ is a ___ year old woman with a history of rheumatoid \narthritis on remicade, prednisone, MTX who presents with \nsciatica down L leg.  Originally, she was thought to have L hip \npain but was later felt by Dr. ___ to have adequate ROM without \npain and an exam more suggesttive for sciatica.  Her course has \nbeen notable for waxing and waning pain requiring IV morphine.  \nMRI was attempted on ___ but the machine was too small to \naccommodate MS. ___ so arrangements were made for exam to happen \non the ___ on ___ and it revealed L4-L5 disc \nherniation.  Neurosurgery was consulted and recommended \nconservative treatment as well as IV Decadron.  Since she is \nalready on steroids (Prednisone 15 mg daily), after discussion \nwith Dr. ___ was decided to go up on the Prednisone \nto 60 mg po daily for a few days.  She continued to have severe \npain, and was seen by the pain service.  Narcotic pain \nmedications were increased, with mscontin, oxycodone, and \nneurontin.  She continued to have pain, and had injections in \nher SI joint, GTB bursa, and her ultimately in her epidural \nspace.  With treatment, she improved, was able to ambulate, and \nwas discharged home.\n\nHer remaining medical problems included rheumatoid arthritis, \nobesity, ulcerative proctitis, hypertension, asthma, \nosteoporosis all remained stable, and she was continued on her \nhome medications.\n \nMedications on Admission:\nActive Medication list as of ___ OMR reviewed with pt. \n \nMedications - Prescription\nALBUTEROL SULFATE - 90 mcg HFA Aerosol Inhaler - 2 inhalations \nevery four (4) hours as needed for asthma\nCITALOPRAM - 20 mg Tablet - 0.5 (One half) Tablet(s) by mouth at \nbedtime\nCLONAZEPAM - 0.5 mg Tablet - two Tablet(s) by mouth at bedtime \nas needed\nFLUTICASONE [FLONASE] - 50 mcg Spray, Suspension - 2 squirts to \neach nostril daily\nFOLIC ACID - 1 mg Tablet - 2 Tablet(s) by mouth day\nHYDROCHLOROTHIAZIDE - 25 mg Tablet - 1 (One) Tablet(s) by mouth \nonce a day\nHYDROCODONE-ACETAMINOPHEN - 7.5 mg-325 mg Tablet - ___ Tablet(s) \nby mouth every four (4) hours as needed for pain\nHYDROCORTISONE ACETATE -  (Prescribed by Other Provider) - 25 mg \nSuppository - apply rectally ___ times/day as needed for \nhemorrhoidal irritation\nINFLIXIMAB [REMICADE] -  (Dose adjustment - no new Rx) - 100 mg \nRecon Soln - Infuse 800 mg (7.2mg/kg) once every 4 weeks\nINSPIREASE INHALER -  Device - USE WITH INHALER AS DIRECTED\nMETHOTREXATE SODIUM - 2.5 mg Tablet - 9 Tablet(s) by mouth per \nweek- takes it on ___\nMOEXIPRIL - 15 mg Tablet - 1 (One) Tablet(s) by mouth once a day\nNASAL CPAP -  (Prescribed by Other Provider) -   - 12 cms at \nbedtime as needed for with sleep\nNYSTATIN-TRIAMCINOLONE - 100,000 unit/gram-0.1 % Cream - apply \ntwice a day\nOLOPATADINE [PATANOL] - 0.1 % Drops - 2 drops each eyes twice a \nday as needed for allergies\nOMEPRAZOLE - 20 mg Capsule, Delayed Release(E.C.) - 2 (Two) \nCapsule(s) by mouth once a day\nPREDNISONE - 5 mg Tablet - 3 Tablet(s) by mouth once a day- \nconfirmed with pt \nRELAFEN - 750 mg Tablet - 2 (Two) Tablet(s) by mouth once a day\nSIMVASTATIN - 20 mg Tablet - 1 Tablet(s) by mouth once a day\nSULFAMETHOXAZOLE-TRIMETHOPRIM [BACTRIM DS] - 800 mg-160 mg \nTablet - 1 (One) Tablet(s) by mouth 3 times per week, ___\n \nMedications - OTC\nACETAMINOPHEN [TYLENOL EXTRA STRENGTH] -  (Prescribed by Other \nProvider) - 500 mg Tablet - 2 Tablet(s) by mouth three times a \nday as needed for pain\nCALCIUM CITRATE-VITAMIN D3 [CITRACAL + D MAXIMUM] -  (OTC) - 315 \nmg-250 unit Tablet - 1 Tablet(s) by mouth twice a day\nDIPHENHYDRAMINE HCL [BENADRYL] -  (Prescribed by Other Provider) \n- Dosage uncertain\nERGOCALCIFEROL (VITAMIN D2) -  (OTC) - 400 unit Capsule - 1 \nCapsule(s) by mouth once a day\nPSEUDOEPHEDRINE HCL [SUDAFED] -  (Prescribed by Other Provider) \n- Dosage uncertain\n\n \nDischarge Medications:\n1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n2. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n3. Sulfamethoxazole-Trimethoprim 800-160 mg Tablet Sig: One (1) \nTablet PO DAILY ___ ().  \n4. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for \nNebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as \nneeded for shortness of breath or wheezing.  \n5. Citalopram 20 mg Tablet Sig: 0.5 Tablet PO QHS (once a day \n(at bedtime)).  \n6. Clonazepam 1 mg Tablet Sig: One (1) Tablet PO QHS (once a day \n(at bedtime)) as needed for insomnia.  \n7. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) \nSpray Nasal DAILY (Daily).  \n8. Folic Acid 1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  \n\n9. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n10. Moexipril 15 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n11. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n12. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n13. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO TID (3 \ntimes a day).  \n14. Calcium Carbonate 200 mg (500 mg) Tablet, Chewable Sig: Two \n(2) Tablet, Chewable PO DAILY (Daily).  \n15. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) \nTablet PO DAILY (Daily).  \n16. Methotrexate Sodium 2.5 mg Tablet Sig: Five (5) Tablet PO \nQWED (every ___.  \n17. Methotrexate Sodium 2.5 mg Tablet Sig: Four (4) Tablet PO \nQWED (every ___.  \n18. hydrocortisone acetate 25 mg Suppository Sig: One (1) \nSuppository Rectal TID (3 times a day).  \n19. pseudoephedrine HCl 30 mg Tablet Sig: One (1) Tablet PO Q6H \n(every 6 hours) as needed for nasal congestion.  \n20. Neurontin 300 mg Capsule Sig: One (1) Capsule PO three times \na day.  \n21. oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q3H (every 3 \nhours) as needed for pain .\nDisp:*100 Tablet(s)* Refills:*0*\n22. nabumetone 750 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n23. prednisone 5 mg Tablet Sig: Four (4) Tablet PO once a day \nfor 1 days: Then resume 15 mg per day on ___.  \n24. morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO Q12H (every 12 hours).\nDisp:*60 Tablet Sustained Release(s)* Refills:*0*\n25. Bariatric commode\nUse as directed.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n## L4-L5 Disc herniation with severe back pain/sciatica\n## Rheumatoid Arthritis on Remicaid, MTX, Prednisone\n## Immunosuppressed secondary to above\n## Hypertension\n## Hypercholesterolemia\n## Osteoporosis/High risk\n## Depression\n## Neuropathy\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nYou were admitted to the hospital with acute onset back/leg pain \nthat we feel is likely due to a herniated disk in your back at \nthe L4-L5 level.  Neurosurgical Spine (Dr. ___ saw you \nin consultation and recommended conservative treatment and pulse \ndose systemic steroids (we increased your prednisone). As you \ncontinued to have pain and difficulty walking, we consulted the \nPain Service for an epidural injection. The procedure was \ndelayed due to a lab value indicating a higher risk of bleeding, \nwhich we attributed to antibiotics and treated with vitamin K. \nIn the meantime, you underwent an injection of your sacroiliac \njoint and greater trochanteric bursa, which provided some \nrelief. We also added a long-acting oral morphine. You finally \nhad the epidural injection on ___.\n.\nMedication changes:\nStart MSCONTIN 30 MG twice daily\nStart OXYCODONE 10 MG every ___ hours for pain\nStart NEURONTIN 300 mg three times daily (same dose as \npreviously)\nStop VICODIN\nContinue PREDNISONE 20 mg for 1 more day, and then restart 15 mg \nevery day\n.\nTake the Mscontin, oxycodone, neurontin first thing in the \nmorning.  Then with breakfast, take the relafen and prednisone.  \nThis should help with your morning pain.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18589204","hadm_id":"23655689","text":" \nName:  ___         Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nrash, nosebleed  \n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMrs ___ is a pleasant ___ yo female with no PMH who presented \nto her PCP today with 2 days of rash, nose bleeding with blowing \nnose and mild cough with blood-streaked sputum. Pt was seen by \nher PCP who noted ___ over legs, ___, face and arms. She \nhas also had easy bruising over the past few days with \necchymoses over her L leg. She denies any recent CP, URI sxs, \nSOB, CP, abd pain, N/V/D. No recent med changes or OTC meds \nother than ibuprofen. She did have some headaches and \nlightheadedness.  \n.  \nIn the ED, admission vitals were 99 67 125/85 18 100% RA. Labs \nin the ED were notable for plts \u003c5, previously 125 on ___. Exam \nnotable for non blanching petechiae over torso, lower/upper \nextremity, face, ecchymoses over L lower leg, no signs \nhemearthroses.  \nShe was started on 60 mg prednisone.  \n.  \nOn arrival to the floor, pt is comfortable with no complains \nother than feeling tired.  \n\n \nPast Medical History:\nMEDICAL \u0026 SURGICAL HISTORY:  \nc-section  \ns/p hysterectomy  \n\n \nSocial History:\n___\n___:\nfather killed in a car accident, mother has  \ndiabetes, HTN, heart surgery. Sister with DM, htn  \n\n \nPhysical Exam:\nOn discharge \nVtitals: 96.6, 111/58, P-57, RR-20, 99% RA \nGENERAL: Well-appearing woman in NAD, comfortable, appropriate.  \n\nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear.One \nulcer on the inside of each cheek b/l,3-5 mm, nonbleeding. \nMucosal ___. Dark 5mm black lesion on left cheek.  \nNECK: Supple, no thyromegaly, no JVD, no carotid bruits.  \nLUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. \n \nHEART: RRR, no MRG, nl S1-S2.  \nABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding.  No \nspleen palpated, difficult due to body habitus\nEXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses.  \nSKIN: Diffuse ___ over face, chest, legs, arms. Ecchymoses \non LL leg.  \nLYMPH: No cervical LAD.  \nNEURO: Awake, A\u0026Ox3, CNs II-XII intact, moves all extremities \nfreely.  \n\n \nPertinent Results:\nAdmission Labs \n___ 08:07PM URINE  HOURS-RANDOM\n___ 08:07PM URINE  UCG-NEGATIVE\n___ 06:47PM   GLUCOSE-110* K+-3.5\n___ 06:20PM   GLUCOSE-116* UREA N-13 CREAT-0.6 SODIUM-141 \nPOTASSIUM-3.4 CHLORIDE-103 TOTAL CO2-32 ANION GAP-9\n___ 06:20PM   estGFR-Using this\n___ 06:20PM   ALT(SGPT)-20 AST(SGOT)-23 LD(LDH)-205 TOT \nBILI-0.3\n___ 06:20PM   HAPTOGLOB-130\n___ 06:20PM   WBC-5.8 RBC-4.06* HGB-11.1* HCT-33.3* MCV-82 \nMCH-27.3 MCHC-33.2 RDW-14.0\n___ 06:20PM   NEUTS-47.6* LYMPHS-46.3* MONOS-4.0 EOS-1.4 \nBASOS-0.7\n___ 06:20PM   I-HOS-DONE\n___ 06:20PM   PLT SMR-RARE PLT COUNT-\u003c5\n___ 06:20PM   ___ PTT-24.5 ___\n___ 06:20PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 06:20PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-SM \n___ 06:20PM URINE  RBC-2 WBC-4 BACTERIA-NONE YEAST-NONE \nEPI-2\n___ 06:20PM URINE  MUCOUS-RARE\n.\nDischarge Labs \n\n___ 07:40AM BLOOD WBC-10.2 RBC-4.03* Hgb-11.1* Hct-33.2* \nMCV-83 MCH-27.4 MCHC-33.2 RDW-14.5 Plt Ct-50*#\n___ 07:55AM BLOOD WBC-11.0 RBC-3.97* Hgb-10.8* Hct-32.9* \nMCV-83 MCH-27.2 MCHC-32.9 RDW-14.1 Plt Ct-23*\n___ 04:15AM BLOOD Neuts-53.3 Lymphs-42.8* Monos-3.2 Eos-0.1 \nBaso-0.5\n___ 07:40AM BLOOD Plt Ct-50*#\n___ 07:55AM BLOOD Plt Ct-23*\n___ 11:35AM BLOOD Plt Ct-31*#\n___ 07:20AM BLOOD Plt Ct-\u003c5*\n___ 04:15AM BLOOD Plt Smr-RARE Plt Ct-5*#\n___ 07:59AM BLOOD Plt Smr-RARE Plt Ct-\u003c5\n___ 06:20PM BLOOD Plt Smr-RARE Plt Ct-\u003c5\n___ 07:59AM BLOOD ___\n___ 04:15AM BLOOD Glucose-110* UreaN-16 Creat-0.6 Na-140 \nK-3.6 Cl-103 HCO3-32 AnGap-9\n___ 07:59AM BLOOD Glucose-166* UreaN-10 Creat-0.6 Na-138 \nK-4.0 Cl-102 HCO3-29 AnGap-11\n___ 06:20PM BLOOD ALT-20 AST-23 LD(LDH)-205 TotBili-0.3\n___ 04:15AM BLOOD Calcium-9.3 Phos-3.9 Mg-1.9\n___ 06:20PM BLOOD Hapto-130\n___ 06:47PM BLOOD Glucose-110* K-3.5\n.\nReports \nCXR \nLow lung volumes. Repeat radiograph with improved inspiratory \nlevel may be helpful to differentiate crowding of \nbronchovascular structures from early foci of infection.  \n.\nEKG\nSinus rhythm. Modest precordial lead T wave changes are \nnon-specific. Since the previous tracing of ___ precordial \nlead T wave changes appear slightly more prominent but may be no \nsignificant change. \n.\nURINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( \u003e= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION.\n \nBrief Hospital Course:\n___ yo woman with no PMH, admitted for rash, plts\u003c 5 concerning \nfor ITP.  \n.  \n# Thrombocytopenia: most likely ITP. Smear was not consistent \nwith TTP given no schistocytes, or DIC (fibrinogen is normal), \nlabs not consistent with DIC. There was no clear etiology given \nno new meds and no recent viral illness.Was placed on oral \nsteroids which increased her platelet count to 50.Was \nhemodynamically stable but did  have ___ episodes of bright red \nurine and clots with no dysuria or pain. This hematuria resolved \nwith 1 unit of platelets and she was urinating yellow urine on \nthe day of discharge.She was discharged on steroids with close \noutpatient follow up\n.  \n# Cough: CXR unremarkable. Pt stated no worse than usual. \nComplained of no significant cough or dyspnea during the \nadmission\n.\nOutpatient follow up \n-The patient had hematuria in the setting of thrombocytopenia, \nif this recurs consider further workup such as renal/bladder \nultrasound to rule out other causes like cysts or carcinoma.\n.  \n.  \n\n \nMedications on Admission:\n-citalopram 20 mg daily-pt not taking  \n-advil\n \nDischarge Medications:\n1. prednisone 20 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily) for 12 days.\nDisp:*36 Tablet(s)* Refills:*0*\n2. Outpatient Lab Work\nPlease Draw CBC on ___\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagonsis:\n1)ITP\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\nYou were admitted to our hospital for a concern of low platelets \nand blood in your urine. You were found to have low platelets \nand were started on a medicine to treat this condition. Your \nplatelets have improved. \n\nThe following changes were made to your medications:\nSTART PREDNISONE  daily take this for 2 weeks unless told to \nstop by your primary care provider. \n\nYou will need to give blood to check your platelets. Please do \nso at ___ facility on ___.\n\nPlease call Hematology services here ___ on ___ \n___ to set up follow - up appointment to discuss your \nplatelets, as well as prednisone dosing. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"15308316","hadm_id":"23048603","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Aspirin\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo F with a h/o of LV diastolic dysfunction, \nHTN, and COPD who presents with one week of SOB and weakness.  \nShe was first diagnosed with COPD about a year ago when she \nstarted sleeping upright in a chair and became unable to catch \nher breath. At that time, she was hospitalized.  She has some \ntriggers for SOB, including walking down the detergent aisle at \nthe grocery store.\n.\nShe woke a week ago and was out of breath walking to the \nbathroom. Normally she can walk up the stairs of her apartment, \nand now she has to stop and rest, almost becoming incontinent.  \nShe has been feeling weak and tired, and she now sleeps with \nthree pillows, waking from sleep short of breath. Her SOB is \nrelieved somewhat by standing at the open window.  She also has \na cough productive of clear sputum. She has been using \nsupplemental oxygen at home (___) since ___, which helped at \nfirst, but today it was not helping.  With her SOB this week, \nshe has had no CP or symptoms of respiratory illness.\n.\nShe has had a number of recent medication changes. She stopped \ntaking steroids two months ago, and stopped lisinopril on the \n___ because it made her cough.  She started lasix two months \nago, and 3 weeks ago her dose was increased from 10 to 20 mg QD \nbecause of increased ankle swelling. She reports that her \nspireva and symbicort do not help with her SOB.\n.\nShe has made no changes in her diet, but admits that she eats \nsalty foods like the entire bag of smartfood popcorn or fritos. \nShe has noted an 8 lb weight loss over the last two months.\n.\nIn the ED, initial vs were: T 97.8 P 64 BP 118/97 R 24 O2 sat \n99% 3L. Patient was given Combivent Nebs x3, Lasix 20 mg, HCTZ \n12.5 mg, Azithromycin 500 mg, Solumedrol 125mg.\n.\nOn the floor, she was not feeling short of breath unless she \nreclined.\n.\nReview of sytems: \n(+) Per HPI\n(-) Denies fever, headache, rhinorrhea or congestion. Denied \nchest pain or palpitations. Denied nausea, vomiting, diarrhea, \nconstipation or abdominal pain. No recent change in bowel or \nbladder habits. No dysuria. Denied arthralgias or myalgias. She \nhas no animals, no new soap, and has not traveled recently.\n\n \nPast Medical History:\nCOPD\nLV diastolic dysfunction ___\nHTN\nMild Pulmonary hypertension ___\nNormal EF ___\nh/o ectopic pregnancy\nh/o positive PPD, normal CXR, never treated \n\n \nSocial History:\n___\nFamily History:\nMother had COPD, Father died of stroke, two siblings with DM, \none half sibling with \"kidney problem\" now deceased.\n\n \nPhysical Exam:\nVitals: T: 97.7 P: 86 BP: 104/84 R: 22 O2: 93% 3L  \nGeneral: Alert, oriented, no acute distress, sitting up.\nHEENT: MMM, oropharynx clear\nNeck: JVP not elevated, no LAD\nLungs: Sparse wheezes, R\u003eL, distant breath sounds bilaterally, \nnot moving good air.\nCV: RRR low pitched, hard to hear heart sounds\nAbdomen:  Non-tender, non-distended, positive bowel sounds. \nExt: 2+ DP, radial pulses, no clubbing, cyanosis. BLE mildly \nedematous\nNeuro: CNII-XII intact, ___ Biceps, grip, leg lift, Tibialis \nanterior, gastroc/soleus.\n\n \nPertinent Results:\nAdmission labs:\n___ 07:33AM\nWBC-6.7 RBC-5.44* Hgb-12.2 Hct-38.4 MCV-71* MCH-22.4* MCHC-31.7 \nRDW-15.6* Plt ___\nNeuts-49.4* ___ Monos-4.9 Eos-8.3* Baso-0.4\nUreaN-9 Creat-1.0 Na-136 K-3.7 Cl-100 HCO3-30 AnGap-14\nCalcium-8.7 Phos-4.2 Mg-2.1\nLactate-2.5* \nCK(CPK)-468*\nproBNP-35\n \n___ Arterial blood gas\npO2-71* pCO2-49* pH-7.40 calTCO2-31* Base XS-3\n\n___ Smear\nHypochr-1+ Anisocy-1+ Poiklo-1+ Macrocy-NORMAL Microcy-1+ \nPolychr-1+ Target-2+ Schisto-OCCASIONAL Tear ___ \n___ Ellipto-1+\n\n___ 07:33AM BLOOD CK-MB-5 cTropnT-\u003c0.01\n___ 05:00PM BLOOD CK-MB-4 cTropnT-\u003c0.01\n___ 07:25AM BLOOD CK-MB-4 cTropnT-\u003c0.01\n\nIron-47\ncalTIBC-359 Ferritn-82 TRF-276\n%HbA1c-6.3*\n\n___ CXR\nIMPRESSION: No acute pulmonary process detected. Stable opacity \nin the left lower lung zone, which represents a pleural lipoma. \n\n \nBrief Hospital Course:\n___ yo F with a h/o of LV diastolic dysfunction, HTN, and COPD \nwho presents with one week of shortness of breath likely due to \nCOPD flare. \n.\n#COPD flare: Possible etiologies for her SOB were MI, CHF flare, \nAsthma, COPD flare, pulmonary hypertension, pneumonia, \ninterstitial lung disease, PE. Her EKG was unchanged from the \nprior EKG, showing a possible old septal infarct and no changes \nconsistent with PE. She had no chest pain and cardiac enzymes \nwere also negative. Her SOB is likely not related to MI. CXR \nshowed no pulmonary edema and BNP was also normal, suggesting \nshe had no CHF, even though her history of increased dyspnea \nwhen she reclines sounds like CHF. She has wheezes and \neosinophilia, suggestive of asthma, but she does not have a \nprior history of asthma.  Pulmonary hypertension would most \nlikely have a more insidious onset than her presentation. \nPneumonia is possible, but CXR is clear and her sputum is clear. \nShe was given albuterol and ipratropium nebs as well as a \nprednisone taper from 60mg. A course of azithromycin was started \non ___. ABG showed respiratory acidosis with metabolic \ncompensation and additional metabolic alkalosis likely due to \nlasix. Her shortness of breath improved on these treatments, \nsuggesting that her SOB was a COPD flare. Her outpatient \ncardiologist was contacted and wished to defer further cardiac \nworkup (likely a nuclear stress test) to the outpatient setting. \nAt the time of discharge, she was feeling at her baseline; she \nwas discharged with follow up appointments with her \npulmonologist and cardiologist and to complete a steroid taper.\n.\n#Microcytosis: ___ TIBC, ferritin, and TRF were normal and \nHCT was normal. Smear is consistent with Thalassemia trait or \nsideroblastic anemia.  Thought likely to be  thalassemia trait, \nbut further workup may be required.\n.\n#HTN: Continued HCTZ. Her blood pressures remained within normal \nlimits. \n.\n#CK elevated: CK is chronically elevated in Ms. ___. Troponin \nwas negative this admission. CK elevation is common among \n___ americans and also seen in hypothyroidism. Ms. ___ \nTSH is normal, so likely this is a benign elevation.\n.\n#Elevated HbA1c: HBA1c was 6.3.  Fingersticks were not elevated \non prednisone. ___ will check fingersticks.\n. \n#FEN: Low Salt diet\n. \n#Prophylaxis: DVT prophylaxis was with subutaneous heparin. \nCalcium and Vitamin D were given for bone protection with \nsteroids. She was also given a bowel regimen and omeprazole.\n\nCode:  Full (discussed with patient)\n. \nCommunication: Emergency contact and HCP is daughter ___ ___\n \n___ on Admission:\nFurosemide 20 mg QD as needed for edema\nSupplemental oxygen ___ L\nHCTZ 12.5 mg QD\nProAir HFA ___ puffs Q4-6H as needed for sob or wheeze\nSpireva 18 mcg 1 puff/day\nSymbicort 160 mcg 1 puff BID\n\n \nDischarge Medications:\n1. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n2. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n3. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): \nTake two tablets on ___ and ___. Take one tablet on \n___, and ___ and then STOP. .\nDisp:*9 Tablet(s)* Refills:*0*\n4. Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device \nSig: One (1) puff Inhalation once a day.  \n5. ProAir HFA 90 mcg/Actuation HFA Aerosol Inhaler Sig: ___ \npuffs Inhalation every ___ hours as needed for shortness of \nbreath or wheezing.  \n6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for \nNebulization Sig: One (1) neb Inhalation Q6H (every 6 hours) as \nneeded for shortness of breath.  \n7. Azithromycin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every \n24 hours).\nDisp:*2 Tablet(s)* Refills:*0*\n8. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) \nTablet, Chewable PO TID (3 times a day).  \n9. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n10. Symbicort 160-4.5 mcg/Actuation HFA Aerosol Inhaler Sig: One \n(1) inh Inhalation twice a day.  \n11. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nOne (1)  Inhalation three times a day as needed for shortness of \nbreath or wheezing.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis:\nCOPD\n.\nSecondary diagnosis:\nDiastolic heart failure\nHypertension\nPulmonary hypertension\n\n \nDischarge Condition:\nstable, afebrile, on baseline oxygen support of 2LNC, including \nwith ambulation.\n\n \nDischarge Instructions:\nYou were admitted to the hospital because you had a flare of \nyour COPD. Your blood tests showed that you did not have a heart \nattack.  We treated you with steroids, albuterol, and \nipratropium, and an antibiotic called azithromycin, and your \nbreathing improved.\n\nWhile you were here we noticed that your red blood cells are \nsmall. This may require additional workup by your primary care \nphysician. \n\nWe also tested something called hemoglobin A1c, which is a \nmeasure of how high your blood sugars have been.  Yours was 6.3, \nwhich is slightly high, so you should follow up with your \nprimary care physician and be tested for Diabetes in the future.\n.\n\nPlease take all of your mediations as you were previously \ntaking, in addition, please make the following changes:\n* Please take azithromycin for 2 more days\n* Please take Prednisone for 6 more days.  For the next three \ndays (___) please take two tablets daily (40 \nmg).  For the next three days (___), please take \none tablet daily (20 mg).\n\nPlease contact your physician or return to the hospital if you \nhave worsening shortness of breath, chest pain, chest tightness, \npalpitations, or fever.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11153842","hadm_id":"25482120","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nvancomycin / oxybutynin / amoxicillin / Augmentin / Macrobid / \nCipro / Bactrim\n \nAttending: ___\n \nChief Complaint:\npain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ female with the past medical\nhistory of neurofibromatosis complicated by \nspinal astrocytoma and paraplegia, with chronic sacral ulcer, \ns/p ostomy, who presented with increasing pain and fevers at \nhome. She is well-known to ___ and has had multiple visits,\nalmost monthly with similar issues.  History is challenging, as\nthe patient is tangential with questions, but she states that \nshe\nhas pain in her coccyx, \"100/10,\" sharp, like someone is\n\"scooping\", possible radiation to back, no associated dysuria or\nchange in urine color or smell, but she does report fever to 103\nor 104 5 days prior to admission. She has no cough, sick\ncontacts, or diarrhea.  She also has new foot wound. She states\nthat she changes the dressings herself at home because she has\nissue with the ___ (unclear what this is exactly).  She also\nstates that, \"I've been non-stop crying\" but denies any acute\nanxiety. She also states, \"When I get to the hospital I get IV\nmorphine.\"  She has apparently not been compliant with her diet\nof high protein and calories at home.  \n\nVitals in the ER: 100.8  110  100/62  20  100% RA \n\nThere, the patient received: \n___ 02:30 PO OxyCODONE (Immediate Release) 10 mg \n___ 04:36 PO Zolpidem Tartrate 10 mg ___  \n___ 07:19 PO OxyCODONE (Immediate Release) 10 mg\n___ 09:18 PO Lorazepam 1 mg ___  \n___ 12:07 IV Morphine Sulfate 4 mg ___ \n\nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative. \n\n \nPast Medical History:\n-Neurofibromatosis Type II\n-Spinal cord astrocytomas s/p resection c/b paraplegia: \nwheelchair-bound but able to transfer, has sensation in all \nextremities, full use of arms\n-History of hip osteomyelitis of the hips \n-Resection of R proximal femur\n-Neurogenic Bladder requiring self-catheterization\n-Anxiety\n-Right gluteal decubitus ulcer/right ischial pressure ulcer s/p \nexicision of right ischial pressure ulcer and closure with re \nadvancement of local rotational flap\n-Hx of recurrent UTI - being treated only when symptomatic\n-Left common iliac vein DVT ___ , treated with six months of\nanticoagulation\n\nPSHx:\nIVC filter removal ___\nLaparoscopic colostomy ___\nClosure of ischeal pressure ulcer ___\n  1. Wide radical debridement of sacrum and ischium.\n  2. Femoral shortening.\n  3. Local muscle flap to the perineum.\n  4. Posterior thigh myocutaneous flap to sacral pressure\n    sore.\nL PICC placement ___\n# Resection of R proximal femur\n# spinal cord astrocytomas s/p resection c/b paraplegia: \nwheelchair-bound but able to transfer, has sensation in all \nextremities, full use of arms\n# right gluteal decubitus ulcer s/p local myocutaneous flap\ncoverage to right ischium   \n\n \nSocial History:\n___\nFamily History:\nMother with NF, died from brain tumor at ___.\n \nPhysical Exam:\nVITALS: ___ 1245 Temp: 98.6 PO BP: 113/77 HR: 97 RR: 18 O2\nsat: 100% O2 delivery: ra Dyspnea: 0 RASS: 0 Pain Score: ___\nGENERAL: Alert and intermittently tearful.  When discussing\ndressing changes, she begins crying.  Cachectic.  \nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular rate; normal perfusion, no appreciable JVD\nRESP: Symmetric breathing pattern with no stridor. Breathing is\nnon-labored\nGI: Abdomen soft, non-distended, no hepatosplenomegaly\nappreciated.  Colostomy is in place.  \nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, flaccid muscle tone with low bulk \nSKIN: left dorsum of foot has weeping ulcer of approximately 6cm\nin largest diameter without ous or foul odor.  Similar wound on\nright tibia.  Her sacral ulcer has granulated tissue, slightly\nweeping with no pus.  Did not attempt to probe to bone, but no\nbone was visible.  \nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nreported blindness in right eye.  Flacid paralysis. \nPSYCH: normal thought content, anxious, fair insight. \n\nDISCHARGE EXAM:\nAVSS\ncachectic\nMMM, poor dentition\nRRR\nCTAB\nsntnd, colostomy site pink\nwwp, trace ___ bilaterally\nsacral ulcer approx 8x8cm with granulation tissue without \npurulence, mild rim of surrounding erythema\nL dorsum of foot with minimal residual erythema\nA\u0026O grossly, face symmetric, reported blindness in R eye, \nparalysis in BLEs\nodd affect, pleasant\n \nPertinent Results:\nADMISSION RESULTS\n===========\n___ 08:50AM   GLUCOSE-101* UREA N-7 CREAT-0.3* SODIUM-134* \nPOTASSIUM-4.2 CHLORIDE-94* TOTAL CO2-26 ANION GAP-14\n___ 08:50AM   estGFR-Using this\n___ 08:50AM   CRP-75.4*\n___ 05:51AM   LACTATE-1.8\n___ 05:30AM   WBC-13.3* RBC-4.17 HGB-8.5* HCT-28.6* MCV-69* \nMCH-20.4* MCHC-29.7* RDW-17.9* RDWSD-42.7\n___ 05:30AM   NEUTS-53.5 ___ MONOS-8.4 EOS-0.4* \nBASOS-0.5 IM ___ AbsNeut-7.13* AbsLymp-4.88* AbsMono-1.11* \nAbsEos-0.05 AbsBaso-0.06\n___ 05:30AM   HYPOCHROM-NORMAL ANISOCYT-1+* \nPOIKILOCY-OCCASIONAL MACROCYT-OCCASIONAL MICROCYT-NORMAL \nPOLYCHROM-NORMAL SPHEROCYT-OCCASIONAL\n___ 05:30AM   PLT SMR-VERY HIGH* PLT COUNT-938*\n\nCXR:\nFINDINGS:  \n  \nThe cardiomediastinal silhouette is within normal limits.  No \npleural effusion \nor pneumothorax.  There is increased kyphosis of the thoracic \nspine.  The \nlungs are clear. \n  \nIMPRESSION:  \n  \nNo acute cardiopulmonary abnormality. \n  \nMRI PELVIS:\nIMPRESSION: \n1. Overall stable S2 vertebral body osteomyelitis, in the \nsetting of overlying decubitus ulcer.  Please note that MR \nfindings of marrow edema can lag behind clinical response to \nantibiotic treatment. \n2. Minimal if any change in extension to/involvement of the \npresacral space, overlying soft tissues, and right SI joint. \n3. Stable size of a 5-6 mm enhancing nodule in the left \nposterior spinal canal at the level of L3. \n4. Postsurgical changes from prior right myocutaneous flap \ncoverage and \nbilateral Girdlestone procedures. \n\n==========\nPERTINENT INTERVAL RESULTS\n\n___ 06:32AM BLOOD 25VitD-6*\n___ 08:50AM BLOOD CRP-75.4*\n___ 06:32AM BLOOD CRP-39.4*\n___ 06:53AM BLOOD CRP-54.3*\n___ 07:11AM BLOOD CRP-11.5*\n___ 10:41AM URINE Blood-SM* Nitrite-POS* Protein-100* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-LG*\n___:41AM URINE RBC-10* WBC-\u003e182* Bacteri-MANY* \nYeast-NONE Epi-1 TransE-\u003c1\n___ 10:41AM URINE Color-Straw Appear-Hazy* Sp ___\n\n___ 10:41 am URINE      Source: Catheter. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      ESCHERICHIA COLI.    \u003e100,000 CFU/mL. \n         Cefazolin interpretative criteria are based on a dosage \nregimen of\n         2g every 8h. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =\u003e32 R\nAMPICILLIN/SULBACTAM--    16 I\nCEFAZOLIN-------------   \u003c=4 S\nCEFEPIME--------------   \u003c=1 S\nCEFTAZIDIME-----------   \u003c=1 S\nCEFTRIAXONE-----------   \u003c=1 S\nCIPROFLOXACIN---------   0.5 S\nGENTAMICIN------------  =\u003e16 R\nMEROPENEM-------------\u003c=0.25 S\nNITROFURANTOIN--------  \u003c=16 S\nPIPERACILLIN/TAZO-----   \u003c=4 S\nTOBRAMYCIN------------     4 S\nTRIMETHOPRIM/SULFA----  =\u003e16 R\n\n==========\nDISCHARGE RESULTS\n\n___ 06:57AM BLOOD WBC-7.1 RBC-3.98 Hgb-8.0* Hct-28.5* \nMCV-72* MCH-20.1* MCHC-28.1* RDW-17.9* RDWSD-46.1 Plt ___\n___ 06:57AM BLOOD Glucose-83 UreaN-7 Creat-\u003c0.2* Na-142 \nK-4.9 Cl-102 HCO3-28 AnGap-12\n___ 10:15AM BLOOD ALT-7 AST-20 AlkPhos-67 TotBili-\u003c0.2\n___ 06:57AM BLOOD Calcium-7.8* Phos-4.8* Mg-1.8\n \nBrief Hospital Course:\nMs. ___ is a ___ year old woman with a PMHx of \nneurofibromatosis complicated by spinal astrocytoma and \nparaplegia, with chronic sacral/heel decubitus ulcer, s/p \nostomy, with history of osteomyelitis and complicated infections \nrequiring long courses of antibiotics who presented with \nincreasing subjective pain and fevers at home likely due \ncellulitis superimposed on chronic osteomyelitis of her sacrum\n\nSubjective acute on chronic ulcer pain and fever:\nChronic stage IV sacral/hell ulcers:\nChronic osteomyelitis\nThe patient was hospitalized to exclude acute infection given \nsubjective fever and elevated CRP.  ___ RN was concerned about \nher ulcer given interval increase in size and tunneling noted, \nthough no apparent clearly infected tissue requiring debridement \nwas seen.  In terms of other infections, she had no resp \nsymptoms and CXR was negative.  LFTs were neg.  Her Ucx grew E. \ncoli which has been a colonizer.  Her CRP remained elevated \ncompared to her most recent hospitalization.  MRI demonstrated \nlikely chronic osteomyelitis.  ID was consulted to help \ndetermine a treatment plan given her medical complexity and \nhistory of poor adherence to treatment and ability to follow \ntreatment plans in the outpatient setting. It was thought that \nbest plan was to treat for the soft tissue infection and have \naggressive wound care. She was recommended to start \nlinezolid/moxifloxacin for a 10d course but she refused \nlinezolid for unclear reasons. She was trialed in house on \nmoxifloxacin (given her history of lip itching with cipro) and \ntolerated well other than some mild nausea. Her CRP trended down \nprior to initiation of abx, suggesting appropriate wound care \nwas very helpful. She was advised repeatedly about the \nimportance of aggressive wound care as being a necessary part of \nany solution to her chronic infection, and was set up with a new \n___ for daily wound care dressings (as she had previously not \nallowed her previous wound care ___ company into her house at \ntimes reportedly). She was intermittently not very engaged in \nwound care management and at times refused appropriate wound \ncare and frequently refused to straight cath herself, leading to \nurinary incontinence. Note QTc was wnl while on moxifloxacin and \nondansetron prn. \n\nSevere protein calorie malnutrition: \nVitamin D Deficiency:\nShe was previously seen by nutrition and will continue on ensure \nsupplements. Added back MVI, thiamine, ascorbic acid, and zinc \nsupplementation that were previously recommended even though she \nrefused last time.  Added vitamin D ___ units weekly. She \nrefused many of these meds. \n\nIron deficiency anemia / anemia secondary to inflammation:\nEvaluation for anemia neg for hemolysis previously. Previous Fe \nstudies showed low ferritin and low iron. Added supplementation. \n No evidence of ongoing blood loss. She refused this. \n\nAnxiety:\nChronic issue contributing to her distress.  She is on Ativan at \nhome.  Psychiatry was last consulted in ___ out of concern for \nself-care apparently, but she refused to speak with them.  We \nasked her to speak with this team but she is again refusing. We \nexplained that she does not have to take any medications she \ndoes not want to but just would need to have a conversation.  \nShe refused again. Lorazepam was continued at home dose.\n\nInsomnia: continued home zolpidem.\n\nThrombocytosis. Long term, likely due to chronic inflammation.\n\nPlease note that she declined most medications despite our \nstrong recommendations to continue these treatments, including \nheparin ppx.\n\n\u003e30 minutes spent on patient care and coordination on day of \ndischarge. \n\nTRANSITIONAL ISSUES:\n- please continue to ensure pt is adherent with wound care and \nnutrition recommendations\n- monitor erythema around sacrum on antibiotics\n- after abx complete and if patient is able to adhere to \nrecommendations around wound care and nutrition, can consider \noutpatient plastics follow up with Dr ___ by calling \n___ at that time can consider multidisciplinary \ndiscussions regarding  possibility of surgical intervention for \nosteomyelitis\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. LORazepam 1 mg PO BID:PRN anxiety \n2. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate \n\n3. Zolpidem Tartrate 10 mg PO QHS \n4. Docusate Sodium 100 mg PO BID:PRN constipation \n5. Ibuprofen 400 mg PO Q8H:PRN Headache \n\n \nDischarge Medications:\n1.  Ascorbic Acid ___ mg PO DAILY \nRX *ascorbic acid (vitamin C) 1,000 mg 1 tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0 \n2.  Ferrous Sulfate 325 mg PO DAILY \nRX *ferrous sulfate [Feosol] 325 mg (65 mg iron) 1 tablet(s) by \nmouth daily Disp #*30 Tablet Refills:*0 \n3.  Moxifloxacin 400 mg oral DAILY \nRX *moxifloxacin 400 mg 1 tablet(s) by mouth daily Disp #*9 \nTablet Refills:*0 \n4.  Multivitamins W/minerals 1 TAB PO DAILY \nRX *multivitamin,tx-minerals [Vitamins and Minerals]  1 \ntablet(s) by mouth daily Disp #*30 Tablet Refills:*0 \n5.  Ondansetron ODT 4 mg PO Q8H:PRN nausea \nRX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*30 Tablet Refills:*0 \n6.  Thiamine 100 mg PO DAILY \nRX *thiamine HCl (vitamin B1) [Vitamin B-1] 100 mg 1 tablet(s) \nby mouth daily Disp #*30 Tablet Refills:*0 \n7.  Vitamin A ___ UNIT PO DAILY Duration: 10 Days \nRX *vitamin A 10,000 unit 1 capsule(s) by mouth daily Disp #*8 \nCapsule Refills:*0 \n8.  Vitamin D ___ UNIT PO 1X/WEEK (WE) Duration: 8 Weeks \nRX *ergocalciferol (vitamin D2) [Vitamin D2] 50,000 unit 1 \ncapsule(s) by mouth weekly Disp #*8 Capsule Refills:*0 \n9.  Zinc Sulfate 220 mg PO DAILY \nRX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth daily \nDisp #*1 Capsule Refills:*0 \n10.  Docusate Sodium 100 mg PO BID:PRN constipation  \n11.  Ibuprofen 400 mg PO Q8H:PRN Headache  \n12.  LORazepam 1 mg PO BID:PRN anxiety  \n13.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - \nModerate  \n14.  Zolpidem Tartrate 10 mg PO QHS  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nCellulitis\nOsteomyelitis\nAcute on chronic pain\nStage IV sacral ulcer\nParaplegia\nNeurogenic bladder\nAnxiety\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nYou were admitted with reported fever with increased pain at \nyour ulcers.  You underwent a large work up to determine the \ncause.  Most likely you have a chronic infection in the sacral \nbone next to your chronic ulcer as well as some infection in the \nskin around the area. \nFor this, we gave you antibiotics. While we would have ideally \nwanted to give you two antibiotics (linezolid and moxifloxacin), \nyou preferred to take just one, so we are sending you out on \nthis. \nIt is very important that you do your wound care as best as \npossible, as that is the best way to give your infection a \nchance to heal. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15693523","hadm_id":"21880184","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \ngemcitabine\n \nAttending: ___.\n \nChief Complaint:\n anemia and thrombocytopenia, concern for HUS\n\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n Feels fatigue, Denies shortness of breath at rest.   Denies \nsignificant nausea, vomiting or diarrhea. Denies constipation, \nneurologicla symptoms, eating undercooked ___.   He denies any \nchest discomfort.  Denies abnormal bleeding. His labs work was \nworrisome for Gemzar induced HUS, which was held and directly \nadmitted from clinic. \nvitals at ___ \n  BP: 96/69 mmHg \n  Pulse: 95 \n  Temp: 98 F (36.7 C) \n  Temp src: Oral \n  SpO2: 95 % \n  Weight: 179 lb (81.194 kg) \n  Pain Score: Zero \n\nOn arrival to the floor, patient is stable and doing well. HD \nstable with no complaints. \n\n \nPast Medical History:\nNon-Hodgkin's lymphoma (care via Atrius Oncology, diagnosed in \n___, quiescent)  \nLung cancer (care via Atrius Oncology, diagnosed in ___, \nquiescent)  \nVentricular tachycardia s/p pacemaker/defibrillator placement  \nAnemia  \nNeuropathy  \nTobacco use  \nChronic pain  \nDepression \n \nSocial History:\n___\nFamily History:\nBrother with prostate cancer, sisters with thyroid and parotid \ngland cancer. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM: \nVS: 98.4 100/62 110 18 97% RA 177.9 lbs. \nGENERAL: NAD  \nHEENT: NC/AT, EOMI, PERRL, MMM\nCARDIAC: RRR, nl S1 and S2, no murmurs\nLUNG: CTAB no w/r/rh, Right port in place. \nABD: +BS, soft, NT/ND, no r/g \nEXT: No lower extermity pitting edema   \nPULSES: 2+DP pulses bilaterally\nNEURO: CN II-XII intact. \nSKIN: Warm and dry\n\nDischarge:\nVS: 98.4 94/62 85 20 94% RA. \nGENERAL: NAD  \nHEENT: NC/AT, EOMI, PERRL, MMM\nCARDIAC: RRR, nl S1 and S2, no murmurs\nLUNG: CTAB no w/r/rh, Right port in place. \nABD: +BS, soft, NT/ND, no r/g \nEXT: No lower extermity pitting edema   \nPULSES: 2+DP pulses bilaterally\nNEURO: CN II-XII intact. \nSKIN: Warm and dry\n\n \nPertinent Results:\nAdmission:\n\n___ 08:51PM URINE  HOURS-RANDOM UREA N-796 CREAT-110 \nSODIUM-40 POTASSIUM-64 CHLORIDE-38\n___ 08:51PM URINE  OSMOLAL-520\n___ 08:51PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 08:51PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \nLEUK-NEG\n___ 06:15PM   GLUCOSE-112* UREA N-40* CREAT-1.8*# \nSODIUM-138 POTASSIUM-4.0 CHLORIDE-101 TOTAL CO2-27 ANION GAP-14\n___ 06:15PM   estGFR-Using this\n___ 06:15PM   ALT(SGPT)-19 AST(SGOT)-27 LD(LDH)-215 ALK \nPHOS-72 TOT BILI-0.2\n___ 06:15PM   CALCIUM-8.9 PHOSPHATE-4.4 MAGNESIUM-2.4\n___ 06:15PM   D-DIMER-1656*\n___ 06:15PM   ___ PTT-28.4 ___\n___ 06:15PM   RET AUT-4.3*\n___ 06:15PM   RET AUT-4.3*\n\nDischarge:\n\n___ 12:06PM BLOOD WBC-2.9* RBC-2.69* Hgb-8.6* Hct-24.9* \nMCV-93 MCH-31.8 MCHC-34.4 RDW-20.6* Plt Ct-31*\n___ 12:06PM BLOOD Plt Ct-31*\n___ 12:53AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ \nMacrocy-1+ Microcy-1+ Polychr-1+ Ovalocy-1+ Schisto-OCCASIONAL \nStipple-OCCASIONAL Tear Dr-OCCASIONAL\n___ 07:00AM BLOOD ___ 12:06PM BLOOD Glucose-114* UreaN-27* Creat-1.4* Na-141 \nK-4.0 Cl-106 HCO3-24 AnGap-15\n___ 07:00AM BLOOD ALT-18 AST-25 LD(LDH)-223 AlkPhos-63 \nTotBili-1.0\n___ 07:00AM BLOOD D-Dimer-___*\n \nBrief Hospital Course:\nAssessment/Plan: ___ yrs. heavy smoker with h/o T cell anaplastic \nlarge cell lymphoma s/p autologous stem cell transplant in ___, \nh/o stage Ia left lung adenocarcinoma with squamous \ndifferentiation s/p wedge resection in ___, and h/o asystolic \ncardiac arrest s/p a defibrillator placement.  PET at ___ on \n___ showed a large FDG avid lesion in the upper left lung \nand FDG avid lesions in the right fifth and tenth ribs \nconsistent with bony metastases with subsequent transbronch \nbiopsy showed squamous cell carcinoma.\n\n- ___ - Baseline appears to be 1.5 with an acute rise to 2.0, \nnow back down to 1.6 with blood and fluids. Urine lytes were \nsuggestive of pre-renal. Differential includes HUS/TTP, pre \nrenal azotemia, and chemo-induced ___. \n\n1. Thrombocytopenia/worsening anemia - Appears to be stable and \nimproving today without intervention, thus likely Gemzar \ninduced, immune type low grade hemolysis as haptoglobin is low \nand LDH is high normal. Will held Gemzar and added to his list \nof meds to avoid.  \n \n- He was Typed and Screened and give a total of 2 units of pRBC. \n\n\n2. Lung cancer \nCounts improved off of gemzar and this medication should not be \nused as a future treatment. \n\n3. Decreased appetite\n Marinol was not approved by his insurance. Will start as \ninpatient. Pt was not here long enough to assess efficacy.  \n\n4. Depression - Continued home Citalopram\n\n5. Anxiety - Continued home Clonazepam \n\n6. Nausea - Continued home Prochlorperazine 10 mg PO Q6H:PRN and \nZofran 8 mg PO q8H\n\n7. Pain - Continude home Morphine SR (MS ___ 60 mg PO Q12H \nMorphine SR (MS ___ 30 mg PO Q6H, and 10 mg Oxycodone q6H \nfor breakthrough. \n\n8. Fatigue - Continued home Provigil BID.  \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lorazepam 1 mg PO QHS:PRN insomnia \n2. Morphine SR (MS ___ 60 mg PO Q12H \n3. Morphine SR (MS ___ 30 mg PO Q6H \n4. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN pain \n5. ClonazePAM 0.5 mg PO BID:PRN anxiety \n6. Dronabinol 2.5 mg PO BID \n7. Albuterol Inhaler 2 PUFF IH Q6H:PRN cough or wheeze \n8. Prochlorperazine 10 mg PO Q6H:PRN nausea \n9. Ondansetron 8 mg PO Q8H:PRN nausea \n10. Provigil (modafinil) 200 mg oral BID \n11. Citalopram 40 mg PO DAILY \n12. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheeze \n13. Atorvastatin 20 mg PO QPM \n14. Cyanocobalamin 1000 mcg PO DAILY \n\n \nDischarge Medications:\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheeze \n2. Albuterol Inhaler 2 PUFF IH Q6H:PRN cough or wheeze \n3. Atorvastatin 20 mg PO QPM \n4. Citalopram 40 mg PO DAILY \n5. ClonazePAM 0.5 mg PO BID:PRN anxiety \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Dronabinol 2.5 mg PO BID \n8. Lorazepam 1 mg PO QHS:PRN insomnia \n9. Morphine SR (MS ___ 60 mg PO Q12H \n10. Morphine SR (MS ___ 30 mg PO Q6H \n11. Ondansetron 8 mg PO Q8H:PRN nausea \n12. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN pain \n13. Prochlorperazine 10 mg PO Q6H:PRN nausea \n14. Provigil (modafinil) 200 mg oral BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY\n1. Hemolytic Uremic Syndrome\n2. Adverse reaction to medication: Gemcitabine\n\nSECONDARY\n1. Metastatic Squamous Cell Cancer of the Lung\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure to take care of you during your recent \nadmission at ___. You were \nadmitted due to worsening red blood cell and platelet counts as \nwell as worsening renal function. We believe this is due to an \nadverse reaction to the gemcitabine infusion you had (Gemzar) \ncalled Hemolytic Uremic Syndrome. Unfortunately you will not be \nable to have any more of that drug. You received a transfusion \nof red blood cells, your platelet counts are stable and you \nkidney function is improving. \nYou should be able to do well at home with close follow-up by \nyour oncologist. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"17429237","hadm_id":"20191225","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\nelevated INR\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMs ___ is a ___ year-old female with a history of Afib with a \npacemaker in place and s/p mechanical AVR and MVR on warfarin \nreferred here by her PCP for an INR of 7.9. Her dose of warfarin \nwas increased from 6 to 7 mg daily on ___ (INR last ___ \nwas 1.8). She denies any bleeding, BRBPR, melena. Denies CP, \nSOB, fevers, chills, dysuria. Has had lower right back pain \nsince yesterday. She is a very poor historian with significant \ndementia.  \n.  \nIn the ED, inital VS were T 98.4 HR 68 BP 125/48 RR 18 Sat 96%. \nLabs were significant for ARF with a Cr of 2.2 (from 1.4), INR \nof 9.4. No CVA tenderness. UA was positive with \u003e50 WBC and ___ \nWBC on repeat. No medications were given. She was admitted to \nMedicine for further management.  \n.  \nReview of Systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denies chest pain or tightness, palpitations. Denies \ncough, shortness of breath, or wheezes. Denied nausea, vomiting, \ndiarrhea, constipation or abdominal pain. No recent change in \nbowel or bladder habits. No dysuria. Denies arthralgias or \nmyalgias. Denies rashes or skin breakdown. No numbness/tingling \nin extremities. No feelings of depression or anxiety. All other \nreview of systems negative.\n \nPast Medical History:\n- Mechanical MVR, AVR, and tricuspid repair with ___ ring \nin ___  \n- Rheumatic heart disease  \n- Chronic atrial fibrillation  \n- Pacemaker in place  \n- Hypertension.  \n- Recurrent urinary tract infections\n \nSocial History:\n___\nFamily History:\n- Multiple relatives with rheumatic heart disease\n \nPhysical Exam:\nVS: 96.7 117/53 61 16 95% on RA  \nGEN: Elderly, cachectic  \nHEENT: MMM, no OP lesions, JVP 10 cm, no LAD  \nCV: Irregular, IV/VI SEM with loud S1  \nPULM: CTAB  \nABD: BS+, soft NTND, no masses or HSM, + gas on percussion  \nLIMBS: No ___ edema, +arthritic changes  \nSKIN: No petechiae or bruises, chronic ___ venous stasis  \nNEURO: A and O x 1 to self only, reflexes diffusely 2+  \n \nPertinent Results:\nLABS ON ADMISSION:\n___ 07:40PM BLOOD WBC-11.4* RBC-4.31 Hgb-12.9 Hct-39.7 \nMCV-92 MCH-29.9 MCHC-32.6 RDW-15.4 Plt ___\n___ 07:40PM BLOOD Neuts-78.2* Lymphs-15.2* Monos-5.2 \nEos-0.9 Baso-0.5\n___ 01:30PM BLOOD ___\n___ 07:40PM BLOOD Glucose-91 UreaN-77* Creat-2.2* Na-140 \nK-4.5 Cl-96 HCO3-34* AnGap-15\n___ 06:35AM BLOOD Albumin-3.6 Calcium-9.0 Phos-3.7 Mg-2.6\n.\nLABS ON DISCHARGE:\n___ 04:20AM BLOOD WBC-7.8 RBC-3.72* Hgb-11.2* Hct-33.5* \nMCV-90 MCH-30.1 MCHC-33.5 RDW-15.0 Plt ___\n___ 04:20AM BLOOD Plt ___\n___ 04:20AM BLOOD ___ PTT-34.3 ___\n___ 04:20AM BLOOD Glucose-87 UreaN-67* Creat-1.5* Na-140 \nK-4.1 Cl-103 HCO3-30 AnGap-11\n___ 04:20AM BLOOD Calcium-8.6 Phos-3.5 Mg-2.3\n.\nCXR PA and lateral:\nIMPRESSION:  \n1. Compression fracture of one of the upper thoracic spine \nvertebral bodies is new since ___. \n2. Emphysema. \n3. Severe enlargement of the cardiac silhouette appears somewhat \nglobular; however, unchanged since ___.  \n \nBrief Hospital Course:\n___ y/o female with a history of Afib as well as a mechanical MVR \nand AVR presents with a supratherapeutic INR without evidence of \nbleeding and ARF, also noted to have Ecoli UTI.  \n.  \n# Coagulopathy: supratherapeutic INR without bleeding, likely \nfrom newly increased coumadin dose from 6 mg daily to 7 mg \ndaily. INR on admission \u003e 9. Goal INR 2.5-3.5 due to MVR. \nPatient received 1 mg vitamin K PO and allowed INR to drift down \nto 3.0; she received 4 mg PO on this date and was discharged on \n6 mg coumadin daily. She will have INR check on ___ with results to be faxed to PCP. She will need coumadin \nadjusted accordingly.\n.  \n# Bacturia/Ecoli UTI: Pt had WBC in urine with positive \nleukocyte esterase. Pt denied dysuria, but in setting of ARF, \nshe was initially treated with IV ceftriaxone. Once \nsensitivities returned, she was transitioned to macrobid BID x 7 \ndays.\n.\n# ARF: Cr on presentation 2.2 with most recent baseline of 1.4 \n(on ___. She was given IVF hydration and treated for UTI. \nCr on discharge was 1.5. She will have repeat renal function \nlabs drawn with her INR on ___, with results faxed to \nPCP. She was informed to hold her ACEi until seen by PCP.\n.\n# AVR / MVR / Afib: paced rhythm. Goal INR 2.5 to 3.5; coumadin \nwas restarted once INR was 3.0 and she was discharged with 6 mg \ncoumadin daily. As above, her INR will be checked ___, \nwith results to be faxed to PCP.\n.  \n# HTN: ACEi was held in setting of ARF. Home HCTZ and lasix were \ncontinued in house, and were continued on discharge.  \n.  \n# CHF: Not clinically in failure. Continued digoxin 125mcg PO \ndaily, lasix 40mg PO daily, HCTZ per home regimen.  \n.\n# Dispo: discharge to home, PCP ___, INR and renal \nfunction labs to be drawn tomorrow\n \nMedications on Admission:\n- Digoxin 125mcg PO daily  \n- HCTZ 25mg PO daily  \n- Moexipril 15mg PO daily  \n- Warvarin 7mg PO daily - recently adjusted  \n- Furosimide 40mg PO daily\n \nDischarge Medications:\n1. Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n2. Coumadin 6 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n3. Outpatient Lab Work\nPlease have ___ and Chemistry 7 blood work drawn on ___, \n___ and have results faxed to Dr. ___, \nprimary care\n4. Macrobid ___ mg Capsule Sig: One (1) Capsule PO twice a day \nfor 7 days.\nDisp:*14 Capsule(s)* Refills:*0*\n5. Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once \na day.  \n6. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\n1. supratherapeutic INR\n2. acute renal failure\n3. Ecoli UTI\n.\nSECONDARY:\n1. mechanical mitral valve replacement\n2. chronic atrial fibrillation\n3. status post pacemaker\n4. recurrent urinary tract infections\n5. hypertension\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital for elevated INR, acute kidney \ninjury, and urinary tract infection. Your coumadin was initially \nheld, until your INR was in the normal range (goal INR 2.5-3.5) \nand then resumed at 6 mg daily on discharge. Please have your \nINR blood work checked on ___. Your kidney \nfunction was improving on discharge with intravenous fluids and \nantibiotics. Please ensure you stay well hydrated. Please take \nyour new antibiotic, as prescribed below, for the urinary tract \ninfection.\n.\nMEDICATION CHANGES/NEW MEDICATIONS:\n- START macrobid ___ mg twice a day for 7 days\n- CHANGE coumadin to 6 mg daily for now. Please have INR blood \ntest on ___ with results sent to your primary \ncare doctor, ___. He will adjust your coumadin \naccordingly.\n- HOLD moexipril until discussed with your primary care doctor, \nas this medication can affect the kidney function.\n.\nPlease seek medical attention for decreased urine output, \nfevers, chills, chest pain, shortness of breath, abdominal pain, \nor any other concerning symptoms.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10446872","hadm_id":"22625794","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / adhesive tape / tramadol\n \nAttending: ___.\n \nChief Complaint:\nCough\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with diffuse myopathy who was brought in by ambulance from \nPCP office due to concern for pneumonia.  \nStarting ___, patient has developed productive cough, sore \nthroat, wheezing and fevers up to 100.8. She was given one dose \nof 500mg azithromycin yesterday prior to being seen by her PCP \n___. Upon evaluation, she was found to be hypoxic to 91% on RA \nand CXR showed multilobar pneumonia. Because of her history of \nrespiratory issues, she was sent in to the ED for further \nevaluation and management.  \nShe endorses cough productive of green sputum and dyspnea. She \nhas weakness in her hands, legs and lungs from her myopathy, but \nthis is not worse than baseline. No sick contacts, no recent \ntravel. No chest pain or abdominal pain.  \nIn the ED, initial vitals were: 98.9 76 148/72 20 98% 2L NC  \n- Labs were significant for WBC 16.1 with 91% PMNs, sodium 128, \nHCO3 21, anion gap 13 and lactate 1.7.  \n- Imaging revealed multilobar infiltates (review this)  \n- The patient was given 750mg IV levofloxacin in the ED.  \nVitals prior to transfer were: HR 80, BP 145/86, RR 20, SpO2 96% \nNC.  \nUpon arrival to the floor, the patient complained of a cough. \nShe denies history of difficulty with swallowing foods or \nliquids.  \n \nPast Medical History:\nUrinary incontinence  \nInclusion Body Myositis\nOsteoporosis\nHYPOGAMMAGLOBULIMEMIA, UNSPEC  \nFRACTURE - THORACIC COMPRESSION  \nMYOPATHY, OTHER  \nHYPERCHOLESTEROLEMIA  \nOSTEOARTHRITIS, R CMC joint - HAND  \nSPINAL STENOSIS - LUMBAR L2-3  \nHISTORY BASAL CELL CARCINOMA-nose and ant chest  \nGLAUCOMA SUSPECT, UNSPEC  \nHISTORY TOBACCO USE  \nHYPERTENSION - ESSENTIAL  \n\n \nSocial History:\n___\nFamily History:\nParents- strokes\nSister- unknown heart problem\nBrother- glaucoma\n  \n \nPhysical ___:\nADMISSION PHYSICAL EXAM\n=======================\nVitals: T99.5, BP ___, HR 92, RR 20, SpO2 99%2L NC  \n\nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: exam limited by patient coughing; mild wheezing and \ndulness to percussion in the right hemithorax approximately \nhalfway up; no cracklesAbdomen: Soft, non-tender, non-distended, \nbowel sounds present, no organomegaly, no rebound or guarding  \nGU: No foley  \nExt: Warm, well perfused, no clubbing, cyanosis or edema  \nNeuro: CNII-XII intact, ___ hand grip in left hand and ___ in \nleft hip flexor, otherwise ___ throughout  \n\nDISCHARGE PHYSICAL EXAM\n=======================\nVitals:  99.2 76 148/75 18 93% (RA)\nGeneral: alert, oriented, no acute distress, coughing \noccasionally\nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: audible wheeze with cough, diffuse mild wheezing and \ncrackles on the right. Few crackles and mild wheezing on left. \nDullness to percussion in the right hemithorax approximately \nhalfway up; Abdomen: Soft, non-tender, non-distended, bowel \nsounds present, no organomegaly, no rebound or guarding  \nGU: No foley  \nExt: Warm, well perfused, no clubbing, cyanosis or edema  \nNeuro: CNII-XII intact, ___ hand grip in left hand and ___ in \nleft hip flexor, otherwise ___ throughout  \n \nPertinent Results:\nADMISSION LABS\n=================\n___ 04:25PM BLOOD WBC-16.1*# RBC-4.71 Hgb-13.7 Hct-41.0 \nMCV-87 MCH-29.1 MCHC-33.4 RDW-14.0 RDWSD-45.2 Plt ___\n___ 04:25PM BLOOD Glucose-191* UreaN-17 Creat-0.5 Na-128* \nK-4.2 Cl-94* HCO3-21* AnGap-17\n___ 07:26AM BLOOD Albumin-2.8* Calcium-8.7 Phos-2.8 Mg-1.3*\n___ 04:48PM BLOOD Lactate-1.7\n\nDISCHARGE LABS\n=================\n___ 08:05AM BLOOD WBC-8.0 RBC-4.45 Hgb-13.2 Hct-38.9 MCV-87 \nMCH-29.7 MCHC-33.9 RDW-13.9 RDWSD-44.4 Plt ___\n___ 08:05AM BLOOD Glucose-107* UreaN-12 Creat-0.4 Na-132* \nK-4.4 Cl-95* HCO3-25 AnGap-16\n___ 08:05AM BLOOD Calcium-9.5 Phos-3.7 Mg-1.5*\n\nIMAGING\n=================\nNo imaging at ___\n\nAtrius CXR ___  \nMultifocal infiltrates right lung as above. An additional lower \nthoracic compression fracture.  \n\n \nBrief Hospital Course:\n___ with history of inclusion body myositis and recurrent UTIs \npresented to PCP with fever and productive cough x 5 days found \nto be hypoxic on room air with multifocal infiltrates in right \nlung. \n\n# COMMUNITY ACQUIRED PNEUMONIA: Presented with cough to PCP who \nfound her with sat of 91%. No CP or EKG changes to suggest \ncardiac etiology. Felt most likely to be PNA and as she has no \nrecent hospitalizations and lives at home it was likely \ncommunity-acquired PNA as evidenced by leukocytosis, hypoxia, \nproductive cough and infiltrates on CXR. She had gotten one dose \nof azithromycin as an outpatient but was broadened to \nlevofloxacin 750mg for 5 day course to end ___. Her sputum grew \nout gram positive cocci in pairs/respiratory flora. She was \nweaned off of oxygen on hospital day 2, she never needed more \nthan 2L via NC. Her WBC downtrended during her stay and she was \ndischarged home with antibiotics as above, benzonatate, and \nguaifenesin. \n\n# HYPONATREMIA: Presented with a Na of 128. Urine osms returned \n363 and likely indicates an amount of SIADH given a history of \nthe same in the past and now with pneumonia. Also likely to have \na low solute component ___ to poor PO intake since kyphoplasty \n(10-lb wt loss over 4 months). No evidence of hypervolemia on \nexam. Her diet was adjusted to a 2L fluid restriction after \ninitially receiving a 1L bolus for resuscitation. Her Na \nincreased to 131 and her ___ (who works in ___ said that \nthis is normal for her so no further repletion was sought.\n\n# FALL: Suffered a fall in the setting of raising arms for \nlateral CXR at PCP's office. She states she is unstable on her \nfeet ___ inclusion body myositis. No new back pain or \ntenderness. T11 Fracture that is seen on CXR and commented as \nnew is actually old and mentioned on old MRI. Physical therapy \nsaw and recommended home ___. \n\n# INCLUSION BODY MYOSITIS: Patient on no specific treatment for \nthis. Followed by ___ Neurologist, Dr. ___/ Has \nweakness in hands, pulmonary muscles and legs per report. PFTs \ndone in ___ suggested moderate restrictive defect felt to be \nconsistent with muscle weakness. Discussed with patient that \nthis puts her at risk for decompensation from a respiratory \nstandpoint due to current pneumonia. **She would accept \nintubation for a reversible and temporary cause.**\n\n# RECURRENT UTIs: patient with history of recurrent UTIs on \nkeflex prophylaxis. Also performes intermittent striaght \ncatheterization due to neurogenic bladder. Keflex held since she \nis on levofloxacin. Per PCP, ordered UA and urine cx which were \nnegative. Discharged to restart Keflex after Levofloxacin. \n\nCHRONIC ISSUES: \n# HTN: continued atenolol, lasix, clonidine. \n# HLD: not on therapy. \n#compression fxs-old, continue calcium and vit D\n\nTRANSITIONAL ISSUES:\n====================\n- F/u with PCP within next 2wks\n- 5d Levofloxacin to end ___\n- discuss bisphosphate therapy with primary care physician\n\nCODE STATUS: DNR/Ok to intubate \nCONTACT: ___ and HCP  \nPhone number: ___  \nCell phone: ___  \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Cyproheptadine 4 mg PO Q8H:PRN Nausea \n2. Furosemide 20 mg PO DAILY Leg swelling \n3. Metoclopramide 10 mg PO QIDACHS \n4. TraZODone 25 mg PO QHS:PRN Insomnia \n5. NexIUM (esomeprazole magnesium) 40 mg oral BID \n6. Cephalexin 250 mg PO QHS \n7. CloniDINE 0.1 mg PO BID \n8. Sertraline 25 mg PO DAILY \n9. imiquimod 5 % topical Unknown \n10. Polyethylene Glycol 17 g PO DAILY:PRN Constipation \n11. Senna 8.6 mg PO BID:PRN Constipation \n12. Atenolol 25 mg PO BID \n13. Lactobacillus rhamnosus GG 1 capsule oral DAILY \n14. cranberry extract ___  oral DAILY \n15. Albuterol Inhaler 2 PUFF IH Q6H:PRN shorntess of breath \n16. Lactulose 15 mL PO BID \n17. Ascorbic Acid ___ mg PO DAILY \n18. Vitamin D 800 UNIT PO DAILY \n\n \nDischarge Medications:\n1. Cephalexin 250 mg PO QHS \n2. cranberry extract ___  oral DAILY \n3. Furosemide 20 mg PO DAILY Leg swelling \n4. imiquimod 5 % topical Unknown \n5. Lactobacillus rhamnosus GG 1 capsule oral DAILY \n6. NexIUM (esomeprazole magnesium) 40 mg oral BID \n7. Calcium Carbonate 1000 mg PO DAILY \nRX *calcium carbonate 500 mg calcium (1,250 mg) 1 tablet(s) by \nmouth daily Disp #*30 Tablet Refills:*0\n8. Benzonatate 100 mg PO TID \nRX *benzonatate 100 mg 1 capsule(s) by mouth three times a day \nDisp #*30 Capsule Refills:*0\n9. Guaifenesin ER 1200 mg PO Q12H \nRX *guaifenesin 600 mg 1 tablet(s) by mouth every twelve (12) \nhours Disp #*20 Tablet Refills:*0\n10. Levofloxacin 750 mg PO DAILY Duration: 4 Days \n11. Vitamin D 800 UNIT PO DAILY \n12. Atenolol 25 mg PO BID \n13. CloniDINE 0.1 mg PO BID \n14. Cyproheptadine 4 mg PO Q8H:PRN Nausea \n15. Metoclopramide 10 mg PO QIDACHS \n16. Polyethylene Glycol 17 g PO DAILY:PRN Constipation \n17. Senna 8.6 mg PO BID:PRN Constipation \n18. Sertraline 25 mg PO DAILY \n19. TraZODone 25 mg PO QHS:PRN Insomnia \n20. Lactulose 15 mL PO BID \n21. Ascorbic Acid ___ mg PO DAILY \n22. Albuterol Inhaler 2 PUFF IH Q6H:PRN shorntess of breath \n23. Space Chamber Plus (inhalational spacing device) use with \ninhaler  miscellaneous with inhaler \nRX *inhalational spacing device [ProChamber]   with inhalers \nDisp #*1 Each Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\n==================\n- Pneumonia\n\nSECONDARY DIAGNOSES:\n====================\n- Hyponatremia\n- Inclusion body myositis\n- Recurrent urinary tract infections\n- Hypertension\n- Hyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure caring for you at ___. You were admitted for \nyour pneumonia and out of concern for your breathing. We treated \nyou with a strong antibiotic called levofloxacin and your blood \ntests showed that your infection seemed to be getting better. \nYour breathing was still strained so we gave you an albuterol \nnebulizer to use. You were discharged with 1 day left of your \nantibiotics which will finish on ___.\n\nBest of luck with your recovery,\nYour ___ medicine team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11362794","hadm_id":"29152597","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\naltered mental status \n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMr. ___ is a ___ year old gentleman with a history of EtOH \nabuse, cervical DJD, and multiple psych issues admitted for EtOH \nintoxication and fall.He was s/p elective Anterior/posterior \ndecompression and fusion C3-7 for chronic neck pain and arm pain \non ___ referred to surgery after failed conservative therapy. \nThe patient reportedly had a witnessed fall on the street and \nEMS was called. A bottle of benzodiazepines were reportedly \nfound on scene by EMS. The patient was reportedly seen earlier \nin the day at ___ for overdose of unknown substance, however his \ntox screen at BID was positive for cocaine. He does not remember \nwhen he last took cocaine. He thinks that his last drink was ___ \npint liquor the day after his surgery. It is unclear if he \nexperienced LOC as he is a poor historian. His last admission \nfor EtOH intoxication was in ___ and required admission to \nthe FICU, however following his neck surgery he was noted to be \nconfused, thought to be withdrawing from alcohol and placed on \nCIWA. He was also seen taking his home at___ and required 1:1 \nsitter with d/c inhouse narcotics.  \n.  \nIn the ___ ED, VS 97 104 122/80 20 97%RA. The patient received \ndiazepam 15mg,ativa 2mg, haldol total 15mg, folate, thiamine. CT \nSpine/head showed no acute fracture or intracranial abnormality. \nOrtho spine was consulted and said prevertebral edema on CT \nlikely represents postoperative changes but given new fall \nhistory, will need to continue c-collar for now. Transferred to \nthe MICU given altered mental status, anticipated difficult \nintubation if it were needed.  \n.  \nIn ICU pt placed on CIWA scale requiring valium x 3 for \nagitation. Also noted to be tachycardic ___ hypovolemia/pain. \nReceived IVF with mild improvement tachycardia.  \n.  \nOn arrival to floor pt endorsing mild neck pain and mild sore \nthroat.  \n.  \n\n \nPast Medical History:\nSubstance Abuse\nEtOH abuse - no history of withdrawl seizures or DTs.  \nCervical DJD\ns/p Spinal fusion C3-C7 ___   \nBipolar disorder  \nPTSD  \n\n \nSocial History:\n___\nFamily History:\n___\n \nPhysical Exam:\nExam on admission:\n\nGeneral: agitated appearing man, no acute distress\nHEENT: Perrl, sclerae anicteric, MMM, OP clear without lesions, \nexudate or erythema. Cervical collar in place.  \nCV: Nl S1+S2  \nPulm: CTAB  \nAbd: S/NT/ND +bs  \nExt: No C/c/e  \nNeuro: disoriented, unable to answer questions or follow \ncommands\n.\nExam on d/c\nVS:Tc: 98.1 HR: 95 BP: 130/90 RR:20 96% RA  \nGeneral: mild gurgling on vocalization.  \nHEENT: Perrl, Sclerae anicteric, MMM, OP clear without lesions, \nexudate or erythema. Cervical collar in place.  \n4 follicular lesions in background of erythema at nape of neck \nat edge of cervical collar,non tender, non pruritic  \nCV: Nl S1+S2  \nPulm: CTAB  \nAbd: S/NT/ND +bs  \nExt: No C/c/e  \nNeuro: AOX3, able to follow commands. \n\n  \n \nPertinent Results:\nADMISSION LABS:\n___ 03:00AM   GLUCOSE-93 UREA N-10 CREAT-0.6 SODIUM-139 \nPOTASSIUM-4.2 CHLORIDE-101 TOTAL CO2-27 ANION GAP-15\n___ 03:00AM   CALCIUM-8.9 PHOSPHATE-3.3 MAGNESIUM-1.8\n___ 03:00AM   OSMOLAL-285\n___ 03:00AM   WBC-8.2 RBC-3.26* HGB-10.4* HCT-30.8* MCV-94 \nMCH-31.9 MCHC-33.8 RDW-15.0\n___ 03:00AM   PLT COUNT-529*\n___ 08:45PM URINE  bnzodzpn-POS barbitrt-NEG opiates-NEG \ncocaine-POS amphetmn-NEG mthdone-NEG\n___ 08:45PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 08:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 07:50PM   GLUCOSE-84 UREA N-12 CREAT-0.6 SODIUM-138 \nPOTASSIUM-4.4 CHLORIDE-95* TOTAL CO2-28 ANION GAP-19\n___ 07:50PM   ASA-NEG ETHANOL-34* ACETMNPHN-NEG \nbnzodzpn-POS barbitrt-NEG tricyclic-NEG\n___ 07:50PM   WBC-9.5 RBC-3.41 HGB-10.9 HCT-32.0* MCV-94 \nMCH-31.9 MCHC-33.9 RDW-15.3\n___ 07:50PM   NEUTS-85.6* LYMPHS-9.6* MONOS-3.5 EOS-1.2 \nBASOS-0.1\n___ 07:50PM   PLT COUNT-536\n.\n___ CT HEAD: No acute fracture/hemorrhage; chronic nasal \ndeformity  \n.  \n___ CT SPINE: No fracture or malalignment. Prevertebral soft \ntissue thickening; may be postoperative but no post-op \ncomparisons, and could instead represent softtissue swelling if \nthere is concern for ligamentous injury. Multilevel degenerative \nchange and post-operative appearance of anterior-posterior upper \nC-spine fusion. Sub-cm locule gas adjacent right SCM muscle at \nlevel of thyroid cartilage unclear significance. Atherosclerotic \ncalcs of great vessels, chronic. D/W Dr. ___ in ED.  \n. \n___ CXR:   \nCHEST AP  \n  \nCardiac size is normal. The lung fields are clear. The \ncostophrenic angles \nare sharp. Note is made of a fusion within the cervical spine. \n  \nIMPRESSION: Normal chest. \n  \n\n \nBrief Hospital Course:\nMr. ___ is a ___ year old gentleman with a PMH significant for \ncervical DJD and EtOH abuse, discharged ___ after cervical \nspinal fusion admitted in the setting of witnessed fall and \npolysusbstance abuse.\n\n# Altered Mental Status: This was likely related to \npolysubstance abuse. He was found by EMS with altered mental \nstatus with an empty pill bottle at his side. Urine and serum \ntoxicology were positive for ethanol, benzodiazapines and \ncocaine. He was admitted to the ICU given the potential for a \ndifficult intubation if needed, given his recent neck surgery. \nHe did not require intubation, and his sensorium cleared. He \nrequired valium on a CIWA scale, but no longer required valium \nby the time he transferred to the floor. He did have a history \nof hallucinations and blackouts on withdrawing from alcohol, and \nhe was started on thiamine and folate. During his \nhospitalization he briefly refused to wear his neck brace.He was \nseen by the psychiatry service to evaluate competency and he was \ndeemed competent to make this decision. He then decided to \ncomply with wearing the neck brace. \n.\n# s/p Fall: This was likely related to polysubstance abuse. He \nwas found by EMS with altered mental status with an empty pill \nbottle at his side. Urine and serum toxicology were positive for \nethanol, benzodiazapines and cocaine. The patient had recently \nhad C3-C7 fusion (___). He was seen by the ortho spine \nservice, and the determination was made that he had no acute \nfracture, but should continue to wear a heard collar until he \nwas seen by orthopedics for follow up as an outpatient. His pain \nwas controlled initially with tylenol, ultram and flexoril. \nOxycodone was eventually reintroduced and he was discharged on \nthe same dose recommended by orthopedics following his C3-C7 \nfusion. \n.\nPolysubstance Abuse: The patient has a history of alcohol, \ncocaine and narcotic abuse. He engaged in extreme drug seeking \nbehavior during his hospitalization, including throwing himself \non the floor in order to obtain higher doses of narcotic \nmedications. He was discharged on the same dose recommended in \nthe post surgical period by his orthopedic surgeon. He was seen \nby social work and routed to an outpatient addictions support \nfacility. \n.\n? Bipolar d/o, anxiety d/o: The patient was seen by psychiatry. \nThey felt that it was difficult to evaluate the patient's \nreports of anxiety disorder or bipolar disorder in face of his \nactive substance abuse. He endorsed worsening of his anxiety and \nmoderate weight loss. He should have a TSH checked as an \noutpatient with further work up of this complaint in the \noutpatient setting.  \n\n \n \nMedications on Admission:\nMedications (Discharge Meds ___:\n1. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for fever.  \n2. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).  \n3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \n\ntimes a day).  \n4. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \n5. Fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n6. Oxycodone 5 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) \n\nas needed for pain.  \n7. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).  \n8. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n\n \nDischarge Medications:\n1. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n2. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n3. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).  \n4. Fluoxetine 20 mg Capsule Sig: One (1) Capsule PO once a day.  \n\n5. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \nTablet, Delayed Release (E.C.) PO once a day.  \n6. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO once a day: \nplease do not drink alcohol or perform activities that require \nfast reaction time. ___ cause sedation.  \n7. Nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily).  \n8. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.  \n9. Docusate Sodium 100 mg Capsule Sig: Two (2) Capsule PO BID (2 \ntimes a day) as needed for prn constipation.  \n10. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six \n(6) hours as needed for fever or pain.  \n11. Oxycodone 5 mg Capsule Sig: ___ Capsules PO every three \nhours as needed for pain: please do not drink alcohol or perform \nactivities that require a fast reaction time while taking this \nmedication. ___ cause sedation. .\nDisp:*80 Capsule(s)* Refills:*0*\n12. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary\nAltered mental status \nSubstance abuse. \n.\nSecondary \nCervical DJD  \ns/p Spinal fusion C3-C7 ___  \nBipolar disorder  \nPTSD \n\n \nDischarge Condition:\nalert and oriented to person, place and time. \nFully ambulatory. \n\n \nDischarge Instructions:\n \n\nYou were admitted to the hospital because you had suffered a \nfall in the setting of overdosing on drugs and alcohol. You went \nto the intensive care unit for concern that you would need a \nbreathing tube. You did not need a breathing tube and your \nmental status cleared. \n.\nThe following changes were made to your medications. \nWe ADDED\nfolate 1mg daily\nthiamine 100mg daily\n.\nYou can continue to take oxycodone ___ every three hours as \nneeded for pain. You have sufficient supply to last you until \nyour doctor's appointment on ___. \n.\nActivity: You should not lift anything greater than 10 lbs for \n2 weeks. You will be more comfortable if you do not sit or stand \n\nmore than ~45 minutes without getting up and walking around.\n.\nRehabilitation/ Physical Therapy: \n___ times a day you should go for a walk for ___ minutes as \npart of your recovery. You can walk as much as you can tolerate. \n\n \nDiet: Eat a normal healthy diet. You may have some constipation \nafter surgery. You have been given medication to help with this \nissue.\n. \nBrace: You have been given a brace. This brace is to be worn \nfor comfort when you are walking. You may take it off when \nsitting in a chair or while lying in bed. You should continue to \nuse this brace until you see Dr ___ in clinic and he gives \nyou further instructions.  \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10568795","hadm_id":"20075060","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: PODIATRY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\n L foot contractures\n \nMajor Surgical or Invasive Procedure:\n1. Soft tissue contracture release.\n2. First and ___ metatarsophalangeal release.\n3. Split-thickness skin graft, left foot.\n\n \nHistory of Present Illness:\nThe patient is a ___\nfemale who suffered some severe burn injuries to bilateral\nfeet approximately ___ years ago and has now subsequently\ndeveloped some severe soft tissue contractures that prevent\nthe patient from being able to fit into normal shoe gear.\nThese contractures also cause her significant pain, and she\nnow desires surgical correction.\n \nPast Medical History:\nNIFEdipine CR 60 mg', Albuterol MDI 2 PUFF IH Q4H, Evista 60 \nmg', Fluoxetine 10 mg', Simvastatin 40 mg', Zomig 2.5 mg', \nMicardis 40 mg', Zonisamide 100 mg'\n \nSocial History:\n___\nFamily History:\nn/c\n \nPhysical Exam:\nAppearance: NAD, AAOx3\nHeart: RRR\nLungs: CTA b/l\nAbdomen: Soft, NT/ND, (+)BS\n\nVASCULAR\nPedal Pulses:      [x] Palpable  [] Non-palpable\n\nSub-Papillary VFT: [x] \u003c 3 sec.  [] \u003e 3 sec. [] Immediate\n\nNEUROLOGICAL       Sensation:      [x] Intact  [] Absent\n                   Proprioception: [x] Intact  [] Absent\n\n \nPertinent Results:\nnone\n \nBrief Hospital Course:\nThe patient was brought to the OR on ___.  She had a soft \ntissue contracture release of the ___ and ___ \nmetatarsophalangeal release and a split-thickness skin graft \nwith a vac placement, left foot.  The patient tolerated the \nprocedure and anesthesia well without apparent complications \n(see op report for full details).  The vac was maintained on the \nskin graft for 5 days post-op.  The vac was taken down on \n___. The pt's wound was clean, dry. The skin graft was \nintact. L thigh wound was also clean, dry without any signs of \ninfection.\n.\nThe patient was kept on bedrest while the vac was intact.  The \npatient was then seen by physical therapy. They recommended Home \nwith ___.\n.\nThe patient was advised to follow up with Dr. ___ a week \nof discharge.  \n.\nThe patient was discharged in good condition with vital signs \nstable and vascular status intact to the left foot.\n\n \nMedications on Admission:\nNIFEdipine CR 60 mg', Albuterol MDI 2 PUFF IH Q4H, Evista 60 \nmg', Fluoxetine 10 mg', Simvastatin 40 mg', Zomig 2.5 mg', \nMicardis 40 mg', Zonisamide 100 mg'\n \nDischarge Medications:\n1. Fluoxetine 10 mg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n2. Nifedipine 60 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO DAILY (Daily).  \n3. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation \nQ4H (every 4 hours) as needed.  \n4. Raloxifene 60 mg Tablet Sig: One (1) Tablet PO daily ().  \n5. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Micardis 40 mg Tablet Sig: One (1) Tablet PO daily ().  \n7. Zomig 2.5 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. Zonisamide 100 mg Capsule Sig: One (1) Capsule PO once a day. \n \n9. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation for 2 weeks.\nDisp:*28 Tablet(s)* Refills:*2*\n10. Docusate Sodium 100 mg Capsule Sig: Two (2) Capsule PO BID \n(2 times a day) as needed for constipation for 2 weeks.\nDisp:*28 Capsule(s)* Refills:*2*\n11. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLeft digital contractures\n \nDischarge Condition:\nGood\n \nDischarge Instructions:\nPlease resume all pre-admission medications.  You were given new \nprescriptions, please take as directed.\n.\nKeep your dressing clean and dry at all times.  You will not \nrequire dressing change until your follow up visit.\n.\nYou are to remain NON WEIGHT BEARING to your LEFT foot with \npartial weight bearing to the heel for transfers only in a \nsurgical shoe with crutches/walker/wheelchair at all times. Keep \nyour LEFT foot elevated to prevent swelling.\n.\nCall your doctor or go to the ED for any increase in LEFT foot \nredness, swelling or purulent drainage from your wound, for any \nnausea, vomiting, fevers greater than 101.5, chills, night \nsweats or any worsening symptoms.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18578459","hadm_id":"20608116","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \ncodeine\n \nAttending: ___.\n \nChief Complaint:\nGTC\n \nMajor Surgical or Invasive Procedure:\nLumbar puncture\n\n \nHistory of Present Illness:\n___ hx seizure disorder on keppra, depression ,anxiety, graves\ndisease, HTN restless leg syndrome, OSA not on CPAP, aortic\nstenosis s/p valve repair, thyrotoxic periodic paralysis who\npresents as an intubated transfer from ___. \n\nBriefly, pt was reportedly golfing when he developed GTC. He was\nbrought to ___, en route received a total of lorazepam 6 \nmg\nwhich did not brake the seizure. At ___ was given keppra\n1.5g, phenytoin 1g and seizure broke. Patient was intubated for\nairway protection. Workup there notable for WBC 15, glucose 222,\nnormal renal function, normal NCHCT. \nPer wife who is at bedside, pt developed sz 6 months ago. \nFollows\nwith Neurologist in ___ (Dr. ___).Per wife \ninitially\nit was thought that he had a sz due missed Xanax. However when \nhe\nhad another sz soon after he was started on keppra.  Family\nstates that he had circa 9 sz since he was diagnosed with sz.\nFamily denies prior hx of seizures or family hx of seizures.\nUnclear if he missed medications. Of note family reports pt was\nheavy drinker until ___ years ago but has been abstinent since.\nHowever, there are reports that he was drinking on golf course.\nNo recent fevers, illness. \n\n \nPast Medical History:\nseizure disorder\ndepression\nanxiety\ngraves disease\nHTN \nrestless leg syndrome\nOSA not on CPAP\naortic stenosis s/p valve repair\nthyrotoxic periodic paralysis \n \nSocial History:\n___\nFamily History:\nNo family hx of seizures\n \nPhysical Exam:\nGeneral: NAD\nHEENT: NC/AT\nAbdomen: soft, NT/ND\nExtremities: wwp, no C/C/E bilaterally\nSkin: no rashes or lesions noted.  \n\nNeurologic: \n-MS: alert, oriented to self, place, and time. attentive, can \nname months of the year backwards. speech is\nfluent and he provides a reasonable history.\n-CN: PERRL 3-\u003e2mm bilaterally, EOMI without nystagmus. face is\nsymmetric. \n-Motor\n   [Delt] [Bic] [Tri] [ECR] [FEx] [IP] [Quad] [Ham] [TA] [Gas]\n L   5      5     5     5     5    5     5      5    5     5\n R   5      5     5     5     5    5     5      5    5     5\n-Sensory: intact to LT\n-Coordination: intact FNF bilaterally\n \nPertinent Results:\n___ 04:00AM BLOOD WBC-9.4 RBC-4.27* Hgb-13.1* Hct-38.9* \nMCV-91 MCH-30.7 MCHC-33.7 RDW-12.0 RDWSD-40.0 Plt ___\n___ 06:48AM BLOOD ___ PTT-26.2 ___\n___ 04:00AM BLOOD Glucose-88 UreaN-6 Creat-0.7 Na-143 K-4.0 \nCl-104 HCO3-27 AnGap-12\n___ 03:08AM BLOOD ALT-7 AST-16 LD(LDH)-292* CK(CPK)-200 \nAlkPhos-71 TotBili-0.5\n___ 04:00AM BLOOD Calcium-8.5 Phos-2.7 Mg-1.6\n___ 03:08AM BLOOD %HbA1c-5.3 eAG-105\n___ 03:08AM BLOOD TSH-0.70\n___ 03:08AM BLOOD Free T4-1.1\n___ 03:08AM BLOOD Phenyto-8.9*\n___ 01:15PM BLOOD Phenyto-11.0\n___ 01:15PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n___ 04:02PM BLOOD Lactate-2.0\n___ 01:24PM BLOOD Lactate-3.2*\n\nEEG ___\nIMPRESSION: This is video-EEG monitoring session captured \nseveral written\nnotations of leg movements and ___ shaking without \nelectrographic correlate\nfor seizures. The telemetry is notable for faster syperimposed \nbeta activity\nlikely attributable to medication effect (i.e. benzodiazepine \nuse). There are\nno epileptiform discharges and no electrographic seizures \ncaptured. Compared\nto the prior day's recording there is no change.\n\n___ MR ___ w and w/o contrast\nIMPRESSION:\n \n \n1. Essentially unremarkable brain MRI without evidence for a \nseizure focus.\n2. Small foci of high T2/FLAIR signal abutting the frontal horns \nof lateral\nventricles, right larger than left, are nonspecific but likely \nsequela of mild\nchronic small vessel ischemic disease in this age group.\n \nBrief Hospital Course:\n___ y.o male with PMH seizure disorder (approximately ___ year), AS \ns/p valve repair, thyrotoxic periodic paralysis who presented as \na transfer from ___ after multiple witnessed generalized \nconvulsive seizures. After 6mg of lorazepam seizure had not \nbroken so he received keppra 1.5g and phenytoin 1gm which broke \nthe seizure and was subsequently intubated for airway \nprotection. ___ CT was normal. Patient is followed by \nneurologist in ___ (Dr. ___) and was placed on \nkeppra 750mg BID with possible etiology of benzodiazepine \nwithdrawal. He estimates having approximately 11 seizures over \nthe past year with no medication changes. He has a remote \nhistory of etoh use. Tox screen positive for benzodiazepines \nonly. Denies recent illness, fever, medication changes or missed \ndoses.\n\nEEG showed a right hemispheric focus with a clinically \nassociated prolonged post-ictal Todds (now resolved) of the left \nside. Patient extubated to room air. Etiology still remains \nunclear, though likely\nsubtherapeutic keppra for his size. Currently well appearing. \nCSF showing mild poly-predominant pleocytosis, which is likely \nsequelae from seizure rather than infection. \n\nTransitional Issues:\n-HSV PCR pending, however acyclovir was discontinued due to low \nclinical suspicion\n-Follow-up in Dr. ___\n-Repeat lab testing in ___ months (elevated LDH)\n \nMedications on Admission:\nSertraline 50mg daily\n \nDischarge Medications:\n1.  LevETIRAcetam 1500 mg PO BID \nRX *levetiracetam 500 mg 3 tablet(s) by mouth twice daily Disp \n#*180 Tablet Refills:*3 \n2.  Sertraline 50 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nEpilepsy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted after having multiple seizures. You were \nunable to safely breath on your own, so you were briefly \nintubated. You underwent a workup including MRI of the brain, \nwhich was normal. The most likely etiology was felt to be due to \nthe need for higher doses of your anti seizure medication. This \nwas increased to 1500mg twice daily. Please take your medication \nas prescribed and do not miss doses. \n\nYou will be seen in Dr. ___ clinic on ___ at 4pm. Prior to appointment, please call ___ to \nregister your insurance information on ___. Please review the \nseizure safety plan as below.\n\nIt was a pleasure taking care of you.\n\nSincerely,\n___ Neurology\n\n=======================================================\nSeizure Safety Plan\n\nPatients at risk for seizures that involves loss of \nconsciousness must avoid:\n- Driving (for 6 months after a seizure...\n            ...UNTIL A PHYSICIAN STATES THAT IT IS ___\n- unattended baths, unattended swimming,power tools, heavy \nmachinery\n- ladders, high platforms, roofs\n- any other activity that could pose a safety risk if there was \na loss of consciousness or uncontrolled body movements\n\nFor any seizure involving loss of consciousness, do the \nfollowing:\n1. Don't panic - take a deep breath\n2. Look at the clock to see what time the seizure started.\n3. If the patient is shaking for more than 5 minutes - or has \nrepeated seizures without returning to normal in between, call \n___ this is an emergency.\n4. As much as possible, move things away from the patient's ___ \nto avoid injury\n5. Use pillows or towels to protect the from injury\n6. Put them on a bed, couch, or the floor ON THEIR SIDE. This is \nto avoid a condition called aspiration pneumonia, when vomit \ngoes into the lungs.\n7. DO NOT PUT ANYTHING IN THEIR MOUTH. Patients don't swallow \ntheir tongues despite the old wives tale. However, putting \nthings inside the mouth could lead to choking hazard.\n8. When the seizure is over and you are sure they are safe, \nplease call the neurology clinic to let us know about a seizure. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"14345767","hadm_id":"27182038","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nmesalamine / Rectiv\n \nAttending: ___.\n \nChief Complaint:\npostdates induction of labor\n \nMajor Surgical or Invasive Procedure:\nSVD\nmanual removal of placenta\nBackri Balloon \nblood transfusion\n\n \nHistory of Present Illness:\n___ is a ___ yo G1P0 with a\nlong-standing history of palpitations. She first started having\nthe sensation of rapid beats followed by a pause ___ years ago. \nAt\nthat time, a couple episodes were associated with syncope.\nWork-up was performed with Echo, tilt-table test, and Holter\nwhich was reportedly negative. These progressively improved, but\nhave now worsened again in  pregnancy with occasional\nlightheadedness that is not necessarily correlated with\npalpitations. Holter evaluation performed in ___ showed\nevidence of PVC's. However, she was only able to wear this for a\nweek due to a rash from the electrode. Echo showed no structural\nconcerns.  She was seen by Cardiology, who discussed \n___\ntherapy but decision was made to hold off given potential side\neffects during pregnancy as the PVC's did not appear to be\ncausing any other symptoms.\n \nPast Medical History:\nPast Medical History: ulcerative colitis, history of PVCs\n\nPast Surgical History: Umbilical Hernia Repair (___)\n\nOB History: G1\n\nGYN History: denies STIs, abnormal pap smears, GYN surgeries\n \nSocial History:\n___\nFamily History:\nmother with DM, HTN, father with diverticulitis, no hx \nulcerative colitis, crohns, or autoimmune disorders  \n\n \nPhysical Exam:\nPhysical Exam on Arrival:\nGeneral: NAD, A\u0026Ox3\nLungs: No respiratory distress, normal work of breathing\nAbd: soft, gravid, nontender, no RUQ tenderness\nExtremities: no calf tenderness\n\nPhysical Exam on Discharge:\nVitals: ___ 2142 Temp: 97.9 PO BP: 98/61 HR: 78 RR: 18 O2\nsat: 97% \nGeneral: NAD, A\u0026Ox3\nBreasts: non-tender, no erythema, soft, nipples intact\nLungs: No respiratory distress\nAbd: soft, nontender, fundus firm at 2cm below umbilicus\nLochia: minimal, no malodor\nperineum 2nd degree intact, no edema\nExtremities: no calf tenderness\n \nPertinent Results:\n___ 04:08PM   WBC-10.3* RBC-3.72* HGB-12.5 HCT-36.6 MCV-98 \nMCH-33.6* MCHC-34.2 RDW-13.2 RDWSD-47.7*\n___ 04:08PM   PLT COUNT-134*\n \nBrief Hospital Course:\nPatient is a ___ year old female with past medical history of \nPVCs who underwent an induction of labor using cytotecs and \npitocin for post-dates.\n\nShe had vaginal delivery of viable baby boy complicated by a \npostpartum hemorrhage due to uterine atony. She had placenta and \ntrailing membranes manually extracted due to increased bleeding. \nShe was given pitocin and cytotec PR. She was hypotensive to \nsystolic BP of ___ and HR 140s. She was taken back to the \noperating room for a D\u0026C with Bakri placement and vaginal \npacking. EBL of PPH in delivery room was 800 and in OR was 100.  \nHer hematocrit at presentation was 36, which trended down to \n19.3 on postpartum day #1. She was asymptomatic and declined \nblood transfusion. She was started on oral iron BID. Her Bakri \nand vaginal packing were removed on postpartum day #1 without \nfurther bleeding.\n\nShe also had spiked a fever intrapartum and was given 1 dose of \nkefzol and gentamicin postpartum for chorioamnionitis. \n\nIn regards to her history of PVCs, she has been followed by \n___ Cardiology outpatient. She had a normal echo and was \nmonitored on telemetry for the first 24 hours postpartum.\n\nHer pain was well controlled on oral medications, she was \nvoiding spontaneously, and ambulating without dizziness. She was \ndischarged home on postpartum day #2 with outpatient followup \nscheduled.\n \nMedications on Admission:\nASA 81 mg daily\nPNV\nRemicade Infusions\n \nDischarge Medications:\n1.  Docusate Sodium 100 mg PO BID:PRN Constipation \nRX *docusate sodium 100 mg 1 (One) capsule(s) by mouth twice a \nday Disp #*20 Capsule Refills:*0 \n2.  Ibuprofen 600 mg PO Q8H:PRN Moderate Pain \ntake with food and take only if needed \nRX *ibuprofen 600 mg 1 (One) tablet(s) by mouth every eight (8) \nhours Disp #*20 Tablet Refills:*0 \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nvaginal birth of a male\npostpartum hemorrhage\nanemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nper written instructions reviewed by nursing and OB providers\nanemia precautions, avoid prolonged bending of head, assistance \nwith showers for 2 weeks\nFloradix iron supplement twice a day\nresume prenatal vitamins in one week\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18563813","hadm_id":"20918418","text":" \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPneumovax 23\n \nAttending: ___.\n \nChief Complaint:\nepigastric pain, asymptomatic bradycardia\n \nMajor Surgical or Invasive Procedure:\nNone.\n\n \nHistory of Present Illness:\nMs. ___ is a ___ with PMH of aortic stenosis s/p \nbioprosthetic AVR and single-vessel CABG (SVG-PDA) in ___, DM, \nHTN, diastolic HF who had sharp epigastric pain at home the \nnight before admission.  The pain began in the evening on the \nday prior to admission when she tried to swallow her evening \npills.  She felt nauseated, but did not throw up.  The pain was \nin her epigastrum, sharp, and radiated to her back.  She was \nunable to eat dinner and unable to sleep all night due to the \npain. \nHer visiting nurse saw her on the morning of admission, and \nnoticed she wasn't feeling well, so took her vitals, had a pulse \nin the ___. Per report, her blood pressure at this time was \n150s/50s.  EMS was called, and when they arrived, she was \nbradycardic in the ___ with a junctional escape rhythm. She was \ngiven 0.5mg atropine with reported improvement in her HR to the \n___.  Of note, the patient stated that she has been taking all \nof her medications as prescribed, and does not feel dehydrated \nand has not noticed any changes to her bowel or bladder habits.\nIn the ED, initial vitals were T97 HR47 BP131/59 RR21 O2sat \n95(RA).\nShe was comfortable and without complaints. She was put on 2L O2 \nby NC and transferred to the floor.\nROS negative for chest pain or pressure, palpitations, SOB, \nlightheadedness, dizziness, loss of consciousness.  She denies \northopnea, dyspnea on exertion, lower extremity edema.  She has \nnot noticed any recent changes in her stool (no melana) or bowel \nhabits (no constipation or diarrhea).  Denies dysuria, \nfrequency.  Does not feel dehydrated. \n\n \nPast Medical History:\n1. CARDIAC RISK FACTORS: DM, hyperlipidemia, HTN\n2. CARDIAC HISTORY:  \n-Aortic stenosis s/p bioAVR ___\n-Diastolic Heart Failure (EF \u003e75%)\n-CABG: CAD s/p single-vessel CABG ___ (SVG-PDA)\n3. OTHER PAST MEDICAL HISTORY:  \n___\nGERD\nReducible umbilical hernia\n \nSocial History:\n___\nFamily History:\nFamily hx of heart disease in many members, unable to specify \nwhat kind, otherwise non-contributory.\n \nPhysical Exam:\nPHYSICAL EXAM ON ADMISSION:\nVS: T=98.7 BP=115/81 HR=50 RR=20 O2 sat=98 (3L)  \nOrthostatics: lying - 128/51  51; sitting - 130/55  56; standing \n130/59  48\nGENERAL: NAD. Oriented x3. Mood, affect appropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Moist mucous \nmembranes.\nNECK: Supple with JVP of 8 cm.  \nCARDIAC: bradycardic, regular, normal S1, S2. crescendo systolic \nmurmur best heard at aortic region. No S3 or S4.  \nLUNGS: Resp were unlabored, no accessory muscle use. CTAB, no \ncrackles, wheezes or rhonchi.  \nABDOMEN: +BS, soft, obese, tenderness to palpation in the \nepigastrum. \nEXTREMITIES: No edema, warm\nSKIN: No stasis dermatitis, good tugor  \n\nPHYSICAL EXAM ON DISCHARGE:\nVS: T=98.0 BP=110-130s/80s HR=51-60 RR=20 O2 sat=97 (RA)\nGENERAL: NAD. Oriented x3. Mood, affect appropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Moist mucous \nmembranes.\nNECK: Supple with JVP of 8 cm.  \nCARDIAC: bradycardic, regular, normal S1, S2. crescendo systolic \nmurmur best heard at aortic region. No S3 or S4.  \nLUNGS: Resp were unlabored, no accessory muscle use. CTAB, no \ncrackles, wheezes or rhonchi.  \nABDOMEN: +BS, soft, obese, tenderness to palpation in the \nepigastrum. \nEXTREMITIES: No edema, warm\nSKIN: No stasis dermatitis, good tugor  \n \nPertinent Results:\nCBC:\n___ 12:05PM BLOOD WBC-10.2 RBC-3.19* Hgb-10.0* Hct-28.7* \nMCV-90 MCH-31.3 MCHC-34.8 RDW-13.5 Plt ___\n___ 06:30AM BLOOD WBC-8.2 RBC-3.02* Hgb-9.6* Hct-27.2* \nMCV-90 MCH-31.9 MCHC-35.5* RDW-13.3 Plt ___\n___ 06:38AM BLOOD WBC-5.9 RBC-2.79* Hgb-9.0* Hct-26.0* \nMCV-93 MCH-32.2* MCHC-34.6 RDW-13.5 Plt ___\n\nCoagulation Panel:\n___ 12:05PM BLOOD ___ PTT-25.0 ___\n\nChemistries:\n___ 12:05PM BLOOD Glucose-134* UreaN-69* Creat-2.8*# \nNa-131* K-5.5* Cl-97 HCO3-20* AnGap-20\n___ 09:30PM BLOOD Na-134 K-4.9 Cl-101\n___ 06:30AM BLOOD Glucose-107* UreaN-60* Creat-2.0* Na-136 \nK-5.1 Cl-104 HCO3-22 AnGap-15\n___ 06:38AM BLOOD Glucose-120* UreaN-43* Creat-1.6* Na-137 \nK-4.7 Cl-105 HCO3-22 AnGap-15\n\nCardiac Enzymes:\n___ 09:30PM BLOOD CK(CPK)-240*\n___ 06:30AM BLOOD CK(CPK)-237*\n___ 12:05PM BLOOD cTropnT-0.01\n___ 09:30PM BLOOD CK-MB-4 cTropnT-\u003c0.01\n___ 06:30AM BLOOD CK-MB-3 cTropnT-\u003c0.01\n\nLFTs:\n___ 09:30PM BLOOD ALT-33 AST-25 LD(LDH)-205 AlkPhos-79 \nAmylase-80 TotBili-0.3\n___ 09:30PM BLOOD Lipase-67*\n\nMisc.\n___ 06:38AM BLOOD calTIBC-220* VitB12-420 Ferritn-157* \nTRF-169*\n___ 06:38AM BLOOD TSH-1.3\n\nCXR ___:\nIMPRESSION: Exam limited by low lung volumes. No acute \ncardiopulmonary process. \n\n \nBrief Hospital Course:\nPrimary Reason for Hospitalization:  Ms. ___ is a ___ \nwith PMH with Aortic Stenosis s/p bioprosthetic AVR and \nsingle-vessel CABG (SVG-PDA) in ___, DM, HTN, diastolic HF had \nsharp epigastric pain at home the night before admission, found \non the morning of admission to be bradycardic to mid-30s.\n\nActive Diagnoses:\n# RHYTHM: Patient was in sinus bradycardic vs. junctional escape \nrhythm of unclear etiology, and remained asymptomatic through \nout admission with no lightheadedness, dizziness, syncope, chest \npain or pressure.  Likely etiology of bradycardia is a vagal \nresponse to abdominal pain, but another possibility is verapamil \naccumulating in her system in the setting of renal failure \n(verapamil is hepatically metabolized, but the metabolite is \nstill active and renally excreted).  Throughout hospitalization, \nher heart rate remained in the ___ with no intervention.  \nHer verapamil held as an inpatient and restarted as an \noutpatient as it is beneficial for diastolic heart failure.  \n\n# PUMP: Patient has a hx of diastolic dysfunction (EF\u003e75%).  She \ntakes furosemide 20mg po daily and did not seem volume \noverloaded today.  By CXR, did not appear volume overloaded \neither.  Furosemide was held while she was an inpatient in the \nsetting of ARF but will be restarted as an outpatient at half \nthe dose (now at furosemide 10mg po daily).\n  \n# CORONARIES: Patient has a history of CAD s/p single-vessel \nCABG ___.  Her current sharp epigastric pain does not sound \nanginal in nature.  She has nonspecific TWI on EKG and negative \ntroponin x2.  She was continue simvastatin and ASA, but her \nenalapril was held in the setting of ARF.  She will restart \nenalapril as outpatient at her home dose.\n  \n# ARF: Patient's Cr of 2.8 is much higher than her baseline of \n1.2.  She did not appear dry on exam during admission (moist \nmucous membranes, is not orthostatic, skin turgor is good).  She \nwas also hyponatremic and hyperkalemic, both of which can be \nexplained by dehydration (hypovolemic hyponatremia and decreased \nK clearance with renal failure).  She received 1L NS overnight \nat 75cc/hr, which she tolerated well.  Her creatinine has \nimproved to 1.6 from 2.8 on the day of discharge and her \nhyponatremia and hyperkalemia resolved.\n\n#  Epigastric Pain: The patient endorsed sharp epigastric pain \nexacerbated by food, radiating toward back that began last night \nbut improved today.  Differential included gastritis, \npancreatitis, biliary disease.  Her LFTs were unimpressive and \nher pain had resolved by the time she was admitted.  She was \nmonitored without further interventions, and continued on her \nhome dose of Nexium 40mg daily.\n\n#Anemia: Patient is anemic to 26, which is stable but down from \nher baseline of low ___.  Iron studies were ordered on the \npatient, as pt has hx of iron deficiency, and the patient was \nstarted on iron supplemenation as an outpatient.  Her labs \nreturned after discharge showing an anemia of chronic disease \ntype of picture.  This was communicated to her primary care \nphysician who will make adjustments to her medications.\n\nChronic issues:\n#  DM2.  Her oral hypoglycemics were held in the hospital and \nshe was maintained on an insulin sliding scale.  Her blood \nsugars remained well-controlled.\n  \n# Dementia: She continued Donepezil 10mg daily per her home \ndose.\n  \n# Lower back pain: She was continued on Acetaminophen 500mg BID \nper her home dose.\n\nTransitional Issues:  \nCODE: Full code\nEMERGENCY CONTACT:  ___ (granddaughter) ___\nDischarge summary was faxed to patient's PCP, ___.\n \nMedications on Admission:\nASA 81mg daily\nVerapamil 120mg daily\nSimvastatin 20mg daily\nEnalapril 10mg daily\nFurosemide 20mg daily\nGlipizide 2.5mg daily\nMetformin 500mg daily\nDonepezil 10mg daily\nNexium 40mg daily\nAcetaminophen 500mg BID\n \nDischarge Medications:\n1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n2. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n3. metformin 500 mg Tablet Sig: One (1) Tablet PO once a day.  \n4. donepezil 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n5. Nexium 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO once a day.  \n6. acetaminophen 500 mg Tablet Sig: One (1) Tablet PO twice a \nday.  \n7. furosemide 20 mg Tablet Sig: 0.5 Tablet PO once a day: Please \nresume taking 10mg Lasix (half a pill) on ___.\nDisp:*15 Tablet(s)* Refills:*2*\n8. enalapril maleate 10 mg Tablet Sig: One (1) Tablet PO once a \nday: Please start taking enalapril again on ___.  \n9. verapamil 120 mg Tablet Extended Release Sig: One (1) Tablet \nExtended Release PO once a day.  \n10. ferrous sulfate 325 mg (65 mg iron) Tablet Sig: One (1) \nTablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n11. senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as \nneeded for constipation.  \n12. glipizide 2.5 mg Tablet Extended Rel 24 hr Sig: One (1) \nTablet Extended Rel 24 hr PO once a day.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___ \n \nDischarge Diagnosis:\nBradycardia\nAcute Renal Failure\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nActivity Status: Ambulatory - Independent.\nLevel of Consciousness: Alert and interactive.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you at ___ \n___.  You were admitted for having a very slow heart \nrate, down to 35 beats per minute.  Before you came in to the \nhospital, you also complained of some stomach pain and nausea \nwhen trying to eat.  While in the hospital, we also found that \nyour kidneys were not functioning properly, most likely because \nyou have not been drinking enough water.  While you were in the \nhospital, we monitored you on our heart rhythm monitor and your \nheart rates remained in the ___, which we find reassuring.  \nYou were given fluids by IV and your kidney function is \nreturning to normal.  Your stomach pain improved and you were \nable to eat normal foods again.  At this point, we felt you were \nsafe to go home.\nPlease note that the following changes have been made to your \nmedications:\n- Please STOP taking your Lasix for now and RESUME on ___, \n___ at a dose of 10mg daily \n- Please STOP taking your Enalapril for now and RESUME on \n___ at the original dose\n- Please start to take Ferrous Sulfate (iron supplement) to \nincrease your blood levels\n- Please take colace twice a day while taking iron to improve \npossible constipation\n\nPlease continue to take all your other medications as \nprescribed.\nPlease weigh yourself every morning, call MD if weight goes up \nmore than 3 lbs.\nPlease make sure you drink enough water every day to help with \nyour kidney problems.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18977059","hadm_id":"28962181","text":" \nName:  ___                  ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIodinated Contrast Media - IV Dye / Corticosteroids \n(Glucocorticoids)\n \nAttending: ___\n \nChief Complaint:\nDyspnea\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ y/o ___ speaking woman with a H/O diastolic heart \nfailure, severe mitral regurgitation, CKD (baseline Cr \n~1.5-1.8), atrial fibrillation (on anticoagulation), unspecified \nrespiratory disorder, Alzheimer's dementia and osteoporosis, who \nwas sent in from her nursing home with weight gain from 101 lb \nto 103 lb in the last day, progressive dyspnea x 1 week with \nwheezing, increased confusion and increase in lower extremity \nedema.\n\nHistory was obtained from the patient's daughter who was at her \nbedside. Patient has had recent hospitalization in ___ at \n___ for lower GI bleed secondary to an ano-rectal tear \nin setting of constipation and anticoagulation. The patient \nlives in a nursing home where she was recently treated for a UTI \nwith ciprofloxacin. Since the completion of her antibiotic \ncourse 7 days prior to admission, the patient's family has noted \nincreased bilateral pedal edema. In addition, the patient has \nbeen more confused and complaining of increased dyspnea with \nwheezing. Of note, upon talking to the patient's health care \nproxy who is a physician, she has stated that her mother has had \nmultiple admissions in the past with similar presentations. One \nof these required an ICU admission during which the patient was \ndiscovered to have severe mitral regurgitation. The HCP stated \nthat her mother initially presents looking like an asthma \nexacerbation given a cardiac wheeze and then is found to be in \nacute diastolic heart failure exacerbation.\n\nIn the ED initial vitals were: T 97.2 HR 82 BP 152/61 RR 16 SaO2 \n100% on NRB. EKG: Atrial Fibrillation with LBBB and PVCs, \nventricular rate 92 QRS 131 QT 455. Labs/studies notable for \nTrop-T 0.05, CK 285, MB 3, Na 133 Cl 97 BUN 39 BG 128 AGap 21, K \n8.8 with repeat K 4.1 HCO3 24 Cr 2.2. Hgb 8.7 WBC 6.9 Plt 284K \nINR 3.5. Patient was given albuterol 0.083% Neb Soln, \nIpratropium Bromide Neb, and furosemide 40 mg IV. She was guaiac \nnegative. Vitals on transfer: T 98.0 HR 76 BP 151/56 RR 18 SaO2 \n95% on O2 via Nasal Cannula.\n\nAfter arrival to the cardiology ward, the patient was wheezing \nbut hemodynamically stable. She denied pain but endorsed \ndyspnea.\n\nREVIEW OF SYSTEMS: No fevers/chills. +non-productive cough; no \nnausea, vomiting, diarrhea. No chest or abdominal pain. No \ndysuria.\n \nPast Medical History:\n1. CAD RISK FACTORS\n +Hypertension  \n +Dyslipidemia  \n2. CARDIAC HISTORY  \n - CABG: None  \n - PERCUTANEOUS CORONARY INTERVENTIONS: None  \n - PACING/ICD: None  \n3. OTHER PAST MEDICAL HISTORY (Per ___ records)\n-Atrial fibrillation (on apixaban and diltiazem, previously on \nunknown antiarrhythmic but discontinued after less than one \nyear) on warfarin\n-Diastolic CHF \n-Type 2 Diabetes not on medication  \n-Alzheimer's dementia  \n-Hypertension  \n-CKD stage 4 (baseline Cr 1.5-1.8)  \n-Osteoporosis  \n-Unspecified Respiratory disease: Initially hospitalized ___ \nyears ago for respiratory symptoms that improved with asthma \ntreatment. Roughly ___ years ago was treated with systemic \nsteroids and had debilitating hallucinations. Pulmonary fibrosis \nwas implicated at some point. She was followed by a \npulmonologist who felt CHF was more likely etiology, though \ninhalers are continued. No known pulmotoxic exposures (possible \nbrief amiodarone use), PPD reportedly negative.\n \nSocial History:\n___\nFamily History:\nNon-contributory\n \nPhysical Exam:\nOn admission\nGENERAL: cachetic frail appearing elderly Asian Oriental woman, \nin NAD. She was sleeping but arousable, but fell back to sleep \nafter waking.\nVS: T 97.6 BP 154-164/52-72 HR ___ RR 18 O2 sat 94% on O2 2 \nLPM via NC\nWeight: 49.6 kg ___ weight 46.9 kg)\nHEENT: NCAT. Sclera anicteric. PERRL, EOM grossly normal. \nConjunctiva were pink\nNECK: Supple with JVD at 45 degree incline angle of jaw\nCARDIAC: irregular irregular rhythm. ___ holosystolic at apex \nLUNGS: No chest wall deformities. Resp were unlabored, no \naccessory muscle use. Decreased breath sounds at both bases, \ninspiratory crackles up to ___ back posteriorly. + mild exp \nwheezing\nABDOMEN: Soft, non-tender, not distended.\nGU: Foley draining clear yellow urine\nEXTREMITIES: No lower extremity edema\nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Warm \nand well perfused.\nPULSES: 2+ DP bilaterally\nNEURO: moving all 4 extremities spontaneously\n\nAt discharge\nGENERAL: cachetic frail appearing elderly woman in NAD. Awake, \neyes open resting in bed, not tachypneic, appeared comfortable.\nVitals: T 97.9 HR ___ BP 113-138/52-60 RR 18 SaO2 95% on RA\nWeight: 44.5 kg \u003c-- (bed weight) 44.1 (bed weight) \u003c-- 48.3 (bed \nweight) \u003c-- 49.6 (bed weight)\nTele: atrial fibrillation \nHEENT: NCAT. Sclera anicteric. Moving her eyes spontaneously. \nConjunctiva were pink. Left lower lid erythematous/edematous.\nNECK: Supple with no appreciable JVD\nCARDIAC: irregular irregular rhythm.  ___ holosystolic at apex \nradiating to axilla\nLUNGS: No chest wall deformities. Resp were unlabored, no \naccessory muscle use. Decreased breath sounds at bases \nbilaterally with inspiratory crackles.\nABDOMEN: Soft, non-tender, not distended. Normoactive BS.\nGU: no Foley\nEXTREMITIES: No lower extremity edema\nSKIN: No stasis dermatitis. Warm and well perfused. \nPULSES: 2+ DP bilaterally\nNEURO: moving all 4 extremities spontaneously, follows basic \ncommands\n \nPertinent Results:\n___ 10:41AM BLOOD WBC-6.9 RBC-3.44*# Hgb-8.7*# Hct-30.4*# \nMCV-88 MCH-25.3*# MCHC-28.6*# RDW-18.4* RDWSD-58.4* Plt ___\n___ 10:41AM BLOOD Neuts-65.2 ___ Monos-10.9 \nEos-0.6* Baso-0.6 Im ___ AbsNeut-4.50 AbsLymp-1.54 \nAbsMono-0.75 AbsEos-0.04 AbsBaso-0.04\n___ 10:41AM BLOOD ___ PTT-33.1 ___\n\n___ 06:28PM URINE Color-Straw Appear-Clear Sp ___\n___ 06:28PM URINE Blood-SM  Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 06:28PM URINE RBC-14* WBC-1 Bacteri-FEW Yeast-NONE \nEpi-\u003c1\n\n___ 10:41AM BLOOD Glucose-128* UreaN-39* Creat-2.2* Na-133 \nK-8.8* Cl-97 HCO3-24 AnGap-21*\n___ 10:41AM BLOOD ALT-15 AST-88* CK(CPK)-285* AlkPhos-50 \nTotBili-0.7\n\n___ 10:41AM BLOOD Lipase-44\n___ 10:41AM BLOOD CK-MB-3\n___ 10:41AM BLOOD cTropnT-0.05*\n___ 10:41AM BLOOD Albumin-3.4*\n___ 07:30PM BLOOD Calcium-7.8* Phos-3.9 Mg-2.3\n___ 10:49AM BLOOD ___ pO2-55* pCO2-58* pH-7.35 \ncalTCO2-33* Base XS-3 Comment-PERIPHERAL\n___ 10:49AM BLOOD Lactate-1.6 K-5.1\n\n___ 07:30PM BLOOD Ret Aut-2.9* Abs Ret-0.10\n___ 07:30PM BLOOD Hapto-132\n___ 07:30PM BLOOD TSH-1.8\n\n___ 06:50AM BLOOD ___ PTT-30.0 ___\n___ 06:50AM BLOOD Glucose-100 UreaN-22* Creat-1.6* Na-140 \nK-4.0 Cl-97 HCO3-27 AnGap-20\n___ 06:50AM BLOOD Calcium-8.8 Phos-4.5 Mg-2.4\n\n___ BLOOD CULTURE- NO GROWTH\n___ BLOOD CULTURE- NO GROWTH\n___ MRSA SCREEN- NEGATIVE\n___ URINE CULTURE- NO GROWTH\n___ BLOOD CULTURE- NO GROWTH\n\nECG ___ 10:33:47 AM\nSignificant baseline artifact is present. There appears to be \nsinus rhythm with ventricular bigeminy. First degree A-V \nconduction delay. Left bundle-branch block. There are diffuse ST \nsegment and T wave abnormalities that are non-specific. No \nprevious tracing available for comparison.\n\nECG ___ 5:43:20 ___\nAtrial fibrillation. Cannot rule out inferior wall myocardial \ninfarction of indeterminate age. Non-specific intraventricular \nconduction delay with repolarization abnormalities. Compared to \nthe previous tracing of ___ ventricular premature \ncontractions are no longer present but atrial fibrillation \npersists. \n\nCXR ___\nThere is moderate pulmonary edema. There are also bilateral \npleural effusions, right greater than left. Stable enlargement \nof the cardiac silhouette. No focal consolidations to suggest \npneumonia. Calcifications of the aortic knob are demonstrated. \nNo evidence of pneumothorax.\n \nBrief Hospital Course:\n___ with H/O dementia, diastolic heart failure with severe \nmitral regurgitation, atrial fibrillation on warfarin admitted \nwith acute diastolic heart failure exacerbation.\n\n# Acute Exacerbation of Diastolic Heart Failure: Patient had \nprogressive symptoms of dyspnea on exertion with elevated JVP on \nexam, bilateral pedal edema, CXR evidence of pulmonary edema, \nand NT-Pro-BNP 7836. Patient was 46.6 kg a few days prior to \nadmission, but unclear \"dry weight\". Heart failure exacerbation \nsecondary to worsening severe mitral regurgitation versus \ndietary indiscretion given family brings food to her nursing \nhome for her. HCAP coverage initially started on admission given \nconcern for potential infectious source of dyspnea, however \nantibiotics discontinued shortly after admission, as she was \nafebrile with no leukocytosis and no cough. She occasionally had \nwheezing but has known lung disease and possible cardiac \nwheezing in addition. Her PO furosemide dose was increased from \n40 mg to 80 mg on discharge. She will need to have a chemistry \npanel checked on ___. In addition to her home medication \nof isosorbide mononitrate 30 mg, hydralazine 20 mg TID was added \nto her afterload reduction regimen to counteract the mitral \nregurgitation.\n\n# Atrial Fibrillation: On Warfarin. Last INR 3.0 on warfarin 1 \nmg. Her diltiazem was fractionated to 15 mg q6h due to hospital \nformulary issues. She will resume her long acting diltiazem on \ndischarge as her LVEF was preserved on most recent \nechocardiogram.\n\n# Anemia: Stable, Hgb on admission 8.8. Patient has Hgb of 8 \nfrom 10 in ___. She had a recent admission for LGIB in setting \nof ano-rectal tear and anticoagulation. She was guaiac negative \nin ED. Hemolysis labs unremarkable. Retic count appropriate. \nHemoglobin trended up with diuresis and was 9.3 on ___.\n\n# Acute Kidney Injury on Chronic Kidney Disease, Stage 4: Cr 2.2 \non admission from baseline ~1.5-1.8. Cr 1.6 on discharge. \nImprovement following diuresis consistent with cardiorenal \nphysiology. Chemistry panel should be checked on ___ to \nensure creatinine is not rising with increased furosemide dose.\n\n# Advanced dementia: She was intermittently agitated and \nconfused during this admission. Continued home donezepil.\n\n# Unspecified respiratory disorder: Continued home Duonebs, \nAdvair, and Spiriva. \n\n*****TRANSITIONAL ISSUES*****\nDischarge Weight: 44.5 kg (bed weight)\nDischarge Cr: 1.6\nDischarge INR: 3.0\n- Please recheck INR on ___ and dose warfarin as necessary.  \nPlease recheck BMP on ___ to ensure stability in renal \nfunction.  \n- Please have patient follow up with Cardiologist as scheduled \non ___ @ 10:30am with Dr. ___ at ___\n- Please ensure patient is following a 2g Na restricted diet at \nnursing home.\n- NEW MEDICATIONS: Furosemide 80 MG PO DAILY, Hydralazine 20 MG \nPO TID\n# CODE STATUS: DNR/DNI (confirmed)\n# CONTACT: \n Name of health care proxy: ___, MD ___ in ___\n Relationship: granddaughter  \n Phone number: ___  \n Emergency Contact: ___ daughter ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Alendronate Sodium 70 mg PO QFRI \n2. Diltiazem Extended-Release 60 mg PO DAILY \n3. Donepezil 10 mg PO Q24H \n4. Tiotropium Bromide 1 CAP IH DAILY \n5. Warfarin 2 mg PO DAILY16 \n6. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n7. Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES BID \n8. Furosemide 40 mg PO DAILY \n9. Ipratropium-Albuterol Neb 1 NEB NEB Q12H \n10. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN SOB/WHEEZE \n11. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY \n12. Omeprazole 20 mg PO DAILY \n13. Polyethylene Glycol 17 g PO BID \n14. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation \nQ4H:PRN SOB/WHEEZE \n15. Silver Sulfadiazine 1% Cream 1 Appl TP DAILY \n16. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever \n17. Calcium Carbonate 500 mg PO DAILY \n18. FoLIC Acid ___ mcg PO DAILY \n19. Senna 8.6 mg PO DAILY:PRN CONSTIPATION \n20. Cyanocobalamin 500 mcg PO DAILY \n21. Vitamin D 1000 UNIT PO DAILY \n22. Ocuvite Eye Health (vit C-E-zinc cit-lutein-zeaxan) 50 mg-15 \nunit- 4.5 mg-2.5 mg oral DAILY\n \nDischarge Medications:\n1.  Diltiazem 15 mg PO Q6H \nPlease give 1 (ONE) dose at midnight and resume long acting \ndiltiazem 60mg ___ am  \n2.  HydrALAZINE 20 mg PO Q8H \nRX *hydralazine 10 mg 2 tablet(s) by mouth every 8 hours Disp \n#*90 Tablet Refills:*0 \n3.  Furosemide 80 mg PO DAILY \nRX *furosemide 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n4.  Warfarin 1 mg PO DAILY16 Duration: 1 Dose  \n5.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  \n6.  Alendronate Sodium 70 mg PO QFRI  \n7.  Calcium Carbonate 500 mg PO DAILY  \n8.  Cyanocobalamin 500 mcg PO DAILY  \n9.  Diltiazem Extended-Release 60 mg PO DAILY  \n10.  Donepezil 10 mg PO Q24H  \n11.  Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES BID  \n12.  Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID  \n13.  FoLIC Acid ___ mcg PO DAILY  \n14.  Ipratropium-Albuterol Neb 1 NEB NEB Q12H  \n15.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN SOB/WHEEZE  \n16.  Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY  \n17.  Ocuvite Eye Health (vit C-E-zinc cit-lutein-zeaxan) 50 \nmg-15 unit- 4.5 mg-2.5 mg oral DAILY  \n18.  Omeprazole 20 mg PO DAILY  \n19.  Polyethylene Glycol 17 g PO BID  \n20.  ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation \nQ4H:PRN SOB/WHEEZE  \n21.  Senna 8.6 mg PO DAILY:PRN CONSTIPATION  \n22.  Silver Sulfadiazine 1% Cream 1 Appl TP DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  Vitamin D 1000 UNIT PO DAILY  \n25.Outpatient Lab Work\n___\nINR\nBMP\nICD___: ___\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n-Acute on chronic left ventricular diastolic heart failure\n-Mitral Regurgitation, severe\n-Stage 4 chronic kidney disease\n-Acute kidney injury\n-Atrial fibrillation, permanent, with\n-Long-term use of anticoagulation\n-Anemia, normocytic\n-Alzheimer's Dementia\n-Type 2 diabetes mellitus\n-Hypertension\n-Dyslipidemia\n-Reactive airway disease\n \nDischarge Condition:\nMental Status: Confused - always.\nLevel of Consciousness: Lethargic but arousable.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___ \n___.  \n\nYou were admitted with worsening heart failure. While you were \nhere, we gave you diuretics, which are medications to help you \nurinate. First, we did this through your IV and then we switched \nyou to an oral regimen.  \n\nAt discharge, you weighed 44.5kg (98.1 pounds). Please weigh \nyourself every morning in lightweight clothing after urinating \nand notify your cardiologist or primary care doctor if your \nweight increases more than 2lbs in one day or 5 lbs in three \ndays.  \n\nWe wish you all the best,  \n\nYour ___ Cardiac Care team  \n \nFollowup Instructions:\n___\n"}
{"subject_id":"10169796","hadm_id":"22796824","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROSURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nL temporal lobe epilepsy\n\n \nMajor Surgical or Invasive Procedure:\nLeft temporal craniotomy for left temporal lobectomy\n\n \nHistory of Present Illness:\n___ yo M with h/o L temporal lobe epilepsy with complex\npartial seizures and occasional grand mal seizures. This started\napproximately ___ years ago and he has had increasing frequency \nof\nseizures requiring medication adjustments. He reports no recent\nseizures but does have feelings ___ which have preceded\nseizures in the past. He has been evaluated by neurology and the\nfocus of the seizures appears to come from the left temporal\nlobe. He had a recent ___ study which showed L cerebral\ndominance and R sided memory. \n\n \nPast Medical History:\nL temporal lobe epilepsy, s/p splenectomy after MVC trauma\n\n- ADHD\n\n \nSocial History:\n___\nFamily History:\nFamily Hx: Parents both abused drugs, additional history \nunknown.\nHistory of a paternal first cousin with seizures.\n \nPhysical Exam:\nGen: WD/WN, comfortable, NAD.\nNeck: Supple.\nLungs: CTA bilaterally.\nCardiac: RRR. S1/S2.\nAbd: Soft, NT\nExtrem: Warm and well-perfused. No C/C/E.\n\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect.\nOrientation: Oriented to person, place, and date.\nLanguage: Speech fluent with good comprehension and repetition.\nNo dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light, 3 to 2 mm\nbilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to finger rub bilaterally.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength full power ___ throughout. No pronator drift\n\nSensation: Intact to light touch bilaterally\n\nReflexes: B T Br Pa Ac\nRight     ___  1  1\nLeft      ___  1  1\n\nCoordination: normal on finger-nose-finger, rapid alternating\nmovements\n\nHandedness Right\n\nOn Discharge:\nA\u0026Ox3\nPERRL\ndiplopia bilaterally\nNo pronator drift\nEOMs intact\nFace symmetrical\nFull strength throughout\nIncision c/d/i\n \nPertinent Results:\nMRI head ___: 1. Incidentally noted developmental venous\nanomaly in the right frontal lobe. 2. Minimal asymmetry of the\nlateral ventricles of right larger than left. This is likely\ndevelopmental in nature. 3. No masses or cortical lesions were\nidentified. \n\nMRI head ___:\nIMPRESSION: Stable appearance of incidentally noted right \nfrontal and left \ncerebellar developmental venous anomalies. Otherwise, \nunremarkable appearance of the brain, limited presurgical \nplanning post-contrast MR sequences performed only. \n\nCT Head ___:\nFINDINGS: The patient is status post left temporal craniotomy \nand partial left temporal lobectomy, with expected post-surgical \nchanges with overlying soft tissues and pneumocephalus in the \nresection bed as well as layering non-dependently along the \nbifrontal convexities. Scattered additional foci of \npneumocephalus are seen.  \nLayering hyperdensity along the resection bed (2:11) could \nreflect small \namount of layering blood. Hypodensity in the left temporal horn \nalsolikely \nreflects a small amount of blood. The residual left temporal \nhorn is \nhypodense, which likely reflects edema. No hydrocephalus is \nseen. There is \nno shift of normally midline structures.  \nThe prior MR demonstrated that the left lateral ventricle is \nasymmetrically smaller than the right; however, it may even be \nslightly compressed giving an even smaller appearance on the \ncurrent examination.  \n  \nIMPRESSION: Status post left temporal lobectomy with \npost-surgical changes as described above, with layering blood \nalong the resection margin and in the temporal horn of the left \nlateral ventricle and slight mass effect on the left lateral \nventricle.  \n\nCT Head ___:\nIMPRESSION: Status post temporal lobectomy with interval \ndecrease in the \ndegree of pneumocephalus without other change. \n\nMRI Head ___:\nFINDINGS: The patient is status post left temporal lobectomy \nwith expected \npost-operative changes including scalp swelling, a small \nsubdural fluid \ncollection, and hyperintensity on FLAIR at the margins of the \nsurgical site.  There is also slow diffusion at the periphery of \nthe left temporal lobectomy site. In the setting of acute \nsurgery, it is impossible to distinguish surgical trauma from \npossible infarction in these areas. No other abnormalities are \ndetected. The remainder of the brain demonstrates no evidence of \nhemorrhage, edema, masses, or infarction. \n  \nCONCLUSION: Status post left temporal lobectomy with expected \npost-operative changes. Foci of slow diffusion at the margins of \nthe surgical site may reflect surgical trauma or infarction. \n\n \nBrief Hospital Course:\n___ y/o M with L temporal lobe seizures presents for elective L \ntemporal lobectomy. Patient was taken to the OR on ___. OR \ncourse was uncomplicated. Post-operatively he was admitted to \nthe ICU for monitoring. His exam remained stable and he was \ntransferred to the floor on ___. Later that day, he had an \nepisode of speech arrest and a STAT head CT was performed which \nshowed no acute intercranial process. His medications were \ncorrected to home dosing. On ___, EEG was initiated. On ___, \nhe was witnessed to have some staring spells, on EEG there was \nno seizure activity. EEG was then discontinued as it was felt \nhis seizures may not be accurately seen on EEG and to continue \nto treat clinically.\n\nOn ___ the patient's speech was much improved.  He continued to \ncomplain of double vision from his left sided ___ nerve palsy.  \nHe was seen by physical therapy and occupational therapy. OT \nrecommended changing eye patch on each eye Q2H. He was \ndetermined safe to be discharged home on ___. \n\nAt the time of discharge he was tolerating a regular diet, \nambulating without difficulty, afebrile with stable vital signs.\n \nMedications on Admission:\nLACOSAMIDE 125 mg po bid; LAMOTRIGINE 300 mg\npo bid; LORAZEPAM 0.5 mg po prn seizures, taking approximately\n1x/week; ACETAMINOPHEN prn headache\n\n \nDischarge Medications:\n1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n2. lamotrigine 100 mg Tablet Sig: Three (3) Tablet PO BID (2 \ntimes a day).  \n3. lacosamide 50 mg Tablet Sig: 2.5 Tablets PO BID (2 times a \nday).  \n4. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q4H (every 4 \nhours) as needed for pain.\nDisp:*50 Tablet(s)* Refills:*0*\n5. famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLeft temporal lobe seizures\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nHave a friend/family member check your incision daily for \nsigns of infection.\nTake your pain medicine as prescribed.\nExercise should be limited to walking; no lifting, straining, \nor excessive bending.\nYour wound closure uses dissolvable sutures, you must keep \nthat area dry for 10 days. \nYou may shower before this time using a shower cap to cover \nyour head.\nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nUnless directed by your doctor, do not take any \nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and \nIbuprofen etc. \nClearance to drive and return to work will be addressed at \nyour post-operative office visit.\nMake sure to continue to use your incentive spirometer while \nat home, unless you have been instructed not to. \n\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING\n\nNew onset of tremors or seizures.\nAny confusion or change in mental status. \nAny numbness, tingling, weakness in your extremities.\nPain or headache that is continually increasing, or not \nrelieved by pain medication.\nAny signs of infection at the wound site: redness, swelling, \ntenderness, or drainage.\nFever greater than or equal to 101 F.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11480388","hadm_id":"24593957","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nChest pain\n \nMajor Surgical or Invasive Procedure:\nCardiac catheter with DES to distal RCA\n \nHistory of Present Illness:\n___ year old male with cardiac history of hypertension and \ndyslipidemia who was in his usual state of health until this \nmorning. He reports being fairly active until he retired six \nmonths ago and has been sedentary since than. He was working in \nhis yard this morning and then took a nap in the afternoon. He \nwoke up with ___ elephant sitting on him like chest pressure \nwithout any associated symptoms. He called his wife who took him \nto ___. His EKG at ___ was concerning \nfor inferior STEMI with reciprocal depression in I and aVL. He \nwas given aspirin and plavix loaded with 600 mg x 1. He was \nsubsequently transferred to ___.\n.\nCardiac cath revealed thrombus in distal RCA, 40% left main, 40% \nmid LAD and 70% OM1. His course was complicated by one episode \nof hypotension. He received promus DES to his RCA with 0% \nresidual stenosis. He was transferred to CCU on integrillin \ndrip.\n.\nCardiac review of systems is notable for absence of dyspnea on \nexertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, \npalpitations, syncope or presyncope. \n \nPast Medical History:\n1. CARDIAC RISK FACTORS: Dyslipidemia, Hypertension  \n2. CARDIAC HISTORY:  \n- CABG:  None\n- PERCUTANEOUS CORONARY INTERVENTIONS:  None\n- PACING/ICD:  None\n3. OTHER PAST MEDICAL HISTORY:  None\n \nSocial History:\n___\nFamily History:\n- No family history of early MI, arrhythmia, cardiomyopathies, \nor sudden cardiac death; otherwise non-contributory.  \n- Mother:  ___ cancer\n- Father:  Leg cancer\n- Brother: ___ cancer\n \nPhysical Exam:\nAdmission Exam\nGENERAL: NAD. Oriented x3. Mood, affect appropriate.  \nHEENT: NCAT. Anicteric. PERRLA. EOMI\nNECK: Supple with JVP of 8 cm.  \nCARDIAC: PMI located in ___ intercostal space, midclavicular \nline. RR, normal S1, S2. No murmurs or gallops appreciated \nLUNGS: CTAB. No crackles or wheezing noted\nABDOMEN: Soft, NTND. No HSM or tenderness. \nEXTREMITIES: No c/c/e. No femoral bruits.  \nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas. \n\n \nPertinent Results:\n___ 06:40PM BLOOD WBC-10.4 RBC-4.80 Hgb-14.4 Hct-40.3 \nMCV-84 MCH-30.0 MCHC-35.7* RDW-13.3 Plt ___\n___ 06:40PM BLOOD ___ PTT-150* ___\n___ 06:40PM BLOOD Glucose-126* UreaN-20 Creat-0.9 Na-132* \nK-3.5 Cl-98 HCO3-24 AnGap-14\n___ 06:40PM BLOOD CK(CPK)-62\n\nECG:  NSR. NA. NI. Q waves and ST elevation (III \u003e II) in \ninferior leads with reciprocal depressions in I and aVL.    \n  \nECHO: The left atrium is mildly dilated. No atrial septal defect \nis seen by 2D or color Doppler. There is mild symmetric left \nventricular hypertrophy with normal cavity size and global \nsystolic function (LVEF\u003e55%). Due to suboptimal technical \nquality, a focal wall motion abnormality cannot be fully \nexcluded, but there is a suggestion of possible mid to distal \nhypokinesis of the inferolateral segments in some views . Right \nventricular chamber size is normal. with normal free wall \ncontractility. The abdominal aorta is mildly dilated. The aortic \nvalve leaflets (3) are mildly thickened but aortic stenosis is \nnot present. No aortic regurgitation is seen. The mitral valve \nleaflets are mildly thickened. The mitral valve leaflets are \nelongated. Trivial mitral regurgitation is seen. The estimated \npulmonary artery systolic pressure is normal. There is no \npericardial effusion. \n\nIMPRESSION: Normal left ventricular cavity size with mild left \nventricular hypertrophy and globally preserved systolic function \nwith possible regional wall motion abnormalities as described \nabove. Mildly dilated abdominal aorta. No clinically significant \nvalvular disease. Normal pulmonary artery systolic pressure.  \n\nCARDIAC CATH:  LMCA:40%; LAD:40% Mid; LCx:70%OM1: RCA: distal \noccluded s/p promus DES with 0% residual stenosis. \n.\nOn discharge: \n___ 07:10AM BLOOD WBC-9.9 RBC-4.94 Hgb-15.4 Hct-42.9 MCV-87 \nMCH-31.1 MCHC-35.8* RDW-13.4 Plt ___\n___ 07:10AM BLOOD ___\n___ 07:10AM BLOOD Glucose-123* UreaN-17 Creat-1.0 Na-140 \nK-4.2 Cl-106 HCO3-27 AnGap-11\n___ 07:10AM BLOOD CK(CPK)-212\n___ 02:05AM BLOOD CK(CPK)-744*\n___ 06:40PM BLOOD CK(CPK)-___ year old male with hypertension and hyperlipidemia presents \nwith inferior STEMI s/p PROMUS DES to RCA.\n.  \n# CAD:  The patient presented to OSH with acute onset CP. EKG \nshowed inferior STE. On transfer, he was taken urgently to the \ncath lab, where an RCA thrombus was visualized. He received a \nDES to the RCA. Cath was also notable for 40% LM disease, 40% \nmid-LAD lesion, and 70% OM1 lesion. CK peaked at 744. Echo \nshowed normal EF ~ 55% with hypokinesis of the inferolateral \nsegments. Integrillin was continued for 18 hours post-cath. \nDischarge regimen included ASA 325 mg, Atorvastatin 80 mg, \nPlavix 75 mg, Toprol 25 mg, and lisinopril 5 mg daily. Lipids \nwere pending at the time of discharge. \n.  \n# HTN: The patient was unsure of his home BP regimen on \nadmission. He was discharged on lisinopril 5 mg and Toprol 25 mg \nper day. \n. \nThe patient was on subQ heparin for DVT prophylaxis. He remained \nfull code. He was scheduled with PCP and cardiology ___ on \ndischarge. \n \nMedications on Admission:\nAspirin 81 mg po qdaily\nSimvastatin 20 mg po qdaily\nTwo other blood pressure medications that patient did not know. \nHCTZ/amlodipine? Pharmacy was closed.\n \nDischarge Medications:\n1. aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).\nDisp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*11*\n2. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*11*\n3. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*11*\n4. Toprol XL 25 mg Tablet Extended Release 24 hr Sig: One (1) \nTablet Extended Release 24 hr PO once a day.\nDisp:*30 Tablet Extended Release 24 hr(s)* Refills:*11*\n5. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*11*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: \nST elevation Myocardial Infarction\nHypertension\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure caring for you at the ___ \n___. You were admitted for a heart attack - an ST \nelevation MI. You had a drug-eluting stent placed into your \nright coronary artery. We started several new medications to \nhelp heal your heart and to keep your stent open. The most \nimportant medications are Plavix and Aspirin, which will help to \nprevent your stent from becoming blocked. You should never stop \nthese medications unless instructed by your cardiologist. \n. \nWe made the following changes to your medications: \nWe INCREASED Aspirin to 325 mg per day\nWe STOPPED Simvastatin\nWe STARTED Atorvastatin 80 mg per day\nWe STARTED Plavix 75 mg per day\nWe STARTED Lisinopril 5 mg per day\nWe STARTED Toprol XL 25 mg per day\n. \nYour follow-up information is listed below. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"17670296","hadm_id":"28805582","text":" \nName:  ___            Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain, nausea, vomiting\n \nMajor Surgical or Invasive Procedure:\nERCP - ___\nPercutaneous cholecystostomy tube placement - ___\n\n \nHistory of Present Illness:\nPatient is a ___ year old woman with history of HTN, COPD, GERD, \ndepression who was transferred from OSH with several days of \nabdominal pain, nausea and vomiting and found to have evidence \nof cholecystitis on imaging.\n\nShe initially presented to ___ on ___ with nausea that \nbegan the night prior, associated with several episodes of \nvomiting on the following morning. She also developed RUQ pain. \nDenies fever, vomiting, chest pain, shortness of breath. \n\nIn ED, VSS. Lab showed leukocytosis to 28, INR 1.5, lipase 343, \nAST 247, ALT 147. OSH CT showed distended gallbladder with a \ngallstone and evidence of pericholecystic inflammation, \nconsistent with cholecystitis. Seen by surgery there, and \nrecommended transfer to ___. Given cipro, flagyl, morphine \nand Zofran prior to transfer. ACS and ERCP made aware of \npatient. Of note, patient is DNR/DNI with MOLST form, which was \nreversed temporarily for the procedure.\n\nShe underwent ERCP today with sphincterotomy, with removal of \nsludge/CBD stones fragments. There was evidence of a small \namount of contrast extravasation adjacent to the CBD concerning \nfor a small tear. Thus a metal biliary stent was placed \nsuccessfully as a means of closure.  Received dilaudid 0.25mg x1 \nand zofran 4mg x1 prior to transfer.\n\nOn arrival to floor, noted to be tachycardic to 110s, satting \n95% on 3L. Denies pain or nausea. Reprots feeling very fatigued. \nAlso reports mild abdominal tenderness diffusely.\n \nPast Medical History:\nCOPD\nHLD\nHTN\nDepression\nHistory of generalized tonic clonic seizure\nGlaucoma\nSpondylosis w/o myelopathy or radiculopathy, lumbar region\nChronic constipation\nMigraines\nGERD\n\nPSH:\nHysterectomy\nAppendectomy\nCataract surgery\nR TKR\n \nSocial History:\n___\nFamily History:\nNo family history of gallbladder disease\n \nPhysical Exam:\nADMISSION \nGen: NAD, appears very fatigued, pleasant\nEyes: EOMI, no scleral icterus\nHENT: NCAT, trachea midline\nCV: RRR, S1-S2, no m/r/g, no edema, 2+ ___ BLE\nLungs: CTA B, no w/r/c\nGI: +BS, soft, mildly tender to palpation diffusely, worst at \nRUQ. Negative ___ sign\nGU: No foley\nMSK: ___ strength bilaterally, intact ROM\nNeuro: Moving all extremities, no focal deficits\nSkin: Multiple seb keratosis lesions. Bruising bilaterally on \nanterior shins\n\nDISCHARGE\nVS: 98.5 157/69 69 18 93%RA \nGen - sitting up in bed, comfortable\nEyes - EOMI\nENT - OP clear, MMM\nHeart - RRR no mrg\nLungs - CTA bilaterally\nAbd - soft nontender, normoactive bowel sounds; improved from \nyesterday\nExt - no edema\nSkin - no rashes\nVasc - 2+ DP/radial pulses\nNeuro - AOx2 (full name, ___), moving all extremities\nPsych - appropriate\n\n \nPertinent Results:\nADMISSION \n___ ___\nNa 137, Cl 104, K 4.2, HCO3 23, Cl 104, BUN 22, Cr 0.7\nINR 1.5\nLipase 343, ALb 3.1, AKLP 130, ALT 117\nWBC 26.8, Hgb 13.5, Plt 284 \nLactate 1.7\n\n___ 03:41AM   ___ PTT-29.9 ___\n___ 02:25AM   GLUCOSE-92 UREA N-25* CREAT-0.9 SODIUM-139 \nPOTASSIUM-3.8 CHLORIDE-101 TOTAL CO2-21* ANION GAP-21*\n___ 02:25AM   ALT(SGPT)-197* AST(SGOT)-247* ALK PHOS-164* \nTOT BILI-3.1*\n___:25AM   LIPASE-138*\n___ 02:25AM   ALBUMIN-3.2*\n___ 02:25AM   WBC-28.0* RBC-4.37 HGB-13.3 HCT-41.4 MCV-95 \nMCH-30.4 MCHC-32.1 RDW-14.1 RDWSD-48.9*\n___ 02:25AM   NEUTS-81.0* LYMPHS-6.5* MONOS-10.7 EOS-0.0* \nBASOS-0.2 IM ___ AbsNeut-22.68* AbsLymp-1.83 AbsMono-3.00* \nAbsEos-0.00* AbsBaso-0.07\n\nCT OSH:\nDistended gallbladder with a gallstone and evidence of \npericholecystic inflammation, consistent with cholecystitis\n\nTTE ___\nThe left atrial volume index is mildly increased. The estimated \nright atrial pressure is ___ mmHg. Left ventricular wall \nthickness, cavity size, and global systolic function are normal \n(LVEF\u003e55%). Right ventricular chamber size and free wall motion \nare normal. The aortic valve leaflets are moderately thickened. \nThere is no aortic valve stenosis. No aortic regurgitation is \nseen. The mitral valve leaflets are mildly thickened. Mild (1+) \nmitral regurgitation is seen. There is mild pulmonary artery \nsystolic hypertension.  \n\nGB Drainage ___\nSuccessful ultrasound-guided placement of ___ pigtail \ncatheter into the gallbladder. Sample was sent for microbiology \nevaluation. \n\nERCP ___\nCannulation of the biliary duct was successful and deep with a \nsphincterotome using a free-hand technique. Contrast medium was \ninjected resulting in complete opacification. The procedure was \nnot difficult \nThe common bile duct, common hepatic duct, right and left \nhepatic ducts, and biliary radicles were filled with contrast \nand well visualized.  \nThere was evidence of mid CBD filling defects consistent with \nsludge/CBD stones.  \nThe course and caliber of the structures are otherwise normal \nwith no evidence of extrinsic compression, no ductal \nabnormalities, and no additional filling defects  \nA sphincterotomy was performed in the 12 o'clock position using \na sphincterotome. \nThe sphincterotome was exchanged for extraction balloon \ncatheter. Balloon sweeps were performed and yielded sludge and \nstone fragments.  \nAdditional sweeps were performed until only bile was obtained.  \n\nPost balloon sweeps there was evidence of a small amount of \ncontrast extravasation adjacent to the CBD concerning for a \nsmall tear.  \nA WallFlex fully covered RX 8mm x 60 mm biliary stent (REF: \n___, ___ was placed successfully as a means of \nclosure.\n\n \nBrief Hospital Course:\nThis is an ___ year old female with past medical history of \ndementia, hypertension, COPD, admitted ___ with \ncholedocholithiasis with obstruction, as well as acute \ncholecystitis, acute cholangitis, and acute pancreatitis \nsecondary to gallstones, status post ERCP and cholecystostomy \ntube placement on ___, on antibiotics with clinical \nimprovement\n\n# Sepsis / Choledocholithiasis with obstruction, acute \ncholecystitis, acute cholangitis - Patient initially presented \nwith significant leukocytosis and LFT abnormalities with CT \nfindings of cholecystitis. She was treated with antibiotics and \ndecompressed from below with ERCP, sphincterotomy and balloon \nextraction.  Given concurrent acute cholecystitis she was seen \nby general surgery who recommended antibiotics and ___ drainage.  \n___ evaluated and successfully placed ultrasound guided \npercutaneous cholecystostomy tube.  She improved \nsymptomatically, and LFTs, WBC and fever curve normalization.  \nContinued ciprofloxacin and flagyl with plan to complete course \nat rehab on ___. Scheduled for repeat ERCP for stent pull \nand re-evaluation.  Scheduled for surgery follow-up with Dr. \n___ discussion / assessment regarding cholecystectomy. \n   \n# Acute Hypoxic Respiratory Failure - Developed acute hypoxemic \nrespiratory failure requiring 3L NC. Likely related to acute \npulmonary edema from iatrogenic fluid administration in setting \nof sepsis. Hypoxia resolved as clinical status improved. \n \n# Hypertension - Home regimen held initially due to sepsis but \nrestarted back on home regimen (Captopril, Metoprolol) once \nstabilized.  \n \n# History of Hx seizure disorder - Continued home LevETIRAcetam \n \n# Depression - continued home sertraline \n  \n# HLD - Continued home simvastatin \n\n# GERD - Continued home PPI\n\n# Glaucoma - continue latanoprost\n\nTransitional Issues:\n# NOK: Son ___ ___\n- Is scheduled for follow-up with ERCP for stent pull and \nre-evaluation\n- Is scheduled for follow-up with Dr. ___ evaluation / \ndiscussion re: cholecystectomy\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. butalbital-aspirin-caffeine 50-325-40 mg oral Q6H:PRN \n2. Captopril 25 mg PO TID \n3. Vitamin D ___ UNIT PO DAILY \n4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n5. LevETIRAcetam 1000 mg PO BID \n6. Sertraline 50 mg PO DAILY \n7. Simvastatin 20 mg PO QPM \n8. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY \n9. Metoprolol Tartrate 25 mg PO BID \n\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q8H:PRN Pain - Mild  \n2.  Ciprofloxacin HCl 500 mg PO Q12H \nLast day ___  \n3.  MetroNIDAZOLE 500 mg PO Q8H \nlast day ___  \n4.  Captopril 25 mg PO TID  \n5.  Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY  \n6.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  \n7.  LevETIRAcetam 1000 mg PO BID  \n8.  Metoprolol Tartrate 25 mg PO BID  \n9.  Sertraline 50 mg PO DAILY  \n10.  Simvastatin 20 mg PO QPM  \n11.  Vitamin D ___ UNIT PO 1X/WEEK (FR)  \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n# Choledocholithiasis with obstruction, acute cholecystitis, \nacute cholangitis\n# Hypertension\n# Seizure disorder\n# GERD\n# Glaucoma\n# Hypertension\n# Depression\n# Hyperlipidemia\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nMs. ___,\n\nIt has been a pleasure taking care of you at ___.  You were \nadmitted with an infection of your gallbladder (cholecystitis) \nand an infection of your biliary ducts (cholangitis).  This was \nmost likely caused by a blockage in the ducts draining your \ngallbladder (a gallstone).  You were seen by biliary specialists \nand surgeons.  You were treated with antibiotics and procedures \nto drain the infection and remove the blockage (\"ERCP\" and \n\"cholecystostomy tube\").  You improved and are now ready for \ndischarge. \n\nThe drain will treat your infection until you see the surgeon \nDr. ___ in surgery clinic in 2 weeks. At that time he will \nevaluate whether you will need your gallbladder removed and the \ndrain removed. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"12498717","hadm_id":"24092015","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nCC: abdominal pain, nausea, vomiting\n \n\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nHPI: Ms. ___ is a ___ y/o at ___'1 with a history of Hep C and \ndepression, here with right-sided abdominal pain and \nnausea/vomiting.  She reports constant ___ right-sided \nabdominal pain that does not change with eating, movement, and \nis not relieved by tylenol. She was seen in triage yesterday for \nsimilar complaints and had lab work notable for ALT 56, Hct \n28.3, otherwise normal. She was given one dose of Indocin \nwithoutimprovement in her symptoms, and was given 5mg oxycodone \nwith improvement in her symptoms. She was also recommended to \nfollow-up with GI today. \n\nShe reports that she went home last night and after the \noxycodonehad worn off, she developed nausea and vomiting and was \nunable to keep food or liquids down. She was seen at ___ GI \ntoday, and had normal bloodwork and UA, and urine culture was \ncollected. She was recommended for an abdominal ultrasound, \nhowever per patient, she was in too much pain to have the \nprocedure done today. She denies fevers, chills, urinary \nsymptoms, chest pain, shortness of breath. Reports + FM, no \ncontractions, VB or LOF. \n\nOf note, per the patient, she is also s/p MRI x 2 (most recently \ndone on ___ at ___, showing 4cm fibroid, otherwise \nnormal). Per her ___ documentation, she has had work-up for \nthis pain at three different hospitals thus far. \n\n\n\n--------------- --------------- --------------- ---------------\nActive Medication list as of ___:\n\nMedications - OTC\nDOCUSATE SODIUM [COLACE] - Colace 100 mg capsule. 1 capsule(s) \nby\nmouth daily take with iron.  You may increase dose to twice a \nday\nif constipation is a problem with once daily dosing\nFERROUS SULFATE [FEOSOL] - Feosol 325 mg (65 mg iron) tablet. 1\ntablet(s) by mouth daily Take with Colace\nGabapentin 300mg TID\n--------------- --------------- --------------- ---------------\nAllergies (Last Verified ___ by ___:\nPatient recorded as having no known allergies to drugs           \n\n\n\nA/P: ___ yo G3P1 at 26w1d here with persistent abdominal pain, \nnausea, and vomiting. \n\n*) Abdominal pain, N/V\n- IVF if unable to tolerate PO\n- Zofran, pepcid PRN\n- Avoid narcotics, avoid Tylenol given elevated ALT in setting \nof Hep C\n- s/p normal CBC, Chem ___, no plan for further labs\n[ ] Abdominal ultrasound, pelvic ultrasound\n\n*) Hep C\n- new diagnosis this pregnancy\n- ALT 56 (___), avoid tylenol\n\n*) Dispo: admit to Antepartum for observation overnight\n\n\nDiscussed with Dr. ___\n\n___, MD, ___\nObstetrics and Gynecology, PGY2\n___ ___\n\n___ MD addendum\n___ seen and examined.  Briefly she is a ___ yo G2P1 at 26+1 \nwith acute on chronic abdominal pain.  She has had a thorough \nevaluation in multiple EDs and with GI.  No etiology defined. \nShe has had ___ MRIs, most recent on ___ and she notes that the \npain has not changed since then.  Denies fevers, hematuria.  Ddx \nis broad and many diagnoses have already been explored including \nappy, kidney stones, degenerating fibroid.  Will obtain \nabdominal ultrasound per GI recs this morning and pelvic \nultrasound to eval ovaries.  Offered overnight admission for obs \ngiven multiple presentations with same complaint.  Accepted by \npatient.  All questions answered.\n\nAdmission  (Full documentation of this service is in the \nhospital record. This is a brief summary)\n    Date:  ___\n    Admitting clinician:  ___, MD          \n    Presented to ___ \n    On site/collaborating MD:  not applicable\n    Admission level: 2\n    GA: 26w1d\n    Studies:  \n    \n      NST: Indication: abdominal pain\n      Baseline: 140's\n      Variability: moderate\n      Accelerations: consistent with gestational age\n      Decelerations: none\n      Contractions: none\n      Duration of the NST was 15 minutes\n      Impression: appropriate for gestational age\n      Read \u0026 Interpreted by: ___, MD\n\n    Diagnosis(es):  Abdominal pain at 26 weeks gestation\n\nResident attestation:  I evaluated this patient in conjunction \nwith the resident.  I was personally present for key portions of \nthis visit, which included formation of assessment and plan.  \nDiscussed with resident and agree with their findings and plan \nas documented in their note.\n\n\n \nPast Medical History:\nPNC:\n- ___ ___ by ___\n- Labs: Rh +, HIV neg, Hep B neg, RPR neg, RI\n- FFS: normal\n- Screening: LR ERA\n- Issues: Chlamydia infection in early pregnancy, s/p treatment \nwith neg TOC.\n- Multiple triage visits for abdominal pain/N/V\n- New Hep C diagnosis in pregnancy, per patient, plan to defer \ntreatment until after delivery\n \nOB History:\nSVD x 1, term, uncomplicated\nSAB with D\u0026C\n \nGyn history: denies fibroids, endometriosis, ovarian cysts or \nother GYN diagnoses\n \nPMH: Hep C (diagnosed in this pregnancy), Depression, \nFibromyalgia, h/o depression/anxiety previous hospitalization \nfor suicide attempt age ___, PP depression in setting of breakup \nwith FOB 2 weeks PP, currently no meds or therapist, reports \nstable mood, lumbar disc disease\nPSH: denies\n \n\n \nSocial History:\nPatient screened for DV without boyfriend in room; denies \nconcerns for abuse or safety in her relationship. \n \n\n \nPhysical Exam:\nPhysical Exam:\n \nVitals: ___ 15:09                       MHR: 77\n          ___ 14:23                  Resp.: 18 / min\n          ___ 14:23                  Temp.: 97.9F\n          ___ 14:15                  BP: 110/58 (71)\nGen: Gravid well developed, well nourished female,\nappearing in no acute distress\nAbdomen: no masses, no palpable organomegaly, gravid, no fundal\ntenderness, mild right mid abdominal tenderness to deep\npalpation, no rebound, no guarding, no abdominal distention\nExt: symmetric, non-tender, no edema\nPelvic exam: deferred given no contractions\n \nToco: no ctx\n  \n\n \nBrief Hospital Course:\npt was admitted for recurrence and persistence of abd pain\nabd U/S and pelvic U/S were obtained which were negative \n(appendix visualized)\nlabs normal\npt with benign and non-acute exam entire hospitalization; always \nafebrile with VSS\npt did receive oxycodone X 1 on HD#1\netiology at end of hospitalization unclear but no s/sx of acute \nprocess and pt always looked well\n \nMedications on Admission:\nMedications - OTC\nDOCUSATE SODIUM [COLACE] - Colace 100 mg capsule. 1 capsule(s) \nby\nmouth daily take with iron.  You may increase dose to twice a \nday\nif constipation is a problem with once daily dosing\nFERROUS SULFATE [FEOSOL] - Feosol 325 mg (65 mg iron) tablet. 1\ntablet(s) by mouth daily Take with Colace\nGabapentin 300mg TID\n\n \nDischarge Medications:\ngabapentin 400 mg po TID\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nabdominal pain\n\n \nDischarge Condition:\nActivity Status: Ambulatory - Independent.\nLevel of Consciousness: Alert and interactive.\nMental Status: Clear and coherent.\n\n \nDischarge Instructions:\ncall for worsening persistent abdominal pain, fevers, persistent \nvomitting\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15157126","hadm_id":"29373958","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics)\n \nAttending: ___.\n \nChief Complaint:\nmechanical fall\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ PMHx of recurrent VTE, now presents s/p mechanical fall on \n___ on broken sidewalk presents to the ED c/o R knee, L elbow, \nL wrist, and tooth pain.  Prior to arrival she also complained \nsome mild chest discomfort on deep inspiration that began after \nher fall.  Patient reports that she fell fowrad on her \nnose/mouth, did not hit the back of her head. She denied LOC.   \nIn the ED, initial vital signs were: T 98.5 P 86 BP 119/62  R 18 \nO2 sat 96% RA. Labs were notable for therapeutic INR of 2.3.  \nPatient complained of nausea.  Exam notable for scattered \nabrasions to L ulnar hand, contusion over the thenar eminance, \nno snuff box tenderness.  There is a skin tear over the R knee \nwith limited ROM secondary to pain. X-ray showed right patellar \nfracture. NCHCT showed no acute intracranial process. Patient \ninitially held in observation. In the morning the patient is c/o \nheadache which she attributed to the oxycodone, though it was 5 \nhours after she had taken it. She also had several episodes of \nemesis relieved by Zofran. Repeat heat CT showed no sign of ICH. \nPatient admitted after being unable to tolerate PO. \n\nPatient is on lifelong Coumadin afetr several episodes of DVT on \nin ___ and a second episode in ___.  She has been tested for \nhypercoagulable states but was on Coumadin for the test so \nresults were invalid.  She is followed by hematologist Dr. ___ \n___ at ___.\n\nOn evaluation on the medical floor, patient reports headache \nmuch improved (now ___, she is no longer nauseous and is very \nthirsty.  She still complains of right sided rib pain that hurts \nwhen she moves.  Denies abdominal pain, pain on urination, chest \npain, SOB. \n\nROS: 10 point ROS negative, except as mentioned above in HPI.\n\n \nPast Medical History:\nrecurrent VTE, on lifelong Coumadin\nviral meningitis\nhypothyroidism\nSVT\n\n \nSocial History:\n___\nFamily History:\nMother - COPD, CHF (deceased)\nFather - ___, carotid stenosis (deceased)\nBrother - MI @ ___ (deceased)\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: T98.3, BP 103/36, HR 65, RR 18, Sat 98%RA\nGeneral: well appearing, NAD\nHEENT: normocephalic, atraumatic, tenderness along nasal bridge, \nnares patent, no hematoma\nCV: RRR no m/r/g\nLungs: CTA b/l\nChest: no tenderness to palpation along ribs, no contusion or \necchymyosis\nAbdomen: soft, non tender\nExt: right leg in fixed extension, left leg \nNeuro: pupils are equal and reactiveCN II-XII intact, no \npronator drift, no orbiting on arm rotation, Exam of right ___ \nlimited by pain left ___ ___ strength, ___ strength in upper \nextremity\nMSK: full ROM and strength in upper extremities\nSkin: multiple echymyotic lesions on arms b/l\n\nDISCHARGE PHYSICAL EXAM\nVitals: T98.7, BP 110/44-122/61, HR 61, RR 18, Sat 98%\nGeneral: sitting in bed, NAD, pleasantly conversant\nHEENT: normocephalic, atraumatic, tenderness along nasal bridge, \nnares patent, no hematoma\nLungs: CTA b/l \nCV: RRR\nAbdomen: soft, NT\nExt: right leg in brace, right ankle swollen, non-tender, \npalpable pulses but warm, left leg unremarkable\nNeuro: CN II-XII intact, pupils equal and reactive, ___ strength \nin upper extremities b/l\n \nPertinent Results:\nINITIAL LABS:\n___ 12:45PM   ___ PTT-43.3* ___\n___ 12:45PM   PLT COUNT-209\n___ 12:45PM   NEUTS-65.7 ___ MONOS-5.5 EOS-1.0 \nBASOS-0.6\n___ 12:45PM   WBC-6.9 RBC-4.96 HGB-15.4 HCT-47.5 MCV-96 \nMCH-31.1 MCHC-32.5 RDW-14.5\n___ 12:45PM   estGFR-Using this\n___ 12:45PM   GLUCOSE-97 UREA N-15 CREAT-0.8 SODIUM-140 \nPOTASSIUM-3.6 CHLORIDE-101 TOTAL CO2-32 ANION GAP-11\n\nDISCHARGE LABS: \n___ 07:00AM BLOOD WBC-4.9 RBC-4.21 Hgb-13.1 Hct-40.5 MCV-96 \nMCH-31.2 MCHC-32.4 RDW-14.7 Plt ___\n___ 07:00AM BLOOD Plt ___\n___ 07:00AM BLOOD ___ PTT-33.5 ___\n___ 07:00AM BLOOD Glucose-86 UreaN-6 Creat-0.4 Na-140 K-3.8 \nCl-106 HCO3-26 AnGap-12\n___ 07:00AM BLOOD Calcium-7.7* Phos-2.8 Mg-1.9\n___ 06:45AM BLOOD ___\nIMAGING STUDIES:\n___ CXR PA/lateral:\nIMPRESSION:\nNo acute cardiopulmonary process.\n.\n___  KNEE (AP, LAT \u0026 OBLIQUE) RIGHT \nIMPRESSION:\nMildly comminuted patellar fracture with associated \nlipohemarthrosis.\n.  \n___ ELBOW LEFT X-ray\nIMPRESSION:\nNormal exam.\n.\n___ Left Wrist X-ray\nIMPRESSION:\nNo evidence of fracture or dislocation of the left wrist.\n.\n___ PELVIS + HIP X-ray\nIMPRESSION:\n1. No acute findings.\n2. Mild degenerative changes of the hips.\n.\n___ CT HEAD\nIMPRESSION:\nNo acute intracranial process\n.  \n___ CT HEAD \nIMPRESSION:\nNo acute intracranial process and no change from 19 hr prior.\n.\n___ Left Rib series\nIMPRESSION:\n1. Possible nondisplaced fractures of the lateral fourth and \nfifth ribs.\n2. Possible healing fracture of the distal left tenth rib.\n3. No pneumothorax.\n4. Small area of increased density in the left lung base, likely \natelectasis.  Followup radiographic examination is suggested to \nassess resolution.\n.\n___ Right lower extremity US\nIMPRESSION:\nNo evidence of deep venous thrombosis in the right lower \nextremity veins. \n \nBrief Hospital Course:\n___ year old female with history of osteoporosis, DVTx3 presents \nafter a mechanical fall on ___ with LOC, found to have a right \npatellar fracture. \n\nACUTE ISSUES: \n# Mechanical fall - Patient suffered a mechanical fall due to an \nuneven sidewalk.  She did not hit the back of her head, no loss \nof consiousness.  The patient developed intractable \nnausea/vomiting with headache; serial noncontrast head CTs in \nthe ED were not revealing of any head bleeds and her symptoms \nwere felt to be consistent with a post-concussive syndrome. The \npatient did suffer a R patellar fracture per below.  \n\n# R patellar fracture - Found to have non-displaced comminuted R \npatellar fracture, with flexor and extensor function intact. \n___ brace was placed by Orthopedics; brace is to remain \nlocked in full extension at all times and the patient is \nweight-bearing as tolerated.  She did not require surgical \nintervention while hospitalized and pain was well controlled \nwith Tylenol.  She will follow-up with Ortho as an outpatient.  \nThe patient was evaluated by ___ while in-house and will require \nrehab due to decreased functional mobility.\n\n#Rib fractures - patient complained of left sided rib pain. Rib \nseries revealed non displaced new ___ and ___ left rib fractures \nwith healing 10th rib fractures.  She only required Tylenol for \npain control. \n \n# History of multiple DVTs - all DVTs seem to have been \nprovoked. She was told by her outpatient hematologist that she \nwill require lifelong anticoagulation because of her history of \nmultiple DVTs.  She was continued on her home Coumadin and her \nINR was within therapeutic range.  She is interested in further \ndiscussion regarding the new anticoagulants.\n\n# RLE swelling - Patient noted to have some increased RLE \nswelling thought to be ___ fracture and placement ___ \nbrace.  INR was therapeutic throughout hospitalization and RLE \nultrasound showed no evidence of a DVT.\n\nCHRONIC ISSUES: \n# Hypothyroidism - continued home levothyroxine 125 mcg daily\n\n# HLD - continued on simvastatin 20 mg daily\n\n***TRANSITIONAL ISSUES***\n-Patient expressed interest in different anticoagulation \nregimens.  She should discuss these issues with her outpatient \nhematologist. \n-Please consider a repeat CXR in 1 month to assess for \nresolution of LLL infiltrate seen on left rib series X-ray, to \nassess for resolution of the infiltrate, if clinically \nindicated.\n-f/u with Orthopedics Clinic\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Levothyroxine Sodium 125 mcg PO DAILY \n2. Warfarin 1.25 mg PO DAYS (___) \n3. Warfarin 2.5 mg PO DAYS (___) \n4. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n5. Simvastatin 20 mg PO DAILY \n\n \nDischarge Medications:\n \n\n1. Levothyroxine Sodium 125 mcg PO DAILY \n2. Simvastatin 20 mg PO DAILY \n3. Warfarin 1.25 mg PO DAYS (___) \n4. Warfarin 2.5 mg PO DAYS (___) \n5. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n6. Acetaminophen 325-650 mg PO Q6H:PRN pain \n7. TraMADOL (Ultram) 50 mg PO Q6H:PRN breakthorugh pain \nRX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*15 Tablet Refills:*0\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nFinal Diagnosis: \nmechanical fall\npatella fracture\n\nSecondary Diagnosis:\nRecurrent deep venous thromboses\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Dr. ___, \n\n___ were admitted to the hospital after ___ fell on the sidewalk \nand hit your face.  In the ED ___ were found to have a patella \nfracture and was seen by orthopedic surgery who immobilized ___ \nknee; ___ did not require any surgical intervention for your \nfracture.  While in the ED ___ developed worsening headache, \nnausea and photophobia with inability to keep food down, most \nlikely from a post-concussive syndrome.  ___ were monitored and \ntreated with zofran for nausea and tramadol and tyelenol for \npain control.  ___ can continue to take these medications aftre \ndischarge for symptom control as ___ recover. Thankfully, head \nCT did not show any sign of a head bleed so ___ were restarted \non your home coumadin. ___ were also seen by physical therapy \nwhile inpatient who felt that ___ would benefit from rehab. \nWhile ___ were admitted ___ developed some right foot swelling.  \nWe did an ultrasound study of your right leg which did not show \nsigns of a clot. \n\n___ also had a rib x-ray done and was found to have a new \nnon-displaced fracture of two ribs on the left side which causes \n___ pain when ___ take a deep breath and move.  We normally \ntreat rib fractures with pain control.  Please continue to take \ntylenol after your discharge for pain control. \n\nThank ___ for allowing us to participate in your care.\n\nAll the best, \nYour ___ care team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19258601","hadm_id":"25304216","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nTable saw injury to the left hand including the left long, ring, \nand small fingers -- with lacerations of long and ring fingers,\nlaceration of small finger nail bed, and multiple phalangeal\nfractures\n \nMajor Surgical or Invasive Procedure:\n___ with Dr. ___\n\n1.  Small finger nail bed repair.\n 2.  Left ring finger irrigation and debridement with excision\n of necrotic bone; Primary DIP joint arthrodesis; Repair of the \nulnar digital nerve; nail bed repair.\n 3.  Left long finger irrigation and debridement of an open\n fracture down to bone with excision of necrotic fragments. \nRepair of the ulnar digital nerve, Repair of the radial digital \nnerve, Repair of the radial digital artery, Nail bed repair.\n\n \nHistory of Present Illness:\nCC: left long, ring finger partial laceration by table saw\n\nHPI:\n___ is a ___ year old male who was cutting a piece of\nplastic on a table saw earlier today he sliced his left hand on\nthe saw.\n\nHe has not eaten or had anything to drink since this morning.  \n\nHe takes lisinopril 40 and allopurinol ___ daily.\n\nHe received tetanus shot and ancef. \n\nOf note, he endorses prior injuries to left hand including thumb\nfingertip injury treated by secondary intention, index fingertip\ninjury. These have left him insensate at fingertips of index and\nthumb on the left. \n\nHe is married with children. Lives with wife in ___. Denies\nsmoking. social alcohol use. denies drug use. active in ___ as ___, ___ in ___ and ___. \n\nROS: as mentioned in the HPI, and otherwise negative in the\nfollowing systems: constitutional, skin, heme, lymphatic,\nneurological, psychiatric, HEENT, pulmonary, cardiac,\ngastrointestinal, genitourinary, musculoskeletal, endocrine, and\nallergic/immune.\n\n \nPast Medical History:\nProblems  (Last Verified - None on file):\nGout, hypertension                                           \n\nPSH:\n\nbilateral TKR ___\nlaminectomy ___                         \n\nMedications:\nas above\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nTemp: 98.3 PO BP: 147/88 HR: 70 RR: 18 O2 sat: 95%\nO2 delivery: Ra \nPatient well-appearing \nNAD\nLeft hand in splint; all exposed finger tips with cap refill \u003c2\nseconds\nPatient endorses improving sensation throughout exposed \nfingertips, though no sensation to light touch at the ulnar and \nradial aspects of the distal long finger, sensation of the ___ \nand ___ digits intact distally\n \nPertinent Results:\n___ 04:23AM BLOOD WBC-10.5* RBC-3.62* Hgb-11.2* Hct-34.1* \nMCV-94 MCH-30.9 MCHC-32.8 RDW-13.8 RDWSD-47.5* Plt ___\n___ 03:30PM BLOOD WBC-9.1 RBC-4.39* Hgb-13.8 Hct-41.0 \nMCV-93 MCH-31.4 MCHC-33.7 RDW-13.5 RDWSD-46.5* Plt ___\n___ 04:23AM BLOOD Neuts-71.4* Lymphs-17.5* Monos-9.9 \nEos-0.5* Baso-0.3 Im ___ AbsNeut-7.49* AbsLymp-1.84 \nAbsMono-1.04* AbsEos-0.05 AbsBaso-0.03\n___ 03:30PM BLOOD Neuts-78.0* Lymphs-14.0* Monos-7.2 \nEos-0.3* Baso-0.3 Im ___ AbsNeut-7.06* AbsLymp-1.27 \nAbsMono-0.65 AbsEos-0.03* AbsBaso-0.03\n___ 10:16AM BLOOD PTT-PND\n___ 04:23AM BLOOD Plt ___\n___ 03:30PM BLOOD Plt ___\n___:30PM BLOOD ___ PTT-25.2 ___\n___ 04:23AM BLOOD Glucose-118* UreaN-14 Creat-0.8 Na-140 \nK-3.9 Cl-105 HCO3-26 AnGap-9*\n___ 03:30PM BLOOD Glucose-97 UreaN-15 Creat-0.8 Na-140 \nK-4.5 Cl-103 HCO3-25 AnGap-12\n___ 04:23AM BLOOD Calcium-8.4 Phos-4.3 Mg-2.1\n \nBrief Hospital Course:\nThe patient presented to the emergency department and was \nevaluated by the hand surgery team. The patient was found to \nhave Table saw injury to the left hand including the left long, \nring, and small fingers -- with lacerations of long and ring \nfingers,\nlaceration of small finger nail bed, and multiple phalangeal\nfractures and was admitted to the orthopedic surgery service. \nThe patient was taken to the operating room on ___ with Dr. \n___:\n1.  Small finger nail bed repair.\n 2.  Left ring finger irrigation and debridement with excision\n of necrotic bone; Primary DIP joint arthrodesis; Repair of the \nulnar digital nerve; nail bed repair.\n 3.  Left long finger irrigation and debridement of an open\n fracture down to bone with excision of necrotic fragments. \nRepair of the ulnar digital nerve, Repair of the radial digital \nnerve, Repair of the radial digital artery, Nail bed repair\n which the patient tolerated well. For full details of the \nprocedure please see the separately dictated operative report. \nThe patient was taken from the OR to the PACU in stable \ncondition and after satisfactory recovery from anesthesia was \ntransferred to the floor. The patient was initially given IV \nfluids and IV pain medications, and progressed to a regular diet \nand oral medications by POD#1. The patient was given \n___ antibiotics and anticoagulation per routine. The \npatient's home medications, with the exception of lisinopril and \nallopurinol were continued throughout this hospitalization.  The \n___ hospital course was otherwise unremarkable.\n\nAt the time of discharge the patient's pain was well controlled \nwith oral medications, incisions were clean/dry/intact, and the \npatient was voiding/moving bowels spontaneously. The patient is \nnon weight bearing in the left upper extremity in splint to be \nworn until follow-up. He will continue on PO Augmentin for 5 \ndays from discharge. The patient will follow up with Dr. \n___ routine. A thorough discussion was had with the \npatient regarding the diagnosis and expected post-discharge \ncourse including reasons to call the office or return to the \nhospital, and all questions were answered. The patient was also \ngiven written instructions concerning precautionary instructions \nand the appropriate follow-up care. The patient expressed \nreadiness for discharge.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Allopurinol ___ mg PO DAILY \n2. Lisinopril 40 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO 5X/DAY \nRX *acetaminophen 650 mg 1 tablet(s) by mouth 5 times daily Disp \n#*60 Tablet Refills:*0 \n2.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 5 Days \nRX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by \nmouth twice daily Disp #*10 Tablet Refills:*0 \n3.  Aspirin 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*28 \nTablet Refills:*0 \n4.  Gabapentin 300 mg PO TID \nRX *gabapentin 300 mg 1 capsule(s) by mouth three times a day \nDisp #*90 Capsule Refills:*0 \n5.  OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain \nRX *oxycodone 5 mg 0.5 to 1 tablet(s) by mouth every four (4) \nhours Disp #*28 Tablet Refills:*0 \n6.  Allopurinol ___ mg PO DAILY  \n7.  Lisinopril 40 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nTable saw injury to the left hand including the left long, ring, \nand small fingers -- with lacerations of long and ring fingers,\nlaceration of small finger nail bed, and multiple phalangeal\nfractures\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nINSTRUCTIONS AFTER HAND/UPPER EXTREMITY SURGERY:\n\n- You were in the hospital for hand surgery. It is normal to \nfeel tired or \"washed out\" after surgery, and this feeling \nshould improve over the first few days to week. \n- Resume your regular activities as tolerated, but please follow \nyour weight bearing precautions strictly at all times.\n\nACTIVITY AND WEIGHT BEARING:\nNonweightbearing to the left upper extremity in a splint to be \nworn until follow-up appointment \n\nMEDICATIONS:\n- Please take all medications as prescribed by your physicians \nat discharge.\n- Continue all home medications unless specifically instructed \nto stop by your surgeon.\n- Do not drink alcohol, drive a motor vehicle, or operate \nmachinery while taking narcotic pain relievers.\n- Narcotic pain relievers can cause constipation, so you should \ndrink eight 8oz glasses of water daily and take a stool softener \n(colace) to prevent this side effect.\n-- you will continue to take the antibiotic AUGMENTING for the \nnext 5 days to protect you from infection, please be sure to \ntake this medication as prescribed\n\nWOUND CARE:\n- You may shower. No baths or swimming for at least 4 weeks.\n- Any stitches or staples that need to be removed will be taken \nout at your 2-week follow up appointment.\n- Please remain in your dressing and do not change unless it is \nvisibly soaked or falling off.\n- Splint must be left on until follow up appointment unless \notherwise instructed\n\nSPLINT CARE:\n- Do NOT get splint wet\n- Please remain in the splint until follow-up appointment.  \nAgain, please keep your splint dry at all times.  If you have \nconcerns regarding your splint, please call the clinic at the \nnumber provided.\n\nDANGER SIGNS:\nPlease call your PCP or surgeon's office and/or return to the \nemergency department if you experience any of the following:\n- Increasing pain that is not controlled with pain medications\n- Increasing redness, swelling, drainage, or other concerning \nchanges in your incision\n- Persistent or increasing numbness, tingling, or loss of \nsensation\n- Fever ___ 101.4\n- Shaking chills\n- Chest pain\n- Shortness of breath\n- Nausea or vomiting with an inability to keep food, liquid, \nmedications down\n- Any other medical concerns\n\nTHIS PATIENT IS EXPECTED TO REQUIRE ___ DAYS OF REHAB\nPhysical Therapy:\nNWB to the LUE\nTreatments Frequency:\n \n \nFollowup Instructions:\n___\n"}
{"subject_id":"12024744","hadm_id":"21959048","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Compazine / Sulfa (Sulfonamide Antibiotics)\n \nAttending: ___\n \nChief Complaint:\n___ edema, redness\n \nMajor Surgical or Invasive Procedure:\nNONE\n\n \nHistory of Present Illness:\n___ yo woman with stage IV high grade B cell non-Hodgkin lymphoma \nwith features intermediate between large B cell and Burkitt \n(double hit lymphoma) refractory to DA-EPOCH and RICE, now on \nrituximab monotherapy, who presents to the hospital for \nevaluation of leg edema.  \nPatient stated that she shaved her leg three days ago. The next \nday, she noticed worsening erythema and edema in her left leg. \nThis was also associated with leg cramps, occurring bilaterally, \nradiating from thigh to ankle. Symptoms also affect her fingers, \nwith \"my fingers twisting\".  \nPatient called ___, who recommend her presenting to the \nED for evaluation.  \nIn the ED, initial VS were: 97.3 54 150/62 16 99% RA. ___ was \nperformed, and there were no evidence of deep venous thrombosis \nin the left lower extremity veins.  \n\n \nPast Medical History:\nPAST ONCOLOGIC HISTORY:\n- ___ CT A/P revealing: Large mass involving the pancreatic \ntail with large cystic central portion, which invades the \nspleen. Several liver ill-defined liver lesions are visualized, \nsuggestive of metastatic disease\n- ___ EUS with FNA revealed: large, heterogenous and \nill-defined mass was seen of the pancreatic tail measuring at \nleast 5.03cm. Left lobe of the liver revealed two large \nhypoehoic liver lesions concerning for metastatic disease\n- ___ FNA biopsies revealed: Atypical lymphoid population \nwith necrosis Final dx: high grade B cell lymphoma, features\nintermediate  between large B cell lymphoma and Burkitt \nlymphoma, Bcl-6 and  CD10 pos, Ki-67 \u003e95%, C-MYC 80% pos.\n\nCHEMOTHERAPY:\n___ Cycle #1 DA EPOCH level 1\n___ Rituximab #1\n___ Cycle #2 DA EPOCH level 1\n___ Rituximab #2\n___ Cycle #3 DA EPOCH level 2 with IT MTX #1 and #2\n___ Rituximab #3\n___ Cycle #4 DA EPOCH level 1\n___ Rituximab #4\n___ Cycle #5 DA EPOCH level 2\n___ Rituximab #5\n___ Cycle #6 DA EPOCH level 3\n___ Rituximab #6\n___ ICE #1\n___ Rituximab #7\n___ ICE #2\n___ Rituximab #8\n___ - ___ RADIATION 4140 cGy\n___ weekly rituximab x 4 \n___ cycle #1 lenalidomide 15 mg ___ \n___ cycle #2 lenalidomide 25 mg ___ with monthly \nrituximab\n___ cycle #3 lenalidomide 25 mg ___ with monthly \nrituximab\n___ cycle #4 lenalidomide 25 mg ___ with rituximab\n___ cycle #5 lenalidomide 25 mg ___ with rituximab\n___ cycle #6 lenalidomide 25 mg ___ \n___ cycle #7 lenalidomide 25 mg ___ with rituximab\n\nPAST MEDICAL HISTORY:\n- Schizophrenia, previously on Clozaril and currently on Haldol\n- Glucose Intolerance\n- Mesenteric venous thrombosis\n- History of rheumatic fever\n- L1 compression fracture\n- s/p tubal ligation\n \nSocial History:\n___\nFamily History:\n- Mother with carcinoid, uterine cancer \n- Father died of metastatic cancer\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM: \nVS: 98.5 62 132/66 20 98% on RA  \nGENERAL: NAD  \nHEENT: NC/AT, EOMI, PERRL, MMM  \nCARDIAC: RRR, normal S1 \u0026 S2, without murmurs, S3 or S4  \nLUNG: clear to auscultation, no wheezes or rhonchi  \nABD: +BS, soft, NT/ND, no rebound or guarding  \nEXT: 1+ bilateral pitting edema  \nNEURO: CN II-XII intact  \nSKIN: Warm and dry, without rashes  \n\nDISCHARGE PHYSICAL EXAM:\nVitals: 98.5, 132/66, 62, 20, 98% on RA, admit weight 170.3lbs \nGen: Pleasant, calm  \nHEENT: oropharynx clear \nNECK: JVP not visualized \nLYMPH: No cervical or supraclav LAD\nCV: RRR, nl S1 S2, no murmurs/rubs/gallops    \nLUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi.  \nABD: NABS, soft nontender, nondistended\nEXT: WWP, DP 2+ b/l, no edema or erythema, ___ symmetric \nSKIN: No rashes/lesions, petechiae/purpura ecchymoses\nNEURO: A\u0026Ox3\nLINES: PIV \n\n \nPertinent Results:\nADMISSION LABS:\n___ 01:25PM BLOOD WBC-0.8*# RBC-3.03* Hgb-10.0* Hct-30.6* \nMCV-101* MCH-33.0* MCHC-32.7 RDW-15.2 RDWSD-56.1* Plt Ct-31*#\n___ 01:25PM BLOOD Neuts-36 Bands-9* Lymphs-10* Monos-8 \nEos-34* Baso-3* ___ Myelos-0 AbsNeut-0.36* \nAbsLymp-0.08* AbsMono-0.06* AbsEos-0.27 AbsBaso-0.02\n___ 01:25PM BLOOD Plt Smr-VERY LOW Plt Ct-31*#\n___ 03:30AM BLOOD ___ PTT-33.3 ___\n___ 01:25PM BLOOD UreaN-11 Creat-0.8 Na-138 K-3.7 Cl-103\n___ 01:25PM BLOOD ALT-36 AST-29 LD(LDH)-136 AlkPhos-140* \nTotBili-0.4\n___ 01:25PM BLOOD Albumin-4.1 Calcium-8.3* Phos-3.5 Mg-1.9\n___ 01:25PM BLOOD TSH-2.9\n\nDISCHARGE LABS:\n___ 03:30AM BLOOD WBC-1.4*# RBC-3.10* Hgb-10.1* Hct-30.6* \nMCV-99* MCH-32.6* MCHC-33.0 RDW-15.1 RDWSD-54.5* Plt Ct-32*\n___ 03:30AM BLOOD Neuts-52 Bands-7* Lymphs-3* Monos-14* \nEos-21* Baso-1 ___ Metas-2* Myelos-0 AbsNeut-0.83* \nAbsLymp-0.04* AbsMono-0.20 AbsEos-0.29 AbsBaso-0.01\n___ 03:30AM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-1+ \nMacrocy-1+ Microcy-NORMAL Polychr-OCCASIONAL Ovalocy-1+ Tear \nDr-1+ Bite-OCCASIONAL\n___ 03:30AM BLOOD Glucose-159* UreaN-10 Creat-0.7 Na-140 \nK-3.6 Cl-103 HCO3-26 AnGap-15\n\nIMAGING: \n___ LLE DOPPLER US: No evidence of deep venous thrombosis in \nthe left lower extremity veins.   \n___ CXR: No acute intrathoracic process.\n\nMICROBIOLOGY\n___ 03:30AM URINE Color-Straw Appear-Clear Sp ___\n___ 03:30AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\n___ URINE CULTURE PENDING\n \nBrief Hospital Course:\n___ yo woman with stage IV high grade B cell non-Hodgkin lymphoma \nwith features intermediate between large B cell and Burkitt \n(double hit lymphoma) refractory to DA-EPOCH and RICE, now on \nrituximab and lenalidomide, with a history of SMV/portal vein \nthrombosis on chronic anticoagulation, who presented to the \nhospital for evaluation of leg edema and erythema found to have \nno evidence of DVT and resolution ___ edema. \n\n# Leg edema/erythema: The patient reported a history of left \nlower extremity edema and redness after shaving her legs. The \npatient was evaluated with ___ which showed no DVT. The patient \ndid not have evidence of erythema or edema on admission \nsuggestive of infection and the patient's lower extremity edema \nresolved. The patient will continue to monitor for additional \nerythema or edema of her extremities and follow up with her \noutpatient providers as needed. \n\n# Thrombocytopenia: The patient has a history of \nthrombocytopenia with platelet counts generally between 40-60k. \nThe patient was found to have decreased platelets, from 78 on \n___ to 31 on ___, lower than her usual baseline. This drop was \nthought to be caused by her lenalidomide. Per outpatient \nprovider, the patient was instructed to hold her lovenox until \n___. She will follow up with her oncologist at that \ntime for repeat CBC and further management of this medication.  \n\n# Lymphoma: Patient has failed DA-EPOCH-R and R-ICE, now with \npersistent disease, currently on lenalidomide and rituximab. She \nwas continued on acyclovir and atovaquone prophylaxis. Her ANC \non admission was 830. She was instructed per her outpatient \nprovider to continue her neupogen as prescribed until ___ \n___. The patient will f/u with her outpatient oncologist for \nfurther management.\n\n# Intra-abdominal venous thrombosis of the SMV and portal vein, \ndiagnosed incidentally on staging imaging in ___: The patient \nhad been on chronic anticoagulation with lovenox 60mg subQ \ndaily. As above, this medication will be held until ___ \n___ until outpatient oncology f/u. \n\n# Schizophrenia: continued home Haldol, Zyprexa, Benztropine, \nSertraline, and Clonazepam\n# Hypothyroidism: continued home levothyroxine \n# Overactive bladder: continued tolteradine\n# Allergies: continued home certrizine, montelukast   \n\nTransitional Issues:\n- Per outpatient provider, hold lovenox until ___. Pt will restart per outpatient oncologist. \n- Per outpatient provider, pt will continue neupogen until \n___. Will follow up with outpatient \noncologist for further dosing and management \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acyclovir 400 mg PO Q8H \n2. Atovaquone Suspension 1500 mg PO DAILY \n3. Benztropine Mesylate 2 mg PO QHS \n4. Cetirizine 10 mg PO DAILY \n5. ClonazePAM 0.5 mg PO BID \n6. Filgrastim 300 mcg SC 2X/WEEK (___) \n7. Haloperidol 2.5 mg PO DAILY \n8. Levothyroxine Sodium 50 mcg PO DAILY \n9. Montelukast 10 mg PO DAILY \n10. Omeprazole 20 mg PO BID \n11. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \n12. Sertraline 100 mg PO DAILY \n13. Tolterodine 4 mg PO DAILY \n14. Vitamin D ___ UNIT PO DAILY \n15. Enoxaparin Sodium 60 mg SC DAILY \n16. lenalidomide 25 mg PO DAILY \n17. Spectravite Adult (multivit with min-folic acid) 200 mcg \noral DAILY \n18. OLANZapine 15 mg PO QHS \n \nDischarge Medications:\n1. Acyclovir 400 mg PO Q8H \n2. Atovaquone Suspension 1500 mg PO DAILY \n3. Benztropine Mesylate 2 mg PO QHS \n4. Vitamin D ___ UNIT PO DAILY \n5. Cetirizine 10 mg PO DAILY \n6. ClonazePAM 0.5 mg PO BID \n7. Haloperidol 2.5 mg PO DAILY \n8. Levothyroxine Sodium 50 mcg PO DAILY \n9. Montelukast 10 mg PO DAILY \n10. OLANZapine 15 mg PO QHS \n11. Omeprazole 20 mg PO BID \n12. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \n13. Sertraline 100 mg PO DAILY \n14. Tolterodine 4 mg PO DAILY \n15. Filgrastim 300 mcg SC 2X/WEEK (___) \n16. lenalidomide 25 mg PO DAILY \n17. ___ Adult (multivit with min-folic acid) 200 mcg \noral DAILY \n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: stage IV high grade non-Hodgkin lymphoma, unilateral \nlower extremity edema, thrombocytopenia \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___, \n\nThank you for allowing us to participate in your care at ___! \nYou were admitted to the hospital because of swelling and \nredness in your leg. We evaluated you with an ultrasound which \nshowed no clot in your leg. You should continue to monitor your \nleg for any additional redness and swelling and call your doctor \nif you have any concern. \n\nWhile in the hospital, you were found to have low platelets. \nYour outpatient oncology providers recommended that you hold \nyour lovenox until ___ until your follow up \nappointment. You should continue to take your neupogen as \ninstructed.\n\nWe wish you the best! \nSincerely, \nYour ___ Care Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18151206","hadm_id":"29698395","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ year-old M with PMHx of HTN, IDDM, anxiety, and chronic \nabdominal pain (likely gastritis or gastroparesis) with 11 \nhospital admissions in the last 12 months, with multiple ED \nvisits in between, who presents for recurrence of his same \nabdominal pain symptoms.\n\n \nIn ED: VS: 93 171/110 18 100% RA \nFound to be in AFIB 112, which reverted to NSR; found to have \nleukocytosis with no bandemia; CXR unremarkable, KUB \nunremarkable\n\nMeds received in ED: Morphine 4 mg IV x 2\n\nVS prior to transfer to floor: 176/90 65 12 97%RA\n\nOn floor, patient reports his abdominal pain \"comes and goes\". \nHe also endorses constipation, but last bowel movement was \nyesterday (___). He also reports nausea without vomitting. He \ndenies cough, sneezing, diarrhea, skin problems, headache, chest \npain or dysuria.\n \nReview of Systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies visual changes, headache, sinus tenderness, \nrhinorrhea, congestion or sore throat. Denies chest pain or \ntightness, palpitations, orthopnea, dyspnea on exertion. Denies \ncough, shortness of breath, wheezes or pleuritic pain. Denies \nnausea, vomiting, diarrhea, BRBPR or melena. No dysuria, urinary \nfrequency. Denies arthralgias or myalgias. Denies rashes. No \nnumbness/tingling or muscle weakness in extremities. No feelings \nof depression or anxiety. All other review of systems negative. \n \nPast Medical History:\nHTN\nDiabetes mellitus type II, insulin-dependent\nChronic abdominal pain \nAnxiety NOS  \nHx of EtOH abuse: reports no alcohol for past ___ yrs.  \ns/p bilateral cataract surgery ___  \nRight knee trauma in ped v truck accident at work\n\n \nSocial History:\n___\nFamily History:\nmother alive in ___ with HTN, and DM  \nfather - died in his ___ of unknown causes  \nsister with HTN  \nFour kids, all well \n(confirmed)\n \nPhysical Exam:\nVS: 97.5 ___ 100%RA\n \nGEN: Alert and oriented to person, place and situation; no \napperent distress\nHEENT: no trauma, pupils round and reactive to light and \naccomodation, no LAD, oropharynx clear, no exudates\nCV: regular rate and rhythm, no murmurs/gallops/rubs\nPULM: clear to auscultation bilaterally, no \nrales/crackles/rhonchi\nGI: soft, non-tender, non-distended; no guarding/rebound\nEXT: no clubbing/cyanosis/edema; 2+ distal pulses; peripheral IV \npresent\nNEURO: CN II-XII intact, ___ motor function globally\nDERM: no lesions appreciated\n \n \n \nPertinent Results:\n___ 03:05PM   WBC-12.8*# RBC-4.89 HGB-14.1 HCT-43.2 MCV-88 \nMCH-28.8 MCHC-32.6 RDW-15.3\n___ 03:05PM   NEUTS-78.3* LYMPHS-14.6* MONOS-5.2 EOS-1.3 \nBASOS-0.6\n___ 03:05PM   PLT COUNT-292\n___ 04:45PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 03:50PM URINE  HOURS-RANDOM\n___ 03:50PM URINE  HOURS-RANDOM\n___ 03:50PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 03:50PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 03:50PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-75 \nGLUCOSE-TR KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-NEG\n___ 03:50PM URINE  RBC-0 ___ BACTERIA-NONE YEAST-NONE \nEPI-0\n___ 03:12PM   PH-7.49* COMMENTS-GREEN TOP\n___ 03:12PM   GLUCOSE-146* LACTATE-2.6* NA+-143 K+-3.8 \nCL--101 TCO2-23\n___ 03:12PM   freeCa-1.08*\n___ 03:05PM   UREA N-10 CREAT-0.8\n\nCXR PA/LAT:\nFRONTAL AND LATERAL VIEWS OF THE CHEST: Lungs are clear with no \npneumonia or congestive heart failure. There is no pneumothorax \nor pleural effusion. \nHeart, mediastinum, hila, and pleural surfaces are normal. There \nis no \nevidence of free air. \nIMPRESSION: No acute intrathoracic abnormality. \nThe study and the report were reviewed by the staff radiologist. \n\n\nKUB:\nSUPINE AND UPRIGHT VIEWS OF THE ABDOMEN: There is no evidence of \nfree air or bowel obstruction. Nonspecific bowel gas pattern is \nnoted. Imaged osseous structures are grossly unremarkable. \nVascular calcifications in the pelvis are noted.  \nIMPRESSION: No free air or bowel obstruction. \nThe study and the report were reviewed by the staff radiologist. \n\n.\n___ 05:30AM BLOOD WBC-6.7 RBC-4.35* Hgb-12.6* Hct-38.4* \nMCV-88 MCH-28.9 MCHC-32.8 RDW-15.1 Plt ___\n___ 05:30AM BLOOD Glucose-69* UreaN-17 Creat-0.9 Na-137 \nK-3.7 Cl-98 HCO3-31 AnGap-12\n___ 07:05AM BLOOD ALT-15 AST-18 LD(LDH)-202 CK(CPK)-164 \nAlkPhos-80 TotBili-0.7\n___ 07:05AM BLOOD CK-MB-3 cTropnT-\u003c0.01\n___ 11:59AM BLOOD CK(CPK)-148\n___ 11:59AM BLOOD CK-MB-3 cTropnT-\u003c0.01\n___ 07:33PM BLOOD CK(CPK)-175\n___ 07:33PM BLOOD CK-MB-3 cTropnT-LESS THAN \n___ 10:18AM BLOOD ALT-19 AST-21 CK(CPK)-215 AlkPhos-78 \nTotBili-0.7\n___ 10:18AM BLOOD CK-MB-3 cTropnT-\u003c0.01\n.\nSerial EKGs showed NSR with LVH consistent with baseline, \notherwise no acute ST changes.\n.\nCT head ___: IMPRESSION: No acute intracranial hemorrhage.\n \nBrief Hospital Course:\nPt was admitted with abd pain/N/V and elevated blood pressures. \nOn the morning of ___, a code blue was called for his roomate \nand during the commotion he started complaining of severe chest \npain. Pt was diaphoretic and grabbing his chest with BPs of \n220/120.  EKGs showed LVH without acute ST changes and pt was \nendorsing confusion. He was taken for stat head CT that did not \nshow any acute hemorrhage. BP came down to 180/100 (bilaterally) \nwith nitropaste, IV metoprolol and 10mg IV morphine. Pt was \ntransferred to the ICU for concern of hypertensive emergency and \nhe had a PICC placed prior to being started on a nitro gtt.   Pt \nhad four sets of negative cardiac enzymes, stable creatinine and \nEKGs.  On further examination, he was not endorsing any \nconfusion and was transitioned to his home regimen of Valsartan, \nDiltiazem with low dose labetalol. Pt was examined serially in \nthe ICU and was inconsistent in describing his symptoms. It was \nunclear whether the acute pain episode was actually consistent \nwith his recurrent epigastric pain, chest pain or an acute \nanxiety attack.  Given his history of anxiety/stress \nprecipitating his symptoms, he was seen by Social Work after \ntransfer back to the medicine floor.  He reported a number of \nstressors at home that he felt were contributing to his \nsymptoms.  Pt did report some ongoing epigastric pain but was \ntolerating po and denied any chest pain or shortness of breath.  \nAfter speaking with social work, pt was feeling better and \nasking to return home. He reported that he had run out of his \nblood pressure medications and he was given refills for \nValsartan, Diltiazem and ___ referral. He was scheduled to have \na home visiting nurse with social work consult on ___, ___.  They will assist in getting him close follow up with Dr. \n___ and help with blood sugar management at home.\n.\nThere were no changes made to his diabetes, Atrial Fib or \nanti-hypertensive regimen.  By the time of discharge, his blood \npressure was well controlled on his home regimen of ___ and \nhe was tolerating po well.\n\n \nMedications on Admission:\n1. Metoclopramide 10 mg 1 Tablet PO QIDACHS. \n2. Simethicone 80 mg 1 Tablet PO TID.\n3. Omeprazole 20 mg (E.C.) 1 Capsule PO BID.\n4. Sucralfate 1 gram 1 Tablet PO four times a day.  \n5. Valsartan 160 mg 1 Tablet PO Daily. \n6. Diltiazem HCl 120 mg Capsule, Sustained Release 2 Capsules PO \nDaily.\n7. Acetaminophen 500 mg ___ Tablets PO three times a day as \nneeded for pain.  \n8. Insulin Glargine 20 units Subcutaneous at bedtime.  \n\n \nDischarge Medications:\n1. metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QIDACHS (4 \ntimes a day (before meals and at bedtime)).  \n2. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n3. simethicone 80 mg Tablet Sig: One (1) Tablet PO three times a \nday.  \n4. sucralfate 1 gram Tablet Sig: One (1) Tablet PO four times a \nday.  \n5. valsartan 160 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n6. diltiazem HCl 240 mg Capsule, Sustained Release Sig: One (1) \nCapsule, Sustained Release PO once a day.\nDisp:*30 Capsule, Sustained Release(s)* Refills:*2*\n7. Tylenol ___ mg Tablet Sig: One (1) Tablet PO three times a \nday as needed for pain.  \n8. insulin glargine 100 unit/mL Cartridge Sig: Twenty (20) units \nSubcutaneous once a day.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nAbdominal pain\nHypertensive Urgency\nChest pain\nAnxiety\n.\nSecondary:\nDiabetes\nHypertension\n\n \nDischarge Condition:\nMental Status: Clear\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted with abdominal pain and elevated blood \npressure.  There has been no evidence of damage to the heart \nmuscle.  You have been treated for the abdominal pain and have \nbeen seen by the social worker.  We have requested a home \nvisiting nurse to come and help you at home with medications and \nblood sugar management.   \n.\nPlease continue to take your medications as prescribed and call \nDr. ___ office on ___ morning.  The visiting nurse ___ \nhelp you schedule a follow up appointment next week.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10034272","hadm_id":"25048680","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\nChest Pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo M with recent diagnosis of CAD s/p DES x2 to RCA (___), \npresents with one day history of chest pain. On morning of \nadmission had 30 minute episode of chest \"pulsating\" sensation \nwhile walking. Then fleeting episodes of chest discomfort and \n\"tenderness\" (less than 30 seconds) throughout day following the \noriginal episode, so patient decided to present to ___ \n___. He had one negative set of cardiac enzymes at \n___ and was rapidly transferred to ___ for \n\"increased level of care.\" He did not take any nitro during his \nmultiple episodes of chest discomfort. He notes that the feeling \nin his chest is unlike his episode of chest pain associated with \nhis NSTEMI in ___. Reports that he has had lightheadedness \ntoday, though the LH does not specifically correlate with the \nchest discomfort. Additionally, he reports that several days \nprior to presentation, he was started on metoprolol tartrate 25 \nmg daily by his primary physician.\n\nPatient was previously healthy until early ___ reported to \nprimary care physician reporting dyspnea on exertion. This led \nto a stress test during which patient developed chest pain, was \nidentified as having NSTEMI at ___ and was subsequently \ntransferred to ___. At ___, patient had cardiac \ncatheterization with intervention to RCA x 2 on ___. Was \nnote of 60% LAD lesion with no intervention. Patient was \ndischarged from hospital on ___ and has been doing well \nsince that time without chest pain and, reportedly taking \naspirin and clopidogrel religiously.\n\nIn the ___ ___, vitals at presentation were T 97.6, BP 116/76, \nHR 50, RR 18, O2sat 98% RA. Had sinus bradycardia with rate in \n___ and ___. Patient had no intervention in ___. He has multiple \nepisodes of fleeting CP (\u003c 5 seconds) while there. First set \ncardiac enzymes were negative and D-dimer was normal. CXR was \nwithout concern for acute process. Patient being admitted for \ncompletion of rule-out for MI. Vital signs immediately prior to \ntransfer were T 97.6, BP 126/71, HR 52, RR 12, O2sat 98% RA.\n\nUpon arriving to the floor, patient was comfortable and CP free.\n\nREVIEW OF SYSTEMS:\nCardiac:\n(+)ve: chest pain, lightheadedness\n(-)ve: dyspnea on exertion, paroxysmal nocturnal dyspnea, \northopnea, ankle edema, palpitations, syncope\nGeneral:\n(+)ve: Denies\n(-)ve: fevers, chills, rigors, stroke, TIA, deep venous \nthrombosis, pulmonary embolism, bleeding at the time of surgery, \nmyalgias, joint pains, cough, hemoptysis, black stools, red \nstools. All of the other review of systems were negative.\n \nPast Medical History:\nCardiac Risk Factors:\n(-)ve Diabetes\n(-)ve Dyslipidemia\n(-)ve Hypertension\n\nCardiac History:\nPercutaneous coronary intervention: ___: NSTEMI after \nstress test leading to stenting of distal RCA and proximal RCA \nwith DES.\nCABG: None\nPacemaker/ICD: None\n\nOther Past History:\ns/p appendectomy\n \nSocial History:\n___\nFamily History:\nFather with MI at age ___.\nThree brothers with CABG and MI's in ___, ___, and ___.\n \nPhysical Exam:\nVS: T 97.6 (in ___, BP 143/75, HR 52, RR 16, O2sat 95% RA\nGen: NAD. Oriented x3. Mood, affect appropriate.\nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa. No xanthalesma.\nNeck: Supple with no elevation of JVP, no ___\nCV: PMI located in ___ intercostal space, midclavicular line. \nRR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.\nChest: No chest wall deformities, scoliosis or kyphosis. Resp \nwere unlabored, no accessory muscle use. CTAB, no crackles, \nwheezes or rhonchi.\nAbd: BS+, soft, NTND. No HSM or tenderness. No abdominial \nbruits.\nExt: No c/c/e. No femoral bruits.\nSkin: No stasis dermatitis, ulcers, scars, or xanthomas.\n\nPulses:\nRight: Carotid 2+ Femoral 2+ DP 2+ ___ 2+\nLeft: Carotid 2+ Femoral 2+ DP 2+ ___ 2+\n \nPertinent Results:\nCHEST (PA \u0026 LAT)Study Date of ___:\nCONCLUSION: No acute cardiopulmonary process.\n\nHEMATOLOGY:\n___ 04:40PM BLOOD WBC-6.7 RBC-4.13* Hgb-13.1* Hct-38.6* \nMCV-94 MCH-31.6 MCHC-33.8 RDW-13.2 Plt ___\n___ 04:40PM BLOOD Neuts-40.9* Lymphs-48.9* Monos-5.2 \nEos-4.4* Baso-0.6\n___ 06:35AM BLOOD WBC-6.1 RBC-4.07* Hgb-13.0* Hct-37.8* \nMCV-93 MCH-31.9 MCHC-34.3 RDW-13.2 Plt ___\n\nCHEMISTRY:\n___ 04:40PM BLOOD Glucose-70 UreaN-14 Creat-1.0 Na-142 \nK-4.2 Cl-106 HCO3-29 AnGap-11\n___ 06:35AM BLOOD Glucose-90 UreaN-13 Creat-0.9 Na-141 \nK-4.2 Cl-107 HCO3-25 AnGap-13\n\nCARDIAC ENZYMES:\n___ 04:40PM BLOOD CK(CPK)-87\n___ 04:40PM BLOOD CK-MB-NotDone\n___ 04:40PM BLOOD cTropnT-\u003c0.01\n___ 01:40AM BLOOD CK(CPK)-78\n___ 01:40AM BLOOD CK-MB-NotDone cTropnT-\u003c0.01\n___ 06:35AM BLOOD CK(CPK)-77\n___ 06:35AM BLOOD CK-MB-NotDone cTropnT-\u003c0.01\n\n___ 04:40PM BLOOD D-Dimer-248\n \nBrief Hospital Course:\n#. CAD / Chest pain:\nPatient's chest pain was atypical for cardiac pain as it was \ncompletely unlike the pain he experienced during NSTEMI in \n___. Additionally, we measured three negative sets of cardiac \nenzymes. His CXR was without evidence of acute cardiopulmonary \nprocess. He had a D-dimer measured due to low probability of PE \nin the ___ and his D-dimer level was normal, ruling out PE.  He \nhad no EKG changes at presentation or on morning of discharge. \nHis telemetry was without concerning arrhythmia while in the \nhospital. Prior to discharge, patient was ambulated through the \nhalls and was without chest pain. Upon discharge, we continued \nhim on home aspirin, clopidogrel, atorvastatin, nitroglycerin. \nHe was discharged with instruction to follow-up with his primary \ncare physician ___ 1 to 2 weeks.\n\n#. Pump:\nPatient with normal LVEF = 50% at last ECHO on ___. \nEuvolemic on exam at presentation.\n\n#. Rhythm:\nSinus bradycardia in ___ with rate ___ to ___. Patient also \nreporting periods of lightheadedness since starting on \nmetoprolol. We decided to discontinue metoprolol at time of \ndischarge.\n \nMedications on Admission:\n1) Aspirin 325 mg Tablet DAILY\n2) Clopidogrel 75 mg PO DAILY\n3) Atorvastatin 80 mg PO DAILY\n4) Nitrostat 0.3 mg Tablet PRN\n5) Metoprolol tartrate 25 mg DAILY\n\n \nDischarge Medications:\n1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n2. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n3. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n4. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: As directed  \nSublingual Every 5 minutes as needed for chest pain: Up to 3 can \nbe taken every 5 minutes until there is relief of pain.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\n1) Musculoskeletal chest pain\n2) Bradycardia\nSecondary:\n3) Coronary artery disease\n\n \nDischarge Condition:\nvital signs stable, chest pain free\n\n \nDischarge Instructions:\nYou were admitted to the hospital with chest pain. We measured \nthree sets of lab tests that confirmed you did not have a heart \nattack. We also measured a lab test to tell us that you did not \nhave a blood clot travel to your lungs. We are unsure of the \nexact cause of your chest pain; however, your story makes us \nbelieve that it is a muscular or bone pain. You can further \nexplore this particular pain with Dr. ___ it continues to \ntrouble you. We noted that you had a low heart rate while in the \nhospital. This was likely related to your metoprolol.\n\nMEDICATIONS:\nSTOP taking metolprolol as it seems to make your heart too slow.\nPlease continue all other medications as previously prescribed.\n\nPlease call your primary care physician ___, MD \n(___) to follow-up on this hospitalization within 2 \nweeks from discharge. As you are already considering cardiology \ncare at ___, Dr. ___ help refer you to been seen \nby a general cardiologist here.\n\nRegarding future chest pain. Please sit and rest immediately if \nyou have chest pain and take a nitroglycerin tab if the pain \ndoes not resolve within minutes of rest. You should take an \nadditional nitro tab every 5 minutes for a total of 3 tabs until \nthe pain resolves. Please call a doctor to report this episode \nof chest pain following relief of the pain, or if the pain is \nunable to be relieved.\n\nShould you have any chest pain, shortness of breath, \nlightheadedness, loss of consciousness, or other symptoms that \nare concerning to you, please call your physician or report to \nan emergency department immediately.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"17714334","hadm_id":"25853489","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\n nausea/vomiting  \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ M w/ history of CKD IV (GFR 16) undergoing\ntransplant evaluation, planning to start PD, T2DM, who presents\nas a transfer from ___ for N/V, hyperglycemia,\nNSTEMI.  \n\nMr. ___ initially presented to ___ for 4 days of\nnausea/vomiting with one day of red/pink tinge to vomiting. He\nhas been unable to tolerate PO including his medications as a\nresult of these symptoms. He also reports that he had not taken\nany of his insulin in 3 days given these symptoms and inability\nto eat anything. He otherwise denies any fevers, chills, chest\npain, dyspnea. No frank hematemesis. No EtOH use. \n \nAt ___:  \n - Initial vitals: hypertensive to 220s/110s  \n - Was given IV hydralazine, IV labetalol with improvement to\nSBPs 120s  \n - Notable labs: troponin-I of 0.14, BG 414, BMP notable for Cr\n5.4 up from baseline of ~3. Otherwise no electrolyte\nabnormalities reported.  \n - Patient additionally given 8u regular insulin, protonix IV  \nPatient additionally reportedly had a near syncopal episode\nduring transfer.  \n\nIn ___ ED:  \n - Initial vital signs were notable for: \n96.7 HR 71 BP 110/88 RR 17 95% RA FSBS 392 \n\n - Exam notable for: \n\nwell appearing overall, no remarkable findings  \n - Labs were notable for: \n     10.0\n16.4\u003e-----\u003c217\n    30.8\n \n___: 11.9  PTT: 20.6  INR: 1.1  \n\n145 | 113 | 87 \n-----------------\u003c 365\n4.1 | 18  | 5.7\n\nCa: 8.6 Mg: 2.2 P: 6.1\n\nLFTs wnl except albumin 2.4. \nTrop 0.09 (MB 4) -\u003e Trop 0.10 (MB 4). \n\nLactate 1.1.  \n\n - Urinalysis: \nsm blood, prot 600, glucose 1000, trace ketones, few bacteria,\nWBC 2, neg leuks, neg nitrites, \u003c1 epi  \n\n - VBG ___  \n\n - EKG notable for NSR, TWI in I, aVL. T-wave flatting in the\nlateral leads.  \n\n - Patient was given: \n___ 03:18 SC Insulin Lispro 10 UNIT \n___ 06:03 IVF  NS  \n___ 07:08 PO Rosuvastatin Calcium 20 mg  \n___ 07:08 PO/NG HydrALAZINE 100 mg   \n___ 07:08 PO Metoprolol Succinate XL 150 mg   \n___ 07:13 PO/NG Aspirin 81 mg \n___ 08:00 PO/NG Aspirin  \n___ 08:54 IVF  NS 500 mL   \n___ 10:00 SC Insulin 4 Units  \n___ 10:00 PO Ondansetron ODT 4 mg \n___ 12:00 SC Insulin  \n___ 14:10 IVF  LR  \n___ 16:00 IVF  LR ( 1000 mL ordered) \n___ 16:28 IVF  LR 1000 mL   \n___ 16:39 PO/NG HydrALAZINE 100 mg \n___ 16:39 IV Ondansetron 4 mg \n___ 16:39 PO/NG Acetaminophen 650 mg \n___ 19:49 SC Insulin 10 UNIT \n___ 19:49 SC Insulin 6 Units \n___ 19:49 IVF  LR  continued at 100 mL/hr \n\n - Consults:  \n Vitals on transfer: \n\n Upon arrival to the floor, patient denies any chest pain,\nshortness of breath. States that nausea/vomiting have resolved. \n \n REVIEW OF SYSTEMS: Complete 10pt ROS obtained and is otherwise\nnegative.  \n\n \nPast Medical History:\n T2DM (diagnosed at age ___, on insulin) c/b retinopathy, CKD  \n Transplant Candidate  \n - Currently inactive on the list pending cardiac catherization\nafter dialysis.  \n HLD  \n HTN  \n Obesity  \n GERD  \n Macular edema  \n OSA on CPAP  \n No history of heart disease, stroke, lung disease, liver\ndisease,  \n cancer or tuberculosis.\n \nSocial History:\n___\nFamily History:\nMother ___ living with asthma  \nFather ___ deceased, lung cancer  \nBrother, two sons all living and well \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVITALS:  ___ Temp: 98.0 PO BP: 183/103 HR: 72 RR: 18\nO2 sat: 97% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ \nGENERAL: Alert and interactive. In no acute distress.  \nHEENT: NCAT, MMM  \nNECK: No cervical lymphadenopathy. No JVD.  \nCARDIAC: rrr, no m/r/g\nLUNGS: Clear to auscultation bilaterally \nBACK:  No CVA tenderness.  \nABDOMEN: Normal bowels sounds, non distended, non-tender to deep\npalpation in all four quadrants  \nEXTREMITIES: No clubbing, cyanosis. Trace ___ edema. Pulses\nDP/Radial 2+ bilaterally.  \nSKIN: Warm. Cap refill \u003c2s. No rash.  \nNEUROLOGIC: CN2-12 intact. ___ strength throughout. Normal\nsensation. AOx3.  \n\nDISCHARGE PHYSICAL EXAM:\n24 HR Data (last updated ___ @ 824)\n    Temp: 98.6 (Tm 98.8), BP: 166/89 (143-168/72-89), HR: 87\n(56-87), RR: 18, O2 sat: 97% (97-987), O2 delivery: Ra, Wt: \n249.8\nlb/113.31 kg  \nGENERAL: Alert and interactive. In no acute distress.  \nHEENT: NCAT, MMM  \nNECK: No cervical lymphadenopathy. No JVD.  \nCARDIAC: RRR, no m/r/g\nLUNGS: Clear to auscultation bilaterally \nBACK:  No CVA tenderness.  \nABDOMEN: Normal bowels sounds, non distended, non-tender to deep\npalpation in all four quadrants  \nEXTREMITIES: No clubbing, cyanosis. Trace ___ edema. Pulses\nDP/Radial 2+ bilaterally.  \nSKIN: Warm. Cap refill \u003c2s. No rash.  \nNEUROLOGIC: CN2-12 intact. ___ strength throughout. Normal\nsensation. AOx3.  \n \nPertinent Results:\nADMISSION LABS\n===============\n___ 02:42AM BLOOD WBC-16.4* RBC-3.45* Hgb-10.0* Hct-30.8* \nMCV-89 MCH-29.0 MCHC-32.5 RDW-13.2 RDWSD-43.0 Plt ___\n___ 02:42AM BLOOD ___ PTT-20.6* ___\n___ 02:42AM BLOOD Glucose-365* UreaN-87* Creat-5.7* Na-145 \nK-4.1 Cl-113* HCO3-18* AnGap-14\n___ 02:42AM BLOOD ALT-9 AST-9 CK(CPK)-84 AlkPhos-81 \nTotBili-0.4\n___ 02:42AM BLOOD CK-MB-4 cTropnT-0.09*\n___ 06:09AM BLOOD CK-MB-4 cTropnT-0.10*\n___ 06:20AM BLOOD cTropnT-0.07*\n___ 02:42AM BLOOD Albumin-2.4* Calcium-8.6 Phos-6.1* Mg-2.2\n___ 02:50AM BLOOD Lactate-1.1\n___ 06:22AM BLOOD ___ pO2-92 pCO2-38 pH-7.37 \ncalTCO2-23 Base XS--2 Comment-GREEN TOP \n\nDISCHARGE LABS\n===============\n___ 07:40AM BLOOD WBC-7.5 RBC-3.73* Hgb-11.0* Hct-33.3* \nMCV-89 MCH-29.5 MCHC-33.0 RDW-12.5 RDWSD-40.8 Plt ___\n___ 07:40AM BLOOD Glucose-78 UreaN-61* Creat-4.9* Na-142 \nK-3.4* Cl-109* HCO3-22 AnGap-11\n___ 07:40AM BLOOD Calcium-8.0* Phos-4.9* Mg-1.9\n\nIMAGING/STUDIES\n================\nCT A/P w/o contrast  ___\n1. There is bilateral symmetric perinephric stranding, a \nnonspecific finding. There is no hydronephrosis or renal stones \nbilaterally.  \n2. Mildly ectatic bilateral common iliac arteries, measuring up\nto 1.6 cm on the right and 1.7 cm on the left.  \n3. Multiple conspicuous although not pathologically enlarged \nretroperitoneal periaortic lymph nodes, a nonspecific finding. \n \nBrief Hospital Course:\n___ w/ history of CKD on transplant list, T2DM, transferred from \n___ for 4 days of nausea/vomiting ___ to presumed \ngastroparesis, hypertensive emergency c/b NSTEMI, ___ and \nhyperglycemia in setting of missed home medications. \n\nTRANSITIONAL ISSUES\n===================\n[] Hypertension Regimen: patient reports he has been told to \nstop Lisinopril, torsemide, metolazone; this is not well \ndocumented but these medications were held during admission. \nPatient is also supposed to take hydralazine 100 mg but patient \nreports headache with this dose and usually takes 50 mg at home. \nBlood pressures remain elevated and regimen should be addressed\n[] consider LHC/coronary angiogram prior to transplant given \nNSTEMI \n[] Gastroparesis: Unclear work up for gastroparesis but could \nbenefit from outpatient GI follow up including gastric emptying \nstudy. \n[] Patient has proteinuria: Please order and follow up UPEP/SPEP\n\nACUTE ISSUES: \n============= \n#Nausea, vomiting \n#Gastroparesis flare\nPatient admitted for significant nausea/vomiting that started \nabruptly after eating breakfast ___. States that he has had \nmultiple similar prior episodes requiring admission to ___ and \nhas been told it is gastroparesis. No other specific infectious \nsigns/symptoms. Received 4L IVF. Symptoms improved with \nmetoclopramide. Patient was seen by nutrition who discussed \ndietary modifications with patient and wife. \n\n#NSTEMI \nLikely Type II in setting of hypertensive emergency given SBPs \n220s/110s at OSH + poor clearance in setting of CKD. ___ had \necho and stress without concerning findings while getting worked \nup for kidney transplant. Does not have hx of CAD. Troponins \npeaked at 0.1. Has not had a LHC though this has been discussed \npreviously as an outpatient. \n\n___ on CKD \nBeing worked up for kidney transplant. Admission Cr 5.7 with \nbaseline Cr ~5. Likely pre-renal in setting of hypovolemia from \nvomiting. No electrolyte abnormalities/urgent indication for \ndialysis. Has appointment with transplant team on ___. ___ \nimproved with IVF. \n\n#Hyperglycemia \n#Type II DM \nPatient found to be hyperglycemic to 400s at ___ in setting of \nstopping his insulin while unable to tolerate any PO. Restarted \nhome Levemir 24u with breakfast, 10u with dinner + ISS. \n\n#Hypertension \nPatient with hypertensive urgency at OSH s/p IV hydralazine and \nIV labetalol. Now back on home regimen. Patient reports he has \nbeen told to stop torsemide, aspirin, Lisinopril (though recent \nCardiology note conflicts with this). Continued home hydralazine \n100 mg PO TID, Metoprolol Succinate XL 25 mg PO DAILY. \n\n# Leukocytosis\nElevated to 16.4 and does report history of 1x episode dysuria. \nUA unrevealing for infection. UCx, BCx without growth. \n\nCHRONIC ISSUES: \n=============== \n# OSA\nPatient with known OSA. Continued CPAP in house.\n\nCORE MEASURES \n============= \n#CODE: Full presumed\n#CONTACT: ___ ___\n\n\u003e30 min spent on discharge planning including face to face time. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. HydrALAZINE 100 mg PO TID \n2. Metoprolol Succinate XL 150 mg PO DAILY \n3. Rosuvastatin Calcium 20 mg PO QPM \n4. levemir 24 Units Breakfast\nlevemir 10 Units Bedtime\n5. Multivitamins 1 TAB PO DAILY \n6. Vitamin D ___ UNIT PO 1X/WEEK (___) \n\n \nDischarge Medications:\n1.  Metoclopramide 10 mg PO BID:PRN nausea \nRX *metoclopramide HCl 10 mg 1 tablet(s) by mouth twice a day \nDisp #*20 Tablet Refills:*0 \n2.  HydrALAZINE 50 mg PO TID \nplease talk to your primary care and kidney doctors about this \nchange \nRX *hydralazine 50 mg 1 tablet(s) by mouth three times a day \nDisp #*90 Tablet Refills:*0 \n3.  Calcitriol 0.25 mcg PO DAILY  \n4.  levemir 24 Units Breakfast\nlevemir 10 Units Bedtime \n5.  Metoprolol Succinate XL 150 mg PO DAILY  \n6.  Multivitamins 1 TAB PO DAILY  \n7.  Rosuvastatin Calcium 20 mg PO QPM  \n8.  Vitamin D ___ UNIT PO 1X/WEEK (___)  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES\n==================\nGastroparesis \nType II Diabetes Mellitus \n\nSECONDARY DIAGNOSES\n====================\n___ on CKD \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___, \n \nIt was a pleasure caring for you at ___ \n___.  \n \nWHY WAS I IN THE HOSPITAL?  \n - You were admitted for nausea and vomiting\n \nWHAT HAPPENED TO ME IN THE HOSPITAL?  \n - While you were in the hospital, we found that you had very \nhigh blood pressure, some evidence of heart damage (likely \nbecause of the high blood pressure) and high blood sugars. \n\n - Your nausea/vomiting improved with anti-nausea medications \nand fluids. We suspect it is because of gastroparesis. \n\n - Your lab work showed evidence of kidney damage, so we had our \nkidney doctors ___. \n \nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  \n - Continue to take all your medicines and keep your \nappointments.\n \nWe wish you the best!  \n \nSincerely,  \nYour ___ Team  \n \nFollowup Instructions:\n___\n"}
{"subject_id":"16814111","hadm_id":"22252820","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nHyperglycemia\nAcute renal failure\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y/o gentleman w/ asthma, DM, hx of PPM placement, and R \nshoulder pain s/p steroid injection on ___ presents to the ED \nwith asymptomatic hyperglycemia and renal failure. He has a hx \nof COPD and has had a slight nonproductive cough over months but \nno other infectious complaints. He has not been on steroids for \nthis. His DM is managed with oral hyperglemic meds including \njanuvia and pioglitazone with lantus 15 at night. He does not \nendorse any medication noncompliance. He was at adult daycare \ntoday where he was noted to have a fingerstick in the 500s, so \nhe was transferred here for management.\nIn the ED intial vitals were: 98.6 86 161/64 16 100% RA. Labs \nwere notable for WBC 14.2, HCT 42 (baseline 36), BUN/Cre 46/2.7 \n(baseline 1.2), Na 127 (above baseline 1.2), lactate 3.1. UA \nwith no ketones and glucose of 1000. CXR with no acute process. \nEKG with no e/o hyperkalemia. In the ED, she received duoneb x \n2, calcium gluconate 1g, kayexalate 60mg, and insulin regular 10 \nx 4.\n\n \nPast Medical History:\nasthma\ndiabetes\npacemaker placed after syncopal episode about ___ years ago\ndenies MI history\nper pt stress test \"OK\" ___ years ago, but needs echo\n \nSocial History:\n___\nFamily History:\nHis father died at age ___, extensive family history of \ndiabetes.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n97.4 61 136/44 12 97% RA\nGeneral: NAD\nHEENT: EOMI, PERRL, dry MM\nNECK: supple with flat JVP\nCV: irregularly irregular, no m/r/g\nLungs: cta bilaterally no crackles or wheezes\nAbdomen: obese and soft, no tenderness to palpation\nExt: no pedal edema\nNeuro: alert, oriented x3, speech is fluent\nSkin: no rash\n\nDISCHARGE PHYSICAL EXAM:\nVitals: Tm:98.3, Tc 97.7, BP: ___ R:20 O2: \n96-98RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, obese, non-tender, non-distended, bowel sounds \npresent, no rebound tenderness or guarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema, R shoulder with no evidence of redness, swelling around \nsite of injection or joint. Normal ROM.  \nSkin:  No rashes.\n\n \nPertinent Results:\nADMISSION LABS:\n___ 05:30PM BLOOD WBC-14.2*# RBC-4.14* Hgb-13.2* Hct-42.2 \nMCV-102* MCH-31.9 MCHC-31.3 RDW-12.7 Plt ___\n___ 05:30PM BLOOD Neuts-86.2* Lymphs-8.7* Monos-5.0 Eos-0 \nBaso-0.1\n___ 05:30PM BLOOD Glucose-564* UreaN-46* Creat-2.7*# \nNa-127* K-6.0* Cl-93* HCO3-23 AnGap-17\n___ 10:15PM BLOOD ALT-13 AST-16 LD(LDH)-260* CK(CPK)-55 \nAlkPhos-81 TotBili-0.2\n___ 10:15PM BLOOD Lipase-68*\n___ 10:15PM BLOOD CK-MB-2 cTropnT-\u003c0.01\n___ 05:30PM BLOOD Calcium-9.6 Phos-3.8 Mg-1.7\n___ 10:15PM BLOOD Albumin-3.7\n___ 05:09PM BLOOD ___ pO2-32* pCO2-42 pH-7.34* \ncalTCO2-24 Base XS--3\n___ 05:09PM BLOOD Lactate-3.1*\n___ 10:30PM BLOOD Glucose-426* Lactate-3.3* Na-135 K-4.3 \nCl-102 calHCO3-22\n\n___ 06:58PM URINE Color-Yellow Appear-Clear Sp ___\n___ 06:58PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG\n___ 06:58PM URINE RBC-\u003c1 WBC-1 Bacteri-NONE Yeast-NONE \nEpi-\u003c1\n___ 06:58PM URINE CastHy-21*\n___ 06:58PM URINE Mucous-RARE\n___ 01:24AM URINE Eos-NEGATIVE  \n___ 01:24AM URINE Hours-RANDOM UreaN-644 Creat-72 Na-60 \nK-20 Cl-53 TotProt-6 Prot/Cr-0.1 Albumin-PND\n\nIMAGING:\nCXR ___\nIMPRESSION:  No acute cardiopulmonary process.\n\nRENAL U/S ___\nIMPRESSION:No hydronephrosis seen in either kidney.  Small \nbilateral simple cysts are incidentally noted in the kidneys. \n\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\nDISCHARGE LABS:\n\n___ 12:00PM BLOOD WBC-13.0* RBC-3.86* Hgb-12.3* Hct-39.1* \nMCV-101* MCH-32.0 MCHC-31.5 RDW-12.9 Plt ___\n___ 12:00PM BLOOD Glucose-272* UreaN-20 Creat-1.3* Na-136 \nK-3.7 Cl-102 HCO3-24 AnGap-14\n___ 12:00PM BLOOD Calcium-8.8 Phos-2.1* Mg-1.8\n___ 12:17PM BLOOD Lactate-2.2*\n\n___ 5:30 pm BLOOD CULTURE: Routine (Pending): \n___ 5:15 pm BLOOD CULTURE\n   Blood Culture, Routine (Preliminary): \n      GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS. \n   Anaerobic Bottle Gram Stain (Final ___: \n      Reported to and read back by ___. ___ ON ___ AT \n0255. \n      GRAM POSITIVE COCCI IN CLUSTERS. \n \nBrief Hospital Course:\n#) Acute on Chronic KI c/b hyperkalemia: Cre 1.2 at baseline \nindicating CKD. Creatinine was found to be2.7 in ED, in the \nsetting of hyperglycemia. This most likely contributed to \nosmotic diuresis and thereby intravascular volume depletion. \nFurther supporting the theory of volume depletion is his \nhemoconcentration compared to labs from ___ of this past year. \nHis acute renal failure has been further precipitated by his \nhigh dose linsinopril therapy and lasix. There were no symptoms \nof obstruction and a renal ultrasound showed no hydronephrosis. \nHe never appeared volume overloaded. He is anemic at baseline \nbut had no bone pain or hypercalcemia to suggest myeloma. His \nurine sediment was bland with no evidence of casts or dysmorphic \nreds, as reported by lab tech. His acute kidney injury was \ncompliacted by hyperkalemia, for which he received insulin, Ca, \nand kayexalate in the ED. Lisinopril and lasix were held while \nin-house. No urine eosinophilias were found. He received a total \nof 2.5L of supplemental IVF which greatly improved his Cr \ntrending down to almost near his baseline in 24 hours. Was \ndischarged with his Cr at 1.3 (baseline 1.2)\n\n#) DM2 c/b acute hyperglycemia: Patient on basal glargine, \npioglitazone, and januvia as outpatient. Had shoulder steroid \ninjection on ___ with a resultant hyperglyemia. Further renal \nclearance of glucose was impaired by the drop in GFR. No clear \ninfectious precipitant. Also possible to be related to \nmedication noncompliance as patient admits to not always \nremembering to take his pills. Normalized with insulin and \nfrequent FSG. LFTs wnl. Hgb A1c was still pending at discharge. \nHe will be discharged with a plan to increase his Lantus by 2 an \n4 Units if blood sugar is greater than 250 and 350 on fasting AM \nblood sugar respectively and to decrease by 2 and 4 units if \nblood sugar is less than 150 and 100 respectively with the added \ncaveat to call PCP if less than 100.\n\n#) Positive blood culture: One bottle from the ED grew out GPC \nout of 4. Patient is afebrile, normotensive, and feels well. \nHowever, he did have a leukocytosis on last labs, a history of \nan invasive procedure as well as recent steroids which could be \nconcerning. He received two doses of renally-dosed Vanco for \nempiric coverage. Given that his white count at discharge was \n13, and there is no clear infectious source, it is thought to be \na skin contaminant.\n\n#) Elevated Lactate: Likely from volume depletion and impaired \nclearance. Trended down towards normal with fluids.\n\n#) HTN/HLD/CAD equivalent: Hypertensive during this admission to \nthe 150s systolic. Lisniopril was held given ___, but ASA and \nsimvastatin were continued. All antihypertensives were restarted \non discharge.\n\n#) Asthma: Stable. Was continued on home advair, theophylline \nand albuterol nebs PRN. Flovent was held while in-house to \ndecrease steroid load. Will continue on it as an outpatient.\n\nTRANSITIONAL ISSUES:\n[ ] Patient should check daily fasting blood glucose levels \nuntil f/u with PCP with the following titration for Lantus:\nIf blood sugar is: \n\u003c100, decrease Lantus by 4 Units and call your PCP's office\n\u003c150, decrease Lantus by 2 Units\n\u003e250, increase Lantus by 2 Units\n\u003e350, increase Lantus by 4 Units \n[ ] Should avoid NSAIDs in the setting of decreased renal \nfunction\n[ ] Encourage good PO intake and education on the signs and \nsymptoms of hyper/hypoglycemia\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN sob, wheeze \n2. Aspirin 81 mg PO DAILY \n3. Docusate Sodium 100 mg PO BID:PRN constipation \n4. Fluoxetine 20 mg PO DAILY \n5. Fluticasone Propionate 110mcg 2 PUFF IH DAILY \n6. Fluticasone Propionate NASAL 2 SPRY NU DAILY \n7. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n8. Glargine 15 Units Bedtime\n9. Lisinopril 40 mg PO DAILY \n10. Magnesium Oxide 400 mg PO DAILY \n11. Omeprazole 20 mg PO DAILY \n12. Simvastatin 20 mg PO DAILY \n13. Tamsulosin 0.4 mg PO HS \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. Cyanocobalamin 250 mcg PO DAILY \n16. Acetaminophen w/Codeine 1 TAB PO BID:PRN pain \n17. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob \n18. Elocon (mometasone) 0.1 % Topical BID to affected area \n19. Loratadine 10 mg Oral daily \n20. Salonpas (camphor-methyl salicyl-menthol;\u003cbr\u003emethyl \nsalicylate-menthol) ___ % Topical BID:prn pain \n21. Acetaminophen ___ mg PO Q6H:PRN pain, fever \n22. Theophylline SR 300 mg PO BID \n23. Furosemide 20 mg PO QAM \n24. Januvia (sitaGLIPtin) 50 mg Oral daily \n25. Pioglitazone 30 mg PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen ___ mg PO Q6H:PRN pain, fever \n2. Aspirin 81 mg PO DAILY \n3. Cyanocobalamin 250 mcg PO DAILY \n4. Docusate Sodium 100 mg PO BID:PRN constipation \n5. Fluoxetine 20 mg PO DAILY \n6. Fluticasone Propionate NASAL 2 SPRY NU DAILY \n7. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n8. Loratadine 10 mg Oral daily \n9. Omeprazole 20 mg PO DAILY \n10. Simvastatin 20 mg PO DAILY \n11. Tamsulosin 0.4 mg PO HS \n12. Theophylline SR 300 mg PO BID \n13. Tiotropium Bromide 1 CAP IH DAILY \n14. Acetaminophen w/Codeine 1 TAB PO BID:PRN pain \n15. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob \n16. Elocon (mometasone) 0.1 % Topical BID to affected area \n17. Fluticasone Propionate 110mcg 2 PUFF IH DAILY \n18. Magnesium Oxide 400 mg PO DAILY \n19. Salonpas (camphor-methyl salicyl-menthol;\u003cbr\u003emethyl \nsalicylate-menthol) ___ % Topical BID:prn pain \n20. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN sob, wheeze \n21. Januvia (sitaGLIPtin) 50 mg Oral daily \n22. Pioglitazone 30 mg PO DAILY \n23. Glargine 15 Units Bedtime\n24. Furosemide 20 mg PO QAM \n25. Lisinopril 40 mg PO DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHyperglycemia\nAcute on Chronic Renal Failure\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n  \n It was a pleasure taking care of you while you were at ___ \n___. You were admitted to the \nhospital after your blood sugar was found to be very high. When \nyou came to the emergency room, routine blood work also showed \nthat you had a significant decrease in your kidney function \ncompared to your normal. You also had a high potassium level and \na high white blood cell count. You did not have any evidence of \ninfection, and we think that your elevated sugars caused most of \nthese problems. As your sugars were more controlled and we gave \nyou some IV fluid, your kidney function and sugar levels quickly \ngot better. Your potassium level was treated in the emergency \nroom and caused you some diarrhea that also resolved quickly. \nPlease stop taking naprocin or any other medications like \nibuprofen, advil or aleve. It would be best for your kidneys to \ntake Tylenol when you have pain. We determined that you did not \nhave an infection and you were discharged home. Please take all \nyour medications as scheduled and keep your follow-up \nappointments.\n\nBest Wishes,\nYour ___ Team\n\nPlease use this guide when you take your blood sugar in the \nmorning:\nIf blood sugar is:\n...less than 100, decrease Lantus by 4 Units and call your PCP's \noffice that morning\n...less than 150, decrease Lantus by 2 Units\n...greater than 250, increase Lantus by 2 Units\n...greater than 350, increase Lantus by 4 Units \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16207116","hadm_id":"20695781","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Donnatal / nitroglycerin\n \nAttending: ___.\n \nChief Complaint:\nAgitation, UTI\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old female with history of atrial fibrillation not on \nanticoagulation, CHF, ovarian cancer s/p TAH/BSO and \nchemotherapy who was brought to the ED by family for agitation. \nPer report, the patient has not been acting herself and has \nbecome more agitated and aggressive. She has been refusing \nmedications, has not bathed, and has been throwing knives. She \nwas diagnosed with a urinary tract infection one day prior to \nadmission and was prescribed ciprofloxacin. However, per report \npatient has not been taking medications.\n\nCollateral information from her grandson includes that patient \nwas independent until 1 month ago when she fell trying to get \nher husband breakfast. Afterwards, she was in rehab for one \nmonth. She was discharged home on ___. Patient has since had \n24 hour care with ___ providing 10 hours during the day and \nson/grandson alternating care in the evenings. \n\nThe patient was subsequently admitted to ___ from ___ \nfor hypoxia which was attributed to CHF and aspiration. \nHospitalization was complicated by anemia and atrial \nfibrillation with RVR. Anemia was attributed to slow GI bleed \nand CKD. Patient deferred EGD/colonoscopy and was transfused \nRBCs. Patient was evaluated by speech and swallow with overt \naspiration. The patient and family deferred dysphagia workup and \ndid not want a feeding tube. She was continued on an oral diet \nwith, understanding the risks of aspiration. Goals of care were \ndiscussed with the patient and family and it was confirmed \nDNR/DNI. Patient was discharged with home hospice services and \nhome health aid for nearly 24 hour assistance. \n\nGrandson notes that patient has had significant behavioral \nsymptoms especially over the last 7 days. Her PCP prescribed \nciprofloxacin prophylactically for UTI but patient refused to \ntake it. PCP actually came and visited her in the home and \nconvinced her to take one tablet. Otherwise, patient has refused \nall medications over the last week.  Of note, grandson asked PCP \nto fill out forms that would allow him to make decisions for her \n- PCP stated he did not feel comfortable doing this and wanted \nformal evaluation by psychiatry. \n\nYesterday evening, patient was noted to be despondent and \nscreaming at everyone. Grandson subsequently called ___. Patient \nwas reportedly hitting people with canes and trying to throw \nthings in the kitchen, ?\n?throwing knives. \n\nIn the ED, initial VS were T 98.9, HR 94, BP 186/58, RR 20, 100% \nRA. Patient was agitated and placed in soft restraints. She \nreceived olanzapine 5 mg IM x1 and was calm following \nintervention.\n- Labs: WBC 13.1, H/H 8.6/27.1, Cr 1.6 (baseline). UA negative \nleukocytes/nitrites. \n- CXR was deferred due to agitation.   \nVitals on transfer: 101 116/75 18 99% RA \n\nUpon arrival to the floor, patient was extremely upset with her \nfamily for bringing her to the hospital. She denied any pain or \ndiscomfort. She declined vital signs and declined to be \nexamined. \n\nREVIEW OF SYSTEMS:  \nUnable to obtain secondary to agitation \n\n \nPast Medical History:\n- Atrial fibrillation not on anticoagulation\n- HFpEF\n- Aspiration\n- Anemia\n- CKD (baseline Cr 1.6)\n- Hypertension\n- Headaches\n- Spinal stenosis\n- GERD\n- Ovarian cancer s/p TAH/BSO and chemotherapy\n- Neurofibroma\n- Lower GI bleed s/p syncopal event.\n- IBD\n- Internal hemorrhoids\n- Esophagitis\n- S/p bilateral TKAs\n- S/p cholecystectomy\n \nSocial History:\n___\nFamily History:\nUnknown \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\nVS: Refused. \nGENERAL: Chronically ill appearing, alert and oriented x 3. \nSpeaking in full sentences. Refusing to be examined.\n\nDISCHARGE PHYSICAL EXAM\nVitals: T98.8 BP 105/79 HR 72 RR 18 Sats 98 RA\nGeneral: alert, oriented, no acute distress  \nHEENT: sclera anicteric, dry MM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno rebound tenderness or guarding, no organomegaly  \nGU: no foley  \nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro: CNs2-12 intact, motor function grossly normal  \nPsych: conversing appropriately, able to say WORLD backwards\n \nPertinent Results:\nADMISSION LABS\n___ 08:30PM BLOOD WBC-13.1* RBC-2.86* Hgb-8.6* Hct-27.1* \nMCV-95 MCH-30.1 MCHC-31.7* RDW-14.9 RDWSD-51.2* Plt ___\n___ 08:30PM BLOOD Neuts-74.7* Lymphs-14.3* Monos-8.9 \nEos-1.0 Baso-0.8 Im ___ AbsNeut-9.78* AbsLymp-1.87 \nAbsMono-1.16* AbsEos-0.13 AbsBaso-0.11*\n___ 08:30PM BLOOD Glucose-100 UreaN-26* Creat-1.6* Na-140 \nK-4.6 Cl-104 HCO3-23 AnGap-18\n___ 11:41AM BLOOD Calcium-8.7 Phos-3.4 Mg-1.9\n\nURINE\n___ 10:45PM URINE Color-Yellow Appear-Clear Sp ___\n___ 10:45PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 10:45PM URINE RBC-\u003c1 WBC-2 Bacteri-FEW Yeast-NONE Epi-0\n\nMICROBIOLOGY\n___ URINE CULTURE PENDING\n___ BLOOD CULTURE X 2 PENDING\n\nPERTINENT IMAGING\n___ CXR\nPrevious pleural effusions have nearly resolved.  Mild \ncardiomegaly is chronic\n \n___ CT HEAD NONCONTRAST\n1. No acute intracranial abnormality.\n2. No acute intracranial hemorrhage.\n3. Chronic changes as described above.\n4.  Please note MRI of the brain is more sensitive for the \ndetection of acute\ninfarct.\n\n \nBrief Hospital Course:\nMs. ___ is a ___ year old female with history of atrial \nfibrillation, aspiration, CHF, and CKD who was brought to the ED \nby family for agitation.\n\n# Agitation: Patient had been refusing medications, has not \nbathed, and had been throwing things per family members. UA on \nadmission not consistent with UTI. Patient also with \nleukocytosis, however this has persisted since her last \nhospitalization. Patient does have a history of aspiration but \nwas without cough and found to have CXR with no evidence of \nfocal consolidation. EKG was without ischemic changes. On \nfurther history, it seems that patient is more demoralized and \nupset by the lack of independence that she has at home. She is \noriented x 3 and converses appropriately when examined. ___ \nevaluated her and recommended 24 home supervision. Patient was \nevaluated by psychiatry who agreed that patient was not \ndepressed or delirious but rather simply frustrated by home \nsituation. \n\n# Disposition: Patient had prolonged hospitalization as 24 hour \nhome supervision could not be provided. She was evaluated by \nsocial work and palliative care as well as geriatrics. She was \ndetermined to have capacity and thus, her own medical \ndecision-making. Despite her wishes to go home without 24 hour \nsupervision, she was held in order for this care to be \nestablished to provide a safe discharge plan. Multiple family \nmeetings were held with primary care taker, grandson ___, \nprimary team members, social work, and others. Ultimately, with \ngeriatrics and hospice liaison presence and aid, a plan for 24 \nhour supervision was instituted and thus, patient was deemed \nsafe for discharge home with services.\n\n# Leukocytosis: Persistently elevated from last admission. This \nwas attributed to continued aspiration. Decreased to 8.0 on \n___.\n\nCHRONIC ISSUES:\n# HYPERTENSION: Continued home amlodipine, metoprolol.\n# CHF: Currently not symptomatic and on room air. Of note, the \npatient was discharged home on O2 at last admission. Continued \nhome Lasix 20mg PO daily.\n# AFIB: Not on anticoagulation. Continued on fractionated \nmetoprolol while hospitalized and discharged on long-acting \nmetoprolol. \n# Anemia: Likely secondary to slow GI bleed and CKD. Patient \nrequired transfusions during last hospitalization but declined \nfurther intervention or workup with egd/colonoscopy. H/H \nremained stable during this admission. \n\n# CODE STATUS: DNR/DNI\n# CONTACT: Grandson ___: ___ (power of attorney), Son \n___: ___\n\n# TRANSITIONAL ISSUES\n- hospice ___ services to continue support at home\n- consider Seroquel or another antipsychotic to help with \nbehavior issues\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amlodipine 5 mg PO DAILY \n2. Acetaminophen 650 mg PO Q8H:PRN pain, fever \n3. Furosemide 20 mg PO DAILY \n4. Metoprolol Succinate XL 100 mg PO DAILY \n5. LOPERamide 2 mg PO QID:PRN diarrhea \n6. Pantoprazole 40 mg PO Q24H \n7. Famotidine 20 mg PO DAILY \n8. Lorazepam 0.5 mg PO QHS:PRN insomnia \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q8H:PRN pain, fever \n2. Amlodipine 5 mg PO DAILY \n3. Furosemide 20 mg PO DAILY \n4. LOPERamide 2 mg PO QID:PRN diarrhea \n5. Pantoprazole 40 mg PO Q24H \n6. Famotidine 20 mg PO DAILY \n7. Lorazepam 0.5 mg PO QHS:PRN insomnia \n8. Metoprolol Succinate XL 100 mg PO DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis: Anxiety/stress\n\nSecondary diagnosis: atrial fibrillation\nchronic congestive heart failure\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you here at ___. There was \nconcern that you were not acting yourself at home. You were \nfound NOT to have a pneumonia, urinary tract infection, or a \nbleed in your head. Your home situation appears to be causing \nyou significant amount of stress. You were seen by social work, \npalliative care, and the psychiatry teams who recommended that \nyou get further cognitive testing and follow-up with the \n___ clinic. \n\nYou were also evaluated by the geriatric team in the hospital. \nThey determined that you were competent to make your own medical \ndecisions. We hope that you will accept the 24 hour supervision \nthat physical therapy has recommended. Additionally, your \ngrandson ___ has been doing the best he can to provide the \nrecommendations of your doctors.\n\nWe wish you all the best.\n\nSincerely,\n\nYour ___ team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"17611612","hadm_id":"29713825","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nstone fruit / Iodinated Contrast Media - IV Dye\n \nAttending: ___.\n \nChief Complaint:\nconfusion \n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ male with a past medical history of metastatic renal \ncell carcinoma and prior hypercalcemia (with Ca of 15 in the \npast) presenting with confusion.  \nPatient reports several weeks of increasing fatigue which \naccelerated over the last week. Over the last several days he \nalso developed episodes of confusion, difficulty remembering \nthings, and 'not making sense'. Due to similarity to prior \nepisodes of hypercalcemia his wife called his oncologist who \nrecommended he present to the ED.  \nIn the ED, initial VS were: 3 97.6 104 134/74 16 97% RA  \nLabs were notable for: Na 132, lactate 1.3, Ca ___  \nImaging included: CXR showed interval increase in size and \nnumber of pulmonary nodules and masses with most dense \nconsolidation at the right lung base which is new. CT head \nnoncontrast showed a medial right cerebellar hypodense lesion.  \n\n \nPast Medical History:\nPAST MEDICAL HISTORY:\n1. HTN\n2. Renal cell carcinoma, metastatic\n\nPAST SURGICAL HISTORY:\n1. Right nephrectomy - ___\n2. Right hernia repair - ___\n\nONCOLOGIC HISTORY:\nHe was initially diagnosed after having increasing back pain, \nand then developed systemic symptoms. CT ___ showed a large \nosteolytic metastatic deposit involving the right sacrum and \nileum extending through the joint with a large extraosseous \nvascular metastatic deposit measuring approximately 10 x 12 cm \nposteriorly infiltrating the piriformis muscle and extending \ninto the gluteal region.  A partial visualization of the kidney \nrevealed a large 4 x 5 cm right renal neoplasm. CT scan of chest \nand abdomen revealed a focal sclerotic sternal lesion; however, \nno other pulmonary nodules or abnormalities were seen in the \nscan.  \n\nHe underwent fine needle core biopsy of the right gluteal\nmass on ___ revealing metastatic renal cell carcinoma.\n\nHe underwent nephrectomy ___ and palliative radiation \ntherapy\nto the right iliac mass from ___. \n\nIL-2 therapy: He began cycle 1 week 1 on ___ and received ___ \ndoses, complicated by toxic encephalopathy. Then recovered and\nwas admitted ___ for cycle 1 week 2 of HD-IL2. \n \nSocial History:\n___\nFamily History:\nMother with transitional cell carcinoma of kidney, ___ yo, alive \nand well. Grandmother had thyroid cancer. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS: T97.8 BP 140/88 HR 88 RR 16 O2 98%RA  \nGENERAL: Pleasant man, NAD  \nHEENT: NC/AT, EOMI, PERRL, MMM  \nCARDIAC: RRR, normal S1 \u0026 S2, without murmurs, S3 or S4  \nLUNG: clear to auscultation, no wheezes or rhonchi  \nABD: +BS, soft, NT/ND, no rebound or guarding  \nEXT: No lower extremity pitting edema  \nPULSES: 2+DP pulses bilaterally  \nNEURO: Oriented to self and hospital. Not year. Able to ___ \nforward, but missed several days going backward. Occaisional \nword searching, otherwise speech is fluent. CN II-XII intact. \nFull strength in all extremities. FTN intact. Somewhat wide \nbased shuffling gait.  \nSKIN: Warm and dry, without rashes \n=====================================================\nDISCHARGE Physical Exam:  \nVS: 98.7 136/80 83 20 94%RA \nGENERAL: Pleasant man, NAD   \nCARDIAC: RRR, normal S1 \u0026 S2, without murmurs, S3 or S4  \nLUNG: clear to auscultation, no wheezes or rhonchi  \nABD: +BS, soft, NT/ND, no rebound or guarding  \nEXT: No lower extremity pitting edema  \nPULSES: 2+DP pulses bilaterally  \nNEURO: Oriented to self and hospital. Not day/year. Refuses ___ \n___.  speech is fluent. CN II-XII intact. Full strength \nin all extremities. \nSKIN: Warm and dry, without rashes  \n\n \nPertinent Results:\nINITIAL LABS: \n\n___ 12:06PM BLOOD WBC-6.4 RBC-4.38* Hgb-11.8* Hct-37.0* \nMCV-84 MCH-27.0 MCHC-32.0 RDW-13.4 Plt ___\n___ 12:06PM BLOOD Neuts-78.0* Lymphs-14.3* Monos-5.9 \nEos-1.4 Baso-0.4\n___ 12:06PM BLOOD Plt ___\n___ 12:06PM BLOOD Calcium-13.2* Phos-2.6* Mg-2.1\n___ 12:16PM BLOOD Lactate-1.3\n==============================================================\nDISCHARGE LABS: \n\n___ 06:00AM BLOOD WBC-7.8 RBC-4.10* Hgb-11.2* Hct-34.5* \nMCV-84 MCH-27.2 MCHC-32.4 RDW-13.6 Plt ___\n___ 06:00AM BLOOD Plt ___\n___ 06:00AM BLOOD Glucose-105* UreaN-12 Creat-0.9 Na-136 \nK-3.9 Cl-107 HCO3-19* AnGap-14\n___ 06:00AM BLOOD Calcium-10.9* Phos-2.7 Mg-2.2\n\n==============================================================\nMRI BRAIN \n1.  3 mm enhancing focus in the right cerebellum with adjacent \nedema, \nconcerning for a solitary brain metastasis.  No evidence of \nhemorrhage, mass effect, or infarction. \n2.  Stable subcortical white matter hyperintensities are \nnonspecific, possibly related to chronic small vessel ischemic \ndisease. \n\n \nBrief Hospital Course:\n___ male with a past medical history of metastatic renal \ncell carcinoma and prior hypercalcemia presenting with confusion \nfound to have elevated calcium and evidence of brain metastasis. \n\n\n#Toxic Metabolic encephalopathy: Patient with increased \nconfusion on admission, found to have elevated calcium likely \nrelated to known PTHrP. Previous similar episodes in the past.  \nPatient treated with aggressive IV fluid hydration and IV \nbisphosphonates. Calcium on discharge was 10.9 mental status had \nimproved per wife. Plan for repeat calcium check on ___\n\n#Evidence of brain metastasis: Patient with evidence of 3mm \nlesion in cerebellum with surrounding edema. This was not \nthought to be the cause of patients AMS due to small size.  \nRadiation Oncology saw patient while admitted with plan for XRT \nas an outpatient. \n\n#Discontinuation of study drug: Due to evidence of aressive \nprogression of disease in both lung and brain and hospital \nadmission study drug was held. Dr. ___.  \n\n#Metastatic renal cell carcinoma: Concern for progression given \nincrease in pulmonary nodes, CNS lesion, and worsening \nhypercalcemia.  \n\n#Hyponatremia: Mild on admission. Pt w/hx of hypovolemic \nhyponatremia.  trended up to normal with IVF \n\nCHRONIC ISSUES:  \n#Anxiety: Holding alprazolam  \n#Hypertension: Continue losartan  \n#Pain: Con't home methadone/oxycodone  \n\nTransitional Issues: \n-Patient found to have new evidence of brain metastasis 3 mm \nenhancing focus in the right cerebellum. He was seen by \nradiation oncology as an inpatient with plan for single fraction \nof CK treatment with a dose of 22 Gy. He is scheduled to see \nradiation oncology as an outpatient. \n-Please ensure patient has follow up with palliative care \n-pt to have chem 10 drawn on ___ results faxed to oncologist\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Losartan Potassium 25 mg PO BID \n2. Megestrol Acetate 400 mg PO BID \n3. Guaifenesin-Dextromethorphan 5 mL PO Q8H:PRN cough \n4. ALPRAZolam 0.5 mg PO Q4H:PRN anxiety \n5. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n6. Senna 8.6 mg PO BID:PRN constipation \n7. Methadone 20 mg PO QAM \n8. Methadone 30 mg PO BID \n9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n\n \nDischarge Medications:\n1. Guaifenesin-Dextromethorphan 5 mL PO Q8H:PRN cough \n2. Losartan Potassium 25 mg PO BID \n3. Methadone 20 mg PO QAM \n4. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n5. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n6. Senna 8.6 mg PO BID:PRN constipation \n7. ALPRAZolam 0.5 mg PO Q4H:PRN anxiety \n8. Megestrol Acetate 400 mg PO BID \n9. Methadone 30 mg PO BID \n10. Outpatient Lab Work\nplease draw chem 10 on ___\nICD 9:275.42 hypercalcemia\nplease fax results to Dr. ___ at ___\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nFinal diagnosis: \nhypercalcemia\nmetastatic RCC \n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___, \n\nYou were admitted to the hospital for worsening confusion and \nwere found to have elevated calcium. We treated you with IV \nfluids and medications to lower your calcium.  Your calcium \ntrended downward through the day and you reported feeling less \nconfused. We also did an MRI of your brain which shows that you \nhave evidence of cancer in your brain.  You will need to follow \nup with the radiation oncology for treatment. \n\nPlease come back to the hospital if you have worsening \nconfusion. Drink plenty of fluids at home to keep your calcium \ndown.  \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"17796373","hadm_id":"23775463","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nseizure\n \nMajor Surgical or Invasive Procedure:\nLumbar puncture ___\nIntubated ___ (at OSH)\nExtubated ___\n\n \nHistory of Present Illness:\nMr. ___ is a ___ year-old man with a history of seizure\ndisorder, on Tegretol, who initially presented to an OSH after\nbeing found down by family this morning and transferred from\n___ after having 2 witnessed generalized tonic\nclonic seizures s/p Ativan, Keppra, fosphenytoin and intubation.\n\nPer ___ notes and the ED team, the patient's brother found\nhim down this morning on the floor having a seizure. Prior to\nthis he had been feeling well, though may have had some alcohol\nthe night before (2 shots of whiskey). It is unclear if he was\nadministered any rescue medications in the field, though there\nwas reportedly a 30 second seizure witnessed by EMS. He \npresented\nto the ___ shortly after 3 AM and upon arrival had a\ngeneralized tonic clonic seizure with left eye deviation. He was\ngiven Ativan 4 mg and given concerns about airway protection, \nwas\nsubsequently intubated and started on a propofol drip. Vital\nsigns on arrival to ___ were temp 100.4, HR 130, RR 20, BP\n180/100, O2 100%. Initial work-up included CT head and spine\n(negative), WBC 16.3, hgb 14.7, plt 308, Na 140, K 3, Cl 102, \nCO2\n22, BUN 13, Cr 1.2, glucose 226, troponin negative, Tegretol\nlevel 3.9, negative serum tox screen, lactate 10.9, initial gas\n6.98/79.\n\n \nPast Medical History:\nSeizure disorder\n \nSocial History:\n___\nFamily History:\nNo family history of seizures.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVITALS: Reviewed in MetaVision  \nGENERAL: Intubated and sedated \nHEENT: Sclera anicteric, ET tube in place, small amount of blood\nin corner of mouth  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Diffuse anterior upper airway sounds/rhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs,\ngallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no\nrebound tenderness or guarding, no organomegaly  \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or\nedema  \nSKIN: warm, dry\nNEURO: Intubated, sedated. Moving all 4 extremities, withdraws \nto\npain in upper extremities bilaterally. Purposeless movement. Not\nfollowing commands. CN II-XII intact.\n\nDISCHARGE PHYSICAL EXAM:\n========================\nGeneral: alert, cooperative, NAD\nHEENT: no scleral icterus, MMM\nCV: warm, well perfused\nPulm: breathing comfortably on RA\nAbdomen: soft, ND\nGU: some dried blood around foley catheter.\nExtremities: without edema\nSkin: no lesions or rashes\n\nMental status:\nAwake, alert and oriented to person, ___. Does not\nremember the name of the ___ he works for, states his job is\n___\". Unable to accurately explain why he is in the\nhospital, believes he is here for UTI. Able to say ___ \nbackwards.\nAble to follow two step commands. Normal prosody. No dysarthria. \n\n\n-Cranial Nerves:\nII, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI with one beat\nnystagmus left gaze.\nV: Facial sensation intact to light touch.\nVII: No facial droop, facial musculature symmetric.\nVIII: Hearing intact to finger-rub bilaterally.\nIX, X: Palate elevates symmetrically.\nXI: ___ strength in trapezii and SCM bilaterally.\nXII: Tongue protrudes in midline.\n\nMotor: \nNormal bulk, tone. Full strength throughout.\n\nSensory: no deficits to gross touch.\n\nCerebellar: Normal FNF\n\n \nPertinent Results:\nADMISSION LABS\n===============\n___ 07:02AM BLOOD WBC-19.9* RBC-4.27* Hgb-13.2* Hct-40.1 \nMCV-94 MCH-30.9 MCHC-32.9 RDW-12.3 RDWSD-42.9 Plt ___\n___ 07:02AM BLOOD Neuts-84.0* Lymphs-6.7* Monos-8.4 \nEos-0.0* Baso-0.2 Im ___ AbsNeut-16.23* AbsLymp-1.29 \nAbsMono-1.62* AbsEos-0.00* AbsBaso-0.03\n___ 07:02AM BLOOD Plt ___\n___ 11:22AM BLOOD ___ PTT-21.0* ___\n___ 07:02AM BLOOD Glucose-172* UreaN-10 Creat-0.9 Na-140 \nK-5.3 Cl-102 HCO3-15* AnGap-23*\n___ 07:02AM BLOOD ALT-21 AST-42* CK(CPK)-246 AlkPhos-75 \nTotBili-0.4\n___ 07:02AM BLOOD Lipase-28\n___ 07:02AM BLOOD cTropnT-\u003c0.01\n___ 07:02AM BLOOD CK-MB-2\n___ 07:02AM BLOOD Albumin-4.1 Calcium-8.9 Phos-2.7 Mg-1.6\n___ 03:58PM BLOOD TSH-1.2\n___ 07:02AM BLOOD Phenyto-18.5\n___ 07:02AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 07:27AM BLOOD ___ pO2-26* pCO2-42 pH-7.40 \ncalTCO2-27 Base XS-0\n___ 07:27AM BLOOD Lactate-3.8*\n\nIMAGING\n=================\n___ CXR\n\nET tube in standard placement.  Nasogastric drainage tube passes \ninto the mid stomach and out of view. \n  \nNo pneumothorax or pleural effusion.  Heart size normal.  Lungs \nclear aside from mild left infrahilar atelectasis. \n\n___ EEG\n\nThis is an abnormal continuous ICU EEG monitoring study because \nof generalized background slowing indicative of a moderate to \nsevere global encephalopathy, nonspecific as to etiology. No \nepileptiform discharges, areas of focal slowing, or \nelectrographic seizures are seen. There is one  pushbutton \nactivation for a brief period of body tensing, with no change in \nthe EEG background and no electrographic seizure activity \npresent. Compared to  the prior day's study, the background is \nmore continuous on the current study \n\nMICROBIOLOGY\n==================\n\n___ 6:10 pm CSF;SPINAL FLUID      Source: LP. \n\n   Enterovirus Culture (Preliminary):    No Enterovirus \nisolated. \n\n___ 6:10 pm CSF;SPINAL FLUID      Source: LP #3. \n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Preliminary):    NO GROWTH. \n\n   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n\n   ACID FAST CULTURE (Preliminary): \n      The sensitivity of an AFB smear on CSF is very low.. \n      If present, AFB may take ___ weeks to grow.. \n\n___ 6:10 pm CSF;SPINAL FLUID      Source: LP. \n\n                            **FINAL REPORT ___\n\n   CRYPTOCOCCAL ANTIGEN (Final ___: \n      CRYPTOCOCCAL ANTIGEN NOT DETECTED. \n           (Reference Range-Negative). \n      Test performed by Lateral Flow Assay. \n      Results should be evaluated in light of culture results \nand clinical\n      presentation. \n\n___ 3:58 pm Blood (EBV)      Source: Venipuncture. \n\n   ___ VIRUS VCA-IgG AB (Final ___:    POSITIVE \nBY EIA. \n\n   ___ VIRUS EBNA IgG AB (Final ___:    POSITIVE \nBY EIA. \n\n   ___ VIRUS VCA-IgM AB (Preliminary): \n      PENDING. \n      INTERPRETATION PENDING. \n      In most populations, 90% of adults have been infected at \nsometime\n      with EBV and will have measurable VCA IgG and EBNA \nantibodies.\n      Antibodies to EBNA develop ___ weeks after primary \ninfection and\n      remain present for life. Presence of VCA IgM antibodies \nindicates\n      recent primary infection. \n\n___ 3:58 pm SEROLOGY/BLOOD      Source: Venipuncture. \n\n                            **FINAL REPORT ___\n\n   RAPID PLASMA REAGIN TEST (Final ___: \n      NONREACTIVE. \n      Reference Range: Non-Reactive. \n\n___ 7:44 am URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n\nDISCHARGE LABS\n==============\n___ 04:15AM BLOOD WBC-8.3 RBC-4.17* Hgb-12.4* Hct-38.4* \nMCV-92 MCH-29.7 MCHC-32.3 RDW-12.6 RDWSD-42.5 Plt ___\n___ 04:15AM BLOOD Plt ___\n___ 04:15AM BLOOD Glucose-95 UreaN-11 Creat-0.5 Na-142 \nK-3.8 Cl-104 HCO3-25 AnGap-13\n___ 04:15AM BLOOD Calcium-9.1 Phos-3.5 Mg-1.7\n \nBrief Hospital Course:\nMr. ___ is a ___ year-old ___ speaking man with a \nhistory of seizure disorder (on carbamazapine), who initially \npresented to an OSH after being found down by family and \ntransferred from ___ after having 2 witnessed \ngeneralized tonic clonic seizures s/p Ativan, Keppra, \nfosphenytoin and intubation. He was initially admitted to the \nMICU for monitoring, then once stable, transferred to the \nneurology service for further care. His course was complicated \nby fevers and traumatic foley placement.\n\n#Status epilepticus:\nThe patient has an underlying seizure disorder on carbamazepine \n300 mg BID, though his level was subtherapeutic. His medications \nwere managed by PCP in ___ and ___ reported poor \nmedication compliance. He was initially intubated and sedated \nfrom the outside hospital and was able to be extubated on ___. \nThere was concern for infectious trigger given fever to 103 in \nthe ED. He was initially started on broad spectrum antibiotics \nwith vancomycin, ceftriaxone, ampicillin and acyclovir, though \nCSF not clearly consistent with bacterial or viral etiology, so \nantibiotics were discontinued on ___. He did intermittently run \nfevers, though improved even after stopping antibiotics. Other \npossible triggers for his seizures include medication \nnoncompliance and ETOH withdrawal (ETOH history unclear). \nInitiated levetiracetam 1000 mg BID, held home carbamazepine 300 \nmg BID. No additional seizures on the Neurology floor. Prior to \ndischarge, patient was counseled that he should not drive, \noperate heavy machinery, or drink ETOH, he was amenable.\n\n#Fevers: \nEtiology of the patient's fevers are unclear. CXR relatively \nunremarkable. UA without evidence of infection. LP unremarkable. \nLow suspicion for other source. Treated with broad spectrum \nantibiotics (see #status epilepticus). His antibiotics were \nstopped on ___ and he remained afebrile. \n\n#Altered mental status: \nPatient was altered and agitated in the ICU, especially after \nextubation. Unclear etiology. Possibly related to ETOH \nwithdrawal, though unclear how much patient drinks. Placed on \nphenobarbital taper which was discontinued prior to discharge \ngiven low suspicion for withdrawal. ___ also be ICU delirium, \nespecially given re-directability with family members and waxing \nand waning features. In the ICU he was loaded with \nphenobarbital, kept on precedex, and started on Seroquel, with \ngood response. He was able to be weaned off precedex on ___ and \nremained AAOx3. He had no additional episodes of agitation and \nSeroquel was discontinued.\n\n#Acute respiratory failure:\nIn the setting of agitation and status epilepticus, intubated \nfor airway protection and hypercarbia. Extubated on ___ and \nremained without hypoxemia.\n\n#Traumatic foley removal\nPatient pulled out foley on ___ and passed blood clots on ___. \nHe was kept on serial bladder scans to ensure was not clotting \noff. Urology follow-up was scheduled prior to discharge.\n\nTRANSITIONAL ISSUES\n===================\n[] discontinued home carbamazepine\n[] initiated levetiracetam 1000 mg PO BID, please continue.\n[] at urology visit, please perform voiding trial for foley \nremoval.\n[] continue to encourage medication compliance\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. CarBAMazepine 300 mg PO Q12H \n2. Vitamin D 4000 UNIT PO DAILY \n3. Loratadine 10 mg PO DAILY \n\n \nDischarge Medications:\n1.  LevETIRAcetam 1000 mg PO BID \nRX *levetiracetam [Keppra] 1,000 mg 1 tablet(s) by mouth twice a \nday Disp #*60 Tablet Refills:*6 \n2.  Thiamine 100 mg PO DAILY \nRX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth daily \nDisp #*30 Tablet Refills:*0 \n3.  Loratadine 10 mg PO DAILY  \n4.  Vitamin D 4000 UNIT PO DAILY  \n5.Outpatient Physical Therapy\nICD10:  ___.501\nDuration: ongoing\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nStatus epilepticus\nAcute respiratory failure\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure to care for you at the ___ \n___.\n\nWHY DID I COME TO THE HOSPITAL?\n--You developed seizures. \n\nWHAT HAPPENED WHEN I WAS IN THE HOSPITAL?\n--You briefly required a breathing tube to make sure you were \nbreathing safely in the setting of seizures.\n--We gave you a new medication to help control your seizures \n(\"levetiracetam\") . You will continue to stay on this medication \nafter you leave the hospital.\n--You were given antibiotics because you had fevers. We stopped \nyour antibiotics and you did not have any additional fevers.\n--You required a \"foley catheter\" to help you urinate while you \nhad a breathing tube. You passed some blood clots in your urine. \nYou will have the foley catheter at the time of discharge to \nallow healing. This will be removed next week at your urology \nappointment, which we have scheduled for you.\n\nWHAT SHOULD I DO WHEN I LEAVE THE HOSPTIAL?\n--Please continue to take your medications as prescribed and \nfollow-up with your doctors as ___.\n--Because of your risk for seizures, you must take some \nprecautions. You should not drive for 6 months. You also should \navoid operating any heavy machinery or placing yourself at risk \nfor dangerous falls. You should abstain completely from drinking \nalcohol.\n\nWe wish you all the best,\nYour ___ care team \n \nFollowup Instructions:\n___\n"}
{"subject_id":"13835105","hadm_id":"23640028","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nElective chemotherapy\n\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ year old male with CNS lymphoma s/p L\ncraniotomy ___ who presents for his 6th dose of HD-MTX.\n\nThe patient was admitted on ___ for cycle 5 which was tolerated\nwell.\n\nSince discharge he has been doing well aside from occasional L\nankle pain that has been long standing. He has no headache or\nvision changes. No chest pain or palpitations. No dyspnea. No \nabd\npain. No n/v/d. No dysuria. \n\n \nPast Medical History:\nPAST ONCOLOGIC HISTORY:\nCNS Lymphoma:\n- ___: Headache and confusion started\n- ___: Head CT without contrast showed edema and mass effect\nin the left frontal brain\n- ___: Head MRI with gadolinium showed enhancing lesions at\nleft frontal, right parietal, and right temporal regions\n- ___: Torso CT did not show lymphadenopathy or masses \n- ___: Open brain biopsy by Dr. ___. Pathology: \nCD20+\nB-cell lymphoma.\n- ___: C1 induction high-dose methotrexate at 8 grams/m2\n- ___: C2 induction high-dose methotrexate at 8 grams/m2\n- ___: C3 induction high dose MTX\n- ___: C4 induction high dose MTX\n- ___ q2wk Consolidation high dose MTX\n- ___ q2wk Consolidation high dose MTX\n- ___ q2wk Consolidation high dose MTX\n- ___ q2wk Consolidation HD-MTX \n\nPAST MEDICAL HISTORY: \n- CNS lymphoma\n- Hypertension\n\n \nSocial History:\n___\nFamily History:\nHis mother died at ___ after embolic illness, details unknown. \nHis\nfather is healthy. No known family history of leukemia or\nlymphoma.\n\n \nPhysical Exam:\nADMISSION:\nVITALS: ___ 0728 Temp: 98.1 PO BP: 127/89 R Sitting HR: 99\nRR: 16 O2 sat: 96% O2 delivery: RA \n   \nGENERAL:  Sitting comfortably in bed, NAD\nHEENT: clear OP without lesions, moist membranes\nEYES:  PERRL, anicteric\nNECK:  supple\nRESP:  CTAB, no wheezing, rhonchi or crackles\n___:  Regular, no Mumurs\nGI:  soft, Non-tender without rebound and guarding\nEXT:  warm, no edema\nSKIN:  dry, no obvious rashes\nMSK: no obvious deformity, erythema or edema over left ankle.\nSensation and strength intact. Point tenderness over medal \ndistal\naspect of fibula\nNEURO:  CN II-XII intact, alert, fluent speech\nACCESS:  POC c/d/I\n\nDISCHARGE:\n98.5 PO 130 / 86 102 18 96 RA \n\nGENERAL:  Sitting comfortably in bed, NAD\nHEENT: clear OP without lesions, moist membranes\nEYES:  PERRL, anicteric\nNECK:  supple\nRESP:  CTAB, no wheezing, rhonchi or crackles\n___:  Regular, no Mumurs\nGI:  soft, Non-tender without rebound and guarding\nEXT:  warm, no edema\nSKIN:  dry, no obvious rashes\nMSK: no obvious deformity, erythema or edema over left ankle.\nSensation and strength intact. Point tenderness over medal \ndistal\naspect of fibula\nNEURO:  CN II-XII intact, alert, fluent speech\nACCESS:  POC c/d/i\n\n \nPertinent Results:\nADMISSION:\n\n___ 08:05AM BLOOD WBC-6.3 RBC-5.29 Hgb-15.7 Hct-46.2 MCV-87 \nMCH-29.7 MCHC-34.0 RDW-12.7 RDWSD-40.1 Plt ___\n___ 08:05AM BLOOD Glucose-93 UreaN-20 Creat-0.9 Na-140 \nK-4.6 Cl-105 HCO3-22 AnGap-13\n___ 08:05AM BLOOD ___ PTT-22.9* ___\n___ 08:05AM BLOOD ALT-32 AST-25 AlkPhos-96 TotBili-0.5\n___ 08:05AM BLOOD Calcium-9.1 Phos-2.1* Mg-2.1\n\nDISCHARGE:\n\n___ 06:03AM BLOOD WBC-4.3 RBC-4.78 Hgb-14.0 Hct-41.7 MCV-87 \nMCH-29.3 MCHC-33.6 RDW-12.2 RDWSD-39.3 Plt ___\n___ 06:03AM BLOOD ALT-86* AST-37 AlkPhos-66 TotBili-1.1\n___ 06:03AM BLOOD Calcium-8.5 Phos-2.0* Mg-1.9\n\n___ 04:58PM BLOOD mthotrx-2.3*\n___ 05:03PM BLOOD mthotrx-0.14\n___ 06:03AM BLOOD mthotrx-0.10\n \nBrief Hospital Course:\nMr. ___ is a pleasant ___ w/ CNS lymphoma (s/p L frontal \ncraniotomy ___, who presents for his 6th dose of q2wk \nconsolidation therapy with HD-MTX.\n\n#ENCOUNTER FOR CHEMOTHERAPY\n#CNS LYMPHOMA:\n\nPatient presented for elective HD-MTX. His urine was alkalinized \nper protocol and he received HD-MTX per OMS order set. He then \nreceived leucovorin rescue per protocol. MTX levels were checked \nq24H until \u003c0.1. The treatment was tolerated well. He was \nmaintained on a MTX diet while in house. Continued home Keppra \nfor seizure ppx.\n\nPatient was given Rx for Keppra and bicarbonate at discharge.\n\n# Billing: \u003e30 minutes spent coordinating this discharge plan\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. LevETIRAcetam 1000 mg PO BID \n2. Sodium Bicarbonate 1300 mg PO FOUR TIMES PER DAY FOR 2 DAYS \nPRIOR TO CHEMOTHERAPY \n3. Ondansetron ODT 8 mg PO Q8H:PRN nausea/vomiting \n\n \nDischarge Medications:\n1.  LevETIRAcetam 1000 mg PO BID \nRX *levetiracetam 1,000 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n2.  Ondansetron ODT 8 mg PO Q8H:PRN nausea/vomiting \nRX *ondansetron 8 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*30 Tablet Refills:*0 \n3.  Sodium Bicarbonate 1300 mg PO FOUR TIMES PER DAY FOR 2 DAYS \nPRIOR TO CHEMOTHERAPY \nRX *sodium bicarbonate 650 mg 2 tablet(s) by mouth four times a \nday Disp #*30 Tablet Refills:*0 \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\n# Encounter for chemotherapy\n# CNS Lymphoma\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure taking care of you at ___ \n___. You were admitted for your planned HD-MTX \nchemotherapy, which you tolerated well. \n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10717970","hadm_id":"21794732","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nNausea/vomiting, duodenal stent revision\n \nMajor Surgical or Invasive Procedure:\nEGD with duodenal stent placement ___\n \nHistory of Present Illness:\n___ yo ___ man with history of hypertension,\nhyperlipidemia, pre-diabetes, essential thrombocytopenia,\nnon-melanoma skin cancer, and recent diagnosis of pancreatic\nadenocarcinoma complicated by gastric outlet obstruction s/p\nduodenal stent now p/w nausea and vomiting concerning for stent\nobstruction and admitted for monitoring after stent revision. \n\nHistory obtained primarily from ___ given patient's limited\n___ proficiency. \n\nPatient started to develop sx of abdominal pain in ___\nbut did not seek medical attention until ___ when he\npresented to ___ multiple times for severe\nabdominal pain, n/v and was found to have a mass in the area of\nthe pancreas and duodenum. EGD/EUS was performed and FNA showed\nadenocarcinoma. He presented for outpatient evaluation at ___\non ___ and was found to have ___ in the setting of vomiting and\nabdominal pain. EGD showed severe stenosis of D3 with friable \nand\nedematous mucosa as well as esophagitis which correlated to\nan abnormal area of circumferential wall thickening in the lower\nesophagus/upper stomach raising concern for possible carcinoma. \nA\nduodenal stent was placed with improvement, but he now presents\nwith nausea and vomiting with suspected stent occlusion. He\nunderwent an EGD which showed partial obstruction of the stent\nwhich was ballooned, then a second duodenal stent was placed. \n\nOn arrival to floor, the patient denies any pain or complaints. \n\nROS: Positive as per HPI, all systems reviewed and otherwise\nnegative\n\n \nPast Medical History:\n-Hypertension\n-Hyperlipidemia\n-Pre-diabetes\n-Essential thrombocytopenia\n-Pancreatic adenocarcinoma on FOLFOX\n\nPSH: Removal of skin cancer on his forehead\n \nSocial History:\n___\nFamily History:\nThe patient's father died of an MI at ___ years.\nHer mother died with type 2 diabetes mellitus.  A sister died\nwith colon cancer at ___ years.  Another sister died of\n___ disease.  She has two sons without health concerns.\n \nPhysical Exam:\nAdmission Physical Exam:\nVS: 99 122/60 60 16 98% room air   \nGeneral: Well appearing but thin man lying in bed in NAD\nEyes: PERLL, EOMI, sclera anicteric\nENT: MMM, oropharynx clear without exudate or lesions \nLymph: No supraclavicular or cervical lymphadenopathy\nRespiratory: CTAB without crackles, wheeze, rhonchi. \nCardiovascular: RRR, normal S1 and S2, no murmurs, rubs or\ngallops\nGastrointestinal: Soft, nontender, nondistended, +BS, no masses\nor HSM\nExtremities: Warm and well perfused, no peripheral edema \nSkin: warm, no rashes/no jaundice/no skin ulcerations noted\nNeurological: Alert and oriented x3, motor and sensory exam\ngrossly intact \n\ndischarge\n98.5 103/49 81 18 95 RA\naox3\nambulatory\nappears well\nnot coughing\nclear breath sounds no rales or crackles or wheezes\nsoft non tender abdomen \n \nPertinent Results:\nIMAGING: \n___ EGD\n-Normal mucosa in the esophagus\n-Normal mucosa in the stomach\n-The scout film shoed the previously placed duodenal stent in\nplace. \n-During the EGD a partial obstruction of the stent by tissue\ningrowth was noted. \n-A guidewire was used to transvese the stricture. \n-An extraction balloon was used and moderate resistance was \nnoted\nat the mid end of the duodenal stent. \n-Due to these signs of partial obstraction a decision to proceed\nwith placement of a second duodenal stent within the previously\nplcaed one. \n-A 9cm by 22mm metal stent was placed successfully ( ref #\n___ ___ # ___.  \n-Otherwise normal EGD to third part of the duodenum\n\nCompared to ___, interval decrease in size of a \nmass at the \nuncinate process of the pancreas, which again infiltrates the \nduodenal wall \nand retroperitoneum and contacts the IVC and aorta.  Unchanged \nduodenal stent, \nwhich appears patent. \n2. As before, the right proximal ureter is tethered towards the \nretroperitoneal infiltrate, causing interval increase in \nmoderate right \nhydronephrosis. \n3. Interval increase in ___ consolidation in the right \nlower lobe, \nconcerning for pneumonia or aspiration. \n4. There is an incompletely imaged 1.4 x 1.3 cm hypodense lesion \nin the right \nmiddle lobe, new from ___, which may be related to \nthe infectious \nprocess, given rapid growth, however, metastasis cannot be \nexcluded. \n5. Small nonhemorrhagic right pleural effusion. \n\n___ 07:15AM BLOOD WBC-8.2 RBC-3.85* Hgb-10.6* Hct-33.2* \nMCV-86 MCH-27.5 MCHC-31.9* RDW-13.4 RDWSD-41.0 Plt ___\n___ 07:35AM BLOOD Glucose-90 UreaN-14 Creat-1.4* Na-135 \nK-4.8 Cl-97 HCO3-28 AnGap-15\n___ 07:15AM BLOOD Albumin-2.7* Calcium-8.1* Phos-3.1 Mg-1.___ yo ___ man with history of hypertension,\nhyperlipidemia, pre-diabetes, essential thrombocytopenia,\nnon-melanoma skin cancer, and recent diagnosis of pancreatic\nadenocarcinoma complicated by gastric outlet obstruction s/p\nduodenal stent now p/w nausea and vomiting concerning for stent\nobstruction and admitted for monitoring after stent revision. \n\n#Duodenal Obstruction/pancreatic adenocarcinoma: Recent \ndiagnosis\nof pancreatic malignancy, started FOLFOX at OSH about two weeks\nago and is being followed by surgical oncology and pancreatic\ncenter at ___. Duodenal stent placed a little more than one\nmonth ago but has had recurrence of n/v, found to have partial\nobstruction of stent and now s/p revision of stent and placement\nof ___ stent on ___. Patient initially did well, but then had \nsome episodes of vomiting.  These episodes were transient.\n\nHe was able to advance to a mechanically soft low fiber diet \nwith specific instructions that were provided to him by MD and \nnutritionist with in person translator several times. \n\n#Esophagitis/gastritis: As part of malignancy staging, on prior\nadmission, patient underwent a CT chest that showed a \n\"possible primary carcinoma is the lower esophagus upper \nstomach, with circumferential wall thickening.\"  Per review of \nimaging with advanced endoscopy service, this area correlated \nwith area of esophagitis / gastritis seen on endoscopy.  On \nEndoscopy on ___ Normal mucosa in the esophagus Normal mucosa \nin the stomach\n\nHe remains on PPI.  \n\n#Hyperlipidemia: atorvastatin \n\n#Hypertension: Stable, had been held at last discharge given\nnormotension and recent ___.  holding lisinopril\n\nHe had mild hyponatremia\n\nHe had mild acute renal insufficiency with creat 1.4 prior to \ndischarge and stable for 48hrs.\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Atorvastatin 20 mg PO QPM \n2. Pantoprazole 40 mg PO Q12H \n3. Lisinopril 20 mg PO DAILY \n4. Ondansetron 4 mg PO Q8H:PRN Nausea \n5. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild \n\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild  \n2.  Atorvastatin 20 mg PO QPM  \n3.  Ondansetron 4 mg PO Q8H:PRN Nausea  \n4.  Pantoprazole 40 mg PO Q12H  \n5. HELD- Lisinopril 20 mg PO DAILY  This medication was held. Do \nnot restart Lisinopril until BP is higher\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPancreatic cancer\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted with vomiting and found to have a blocked \nduodenal stent. You had a procedure to fix this blockage and a \nsecond stent was placed in your duodenum.\n\nwe reviewed the special diet to avoid blocking this stent.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16235830","hadm_id":"23534790","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAdvanced adenocarcinoma of Mullerian origin\n\n \nMajor Surgical or Invasive Procedure:\nExploratory laparotomy, total abdominal hysterectomy, bilateral \nsalpingo-oophorectomy, total omentectomy, splenectomy, PlasmaJet \nablation of peritoneal and diaphragmatic disease, cystoscopy\n \nHistory of Present Illness:\nMs. ___ is a ___ G3P1 with a history of HTN (non-compliant \nw/medication) who presented to ___ ED on ___ as a transfer \nfrom ___ with abdominal pain, bloating and concern \nfor new diagnosis of intraabdominal malignancy. The patient had \none month of increasing abdominal distension, abdominal/pelvic \ndiscomfort, and decreased appetite. She presented to her primary \ncare providers office in ___ two weeks prior, where she \nunderwent an US and had labwork drawn, was told nothing was \nwrong and was sent home. She then represented to her PCPs office \nwith the same complaints and was sent to ___ for a \nCT abd/pelvis. The provider at ___ told the \npatient she had ovarian cancer with widespread disease and \nneeded to be transferred to ___ for possible surgery.\n\nShe was admitted to the gynecologic oncology service on ___. \nA paracetesis confirmed adenocarcinoma of mullerian origin and \non ___ she underwent an exploratory laparotomy, total \nabdominal hysterectomy, bilateral salpingo-oophorectomy, total \nomentectomy, splenectomy, PlasmaJet ablation of peritoneal and \ndiaphragmatic disease, and cystoscopy.\n \nPast Medical History:\nOBHx: G3P1 (SAB at 6 wks with D\u0026C, TAB, SVD at term, \nuncomplicated)\nPGYNx:\n- endorses remote hx of abnormal Pap testing (in high school),\ndenies colposcopy or bx; denies GYN procedures or surgeries \naside\nfrom D\u0026C for SAB; denies hx of fibroids or endometriosis\n- reports menarche age ___\n- reports regular monthly menses, no intermenstrual bleeding\n- has used IUD for contraception in the past, never on OCPs, not\nusing any contraception currently\nPMHx: HTN (not taking losartan as prescribed)\nPSHx:D\u0026C x1\nMeds: none\nAll: NKDA\n \nSocial History:\n___\nFamily History:\nFHx: \n-Mother: breast cancer in her mother (dx age ___, doing well\n-Paternal aunt: breast cancer (dx in her ___), deceased.\n-Denies a hx of uterine, ovarian, colon or cervical cancer in \nany\nof her family members\n \nPhysical ___:\n==========================================\nPREOPERATIVE PHYSICAL EXAM\n==========================================\nGeneral: Resting comfortable in bed, NAD\nCV: RRR\nResp: decreased breath sounds at bases \nAbdominal: soft, mildly distended, nontender, absent bowel \nsounds\nExtrem: pneumoboots in place, no edema\n\n==========================================\nPHYSICAL EXAM ON DISCHARGE:\n==========================================\nGeneral: no acutedistress , lying awake in bed, A\u0026Ox3\nCV: RRR\nLungs: CTAB\nAbd: soft, mild tenderness of upper abdomen, nondistended,\nnormo activebowel sounds\nIncision:  no visible erythema, staples removed\napproximated without discharge or purulence.\nExtremities: no calf tenderness/erythema, no edema\n\n \nPertinent Results:\n___ 06:40AM BLOOD WBC-11.9* RBC-3.51* Hgb-11.5 Hct-35.1 \nMCV-100* MCH-32.8* MCHC-32.8 RDW-12.5 RDWSD-45.5 Plt ___\n___ 06:50AM BLOOD WBC-12.4* RBC-3.29* Hgb-10.9* Hct-33.1* \nMCV-101* MCH-33.1* MCHC-32.9 RDW-12.5 RDWSD-46.2 Plt ___\n___ 08:45AM BLOOD WBC-15.3* RBC-3.33* Hgb-11.0* Hct-33.5* \nMCV-101* MCH-33.0* MCHC-32.8 RDW-12.7 RDWSD-47.2* Plt ___\n___ 08:00AM BLOOD WBC-13.2* RBC-3.43* Hgb-11.4 Hct-34.2 \nMCV-100* MCH-33.2* MCHC-33.3 RDW-12.6 RDWSD-45.2 Plt ___\n___ 08:20AM BLOOD WBC-12.8* RBC-3.43* Hgb-11.5 Hct-33.7* \nMCV-98 MCH-33.5* MCHC-34.1 RDW-12.5 RDWSD-44.7 Plt ___\n___ 07:45AM BLOOD WBC-12.6* RBC-3.15* Hgb-10.5* Hct-31.1* \nMCV-99* MCH-33.3* MCHC-33.8 RDW-12.2 RDWSD-43.6 Plt ___\n___ 07:50AM BLOOD WBC-15.3* RBC-3.08* Hgb-10.4* Hct-30.9* \nMCV-100* MCH-33.8* MCHC-33.7 RDW-12.3 RDWSD-45.1 Plt ___\n___ 10:36PM BLOOD WBC-15.8* RBC-2.86* Hgb-9.6* Hct-29.0* \nMCV-101* MCH-33.6* MCHC-33.1 RDW-12.3 RDWSD-45.3 Plt ___\n___ 07:00AM BLOOD WBC-16.8* RBC-3.11* Hgb-10.3* Hct-32.5* \nMCV-105* MCH-33.1* MCHC-31.7* RDW-12.6 RDWSD-48.5* Plt ___\n___ 08:00AM BLOOD WBC-14.1* RBC-3.33* Hgb-11.3 Hct-34.0 \nMCV-102* MCH-33.9* MCHC-33.2 RDW-12.5 RDWSD-46.6* Plt ___\n___ 09:38PM BLOOD WBC-14.2*# RBC-3.87* Hgb-13.3 Hct-39.9 \nMCV-103* MCH-34.4* MCHC-33.3 RDW-12.4 RDWSD-46.4* Plt ___\n___ 08:25AM BLOOD WBC-9.1 RBC-3.89* Hgb-13.3 Hct-38.5 \nMCV-99* MCH-34.2* MCHC-34.5 RDW-12.1 RDWSD-43.9 Plt ___\n___ 09:05AM BLOOD WBC-6.6 RBC-3.85* Hgb-12.9 Hct-38.7 \nMCV-101* MCH-33.5* MCHC-33.3 RDW-12.0 RDWSD-44.7 Plt ___\n___ 07:15AM BLOOD WBC-6.5 RBC-3.68* Hgb-12.6 Hct-36.6 \nMCV-100* MCH-34.2* MCHC-34.4 RDW-11.8 RDWSD-43.6 Plt ___\n___ 02:40AM BLOOD WBC-7.9 RBC-3.56* Hgb-12.2 Hct-35.1 \nMCV-99* MCH-34.3* MCHC-34.8 RDW-11.9 RDWSD-43.3 Plt ___\n___ 08:59PM BLOOD WBC-13.4* RBC-4.05 Hgb-13.7 Hct-40.0 \nMCV-99* MCH-33.8* MCHC-34.3 RDW-12.0 RDWSD-43.9 Plt ___\n___ 08:59PM BLOOD Neuts-75.0* Lymphs-15.9* Monos-7.8 \nEos-0.6* Baso-0.3 Im ___ AbsNeut-10.06* AbsLymp-2.14 \nAbsMono-1.05* AbsEos-0.08 AbsBaso-0.04\n___ 06:40AM BLOOD Plt ___\n___ 06:50AM BLOOD Plt ___\n___ 08:45AM BLOOD Plt ___\n___ 08:00AM BLOOD Plt ___\n___ 08:20AM BLOOD Plt ___\n___ 07:45AM BLOOD Plt ___\n___ 07:50AM BLOOD Plt ___\n___ 10:36PM BLOOD Plt ___\n___ 07:00AM BLOOD Plt ___\n___ 08:00AM BLOOD Plt ___\n___ 09:38PM BLOOD Plt ___\n___ 08:25AM BLOOD Plt ___\n___ 09:05AM BLOOD Plt ___\n___ 07:15AM BLOOD Plt ___\n___:40AM BLOOD Plt ___\n___ 08:30AM BLOOD ___ PTT-28.1 ___\n___ 08:59PM BLOOD Plt ___\n___ 06:40AM BLOOD Glucose-98 UreaN-7 Creat-0.5 Na-142 K-4.7 \nCl-99 HCO3-27 AnGap-16\n___ 06:50AM BLOOD Glucose-93 UreaN-5* Creat-0.4 Na-137 \nK-4.4 Cl-95* HCO3-27 AnGap-15\n___ 08:45AM BLOOD Glucose-98 UreaN-5* Creat-0.5 Na-138 \nK-4.4 Cl-94* HCO3-28 AnGap-16\n___ 08:00AM BLOOD Glucose-82 UreaN-3* Creat-0.4 Na-140 \nK-4.6 Cl-97 HCO3-27 AnGap-16\n___ 08:20AM BLOOD Glucose-88 UreaN-\u003c3* Creat-0.4 Na-140 \nK-4.2 Cl-96 HCO3-24 AnGap-20*\n___ 07:45AM BLOOD Glucose-84 UreaN-\u003c3* Creat-0.3* Na-140 \nK-4.1 Cl-98 HCO3-24 AnGap-18*\n___ 07:50AM BLOOD Glucose-79 UreaN-\u003c3* Creat-0.3* Na-137 \nK-3.9 Cl-98 HCO3-26 AnGap-13\n___ 10:36PM BLOOD Glucose-89 UreaN-4* Creat-0.3* Na-135 \nK-3.9 Cl-99 HCO3-26 AnGap-10\n___ 07:00AM BLOOD Glucose-68* UreaN-5* Creat-0.3* Na-136 \nK-4.1 Cl-98 HCO3-24 AnGap-14\n___ 08:00AM BLOOD Glucose-97 UreaN-5* Creat-0.5 Na-136 \nK-4.5 Cl-100 HCO3-22 AnGap-14\n___ 09:38PM BLOOD Glucose-160* UreaN-4* Creat-0.5 Na-137 \nK-4.7 Cl-99 HCO3-21* AnGap-17*\n___ 08:25AM BLOOD Glucose-82 UreaN-5* Creat-0.4 Na-137 \nK-4.5 Cl-98 HCO3-24 AnGap-15\n___ 09:05AM BLOOD Glucose-129* UreaN-5* Creat-0.4 Na-140 \nK-4.0 Cl-101 HCO3-26 AnGap-13\n___ 07:15AM BLOOD Glucose-95 UreaN-4* Creat-0.5 Na-140 \nK-3.9 Cl-100 HCO3-26 AnGap-14\n___ 02:40AM BLOOD Glucose-98 UreaN-3* Creat-0.4 Na-137 \nK-3.5 Cl-99 HCO3-25 AnGap-13\n___ 08:59PM BLOOD Glucose-81 UreaN-6 Creat-0.5 Na-135 K-4.0 \nCl-95* HCO3-22 AnGap-18*\n___ 06:40AM BLOOD Calcium-9.8 Phos-6.1* Mg-2.3\n___ 06:50AM BLOOD Calcium-9.1 Phos-6.3* Mg-2.1\n___ 08:45AM BLOOD Calcium-8.8 Phos-5.0* Mg-2.1\n___ 08:00AM BLOOD Calcium-9.0 Phos-5.7* Mg-2.0\n___ 08:20AM BLOOD Calcium-9.1 Phos-5.0* Mg-1.8\n___ 07:45AM BLOOD Calcium-8.6 Phos-5.5* Mg-1.7\n___ 07:50AM BLOOD Mg-1.6\n___ 10:36PM BLOOD Calcium-7.9* Phos-2.9 Mg-1.6\n___ 07:00AM BLOOD Calcium-8.1* Phos-3.1 Mg-1.9\n___ 08:00AM BLOOD Calcium-7.8* Phos-4.3 Mg-2.2\n___ 09:38PM BLOOD Calcium-8.0* Phos-4.5 Mg-1.5*\n___ 08:25AM BLOOD Calcium-9.1 Phos-4.4 Mg-2.0\n___ 09:05AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0\n___ 07:15AM BLOOD Calcium-9.2 Phos-4.6* Mg-1.8\n___ 02:40AM BLOOD Calcium-8.6 Phos-4.1 Mg-1.7\n___ 08:59PM BLOOD HCG-\u003c5\n___ 08:30AM BLOOD CEA-1.0 ___*\n\nIMAGING:\n___ Paracentesis\n1. technically successful biopsy of omental mass, with a \nleft-sided approach.  \n2. cores were sent for pathology.  No immediate postprocedure \ncomplication. \n___ Pelvic US\n1. The right ovary is not well-demonstrated on this exam due to \nadjacent bowel gas, but appears to have a subcentimeter \nparaovarian cyst.  A right adnexal mass cannot be excluded and \nevaluation with an MRI is recommended. \n2. The left ovary appears heterogeneous with calcifications, \nhowever no discrete mass is seen, demonstrates color flow. \n3. Moderate amount of complex free fluid.  Peritoneal nodularity \nagain noted. \n4. Normal uterus. \n___ CT chest w/contrast\n1. No evidence of suspicious lesions in the chest. \n2. Mildly prominent periesophageal lymph node is not \npathologically enlarged, which is nonspecific. Attention on \nfollow-up is recommended. \n\nPATHOLOGY/CYTOLOGY:\n___ cytology of peritoneal fluid\n1. adenocarcioma\n___ omentum biopsy\n1. adenocarcinoma consistent with mullerian origin\n___ uterus biopsy\n1. Pending\n \nBrief Hospital Course:\nMs. ___ was admitted to the gynecologic oncology service \nafter undergoing exploratory laparotomy, total abdominal \nhysterectomy, bilateral salpingo-oophorectomy, plasmajet \nablation of peritoneal and diaphragmatic disease, mobilization \nof splenic flexure, splenectomy, omentectomy, and cystoscopy. \nPlease see the operative report for full details.  \n\n*)Postoperative course: Her post-operative course is detailed as \nfollows. Immediately postoperatively, her pain was controlled \nwith acetaminophen and an epidural. Her epidural was managed by \nthe Acute Pain service. On postoperative day 3, her epidural was \nremoved and she was transitioned to PO dilaudid and \nacetaminophen. Her urine output was also adequate and thus her \nfoley catheter was removed.  Given that she had surgery \ninvolving the bowels, her diet was slowly advanced. She was \nmaintained on a diet consisting of clears with supplements and \ntoast and crackers. Her diet was advanced to a regular diet on \n___ when there was evidence of return of bowel function on \npostoperative day 7.  \n\nBy post-operative day 8, she was tolerating a regular diet, \nvoiding spontaneously, ambulating independently, and pain was \ncontrolled with oral medications. She was then discharged home \nin stable condition with outpatient follow-up scheduled.\n\n*) ___ erythema c/f cellulitis\n___ there was erythema noted near patient's incision \nconcerning for cellulitis so the the area was marked and a 7 day \ncourse of cephalexin 500mg PO q6H was started. The erythema \ndecreased over the next few days and completely resolved by \n___ staples were also removed prior to discharge on \npostoperative day 9.\n\n*) Hypertension\nOn postoperative day 3,  she developed hypertension which \nprogressed to an episode of hypertensive urgency to 190/104. She \nreceived 20mg IV labetalol but her BP did not decrease so she \nthen received 40mg IV labetalol and her blood pressure dropped \nto 151/76. The same day she was re-started on her home HTN \nmedication (losartan 50mg PO Daily). On postoperative day 4, she \nremained hypertensive and had another episode of hypertensive \nurgency to 183/93 and received 20mg IV labetalol but her blood \npressure did not decrease. She then declined another dose of IV \nlabetalol and remained hypertensive (160s-180s/70s-90s). She \nremained on losartan 50mg PO Daily.\nOn postoperative day 5,a formal medicine consult was initiated \nand per their recommendations she was started on hydralazine \n25mg PO q8H x2 days and amlodipine 5mg PO Daily. On posop day 6, \nshe experienced a hypotensive episode to 103/65 and her \namlodipine was decreased to 2.5mg PO Daily. Patient's blood \npressure remained in 140s/80s upon discharge. She was discharged \nwith amlodipine 2.5 mg daily and her losartan was discontinued \ndue to the fact that it did not appear to affect her blood \npressures while she receive it. Patient was advised to follow up \nwith her PCP in one week for hypertension medication management. \n\n\n*)Post splenectomy vaccinations\nPatient was given vaccines on postoperative day 8 for hemophilus \ninfluenza B, pneumococcal 13, and meningococcal. She was \ninstructed to have her PSV23 vaccine administered within ___ \nweeks or before she starts chemotherapy. She was also given post \nsplenectomy precautions and counseled heavily on warning signs \nof possible infection. \n\n*) Post splenectomy thrombocytosis\nPatient's platelet count continued to trend upward while she was \nin the hospital after her surgery. On day of discharge, her \nplatelet count was 1356. Thrombocytosis is an expected change \nafter a splenectomy. Per medicine team and heme onc team, there \nis no indication for intervention for thrombocytosis. Patient \nwas expectantly managed for this given that platelet counts can \ntake ___ days post splenectomy to peak. \n\n*) VTE prophylaxis: Patient received heparin while she was \ninpatient. After her epidural was removed, she was started on \nlovenox. She was discharged with enough lovenox to complete a 28 \nday postoperative course of daily lovenox prophylaxis at home. \nWhile in the hospital, she also had pneumoboots on and was \nperforming incentive spirometry. \n \nMedications on Admission:\nNone\n \nDischarge Medications:\n1.  Acetaminophen ___ mg PO Q6H PRN\n2.  amLODIPine 2.5 mg PO DAILY\n3.  Cephalexin 500 mg PO Q6H \n4.  Docusate Sodium 100 mg PO BID constipation \n5.  Enoxaparin Sodium 40 mg SC DAILY \n6.  HYDROmorphone (Dilaudid) ___ mg PO Q3H PRN\n7.  Ibuprofen 400 mg PO Q6H pain\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAdenocarcinoma of mullerian origin\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the gynecologic oncology service after \nundergoing the procedures listed below. You have recovered well \nafter your operation, and the team feels that you are safe to be \ndischarged home. Please follow these instructions: \n\nAbdominal instructions:  \n* Take your medications as prescribed.  We recommend you take \nnon-narcotics (i.e. Tylenol, ibuprofen) regularly for the first \nfew days post-operatively, and use the narcotic as needed. As \nyou start to feel better and need less medication, you should \ndecrease/stop the narcotic first.\n* Take a stool softener to prevent constipation. You were \nprescribed Colace. If you continue to feel constipated and have \nnot had a bowel movement within 48hrs of leaving the hospital \nyou can take a gentle laxative such as milk of magnesium.  \n* Do not drive while taking narcotics.  \n* Do not combine narcotic and sedative medications or alcohol.  \n* Do not take more than 4000mg acetaminophen (tylenol) in 24 \nhrs.  \n* No strenuous activity until your post-op appointment.  \n* Nothing in the vagina (no tampons, no douching, no sex) for 12 \nweeks.  \n* No heavy lifting of objects \u003e10 lbs for 6 weeks.  \n* You may eat a regular diet.\n* It is safe to walk up stairs.  \n.\nIncision care:  \n* You may shower and allow soapy water to run over incision; no \nscrubbing of incision. No bath tubs for 6 weeks.  \n* You should allow your steri strips to fall off on their own.   \nIf they are still on after ___ days from surgery, you may \nremove them.  \n\nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___.  \n\n.\nCall your doctor at ___ for:  \n* fever \u003e 100.4  \n* severe abdominal pain  \n* difficulty urinating  \n* vaginal bleeding requiring \u003e1 pad/hr  \n* abnormal vaginal discharge  \n* redness or drainage from incision  \n* nausea/vomiting where you are unable to keep down fluids/food \nor your medication  \n* chest pain or difficulty breathing \n* onset of any concerning symptoms \n\n*** Lovenox injections:\n* Patients having surgery for cancer have risk of developing \nblood clots after surgery. This risk is highest in the first \nfour weeks after surgery. You will be discharged with a daily \nLovenox (blood thinning) medication. This is a preventive dose \nof medication to decrease your risk of a forming a blood clot. \n*Your last injection of lovenox will be on ___.\n\n***Constipation:\n* Drink ___ liters of water every day.\n* Incorporate 20 to 35 grams of fiber into your daily diet to \nmaintain normal bowel function. Examples of high fiber foods \ninclude:\nWhole grain breads, Bran cereal, Prune juice, Fresh fruits and \nvegetables, Dried fruits such as dried apricots and prunes, \nLegumes, Nuts/seeds. \n* Take Colace stool softener ___ times daily.\n* Use Dulcolax suppository daily as needed.\n* Take Miralax laxative powder daily as needed. \n* Stop constipation medications if you are having loose stools \nor diarrhea.\n\n***Hypertension \n*Your blood pressure went as high as the 190s/100s while you \nwere in the hospital. The losartan 50 mg that you were \noriginally prescribed for your hypertension was discontinued as \nit was not controlling your blood pressure. You were started on \namlodipine 2.5 mg daily for blood pressure control and you \nresponded well to it. Please follow up with your PCP in the next \nweek for an appointment to better titrate your medications. \n\n***Post Splenectomy Vaccination\n*After having a splenectomy, you are at increased risk of \ninfection for certain microorganisms. You were given the \nmeningococcal vaccine (Menactra), pneumococcal 13  valent \nvaccine (Prevnar 13), and Haemophilus B conjugate vaccine. \n*YOU ARE DUE FOR YOUR PNEUMOCOCCAL 23 VALENT VACCINE in the next \n___ weeks, BEFORE your chemotherapy starts. PLEASE ensure to get \nvaccinated with the pneumococcal 23 valent vaccine in ___ weeks. \nIt is very important that you receive this vaccination in a \ntimely manner before your chemotherapy starts. \n*Please call ___ if you are having trouble scheduling \nyour vaccination. \n*Please refer to the handout given to you for post splenectomy \nprecautions and warning signs. In summary, warning signs of \ninfection to be aware of and to call the office at ___ \nor 911:\n\n___ greater than 100.4F or 38C\n\n___ chills and/or shivering\n\n___\n\n___, confusion, and/or disorientation\n\n___, vomiting, and/or diarrhea\n\n___ abdominal pain\n\n___ purplish red spots on the skin (petechiae) or \nlarger bluish bruises\n\n___ blood pressure, lightheadedness, or fainting \n(syncope)\n\n___ heart rate\n\n***Wound Cellulitis\n*You developed a skin infection where your staples were for your \nabdominal incision. You were started on Keflex antibiotics on \n___, and your rash has improved while you have been receiving \nthe antibiotics. Your last dose of antibiotics  completed the \nevening of ___. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18369788","hadm_id":"25872087","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \namlodipine / atorvastatin / lisinopril / pravastatin / \nrosuvastatin\n \nAttending: ___.\n \nChief Complaint:\nAbnormal LFTs and abdominal pain\n \nMajor Surgical or Invasive Procedure:\nERCP\n\n \nHistory of Present Illness:\nMr. ___ is a ___ male with the past medical history \nnotable for DM, HTN, admitted for observation post ERCP after \nCBD stone removal and sphincterotomy and sphincteroplasty.  He \ninitially presented to his PCP several weeks ago for right-sided \nflank pain, which was constant and severe in nature.  At his \nPCP's visit, labs were notable for elevated LFTs.  He \nsubsequently underwent an MRCP which reportedly demonstrated a \nCBD stone so was referred here for ERCP.  He had no f/c/s, \nn/v/abd pain, jaundice, bowel or urinary changes prior to \nadmission.  \n\nROS: Pertinent positives and negatives as noted in the HPI.  \nFull 14-system ROS otherwise negative. \n\n \nPast Medical History:\n- Non-insulin-dependent diabetes with neuropathy \n- Hypertension  \n- Hyperlipidemia  \n- Chronic dyspnea on exertion  \n- Gastritis\n- Status post meningioma resection  \n- Chronic low back pain  \n- Morbid obesity  \n- Obstructive sleep apnea without CPAP  \n- Osteopenia\n- h/o TKR\n- s/p CCY\n \nSocial History:\n___\nFamily History:\nNo h/o known cancer \n \nPhysical Exam:\nDISCHARGE EXAM\nVITALS: Afebrile and vital signs stable (see eFlowsheet)\nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma.  \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular, no murmur, no S3, no S4.  No JVD.\nRESP: Lungs clear to auscultation with good air movement \nbilaterally.  Breathing is non-labored\nGI: Abdomen soft, non-distended, non-tender to palpation.  Bowel \nsounds present.  No HSM\nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, strength grossly full \nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI, speech fluent, moves all limbs, sensation to light touch \ngrossly intact throughout\nPSYCH: pleasant, appropriate affect\n\n \nPertinent Results:\nDISCHARGE LABS\n___ 06:15AM BLOOD WBC-5.9 RBC-4.45* Hgb-13.0* Hct-39.3* \nMCV-88 MCH-29.2 MCHC-33.1 RDW-13.8 RDWSD-44.8 Plt ___\n___ 06:15AM BLOOD Glucose-106* UreaN-12 Creat-1.0 Na-140 \nK-4.5 Cl-99 HCO3-29 AnGap-12\n___ 06:15AM BLOOD ALT-21 AST-19 AlkPhos-101 TotBili-0.4\n\nERCP ___ (paraphrased report)\nLarge ___ diverticulum.\nCholangiogram: 8 mm CBD, s/p CCY; one large filling defect in \nthe CBD suggestive of stone. \nSphincterotomy and sphincteroplasty performed.\nSingle oval 8 mm stone removed with balloon sweep, otherwise \nclean. \n\n \nBrief Hospital Course:\n___ w/ obesity, HTN, DM2, seizure disorder, prior CCY in ___, \nrecent diagnosis of choledocholithiasis, admitted after ERCP w/ \nsphincterotomy.\n\n#Choledocholithiasis \nThe patient underwent uncomplicated ERCP with sphincterotomy and \nsphincteroplasty, then extraction of an 8 mm stone. He had mild \npain overnight after the procedure, but was pain free and \ntolerating PO intake the following morning. Labs normal the \nfollowing morning. No NSAIDs or ASA for 5 days. \n\nCHRONIC/STABLE PROBLEMS:\n# DM II: resume metformin and glipizide at discharge\n# HTN - continue ___\n# HL - continue statin\n# h/o seizure d/o - continue keppra\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. MetFORMIN (Glucophage) 1000 mg PO BID \n3. LevETIRAcetam 750 mg PO BID \n4. Omeprazole 40 mg PO DAILY \n5. Simvastatin 5 mg PO QPM \n6. GlipiZIDE XL 2.5 mg PO DAILY \n7. Losartan Potassium 25 mg PO DAILY \n8. Cyanocobalamin 1000 mcg PO DAILY \n9. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 500 mg PO Q4H:PRN Pain - Mild  \n2.  Aspirin 81 mg PO DAILY  \n3.  Cyanocobalamin 1000 mcg PO DAILY  \n4.  GlipiZIDE XL 2.5 mg PO DAILY  \n5.  LevETIRAcetam 750 mg PO BID  \n6.  Losartan Potassium 25 mg PO DAILY  \n7.  MetFORMIN (Glucophage) 1000 mg PO BID  \n8.  Omeprazole 40 mg PO DAILY  \n9.  Simvastatin 5 mg PO QPM  \n10.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCholedocholithiasis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou had a gallstone stuck in your bile duct. This was retrieved \nwith an ERCP procedure. We also opened up the exit to the bile \nduct (sphincterotomy) to decrease the chance that a stone will \nget stuck again in the future.\n\nDo not take any medications that increase risk of bleeding for \nthe next week. This includes aspirin and any over-the-counter \npain medications besides acetaminophen.  \n\nYou may eat normally as tolerated. ___ drink alcohol for 2 \ndays after the procedure.\n\nYou may have a sore throat for 1 to 2 days after the procedure. \nIf this bothers you, you may use throat lozenges or an \nover-the-counter phenol throat spray (Chloraseptic, or similar). \n \n\nMost patients recover very well from this procedure and do not \nneed any specific post-procedure follow up. However, if you have \nany issues or concerns, please call the ___ \nclinic at ___.  \n\nRarely patients may have serious infection or bleeding after \nthis procedure; if you have bloody or black tarry stools, feel \nlightheaded and like you might pass out, have fevers or chills, \nor get severe or worsening abdominal pain please return to the \nemergency room for evaluation. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12294277","hadm_id":"29891304","text":" \nName:  ___                        Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nIV Dye, Iodine Containing / Penicillins / Aspirin / Vancomycin\n \nAttending: ___.\n \nChief Complaint:\nJaundice and abdominal pain for two weeks\n \nMajor Surgical or Invasive Procedure:\n___ ERCP with placement of percutaneous transhepatic \nexternal and internal drainage catheter.\n\n___ Biliary stent placement\n\n___ Biliary catheter check\n\n \nHistory of Present Illness:\n___ year old female with question of stage IV cecal cancer s/p \nresection ___, ___) and FOLFOX (6 cycles), recent increase \nin CEA and obstructive jaundice symptoms x 2 weeks, prompting CT \nscan showing question of biliary\nobstruction with ductal dilatation and distended GB and question \nof portal\nlymphadenopathy.  ERCP done today to look for source of \nobstructed CBD, patient had been developing abdominal pain and \njaundice over the past two weeks and was noted to have a dilated \ngallbladder and common bile duct.  ERCP with malignant \nobstruction and likely complicated by perforation of CBD per GI \nnotes, no stones seen.\n\n \nPast Medical History:\nPMH: asthma\n\nPSH: R hemicolectomy c partial SBR ___  \nappendectomy\nportacath right subclavian\ndiagnostic laparoscopy (GYN)\n\n \nSocial History:\n___\nFamily History:\nNon-contributory.\n \nPhysical Exam:\nOn Admission:\n\nVitals- T 97.3, HR 80, BP 116/70, RR 16, O2sat 98%\nGen- NAD, alert, jaundice\nHead and neck- AT, NC, soft, supple, no masses\nHeart- RRR, no murmurs\nLungs- CTAB, no rhonchi, no crackles\nAbd- soft, ND, mild epigastric tenderness, no peritoneal signs,\nsmall midline well-healed scar\nExt- warm, well-perfused, no edema\n\n \nPertinent Results:\n___ 09:07PM   LACTATE-1.9\n___ 07:30PM   GLUCOSE-93 UREA N-13 CREAT-0.6 SODIUM-138 \nPOTASSIUM-4.3 CHLORIDE-101 TOTAL CO2-25 ANION GAP-16\n___ 07:30PM   ALT(SGPT)-381* AST(SGOT)-247* ALK PHOS-1091* \nTOT BILI-10.2*\n___ 07:30PM   LIPASE-52\n___ 07:30PM   ALBUMIN-3.5\n___ 07:30PM   WBC-7.2 RBC-3.26* HGB-10.2* HCT-30.7* MCV-94 \nMCH-31.2 MCHC-33.2 RDW-14.4\n___ 07:30PM   NEUTS-78.7* LYMPHS-14.7* MONOS-2.5 EOS-3.6 \nBASOS-0.4\n___ 07:30PM   PLT COUNT-283\n___ 07:30PM   ___ PTT-31.1 ___\n___ 07:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-50 BILIRUBIN-SM UROBILNGN-NEG PH-6.5 LEUK-MOD\n___ 07:30PM URINE  ___ BACTERIA-MOD \nYEAST-NONE ___\n.\n___ Abdominal/Pelvic CT W/O Contrast:\n1. Mild thickening of the second portion of the duodenum is not \nunexpected \nafter ERCP. Contrast material is seen within the gallbladder. \nWhile there is diffuse mesenteric stranding and small amount of \nsimple fluid within the pelvis, no free air or evidence of \nextravasated contrast is seen to suggest perforation. Biliary \ntree evaluation and search for underlying mass is limited due to \nlack of IV contrast administration. \n2. Status post right partial colectomy. \n.\n___ PTBD:\nPFI: High-grade stricture at the common bile duct with \nhigh-grade dilation of bile ducts above the common bile duct, \nand placement of percutaneous \ntranshepatic external-internal biliary draining catheter with \nthe catheter \nconnected to a bag for external drainage.\n.\n \n\n  \n\n \nBrief Hospital Course:\nThe patient was admitted to the General Surgical Service for \nevaluation and treatment of the aforementioned problems. She was \nmade NPO, started on IV fluid rescusitation and IV antibiotics, \nand given acetaminophen for disconfort with good effect. \nAbdominal/pelvic CT without contrast was performed. The patient \nwas hemodynamically stable.\n\nNeuro: The patient received acetaminophen in general, and IV \nMorphine post-procedure, with good effect and adequate pain \ncontrol.\nCV: CXR performed on ___ confirmed the placement of her \nport-a-cath, which was used for IV administration during \nhospitalization without issue. The patient remained stable from \na cardiovascular standpoint; vital signs were routinely \nmonitored.\nPulmonary: ___ CXR was unremarkable. The patient remained \nstable from a pulmonary standpoint; vital signs were routinely \nmonitored. Good pulmonary toilet, early ambulation and incentive \nspirrometry were encouraged throughout hospitalization.\nGU/FEN: Initially, the patient was made NPO and received IV \nfluid rescusitation with good response. Her diet was advanced to \na low residue regular over the course of 4 days, which she \ntolerated. She was made NPO for procedures, but each time was \nable to return to the low residue regular. Adequate urine output \nwas maintained. Patient's intake and output were closely \nmonitored, and IV fluid was adjusted when necessary.  \nElectrolytes were routinely followed, and repleted when \nnecessary.\nGI: On ___, the patient underwent PTBD with placement of a \npercutaneous transhepatic external-internal biliary draining \ncatheter for a high-grade stricture at the common bile duct \nwithout complication. Returned on ___ to have a metal stent \nplaced, and then again on ___ to undergo an bilairy drain \ncheck, which showed the drain to be patent and intact. The \nbiliary catheter drain was left in place due to continued \nabdominal pain. All procedures went well without complication. \nBowel function remained normal. \nID: The patient was started on IV Flagyl and Levaquin on \nadmission for UTI and presumptive GI infection. The patient's \nwhite blood count and fever curves were closely watched for \nsigns of infection.\nHematology: The patient's complete blood count was examined \nroutinely; no transfusions were required.\nProphylaxis: The patient received subcutaneous heparin and \nvenodyne boots were used during this stay; was encouraged to get \nup and ambulate as early as possible.\n\nAt the time of discharge on ___, the patient was doing well, \nafebrile with stable vital signs.  The patient was tolerating a \nregular low residue diet, ambulating, voiding without \nassistance, and pain was well controlled.  The patient was \ndischarged home with the biliary catheter in place with ___ \nservices for drain care. Plan is to return ___, ___ for \nrepeat cholangiogram and possible tube removal. The patient \nreceived discharge teaching and follow-up instructions with \nunderstanding verbalized and agreement with the discharge plan.\n \nMedications on Admission:\nGabapentin 300mg PO TID, Pancrease MT 20 PO TID with meals, \nVicodin or Percocet PRN, Herbal products\n \nDischarge Medications:\n1. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 \ntimes a day).  \n2. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nevery ___ hours as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n3. Heparin Flush (10 units/ml) 5 mL IV PRN line flush \nIndwelling Port (e.g. Portacath), heparin dependent: Flush with \n10 mL Normal Saline followed by Heparin as above daily and PRN \nper lumen. \n4. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port \nIndwelling Port (e.g. Portacath), heparin dependent: When \nde-accessing port, instill Heparin as above per lumen. \n5. Medication:\nPancrease MT 20 *NF* 1 tab 20000U-65000U-65000U Oral TID with \nmeals \n\n6. Metronidazole 500 mg Tablet Sig: One (1) Tablet PO Q8H (every \n8 hours) for 7 days.\nDisp:*21 Tablet(s)* Refills:*0*\n7. Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every \n24 hours) for 7 days.\nDisp:*7 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___.\n \nDischarge Diagnosis:\n1. Metastatic cecal cancer\n2. Obstructive jaundice\n3. UTI\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nPlease call your doctor or nurse practitioner or return to the \nEmergency  Department for any of the following:\n\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons.  Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours.  Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication.  Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids.  \n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nGeneral Drain Care:\n*Please look at the site every day for signs of infection \n(increased redness or pain, swelling, odor, yellow or bloody \ndischarge, warm to touch, fever).\n*If the drain is connected to a collection container, please \nnote color, consistency, and amount of fluid in the drain.  Call \nthe doctor, ___, or ___ nurse if the amount \nincreases significantly or changes in character. Be sure to \nempty the drain frequently.  Record the output, if instructed to \ndo so.\n*Wash the area gently with warm, soapy water. Keep the insertion \nsite clean and dry otherwise. ___ apply a drain sponge as \nneeded.\n*Avoid swimming, baths, hot tubs; do not submerge yourself in \nwater.\n*Make sure to keep the drain attached securely to your body to \nprevent pulling or dislocation.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16192841","hadm_id":"22958308","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nirinotecan / oxaliplatin\n \nAttending: ___.\n \nChief Complaint:\ndyspnea\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ with pancreatic adenocarcinoma + pulmonary mets, currently \nbeing treated with gemcitabine (most recent chemo ___, history \nof pneumonitis due to irinotecan and oxaliplatin, who presents \nwith cough, dyspnea and fevers starting ___.\n\nIn terms of a brief oncologic history extrapolated from his \nAtrius Onc notes, in ___ he had a 20lb weight loss, normal \ncolonoscopy and recent normal imaging of liver and kidneys in \nsetting of right sided abdominal pain. Subsequently he had \ndyspnea on exertion and cough, at which time CT chst showed \ndiffuse pulmonary nodules with areas of confluent tumor, as well \nas a 3 cm pancreatic mass. He was hospitalized at ___ later in \n___ with worsening dyspnea, at which time lung biopsy \nshowed metastatic adenocarcinoma with likely pancreatic primary. \nHe was started on Folfirinox on ___. In ___ was \nadmitted to the FICU with SOB/pneumonitis which was attributed \nto the chemotherapy and required prolonged steroids and home \noxygen. \n\nHe had a ___ year chemotherapy holiday, was off of steroids for \u003e6 \nmonths, and on ___ was started on dose-reduced gemcitabine. \nLast chemotherapy was ___ (cycle 2 Day 8). He denies side \neffects so far. \n\nSeveral days prior to admission he noticed cough that was \nintermittently productive of yellow or brownish sputum. The \nmorning of ___ he awoke from sleep feeling acutely dyspneic and \nused a home pulse oximeter which revealed an O2 saturation in \nthe high ___ to ___. He felt progressively short of breath and \ndeveloped a temperature of approximately 101, so after many \nhours presented to the ED. He was also having substernal pain \nwhen he has coughing fits but not otherwise.  No chills, \nnightsweats, rhinorrhea, sore throat, sick contacts or recent \ntravel.  \n\nDid receive Flu shot on ___. Pneumovax given ___, PCV13 \ngiven ___. Has not received second pneumovax. \n\nIn the ED, initial vitals: 101.2 | 116 | 128/62 | 18 | 92% 4L NC\n \nExam notable for: \"Initially uncomfortable with elevated \nrespiratory rate on 4 L by nasal cannula with oxygen saturation \naround 80%; was placed on a nonrebreather mask with improvement \nto the ___. Regular tachycardia without murmurs, rubs, or \ngallops. Distant heart sounds. No jugular venous distention. \nAbdomen soft and nontender. ___ with trc symmetric edema\"\n\nPOCUS: \"Cardiac-attempted to obtain ultrasound views to evaluate \nfor LV function, RV morphology, and diffusion; 4 views were \nattempted in both the supine and the left lateral decubitus \nposition without success.\"\n\nLabs notable for:  \n8.3 \u003e 10.8/31.5 \u003c 211\nproBNP 355\n135 | 99 | 14           8.3\n-------------\u003c 177      1.5\n4.2 | 23 | 0.9          1.8\n\nTrop T \u003c0.01\n\n7.44 | 38 | 52    \n Lactate 1.6\n\nImaging:  \n___ CXR IMPRESSION: Widespread, multifocal opacities. \nSimilar widespread opacities have also been demonstrated on \nprior CT scans and radiographs; differential considerations \ninclude multifocal pneumonia, drug induced pneumonitis, atypical \ninfection, edema, or hemorrhage.\n\n___ ECHOCARDIOGRAM IMPRESSION: Very suboptimal image \nquality. Normal left ventricular cavity size and global systolic \nfunction. No definite valvular pathology or pathologic flow \nidentified.  \n\nPatient received:  \n___ 02:20 IV Azithromycin (500 mg ordered) ___ \nStarted  \n___ 02:20 IV CefePIME  ___ Started  \n___ 02:20 IV Acetaminophen IV 1000 mg ___  \n___ 02:26 IV CefePIME 2 g ___ Stopped ___ \n\nVitals on transfer:  97, 130/63, 20, 97% NRB\n\nUpon arrival to ___, he reports improvement in his breathing \n(on nonrebreather) and resolution of his cough. He quickly \ndesaturated to the ___ on Nasal Cannula. \n \nPast Medical History:\nper prior discharge summary and Atrius records: \n#Oncologic\n Pancreatic adenocarcinoma \n Lung metastases bilateral \n#Pulmonary\n Interstitial lung disease \n Pulmonary fibrosis \n Pneumonitis \n Centrilobular emphysema \n#Cardiac\n CORONARY ARTERY DISEASE, UNSPEC VESSEL TYPE \n Hypercholesterolemia \n#Endocrine\n Type 2 diabetes mellitus without complication, on insulin \n#GI\n Gastroesophageal reflux disease without esophagitis \n#Derm\n Left Ear Zoster\n Post herpetic neuralgia \n#Other\n Anxiety states \n Colonic adenoma \n Psoriasis \n Renal cyst, right \n Elevated PSA \n \nSocial History:\n___\nFamily History:\nMother died age ___, does not know any further details \nFather died age ___, does not know any further details \n1 brother\n2 sisters -\u003e one died of cancer, does not know any further \ndetails \n2 sons \n \nPhysical ___:\nADMISSION PHYSICAL EXAM:\n========================\nVITALS: 97.8 | 89 | 116/75 | 27 | 96%\nGENERAL: Nontoxic, NAD. Diaphoretic. \nHEENT: MMM, oropharynx without lesions.\nNECK: JVP not elevated.\nLUNGS: Lower ___ of lungs and lateral fieldswith diffuse \ncrackles and intermittent wheeze worse in left lower lobe. \nLowest ___ with poor air movement. Apexes with good air movement \nand minimal additional sounds\nCV: Regular rate and rhythm, normal S1 S2, no murmurs heard. \nABD: soft, non-tender, non-distended, no guarding. \nEXT: Warm, well perfused, 2+ pulses. There is no edema\nSKIN: Without evidence of psoriasis on elbows, knees, fingers. \nOnychomycosis of toenails and some pitting in fingernails.\nNEURO: Left face with mild droop and reduced CN strength \ncompared to right. Pupils equal and reactive, CN sensation \ngrossly symmetric. No dysarthria.\nACCESS: Right-sided port, peripherals.\n\nDISCHARGE PHYSICAL EXAM:\n========================\n\nPatient was examined on day of discharge. He was able to walk \u003e \n300 feet. At rest, he was saturating 95% on RA; while ambulating \nher dropped to \u003c 83%. He required ___ liters of O2 to maintain \nhis saturations. Otherwise, lungs CTAB.\n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 01:25AM   WBC-8.3 RBC-3.59* HGB-10.8* HCT-31.5* MCV-88 \nMCH-30.1 MCHC-34.3 RDW-14.9 RDWSD-44.3\n___ 01:25AM   NEUTS-77.4* LYMPHS-9.7* MONOS-10.5 EOS-1.3 \nBASOS-0.4 IM ___ AbsNeut-6.44* AbsLymp-0.81* AbsMono-0.87* \nAbsEos-0.11 AbsBaso-0.03\n___ 01:25AM   CALCIUM-8.3* PHOSPHATE-1.8* MAGNESIUM-1.5*\n___ 01:25AM   proBNP-355*\n___ 01:25AM   cTropnT-\u003c0.01\n___ 01:25AM   GLUCOSE-177* UREA N-14 CREAT-0.9 SODIUM-135 \nPOTASSIUM-4.2 CHLORIDE-99 TOTAL CO2-23 ANION GAP-13\n___ 01:43AM   O2 SAT-82\n___ 01:43AM   LACTATE-1.6\n___ 01:43AM   ___ TEMP-38.3 PO2-52* PCO2-38 PH-7.44 \nTOTAL CO2-27 BASE XS-1\n___ 05:18AM   ___ PTT-29.6 ___\n\nMICRO:\n======\n___ FluAPCR-NEGATIVE FluBPCR-NEGATIVE\n___ MRSA SCREEN - negative\n___ BLOOD CULTURES - ####\n___ RAPID RESPIRATORY VIRAL SCREEN AND CULTURE - negative\n___ SPUTUM CULTURE - gram stain without microorganisms, \nlegionella negative, PJP immunofluorescence negative\n___ URINE LEGIONELLA ANTIGEN - negative\n\nIMAGING:\n========\nCXR (___)\nWidespread, multifocal opacities.  Similar widespread opacities \nhave also been demonstrated on prior CT scans and radiographs; \ndifferential considerations include multifocal pneumonia, drug \ninduced pneumonitis, atypical infection, edema, or hemorrhage. \n\nCTA CHEST (___)\n1.  No pulmonary embolus demonstrated.  Interval worsening of \nnumerous \npulmonary metastases compared to most recent prior. \n3.  Background ground-glass opacities with septal thickening \nwhich could be due to drug induced pneumonitis or atypical \ninfection is improved. \n4.  Stable mediastinal and hilar lymphadenopathy. \n\nDISCHARGE LABS:\n===============\n___ 05:25AM BLOOD WBC-9.7 RBC-3.60* Hgb-11.0* Hct-33.4* \nMCV-93 MCH-30.6 MCHC-32.9 RDW-15.6* RDWSD-51.8* Plt ___\n___ 05:25AM BLOOD Glucose-140* UreaN-19 Creat-0.8 Na-139 \nK-4.4 Cl-97 HCO3-32 AnGap-10\n___ 05:25AM BLOOD Calcium-9.1 Phos-3.7 Mg-2.___ y/o M with pancreatic adenocarcinoma + pulmonary mets, \ncurrently being treated with gemcitabine (most recent chemo \n___, history of pneumonitis due to irinotecan and oxaliplatin, \nwho presents with cough, dyspnea and fevers starting ___ \nconcerning for infection vs. disease progression.\n\n# HYPOXIC RESPIRATORY FAILURE in setting of\n# HX CHEMO-INDUCED PNEUMONITIS\n# EMPHYSEMA:\n# PULMONARY METASTISIS  \nThe differential was initially broad in this cancer patient with \nhistory of pneumonitis and emphysema. No bacterial or viral \ninfection was found thus broad spectrum antibiotics were \ndiscontinued. No PE was found on CTA. He recently received \ngemcitabine and had a CT scan in ___ of this year at year \nthat had increased ground glass opacities during this admission \nmaking chemo-induced pneumonitis the most likely inciting \nfactor. He was treated with initially ___ oxygen and and \ntransitioned to NC. He was also placed on 60 mg PO prednisone. \nHis oxygenation steadily improved, but he still required oxygen \non ambulation. He is discharging on prednisone 60 mg daily, with \nplans for an outpatient taper, as well as TMP-SMX DS three times \na week for prophylaxis. He is also going home on home oxygen \nwhile ambulating.\n\n# STAGE IV PANCREATIC CANCER w/ BX-PROVEN LUNG METS: Folfirinox \ndiscontinued d/t presumed pneumonitis. In ___, a routine CT \nscan showed stable pancreatic mass but new/enlarged pulmonary \nnodules which were asymptomatic. In ___, evidence \nofworsening disease in his pancreatic mass and growth in his \nlung nodes as well as mediastinal LAD. Per oncology note, he was \nseen by ___ in ___ but was not offered clinical trials due \nto pneumonitis and psoriasis. Thus Gemcitibine started ___, \nlast dose C2D8 (reduced dose) on ___, albeit with risk of \npneumonitis. Symptoms initially improved. Atrius oncology \ncontinued seeing the patient during this admission and told the \npatient they will try different chemotherapy agents after he \nimproves from current illness.\n\n# TYPE 2 DM: On Lantus and HISS at home. FSBS were elevated in \nhouse in the setting of high-dose steroids. Insulin regimen was \nadjusted for better glycemic control. He is discharging on 30 \nunits of glargine with his pre-existing sliding scale.\n\n# HX ZOSTER\n# POST-HERPETIC NEURALGIA: \nContinued home medications.\n\n# CAD: continued home aspirin. Held home Lipitor as patient has \nnot been taking this. \n\n# ANXIETY: Had been on Ativan but reports not taking this \nanymore.\n\n# PSORIASIS: Improved on chemotherapy; stopped taking \ncreams/ointments.\n\nTRANSITIONAL ISSUES:\n====================\n- Patient has not been taking his inhalers and some of his other \nmedications as prescribed (such as aspirin). Please continue \nmedication teaching with the patient. \n- Patient remains ok to intubate. His prognosis, if intubated \nwould likely be poor. Please continue to monitor. \n\n\u003e 35 minutes spent on discharge activities.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete\n****I believe that it is accurate to what he takes, but it \nshould also include albuterol inhaler PRN, Lipitor. Not taking \nASA or albuterol regularly. Atrius records have pregabalin at \nwrong dosing compared to his actual note and fill record***\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation\n1. Aspirin 81 mg PO INTERMITTENT \n2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild \n3. Acyclovir 800 mg PO Q12H \n4. Glargine 20 Units Breakfast\nInsulin SC Sliding Scale using HUM Insulin\n5. fluticasone-vilanterol 100-25 mcg/dose inhalation DAILY \n6. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea \n7. Gabapentin 600 mg PO QHS \n \nDischarge Medications:\n1.  Acyclovir 400 mg PO Q8H \nRX *acyclovir 400 mg 1 tablet(s) by mouth Three times daily Disp \n#*90 Tablet Refills:*0 \n2.  PredniSONE 60 mg PO DAILY \nRX *prednisone 20 mg 3 tablet(s) by mouth Daily Disp #*90 Tablet \nRefills:*0 \n3.  Sulfameth/Trimethoprim DS 1 TAB PO 3X/WEEK (___) \nRX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by \nmouth Three times a week -- ___ - ___ - F Disp #*30 Tablet \nRefills:*0 \n4.  Glargine 30 Units Breakfast\nInsulin SC Sliding Scale using HUM Insulin \n5.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \n6.  Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea  \n7.  Aspirin 81 mg PO INTERMITTENT  \n8.  fluticasone-vilanterol 100-25 mcg/dose inhalation DAILY  \n9.  Gabapentin 600 mg PO QHS  \n10.Oxygen\\\n- Equipment: O2 concentrator and portable tank @ 4L flow \ncontinuously\n- Diagnosis: chemotherapy-induced pneumonitis\n- Length of Need: 99 months\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nChemotherapy-induced pneumonitis\nMetastatic pancreatic cancer to lung\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted with chemotherapy-induced pneumonitis (lung \ninflammation) because of your metastatic pancreatic cancer. You \nwere treated with steroids and your symptoms got much better. \nHowever, you were still requiring oxygen and you will be sent \nhome with home O2, as well as steroids, and antibiotics to \nprevent you from getting an infection.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19163747","hadm_id":"23600314","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics)\n \nAttending: ___.\n \nChief Complaint:\nDKA, NSTEMI\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMs. ___ is a ___ with DMI p/w refractory hyperglycemia, lethargy \nand anorexia.  Three weeks ago, she suffered a MVA, fracturing \nher sternum and two ribs (rear passenger wearing seatbelt).  Her \nfracture resulted in severe pain \"in her sternum,\" requiring \noxycodone for ___ days (now improved, ___.  She has also been \npersistently hyperglycemic, with BS 400s-500s, requiring \nuptitration of her insulin regimen (from 5 units glargine -\u003e 10 \nunits glargine).  \n\n10 days ago, she began experiencing a dry cough (worse lying \ndown, better sitting up), with hoarseness of voice, and a new \nrequirement for two pillows when sleeping (previously lay flat). \n Her friend had recently been sick with similar symptoms.  She \nalso experienced decreased urination, needing to get up in the \nmiddle of the night for small volumes of urine.  Denies dysuria. \n BM have been normal.  No blood or diarrhea.\n\nA few days ago, her FSBG rose from baseline of 160s to 400+.  \nShe felt increasingly fatigued and tired.  She also always felt \ncold, which she attributes to the heat not working in her home.  \nLast night (___), she continued to talk with ___ \nregarding management of her refractory hyperglycemia.  She was \nadvised to present to the ED.     \n \nIn the ED, initial vs were: T 98.2, HR 80, BP 155/51, RR 16, O2 \n100%.  She was found to have trop 0.39 and EKG with new V5/6 \nSTD.  Glucose 425 with HCO3 19, AG 20, Lactate 2.5, K 4.8, Na \n127, Cre 1.5 (baseline XXX), WBC 15.5, Hct 33.6, Plt 347.  ABG \npH 7.43, pCO2 33, pO2 66, HCO3 23.  s/p 2L NS and insulin ggt @ \n5U/hr, glucose 425---\u003e275.  CXR negative.  BCx pending.\n \nOn the floor, she appeared short of breath with a hoarse voice \nand increased work of breathing.  She denied chest pain or \npressure, only ___ \"soreness\" in her sternum, improved s/p MVA. \n No headache, chest pain, nausea, vomiting, or shortness of \nbreath.  \n\n \nPast Medical History:\nPMH \nDM I (won the award at ___ for being treated for ___ years)\nOsteoporosis\nCeliac Disease\nChronic renal insufficiency\nHTN\nAnemia\n\nPSH:\nCesarean section x 3\nR hand surgery (procedure was delayed due to her Ice Curling \nschedule, resulting in Dupuytrens contracture)\nBilateral cataract surgery\n\n \nSocial History:\n___\nFamily History:\nMother with stroke, depression; Father with MI, EtOH; Sister \nwith ICH\n\n \nPhysical Exam:\nAdmission:\nVitals:  T 98.3, HR 79, BP 128/45, RR 19, 98% RA\nGeneral: Thin, kyphotic, frail, difficulty completing sentences. \n Weak cough  \nHEENT: Anicteric sclera, dry mucous membranes, oropharynx clear  \n\nNeck: supple, JVP not elevated, no LAD.  Thyroid nontender, not \nenlarged. \nLungs: Increased work of breathing, using accessory muscles.  \nClear to auscultation bilaterally, no wheezes, rales, ronchi  \nCV: Regular rate and rhythm with skipped beats.  Normal S1 + S2, \nno murmurs, rubs, gallops  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present.  \nFaded surgical scars from cesarean sections.  \nBack: No CVA tenderness.  Kyphotic spine.\nGU: no foley  \nExt: warm, well perfused, 1+ pulses, no edema.  Left big toenail \ndiscolored and thick.  \n\nDischarge:\nVitals- T 97.6 BP 128/52 HR 77 RR 16 SpO2 94% RA\nGeneral- Awake, alert, sitting in chair, no acute distress. \nVoice less hoarse than prior exams \nHEENT- Sclera anicteric, MMM, oropharynx clear  \nNeck- supple, JVP not elevated  \nLungs- CTAB\nCV- RRR, normal S1 + S2, no murmurs, rubs, gallops  \nAbdomen- soft, non-tender, non-distended, bowel sounds present, \nno organomegaly    \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema. variscose veins noted in bilateral feet  \nNeuro- motor function grossly normal\n\n \nPertinent Results:\n___ 09:02PM BLOOD WBC-15.5*# RBC-3.53* Hgb-10.6* Hct-33.6* \nMCV-95 MCH-30.1 MCHC-31.6 RDW-12.2 Plt ___\n___ 09:02PM BLOOD Neuts-89.2* Lymphs-3.8* Monos-6.0 Eos-0.7 \nBaso-0.2\n___ 09:02PM BLOOD Plt ___\n___ 02:45AM BLOOD ___ PTT-24.9* ___\n___ 09:02PM BLOOD Glucose-398* UreaN-76* Creat-1.6* Na-125* \nK-4.9 Cl-92* HCO3-17* AnGap-21*\n___ 09:30PM BLOOD LD(LDH)-252* TotBili-0.3\n___ 10:15PM BLOOD CK-MB-2 cTropnT-0.39*\n___ 04:05AM BLOOD CK-MB-2 cTropnT-0.37*\n___ 06:15AM BLOOD ___\n___ 01:03PM BLOOD CK-MB-2 cTropnT-0.47*\n___ 09:30PM BLOOD CK-MB-2 cTropnT-0.43*\n___ 04:05AM BLOOD Calcium-7.6* Phos-2.2* Mg-2.5 Cholest-113\n___ 06:15AM BLOOD Albumin-2.9*\n___ 09:30PM BLOOD calTIBC-160* Hapto-325* Ferritn-335* \nTRF-123*\n___ 10:36PM BLOOD ___ pO2-67* pCO2-30* pH-7.40 \ncalTCO2-19* Base XS--4 Comment-GREEN TOP\n\nImaging:\nCT CHEST ___\nIMPRESSION: \n1.  No evidence of mediastinal hematoma.\n2.  Moderate non-hemorrhagic bilateral pleural effusions.\n3.  Bibasilar consolidations and scattered bilateral opacities, \nconcerning for\nmultifocal infection or aspiration.\n4.  Sternal and manubrial fractures, of uncertain chronicity, \nlikely subacute,\nwithout subjacent hematoma.\n5.  Extensive calcified atherosclerotic disease.\n6.  Compression deformity of T4 vertebral body of uncertain \nchronicity.  \n.\n___ CXR\nFINDINGS:  Old right seventh, eighth, ninth and likely tenth \nposterior rib\nfractures show signs of interval healing.  There is blunting of \nthe right CP angle as well as the left which likely indicates \ntiny pleural effusions.  The heart is within normal limits of \nsize.  No signs of pneumonia or CHF.  No pneumothorax is seen.  \nAn old left clavicular mid shaft deformity is again seen.  A \ndeformity involving the mid body of the sternum is seen on the \nlateral view, showing increased displacement.\n \nBrief Hospital Course:\nMs. ___ is an ___ with T1DM, osteoporosis, recent MVA with \nsternal and rib fractures, presenting with fatigue, cough, \nhoarse voice, and refractory hyperglycemia and mild \nketoacidosis. \n \n# Diabetic Ketoacidosis: pt presented with glucose \u003e400 with \ninitial gap of 16, decreased to 7 by time of ICU arrival. \nPrecipitated by infection vs. MI vs. trauma.  Insulin drip was \nstopped on first day of admission, pt was transitioned to \nglargine and diet was advanced with conservative HISS as per \n___ recs.  Pt was treated with ceftriaxone for UTI.  Other \ninfectious work up, including blood culture, CXR was negative on \nday of call out from ICU. Her blood glucose continued to be \nlabile on the floor, ranging from 59 to 478, though they began \nto stabilize on day prior to discharge. ___ continued to \nfollow her daily throughout her admission and adjusted her \ninsulin regimen as needed. She will resume her regimen of \nbedtime lantus (with gradual dose adjustment) upon discharge, \nwith close ___ follow up.\n\n# NSTEMI: Presentation of hyperglycemia with osmolar gap, new \nEKG changes and elevated troponin all concerning for NSTEMI, \ndespite absence of chest pain, high risk for atypical \npresentation given that patient is an elderly female diabetic. \nCardiac risk factors include her age and diabetes. ACEi was \ninitially started, but held for hyperkalemia (K of 5.5).  \nTroponin 0.37 to 0.47 to 0.43.  Per discussion with cardiology, \npt was initially treated medically with heparin drip, full dose \nASA, with subsequent adjustment of diagnosis to NTMI from \n___ imbalance secondary to metabolic derangement, \nrather tha primary unstable CAD.  Pt was continued on home \nstatin as well as metoprolol. She will follow up with cardiology \n(Dr. ___.  \n\n# Leukocytosis:  Possibly reactive due to hyperglycemia but high \nsuspicion for urinary infection, which was treated. Given chest \nxray without signs of focal consolidation and dry cough, low \nsuspicion for pneumonia, but also completed course of \nazithromycin for atypical coverage. Treated for UTI as well. \nReactivity to persistent hyperglycemia also likely contributed. \nStable at time of discharge (WBC 10.5, down from 14).\n\n# Lactic acidosis:  Most likely Type B lactic acidosis due to \nhyperglycemia, though must consider being due to sepsis in \nsetting of DKA with leukocytosis. Normalized prior to call out \nfrom ICU, no further issues on the floor.\n \n# Hyponatremia: Most likely pseudohyponatremia vs hypovolemic \nhyponatremia vs SIADH from pain. Pt's serum sodium normalized \nfollowing DKA reversal and remained normal throughout remainder \nof inpatient stay.\n\n# Anemia: Baseline appears to be in the low ___, normocytic. \n___ workup demonstrated  normal B12 and folate, iron studies \nwith Fe/TIBC ratio \u003e20% suggestive of anemia of chronic disease. \n Given NSTEMI, transfusion goal hct \u003e30.  Pt had hct of 25.8 on \nevening of ___ from 29.1 earlier during the day. Pt was \ntransfused 2 units with post transfusion hct of 36.4.  No clear \nsource of bleeding was identified, and given the significant hct \nincrease, there was suspicion for the low hct result being \nspurious. Hct remained stable throughout remainder of admission, \nwith dicharge Hct 35.9.\n\n# Difficulty swallowing: She endorses difficulty swallowing \npills, concerning for esophagitis vs. achalasia. Oral mucosa \nclear. Seemed to improve spontaneously. She had a speech and \nswallow consult (cleared for aspiration risk) and was then \nadvanced to a full regular diet without difficulty.   \n\n# Orthopnea:  Likely ___ CHF given NSTEMI, increased pulmonary \ncongestion on CXR, and persistent, dry cough. Echo was deferred \nto outpatient setting given rib and sternum fractures and lack \nof acuity. She was started on 10mg PO lasix which improved her \nsymptoms. No further issues. Can have outpatient echo if \nindicated.\n\n# Sternal/rib fractures: Pain was controlled with tylenol. No \nresidual active issues.\n\n# Chronic kidney disease: Unknown recent baseline but 1.1-1.3 in \n___ of this year, presenting with Cr initially of 1.6, rapidly \nimproved with IVF in ED suggests prerenal etiology engrafted on \nunderlyingh diabetic nephropathy, as does high BUN:Cr ratio. \nAppeared stable throughout admission, with discharge Cr 1.2.\n\nTRANSITIONAL:\n- f/u with Dr. ___ on ___ ___ at ___\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Glargine 10 Units Bedtime\nInsulin SC Sliding Scale using aspart Insulin\n2. Aspirin 81 mg PO DAILY \n3. Metoprolol Succinate XL 12.5 mg PO DAILY \n4. azelastine 137 mcg nasal bid \n5. Nitroglycerin SL 0.3 mg SL PRN chest pain \n\n \nDischarge Medications:\n1. Aspirin 81 mg PO DAILY \nRX *aspirin 325 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n2. Glargine 10 Units Bedtime or as adjusted\nInsulin SC Sliding Scale using aspart Insulin\n3. Atorvastatin 80 mg PO DAILY \nRX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n4. Metoprolol Succinate XL 25 mg PO DAILY \nRX *metoprolol succinate 25 mg 1 tablet extended release 24 \nhr(s) by mouth daily Disp #*30 Tablet Refills:*0\n5. Acetaminophen 650 mg PO Q6H prn pain \ndo not exceed 3000mg/day \nRX *acetaminophen 650 mg 1 tablet extended release(s) by mouth \nevery six hours as needed for pain Disp #*30 Tablet Refills:*0\n6. azelastine 137 mcg nasal bid \n7. Nitroglycerin SL 0.3 mg SL PRN chest pain \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis: Diabetic Ketoacidosis Secondary diagnoses: \nType I Diabetes Mellitus; Subendocardial ischemic injury; \nDiabetic nephropathy, mild; Pneumonia (suspected)\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent but will have home ___ \nservices and stay with her daughter for a few days.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you at ___. As you \nknow, you came to the hospital because your blood sugar levels \nwere persistently high in the weeks following your recent car \naccident. We were able to bring you blood sugar levels down and \ncontinued to work with our colleagues at ___ to optimize your \ninsulin plan during your stay. \n They followed you throughout your stay and will continue to \nwork with you going forward. You should return to your regular \ninsulin schedule and take your lantus at bedtime tonight. We \nrecommend that you set an alarm to check your blood sugar once \nin the night tonight and keep a kit and glass of juice by the \nbedside, which you will drink for blood sugar less than 70. You \ncan discuss whether you need to continue to do this at your \ndiabetes appointment on ___. Please follow the \nsliding scale using your home novolog. \nWhen you arrived to the emergency room, they also found evidence \nof a mild heart attack (we call this an NSTEMI, or \nNon-ST-Elevation Myocardial Infarction). We were able to treat \nyou with medications and no surgery was required. You will \ncontinue to take metoprolol, atorvastatin, and aspirin to help \nkeep your heart healthy and follow up with Dr. ___.\n\nWe also treated you for a urinary tract infection which \nresolved, as well as what is called an atypical pneumonia, which \nalso resolved with a full treatment course. You continued to \nimproved and were able to be discharged. Physical therapy will \nwork with you at home as you continue to recover. You will \nfollow up with the ___ team, your cardiologist, and your \nprimary care doctor. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13281479","hadm_id":"22218287","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: UROLOGY\n \nAllergies: \nCodeine\n \nAttending: ___.\n \nChief Complaint:\n___ y/o female with MEN 2A and adrenal medullary hyperplasia, \nelevated plasma free with clinical signs/symptoms of an \nexcessive catecholamine state.\n \nMajor Surgical or Invasive Procedure:\nLaparoscopic bilateral adrenalectomy - ___ - Dr. ___ \n___\n\n \nHistory of Present Illness:\n___ is a ___ yo female with MEN2A, h/othyroidectomy, \nand adrenal medullary hyperplasia who presents for bilateral \nadrenalectomy. The patient was diagnosed with MEN2A at the age \nof ___ by a blood test (likely RET mutation analysis) due to the \nsignificant family history (see below). She had a prophylactic \nthyroidectomy shortly thereafter. The patient had been followed\nby a pediatric endocrinologist at ___ for \nmost of her life, and switched her care to adult endocrinology \nin ___ of this year. The patient is scheduled to undergo \nbilateral adrenalectomy by Dr. ___. \n\n \nPast Medical History:\n- MEN II (thyroid mass, s/p thyroidectomy)\n- Depression\n- Anxiety\n \nSocial History:\n___\nFamily History:\n___ at ___, majoring in biobiopsychology with \nminor statistics with plans for career in ___. Lives with 1 \nroommate in dorm. Family in ___. Denies tobacco or \nillicit drug use; occasional EtOH. Sexually active with 1 \npartner, always uses condoms, no h/o STDs. \n \nPertinent Results:\n___ 06:00AM BLOOD WBC-9.9 RBC-3.61* Hgb-11.3* Hct-31.7* \nMCV-88 MCH-31.2 MCHC-35.6* RDW-12.9 Plt ___\n___ 06:50PM BLOOD WBC-8.4 RBC-3.41* Hgb-10.5* Hct-29.8* \nMCV-87 MCH-30.8 MCHC-35.2* RDW-12.3 Plt ___\n___ 06:00AM BLOOD Glucose-133* UreaN-4* Creat-0.6 Na-141 \nK-3.5 Cl-104 HCO3-28 AnGap-13\n \nBrief Hospital Course:\nMs. ___ is a very pleasant ___ y/o female with history of \nMEN 2A and adrenal medullary hyperplasia. The patient was \nadmitted to Urology after undergoing laparoscopic right and left \nadrenalectomy. No concerning intraoperative events occurred; \nplease see dictated operative note for details. The patient \nreceived perioperative antibiotic prophylaxis. The patient was \ntransferred to the floor from the PACU in stable condition. Due \nto her Endocrinological requirements, the Endocrine service was \ncontacted and provided instruction and guidance related to her \npost operative care and for the duration of her stay. On POD0, \npain was well controlled on PCA, she  was hydrated for urine \noutput \u003e30cc/hour, and provided with pneumoboots and incentive \nspirometry for prophylaxis. On POD1, the patient ambulated, was \nrestarted on home medications excluding Labetalol, a basic \nmetabolic panel and complete blood count were checked, her pain \ncontrol was transitioned from PCA to oral analgesics, diet was \nadvanced to a clears/toast and crackers diet. On POD1 the \nurethral catheter (foley) were removed without difficulty and \nthe patient voided. The Endocrine Department monitored her post \nop steroid regimen closely. The remainder of the hospital course \nwas relatively unremarkable. The patient was discharged in \nstable condition, eating well, ambulating independently, voiding \nwithout difficulty, and with pain controled on oral analgesics. \nOn exam, incision was clean, dry, and intact with steristrips in \nplace, with no evidence of hematoma collection or infection. The \npatient was given explicit instructions related to new \nmedications, she was given a lab slip by Dr. ___ Chem 7 \nto be drawn on the upcoming ___, she has a follow up \nappointment scheduled with Dr. ___ on ___ at 1:30. \nAdditionally she was instructed to contact Dr. ___ \ndischarge to arrange a follow up appointment. \n \nMedications on Admission:\nMedications:  \n1. Labetalol \n2. Bupropion HCl 100 mg Tablet Sustained Release Sig: Two (2) \nTablet Sustained  Release PO QAM (once a day (in the morning)).  \n\n3. Lamotrigine 100 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n4. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n5. Paroxetine HCl 10 mg Tablet Sig: 1.5 Tablets PO DAILY \n(Daily). \n \nDischarge Medications:\n   \n1. Hydrocodone-Acetaminophen ___ mg Tablet Sig: One (1) Tablet \nPO Q6H (every 6 hours) as needed for break through pain only \n(score \u003e4) : to be taken in place of Tylenol for break through \npain, max Tylenol dose 4 gms daily.\nDisp:*90 Tablet(s)* Refills:*0*\n2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n3. Bupropion HCl 100 mg Tablet Sustained Release Sig: Two (2) \nTablet Sustained Release PO QAM (once a day (in the morning)).  \n4. Lamotrigine 100 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n5. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Paroxetine HCl 10 mg Tablet Sig: 1.5 Tablets PO DAILY \n(Daily).  \n7. Prednisone 5 mg Tablet Sig: 2 tabs for next two days, then 1 \ntablet daily Tablets PO once a day: take medication in am upon \nwaking.\nDisp:*30 Tablet(s)* Refills:*2*\n8. Fludrocortisone 0.1 mg Tablet Sig: ___ tab Tablet PO once a \nday: take medication ___ tab) in am upon waking.\nDisp:*30 Tablet(s)* Refills:*1*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAdrenal hyperplasia\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\n-You may shower but do not bathe, swim or immerse your incision.\n\n-Do not eat constipating foods for ___ weeks, drink plenty of \nfluids.\n\n-Do not lift anything heavier than a phone book (10 pounds) or \ndrive until you are seen by your Urologist in follow-up. \n\n-Do not drive or drink alcohol while taking narcotics. \n\n-Resume all of your home medications EXCLUDING Labetalol, and \nstart your new steroid regimen as dictated by Dr. ___ \nthe ___ team.\n\n-Please have your labs drawn on ___ as requested by Dr. \n___ results ___ be faxed to her attention.\n\n-If you have fevers \u003e 101.5 F, vomiting, or increased redness, \nswelling, or discharge from your incision, call your doctor or \ngo to the nearest ER.\n\n-Call Dr. ___ to set up follow-up appointment and if \nyou have any urological questions. ___\n\n-A follow-up appointment with Dr. ___ has been arranged \nfor you on ___ at 1:30.  Her office phone # is ___\n\n-Dr. ___ with you sick and warm day changes to your \nmedications if you have any questions regarding these \ninstructions please do not hesistate to contact her office at \nthe number above.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13501970","hadm_id":"29033828","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAmoxicillin\n \nAttending: ___.\n \nChief Complaint:\nPericardial effusion on Echo\n \nMajor Surgical or Invasive Procedure:\nPericardiocentesis with serosanguinous fluid\n \nHistory of Present Illness:\nMrs. ___ is a ___ yo woman with a h/o DCD renal transplant ___ \nIgA nephropathy in ___, dyslipidemia and bipolar disorder who \npresents from clinic due to a large pericardial effusion noticed \non routine echo. Echo was first ordered one month prior to \nevaluate palpitations which have since resolved.  \n \nThe patient reports dyspnea on exertion over the past month that \nhas actually improved with exercise. She denies chest pain, \nweight loss, fevers, night sweats. She is at her baseline level \nof energy/fatigue. Her leg edema has improved over the past \nmonth.  \n \nPer the patient's daughter, the patient has a history of a \npositive PPD with 9 months of INH therapy pre-transplant with a \nDr. ___ in ___, ___. The patient has also recently travelled to \n___, although she denies any outside time. She \nreports no joint pain or rashes. She has also been present in a \n___ home that is being renovated.  \n\nROS: Otherwise negative for lightheadedness, changes in urine or \nstool, sick contacts or other exposures.  \n\n \nPast Medical History:\nESRD ___ IgA nephropathy s/p DCD renal transplant ___ \n(Baseline Cr 1.4)\nDyslipidemia\nBipolar disorder\nPTSD\nHypertension\ns/p fibroid surgery -___\nhistory of AV fistulas ___\ns/p Cesarean section\n \nSocial History:\n___\nFamily History:\nPatient's daughter explains that the patient lost nearly her \nwhole family in a war in ___ as a child and has no details \nregarding family history of illnesses/cancers. \n \nPhysical Exam:\nVS: T 97.3F BP 134/63mmHg HR 60 bpm RR 18 98%@RA  \nGen: Obese female in no acute distress  \nHEENT: CN II-XII. No thyromegaly. No JVD  \nCV: S1 + S2 obscured by a murmur vs. rub throughout the cardiac \ncycle.  \nPulm: B CTA  \nAbd: Soft, NTND. No HSM or tenderness. No hepatojugular reflux \nappreciated.  \nExt: 1+ edema in ___, 2+ DP. ___  \n\n \nPertinent Results:\n___ ADMISSION EKG: rate 60, NSR, normal axis, with biphasic \nT-waves in V2, no other ST changes\n\n___ CXR PA and Lateral: marked enlargement of the cardiac \nsilhouette in the absence of significant congestion or pneumonic \ninfiltrate. The finding is compatible with chronic pericardial \neffusion.\n\n___ 2D-ECHOCARDIOGRAM / Pre-cath prior to drainage \ndemonstrated the following: The left atrium is normal in size. \nNo atrial septal defect is seen by 2D or color Doppler. Left \nventricular wall thickness, cavity size and regional/global \nsystolic function are normal (LVEF 60%). There is no ventricular \nseptal defect. Right ventricular chamber size and free wall \nmotion are normal. The aortic valve leaflets (3) appear \nstructurally normal with good leaflet excursion and no aortic \nregurgitation. The mitral valve leaflets are structurally \nnormal. There is no mitral valve prolapse. Mild (1+) mitral \nregurgitation is seen. There is mild pulmonary artery systolic \nhypertension. There is a moderate to large sized pericardial \neffusion. The effusion appears circumferential. There are no \nechocardiographic signs of tamponade. No right atrial or right \nventricular diastolic collapse is seen.\n\n___ 2D-ECHOCARDIOGRAM in cath lab after drainage of 400cc \nfluid: left ventricular cavity is unusually small. Left \nventricular systolic function is hyperdynamic (EF\u003e75%). There is \na moderate to large sized pericardial effusion. The effusion \nappears circumferential. The effusion is echo dense, consistent \nwith blood, inflammation or other cellular elements.Compared \nwith the findings of the prior study (images reviewed) of ___, the size of the pericardial effusion is similar. \nNo echocardiographic evidence of cardiac tamponade is present.\n\n___ STRESS MIBI: Normal myocardial perfusion study at the \nlevel of stress achieved, ejection fraction is 69% \n\nDischarge Labs: \n___ 05:25AM BLOOD WBC-4.7 RBC-3.99* Hgb-10.3* Hct-31.5* \nMCV-79* MCH-25.7* MCHC-32.6 RDW-12.9 Plt ___\n___ 05:25AM BLOOD Glucose-108* UreaN-23* Creat-1.6* Na-140 \nK-4.0 Cl-108 HCO3-24 AnGap-12\n___ 05:45PM BLOOD C3-143 C4-37\n___ 05:45PM BLOOD TSH-5.0*\n___ 05:26AM BLOOD Anti-Tg-PND\n___ 11:47AM BLOOD dsDNA-PND\n___ 06:12AM BLOOD Triglyc-60 HDL-64 CHOL/HD-2.3 LDLcalc-72\n___ 01:15PM OTHER BODY FLUID ___ ___ \nPolys-56* Bands-4* Lymphs-38* Monos-2*\n___ 01:15PM OTHER BODY FLUID TotProt-5.6 Glucose-107 \nLD(LDH)-187 Amylase-108 Albumin-3.7\n___ 01:15PM OTHER BODY FLUID ADENOSINE DEAMINASE, FLUID-PND\n \nBrief Hospital Course:\nIn summary, the patient is a ___ ___ speaking \nfemale who presented to her nephrologist complaining of 1 month \nof intermittent palpitation episodes and worsening shortness of \nbreath with exertion. On further workup she was found to have \na moderate to large size pericardial effusion noted on \nechocardiogram without tamponade. She was admitted for an \nelective pericardial drainage on ___. She was monitored in \nthe CCU s/p procedure and recovered smoothly without any serious \ncomplications. \n\n1) Pericardial Effusion: The etiology of the effusion remains \nunclear.  The patient had CT, CXR, and pericardiocentesis with \nfluid analysis which did not reveal the etiology of the disease. \nThe differential includes TB, malignancy or idiopathic. She was \nbriefly transferred to the CCU post procedure where she \nexperienced an episode of bradycardia and hypotension which \nresolved and did not return.  In addition, she briefly developed \natrial tachycardia which was controlled on metoprolol. The \npatient was comfortable without signs or symptoms of effusion or \ntamponade on discharge.  Her ___, dsdna and fluid cultures were \npending on discharge.  A CT showed continued effusion confirmed \nas stable on follow up echocardiogram. She will continue \namlodipine and metoprolol and have a follow up echocardiogram in \n1 week, followed by an appointment with Dr. ___ in 2 weeks.\n\n2. Renal Transplant: The patient is status post renal transplant \nfor IgA Nephropathy in ___.  She was continued on Mycophenolate \nMofetil and Sirolimus while admitted, with Sirolimus levels \nfollowed.  She was also continued on Vitamin D \u0026 calcium.  Her \ncreatinine remained at baseline while admitted. \n \n3. Hypertension: The patient was continued on her home dose of \nAmlodipine 5mg and Toprol 100mg.\n \n4. Bipolar disorder: The patient was continued on her home dose \nBenztropine \u0026 Risperidal. \n \nMedications on Admission:\nMycophenolate Mofetil 500mg PO BID  \nSirolimus 2mg PO Qday  \nAmlodipine 5mg PO Qday  \nMetoprolol Succinate 100mg PO Daily  \nCalcium/Vitamin D 500  \nRisperdal 3mg PO Qday  \nBenztropine 1mg PO Qday  \nTrimethroprim-Sulfamethoxazole 400/80 PO Qday\n \nDischarge Medications:\n1. Mycophenolate Mofetil 500 mg Tablet Sig: One (1) Tablet PO \nBID (2 times a day).  \n2. Sirolimus 1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  \n3. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n4. Risperidone 1 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n5. Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n6. Benztropine 1 mg Tablet Sig: One (1) Tablet PO QHS (once a \nday (at bedtime)).  \n7. Metoprolol Succinate 100 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  \n8. CALCIUM 500+D 500 (1,250)-200 mg-unit Tablet Sig: One (1) \nTablet PO once a day.  \n9. Outpatient Lab Work\nPlease have a CH50 drawn with results sent to Dr. ___, \n___\n10. Outpatient Lab Work\nPlease schedule an outpatient echocardiogram in 1 week, \ninstructions attached.\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagosis:\n1) Pericardial effusion\n\nSecondary Diagnoses:\n1) Renal Transplant\n2) Hypertension\n3) Bipolar Disorder\n\n \nDischarge Condition:\nVital signs stable on room air, no discomfort.\n\n \nDischarge Instructions:\nYou have been admitted to the hospital because of a fluid \ncollection that was found around your heart.  While you were \nhere we extracted the fluid and found that it was a mix of blood \nand fluid.  We are still unsure why you have an effusion but we \nthink you are safe to go home.  \n\nPlease take all of your medicines as described. \n\nPlease schedule an echocardiogram in 1 week and make all doctors \n___.\n\nIf you should feel short of breath or have chest pain (or any \nother concerning medical symptom), please call your doctor or \n911 to return to the emergency room.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"14428363","hadm_id":"23084061","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nsimpathomimetics / phenylephrine / zinc / acetazolamide\n \nAttending: ___\n \nChief Complaint:\nBack pain, lung mass\n \nMajor Surgical or Invasive Procedure:\n___ Supraclavicular lymph node biopsy\n___ Bronchoscopy with lung biopsy\n___ Radiation treatment to spine x5\n\n \nHistory of Present Illness:\n___ with pmhx of hypothyrodism who presents with worsening back \nand neck pain. Pt presented to her primary care clinic on ___ \nwith worsening right rib and neck pain. The rib pain started on \nthe left and then radiated to her right. She initially \nattributed the pain to musculoskeletal injury after throwing \nthings in a dumpster. She also noted a large bruise on R \naxillary line as well as a lump at lower R neck.\n  \nShe had a CXR which showed linear density right perihilar region \nquestion atelectasis, question healing or healed lateral left \nsixth and eighth rib fractures with callus formation. She had \nthen had CT chest and neck which showed multiple lytic lesions \ninvolving cervical and thoracic spine and Right parahilar \nspiculated mass. Palpable mass at the base of right neck \nrepresents an enlarged likely metastatic lymph node as well as 6 \nmm x 7 mm suprasellar mass. Overall clinical presentation \nconcerning for lung cancer. Today she was seen in ___ \n___ clinic by Dr. ___ referred to the ED for \nworsening pain and inability to ambulate.  \n\nIn the ED, initial VS were: 97.4 76 195/88 16 100% RA  \nLabs were notable for: wbc ct 8.7, h/h ___, platelets 151  \nAn MRI was done and she was given medication for pain.\n \nPast Medical History:\nHypercholesterolemia  \nMENOPAUSE  \nGLAUCOMA SUSPECT W OPEN ANGLE  \nFAMILY HISTORY GLAUCOMA  \nHYPOTHYROIDISM, UNSPEC  \nINSOMNIA  \nVITREOUS DEGENERATION  \nScreening for colon cancer  \nCataract, nuclear sclerotic senile  \nDermatochalasis  \nStatus post THR (total hip replacement) left ___  \nMacular drusen  \nEpiretinal membrane, left eye  \nOpen angle with borderline findings, low risk  \nOnychomycosis  \nRotator cuff tear  \nRetinal drusen  \nOcular hypertension of right eye  \nOsteopenia  \n\n \nSocial History:\n___\nFamily History:\nMother-lung cancer  \nFather-lung cancer  \n\n \nPhysical Exam:\nAdmission Physical Exam:\nVS: T 97.6 HR 75 BP 170/80 RR 20 O2 97%RA\nGENERAL: NAD  \nHEENT: EOMI, MMM\nCARDIAC: RRR, normal S1 \u0026 S2 \nLUNG: clear to auscultation, no wheezes or rhonchi  \nABD: Soft, NT/ND, no rebound or guarding  \nEXT: No lower extremity pitting edema  \nNEURO: Alert and oriented, CN II-XII intact, no focal deficits\nbut exam limited by pain.\nSKIN: Warm and dry, without rashes   \n\nDischarge Physical Exam:\nVS: 98.0-97.8   ___   120-134/60-62   18   94-98RA\nGEN: AOx3, NAD  \nHEENT: PERRLA. MMM. no LAD. no JVD. neck supple.\nCards: RRR S1/S2 normal. no murmurs/gallops/rubs.  \nPulm: CTAB no crackles or wheezes  \nAbd: BS+, soft, NT, no rebound/guarding  \nExtremities: wwp, no edema. DPs, PTs 2+.\nSpine: No midline tenderness on palpation \nSkin: no rashes or bruising\nNeuro: ___ strength in U/L extremities. DTRs\n2+ ___.\n \nPertinent Results:\nAdmission Labs:\n---------------\n___ 11:45AM BLOOD WBC-8.7 RBC-4.43 Hgb-12.0 Hct-36.8 MCV-83 \nMCH-27.1 MCHC-32.6 RDW-13.9 RDWSD-42.2 Plt ___\n___ 11:45AM BLOOD Neuts-75.3* Lymphs-12.4* Monos-7.7 \nEos-2.4 Baso-0.7 Im ___ AbsNeut-6.52* AbsLymp-1.07* \nAbsMono-0.67 AbsEos-0.21 AbsBaso-0.06\n___ 11:45AM BLOOD Plt ___\n___ 11:45AM BLOOD Glucose-91 UreaN-21* Creat-1.1 Na-135 \nK-5.4* Cl-97 HCO3-28 AnGap-15\n\nCytology:\n---------\n___ Supraclavicular Node Bx: \nNectrotic tissue, could not assess further \n\n___ Lung biopsy:\nConsistent with non-small cell carcinoma, favor adenocarcinoma. \nCell block preparation shows moderate tumor cellularity. On \nimmunohistochemical stains tumor cells are positive for TTF-1 \nand negative for p63.\n\nImaging:\n--------\n___ MRI Head  \n1. Enhancing 8 x 8 x 9 mm suprasellar mass just posterior to the \noptic chiasm in the region of tuber cinereum / mamillary bodies, \nfavored to be intracranial metastasis. Possible differential \ndiagnosis include Langerhans cell histiocytosis, \nneurosarcoisodid and other inflammatory conditions but favored \nto be less likely.  \n2. Multiple osseous metastatic lesions as described above.  \n\n___ MRI C-spine, T-spine  \n1. Diffuse osseous metastatic disease as described above. There \nis no significant osseous expansion into the spinal canal.  \n2. 2 mm nodular enhancing nodule of a right L3 level nerve root \nis highly suspicious for leptomeningeal metastasis. Additional \nequivocal regions of nodular enhancement right T8 and the left \nT9-T10 levels may also represent additional metastatic foci.  \n3. A 3 cm right lower lobe enhancing mass with a subjacent \nsubpleural 1.2 cm nodule are noted, which may represent the \npatient's primary lesion.  \n4. Superimposed multilevel multifactorial cervical, thoracic and \nlumbar spine spondylosis as described.\n\n___ CXR\nIrregular opacity in the right mid lung is nonspecific and in \nthe absence of prior could represent site of infection, \natelectasis or malignancy in this patient with prior \nadenocarcinoma. \n  \nDischarge Labs:\n---------------\n___ 06:35AM BLOOD WBC-6.6 RBC-3.73* Hgb-10.2* Hct-31.0* \nMCV-83 MCH-27.3 MCHC-32.9 RDW-15.5 RDWSD-47.0* Plt ___\n___ 06:35AM BLOOD Glucose-96 UreaN-25* Creat-0.8 Na-134 \nK-4.6 Cl-100 HCO3-26 AnGap-13\n___ 06:35AM BLOOD Calcium-7.7* Phos-2.7 Mg-2.___ with pmhx of hypothyrodism who presents with worsening back \nand neck pain, found to have lung mass with concern for \nmetastasis to spine and brain.  \n\n#) Lung Mass: Patient found to have spiculated right lung mass \nwith concern for mets to lymph nodes, spine and brain.  ___ core \nbiopsy of palpable supraclavicular LN was necotic tissue. Lung \nbiopsy showed adenocarcinoma. Patient received 5 treatments XRT \nto T7-L4. Patient was started on pamidronate 60mg, monthly for \nprophylactic hypercalcemia due to bone mets. MRI brain showed \nlesion that will need followup for growth in 1 month.\n\n#) Back and neck pain: Secondary to mets. MRI in ED to rule out \ncord compression given her progressive pain and inability to \nambulate. Spoke with neurosurgery: no current cord compression, \ndid not recommend bracing before ambulation. Patient has had \nincreasing pain and requiring for use of PRN medication, no loss \nof sensation or strength in ___, urinary retention resolved.  \nStarted on 50mcg/hr fentanyl patch + PRN ultram, dilaudid 2mg \nPRN, and gabapentin 300mg TID. ___ evaluated patient during \nadmission and recommended home ___ upon discharge.\n\n#) Abdominal pain: Patient with new pain over abdomen without \nttp on exam but reports sensitivity over skin. Likely related to \nXRT and constipation.  Pain relief following large bowel \nmovement.\n\n#) GN Bactermia: Likely secondary to UTI. Pt initially started \non CTX and antibiotics were narrowed to cipro\n\n====================\nTransitional Issues:\n====================\n- Followup with Atrius Oncology for lung cancer.\n- Continue ciprofloxacin for 10 more days for UTI/bacteremia \n___\n- Steroid taper with dexamethasone 4mg BID x 3days (___), \nthen 2mg BID x 3days (___), then 2mg daily x3days \n(___), then stop completely.\n- Recommend MRI head in 1 month for monitoring of brain lesion \nfor possible growth.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Levothyroxine Sodium 75 mcg PO DAILY \n2. Zolpidem Tartrate 10 mg PO QHS:PRN Insomnia \n3. Simvastatin 20 mg PO QPM \n4. Naproxen 500 mg PO Q12H:PRN Pain \n5. Acetaminophen w/Codeine ___ TAB PO Q4H:PRN Pain \n6. Ibuprofen 400-600 mg PO Q6H:PRN Pain \n\n \nDischarge Medications:\n1. Levothyroxine Sodium 75 mcg PO DAILY \n2. Simvastatin 20 mg PO QPM \n3. Zolpidem Tartrate 10 mg PO QHS:PRN Insomnia \n4. Fentanyl Patch 50 mcg/h TD Q72H \nRX *fentanyl 50 mcg/hour Apply 1 patch to upper arm, change \nevery 72hrs. Q72H Disp #*10 Patch Refills:*0\n5. Gabapentin 300 mg PO TID \nRX *gabapentin 300 mg 1 capsule by mouth three times a day Disp \n#*90 Capsule Refills:*0\n6. Ciprofloxacin HCl 500 mg PO Q12H Duration: 10 Days \nRX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth twice \na day Disp #*20 Tablet Refills:*0\n7. Omeprazole 20 mg PO DAILY \nRX *omeprazole 20 mg 1 capsule by mouth DAILY Disp #*30 Capsule \nRefills:*0\n8. HYDROmorphone (Dilaudid) ___ mg PO Q2H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg 1 tablet by mouth every four \n(4) hours Disp #*60 Tablet Refills:*0\n9. TraMADOL (Ultram) 50 mg PO Q4H:PRN Pain \nRX *tramadol 50 mg 1 tablet by mouth every four (4) hours Disp \n#*60 Tablet Refills:*0\n10. Senna 8.6 mg PO BID constipation \nRX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day \nDisp #*60 Capsule Refills:*11\n11. Bisacodyl 10 mg PO DAILY \nRX *bisacodyl [Laxative] 5 mg 2 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*11\n12. Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*60 Capsule Refills:*11\n13. Polyethylene Glycol 17 g PO DAILY constipation \nRX *polyethylene glycol 3350 [Miralax] 17 gram/dose 17 gram by \nmouth daily Refills:*11\n14. Dexamethasone 4 mg PO Q12H Duration: 6 Doses \nStart: Today - ___, First Dose: Next Routine Administration \nTime \nThis is dose # 1 of 3 tapered doses\n15. Dexamethasone 2 mg PO Q12H Duration: 6 Doses \nStart: After 4 mg Q12H tapered dose \nThis is dose # 2 of 3 tapered doses\n16. Dexamethasone 2 mg PO DAILY Duration: 3 Doses \nStart: After 2 mg Q12H tapered dose \nThis is dose # 3 of 3 tapered doses\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n- Metastatic lung adenocarcinoma\n- Back pain secondary to metastatic disease\n- Urinary tract infection, complicated, E.Coli\n- Bacteremia, E.Coli\n- Constipation\n\nSecondary Diagnosis:\n- Hypothyroidism\n- Hyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted to ___ for \nsevere back pain and an undiagnosed lung mass. A biopsy of your \nlung showed adenocarcinoma, a type of lung cancer.\n\nYou had a MRI of your spine with showed tumor spread of your \ncancer to your spine, likely causing your symptoms. You received \nradiation treatment to your back in hope to releave some of your \nback pain. We also started you on new pain medications to \nalleviate your symptoms.  It can cause constipation so you were \ngiven bowel regimen medications.\n\nYou had an MRI of your head that showed a mass in your brain. It \nis uncertain if this is related to your cancer. You will need to \nhave repeat imaging of your head in 1 month to monitor this \nfinding.\n\nDuring your admission, you had a urinary tract infection which \nled to bacteria in your blood. You were started on antibiotics \nand will need to continue ciprofloxacin for 10 more days.\n\nYou will need to take dexamethasone (steroid) for 9 more days to \nprevent brain swelling. Please take 4mg twice a day for 3 days, \nthen 2mg (half tablet) twice a day for next 3 days, and then 2mg \n(half tablet) once a day for final 3 days.\n\nIt was a pleasure taking care of you,\n___\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13557562","hadm_id":"27642048","text":" \nName:  ___                       Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Allergies/ADRs on File\n \nAttending: ___\n \n___ Complaint:\nEncephalopathy, hypotension, tachycardia, fevers\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ is an ___ year-old ___ man with PMH of \nbladder cancer s/p radical cystectomy/ileal conduit at ___ on \n___, HTN who was sent in from ___ with AMS and fevers.  \n \nIn the ED, initial vitals:  T 102.2, HR 95, BP 142/60, RR 28, O2 \n98% RA\n- Exam notable for diffuse mild abdominal pain, bibasilar \ncrackles L\u003eR \n- Labs were notable for: WBC 15.2, Hgb 8.8, HCO3 16, Cr 2.1, AG \n17, lactate 1.0. UA +nitrites, \u003e182 WBCs, many bacteria, 100 \nprotein \n- Imaging:  CXR with patchy left base opacity, CT A/P with 6.0 x \n2.6 cm solid material intermixed with gas at site of cystectomy. \nSurgical material vs. feces. CT head with moderate global \ncerebral atrophy\n- Patient was given: 4L IVF, Vancomycin 1 g, cefepime 2g, \nstarted on norepinephrine for SBP ___ despite IVF with \nunchanged mental status\n- Consults: seen by urology who initially recommended transfer \nto ___ but ED was unable to arrange given pressor need.  Felt \nmass may be surgicell, sponge.  \n\nOn arrival to the MICU, he was rigoring, tachypneic to mid-high \n___, and having difficulty speaking to interpreter over phone. \nGiven respiratory distress decision was made to intubate after \ndiscussion with son ___, HCP listed in ___ records. \n \nREVIEW OF SYSTEMS:  \n(+) Per HPI  \n \nPast Medical History:\n- Recurrent bladder cancer: s/p cystectomy, prostatectomy, \nbilateral ureteral stents, bilateral pelvic lymph node \ndissection with ileal loop conduit ___. Pathology with high \ngrade invasive urothelial carcinoma of bladder, focal squamous \ndifferentiation. Papillary urothelial carcinoma. ___ lymph nodes \npositive. Ureters with urothelial atypia. Previously underwent \nGOLF chemotherapy and radiation therapy ___\n- Poorly differentiated gastric adenocarcinoma\n- ?metastastic liver disease: Previous lesions seen in ___, \nbut no definitive evidence of metastasis to solid organs of \nabdomen on CT ___\n- HTN\n- HLD\n- Gastric ulcer\n- Anemia\n- Vit B deficiency\n- Chronic hepatitis B\n- Renal cysts\n- Nephrolithiasis\n- Gout\n- Distal gastrectomy\n- Billroth II procedure for gastric cancer 1970s\n\n \nSocial History:\n___\nFamily History:\n- Unable to obtain on admission\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVITALS:  T 100.4, HR 89, BP 148/63, O2 100%\nGENERAL: Intubated sedated \nHEENT: PERRL, anicteric sclera, pink conjunctiva \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB anteriorly, mechanical breath sounds throughout \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding, no hepatosplenomegaly  \nEXTREMITIES: no cyanosis, clubbing or edema\nPULSES: 2+ DP pulses bilaterally  \nNEURO: Intubated and sedated \n\nDISCHARGE PHYSICAL EXAM: \nGen: 100% on shovel mask, T 97.5 Bp 118/69 HR 55 \nHEENT: MMM. \nLUNGS: CTAB\nHEART: RRR, no m/r/g\nABDOMEN: NTND, active bowel sounds. Ileal conduit in place with \nyellow urine, clear. \nLower Ext: No lower ext edema\nNeuro: No focal deficits. A\u0026Ox3. \n\n \n\n \nPertinent Results:\n________________________\nADMISSION LABS: \n___ 07:50PM BLOOD WBC-15.2* RBC-2.99* Hgb-8.8* Hct-27.4* \nMCV-92 MCH-29.4 MCHC-32.1 RDW-13.7 RDWSD-46.4* Plt ___\n___ 07:50PM BLOOD Neuts-84.4* Lymphs-6.3* Monos-8.4 \nEos-0.0* Baso-0.2 Im ___ AbsNeut-12.82* AbsLymp-0.95* \nAbsMono-1.27* AbsEos-0.00* AbsBaso-0.03\n___ 09:01PM BLOOD ___ PTT-29.6 ___\n___ 07:50PM BLOOD Glucose-128* UreaN-26* Creat-2.1* Na-133 \nCl-100 HCO3-16* AnGap-22*\n___ 03:57AM BLOOD ALT-41* AST-35 LD(LDH)-203 AlkPhos-337* \nDirBili-0.3\n___ 03:57AM BLOOD Albumin-2.8* Calcium-7.3* Phos-5.5* \nMg-1.8\n___ 03:57AM BLOOD Hapto-435*\n___ 04:07AM BLOOD Type-CENTRAL VE pO2-30* pCO2-44 pH-7.12* \ncalTCO2-15* Base XS--16\n________________________\nPERTINENT LABS: \n___ 07:50PM   PLT COUNT-348\n___ 07:50PM BLOOD Glucose-128* UreaN-26* Creat-2.1* Na-133 \nCl-100 HCO3-16* AnGap-22*\n___ 03:57AM BLOOD Glucose-156* UreaN-25* Creat-2.0* Na-140 \nK-5.8* Cl-110* HCO3-11* AnGap-25*\n___ 12:51PM BLOOD Glucose-113* UreaN-25* Creat-2.1* Na-140 \nK-4.6 Cl-112* HCO3-15* AnGap-18\n___ 04:07AM BLOOD Type-CENTRAL VE pO2-30* pCO2-44 pH-7.12* \ncalTCO2-15* Base XS--16\n___ 07:08AM BLOOD ___ pO2-40* pCO2-35 pH-7.28* \ncalTCO2-17* Base XS--9\n___ 01:36PM BLOOD ___ pO2-43* pCO2-29* pH-7.34* \ncalTCO2-16* Base XS--8\n___ 04:31AM BLOOD ___ pO2-46* pCO2-35 pH-7.30* \ncalTCO2-18* Base XS--7\n___ 08:03PM BLOOD Lactate-1.1 K-4.8\n___ 10:56PM BLOOD Lactate-1.0\n___ 04:07AM BLOOD Lactate-5.5*\n___ 07:08AM BLOOD Lactate-2.1* K-4.2\n________________________\nDISCHARGE LABS: \n___ 12:20PM BLOOD WBC-12.3* RBC-2.71* Hgb-7.8* Hct-24.9* \nMCV-92 MCH-28.8 MCHC-31.3* RDW-15.4 RDWSD-51.5* Plt ___\n___ 03:55AM BLOOD Neuts-87* Bands-2 Lymphs-4* Monos-6 Eos-0 \nBaso-1 ___ Myelos-0 AbsNeut-11.93* AbsLymp-0.54* \nAbsMono-0.80 AbsEos-0.00* AbsBaso-0.13*\n___ 03:55AM BLOOD ___ PTT-38.5* ___\n___ 03:55AM BLOOD ___\n___ 03:55AM BLOOD Ret Aut-1.2 Abs Ret-0.03\n___ 03:55AM BLOOD Glucose-115* UreaN-25* Creat-2.1* Na-140 \nK-4.8 Cl-112* HCO3-14* AnGap-19\n___ 03:55AM BLOOD ALT-28 AST-41* AlkPhos-230* TotBili-0.4\n___ 03:55AM BLOOD Calcium-7.6* Phos-3.6 Mg-1.9 Iron-11*\n___ 03:55AM BLOOD calTIBC-121* Hapto-372* Ferritn-346 \nTRF-93*\n___ 06:08AM BLOOD D-Dimer-5732*\n___ 04:31AM BLOOD ___ pO2-46* pCO2-35 pH-7.30* \ncalTCO2-18* Base XS--7\n___ 07:39AM BLOOD Lactate-1.0\n\nMICRO:\n___ 8:52 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( \u003e= 3 COLONY TYPES), CONSISTENT \nWITH FECAL\n      CONTAMINATION\n\nBCX X 2 (4 BOTTLES) ___, BCX X 1 (2 BOTTLES) ___ NGTD\n\nIMAGING:\nCXR ___\nPatchy left base opacity is nonspecific but could be due to \npneumonia in the appropriate clinical setting. \n\nCT ABD/PELVIS NON CON ___\nFinal Report \nINDICATION:  NO_PO contrast; History: ___ with abd pain, fever, \namsNO_PO \ncontrast  // intraabdominal infection \n  \nTECHNIQUE:  Multidetector CT images of the abdomen and pelvis \nwere acquired \nwithout intravenous contrast. Non-contrast scan has several \nlimitations in \ndetecting vascular and parenchymal organ abnormalities, \nincluding tumor \ndetection. \nOral contrast was not administered. \nCoronal and sagittal reformations were performed and reviewed on \nPACS. \n  \nDOSE:  Acquisition sequence: \n   1) Spiral Acquisition 5.0 s, 54.5 cm; CTDIvol = 13.4 mGy \n(Body) DLP = 730.8 \nmGy-cm. \n Total DLP (Body) = 731 mGy-cm. \n  \nCOMPARISON:  None. \n  \nFINDINGS:  \n  \nLOWER CHEST: No consolidation or mass is identified in bilateral \nlung bases.  \nAtelectasis is minimal. \n  \nABDOMEN: \n  \n  \nHEPATOBILIARY: Liver demonstrates homogeneous attenuation \nthroughout.  No \nfocal lesion is identified within the limits of unenhanced scan. \n Intra and \nextrahepatic bile ducts are not dilated.  Gallbladder is \nunremarkable. \n  \n  \nPANCREAS: Pancreas is homogeneous in attenuation throughout.  \nThere is no \npancreatic duct dilation. \n  \nSPLEEN: Spleen is not enlarged. \n  \nADRENALS: Left adrenal gland appears mildly thickened without \ndiscrete nodule. \nRight adrenal gland is unremarkable. \n  \nURINARY: Patient is post cystectomy and ileal conduit.  \nBilateral ureteral \nstents are in place.  There is no hydronephrosis.  Multiple \nrenal cysts are \nidentified in bilateral kidneys.  Largest cyst in the right \nkidney measures \n8.2 cm.  Largest cyst in the left kidney measures 7.1 cm. \n  \nGASTROINTESTINAL: Patient is post partial gastrectomy. Small and \nlarge bowel \nloops are normal caliber. Appendix is not visualized. \n  \nPELVIS: No free fluid is identified in the pelvis. 6.0 x 2.6 cm \nregion of \nmixed lucencies/gas in the deep pelvis (2:82).  It was later \ndiscovered that \npatient's surgery was 3 weeks prior, reported as ___, so \nthis finding \nmost likely represents surgicel. \n  \nLYMPH NODES: No pathologically enlarged lymph node is \nidentified.  Mild edema \nis noted. \n  \nVASCULAR: There is no abdominal aortic aneurysm.  Mild \nAtherosclerotic disease \nis noted. \n  \nBONES: L4 vertebral body compression deformity is likely \nchronic.  No \nsuspicious bone lesion is identified. \n  \nSOFT TISSUES:  There is diffuse subcutaneous tissue edema. \n  \nIMPRESSION: \n  \n  \n1. 6.0 x 2.6 cm region of possible material intermixed with gas \nis identified \nin the deep pelvis at the site of cystectomy.  Finding may \nreflect surgical \nmaterial (ie surgicel).  Please correlate with prior surgical \nhistory.  Please \nnote that after the original dictation of this report, it was \nreported that \nsurgicel was used during the surgical procedure \n\nCT HEAD ___. No acute intracranial process. \n2. Moderate global cerebral atrophy. \n3. Multifocal sinus disease, as above. \n\nREPEAT NON CON CT ABD/PELVIS ___\nEXAMINATION:  CT abdomen and pelvis with contrast. \n  \nINDICATION:  ___ year old man with hx urologic cancer s/p \ncystectomy, ileal \nconduit here w/sepsis  // Please obtain CT abdpelvis with PO and \nPR contrast \n(NOT IV) to evaluate for fluid collection; ?rectal perforation \n  \nTECHNIQUE:  CT ABDOMEN PELVIS WITHOUT CONTRAST \nOral and rectal contrast were administered. \nCoronal and sagittal reformations were performed and reviewed on \nPACS. \n  \nDOSE:  Found no primary dose record and no dose record stored \nwith the sibling \nof a split exam. \n!If this Fluency report was activated before the completion of \nthe dose \ntransmission, please reinsert the token called CT DLP Dose to \nload new data. \n  \nCOMPARISON:  CT abdomen pelvis from ___. \n  \nFINDINGS:  \n  \nLOWER CHEST: Trace bilateral pleural effusions with overlying \ncompressive \natelectasis.  Central line tip in the right atrium.  Heart is \nmildly enlarged, \nsimilar to prior. \n  \nABDOMEN: \n  \nHEPATOBILIARY: The liver demonstrates homogenous attenuation \nthroughout.  \nThere is no evidence of focal lesions.  There is no evidence of \nintrahepatic \nor extrahepatic biliary dilatation.  The gallbladder is mildly \ndistended.  No \npericholecystic fluid, gallbladder wall thickening or \ncholelithiasis. \n  \nPANCREAS: The pancreas has normal attenuation throughout, \nwithout evidence of \nfocal lesions or pancreatic ductal dilatation.  There is no \nperipancreatic \nstranding. \n  \nSPLEEN: The spleen shows normal size and attenuation throughout, \nwithout \nevidence of focal lesions. \n  \nADRENALS: Persistent mild thickening of the left adrenal gland.  \nThe right \nadrenal gland is normal. \n  \nURINARY:  Patient is post cystectomy and right lower quadrant \nileal conduit \nplacement. Bilateral ureteral stents are noted with the distal \nportion \nidentified within the ileal conduit in the right lower pelvis.  \nAdditional \npercutaneous catheters within right lower quadrant conduit.  \nThere is no \nhydronephrosis.  Bilateral renal cysts are identified, largest \nof which \nmeasures up to 8 cm within the interpolar region of the right \nkidney.  There \nis nonobstructing stone in the lower pole of the right kidney.  \nThere is no \nperinephric abnormality. \n  \nGASTROINTESTINAL:  Post partial gastrectomy, with an enteric \ntube present and \nits tip in the gastric body. Small bowel loops demonstrate \nnormal caliber, \nwall thickness, and enhancement throughout.  The colon is normal \nin caliber.  \nThe appendix is not visualized.  A rectal tube is present within \nthe lower \nrectum.  Again seen area within the lower pelvis containing \nmultiple foci of \nair/lucencies measuring approximately 13 x 62 mm, likely \nrepresents Surgicel \ngiven recent surgery.  Clinically correlate to exclude \ninfection.  There is no \ncontrast extravasation to suggest bowel perforation. \n  \nPELVIS: Post cystectomy and ileal conduit placement.  There is \nno free fluid \nin the pelvis. \n  \nREPRODUCTIVE ORGANS: The visualized reproductive organs are \nunremarkable. \n  \nLYMPH NODES: There is no retroperitoneal or mesenteric \nlymphadenopathy.  There \nis no pelvic or inguinal lymphadenopathy. \n  \nVASCULAR: There is no abdominal aortic aneurysm.  Mild \natherosclerotic disease \nis noted.  There is left femoral line tip seems to be posterior \nto the \nposterior wall of the left common iliac vein.  There is no \nadjacent hematoma. \n  \nBONES: There is no evidence of worrisome osseous lesions or \nacute fracture.  \nAn L4 vertebral body compression deformity is unchanged. \n  \nSOFT TISSUES:  There is diffuse anasarca. Bilateral fat \ncontaining inguinal \nhernias are present. \n  \nIMPRESSION: \n  \n  \n1. No evidence of contrast extravasation to suggest rectal \nperforation. \n2. Persistent 6 cm collection containing multiple lucent foci \nwithin the \nsurgical bed in the lower pelvis. This finding likely reflects \nSurgicel, given \nrecent surgical history.  Close clinical follow-up recommended \nto exclude \ninfection. \n3. Post cystectomy and ileal conduit placement.  No evidence of \nhydronephrosis. \n4. Left femoral catheter tip seems to be posterior to the left \ncommon iliac \nvein, no adjacent hematoma. \n\n \nBrief Hospital Course:\n___ is an ___ year-old ___ man with PMH of \nbladder cancer s/p radical cystectomy/ileal conduit at ___ on \n___, gastric adenocarcinoma, ?metastatic disease, HTN who was \nsent in from ___ with AMS and fevers, septic shock and material \nin pelvis of uncertain etiology (post surgical vs. fecal) \nintubated on arrival for respiratory distress, extubated on \n___, improving on antibiotics but with an unidentified source \nof infection still and then transferred to ___ \nwhich is his site of primary care. \n_____________________________\nICU COURSE (___):\n\n#SEPTIC SHOCK: \nPresented with fevers, AMS, hypotension requiring pressors \n(Levophed) and rising leukocytosis. Most likely urologic or \nintra-abdominal source. No cough prior to intubation despite \npatchy opacity in L lower lobe. Recent cystectomy at ___ with \nleukocytosis, fevers, AMS, UA c/f infection but to be expected \nwith new ileal conduit per urology. Per discussion with urology, \nnot clear that this is purely urologic source. S/p 4L NS IVF and \nvanc/cefepime in ED ___ ___. Lactate 5.5 initially in ICU. S/p 3 \nadditional L (1L NS, 2 L of LR) IVF in ICU and lactate improved \nto 2.1 by ___ @ 0700. Spoke to ___ about draining a fluid \ncollection around his surgicel in the abdomen at the site of his \ncystectomy, but they didn't feel that there was anything \ndrainable. Colorectal surgery recommended at CT A/P with rectal \ncontrast to look for rectal perforation as a source of \ninfection. The study was performed and there were no signs of \nperforation. The patient's fevers and hypotension continued \novernight despite continued treatment with Vancomycin and Zosyn. \nAt this point it was felt to be very unlikely that the fluid \ncollection was the source of infection given that the surgery \nwas weeks ago, and it would be odd for the collection to become \ninfected so far out. Urine culture was negative, so the \nkidneys/conduit were not felt to be a source. Bacterial \ntranslocation was considered as a possibility, though no blood \ncultures were positive at discharge. Because the patient was \nimproving clinically with stable hemodynamics and a lactate back \ndown to 1.0, ID felt that it was appropriate to stop micafungin \nand vancomycin and to just continue Zosyn. \n\nPressors at discharge: Levophed @ 0.08\n\n#RESPIRATORY FAILURE: \nIntubated on arrival to ICU for tachypnea ___, unable to speak \nin full sentences. CXR with patchy left base opacity but per \nreport no cough recently. Was on propofol/fentanyl for sedation, \npressure support ventilation, and extubated successfully on ___ \nAM. \n\n#COAGULOPATHY: \nINR 1.5 and PTT 51 from previously normal. Concern for DIC in \nsetting of septic shock, but platelet count was stable and \nfibrinogen was elevated. No evidence of hemolysis as haptoglobin \nwas elevated, LDH was low and Tbili was low. Likely secondary to \nthe patient's septic shock or antibiotic use, as his INR was 1.0 \non arrival so does not appear to be nutritional and there was no \nevidence of liver failure (His alkaline phosphatase was elevated \nand then came down with treatment, which was possibly from \ncholestasis of sepsis).\n\n#ACIDOSIS: \nInitially anion gap with a large base deficit, then non-anion \ngap. Felt to be a combination of the elevated lactate which was \nresolved and all of the chloride the patient received from \nnormal saline, causing a hyperchloremic acidosis (patients with \nileal conduits take up chloride in exchange for bicarb as the \nurine passes through). \n\n#BLADDER CANCER S/P RADICAL CYSTECTOMY: \nUnderwent procedure at ___ ___. Operative report in chart. \nUrology consulted and saw the patient in the ED, and their main \nrecommendations were to get colorectal surgery involved to \nevaluate for a bowel perforation. \n\n#ANEMIA: \nHgb 8.8 on admission, at previous baseline per ___ records. \nDropped to 6.7 on ___ AM. Looked dilution and gave 1U pRBC and \nthe patient responded appropriately to Hgb 7.8. \n\n#ACUTE KIDNEY INJURY: \nCr 2.1 on admission, baseline appears 1.2-1.3 per ___ records. \nLikely pre-renal component in setting of sepsis, although this \nmay be the patient's new baseline as he remained stable at Cr \n2.1. \n\n#CODE STATUS: Patient urgently intubated on admission with \nconsent from HCP who is the patient's son ___ \nlisted HCP) ___. Per code status conversation on \nadmission to ___, patient was DNR, OK to intubate. At \npreparation for discharge, code status was re-addressed with \nHCP, particularly in-relation to whether the patient would want \nre-intubation should he develop new respiratory distress. HCP \nwas undecided about code status and wanted to readdress with his \nfather. Therefore, code status upon transfer to ___ \n___ was FULL CODE as agreed by patient's HCP. \n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Pantoprazole 40 mg PO Q24H \n2. multivitamin with folic acid ___ mcg oral DAILY \n3. Allopurinol ___ mg PO DAILY \n4. Tenofovir Disoproxil (Viread) 300 mg PO Q48H \n5. Ondansetron 4 mg PO Q8H:PRN nausea \n6. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate \n\n\n \nDischarge Medications:\n1.  Heparin 5000 UNIT SC BID  \n2.  NORepinephrine 0.03-0.42 mcg/kg/min IV DRIP TITRATE TO MAP \u003e \n65  \n3.  Piperacillin-Tazobactam 2.25 g IV Q6H  \n4.  Tenofovir Disoproxil (Viread) 300 mg PO Q48H  \n5. HELD- Allopurinol ___ mg PO DAILY  This medication was held. \nDo not restart Allopurinol until you discuss with your doctors \nat ___. \n6. HELD- multivitamin with folic acid ___ mcg oral DAILY  This \nmedication was held. Do not restart multivitamin with folic acid \nuntil you discuss with your doctors at ___. \n7. HELD- Ondansetron 4 mg PO Q8H:PRN nausea  This medication was \nheld. Do not restart Ondansetron until you discuss with your \ndoctors at ___. \n8. HELD- OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate  This medication was held. Do not restart OxyCODONE \n(Immediate Release) until you discuss with your doctors at \n___. \n9. HELD- Pantoprazole 40 mg PO Q24H  This medication was held. \nDo not restart Pantoprazole until you discuss with your doctors \nat ___. \n\n \nDischarge Disposition:\nExtended Care\n \nDischarge Diagnosis:\nPrimary: \n- Septic shock\n- Respiratory failure\n- Metabolic acidosis\n- Coagulopathy\n- Anemia\n- Acute Kidney Injury\n\nSecondary: \n- History of gastric cancer\n- Bladder cancer s/p cystectomy\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to ___ because you had fevers, were \nconfused, were unable to breath well and your blood pressure was \nvery low. \n\nIn the ICU (intensive care unit) the following was done for you:\n- You were put on a breathing machine until you were able to \nbreath on your own\n- You were given medications to keep your blood pressure from \ndropping too low so that your organs still received enough \noxygen to stay alive\n- You were treated with antibiotics\n- Tests were done to look for a source of infection, but no \nobvious infection was found\n\nWe are transferring you to ___ where you \nusually get your medical care, and they will continue to care \nfor you.\n\nWe wish you all the best!\nYour ___ Team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15868868","hadm_id":"21670040","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ man with a history of recurrent aspirations, \nmultiple\nadmissions for aspiration pneumonia, atrial fibrillation status\npost watchman implant, essential tremor and chronic diastolic\nheart failure who presents for recurrent episode of aspiration \nat\nhome.  Of note the patient was last admitted in ___ \nand\ndischarged on ___ ___t home and course\ncomplicated by recurrent aspiration pneumonia while in-house.\n\nThe patient indicates that he has been his usual health, feeling\nwell and had no complaints up until yesterday.  In fact he\nindicates that yesterday he was shopping, driving his car and\noverall felt well.  He notes that around 11 ___ last night he\nstarted having chills, cold sensation and restlessness.  He went\nto bed but he was awake most of the night feeling weak, short of\nbreath and generally unwell.  He was unable to get up to go to\nthe bathroom in fact he soiled himself multiple times as result\nof this.  By the time morning came around he was so fatigued he\nis unable to get out of bed and had developed a fever, chills \nand\ndiaphoresis at that point in time.  He uses medical alert\nbracelet and called an ambulance.\n \nIn the ___, initial vitals were:  99.5 120 122/49 18 81% RA.  \nExam\nwas notable for somewhat distress and otherwise normal \nneurologic\nexam.  Respiratory exam is not documented in the ___ note.  Labs\nwere notable for profound leukocytosis to 25.8 with predominant\nneutrophils.  Otherwise metabolic panel was largely stable and a\nlactate of 2.2.  Flu swab was negative.  Chest x-ray was \nobtained\nand was concerning for acute aspiration pneumonia.  She was\ntreated with IV vancomycin and Pipracil and tazobactam and\nadmission were requested to medicine.  While the patient was in\nthe emergency department he had acute episode of hypotension \nwith\nblood pressure of 87/38.  He received 1 L of IV fluid bolus and\nhis blood pressure promptly responded to 112/54 and improvement\nin heart rate to the ___.\n \nOn the floor, the patient indicates he feels markedly improved\nfrom prior.  His breathing is comfortable he denies orthopnea,\nPND, cough, sputum production.  He indicates that he has\nrecurrent episodes of aspiration like this and always he\nrebounded quite quickly.  He denies any current fevers, chills,\ndiaphoresis.  He denies any nausea, vomiting, diarrhea.\n \nReview of systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or\ngain. Denies headache, sinus tenderness, rhinorrhea or\ncongestion. Denies cough, shortness of breath. Denies chest pain\nor tightness, palpitations. Denies nausea, vomiting, diarrhea,\nconstipation or abdominal pain. No recent change in bowel or\nbladder habits. No dysuria. Denies arthralgias or myalgias.\nOtherwise ROS is negative.\n \nPast Medical History:\n-Atrial fibrillation, off anticoagulation, now being monitored\nfor atrial fibrillation burden with watchman device\n-Prostate cancer\n-History of GI bleeds, AVM and terminal ileum\n-Chronic diastolic heart failure\n-Essential tremor, movement disorder-pending workup\n-Chronic recurrent aspiration events on a nectar thickened diet\n \nSocial History:\n___\nFamily History:\nMother with heart disease\n \nPhysical Exam:\nAdmission Exam:\nVitals: 98.2 PO122 / 81 R Lying 69 18 96 4L \nPain Scale: ___ \nGeneral: Patient appears overall well and robust when\nencountered.  He is in good humor, pleasant and appropriate. \nAlert, oriented and in no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP low, no LAD appreciated\nLungs: Clear to auscultation on the right, moving air well, only\nvery faint rales predominantly on the left side with reduced\nbreath sounds over the left  \nCV: Regular rate and rhythm, S1 and S2 clear and of good \nquality,\nno murmurs.  ___ murmur right upper sternal border\nAbdomen: soft, non-tender, non-distended, normoactive bowel\nsounds throughout, no rebound or guarding\nExt: Warm, well perfused, full distal pulses, no clubbing,\ncyanosis or edema    \nNeuro: CN2-12 grossly in tact, motor and sensory function \ngrossly\nintact in bilateral UE and ___, symmetric.  Mild essential tremor\nincluding of his jaw at rest.\n\nDischarge Exam:\n___ 1124 Temp: 97.6 PO BP: 112/66 HR: 74 RR: 18 O2 sat: 95% \nO2 delivery: RA\nAOx3\nLungs CTAB, moving air well and symmetrically\nAmbulatory saturations 95-96% on RA\n \nPertinent Results:\nAdmission Labs\n___ 04:15AM BLOOD WBC-25.8* RBC-4.43* Hgb-11.5* Hct-38.2* \nMCV-86 MCH-26.0 MCHC-30.1* RDW-16.3* RDWSD-51.1* Plt ___\n___ 04:15AM BLOOD Neuts-89.3* Lymphs-3.0* Monos-6.4 \nEos-0.0* Baso-0.3 NRBC-0.2* Im ___ AbsNeut-22.98* \nAbsLymp-0.78* AbsMono-1.66* AbsEos-0.01* AbsBaso-0.07\n___ 04:15AM BLOOD Glucose-111* UreaN-27* Creat-1.2 Na-143 \nK-3.8 Cl-102 HCO3-25 AnGap-16\n___ 04:15AM BLOOD ALT-25 AST-45* AlkPhos-117 TotBili-1.6*\n___ 04:15AM BLOOD Lipase-29\n___ 04:15AM BLOOD cTropnT-\u003c0.01\n___ 04:15AM BLOOD Albumin-4.2 Calcium-9.1 Phos-2.4* Mg-1.7\n\nDischarge Labs:\n___ 07:55AM BLOOD WBC-13.0* RBC-3.49* Hgb-8.9* Hct-30.6* \nMCV-88 MCH-25.5* MCHC-29.1* RDW-16.7* RDWSD-53.4* Plt ___\n \nImaging:\nLarge opacification along the left middle and lower lung field \nwith corollary on lateral consistent with lingular and left \nlower lobe pneumonia.  Likely small left parapneumonic effusion.\n \n \nBrief Hospital Course:\n___ is a ___ male with a history of recurrent aspiration \nevents who presented with signs and symptoms of recurrent \naspiration pneumonia.\n    \n#Hypoxemic respiratory failure: Requiring up to 6 L nasal \ncannula in the emergency department \n#Acute aspiration pneumonia:\n#Acute aspiration pneumonitis:\n#Recurrent and chronic aspirations\nPatient presented with acute onset of respiratory failure after \nfeeling his usual self and demonstrated prompt improvement back \nto normal within 24 hours. Picture most likely repreesnts acute \naspiration pneumonitis.  He was also has weaned to RA within 24 \nhours of admission. Typically this would not require antibiotics \nbut given the extensive infiltrate seen on chest x-ray with \nassociated effusion as well as a white count of 26,000 with \nassociated predominant PMNs and given his history of prior \npneumonias elected to treat for CA-PNA with antibiotics.  ___ \nMD comments did make note of possible episode of VT seeing on \ntelemetry and possible prolonged QT though this was not captured \non EKG and EKG performed on arrival to the floor with a QT of \n430.  Patient is also not on any current QT prolonging agents \nand did receive levofloxacin in the past without issue.  Repeat \nEKG morning of discharge was unchanged from prior still with QTc \nof \u003c430 while on the quinolone. Discharged to complete 5 day \ncourse of Levofloxacin\n  \n#Benign essential tremor:\n#Movement disorder:\nChronic, stable continued primidone, propanolol\n  \n#Chronic atrial fibrillation, status post watchman implant, no\nlonger an anticoagulation. Chronic, stable continued propanolol\n\n#GERD:\nChronic, stable, continued pantoprazole\n\n#Neuropathy:\nChronic, stable, continued gabapentin\n\n#Chronic diastolic CHF: LVEF greater than 55%, chronic, stable \nwithout evidence of volume overload during inpatient stay. \nContinued home furosemide\n  \n\nTransitional issues:\n- DNaR/OKInt for short term. Patient is clear he would not want \nprolonged intubation or life-sustaining measures\n- HCP: ___ ___ friend/HCP\n- Should continue to work with SLS to reduce risk of aspiration \nevents\n- Diet: Regular with nectar thickened liquids\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 325 mg PO DAILY \n2. Atorvastatin 80 mg PO QPM \n3. Ferrous Sulfate 325 mg PO DAILY \n4. Furosemide 20 mg PO DAILY \n5. Gabapentin 200 mg PO TID \n6. Multivitamins 1 TAB PO DAILY \n7. Pantoprazole 40 mg PO Q24H \n8. PrimiDONE 125 mg PO BID \n9. Propranolol LA 60 mg PO DAILY \n10. Vitamin D 1000 UNIT PO DAILY \n11. Glucosamine (glucosamine sulfate) 1000 mg oral BID \n\n \nDischarge Medications:\n1.  Levofloxacin 750 mg PO DAILY \nRX *levofloxacin 750 mg 1 tablet(s) by mouth Daily Disp #*4 \nTablet Refills:*0 \n2.  Aspirin 325 mg PO DAILY  \n3.  Atorvastatin 80 mg PO QPM  \n4.  Ferrous Sulfate 325 mg PO DAILY  \n5.  Furosemide 20 mg PO DAILY  \n6.  Gabapentin 200 mg PO TID  \n7.  Glucosamine (glucosamine sulfate) 1000 mg oral BID  \n8.  Multivitamins 1 TAB PO DAILY  \n9.  Pantoprazole 40 mg PO Q24H  \n10.  PrimiDONE 125 mg PO BID  \n11.  Propranolol LA 60 mg PO DAILY  \n12.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nActive:\nAcute aspiration pneumonia\nAcute hypoxemic respiratory failure\nCan be acquired pneumonia\n\nChronic:\nEssential tremor\nChronic diastolic heart failure\nAtrial fibrillation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr ___,\n    \nIt was a pleasure caring for you during this hospitalization.  \nYou admitted to ___ with acute \nonset shortness of breath, cough, fever and chills.  This is all \nthought related to acute aspiration pneumonia.  You promptly \nimproved in your breathing and resolution of fevers.  You are \nbeing treated for possible bacterial pneumonia with levofloxacin \nand should complete a 5 day total course of this medication.\n\nThere is a pleasure caring for you during her stay, her \n___ medical team at ___\n \nFollowup Instructions:\n___\n"}
{"subject_id":"13744125","hadm_id":"27509449","text":" \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\nshortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___, nonsmoker, history of asthma, initially presented to PCPs \noffice with ___ right sided nonradiating pleuritic chest pain \nworsened with inspiration and was alleviated with rest that she \nnoticed soon after the ___.  This pain was \nassociated with SOB and she tried her asthma inhalers without \nrelief.  She denies any objective fevers, but did have night \nsweats, chills, headache and change in appetite.  She denies any \nchest pain, abdominal pain, nausea, vomiting, diarrhea, or leg \npain.\n.\nGiven concern for possible PE, she was sent to the ED were \nworkup consisted of a negative CTA, although CXR and CT Chest \nrevealed a RLL pneumonia.  She was given fluids and started on \nLevofloxacin IV.\n \nPast Medical History:\nAsthma - on singulair and advair\nLow Back Pain - Sees ___ pain clinic and has received epidural \ninjections\nHyperlipidemia\nL Knee pain - s/p Bilateral knee replacements\nDepression - follows with Psych\ns/p laparoscopic sigmoidectomy/rectopexy for rectal prolapse \n___\n \nSocial History:\n___\nFamily History:\nmother-polymyalgia ___\nfather: died of stomach cancer\naunt: died of stomach cancer\n \nPhysical Exam:\nVitals - T:99.7  BP:115/68  HR:105  RR:16  02 sat: 96RA  \nGENERAL: NAD, alert and oriented x 3\nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\nHEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, \npatent nares, dry MM, good dentition, nontender supple neck, no \nLAD, no JVD\nCARDIAC: RRR, S1/S2, no mrg\nLUNG: slight crackles in RLL field, no adventitious sounds\nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding, no hepatosplenomegaly\nM/S: moving all extremities well, no cyanosis, clubbing or \nedema, no obvious deformities\nPULSES: 2+ DP pulses bilaterally\nNEURO: CN II-XII intact\n\n \nPertinent Results:\n___ 11:20AM BLOOD WBC-11.7*# RBC-3.97* Hgb-12.9 Hct-38.0 \nMCV-96 MCH-32.3* MCHC-33.8 RDW-12.6 Plt ___\n___ 05:25AM BLOOD WBC-10.3 RBC-3.66* Hgb-11.9* Hct-35.3* \nMCV-97 MCH-32.6* MCHC-33.7 RDW-12.8 Plt ___\n___ 11:20AM BLOOD Neuts-82.2* Lymphs-11.1* Monos-5.3 \nEos-1.0 Baso-0.5\n___ 11:20AM BLOOD ___ PTT-27.1 ___\n___ 11:20AM BLOOD Glucose-88 UreaN-13 Creat-0.8 Na-137 \nK-4.1 Cl-101 HCO3-26 AnGap-14\n___ 05:25AM BLOOD Glucose-77 UreaN-7 Creat-0.7 Na-143 K-4.5 \nCl-111* HCO3-25 AnGap-12\n___ 11:20AM BLOOD CK(CPK)-180*\n___ 11:20AM BLOOD CK-MB-3\n___ 11:20AM BLOOD cTropnT-\u003c0.01\n___ 08:10PM BLOOD CK-MB-3 cTropnT-\u003c0.01\n___ 05:25AM BLOOD Calcium-8.5 Phos-3.6 Mg-2.2\n___ 03:27PM BLOOD Lactate-0.6\n.\nMicro: \nBlood culture (___): Pending.\n.\nCXR (___): Right lower lobe pneumonia. Recommend followup \nto clearance.\n.\nCTA Chest (___): 1. No evidence of pulmonary embolism. 2. \nFocal right lower lobe infiltrate consistent with infectious \netiology, please follow-up to clearance. 3. Asymetric the right \nbreast tissue. Please correlate clinically, and mammography can \nbe obtained as clinically indicated. \n \nBrief Hospital Course:\nThe patient presented with complaints of chest pain. EKG showed \nno abnormalities. Labs were remarkable for a mild leukocytosis. \nShe had 2 sets of negative cardiac enzymes and a CTA negative \nfor PE but notable for a right lower lobe pneumonia also seen on \nCXR. The patient was started on levofloxacin with improvement in \nWBC to normal within 24 hours and was discharged on a 7 day \ncourse of this antibiotic. The patient should have repeat CXR in \napproximately 6 weeks time to monitor for resolution.\n\nIncidental note was made on CT of asymmetric right breast tissue \nof unclear significance. She should undergo outpatient breast \nexam and mammography in accordance with her age.\n\nThe patient continued on her home pain regimen while in the \nhospital.\n \nMedications on Admission:\nCELECOXIB [CELEBREX] -  (Recording only) - 200 mg Capsule - i\nCapsule(s) by mouth once a day\nFENTANYL -  (Prescribed by Other Provider; Dose adjustment - no\nnew Rx) - 100 mcg/hour Patch 72 hr -  every 48hours\nFLUTICASONE [FLONASE] -  (Recording only) - 50 mcg Spray,\nSuspension - ii puffs intranasal qd right and left\nFLUTICASONE [FLOVENT HFA] - 110 mcg/Actuation Aerosol - ii puffs\nih twice a day\nLEVOTHYROXINE -  (Prescribed by Other Provider) - 100 mcg Tablet \n-\n1 (One) Tablet(s) by mouth once a day\nMETHYLPHENIDATE [RITALIN] -  (Prescribed by Other Provider) - 20\nmg Tablet - 1 (One) Tablet(s) by mouth three times a day\nMONTELUKAST [SINGULAIR] -  (Recording) - 10 mg Tablet - i\nTablet(s) by mouth once a day\nOXYCODONE -  (Prescribed by Other Provider) - 5 mg Tablet - ___\n(Two) Tablet(s) by mouth every four hours as needed\nPOLYETHYLENE GLYCOL 3350 [MIRALAX] - 100 % Powder - 17 gm by\nmouth at bedtime\nVENLAFAXINE [EFFEXOR XR] -  (Prescribed by Other Provider) - 150\nmg Capsule, Sust. Release 24 hr - 2 Capsule(s) by mouth once a\nday\nZIPRASIDONE HCL [GEODON] -  (Prescribed by Other Provider) - 40\nmg Capsule - 1 (One) Capsule(s) by mouth four times a day\nZONISAMIDE -  (Prescribed by Other Provider) - 100 mg Capsule - \n2\n(Two) Capsule(s) by mouth twice a day\n \nMedications - OTC\nCALCIUM-CHOLECALCIFEROL (D3) [CALCIUM 600 + D(3)] -  (OTC) - 600\nmg-400 unit Tablet - i Tablet(s) by mouth twice a day\nSENNOSIDES-DOCUSATE SODIUM [___] -  (Recording only) -\n8.6 mg-50 mg Tablet - iii Tablet(s) by mouth once a day\n \nDischarge Medications:\n1. Celecoxib 200 mg Capsule Sig: One (1) Capsule PO qd ().  \n2. Fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr \nTransdermal Q48H (every 48 hours).  \n3. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n4. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).  \n5. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Methylphenidate 10 mg Tablet Sig: Two (2) Tablet PO TID (3 \ntimes a day).  \n7. Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n8. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 \nhours) as needed.  \n9. Polyethylene Glycol 3350 100 % Powder Sig: One (1)  PO QHS \n(once a day (at bedtime)).  \n10. Venlafaxine 75 mg Capsule, Sust. Release 24 hr Sig: Four (4) \nCapsule, Sust. Release 24 hr PO DAILY (Daily).  \n11. Ziprasidone HCl 40 mg Capsule Sig: One (1) Capsule PO four \ntimes a day.  \n12. Zonisamide 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n13. Levofloxacin 250 mg Tablet Sig: Three (3) Tablet PO Q24H \n(every 24 hours) for 6 days.\nDisp:*18 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPneumonia\n\nChronic pain\nDepression\nAsthma\nHyperlipidemia\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nYou were admitted with a pneumonia. Please complete a course of \nantibiotics as prescribed to treat this problem. You should also \nhave a repeat chest x-ray in 6 weeks to further evaluate for \nresolution of this problem.\n\nFollow-up in your primary care doctor's office.\n\nCall your doctor or return to the hospital for any new or \nworsening fevers, chills, nightsweats, nausea, vomiting or any \nother concerning symptoms.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12882985","hadm_id":"23128275","text":" \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nBactrim DS / Levaquin / Vancomycin Hcl / Dilantin Kapseal / \nKeflex / Ciprofloxacin / Baclofen / Detrol / lisinopril / \noxybutynin / Zosyn / cefepime / pistachio / linezolid / \nazithromycin / fosfomycin\n \nAttending: ___\n \nChief Complaint:\nAbdominal pain, chills \n \nMajor Surgical or Invasive Procedure:\nNone \n\n \nHistory of Present Illness:\n___ with a PMH of polysubstance use disorder, MVC ___ c/b T12\nparaplegia, recurrent sacral/trochanteric decubitus ulcers,\nneurogenic bladder, recurrent UTIs, obstructive uropathy/CKD,\nileal conduit urinary diversion c/b L anastomotic stricture\nrequiring L indwelling PCN (___), ESRD on HD who presents w/\nLUQ pain found to have urinary tract infection. \n\nHe presents with L sided chest/abdominal pain that has been\non/off since his last discharge. Unclear history of\nprovoking/palliating factors, but deep breaths and movement may\nmake it worse. Denies f/c at home, SOB, cough, other chest pain,\nN/V, his typical UTI sx though difficult to tell iso his\ncomplicated history. has been having loose BMs one per day\n\nOf note patient has had multiple recent admissions for urinary\ntract infections. Most recently here from ___ with ___ \nurine\nculture growing pan-sensitive  E.coli, urine culture ___ growing\nVRE. S/p 2 week course of fosfomycin Q72H, last day ___. In the\npast has grown MDR pseudomonas (last ___. Was also admitted\n___ with urine growing pan-sensitive klebsiella but he\nwas treated with IV meropenem for 2 weeks.\n\nIn the ED:\n- Initial vital signs were notable for: 100.5 ___ 17 99%\nRA \n- Exam notable for: TTP in L chest wall (reproduces his pain)\nwithout overlying ecchymosis. soft, TTP in LLQ, 1+ ___ worse on \nL\nthan R (chronic per pt)\n- Labs were notable for: WBC of 12.2, Hb 7.6, UA with 12 WBCs \nand\nmany bacteria.\n- Studies performed include: CXR: No acute cardiopulmonary\nprocess. Patient declined CT A/P.\n- Patient was given: Meropenem, oxycodone 60mg for pain\n- Consults: Case was discussed with ID and he was transitioned \nto\nMeropenem \n\nVitals on transfer: 98.8 67 183/86 14 98% RA \n\nUpon arrival to the floor, patient acting paranoid.\nConfrontational with staff and refusing medical \ntreatment/diagnostic tests. Endorsing auditory hallucinations \nand states that he feels mentally unwell. Initially refusing to \nstay in room, but later returning to room. \n\n \nPast Medical History:\nPAST MEDICAL HISTORY\n====================\n- T12 paraplegia s/p spinal fusion/rod placement after car\naccident ___ c/b neurogenic bladder\n- Neurogenic bladder s/p ileal conduct urinary diversion \n(___)\nc/b L anastomotic stricture requiring chronic indwelling PCN\n___, stent replaced q3months\n- Multiple admissions for recurrent UTI/pyelonephritis growing\nMDR organisms (E. Coli, K. pneumoniae)\n- Recurrent sacral and trochanteric decubitus ulcers s/p\ndebridement and advancement flaps (most recently ___\n- L proximal tibia and fibula fracture ___ \n- Hx R foot cellulitis with R lateral malleolus pressure ulcer\n___, right great to patient amputation ___\n- Hx R hip osteomyelitis\n- H/o c. diff colitis\n- Seizure disorder\n- Chronic pain\n- DJD shoulders/hips\n- GERD\n- Anxiety\n- Hx substance abuse \n- HTN\n- Depression \n- Anemia of chronic disease\n \nSocial History:\n___\nFamily History:\nMother- NHL\nSister- uterine cancer\nFather- fungal infection\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n=========================\nVITALS: 24 HR Data (last updated ___ @ 1637)\n    Temp: 99 (Tm 99.9), BP: 182/95 (182-195/85-114), HR: 122\n(93-142), RR: 18, O2 sat: 97% (96-99), O2 delivery: Ra  \nGEN: Sitting up in wheelchair, moderately anxious. \nNECK: no JVD\nCARD: Tachycardic, regular, S1 + S2 present, SEM loudest at apex\nand radiating to L. axilla \nRESP: CTAB, no wheezes/crackles, breathing comfortably on RA\nABD: Soft, non-distended, moderate LUQ TTP with guarding\nBACK: Left flank PCN in place w/o pain or erythema \nGU: L PCN draining yellow urine, RLQ ostomy in place with dark\nyellow urine \nEXT: WWP, trace ___ edema, rotated (baseline per pt)\nSKIN: L dorsal foot wrapped in gauze \nNEURO: AOx3, ___ UE strength\n\nDISCHARGE PHYSICAL EXAM: \n=========================\nVitals ___ 1130 Temp: 98.2 PO BP: 145/90 R Sitting HR: 86\nRR: 18 O2 sat: 97% O2 delivery: Ra \nGEN: Sitting in wheelchair, cooperative with exam, not agitated.\nCARD: Regular rate and rhythm, no murmurs rubs or gallops\nRESP: On room air, no difficulty breathing, lungs clear to\nauscultation bilaterally, no crackles, wheezing, or\nrhonchi.\nABD: Nondistended, slightly tender to palpation in the left \nlower\nquadrant, no rebound, no guarding.\nGU: L PCN draining yellow urine, RLQ ostomy in place. \nEXT: WWP, no ___ edema\nNEURO: AOx3\n \nPertinent Results:\nADMISSION LABS\n===============\n___ 06:22AM BLOOD WBC-12.2* RBC-2.38* Hgb-7.6* Hct-22.8* \nMCV-96 MCH-31.9 MCHC-33.3 RDW-14.4 RDWSD-49.7* Plt ___\n___ 06:22AM BLOOD Neuts-69.8 ___ Monos-7.5 Eos-2.5 \nBaso-0.2 Im ___ AbsNeut-8.52* AbsLymp-2.36 AbsMono-0.92* \nAbsEos-0.31 AbsBaso-0.03\n___ 06:22AM BLOOD ___ PTT-26.8 ___\n___ 06:22AM BLOOD Glucose-115* UreaN-50* Creat-4.7* Na-142 \nK-4.4 Cl-105 HCO3-19* AnGap-18\n___ 06:22AM BLOOD ALT-10 AST-11 AlkPhos-105 TotBili-0.2\n___ 06:22AM BLOOD CK-MB-2 cTropnT-\u003c0.01\n___ 06:22AM BLOOD Albumin-4.4 Calcium-8.3* Phos-3.6 Mg-1.6\n___ 10:25AM BLOOD Triglyc-315* HDL-44 CHOL/HD-4.3 \nLDLcalc-83\n___ 06:22AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG\n___ 06:22AM BLOOD ASA-NEG Acetmnp-NEG Tricycl-NEG\n___ 06:22AM BLOOD Lactate-0.8\n\nINTERVAL LABS\n=============\n___ 06:20AM BLOOD ALT-28 AST-31 LD(LDH)-177 AlkPhos-117 \nTotBili-\u003c0.2\n___ 06:22AM BLOOD CK-MB-2 cTropnT-\u003c0.01\n___ 06:22AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG\n___ 10:25AM BLOOD Triglyc-315* HDL-44 CHOL/HD-4.3 \nLDLcalc-83\n___ 06:22AM BLOOD ASA-NEG Acetmnp-NEG Tricycl-NEG\n___ 03:45PM BLOOD Ethanol-NEG\n___ 06:47AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n\nDISCHARGE LABS\n===============\n___ 12:00PM BLOOD WBC-8.7 RBC-2.27* Hgb-7.4* Hct-23.0* \nMCV-101* MCH-32.6* MCHC-32.2 RDW-13.7 RDWSD-50.6* Plt ___\n___ 12:00PM BLOOD Glucose-133* UreaN-83* Creat-3.7* Na-135 \nK-5.2 Cl-99 HCO3-21* AnGap-15\n___ 12:00PM BLOOD Calcium-8.1* Phos-5.8* Mg-1.8\n\nIMAGING/STUDIES\n=================\n___ US \n1. No sonographic explanation for abdominal pain identified.  \nNote is made a fluid-filled distended stomach is visualized.  \nThis is not surprising given that the patient reported recently \ndrinking water just before the exam. \n2. Splenic size is within the upper limits of normal.  No \nsplenic abscess is seen.\n3. Stable mild right-sided hydronephrosis.  Atrophic kidneys \nwith echogenic\nappearance of the renal cortex bilaterally consistent with \nunderlying medical renal disease.\n\n___ (SUPINE ONLY)\n\n1.  No radiographic evidence of small bowel obstruction or \nileus.\n2.  Large stool burden within the colon.\n\n___ ABD \u0026 PELVIS W/O CON\n\n1.  No evidence of left upper quadrant pathology.  The spleen is \nnormal in\nappearance, allowing for the limitations of a noncontrast study.\n2.  Large stool burden within the colon. Unremarkable bowel with \nno dilatation or wall thickening.\n3.  Mild fullness of the right renal calyces and right ureter in \na patient\nwith ileal conduit.\n\nMICROBIOLOGY\n==============\n_________________________________________________________\n___ 3:12 pm URINE      Source: Catheter. \n\n   URINE CULTURE (Preliminary): \n      GRAM NEGATIVE ROD(S).    \u003e100,000 CFU/mL. \n      GRAM NEGATIVE ROD #2.    \u003e100,000 CFU/mL. \n__________________________________________________________\n___ 10:08 am URINE      Source: Catheter. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      ENTEROBACTER CLOACAE COMPLEX.    \u003e100,000 CFU/mL. \n         This organism may develop resistance to third \ngeneration\n         cephalosporins during prolonged therapy. Therefore, \nisolates that\n         are initially susceptible may become resistant within \nthree to\n         four days after initiation of therapy.  For serious \ninfections,\n         repeat culture and sensitivity testing may therefore be \nwarranted\n         if third generation cephalosporins were used. \n         FOSFOMYCIN  Susceptibility testing requested per ___. \n___\n         ___ ON ___ (___). \n         ZONE SIZE FOR Fosfomycin IS 18MM Zone size determined \nusing a\n         method that has not been standardized for this \ndrug-organism\n         combination and for which no CLSI or FDA-approved \ninterpretative\n         standards exist. Interpretive results for fosfomycin \nexist only\n         for E. coli, for which zone sizes of \u003c16 are classified \nas\n         non-susceptible. Interpret results with caution.. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ENTEROBACTER CLOACAE COMPLEX\n                             |   \nCEFEPIME--------------   \u003c=1 S\nCEFTAZIDIME-----------   \u003c=1 S\nCEFTRIAXONE-----------   \u003c=1 S\nCIPROFLOXACIN---------\u003c=0.25 S\nGENTAMICIN------------   \u003c=1 S\nMEROPENEM-------------\u003c=0.25 S\nNITROFURANTOIN--------    64 I\nPIPERACILLIN/TAZO-----   \u003c=4 S\nTOBRAMYCIN------------   \u003c=1 S\nTRIMETHOPRIM/SULFA----   \u003c=1 S\n__________________________________________________________\n___ 1:13 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 6:40 am BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 6:20 am BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\n \nBrief Hospital Course:\nPATIENT SUMMARY\n==================\n___ with a PMH of polysubstance use disorder, MVA ___ c/b T12 \nparaplegia, recurrent sacral/trochanteric decubitus ulcers, \nneurogenic bladder, recurrent UTIs, obstructive uropathy/CKD, \nileal conduit urinary diversion c/b L anastomotic stricture \nrequiring L indwelling PCN (___), ESRD on HD who presents w/ \nLUQ pain, found to be febrile with leukocytosis and tachycardia, \ninitially concerning for UTI.\n\nACUTE ISSUES\n===============\n# Leukocytosis\n# Fevers\nPatient presenting with fevers, leukocytosis and LUQ pain found \nto have bacteria and WBCs on UA. Patient has history of \nrecurrent urinary tract infections in setting of ileal conduit \nurinary diversion c/b L anastomotic stricture requiring L \nindwelling PCN (___). His recent urine cultures grew \npan-sensitive Klebsiella on ___, pan-sensitive E. Coli on ___, \nVRE on ___. He grew MDR pseudomonas in ___. He was most \nrecently treated with fosfomycin Q72 hours last dose on ___. He \nwas planning to follow up with ID to discuss suppressive \ntherapy, but he did not make it to appointment. Case discussed \nwith ID in ED and they recommended Meropenem given multiple \nmedication allergies and history of resistant infections in the \npast. Urine culture with colonic bacteria (sample likely taken \nfrom ostomy). Discussed revision of L ureteral stenosis w/ \nurology as frequency of UTIs has increased; however, patient \ndoes not want to pursue any surgical management, therefore \nurology signed off. ID consulted and did not feel picture was \nc/w UTI. Meropenem was stopped and patient watched off ABx. \nLeukocytosis and fevers resolved, but patient again became \nfebrile and developed leukocytosis on ___, this time with 127 \nWBC in urine that also grew enterobacter cloacae. Patient was \ntreated with fosfomycin, and then was started on fosfomycin \nprophylactic treatment on ___. \n\n# Bacteruria\nPatient chronically colonized, likely due to complex renal \nanatomy of ileal conduit and PCN. Patient was started on \nfosfomycin prophylaxis this hospitalization, and asymptomatic \nbacteruria does not require treatment. \n\n# Paranoia, hallucinations, delusions \nPatient endorsing auditory hallucinations. Feeling scared and \nunsafe. Initially believing that he was raped while in the \nhospital, but later acknowledging that this was a delusion. \nIntermittently refusing diagnostic and therapeutic \ninterventions. Was initially verbally threatening staff with \nviolence, but has since become more calm and cooperative, \nalthough did have continued issues with behavioral disturbances, \nyelling, and cursing.\n\nUrine tox positive for cocaine x2 (although patient denies use). \nSearched room given cocaine positivity and threats of violence \nto staff, which was very upsetting to the patient. On room \nsearch, found some home medications, but no illicit substances \nor weapons. In the week after the room search, patient \nvoluntarily told his nurse that he had found some of his home \noxycodone in his sock that he had forgotten about. This was \nplaced in the lock box, and due to concern that the patient was \npocketing his doses of oxycodone while in house, this was \nswitched to a liquid form. \n\nPatient continued to speak with pressured speech and was \nparanoid, at one point claiming to have been raped by staff; \nhowever, later noting that this was \"all in my head\" and that \nhis voices had told him this. Patient was treated with \nolanzapine, which was titrated to 10 mg PO BID with 5 mg PRN for \nbreakthrough agitation. On discharge he still reported hearing \nvoices, however he \"realizes these are fake\" and thinks that \nthey have decreased since he started the olanzapine. He was \ndischarged with home ___ psych nurses as well as olanzapine PO \nBID, with the plan to eventually taper as an outpatient at the \ndiscretion of outpatient psychiatry. \n\n# LUQ Pain\n# Nausea\n# Constipation\nPatient reporting LUQ pain on presentation. He declined a CT A/P \nin the ED. Pain began after a fall about a month ago, so may be \nmusculoskeltal in origin. Initial abdominal US was unremarkable: \ndid not show any evidence of splenic or hepatobiliary pathology. \nKUB ___ without evidence of obstruction but did show large \nstool burden. Patient eventually underwent CT, which again \nshowed large stool burden Abdominal pain and tenderness may \ntherefore be secondary to constipation. Patient was offered \nseveral medications for constipation, but mostly refused. He \nstates that he refuses bowel regimen because after the car \naccident he could no longer feel below the waist, and is \nincredibly embarrassed by frequent accidents. He told nursing \nthat he did manual disempaction every morning. This was not \nwitnessed by nursing or anyone on staff. He did eventually have \na few large bowel movements that were witnessed by nursing, with \nslight resolution of his abdominal pain, and nausea. He \nattributes the bowel movements to the liquid form of oxycodone, \nand is very resistant to taking the liquid oxycodone. He was \ncounseled about constipating effect of opiates and need for \nbowel regimen, and he was encouraged on discharge to make sure \nhe has a bowel movement every day. \n\nCHRONIC ISSUES:\n========================\n# Sinus Tachycardia, resolved\nPatient with HR of 130 on presentation. Serum tox positive for \ncocaine. ___ also represent withdrawal, but patient and mother \ndenying alcohol use and tox negative for benzodiazepines. \nResolved to heart rates in the ___ on discharge.\n\n# Hypertension. \nVery hypertensive on presentation, likely in setting of \nmedication non-adherence. Continued amlodipine 10 mg QD and \nclonidine 0.2 mg TID, with improvements in his blood pressure to \n140s/80s. \n\n# Chronic Pain: \nChronic back pain. On home percocet ___ tab Q4H:PRN and \noxycodone 60 mg Q8H:PRN (recently prescribed by ___ \nCHA). Continued Tylenol ___ Q8hrs, Oxycodone 60mg Q8hrs, \nPercocet 10mg, q4hrs prn, and tizanadine 4 mg BID. However, due \nto concern the patient was subverting his oxycodone in setting \nof finding multiple pills in his sock this hospitalization, he \nwas switched from the pill form of oxycodone to liquid form, to \nimpede the ability to pocket pain meds. However as noted above, \nthe patient made nursing aware of the pain medications in his \nsock and states that he kept them there because he has housing \ninsecurity and needed to keep them safe. \n\n# Allergies: \nPt has multiple antibiotic allergies that limit treatment of \ninfections. Per pt he gets hives to all antibiotics listed. \nUnclear which allergies are true. Patient has outpatient allergy \nappointment to evaluate antibiotic allergies. Continued on \nloratadine 10 mg and flonase.\n\n# Normocytic Anemia: Baseline Hb ___.\n\n# ESRD: \n# Hyperkalemia\nStarted on HD ___. Nephrologist is Dr. ___. Pt \ngets HD TThSa. Received HD session in ED, as well as throughout \nhis hospitalization. He was continued on nephrocaps 1 QD and \nsevelamer 800 mg TID. \n\n# Insomnia: Continued on zolpidem 10 mg QHS\n\n# Nutrition: Continued on calcium, vitamin D\n\n# Anemia: Continued ferrous sulfate 325 mg QD\n\n# Seizure Disorder: Continue on keppra 1000 mg QD, 500 mg TThSa \nw/ HD\n\n# GERD: Continue on omeprazole 40 mg QD, which was increased to \nBID iso post-prandial nausea. \n\n\u003e30 minutes spent on patient care and coordination on day of \ndischarge.\n\nTRANSITIONAL ISSUES\n===================\n***NEW Rx of Olanzapine due to auditory hallucinations, plan for \neventual taper at the discretion of outpatient psychiatry team \n***\n[] Patient discharged to home with mother with psychiatry ___ \narranged. Likely will benefit from outpatient psych services, \nrecommend setting up with ___ where he has primary care \nto plan for eventual safe olanzapine taper. \n[] Mr ___ was started on prophylactic fosfomycin to prevent \nUTIs this hospitalization, and has follow up with ID ___.\n[] He has multiple listed allergies to antibiotics which are of \nunclear severity. He has follow up with allergy team ___ to \nclarify true allergies. \n[] Patient with intermittent nausea and abdominal pain thought \ndue to constipation from high doses of narcotics. Please ensure \npatient is having daily bowel movements. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ascorbic Acid ___ mg PO DAILY \n2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation - Second Line \n3. CloNIDine 0.2 mg PO TID \n4. Loratadine 10 mg PO DAILY \n5. Nephrocaps 1 CAP PO DAILY \n6. Omeprazole 40 mg PO DAILY \n7. OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO Q4H:PRN Pain - \nMild \n8. sevelamer CARBONATE 800 mg PO TID W/MEALS \n9. Tizanidine 4 mg PO BID \n10. Zolpidem Tartrate 10 mg PO QHS \n11. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg \ncalcium- 200 unit oral QD \n12. Ferrous Sulfate 325 mg PO DAILY \n13. Fluticasone Propionate NASAL 1 SPRY NU DAILY \n14. ___ (alprostadil) 1,000 mcg urethral unknown \n15. amLODIPine 10 mg PO DAILY \n16. LevETIRAcetam 500 mg PO Q12H \n17. LevETIRAcetam 500 mg PO 3X/WEEK (___) \n18. OxyCODONE (Immediate Release) 60 mg PO Q8H:PRN Pain - \nModerate \n\n \nDischarge Medications:\n1.  Fosfomycin Tromethamine 3 g PO 1X/WEEK (WE) \nDissolve in ___ oz (90-120 mL) water and take immediately \nRX *fosfomycin tromethamine [Monurol] 3 gram 1 packet(s) by \nmouth once weekly on ___ Disp #*4 Packet Refills:*0 \n2.  OLANZapine 10 mg PO BID \nRX *olanzapine 10 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*0 \n3.  Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 17 gram/dose 17 g by mouth daily \nPRN Refills:*0 \n4.  Ramelteon 8 mg PO QHS \nRX *ramelteon [Rozerem] 8 mg 1 tablet(s) by mouth at bedtime \nDisp #*30 Tablet Refills:*0 \n5.  Senna 17.2 mg PO BID \nRX *sennosides [senna] 8.6 mg 2 tablet by mouth BID PRN Disp \n#*120 Tablet Refills:*0 \n6.  amLODIPine 10 mg PO DAILY  \n7.  Ascorbic Acid ___ mg PO DAILY  \n8.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation - Second Line  \n9.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg \ncalcium- 200 unit oral QD  \n10.  CloNIDine 0.2 mg PO TID  \n11.  Ferrous Sulfate 325 mg PO DAILY  \n12.  Fluticasone Propionate NASAL 1 SPRY NU DAILY  \n13.  LevETIRAcetam 500 mg PO Q12H  \n14.  LevETIRAcetam 500 mg PO 3X/WEEK (___) on dialysis days \n\nafter dialysis  \n15.  Loratadine 10 mg PO DAILY  \n16.  ___ (alprostadil) 1,000 mcg urethral unknown  \n17.  Nephrocaps 1 CAP PO DAILY  \n18.  Omeprazole 40 mg PO DAILY  \n19.  OxyCODONE (Immediate Release) 60 mg PO Q8H:PRN Pain - \nModerate  \n20.  OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO Q4H:PRN Pain \n- Mild  \n21.  sevelamer CARBONATE 800 mg PO TID W/MEALS  \n22.  Tizanidine 4 mg PO BID  \n23.  Zolpidem Tartrate 10 mg PO QHS  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY\n=======\n- Psychotic disorder \n- Polysubstance use disorder \n\nSECONDARY\n=========\n- End stage renal disease \n- neurogenic bladder\n- ileal conduit urinary diversion c/b L anastomotic stricture \nrequiring indwelling nephrostomy tube \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair but independent with wheelchair\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nWHY WAS I HOSPITALIZED?\n==========================\nYou came into the hospital because you were having abdominal \npain and fevers. \n\nWHAT HAPPENED TO ME IN THE HOSPITAL?\n=================================\n- We initially thought that you may have been having a urinary \ntract infection and you received an antibiotic. However, it did \nnot appear that you had a urinary tract infection, so \nantibiotics were stopped. \n- You were found to be hearing voices and had racing thoughts. \nYou received medication for this. \n- Later, you did have a urinary tract infection, which was \ntreated with oral antibiotics. \n- You received hemodialysis while you were in the hospital. \n\nWHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL?\n=========================================\n- Take all of your medications as prescribed.\n- Attend all scheduled clinic appointments.\n\nIt was a pleasure taking care of you, \nYour ___ Care Team\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19363916","hadm_id":"29438461","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nVancomycin / Cephalosporins\n \nAttending: ___.\n \nChief Complaint:\nFound down, altered mental status, renal failure, sepsis\n \nMajor Surgical or Invasive Procedure:\n-Intubation\n-Removal of R subclavian artery CVL in cath lab, with stent \ndeployment\n-Femoral CVL\n-R IJ CVL\n-Arterial line\n \nHistory of Present Illness:\n___ yo M with a history of EtOH abuse was found down in his home. \n He had not been seen by his neighbors for 3 days prior to being \nfound, was reportedly found with many empty alcohol containers \naround him.  The patient was taken to ___, where he \nwas intubated for airway protection due to GCS = 3, no sedation \nwas given but did have spontaneous respirations to 20.  Pt was \nnoted to be incontinent of bloody diarrhea.  Head CT and C-spine \nCT negative. Labs remarkable for Ph 7.03, bicarb 6, cr 5, gluc \n111, K 4.1, CK 10,000.  EtOH 403, NGT placed with coffee ground \nmaterial. UTox negative. R SC CVL placed, given 1L fluid and \nshipped via Medflight. Also given Narcan 1mg IV, Thiamine IV and \nstarted on Levophed.\n.\nUpon arrival to ___ ED, VS T 96, 96, 65/p --\u003e 138/66, \nventilated with 100% SaO2. Negative guaiac, soft abdomen.  CVL \nsubclavian line from OSH noted to be in the R SC artery, \nvascular consulted and recommended leaving in place until \npatient was stable for removal in the controlled setting of the \ncath lab. A L femoral CVl was placed in the ED. he received \nLevophed, Protonix IV, IV NS x 4L, Zosyn 4.5mg IV, Levofloxacin \n750mg IV and Versed 2mg x 1.  VS upon transfer 99/49, 100/ PEEP \n5/FIO2 100 and RR 20.  Admitted with PNA, Rhabdomyolysis, \nencephalopathy, AG metabolic acidosis, guaiac positive from \nabove, ARF, elevated liver enzymes.  \n \nPast Medical History:\nAlcoholism \nSeizure disorder\nHyperlipidemia\nBipolar disorder\nDisasotic dysfunction, Ef = 55%\nH/o AMS ___ seizure\nH/o tubulous adenoma and colon polyps\n? AVR malformation\n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nOn admission - \n97.4, 97, 92/59, 20 and 100% on 100% FIO2\nGEN: obtunded, unkempt\nHEENT: PER minimally reactive but symmetric; no corneal reflex \non initial exam; face symmetric, ET in place\nCV: RRR without ___ harsh systolic murmur throughout precordium\nPULM: Course b/l breath sounds with intermittent wheeze\nABD: Soft, nondistended, without HSM, active bowel sounds, no \ngrimace to deep palpation\nExt: WWP with c/c/e, pulses distally ___\nNeuro: Initially with no corneal reflex, minimal gag, no \nwithdrawl to pain; then spontaneously moving all limbs\n.\nOn Disharge - \n\n \nPertinent Results:\n=====\nlabs\n=====\n\n___ 03:10AM BLOOD WBC-10.1 RBC-3.15* Hgb-9.3* Hct-28.6* \nMCV-91 MCH-29.6 MCHC-32.6 RDW-14.1 Plt ___\n___ 04:07AM BLOOD WBC-13.7* RBC-3.34* Hgb-10.1* Hct-30.2* \nMCV-91 MCH-30.2 MCHC-33.4 RDW-14.1 Plt ___\n___ 05:59PM BLOOD Hct-27.1*\n___ 10:47AM BLOOD WBC-10.3 RBC-2.96* Hgb-9.1* Hct-26.4* \nMCV-89 MCH-30.7 MCHC-34.5 RDW-13.7 Plt ___\n___ 02:31AM BLOOD WBC-7.8 RBC-2.84* Hgb-8.6* Hct-25.6* \nMCV-90 MCH-30.3 MCHC-33.7 RDW-14.0 Plt Ct-95*\n___ 06:04PM BLOOD Hct-20.5*#\n___ 10:35AM BLOOD Hct-29.1*\n___ 04:04AM BLOOD WBC-6.2 RBC-3.26* Hgb-9.9* Hct-28.5* \nMCV-87 MCH-30.5 MCHC-34.9 RDW-13.8 Plt ___\n___ 09:20PM BLOOD WBC-7.6 RBC-3.18* Hgb-9.6* Hct-27.7* \nMCV-87 MCH-30.2 MCHC-34.7 RDW-13.9 Plt ___\n___ 07:29PM BLOOD Hct-30.8*\n___ 06:54PM BLOOD WBC-6.4# RBC-3.70* Hgb-11.4* Hct-31.8* \nMCV-86 MCH-30.9 MCHC-36.0* RDW-13.8 Plt ___\n___ 11:14AM BLOOD Hct-36.2*\n___ 09:02AM BLOOD WBC-2.5* RBC-3.22* Hgb-10.0* Hct-29.4* \nMCV-92 MCH-31.2 MCHC-34.0 RDW-13.5 Plt ___\n___ 08:28AM BLOOD WBC-2.8*# RBC-3.13*# Hgb-10.0*# \nHct-28.6*# MCV-92 MCH-31.8 MCHC-34.8 RDW-13.5 Plt ___\n___ 10:00PM BLOOD WBC-17.1* RBC-4.81 Hgb-14.6 Hct-43.8 \nMCV-91 MCH-30.4 MCHC-33.4 RDW-13.8 Plt ___\n___ 04:04AM BLOOD Neuts-68 Bands-11* Lymphs-14* Monos-5 \nEos-0 Baso-0 Atyps-2* ___ Myelos-0\n___ 06:54PM BLOOD Neuts-81.3* Lymphs-13.5* Monos-4.4 \nEos-0.6 Baso-0.1\n___ 10:00PM BLOOD Neuts-86.4* Lymphs-8.8* Monos-4.0 Eos-0.5 \nBaso-0.2\n___ 04:04AM BLOOD Hypochr-NORMAL Anisocy-NORMAL \nPoiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL\n___ 03:10AM BLOOD Plt ___\n___ 03:10AM BLOOD ___ PTT-29.0 ___\n___ 04:07AM BLOOD Plt ___\n___ 04:07AM BLOOD ___ PTT-28.8 ___\n___ 10:47AM BLOOD Plt ___\n___ 10:47AM BLOOD ___ PTT-29.0 ___\n___ 02:31AM BLOOD ___ PTT-30.8 ___\n___ 04:04AM BLOOD Plt Smr-VERY LOW Plt ___\n___ 04:04AM BLOOD ___ PTT-30.7 ___\n___ 09:20PM BLOOD Plt ___\n___ 09:20PM BLOOD ___ PTT-30.8 ___\n___ 06:54PM BLOOD ___ PTT-30.2 ___\n___ 09:02AM BLOOD Plt ___\n___ 08:28AM BLOOD Plt ___\n___ 03:02AM BLOOD ___ PTT-38.7* ___\n___ 10:47AM BLOOD ___\n___ 04:04AM BLOOD ___\n___ 03:10AM BLOOD Glucose-PND UreaN-PND Creat-PND Na-PND \nK-PND Cl-PND HCO3-PND\n___ 07:58PM BLOOD Glucose-137* UreaN-64* Creat-4.2* Na-151* \nK-3.3 Cl-115* HCO3-25 AnGap-14\n___ 04:04AM BLOOD Glucose-113* UreaN-74* Creat-3.8* Na-148* \nK-3.6 Cl-110* HCO3-25 AnGap-17\n___ 09:20PM BLOOD Glucose-226* UreaN-78* Creat-3.9* Na-143 \nK-3.4 Cl-105 HCO3-28 AnGap-13\n___ 12:45PM BLOOD Glucose-485* UreaN-86* Creat-4.1* Na-142 \nK-2.6* Cl-94* HCO3-22 AnGap-29*\n___ 08:07AM BLOOD Glucose-652*\n___ 03:02AM BLOOD Glucose-288* UreaN-96* Creat-4.4* Na-146* \nK-4.1 Cl-109* HCO3-10* AnGap-31*\n___ 10:00PM BLOOD Glucose-116* UreaN-111* Creat-5.4* Na-144 \nK-5.1 Cl-105 HCO3-5* AnGap-39*\n___ 03:10AM BLOOD ALT-PND AST-PND CK(CPK)-PND AlkPhos-PND \nTotBili-PND\n___ 02:31AM BLOOD CK(CPK)-5781*\n___ 06:54PM BLOOD ALT-248* AST-546* ___ \nAlkPhos-67 TotBili-0.3\n___ 03:02AM BLOOD ALT-291* AST-775* ___ \nAlkPhos-81 Amylase-383*\n___ 10:00PM BLOOD ALT-301* AST-643* ___ \nAlkPhos-108 TotBili-0.2\n___ 10:00PM BLOOD Lipase-257*\n___ 02:31AM BLOOD CK-MB-41* MB Indx-0.7 cTropnT-0.22*\n___ 04:04AM BLOOD CK-MB-111* MB Indx-0.7 cTropnT-0.43*\n___ 10:00PM BLOOD cTropnT-0.06*\n___ 07:58PM BLOOD Calcium-7.8* Phos-4.2 Mg-1.9\n___ 04:07AM BLOOD Calcium-8.1* Phos-4.8* Mg-2.1\n___ 02:31AM BLOOD Calcium-7.2* Phos-5.3* Mg-1.7\n___ 04:04AM BLOOD Albumin-1.7* Calcium-6.0* Phos-4.9* \nMg-2.3\n___ 09:20PM BLOOD Calcium-6.1* Phos-4.4 Mg-1.5*\n___ 06:54PM BLOOD Albumin-2.2* Calcium-6.8* Phos-4.4 Mg-1.7\n___ 12:45PM BLOOD Calcium-6.1* Phos-4.3# Mg-1.6\n___ 10:00PM BLOOD Osmolal-425*\n___ 02:39PM BLOOD Cortsol-96.9*\n___ 12:52PM BLOOD Cortsol-75.9*\n___ 10:48AM BLOOD Genta-1.1* Vanco-17.6\n___ 06:31AM BLOOD Vanco-10.2\n___ 04:04AM BLOOD Genta-2.6*\n___ 10:00PM BLOOD ASA-NEG ___ Carbamz-\u003c1.0* \nAcetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 03:20AM BLOOD ___ pH-7.42 Comment-GREEN TUBE\n___ 04:21AM BLOOD Type-ART Temp-36.1 pO2-72* pCO2-33* \npH-7.48* calTCO2-25 Base XS-1 Intubat-NOT INTUBA\n___ 09:17AM BLOOD Type-ART Temp-35.6 Rates-/18 Tidal V-450 \nPEEP-5 FiO2-40 pO2-94 pCO2-36 pH-7.47* calTCO2-27 Base XS-2 \nIntubat-INTUBATED\n___ 02:36AM BLOOD Type-ART Temp-35.9 pO2-121* pCO2-32* \npH-7.46* calTCO2-23 Base XS-0 Intubat-INTUBATED\n___ 07:49PM BLOOD Type-ART Temp-35.9 pO2-96 pCO2-36 pH-7.44 \ncalTCO2-25 Base XS-0 Intubat-INTUBATED\n___ 04:31AM BLOOD Type-ART Temp-35.9 pO2-104 pCO2-35 \npH-7.46* calTCO2-26 Base XS-1\n___ 09:01PM BLOOD Type-ART pO2-119* pCO2-34* pH-7.54* \ncalTCO2-30 Base XS-7\n___ 05:45PM BLOOD pH-7.52*\n___ 11:26AM BLOOD ___\n___ 02:00AM BLOOD Type-ART PEEP-5 FiO2-100 pO2-419* \npCO2-29* pH-7.12* calTCO2-10* Base XS--19 AADO2-290 REQ O2-53 \nIntubat-INTUBATED Vent-CONTROLLED\n___ 10:17PM BLOOD pO2-428* pCO2-24* pH-7.10* calTCO2-8* \nBase XS--20\n___ 04:31AM BLOOD Glucose-114* Lactate-1.4 K-3.3*\n___ 09:01PM BLOOD Lactate-2.8* K-3.6\n___ 05:45PM BLOOD Lactate-5.4* K-2.7*\n___ 04:12PM BLOOD Lactate-7.8*\n.\n============\nmicrobiology\n============\nBlood culture ___\nSENSITIVITIES: MIC expressed in MCG/ML\n                      \n_________________________________________________________\n                             SALMONELLA ENTERITIDIS\n                             |          STAPHYLOCOCCUS, \nCOAGULASE NEGATIVE\n                             |          |   \nAMPICILLIN------------   \u003c=2 S\nCEFTRIAXONE-----------   \u003c=1 S\nERYTHROMYCIN----------              =\u003e8 R\nGENTAMICIN------------                2 S\nLEVOFLOXACIN----------\u003c=0.25 S   \u003c=0.12 S\nOXACILLIN-------------              =\u003e4 R\nRIFAMPIN--------------            \u003c=0.5 S\nTETRACYCLINE----------             =\u003e16 R\nTRIMETHOPRIM/SULFA----  \u003c=20 S\nVANCOMYCIN------------              \u003c=1 S\n\n.\nFECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA \nFOUND. \n\n   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER \nFOUND. \n\n   CLOSTRIDIUM DIFFICILE TOXIN A \u0026 B TEST (Final ___: \n      REPORTED BY PHONE TO ___ @ 0546 ON ___- \nCC6C. \n      CLOSTRIDIUM DIFFICILE. \n         FECES POSITIVE FOR C. DIFFICILE TOXIN BY EIA.\n\n.\n==========\nCardiology\n==========\nTTE \nThe left atrium is dilated. There is mild symmetric left \nventricular hypertrophy. The left ventricular cavity is \nunusually small. Left ventricular systolic function is \nhyperdynamic (EF\u003e75%). There is a severe resting left \nventricular outflow tract obstruction. Right ventricular chamber \nsize and free wall motion are normal. The aortic valve leaflets \n(3) are mildly thickened but aortic stenosis is not present. No \naortic regurgitation is seen. The mitral valve leaflets are \nmildly thickened. There is systolic anterior motion of the \nmitral valve leaflets. Mild (1+) mitral regurgitation is seen. \nThe estimated pulmonary artery systolic pressure is normal. \nThere is no pericardial effusion. \n\nIMPRESSION: Small left ventricle with hyperdynamic systolic \nfunction. There is systolic anterior movement of the mitral \nvalve with a severe LVOT gradient, due to apposition of the \nvalve leaflet to the septum at end systole. Mild mitral \nregurgitation.\n\nCompared with the prior study (images reviewed) of ___, \nthe measured LVOT gradient is similar to prior study (not \nreported on prior). The other findings are similar.  \n.\n===========\nRadiology\n===========\nCT Head \nIMPRESSION: \n1. Gyriform high density focus at left frontovertex, without \nassociated \nedema, mass effect, or gyral effacement, likely a chronic \nfinding. This could likely represents mineralization, related to \nold trauma or infarct. \n2. Air-fluid levels in the left maxillary and frontal sinuses \nand sphenoid \nair cells, bilaterally, with mild mucosal thickening in the \nethmoid air cells,representing acute-on-chronic inflammation. No \nassociated fracture. \n.\nCT Torso \nIMPRESSION: \n1. Bibasilar dependent consolidation with peripheral \n___ \nopacities worrisome for infection or aspiration. \n2. Marked enlargement of the left chest wall musculature and \nright gluteal \nmuscles. The muscles are overall lower in attenuation, \nsuggesting edema. \n3. Pancolitis, most proiminent of the sigmoid colon. \n4. Irregular contour of the kidneys. Exophytic right renal mass, \nmost c/w \nheamorrhagic cyst. Recommend US evaluation.. \n5. Intra-arterial right chest vascular line as noted on prior \nchest \nradiograph. \n.\nScrotal ultrasound\nIMPRESSION: \n1. Severe scrotal edema, with no evidence of fluid collection or \nabscess. \n2. Normal testes with small hydroceles bilaterally. \n.\n\nRIGHT UPPER QUADRANT ULTRASOUND:\nThe liver is again coarsened in echotexture. The portal vein is \npatent with antegrade flow. There is no ascites. There is no \nintra- or extra-hepatic bile duct dilation. The common duct \nmeasures 3 mm. No gallstones or wall thickening. \nIMPRESSION: No evidence of biliary ductal dilatation. \n.\nMRCP\n1. Trace fluid around the pancreas compatible with acute \npancreatitis. No \nevidence of fluid collection or biliary ductal dilatation. \n2. Small bilateral pleural effusions and trace ascites are \nincreased from the ___ study. \n4. Indeterminate lesion in the mid right kidney which has \nevidence of \nhemorrhagic components. This mass is concerning for malignancy. \nFurther \nevaluation is recommended. \n.\n___\nIMPRESSION: Normal deep veins in the right leg. Noncompressible \nleft common femoral vein is most likely due to edema. \n\n \nBrief Hospital Course:\n# s/p Sepsis secondary to Salmonella/Coag Neg Staph:  Resolved.  \nThe patient was admitted to the MICU intubated in septic shock, \nrhabdo, metabolic acidosis, ARF, and aspiration PNA, and was \nresuscitated with IVF and pressors. He received broad spectrum \nantibiotics, initially with Vancomycin and Zosyn.  A CT scan \nrevealed pancolitis, and Surgery was consulted and recommended \nconservative management.  Patient's blood cx grew out coag neg \nstaph and salmonella; group B strep was cultured from the \nsputum.  Antibiotics were tailored to CTX/Vanco/Flagyl. When he \nstabilized off pressors, the CVL which was placed at ___ \n___ in the R subclavian artery was removed with angio \nguidance by Vascular Surgery; a stent was deployed due to \nongoing extravasation.  The patient was weaned to minimal vent \nsettings and extubated successfully on HD 5.  Patient was \ntransferred to the floor and treated with a 10 day course of \nVancomycin and Ceftriaxone (later switched to cefepime - \ndescribed below), which was shorter duration than the total 14 \ndays anticipated because of patient's pancreatitis, \nhepatotoxicity, and rash (acute generalized exanthematous \npustulosis).  Patient had fluctuating WBC count during his stay \n(likely reactive), but surveillance cultures remained negative, \nand was afebrile and hemodynamically stable.  \n\n#. Transaminitis/Cholestasis/Pancreatitis:  Patient was septic \non admission and required pressors.  On admission, patient had a \ntransaminitis consistent with shock liver that improved during \nthe course of his admission.  Patient had been improving during \nhospitalization, but was noted to have an elevated WBC count \n(18) on ___.  Patient had been afebrile, hemodynamically \nstable, but there was concern for possible intra-abdominal \nabcess vs worsening colitis (noted on admission) that raised \nsuspicion for occult infectious process.  On ___, patient was \nnoted to have elevated amylase/lipase, elevated direct bilirubin \nand Alk phos, and was noted to be somnolent.  Given the \nmultiorgan system involvement, there was concern for possible \ndrug toxicity.  Patient had a Valproate level and Carbamazepine \nlevel checked as the doses of these medication had been \nincreased on ___ to his home doses.  These medications were \ntaped off over several days.  CT abdomen, MRCP, RUQ u/s were \nperformed and were unremarkable as to the etiology of the \npatient's hepatic and pancreatic involement -- no evidence of \nductal dilation or gallstones.  Patient's cholestatic markers \ncontinued to trend upward over several days and so hepatology \nwas consulted.  Hepatology attributed patient's cholestatic \npattern to Zosyn that he received in the MICU earlier in his \ncourse.  Patient's cholestatic markers have stabilized and \namylase,lipase were no longer trended when patient improved \nclinically. \n.\n#. C difficile Colitis: Patient developed C diff colitis on ___ \nwith a fever, increased white count, and tachycardia. Patient \nwas transiently re-admitted to the MICU where he received \nfluids, and was started on flagyl and vancomycin. Vancomycin was \nstopped (see below) and patient continued on Flagyl for planned \n21 day course.  \n.\n# Acute Generalized Exanthematous Pustulosis:  On ___ patient \nwas noted to have an erythematous rash involving his inguinal \nregion that was initially thought to be a candidal cellulitis.  \nOn the following days, was noted to be spreading, and was noted \nto be involving patient's trunk and back.  Dermatology was \nconsulted and diagnosed this rash as acute generalized \nexanthematous pustulosis, attributed to use of B lactam \nantibiotics in the past.  Patient was treated with emollient and \ntriamcinalone cream. Vancomycin oral was started in the setting \nof C diff and patient broke out in a new rash, so this was \nstopped. Rash was not nearly as severe as prior AGEP and \nresolved within 3 days.   \n.\n#Acute on Chronic Renal Failure:  Patient was admitted with a Cr \nof 5, thought to be related to patient's septic shock.  \nPatient's Cr had trended downward to 1.5 during the admission, \nlikely secondary to ATN. Per his PCP, baseline ___ is around 1.4. \nAdditionally, patient reports known history if diabetes \ninsipidus due to prior Lithium use. \n.\n# Pancolitis:  Unclear etiology.  Patient was in septic shock \nwhen he was initially admitted and was noted to have pancolitis \non CT scan on admission.  It was thought that patient may have \ndeveloped this from hypotension, but unclear.  Of note, patient \nwas noted to have salmonella in his blood cultures.  Patient was \nfollowed by general surgery who recommended conservative \nmanagement.  A repeat CT Abd/Pelvis shows interval improvement \nin colonic wall.  Patient's PCP was contacted and faxed \ncolonoscopy records dating ___ years ago that showed normal \ncolon then.  \n.  \n#History seizure disorder:  Patient has a history of seizure \ndisorder and has been on carbamazepine and valproic acid at \nhome.  On admission, patient's home doses of these medications \nwas unclear and was started on low doses of each.  Patient's \npharmacy was contacted.  His home dose (as of ___) was \nCarbamazepine 400/600, and Valproic Acid ___.  Patient \nwas started on this medication on ___.  Patient was noted to \nhave hepatotoxicity/pancreatitis on ___, but it is unclear if \nthese medications are related to his state.  Patient had been \npreviously on these doses as an outpatient and had been \nrefilling regularly.  Neurology was consulted to help taper \nthese medications.  He was taped off over several days and was \nstarted on Keppra for seizure prophylaxis. He had a therapeutic \nKeppra level prior to discharge.  \n.\n# Bipolar disorder: Transitioned to risperidone in house and \npatient did well on this regimen. Psychiatry was involved and \nfelt that patient should have neuro-psych evaluation after acute \nmedical issues resolved, but felt that Bipolar was likely at \nbaseline at the time of discharge. \n.\n#. Hypothyroid: Thyroid studies checked in the setting of \nhypothermia and diarrhea. TSH 16, but free T4 normal at 1.2 \nlikely indicating sick euthryoid in the setting of patient's \nmultiple other medical problems. Plan to retest TSH as \noutpatient after acute issues resolve by PCP.\n.\n# RCC: Mass noted on MRI abdomen in house. It appears patient \nhas known ___ based on prior records from ___ and is s/p RFA \n___. Plan for patient to follow up with Dr. ___ at \n___ with plan for Q3 month CT scans for first year.\n\n# Contact: Brother ___. Cousin ___ \n___. Regarding HCP, patient has indicated that Cousin \n___ should be his HCP, however Cousin has refused. Patient's \nbrother is willing to be HCP, but patient is refusing. For now, \nif there are any issues, will have to use next of kin ___ \n___ for consent. Will need to readdress with patient. \n\n \nMedications on Admission:\nMedications confirmed from pharmacy ___ ___\nCarbamazipine 400mg qam 1200mg qhs (last filled ___\nDepakote 250mg qhs (last filled ___\nSimvastatin 40mg qhs\nTimolol 5% opth soln to left eye prn\n\nof note, in ___ the patient was taking Depakote 500mg qam\n500mg q afternoon and 2000mg qhs\n\nPsych meds are being prescribed by ___ from ___\n___\n\nOther meds rx by Dr. ___ ___\n \nDischarge Medications:\n1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \n2. White Petrolatum-Mineral Oil     Cream Sig: One (1) Appl \nTopical DAILY (Daily).  \n3. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times \na day) for 2 days: through ___.  \n4. Timolol Maleate 0.5 % Drops Sig: One (1) Drop Ophthalmic \nDAILY (Daily).  \n5. Risperidone 1 mg Tablet Sig: Two (2) Tablet PO QPM (once a \nday (in the evening)).  \n6. Risperidone 1 mg Tablet Sig: One (1) Tablet PO QAM (once a \nday (in the morning)).  \n7. Levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n8. Metronidazole 500 mg Tablet Sig: One (1) Tablet PO TID (3 \ntimes a day) Please stop ___.  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n1. Septic shock\n2. Rhabdomylosis\n3. Acute Renal Failure\n4. Respiratory failure\n5. Salmonella septicemia\n6. Clostridium difficile colitis \n \nDischarge Condition:\nstable, afebrile \n\n \nDischarge Instructions:\nYou were initially admitted with septic shock from ___ \n___. You were found to have a very serious blood infection, \nlikely originating from your colon. You were treated with \nantibiotics which caused hepatitis and pancreatitis that \nresolved on their own. These antibiotics also caused a severe \nskin rash that improved on its own. You subsequently developed \nanother infection of your colon called clostridium difficile \ncolitis, and were treated with different antibiotics which would \nwill need to continue. Finally, your depakote was thought to \nhave caused some of your liver problems, so it was stopped and \nyou were started on Risperdal and Keppra instead for your \nbipolar disorder and seizures respectively. \n.\nYou are being discharged to a rehab facility to help you regain \nyour strength. \n.\nPlease seek immediate medical attention if you experience chest \npain, shortness of breath, abdominal pain, nauasea, vomitting, \nfevers, chills, worsening diarrhea or any change from your \nbaseline health status. \n \nFollowup Instructions:\n___\n"}
{"subject_id":"13536576","hadm_id":"25905525","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: CARDIOTHORACIC\n \nAllergies: \nKeflex\n \nAttending: ___.\n \nChief Complaint:\nDyspnea on exertion\n \nMajor Surgical or Invasive Procedure:\nAortic valve replacement ___ Magna Ease), Coronary artery \ndisease times one (LIMA to ___\n \nHistory of Present Illness:\nMrs. ___ is a ___ year old woman with a history of aortic \nstenosis first noted in ___. She has seen been \nfollowed with serial echocardiograms. Recently, she has noted \ndyspnea on exertion and fatigue. Her most recent echocardiogram \nrevealed severe aortic stenosis with mild left ventricular \nhypertrophy, and severe aortic stenosis with peak and mean \ngradients of 77 mmHg and 44 mmHg, respectively. The aortic valve \narea was 0.8 cm2. Given the progression of her aortic stenosis, \nshe was referred to Dr. ___ surgical evaluation. She \nnoted fagitue and dyspnea while playing tennis or walking. She \ndenied syncope, dizziness, lightheadedness, shortness of breath, \nchest pain, palpitations, orthopnea, paroxysmal nocturnal \ndyspnea, or lower extremity edema.\n \nPast Medical History:\nAnemia\nAortic Stenosis\nBasal cell carcinoma, forehead\nDiverticulosis\nGastroesophageal Reflux Disease\nHemorrhoids\nObesity\nOsteoporosis\nSleep Apnea\nC-Section\nCholecystectomy\n \nSocial History:\n___\nFamily History:\nFamily History: - Premature coronary artery disease\nFather - history of stroke in his ___.\nMother - history of aortic valve replacement and CABG, died at \nage ___.\nSister - history of heart murmur.\n \nPhysical Exam:\nPhysical Exam\n\nVital Signs sheet entries for ___:\nBP: 135/79. Heart Rate: 87. Resp. Rate: 16. O2 Saturation%: 99.\nHeight: 65\"  Weight: 270 lbs\n\nGeneral: Pleasant woman, WDWN, NAD\nSkin: Right breast fold warm, tender with surrounding area of \nerythema. Skin otherwise dry and intact.\nHEENT: NCAT, PERRLA, EOMI, OP benign\nNeck: Supple, full ROM, no JVD\nChest: Lungs clear bilaterally\nHeart: Regular rate and rhythm, III/VI SEM heard best at LUSB \nAbdomen: Protruberant, normal BS, non-tender, no masses \nExtremities: Warm, well-perfused, trace edema \nVaricosities: None\nNeuro: Grossly intact\nPulses:\nFemoral      Right: 1+  Left: 1+\nDP           Right: 2+  Left: 2+\n___           Right: 2+  Left: 2+\nRadial       Right: 2+  Left: 2+\n\nCarotid Bruit: bruit vs. transmitted murmur\n\nDischarge Physical Exam:\nVital signs: 98.7 98.4 BP 99/65 HR 83 resp 20 RA 95%\nWgt: 129.8kg\n\nNeuro: A\u0026O x 3 non focal\nlungs: decreased bases\nCV: S1 s1 soft murmur, no JVD\nabd: soft +BS, +BM\nExt: trace lower ext edema\nWounds: CDI\n \nPertinent Results:\nEcho ___: \nPRE BYPASS The left atrium is dilated. No spontaneous echo \ncontrast or thrombus is seen in the body of the left atrium/left \natrial appendage or the body of the right atrium/right atrial \nappendage. No atrial septal defect is seen by 2D or color \nDoppler. There is mild symmetric left ventricular hypertrophy. \nThe left ventricular cavity size is normal. Regional left \nventricular wall motion is normal. Overall left ventricular \nsystolic function is normal (LVEF\u003e55%). The right ventricle \ndisplays normal free wall contractility. There are simple \natheroma in the ascending aorta. There are simple atheroma in \nthe aortic arch. The descending thoracic aorta is mildly \ndilated. There are simple atheroma in the descending thoracic \naorta. There are three aortic valve leaflets. The aortic valve \nleaflets are severely thickened/deformed. There is severe aortic \nvalve stenosis (valve area 0.7cm2). Mild (1+) aortic \nregurgitation is seen. The aortic regurgitation jet is \neccentric, directed toward the anterior mitral leaflet. [Due to \nacoustic shadowing and eccentricity, the severity of aortic \nregurgitation may be UNDERestimated.] The mitral valve leaflets \nare moderately thickened. There is mild valvular mitral stenosis \n(MVA 1.5-2.0 cm2). Due to co-existing aortic regurgitation, the \npressure half-time estimate of mitral valve area may be an \nOVERestimation of true mitral valve area. Mild (1+) mitral \nregurgitation is seen. The left ventricular inflow pattern \nsuggests impaired relaxation. There is no pericardial effusion. \nDr. ___ was notified in person of the results in the \noperating room at the time of the procedure.\nPostbypass:  There is a bioprosthesis in the native aortic \nposition, stable and functioning well. Residual mean gradient is \n12mm of Hg. No significant regurgitant jets Intact thoracic \naorta,. No other new findings.\n.\n\n___ 05:45AM BLOOD WBC-13.6* RBC-3.00* Hgb-8.2* Hct-26.1* \nMCV-87 MCH-27.3 MCHC-31.4* RDW-14.4 RDWSD-45.6 Plt ___\n___ 04:32AM BLOOD WBC-11.9* RBC-2.94* Hgb-8.1* Hct-25.5* \nMCV-87 MCH-27.6 MCHC-31.8* RDW-14.6 RDWSD-46.8* Plt ___\n___ 05:50AM BLOOD WBC-13.1* RBC-3.04* Hgb-8.3* Hct-26.5* \nMCV-87 MCH-27.3 MCHC-31.3* RDW-14.8 RDWSD-47.7* Plt ___\n___ 06:00PM BLOOD ___ PTT-34.8 ___\n___ 05:45AM BLOOD UreaN-26* Creat-0.7 Na-137 K-4.2 Cl-99\n___ 04:32AM BLOOD Glucose-113* UreaN-27* Creat-0.8 Na-136 \nK-4.2 Cl-100 HCO3-26 AnGap-14\n\n___ CXR\nPostoperative widening of the upper mediastinum has improved.  \nLeft lower lobe \nis still severely atelectatic and there is accompanying left \npleural effusion, \nprobably moderate in size.  There is no pneumothorax.  I do not \nbelieve there \nis still a left thoracostomy tube.  Right lung is grossly clear. \n\n\n \nBrief Hospital Course:\nMs. ___ was a same day admit and on ___ she was brought to \nthe operating room where they underwent an aortic valve \nreplacement and coronary artery bypass graft x 1. Please see \noperative note for surgical details. Following surgery she was \ntransferred to the CVICU for invasive monitoring in stable \ncondition. Early on post-operative day one she was weaned from \nsedation, awoke neurologically intact and extubated. \nBeta-blockers and diuretics were initiated and she was diuresed \ntowards her pre-op weight. Later this day she was transferred to \nthe step-down floor for further care. Chest tubes and epicardial \npacing wires were removed per protocol. Follow-up CXR shows \nsmall stable left apical pneumothorax. On the stepdown floor the \npatient worked with nursing and physical therapy service for \nassistance with strength and mobility. By the time of discharge \non POD 4 the patient was ambulating the wound was healing and \npain was controlled with oral analgesics.  The patient was \ndischarged to home with home ___ in good condition with \nappropriate follow up instructions.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Carvedilol 25 mg PO BID \n3. Docusate Sodium 200 mg PO DAILY \n4. Doxazosin 4 mg PO HS \n5. Furosemide 20 mg PO DAILY \n6. glimepiride 2 mg oral DAILY \n7. Isosorbide Mononitrate (Extended Release) 60 mg PO BID \n8. Lisinopril 10 mg PO DAILY \n9. Simvastatin 40 mg PO QPM \n10. DiphenhydrAMINE 50 mg PO QHS \n11. MetFORMIN (Glucophage) 1000 mg PO BID \n \nDischarge Medications:\n1. Walker\nfront wheeled rolling walker for mobility\ndx: AS, CAD, s/p AVR, CABG\nduration: lifetime\nprognosis: good\n2. Aspirin 81 mg PO DAILY \n3. Docusate Sodium 200 mg PO DAILY \n4. Acetaminophen 650 mg PO/PR Q4H:PRN pain or temperature \u003e38.0 \n5. Atorvastatin 20 mg PO QPM \nRX *atorvastatin 20 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*1\n6. Metoprolol Tartrate 12.5 mg PO BID \nRX *metoprolol tartrate 25 mg 0.5 (One half) tablet(s) by mouth \ntwice a day Disp #*60 Tablet Refills:*1\n7. Milk of Magnesia 30 mL PO DAILY \n8. Omeprazole 20 mg PO DAILY \n9. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN Pain: \nmoderate/severe \nRX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours \nDisp #*40 Tablet Refills:*0\n10. Sarna Lotion 1 Appl TP BID:PRN itching \nRX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % apply to \naffected area twice a day Refills:*0\n11. calcium carbonate-vitamin D3 500 mg(1,250mg) -400 unit oral \nDAILY \n12. Multivitamins 1 TAB PO DAILY \n13. Furosemide 40 mg PO BID Duration: 10 Days \nRX *furosemide 40 mg 1 tablet(s) by mouth twice a day Disp #*20 \nTablet Refills:*0\n14. Potassium Chloride 20 mEq PO BID Duration: 10 Days \nHold for K \u003e \nRX *potassium chloride 20 mEq 1 tablet(s) by mouth twice a day \nDisp #*20 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nAortic stenosis, coronary artery disease s/p AVR, CABG x 1\nPast medical history:\nAnemia\nBasal cell carcinoma, forehead\nDiverticulosis\nGastroesophageal Reflux Disease\nHemorrhoids\nObesity\nOsteoporosis\nSleep Apnea\n\n \nDischarge Condition:\n Monitor vitals signs including weight and temperature\n       Concerns - fever of 100.5 degrees Fahrenheit or higher\n                - weight increase more than two pounds in one \nday\n                  or five pounds in a week\n  Monitor wound healing, teach wound care\n         Care   - SHOWER DAILY - including first washing\n                  incisions gently with mild soap\n                - NO lotions, cream, powder, or ointments to\n                  incisions\n       Concerns - warmth, redness, swelling or increased\n                  tenderness/pain\n                - ANY fluid or drainage coming out of\n                  incisions\n   Medication, diet and exercise teaching and compliance\n   Follow-up appointment assistance and compliance\n **Please call cardiac surgery office with any questions or \nconcerns ___. Answering service will contact on call \nperson during off hours**\n\n \nDischarge Instructions:\nPlease shower daily including washing incisions gently with mild \nsoap, no baths or swimming, and look at your incisions\n Please NO lotions, cream, powder, or ointments to incisions\n Each morning you should weigh yourself and then in the evening \ntake your temperature, these should be written down on the chart\n No driving for approximately one month and while taking \nnarcotics, will be discussed at follow up appointment with \nsurgeon when you will be able to drive\n No lifting more than 10 pounds for 10 weeks\n Please call with any questions or concerns ___\n **Please call cardiac surgery office with any questions or \nconcerns ___. Answering service will contact on call \nperson during off hours**\n \nFollowup Instructions:\n___\n"}
{"subject_id":"14237124","hadm_id":"25499711","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nShellfish / Beta-Adrenergic Blocking Agents\n \nAttending: ___.\n \nChief Complaint:\nMorbid obesity\n \nMajor Surgical or Invasive Procedure:\nStatus Post Laparoscopic Gastric Bypass\n\n \nHistory of Present Illness:\nMr. ___ is a ___ gentleman with\nlongstanding morbid obesity refractory to attempts at weight\nloss by nonoperative means. His preoperative weight is 247\npounds. Given his height, this translates to a body mass\nindex of 36.5 kg/m2. Co-morbidities include obstructive sleep\napnea, hypertension, hyperlipidemia. He was evaluated by our\nMultidisciplinary Bariatric Service and deemed a suitable\ncandidate accordance with ___ Health consensus\nstatement. Surgical options including Lap-Band, sleeve\ngastrectomy, gastric bypass were discussed. He understood the\npotential risks, as well as expected outcomes and wished to\nproceed with a gastric bypass.\n\n \nPast Medical History:\ntraumatic brain injury s/p\nMVA in ___ with being comatose for one month requiring\nmultiple surgeries including neurosurgical decompression,\nabdominal surgery, orthopedic repair of knees and ankles and \nskin\ngrafts, struck by car as pedestrian in ___, history of\nintracranial bleed with right hemiparesis, chronic ___ syndrome\ninvolving left shoulder, back, left knee with recurrent \neffusions\nrequiring aspiration (had LS-spine MRI ___ with L4-L5 disk\nprotrusion impinging on right L5) followed in the ___, migraine headaches, history of left shin and left foot\nskin ulcerations, hypertension, hyperlipidemia, moderate-to-\nsevere obstructive sleep disorder breathing (___) with\nrecommendation of CPAP at 16, heartburn, iron deficiency,\nperipheral neuropathy with abnormal EMG study ___ consistent\nwith chronic axonal neuropathy affecting the deep peroneal, \nsural\nand plantar nerves on the left, history of urinary stress\nincontinence and urinary tract infections.\n\n \nSocial History:\n___\nFamily History:\nNo family history of IBD or colon cancer.\n \nPhysical Exam:\nOn day of discharge\nT max:99.3 T current:97.9 HR:78 BP: 128/76 RR: 20 O2 \nsaturation:97% RA\nNo acute distress\nRegular rate and rhythm, no murmurs/rubs/gallops\nLungs clear to auscultation bilaterally\nAbdomen soft non-tender non-distended. incisions c/d/i. No \ndrainage.\nExtremities: well-healed extremity scars from previous \nreconstructive surgeries\n \nPertinent Results:\nUpper Gi Study: ___\n\nNo evidence of leak. Very tight proximal anastomotic stenosis \nlikely due to edema from recent surgery. Contrast has passed \nthrough, \nhowever, very slowly. Recommend keeping patient upright with \nfollowup KUB \n\n \nBrief Hospital Course:\n  Mr. ___ was admitted to the ___ surgery service under \nDr. ___ a ___ Roux-en-Y gastric bypass \nand endoscopy. He tolerated the procedure very well.\n\nNeuro: Post-operatively, the patient received Dilaudid IV/PCA \nwith good effect and adequate ___ control. When tolerating \nStage I diet, the patient was transitioned to oral Roxicet \nelixir with adequate ___ control. \n\nCV: The patient was stable from a cardiovascular standpoint; \nvital signs were routinely monitored.\n\nPulmonary: The patient was stable from a pulmonary standpoint; \nvital signs were routinely monitored. He used a CPAP machine at \nnight for his obstructive sleep apnea. \n \nGI/GU: Post-operatively, the patient was given IV fluids until \ntolerating oral intake. He had an Upper GI series which showed:\n\"No evidence of leak. Very tight proximal anastomotic stenosis \nlikely due to edema from recent surgery. Contrast has passed \nthrough, however, very slowly.\"  \n\nPer radiology recommendations, a f/u KUB was ordered which \nshowed:\n\"Clearance of barium from the gastric pouch. Barium is seen \ndistally in the small bowel. . .\" \n \nAs a result of these two studies his diet was advanced to Stage \nI which he tolerated with out issue. He was later advanced from \nstage I to stage II and then stage III when appropriate. He \ntolerated his dietary advancement without issue and reported \npassage of flatus on multiple occasions. \n\nHis Foley was removed on POD#2. Intake and output were closely \nmonitored. He was able to void without problems.\n\nID: Post-operatively, the patient was given ___ IV \ncefazolin. The patient's temperature was closely watched for \nsigns of infection. \n\nProphylaxis: The patient received subcutaneous heparin during \nthis stay, and was encouraged to get up and ambulate as early as \npossible. \n\nPhysical therapy:\nGiven his know physical limitations, a physical therapy consult \nwas ordered to ensure the patient could be safely discharged to \nhome. During his first session, he was not able to ambulate at \nhis usual baseline and a rehab screen was begun. during \nsubsequent sessions the patient did have rapid improvement with \nhis ambulation and was able to ambulate at his baseline level.  \n\nNutrition: \nThe patient received extensive reading material regarding his \nnew dietary restrictions and general recommendations. He \nexpressed a desire to be compliant with his new diet and read \nthe materials provided. In addition, the ___ nurse \npractitioner provided multiple counseling sessions regarding the \ndietary recommendations and general post-operative instructions. \nThe patient demonstrated improvement in his understanding of his \npost-operative course. In addition, his sister was provided with \na list of foods that the patient should have at home at the time \nof discharge. \n\nAt the time of discharge the patient was hemodynamically stable, \ntolerating stage III diet, ___ was well controlled, he was \nvoiding without issue, ambulating at his baseline.  \n\nFollow up with the ___ clinic will start next week with an \nadditional counseling session with bariatric dietician. He will \nbe followed very closely to ensure understanding of his new \ndiet. \n\n \nMedications on Admission:\nLisinopril 5 mg daily for hypertension;\ncodeine sulfate 30 mg tablets one to two every 8 hours as \nneeded,\noxycodone 5 mg as needed for chronic ___ \nbaby aspirin 81 mg daily for prophylaxis; \nLoratadine 10 mg daily as needed for seasonal allergies; \nmiconazole 2% cream and Lamisil 1% spray for\nfungal infection (athlete's foot); \nmultivitamins with minerals daily, \nvitamin D 1000 units daily and \nomega-3-B12-FA-B6 Phytosterol daily for nutritional \nsupplementation.\n\n \nDischarge Medications:\n1. Roxicet ___ mg/5 mL Solution Sig: ___ ml PO every four (4) \nhours as needed for ___.\nDisp:*500 ml* Refills:*0*\n2. Colace 50 mg/5 mL Liquid Sig: Ten (10) ml PO twice a day as \nneeded for constipation.\nDisp:*500 ml* Refills:*0*\n3. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO once a day: \nPlease crush.  \n4. Actigall 300 mg Capsule Sig: One (1) Capsule PO twice a day: \nPlease take this medication for 6 months. You ___ open capsule \nand place in drink.\nDisp:*60 Capsule(s)* Refills:*5*\n5. Zantac 15 mg/mL Syrup Sig: Ten (10) ml PO twice a day: Please \ntake for one month.\nDisp:*600 ml* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis: Obesity\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nDischarge Instructions: Please call your surgeon or return to \nthe emergency department if you develop a fever greater than \n101.5, chest ___, shortness of breath, severe abdominal ___, \n___ unrelieved by your ___ medication, severe nausea or \nvomiting, severe abdominal bloating, inability to eat or drink, \nfoul smelling or colorful drainage from your incisions, redness \nor swelling around your incisions, or any other symptoms which \nare concerning to you.\n\nDiet: Stay on Stage III diet until your follow up appointment. \nDo not self advance\ndiet, do not drink out of a straw or chew gum.\n\nMedication Instructions:\nResume your home medications, CRUSH ALL PILLS.\nYou will be starting some new medications:\n1.  You are being discharged on medications to treat the ___ \nfrom your operation. These medications will make you drowsy and \nimpair your ability to drive a motor vehicle or operate \nmachinery safely. You MUST refrain from such activities while \ntaking these medications.\n2. You should begin taking a chewable complete multivitamin with \nminerals. No gummy vitamins.\n3. You will be taking Zantac liquid ___ mg twice daily for one \nmonth. This medicine prevents gastric reflux.\n4. You will be taking Actigall 300 mg twice daily for 6 months. \nThis medicine prevents you from having problems with your \ngallbladder.\n5. You should take a stool softener, Colace, twice daily for \nconstipation as needed, or until you resume a normal bowel \npattern.\n6. You must not use NSAIDS (non-steroidal anti-inflammatory \ndrugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and \nNaproxen. These agents will cause bleeding and ulcers in your \ndigestive system.\n\nActivity:\nNo heavy lifting of items ___ pounds for 6 weeks. You ___ \nresume moderate\nexercise at your discretion, no abdominal exercises.\n\nWound Care:\nYou ___ shower, no tub baths or swimming. \nIf there is clear drainage from your incisions, cover with \nclean, dry gauze. \nYour steri-strips will fall off on their own. Please remove any \nremaining strips ___ days after surgery.\nPlease call the doctor if you have increased ___, swelling, \nredness, or drainage from the incision sites. \n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11209674","hadm_id":"23112808","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nScrotal abscess\n\n \nMajor Surgical or Invasive Procedure:\nIncision and drainage of peroneal abscess\nTrans-esophageal echocardiogram\n\n \nHistory of Present Illness:\n___ year-old male previously healthy male with history of IVDU, \nwho initially presented with a peroneal abscess and concern for \nperoneal necrotizing fasciitis, and multiple sepitc lung emboli. \nThe abscess was first noted as a small pimple 5 days prior to \npresentation (___) and has progressively enlarged and become \nmore painful.  He had severals days of fevers and chills and \nstarted experiencing pleuritic chest pain, worse with \ninspiration. He also complained of cough prior to presentation. \nThe day he presented, he noted an area of induration and \nerythema on left shin.  \n.\nPatient underwent I\u0026D of abscess on ___. An idurated, \npurulent area in the scrotal raphe and an area on the left \nbuttock were opened.  Pustular sinus tracts with necrotizing \nsoft tissue wre found and debrided.  Following procedure, \npatient was admitted to the SICU for close monitoring given \nconcern for SIRS/sepsis. Patient initially treated with \nclindamycin, piperacillin-Tazobactam, gentamicin, and \nvancomycin. Patient grew GPC in ___ bottles. Pt had CXR which \nshowed hypodensities, concerning for septic emboli. On CT chest \nhe was found to have numerous bilateral pulmonary nodules, all \nconcerning for septic embolic, infarcts, and disseminated \ninfection felt secondary to abscess.  TTE was negative for \nvegatations.\n.\nID was consulted and felt that the source of the bacteremia and \nseptic emboli was likely his scrotal abscess. The recommended \ncontinuing broad spectrum antibiotics because of polymicrobial \nnature of scrotal abscesses, including clindamycin to cover for \nnecrotizing fasciitis. The gentamycin was discontinued. \n.\nOvernight, on ___, oxygen saturation decreased to mid to high \n___ on 4L NC.  Patient was noted to have increased work of \nbreathing.  He was transitioned to NRB and oxygen saturation \nimproved to low ___, but patient continued to have increased \nWOB.  He was transitioned to BIPAP mask and his breathing \nsymptoms improved.  Given worsening respiratory status and \npersistent tachycardia, patient underwent CTA to assess for PE, \nwhich showed no PE, but does show worsening right sided \nnon-hemorrhagic pleural effusion.  \n.  \nOn transfer to the MICU, patient is comfortable and feels like \nhis breathing is more comfortable on BIPAP.  Scrotal pain is \nwell controlled with current regimen.  Patient reports having \nfevers and chills overnight.  \n.  \nReview of systems:  \n(+) Per HPI. Constipation, has not moved bowels since admission. \n \n(-) Denies night sweats, recent weight loss or gain. Denies \nheadache, sinus tenderness, rhinorrhea or congestion. Denies \nwheezing. Denies  chest pressure, palpitations, or weakness. \nDenies nausea, vomiting, diarrhea, abdominal pain, or changes in \nbowel habits. Denies dysuria, frequency, or urgency. Denies \narthralgias or myalgias.\n \nPast Medical History:\nLeft shoulder surgery ___ \nNo history of skin infections\n\n \nSocial History:\n___\nFamily History:\nNoncontributory\n\n \nPhysical Exam:\nPhysical Exam on Admission:\nVitals: Tm: 101.1, Tc: 99.3, BP: 138/73 P: 89 R: 21 O2: 98% on \nBIPAP  \nGeneral: On BIPAP, appears comfortable \nHEENT: Sclera anicteric, EOMI, PERRL  \nNeck: supple, JVP not elevated, no LAD  \nCV:  Tachy, regular rhythm, no murmurs/rubs/gallops\nLungs: Dull at bases b/l R \u003e L, coarse breath sounds b/l, no \nwheezes\nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno organomegaly  \nGU: Foley in place, scrotal wound packed with wet to dry \ndressings, no drainage or surrounding erythema\nExt: warm, well perfused, 2+ pulses, 3 cm x 3cm area of \ninduration noted on left anterior shin, non-fluctuant\nNeuro: CNII-XII intact, ___ strength upper/lower extremities, \ngrossly normal sensation, 2+ reflexes bilaterally, gait \ndeferred, finger-to-nose intact \n\nPhysial Exam on Discharge:\nVitals: T98.7, BP:144/84, HR:101, RR:20, O2st: 94%RA\nGeneral: breathing comfortably on room air\nCV: RRR, no M/R/G\nLUNGS: rales in right lung base and right middle lobe\nGU: foley removed, scrotal wound packed\nExt: Anterior shin wound packed with wick\nExam otherwise unchanged from admission\n \nPertinent Results:\nLab Results on Admission:\n\n___ 08:30PM BLOOD WBC-22.4* RBC-4.55* Hgb-14.6 Hct-42.1 \nMCV-93 MCH-32.1* MCHC-34.8 RDW-11.3 Plt ___\n___ 08:30PM BLOOD Neuts-81* Bands-1 Lymphs-13* Monos-5 \nEos-0 Baso-0 ___ Myelos-0\n___ 08:30PM BLOOD Hypochr-NORMAL Anisocy-NORMAL \nPoiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL\n___ 08:30PM BLOOD Glucose-127* UreaN-10 Creat-0.7 Na-137 \nK-4.1 Cl-103 HCO3-23 AnGap-15\n___ 06:10PM BLOOD HIV Ab-NEGATIVE\n___ 02:42AM BLOOD Type-ART pO2-62* pCO2-44 pH-7.39 \ncalTCO2-28 Base XS-0\n___ 08:38PM BLOOD Lactate-1.4\n\nStudies:\n\n___ Skin Biopsy: DIAGNOSIS: \n1.  Skin and soft tissue, scrotal raphe; debridement (A-C):\n\n1.Cutaneous acute inflammation with abscess formation, tissue \nnecrosis, and surface bacterial organisms.\n2.Special stains for microorganisms in process, to be reported \nin an addendum.\n2.  Skin, left buttock; debridement (D-E):\n1.Cutaneous acute inflammation and abscess formation with tissue \nnecrosis.\n2.Special stains for microorganisms in process, to be reported \nin an addendum.\n\n___ ECG: Sinus tachycardia. Left axis deviation. No previous \ntracing available for \ncomparison.  \n\n___ CXR: IMPRESSION: Ill-defined nodular opacities primarily \nwithin the lung bases. Findings are concerning for infectious \nprocess such as septic emboli, and a CT can be obtained for \nfurther evaluation. \n\n___ transthoracic Echo: The left atrium is dilated. The right \natrium is moderately dilated. There is moderate symmetric left \nventricular hypertrophy. The left ventricular cavity size is \nnormal. Left ventricular systolic function is hyperdynamic \n(EF\u003e75%). Tissue Doppler imaging suggests a normal left \nventricular filling pressure (PCWP\u003c12mmHg). There is a mild \nresting left ventricular outflow tract obstruction. The aortic \nvalve leaflets (3) are mildly thickened. There is no aortic \nvalve stenosis. No aortic regurgitation is seen. The mitral \nvalve leaflets are mildly thickened. Physiologic mitral \nregurgitation is seen (within normal limits). The tricuspid \nvalve leaflets are mildly thickened. There is moderate pulmonary \nartery systolic hypertension. There is a very small pericardial \neffusion. \nNo vegetation seen (cannot definitively exclude).\n\n___ CTPA: IMPRESSION: \n1. No pulmonary embolism within the limitations of the study. \n2. Numerous pulmonary nodules compatible with septic emboli. \nBilateral lower lobe peripheral heterogenous opacities are now \nlargely obscured by atelectasis are indeterminate but could also \nbe due to septic emboli with possible infarction. \n3. Small-to-moderate bilateral pleural effusions, increased from \nthe study \none day prior.   \n4. Regions of low attenuation within bilateral atelectasis, \nconcerning for \npneumonia. \n \n___ LLE U/S: IMPRESSION: Serpiginous-appearing hypoechoic \nstructure left anterior shin, \npossibly representing a fluid collection or alternatively \nsuperficial \nthrombophlebitis of a markedly distended venous structure. \nClinical \ncorrelation is recommended. \n\n___ CXR: IMPRESSION: \n1. Lung volumes remain low. There is more focal patchy nodular \nopacity at \nthe left apex as well as in the right upper to mid lung which \nappears somewhat cavitary and may reflect known septic emboli \nwhich are now radiographically visible. More focal patchy \nopacity at the right lung base is also present and could \nrepresent a combination of compressive atelectasis, pneumonia \nand/or evolving septic embolic areas. The more rounded \nappearance to the right costophrenic angle is slightly less \napparent on the current examination but still could represent \nloculated pleural fluid. The heart remains enlarged but \nunchanged which may reflect cardiomegaly or pericardial \neffusion. Interval improvement in aeration at the left lung base \nwith no definite left pleural effusion identified on the current \nexamination. Stable mediastinal contours. No evidence of \npulmonary edema. \n.\n___ TEE: No spontaneous echo contrast or thrombus is seen in \nthe body of the left atrium/left atrial appendage or the body of \nthe right atrium/right atrial appendage. No atrial septal defect \nis seen by 2D or color Doppler. Overall left ventricular \nsystolic function is normal (LVEF\u003e55%). Right ventricular \nchamber size and free wall motion are normal. The ascending, \ntransverse and descending thoracic aorta are normal in diameter \nand free of atherosclerotic plaque to 45 cm from the incisors. \nThe aortic valve leaflets (3) appear structurally normal with \ngood leaflet excursion. No masses or vegetations are seen on the \naortic valve. No aortic regurgitation is seen. The mitral valve \nappears structurally normal with trivial mitral regurgitation. \nNo mass or vegetation is seen on the mitral valve. No \nvegetation/mass is seen on the pulmonic valve. There is a \ntrivial/physiologic pericardial effusion. \nIMPRESSION: No valvular pathology or pathologic flow identified.\n\n___ CXR: IMPRESSION: \n1. New left PICC with the tip at least at the estimated location \nof the \ncavoatrial junction but possibly 1-2 cm beyond this. No evidence \nof \nprocedural complication.   \n2. Possible persistent right loculated pleural effusion. \nFollowup with \nconventional PA and lateral radiograph is recommended when \nclinically \nfeasible. \n\nLab results on Discharge:\n\n___ 06:30AM BLOOD WBC-14.3* RBC-3.88* Hgb-12.1* Hct-36.7* \nMCV-95 MCH-31.2 MCHC-33.0 RDW-12.1 Plt ___\n___ 06:20AM BLOOD UreaN-9 Creat-0.6\n___ 03:14AM BLOOD Calcium-8.3* Phos-3.6 Mg-2.2\n___ 04:40PM BLOOD Vanco-18.0\n___ 04:37AM BLOOD Type-ART pO2-81* pCO2-52* pH-7.43 \ncalTCO2-36* Base XS-8\n \nBrief Hospital Course:\nPrimary Reason for Hospitalization: Patient is a ___ year-old, \npreviously healthy, incarcarated male with history of IVDU, who \ninitially presented with a peroneal abscess and concern for \nperineal necrotizing fasciitis, and multiple septic lung emboli. \nThe perineal wound was drained and showed no necrotizing \nfasciitis. Cultures from the wound and blood grew MRSA and \npatient began treatment with vancomycin. A wound on patient's \nanterior left shin was incised and drained as well. He required \na brief ICU stay for respiratory distress but was never \nintubated. His fever and shortness of breath resolved and \npatient went to ___ floor. TEE showed no vegetations and patient \nwas discharged to complete a 6-week course of vancomycin.\n.\nACUTE CARE:\n.\n1. MRSA bacteremia: Patient had a perineal and buttock wound \nthat grew MRSA in culture and blood cultures that grew MRSA as \nwell. He was found to have radiographic evidence of septic \nemboli and was febrile with shortness of breath as well. He was \nstarted on a course of IV vancomycin. Patient received a TEE \nwhich showed no vegetations. He was discharged to complete a \n6-week course of vancomycin.\n.\n2. Perineal wound and other buttock and shin wound: Patient's \ninitial complaint was a tender, erythemetous wound involving the \nscrotum and perineum. It started off as a pimple-sized lesion \nand grew to involve a large area. Surgery evaluated and debrided \nthe wound because of concern for necrotizing fasciitis, which \nwas not present. The wound grew MRSA and patient recieved \nvancomycin and wet-to-dry dressing changes. The additional \nwounds on the left anterior shin and left buttock were incised \nand drained and had daily dressing changes as well. He was \ndishcarged with instructions for antibiotics and dressing \nchanges to continue.\n.\n3. Lung Septic Emboli: Patient had septic emboli to the lung as \nevidenced by chest CT. He showed no neurologic signs suggesting \nbrain lesions. Because of the lung lesions, patient had a period \nof respiratory distress requiring Bipap in the unit. This and \npatient's fever resolved with antibiotics and he did not require \nintubation. He was weaned to room air and previous pain \nexperienced with respiration was greatly decreased. IP evaluated \npatient for a small loculated pleural effusion associated with \nthe involved lung, and it was found to be too small to drain. \nCTPA showed no PE on this admission as well\n.\nCHRONIC CARE:\n.\n1. IVDU history: Patient was informed about the possibility of \ninfection with IVDU and he was made aware that the current \ndamage to his veins from this history interferes with vascular \naccess.\n.\nTRANSITIONS IN CARE:\n1. FOLLOW UP: Patient will follow up with the medical system \nwithin the department of corrections. He should receive follow \nup with infectious disease upon finishing the 6-week course of \nvancomycin.\n2. CARE TRANSITION: Per request of the DOC, patient will be \ntransferred to ___ to complete his inpatient care. \nhe should be continued on heparin SC for DVT ppx.\n3. VACULAR ACCESS: Patient has a PICC line placed. It was \ninitially placed 2 cm too far in as seen on CXR, but was \nretracted 2cm and is OK to use for IV abx now that it is \nproperly positioned.\n4. CODE STATUS: presumed full\n\n \nMedications on Admission:\nnone\n \nDischarge Medications:\n1. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) mL \nInjection TID (3 times a day).  \n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n3. Sodium Chloride 0.9%  Flush 3 mL IV Q8H:PRN line flush \nPeripheral line: Flush with 3 mL Normal Saline every 8 hours and \nPRN. \n4. Heparin Flush (10 units/ml) 2 mL IV PRN line flush \nPICC, heparin dependent: Flush with 10mL Normal Saline followed \nby Heparin as above daily and PRN per lumen. \n5. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain: hold for sedation or RR\u003c10.  \n6. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n7. ipratropium bromide 0.02 % Solution Sig: One (1) neb \nInhalation Q6H (every 6 hours) as needed for dyspnea.  \n8. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every \n6 hours) as needed for fever/pain: do not administer more than \n4g per day.  \n9. vancomycin 1,000 mg Recon Soln Sig: ___ mg \nIntravenous three times a day for 6 weeks: 6 weeks of therapy to \nbe completed with last day ___.  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: MRSA bacteremia\nSecondary: Septic emboli to the lungs\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the hospital because you developed a large \nabscess on your scrotum. We also found wounds on your left shin \nand left buttock and areas of infection in the lungs as well. \nThe cultures from the wound grew a bacteria called MRSA, and you \nwere found to have this growing in your blood stream as well. \nThe bacteria spread from one the above-mentioned skin wounds to \nthe blood and went to the lungs and other wounds from there. We \ndid an ultrasound of your heart that showed no infection in the \nheart itself. \n\nMRSA is a bacteria that is very resistant to most antibiotic \ntreatment, which is why you are being given vancomycin \nintravenously, which does work agaist this bacteria. You will \nneed to continue this antibiotic for a total of 6 weeks.\n\nPlease start the following medications:\n1. START Vancomycin 2g IV q8hr (to be completed ___\n2. START Dilaudid 2mg ___ tablets by mouth every 6 hours as \nneeded for pain\n** This medication can cause sedation and drowsiness\n3. START Docusate 100mg by mouth twice daily for constipation\n4. START Heparin 5000 units subcutaneously three times daily if \nyou are not ambulating\n5. START Ipratropium nebulizer as needed for shortness of breath \nor wheezing\n6. START Ranitidine 150mg by mouth twice daily for heartburn\n7. START Tylenol as needed for pain (do not exceed 4g in one \nday)\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12117565","hadm_id":"28683122","text":" \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet / Vicodin\n \nAttending: ___\n \nChief Complaint:\ndiarrhea\n \nMajor Surgical or Invasive Procedure:\nNone this hospitalization\n\n \nHistory of Present Illness:\nMs ___ is a ___ year old female with hisotory of living \nunrelated kideny transplant ___ secondary to \nIDDM/hypertension, presenting with watery diarrhea and acute \nkidney injury. She was sent in from her nephrologist in \n___ (Dr. ___.  \n\nOver the past ___ weeks, she has been having watery diarrhea (up \nto 20 episodes per day). She had been seen by her primary care \nphysician as well as nephrologist over the past two-three weeks. \nOn lab evaluation creatinine rose to 1.4 (baseline 0.9-1.2 per \nreports). She was subsequently seen at ___ and ___ \nIVF, as thought that this was pre-renal secondary to diarrhea. \nPatient continued to have further diarrhea since that time. \nRepeat creatinine was 1.7. As a result, nephrologist referred \nher to ___ for further evaluation of the chronic diarrhea as \nwell as the ___ given that she is on immunosuppression (cellcept \nand prograf).  \nOf note, as part of her outpatient workup for the diarrhea she \nwas tested for C. diffile x 2. Both were negative. She was \nstarted empirically on metronidazole this week. She had also \nbeen on immodium over these three weeks with no improvement of \nthe diarrhea. \n\nShe denies any travel history, she denies any new foods. The \ndiarrhea wakes her up at night. She has lost ___ due to \nthis watery diarrhea. \n\nShe denies abdominal pain, hematochezia, melena. Denies fevers \nchills, cramps. She does note a loss of appetite. Patient did \nhave a chronic cough prior to the onset of the diarrhea. She \ndoes note that she was on antibiotics for the cough prior to the \nonset of the diarrhea.  \n\nVitals in the ED: 98.6 78 155/81 16 100% RA  \n\nLabs notable for: Cr 1.4, H/H 10.9/32.2 (baseline). UA with \nleuks and bacteria. Renal ultrasound showed \"Parvus tardus \nwaveform within the intrarenal arteries with normal resistive \nindices, normal main renal artery, and patent main renal vein is \nworrisome for main renal artery stenosis near the renal hilum.\"  \n\nPatient given: IVF run at 125 ml/hr.\n \nPast Medical History:\nPMH: IDDM, HTN, hyperchol, h/o TIA, ESRD\nPSH: R tunneled HD line ___, D\u0026C for heavy menstrual bleeding, \ns/p LURT ___\n \nSocial History:\n___\nFamily History:\n- mother - hypertension.  \n- Father - hypertension.  \n- one brother- healthy.  \nShe has four children, all of whom are healthy, there are ages \nin their ___.\n \nPhysical Exam:\nadmission: \n==========\nVitals - T: 97.5 BP: 121/67 HR: 87 RR: 16 02 sat: 100% RA  \nGENERAL: NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding, no hepatosplenomegaly, well healed scar in \nRLQ, no tenderness of renal transplant.  \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n\ndischarge: \n==========\nVitals - 98.2   98.8   108-123 / 59   18   70s-80s   1380/1480, \nBMx1. BRx3 since midnight. \nBG - FSG 92 this am, Glood glucose on CMP 32.\nGENERAL: NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding, no hepatosplenomegaly, well healed scar in \nRLQ, no tenderness of renal transplant.  \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n\n \nPertinent Results:\nadmission: \n----------\n\n___ 09:42PM BLOOD WBC-7.6 RBC-3.75* Hgb-10.9* Hct-32.2* \nMCV-86 MCH-29.0 MCHC-33.8 RDW-13.9 Plt ___\n___ 09:42PM BLOOD Neuts-81.0* Lymphs-11.5* Monos-5.5 \nEos-1.7 Baso-0.3\n___ 06:55AM BLOOD ___ PTT-35.3 ___\n___ 09:42PM BLOOD Glucose-113* UreaN-21* Creat-1.4* Na-136 \nK-4.4 Cl-101 HCO3-24 AnGap-15\n___ 12:55PM BLOOD Amylase-59\n___ 12:55PM BLOOD Lipase-32\n___ 06:55AM BLOOD LD(LDH)-146\n___ 12:55PM BLOOD Calcium-8.8 Phos-3.2 Mg-1.3*\n\ntacrolimus levels:\n------------------\n\n___ 06:55AM BLOOD tacroFK-7.4\n___ 06:05AM BLOOD tacroFK-8.2\n___ 05:50AM BLOOD tacroFK-7.0\n\nmicrobiology:\n-------------\n\n___ 06:05AM BLOOD EBV PCR, QUANTITATIVE, WHOLE BLOOD-PND\n___ 08:00PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD\n___ 08:00PM URINE RBC-1 WBC-11* Bacteri-MANY Yeast-NONE \nEpi-0\n\n___ 8:00 pm URINE      SOURCE: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      KLEBSIELLA PNEUMONIAE.    \u003e100,000 ORGANISMS/ML.. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             KLEBSIELLA PNEUMONIAE\n                             |   \nAMPICILLIN/SULBACTAM--     4 S\nCEFAZOLIN-------------   \u003c=4 S\nCEFEPIME--------------   \u003c=1 S\nCEFTAZIDIME-----------   \u003c=1 S\nCEFTRIAXONE-----------   \u003c=1 S\nCIPROFLOXACIN---------\u003c=0.25 S\nGENTAMICIN------------   \u003c=1 S\nMEROPENEM-------------\u003c=0.25 S\nNITROFURANTOIN--------    64 I\nPIPERACILLIN/TAZO-----   \u003c=4 S\nTOBRAMYCIN------------   \u003c=1 S\nTRIMETHOPRIM/SULFA----   \u003c=1 S\n\n___ 5:15 am STOOL     CONSISTENCY: LOOSE      Source: \nStool. \n\n                            **FINAL REPORT ___\n\n   C. difficile DNA amplification assay (Final ___: \n      Negative for toxigenic C. difficile by the Illumigene DNA\n      amplification assay. \n           (Reference Range-Negative). \n\n   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA \nFOUND. \n\n   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER \nFOUND. \n\n   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA \nFOUND. \n\n   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: \n      NO E.COLI 0157:H7 FOUND.\n\n___ 6:55 am Immunology (CMV)\n\n   CMV Viral Load (Final ___: \n      CMV DNA not detected.\n\n___ 06:05 \n\nEBV PCR, QUANTITATIVE, WHOLE BLOOD \n  Test                          Result              Reference \nRange/Units\nSOURCE                        Whole Blood         \nEBV DNA, QN PCR               \u003c200                \u003c200 copies/mL\n\n___ 13:38 \nADENOVIRUS PCR \n  Test                          Result              Reference \nRange/Units\nSOURCE                        Serum               \nADENOVIRUS DNA, QN PCR        \u003c500                \u003c500 copies/mL\n\n                            **FINAL REPORT ___\n\n   CMV IgG ANTIBODY (Final ___: \n      NEGATIVE FOR CMV IgG ANTIBODY BY EIA. \n      \u003c4 AU/ML. \n      Reference Range:  Negative \u003c 4 AU/ml, Positive \u003e= 6 AU/ml. \n\n\n   CMV IgM ANTIBODY (Final ___: \n      NEGATIVE FOR CMV IgM ANTIBODY BY EIA. \n      INTERPRETATION:  NO ANTIBODY DETECTED. \n \nimaging: \n--------\n\n___ CT ab/p: \n1. Mesenteric lymphadenopathy and fluid within the proximal \ncolon, \nnonspecific, cannot exclude enteritis if clinically suspected.  \nHowever, small bowel loops appear normal in morphology.  \nMesenteric lymphadenopathy with trace surrounding fat stranding \nmay represent mesenteric panniculitis. Followup examination in 6 \nmonths is recommended in order to ensure resolution. \n2. Atrophied native kidneys with several punctate \ncalcifications, either \nrepresenting nonobstructing stones or vascular calcifications. \nUnremarkable transplant kidney. \n3. Otherwise unremarkable non contrast CT examination of the \nabdomen and \npelvis. \n\n___ ABDOMINAL ULTRASOUND: \nThe right iliac fossa transplant renal morphology is normal.  \nSpecifically, the cortex is of normal thickness and \nechogenicity,pyramids are normal, there is no pelvi-infundibular \nthickening, and renal sinus fat is normal.  There is no \nhydronephrosis. There is no perinephric fluid collection.   \nThe resistive index of intrarenal arteries ranges from 0.66 to \n0.71, within the normal range. Acceleration time of the main \nrenal artery has normalized and the parvus et tardus waveform \nhas resolved.  While some delay in late systole is observed, the \ninitial systolic upstroke is brisk. The peak systolic velocity \nof the main renal artery has decreased from 122 to 81 cm/s. \nVascularity is symmetric throughout transplant. The transplant \nrenal vein is patent and shows normal waveform.   \nIMPRESSION:    \nInterval resolution of parvus et tardus waveform in the sampled \nintrarenal arteries.  Main renal artery peak systolic velocity \nhas also decreased from 122 to 81 cm/s. \n\ndischarge labs: \n---------------\n\n___ 05:50AM BLOOD WBC-8.2 RBC-3.60* Hgb-10.5* Hct-30.7* \nMCV-85 MCH-29.1 MCHC-34.1 RDW-14.1 Plt ___\n___ 05:50AM BLOOD Glucose-32* UreaN-12 Creat-1.0 Na-141 \nK-4.4 Cl-106 HCO3-24 AnGap-15\n___ 05:50AM BLOOD Calcium-9.6 Phos-4.4 Mg-1.___ yo F with PMHx of ESRD s/p LURT in ___ on tacrolimus/MMF, \nIDDM, HTN who presents with watery diarrhea and rise in \ncreatinine, and \u003e100,000 GNRs in urine.  \n\n# ESRD s/p LURT: Creatinine downtrended to 1.0 from 1.7 at ___ \nwith IVF resuscitation. Rise in creatinine likely pre-renal from \ndiarrhea and dehydration with perhaps a contribution from a UTI. \nHer MMF was transitioned to three times daily. Her tacrolimus \nwas continued at 1mg PO q12hr. \n\n# Diarrhea: Infectious work-up negative (c. diff, e. coli, \nyersinia, campylobacter, salmonella, shigella). CMV viral load \nwas negative. MMF transitioned to three times a day. Does need \noutpatient screening colonoscopy. EBV Viral load \u003c 200. \nAdenovirus PCR negative as well. \n\n# Urinary Tract Infection: Klebseilla from urine culture on \nadmission. She was started on ceftriaxone and transitioned to \nciprofloxacin based on sensitivities. She will complete a course \non ___.   \n \n# Insulin dependent diabetes mellitus: Patient had several \nepisodes of hypoglycemia so she was instructed to closely \nmonitor her blood sugars in addition to decreased her lantus.  \n\n\u003e\u003e TRANSITIONAL ISSUES: \n* Mesenteric Lymphadenopathy: Please recheck EBV viral in 2 \nweeks. Patient may need to have repeat CT scan in ___ months to \nevaluate for interval progression. \n* Immunosuppression: MMF transitioned to 500mg po three times \ndaily, tacrolimus continued at home dose 1mg PO q12hr\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Glargine 12 Units Breakfast\nGlargine 12 Units Bedtime\nInsulin SC Sliding Scale using HUM Insulin\n2. Tacrolimus 1 mg PO Q12H \n3. Mycophenolate Mofetil 1000 mg PO BID \n4. Metoprolol Succinate XL 50 mg PO DAILY \n5. Omeprazole 20 mg PO DAILY \n6. Aspirin 81 mg PO QHS \n7. Simvastatin 20 mg PO QPM \n8. DiphenhydrAMINE 50 mg PO QHS:PRN insomnia \n\n \nDischarge Medications:\n1. Aspirin 81 mg PO QHS \n2. DiphenhydrAMINE 50 mg PO QHS:PRN insomnia \n3. Glargine 8 Units Breakfast\nGlargine 8 Units Bedtime\nInsulin SC Sliding Scale using HUM Insulin\n4. Metoprolol Succinate XL 50 mg PO DAILY \n5. Mycophenolate Mofetil 500 mg PO TID \nRX *mycophenolate mofetil 500 mg 1 tablet(s) by mouth three \ntimes daily Disp #*42 Tablet Refills:*0\n6. Omeprazole 20 mg PO DAILY \n7. Tacrolimus 1 mg PO Q12H \n8. Ciprofloxacin HCl 500 mg PO Q12H \nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \nDisp #*23 Tablet Refills:*0\n9. Simvastatin 20 mg PO QPM \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY: \n1. diarrhea\n2. status-post renal transplant\n3. end stage renal disease \n4. diabetes mellitus, insulin dependent \n5. hypertension \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a pleasure taking care of you at the ___ \n___. You were admitted with diarrhea. We \nchecked your stool for evidence of infection and did not find \nany. We think your diarrhea is from the mycophenolate so we \nswitched your dosing to 500 mg three times daily. This helped \nimprove your diarrhea. We talked to Dr. ___ agreed with \nthis change. He would like to see you within one to two weeks of \ndischarge. \n\nYou were also found to have a urinary tract infection for which \nyou were started on antibiotics. You will take antibiotics \nthrough ___. \n\nYou had episodes of low blood sugar in the hospital so we \ndecreased your long-acting insulin. \n\nWe wish you all the best, \nYour ___ Team \n \nFollowup Instructions:\n___\n"}
{"subject_id":"12601979","hadm_id":"20157806","text":" \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNaprosyn / Oak\n \nAttending: ___.\n \nChief Complaint:\nSOB and hypoxia\n \nMajor Surgical or Invasive Procedure:\nVATS\n \nHistory of Present Illness:\nPlease see MICU admission note for full details of initial \npresentation. Briefly, pt is a ___ y/o F hx NHL s/p CHOP who has \nsince developed progressively worsening SOB and DOE (baseline is \n2LNC at home). She presented to OSH, received steroids and was \ntransferred to ___ for rule out PE. CTA was negative; however, \nbecause pt initially was unable to wean from NRB, she was \nadmitted to MICU. In MICU, she was started empirically of \nlevaquin for dry cough, diuresed to lasix (20mg IV X2) with \ntotal LOS negative 1.9L and oxygenation improved to 94-95% 4LNC. \n \n.  \nUpon arrival to medical floor, she reports feeling better. \nFurther hx obtained. She tells me that her SOB and DOE really \nstarted after CHOP and also after a trip to ___ in ___ where \nshe stayed in ___ and contracted \"black mold.\" This was \ndiagnosed with bronch and bx at ___ (and per Dr. \n___ this may have been aspergillus). She reports \nbeing treated with 60 mg prednisone for at least 2 months. \nNotably, whenever she tried to come off prednisone, her SOB got \nworse requiring hospitalization. This happened twice.  \n.  \nCurrently, she feels somewhat better. ROS + cough green-yellow \nsputum increased in thickness X few weeks. + headache, no CP, \npalpitations, fever, chills, + nightsweats, + weight gain post \nchemo. She denies ___ swelling.  \n\n \nPast Medical History:\n# NHL dx in ___ s/p RCHOP. thought to be in remission. No XRT  \n# Hypertension  \n# Cerebral aneursym s/p clips  \n# OSA: did not use cpap for a long time  \n# Hypothyroid  \n \nSocial History:\n___\nFamily History:\nFather: asthma  \nMother with severe RA  \nSisters with COPD \n \nPhysical Exam:\nAdmission\nPE: 97.2 153/68 89 93%4LNC O2 Sats  \nGen: pleasant, obese, speaking comfortably  \nHEENT: Clear OP, MMM  \nNECK: Supple, No LAD, No JVD  \nCV: RR, NL rate. NL S1, S2. No murmurs, rubs ___  \nLUNGS: dry, velcro-like crackles ___ bilateral lung-fields  \nABD: Soft, NT, ND. NL BS. No HSM  \nEXT: No edema. 2+ DP pulses ___  \nSKIN: No lesions  \nNEURO: A\u0026Ox3. Appropriate. CN ___ grossly intact. Preserved \nsensation throughout. ___ strength throughout. ___ reflexes, \nequal ___.  \nPSYCH: Listens and responds to questions appropriately, pleasant \n \n.  \nPE: 97.2 120/68 95 18 96% 2.5LNC O2 Sats  \nPE: 97.2 153/68 89 93%4LNC O2 Sats  \nGen: pleasant, obese, speaking comfortably  \nHEENT: Clear OP, MMM  \nNECK: Supple, No LAD, No JVD  \nCV: RR, NL rate. NL S1, S2. No murmurs, rubs ___  \nLUNGS: occaisonal wheezes, no labored breathing \nABD: Soft, NT, ND. NL BS. No HSM  \nEXT: No edema. 2+ DP pulses ___  \nSKIN: No lesions  \nNEURO: A\u0026Ox3. Appropriate. CN ___ grossly intact. Preserved \nsensation throughout. ___ strength throughout. ___ reflexes, \nequal ___.  \nPSYCH: Listens and responds to questions appropriately, pleasant \n \n.  \n \nPertinent Results:\nCTA CHEST/ABD/PELVIS: IMPRESSION:  \n1. No evidence of pulmonary embolism.  \n2. No evidence of pneumonia.  \n3. No evidence of acute intra-abdominal pathology.  \n4. Portocaval lymphadenopathy  \n5. Diffuse airtrapping throughout the lungs with emphysematous \nchange.  \n.  \nCXR: PORTABLE UPRIGHT CHEST RADIOGRAPH: The heart size is \nnormal. The mediastinal and hilar contours are unremarkable. The \nleft costophrenic angle is excluded due to limited positioning. \nVisualized lungs are clear. There is no large effusion. A right \ninternal jugular catheter terminates in the lower SVC.  \nIMPRESSION: No evidence of pneumonia or CHF.\n.\nEcho:\nThe left atrium and right atrium are normal in cavity size. The \nestimated right atrial pressure is ___ mmHg. Left ventricular \nwall thicknesses and cavity size are normal. Regional left \nventricular wall motion is normal. Overall left ventricular \nsystolic function is low normal (LVEF 50-55%). The estimated \ncardiac index is normal (\u003e=2.5L/min/m2). Right ventricular \nchamber size and free wall motion are normal. The aortic valve \nleaflets (3) appear structurally normal with good leaflet \nexcursion and no aortic regurgitation. The mitral valve leaflets \nare structurally normal. There is no mitral valve prolapse. Mild \n(1+) mitral regurgitation is seen. There is mild pulmonary \nartery systolic hypertension. There is no pericardial effusion. \nIMPRESSION: Suboptimal image quality. Normal cavity sizes with \nlow normal left ventricular systolic function. Mild mitral \nregurgitation. Mild pulmonary artery systolic function. \n.\nHigh Resolution Chest CT:\nAgain seen are diffuse scattered areas of ground-glass opacity \nthroughout the lungs bilaterally, in a somewhat mosaic pattern. \nAllowing for differences in technique, this appearance is little \nchanged compared to ___. Findings are increased compared \nto ___. Areas of both increased density and increased \nlucency are seen suggesting mixed infiltrative and obstructive \nprocess. There are no focal consolidations. Airways are patent \nto the subsegmental level. Air trapping is seen on expiratory \nphase images. There is no pleural or pericardial effusion. \nScattered mediastinal lymph nodes are seen; however, none appear \nto meet CT criteria for pathologic enlargement. There are no \npathologically enlarged hilar or axillary lymph nodes. Limited \nviews of the upper abdomen are grossly unremarkable. No \nsuspicious lytic or blastic osseous lesions are identified. \nRight-sided port again identified.\nIMPRESSION: \nDiffuse multifocal ground-glass opacities in a predominating \nmosaic pattern, worse when compared to ___, little \nchanged from ___. Airtrapping seen on expiratory phase \nimages. Findings are most concerning for hypersensitivity \nreaction. Other diagnostic considerations include possibly drug \nreaction or bronchiolitis obliterans.\n.\nPulmonary Report SPIROMETRY, LUNG VOLUMES, DLCO Study Date of \n___  10:23 AM\nSPIROMETRY 10:23 AM Pre drug Post drug \n       Actual Pred  %Pred   Actual  %Pred %chg \nFVC      2.16 3.23   67     2.35     73     +9 \nFEV1     1.24 2.36   52     1.38     59     +12 \nMMF      0.47 2.62   18     0.60     23     +27 \nFEV1/FVC57 73   78   59     81              +3 \n \nLUNG VOLUMES 10:23 AM Pre drug Post drug \n    Actual    Pred    %Pred \nTLC   5.34    5.26     102       \nFRC   3.03    3.01     101       \nRV   2.77    2.03      136       \nVC   2.57    3.23       80       \nIC   2.31    2.25      103       \nERV  0.26    0.98       27       \nRV/TLC 52      39      134       \nHe Mix Time   4.25           \n \nDLCO 10:23 AM   \n      Actual    Pred   %Pred \nDSB    14.23    19.09   75       \nVA(sb)  4.26    5.26    81       \nHB      3.70           \nDSB(HB)14.10    19.09   74       \nDL/VA   3.31     3.63   91       \n.\nCBC\n___ 01:15AM BLOOD WBC-7.3 RBC-4.30 Hgb-13.1 Hct-36.9 MCV-86 \nMCH-30.4 MCHC-35.3* RDW-16.3* Plt ___\n___ 05:05AM BLOOD WBC-6.2 RBC-4.19* Hgb-12.8 Hct-35.9* \nMCV-86 MCH-30.4 MCHC-35.6* RDW-16.2* Plt ___\n___ 05:05AM BLOOD WBC-5.1 RBC-4.47 Hgb-13.8 Hct-38.4 MCV-86 \nMCH-30.9 MCHC-36.0* RDW-15.9* Plt ___\n___ 06:30AM BLOOD WBC-6.8 RBC-4.78 Hgb-14.2 Hct-40.6 MCV-85 \nMCH-29.6 MCHC-34.8 RDW-15.9* Plt ___\n___ 05:35AM BLOOD WBC-5.3 RBC-4.46 Hgb-13.6 Hct-38.1 MCV-86 \nMCH-30.6 MCHC-35.7* RDW-15.6* Plt ___\n___ 05:20AM BLOOD WBC-5.9 RBC-4.35 Hgb-13.0 Hct-37.1 MCV-85 \nMCH-29.9 MCHC-35.1* RDW-15.5 Plt ___\n___ 01:15AM BLOOD Neuts-80.2* Lymphs-17.0* Monos-1.4* \nEos-0.9 Baso-0.5\n___ 05:10AM BLOOD Neuts-58.3 ___ Monos-9.0 Eos-7.3* \nBaso-1.3\n.\nChem7\n___ 01:15AM BLOOD Glucose-125* UreaN-16 Creat-1.2* Na-135 \nK-5.7* Cl-98 HCO3-27 AnGap-16\n___ 04:40AM BLOOD Glucose-93 UreaN-30* Creat-1.5* Na-142 \nK-4.3 Cl-101 HCO3-31 AnGap-14\n___ 05:05AM BLOOD Glucose-98 UreaN-24* Creat-1.3* Na-142 \nK-4.7 Cl-104 HCO3-31 AnGap-12\n___ 05:10AM BLOOD Glucose-95 UreaN-27* Creat-1.2* Na-141 \nK-4.5 Cl-104 HCO3-26 AnGap-16\n___ 06:30AM BLOOD Glucose-96 UreaN-30* Creat-1.2* Na-143 \nK-4.6 Cl-107 HCO3-21* AnGap-20\n___ 05:35AM BLOOD Glucose-93 UreaN-28* Creat-1.2* Na-141 \nK-4.7 Cl-106 HCO3-24 AnGap-16\n___ 05:20AM BLOOD Glucose-104 UreaN-24* Creat-1.1 Na-141 \nK-4.2 Cl-101 HCO3-26 AnGap-18\n.\nMISC\n___ 01:15AM BLOOD ALT-22 AST-61* CK(CPK)-85 AlkPhos-53 \nTotBili-0.5\n___ 01:15AM BLOOD CK-MB-NotDone cTropnT-\u003c0.01 proBNP-996*\n___ 05:19PM BLOOD ANCA-NEGATIVE B\n___ 05:19PM BLOOD ___ Titer-1:40\n___ 05:10AM BLOOD IGE- \u003c2.0\n___ 04:40AM BLOOD ASPERGILLUS GALACTOMANNAN ANTIGEN- \nnegative \n___ 04:40AM BLOOD B-GLUCAN-negative   \n___ 10:39AM BLOOD Type-ART pO2-64* pCO2-52* pH-7.35 \ncalTCO2-30 Base XS-1 Intubat-INTUBATED   \n.\nPathology\nLung, right middle lobe, wedge resection (A-D):\na)  Numerous non-necrotizing granulomas, see note.\nb)  Subpleural fibrosis with honeycomb change.\nc)  Focal organizing pneumonitis\nII.  Lung, right lower wedge resection (E-H):\na)  Numerous non-necrotizing granulomas, see note.\nb)  Subpleural fibrosis with honeycomb change.\nc)  Focal organizing pneumonitis.\nNote:  Special stains for AFB, GMS and PSA are negative with \nsatisfactory controls.  The differential diagnosis includes an \ninfection process, sarcoidosis and less likely hypersensitivity \npneumonitis.  Dr. ___ has reviewed the case (H \u0026 E slides) \nand concurs.\n\n \nBrief Hospital Course:\n # Dyspnea: The patient was admitted for dyspnea and hypoxia. \nShe was initially requiring an NRB and was admitted to the ICU \novernight. She was thought to be volume overloaded and diuresed. \nHer hypoxia improved. She was found to be 84% on RA per her \nhematologist prior to admission. On transfer to the floor, she \nwas 89% RA, 95% 2L. During her hospital stay, her shortness of \nbreath improved subjectively although she still had significant \ndyspnea on exertion. She received albuterol and ipratropium nebs \nq6hours; no steroids or Advair. She was switched from Tiotropium \nand Advair to Combivent 4 times daily as her symptoms and \noxygenation appeared to improve with frequent nebs. Beta-blocker \nwas stopped to avoid bronchospasm. HCTZ was started instead for \nhigh BP. The pulmonary team followed her during her stay.  Echo \nshowed no evidence of systolic or diastolic heart failure. PFT's \nshowed obstrutive pattern with increased lung volumes and \nreduced diffusion capacity. Her work up included: ANCA- \nnegative; ___ 1:40 (negative); Galactomanin and B-glucan \nnegative; IgE \u003c2.0; absolute peripheral eosinophilia of 300; \nHypersensitvity panel negative. High Resolution Chest CT showed \ndiffuse multifocal ground-glass opacities in a predominating \nmosaic pattern, worse when compared to ___. The patient \nwas taken to VATS. VATS showed numerous non-necrotizing \ngranulomas c/w sarcoidosis. Vit D levels and ACE-I were WNL. She \nwas stared on Prednisone 40mg daily. She was started on \nbisphosphate and calcium w/ vit D. She was also started on \nbactrim for PCP ___.\n.\n# Purulent discharge from port-a-cath: On ___, the lumen of \nthe patient's port-a-cath was found to be draining discharge. \nThe IV nurse drew back from the lumen of the port and suctioned \nout yellow fluid. A wound culture was sent, found to have 3+ \nPMN's but no organisms grew. Blood cultures were sent were \nnegative. The patient showed no sign of systemic infection w/o \nfevers, leukocytosis or chills. As the patient had not used the \nport-a-cath for treatment in 6+ months, the port-a-cath was \nremoved at the same time as the VATS.\n.\n# Hypertension: Beta-blocker was stopped to reduce any \ncontribution to obstructive lung disease. HCTZ was started \ninstead. ACE-i was considered but the patient appeared to be in \nacute renal failure. She had no secondary indication for an \nACE-i.\n.\n# ARF: Baseline creatinine from OSH records appears to be \n0.9-1.0. On admission, she had a creatinine 1.2 which rose to \n1.5 then came down to 1.1. The acute renal failure may have been \ndue either to IV contrast or diuresis on admission. No further \ndiuresis was performed and her ins/out kept even.\n \nMedications on Admission:\nMEDS on TRANSFER:  \nLevofloxacin 750 mg IV QDAILY  \nAlbuterol-Ipratropium ___ PUFF IH Q6H:PRN  \nFexofenadine 60 mg PO BID  \nFluticasone-Salmeterol (250/50) 1 INH IH BID  \nTiotropium Bromide 1 CAP IH DAILY  \nLevothyroxine Sodium 100 mcg PO DAILY  \nMetoprolol Tartrate 25 mg PO BID  \nTricor *NF* 145 mg Oral daily  \nAcetaminophen 325-650 mg PO Q6H:PRN  \nCelebrex *NF* 200 mg Oral daily  \nDuloxetine 60 mg PO DAILY  \nPantoprazole 40 mg PO Q24H  \nColace/Senna  \n.  \n.  \nHOME MEDS:  \nfexofenadine  \ncelebrex ___ po daily  \nnexium 40mg po dialy  \nfluticasone/salmeterol 500/50  \ntiotropium  \ncymbalta 60mg po daily  \ncombivent  \ntricor 145  \nmetoprolol 25mg po bid  \nsynthroid ___ po daily  \n.  \n\n \nDischarge Medications:\n1. Fexofenadine 60 mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n2. Celecoxib 200 mg Capsule Sig: One (1) Capsule PO daily ().  \n3. Nexium 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO once a day.  \n4. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n5. Fenofibrate Micronized 145 mg Tablet Sig: One (1) Tablet PO \ndaily ().  \n6. Duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n7. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain.  \n8. Combivent ___ mcg/Actuation Aerosol Sig: Two (2) puffs \nInhalation four times a day.  \n9. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO \nDAILY (Daily).\nDisp:*60 Capsule(s)* Refills:*6*\n10. Lorazepam 0.5 mg Tablet Sig: ___ Tablets PO Q8H (every 8 \nhours) as needed for anxiety.  \n11. Bacitracin Zinc 500 unit/g Ointment Sig: as directed Appl \nTopical BID (2 times a day) for 4 days: apply a small amount to \nVats incisions.  \n12. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).\nDisp:*60 Tablet(s)* Refills:*3*\n13. Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) \nTablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n14. Dextromethorphan-Guaifenesin ___ mg/5 mL Liquid Sig: Five \n(5) ML PO Q6 () as needed for cough for 10 days.\nDisp:*qs ML(s)* Refills:*0*\n15. Morphine 15 mg Tablet Sig: One (1) Tablet PO every six (6) \nhours as needed for pain for 2 weeks.\nDisp:*30 Tablet(s)* Refills:*0*\n16. CALCIUM 500+D 500 (1,250)-400 mg-unit Tablet, Chewable Sig: \nOne (1) Tablet, Chewable PO twice a day.\nDisp:*60 Tablet, Chewable(s)* Refills:*2*\n17. Fosamax 5 mg Tablet Sig: One (1) Tablet PO once a day: Take \nwith a full glass of water in the morning. Do not lie down \nwithin an hour of taking this medication.\nDisp:*30 Tablet(s)* Refills:*3*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___.\n \nDischarge Diagnosis:\nSarcoid\n\n \nDischarge Condition:\nstable, continues to require ___ NC to maintain SaO2 \u003e92%\n\n \nDischarge Instructions:\nYou were admitted with shortness of breath and hypoxia. You \nreceived a VATS and were diagnosed with Sarcoid. You have been \nrestarted on Prednisone. In addition, you should take bactrim to \nprevent PCP. It is also important that you take calcium and vit \nD to prevent decreased bone density on prednisone.\n.\nThe following medication changes have been made:\n1. Start taking Prednisone\n2. Start taking Bactrim\n3. Start taking Calcium with Vit D for bone strength.\n5. Start taking Fosamax to prevent osteoporosis while being on \nprednisone.\n6. Start taking Dextromethorphan with Guiafenisin (cough \nsupressant) as needed for cough.\n7. Stop taking Metoprolol\n8. Start taking Hydrocholorothiazide for blood pressure instead \nof Metoprolol.\n9. You can stop taking tiotoprium. Take Combivent 4 times a day \ninstead.\n10. You do not need to take Advair.\n11. Take tylenol for mild pain. Take Morphine ___ for severe \npain.\n12. You can put a small amount of bacitracin on your VATS \ninscisions for a few days while they are healing.\n.\nIf you have worsening shortness of breath, worsening chest pain, \nfevers or chills, you should return to the emergency room.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"18001922","hadm_id":"22771616","text":" \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nNausea, vomiting\n \nMajor Surgical or Invasive Procedure:\ncardiac catheter ___\n \nHistory of Present Illness:\n___ year old female with CAD s/p CABG, diastolic CHF, \nhypertension presenting with nausea, vomiting and new right \nbundle branch block.  Patient presents with nausea and \nconstipation for the last day or two, although she does report a \nbowel movement yesterday.  She denies chest pain or dyspnea.  \nShe also denies fevers, chills, coughs, or abdominal pain.  She \nhas no reported episodes of vomiting at home.  There have been \nno fevers or chills.\n\nIn the ED, initial vitals were 98 103 153/92 20 100% RA.  Labs \nshowed bicarbonate of 20, normal anion gap, creatinine 1.2.  \nTroponin was \u003c0.01.  UA showed no WBC, no bacteria, 30 protein, \n150 glucose.  ECG showed new right bundle branch block.  CXR and \nKUB showed no free air, no air fluid levels, calcifications \nalong the aorta and iliac vessels, and evidence of COPD but no \nacute cardiopulmonary disease.  CT A/P preliminarily showed no \nacute findings, and diverticulosis without evidence of \ndiverticulitis.  The patient had a few episodes of vomiting up \nPO liquids, no frank vomitus while in the ED.  Urine culture was \nsent.  Patient received aspirin 325 mg, lorazepam 2 mg x 1, and \nondansetron 2 mg x 2.  Vitals on transfer were 98.1 109 173/78 \n18 96% RA.  \n\nCurrently, patient reports no nausea or abdominal pain.\n \nReview of sytems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denies cough, shortness of breath. Denies chest pain \nor tightness, palpitations. Denies nausea, vomiting, diarrhea, \nconstipation or abdominal pain. No recent change in bowel or \nbladder habits. No dysuria. Denies arthralgias or myalgias. Ten \npoint review of systems is otherwise negative.\n\n \nPast Medical History:\n1. Stage 3 colorectal cancer s/p colectomy ___ \n2. CAD s/p cabg x4 SVG to distal LAD, circ, PDA and LIMA to diag \n1\n3. HTN \n4. Pernicious Anemia \n5. CKD \n6. Diastolic CHF \n7. Carpal tunnel syndrome \n8. Carotid bruits \n9. Hearing loss   \n\n \nSocial History:\n___\nFamily History:\nDaughter with MI, no liver disease or cardiac disease otherwise\n\n \nPhysical Exam:\nADMISSION EXAM:\nVitals: T: 98.3 BP: 169/78 P: 118 R: 24 O2: 98% on RA  \nGEN: Alert. Fatigued appearing but comfortable, no acute signs \nof distress.  \nHEENT: NCAT, Pupils equal and reactive, sclerae anicteric, OP \nclear, dry MM.  \nNeck: Supple, no JVD \nLymph nodes: No cervical, supraclavicular LAD.  \nCV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.  \nRESP: Good air movement bilaterally, no rhonchi or wheezing.  \nABD: Soft, non-tender, non-distended, + bowel sounds.  \nEXTR: No lower leg edema, no clubbing or cyanosis  \nDERM: No active rash.  \nNeuro: non-focal.  \nPSYCH: Appropriate and calm. \n\nDISCHARGE EXAM:\n98.7  ___  59  18  99% RA\nGENERAL: WDWN woman in NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. Conjunctiva were pink \nNECK: Supple with JVP of 10cm at 30 degrees.  \nCARDIAC: RR, S1, S2, systolic murmur at RUSB radiating to neck. \nNo S3 or S4.  \nLUNGS: Resp were unlabored, with bibasilar crackles. no wheezes \nor rhonchi.  \nABDOMEN: Soft, NTND. No tenderness.  \nEXTREMITIES: No c/c/e.  \n \nPertinent Results:\nADMISSION LABS\n--------------\n___ 09:16PM BLOOD WBC-9.0# RBC-4.75# Hgb-13.9# Hct-41.6# \nMCV-88 MCH-29.2 MCHC-33.3 RDW-13.3 Plt ___\n___ 09:16PM BLOOD Neuts-83.4* Lymphs-12.1* Monos-3.7 \nEos-0.2 Baso-0.6\n___ 09:16PM BLOOD Glucose-214* UreaN-23* Creat-1.2* Na-143 \nK-3.7 Cl-103 HCO3-20* AnGap-24*\n___ 09:16PM BLOOD ALT-13 AST-33 AlkPhos-102 TotBili-0.5\n___ 09:16PM BLOOD Albumin-4.5 Calcium-10.1 Phos-3.0 Mg-1.9\n\nCardiac Labs \n___ 09:16PM BLOOD cTropnT-\u003c0.01\n___ 04:10PM BLOOD cTropnT-0.51*\n___ 08:10PM BLOOD CK-MB-35* MB Indx-7.5* cTropnT-0.62*\n___ 06:08AM BLOOD CK-MB-33* MB Indx-7.1* cTropnT-0.85*\n___ 12:50PM BLOOD CK-MB-28* MB Indx-6.3* cTropnT-0.76*\n___ 10:55AM BLOOD CK-MB-6 cTropnT-2.29*\n\nDischarge labs \n___ 07:50AM BLOOD WBC-4.5 RBC-4.38 Hgb-12.8 Hct-38.3 MCV-88 \nMCH-29.2 MCHC-33.4 RDW-13.1 Plt ___\n___ 07:50AM BLOOD WBC-4.5 RBC-4.38 Hgb-12.8 Hct-38.3 MCV-88 \nMCH-29.2 MCHC-33.4 RDW-13.1 Plt ___\n___ 07:50AM BLOOD ___ PTT-28.2 ___\n___ 07:50AM BLOOD Glucose-101* UreaN-16 Creat-1.2* Na-141 \nK-3.8 Cl-108 HCO3-27 AnGap-10\n___ 10:55AM BLOOD CK(CPK)-161\n___ 07:50AM BLOOD Calcium-9.2 Phos-3.1 Mg-1.9\n\nECHO \nThe left atrium is mildly dilated. There is mild symmetric left \nventricular hypertrophy with normal cavity size. There is mild \nregional left ventricular systolic dysfunction with focal \nhypokinesis of the basal to mid inferior and inferolateral \nwalls. Overall left ventricular systolic function is mildly \ndepressed (LVEF= 40-45 %). The estimated cardiac index is normal \n(\u003e=2.5L/min/m2). Tissue Doppler imaging suggests an increased \nleft ventricular filling pressure (PCWP\u003e18mmHg). Right \nventricular chamber size and free wall motion are normal. The \ndiameters of aorta at the sinus, ascending and arch levels are \nnormal. The number of aortic valve leaflets cannot be \ndetermined. The aortic valve leaflets are moderately thickened. \nThere is mild aortic valve stenosis (valve area 1.2-1.9cm2). \nThere is no aortic regurgitation. The mitral valve leaflets are \nmildly thickened. Mild (1+) mitral regurgitation is seen. The \nleft ventricular inflow pattern suggests impaired relaxation. \nThe pulmonary artery systolic pressure could not be determined. \nThere is no pericardial effusion. \n\nIMPRESSION: Suboptimal image quality. Regional left ventricular \nsystolic dysfunction c/w possible CAD. Normal right ventricular \ncavity size and systolic function. Mild mitral regurgitation. \nMild aortic stenosis. \n\nECGs with new bifascicular block (LAFB/RBBB) and some slight \ninferolateral ST depressions\n\nCardiac Cath:\nFindings\nESTIMATED blood loss: minimal\nHemodynamics (see above):\nCoronary angiography:  right dominant\nLMCA:  90% distal\nLAD:  70% ___, 95% mid. 70% ostial in D1\nLCX:  100% ostial. 60% ostial in ramus branch\nRCA:  Diffuse 90% disease\nSVG-:  SVG to LAD is widely patent. SVG to PDA has a 60% \nstenosis\nin the mid segment, and 60% stenosis in PDA just distal to the\nanastamosis. SVG to OM is stump occluded.\nLIMA-D1:  60% ostial stenosis in the bypass graft.\n \nBrief Hospital Course:\n___ year old female with CAD s/p CABG, diastolic CHF, \nhypertension presented with nausea, vomiting, new right bundle \nbranch block, and elevated cardiac markers consistent with \nNSTEMI.\n\n# NSTEMI: Patient presented initially with abdominal discomfort \n(described as the sensation of needing to belch) and nausea with \nnegative CT abdomen and KUB.  Trops and CK-MB were elevated and \nECG showed new rate dependent RBBB.  Abdominal pain is likely \nher anginal equivalent.  She was started on heparin gtt for \n48hrs, plavix loaded, given full dose of aspirin and \natorvastatin 80mg. Her beta blocker was uptitrated to maintain \nrates in ___.  A TTE was performed to look for new wall \nmotion abnormalities and it showed a reduced EF of 40-45% (new) \nand regional left ventricular systolic dysfunction c/w possible \nCAD. Pt's pain resolved and CK-MD down trended to within normal \nlimits.  Coronary intervention was discussed with pt and decided \nto undergo cardiac cath which showed left main and 3 vessel \nnative CAD. One of her 4 bypass grafts (SVG to OM) is occluded. \nShe was managed medically and was discharged on aspirin, plavix, \nmetoprolol, lisinopril, and atorvastatin 80mg.  \n\n# Right bundle branch block: rate dependent. Discharged on beta \nblocker.\n \n# Hypertension: Continued amlodipine, clonidine and metoprolol. \nHCTZ was discontinued. She had episodes of hypertension to 170s \nwhen she was due for clonidine doses. One such episode was \nassociated with recurrence of her abdominal discomfort that \nresolved with her dose of clonidine and resolution of \nhypertension. ECG at that time did not show ST changes. ACEi was \nstarted for more consistent blood pressure control in the \nsetting of systolic dysfunction. \n\n# Congestive Heart Failure: now with decreased EF in setting of \nischemic insult. She was medically managed and discharged on \nASA, plavix, metoprolol, atorvastatin, and an ACEi. \n\n# Chronic kidney disease:  Baseline creatinine is around 1.3. \nShe was pre-hydrated with IVF before and after cardiac cath and \nher creatinine remained around baseline. \n\nTransitional issues: \n- Cardiology follow up \n- If ongoing chest/abdominal pain, consider evaluation with \nstress test\n- Code status: Full code, confirmed  \n- Contact: son ___, ___  \n\n \n___ on Admission:\n1. Amlodipine 10 mg PO DAILY \n2. CloniDINE 0.3 mg PO BID \n3. Hydrochlorothiazide 25 mg PO DAILY \n4. Metoprolol Tartrate 75 mg PO BID \n5. Aspirin 162 mg PO DAILY \n6. Cyanocobalamin 1000 mcg IM/SC EVERY MONTH \n7. Ferrous Sulfate 325 mg PO DAILY \n\n \nDischarge Medications:\n1. Amlodipine 10 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet,delayed release (___) by mouth \nonce a day Disp #*30 Tablet Refills:*0\n3. CloniDINE 0.3 mg PO BID \n4. Ferrous Sulfate 325 mg PO DAILY \n5. Metoprolol Tartrate 50 mg PO BID \nRX *metoprolol tartrate 50 mg 1 tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*0\n6. Cyanocobalamin 1000 mcg IM/SC EVERY MONTH \n7. Clopidogrel 75 mg PO DAILY \nRX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0\n8. Omeprazole 20 mg PO DAILY \nRX *omeprazole 20 mg 1 capsule,delayed ___ by \nmouth once a day Disp #*30 Capsule Refills:*0\n9. Lisinopril 2.5 mg PO DAILY \nRX *lisinopril 2.5 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0\n10. Atorvastatin 80 mg PO DAILY \nRX *atorvastatin 80 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nnon S-T elevation myocardial infarction\nAIVR\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear ___,\n\n___ were admitted to the hospital for a heart attack (NSTEMI).  \nWe treated ___ with medications to thin your blood and to \nprevent further damage to the heart.  We discussed options for \npossible interventional treatment and we decided to do a cardiac \ncatheterization.  The catheterization did not show any areas \nthat needed to be stented.  \n\nWe have made several medication changes to protect your heart \nfrom further damage.  \n\nWe have arranged for follow for ___ with your PCP and have \narranged for follow up with Dr. ___ new cardiologist. \n\nWeigh yourself every morning, call MD if weight goes up more \nthan 3 lbs.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11919168","hadm_id":"28720036","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nCodeine\n \nAttending: ___.\n \nChief Complaint:\nleft inguinal hernia\n \nMajor Surgical or Invasive Procedure:\n___- laparoscopic inguinal hernia repair\n\n \nHistory of Present Illness:\nMr. ___ is an ___ year old man with history of open left \ninguinal hernia repair ___ years ago at ___ with increasing \nawareness of left inguinal discomfort and swelling. He believes \nthis started a few months ago after an episode of dry heaving \nrelated to GI illness.  He presents now for scheduled \nlaparoscopic repair.\n \nPast Medical History:\n- Diverticulosis w h/o diverticulitis  \n- Hyperthyroidism  \n- Migraines  \n- Open Angle Glaucoma  \n- Macular Degeneration  \n- Eczematous Dermatitis  \n- Actinic Keratosis  \n- Seborrheic Keratosis  \n- Allergic Rhinitis  \n- Cervical disc degeneration  \n- S/P Rotator cuff repair  \n- S/P hernia repair  \n- s/p appendectomy\n \nSocial History:\n___\nFamily History:\nNo history of sudden cardiac death or malignancy.\n \nPhysical Exam:\nDischarge Physical Exam\nVS: 99.0  80  107/52  19  94% ra\nGen- alert and oriented x3 NAD\nCV- RRR\nPulm- CTAB\nAbd- soft, appropriately TTP, incisions c/d/i, minimal \necchymoses around inferior incision\nExt- WWP\n \nBrief Hospital Course:\nMr. ___ is an ___ man who presented for a scheduled \nlaparoscopic repair of a recurrent left inguinal hernia. For \nfull details please see the separately dictated operative \nreport. He was brought to ___ in stable condition; however \ngiven his known prostatic enlargement and high risk of \npostoperative urinary retention, a foley was placed \nintraoperatively and he was admitted overnight. The foley was \nremoved in the morning of POD 1; he did void but reported some \nfeeling of fullness and incomplete void. A post void residual \nbladder scan showed 500cc and the foley was replaced. He \notherwise advanced appropriately, and on POD ___ontrolled on oral medications and he was tolerating a regular \ndiet. On POD 2 he was ambulating without assistance; the foley \nwas again removed and he did void. His post void residual was \n400cc. He states that he feels at his baseline; that this is his \nusual manner of voiding (several small voids over the course of \nthe morning). He has no suprapubic pressure or pain. He is \ndischarged home on POD 2; he is voiding, and he is encouraged to \ncall or return to the ED if he develops suprapubic pressure or \nhas difficulty voiding. He is also given the number for the \n___ clinic to follow up with them after discharge. He is \notherwise doing well, ambulating, pain well controlled with \ntylenol, and tolerating a regular diet.\n \nMedications on Admission:\n___: amitriptyline 50'', brimonidine eye drops, flunisolide, \nmetoprolol 24', omeprazole 20', lyrica 300', travoprost eye \ndrops\n \nDischarge Medications:\n1. Amitriptyline 50 mg PO BID \n2. Docusate Sodium 100 mg PO BID \ntake while taking dilaudid \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*20 Capsule Refills:*0\n3. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg 1 tablet(s) by mouth q4-6h \nDisp #*25 Tablet Refills:*0\n4. Metoprolol Succinate XL 25 mg PO DAILY \n5. Pregabalin 75 mg PO Q6H \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ninguinal hernia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr. ___,\n\nYou were admitted overnight after a laparoscopic inguinal hernia \nrepair. You had a foley catheter placed to drain your bladder. \nThis has been removed and you are voiding. Your pain is \ncontrolled with pills and you are eating a regular diet. You are \nready to go home. It was a pleasure taking care of you. Please \nrestart all of your home medications, and remember not to lift \nanything over 10 lb for the next 4 weeks.\n\nYou have have small strips of tape (steri-strips) under the \ndressing that will stay on until they fall off on their own.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10962154","hadm_id":"20197195","text":" \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAltered mental status\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ yo male w/ PMHx of chorea-acanthocytosis for\nwhich he is followed in neurology clinic, question first time\nseizure in ___ not on treatment who presents with a witnessed\nseizure lasting about 5 minutes at 8:30am in his bed. There are\nno further details regarding the semiology of the event but\nsounds like likely GTC. He presents to the ED with\nunresponsiveness thought to be post ictal state. The patient was\nnot accompanied by family and facility not answering so unable \nto\nget further collateral. He is unable to operate his ipad at this\ntime given mental status in order to get further information \nfrom\nthe patient. \n\nPer his last clinic note:\nHis chorea-acanthocytosis symptoms began ~ age ___\nwith hand clumsiness, dysphagia, and lip/tongue biting. His most\nproblematic symptom has been dysphagia with an inpatient\nadmission resulting in ___ for dysphagia c/b oxygen\ndesaturation. He previously declined tracheostomy. \n\nPast seizure event: \nHe had a possible first \"seizure\" on ___ found lying in \nhis\nbed. His family is unsure how long the event lasted (they are\nunclear what it looked like). Per nursing staff that observed \nit,\nLips were quivering, eyes partially open, eyes rolled up into \nhis\nhead. Unclear if he had body shaking. Placed on 5L O2 for desat\nfor ___ mins. Immediately after this event he was able to open\nhis eyes but was lethargic and would quickly fall asleep.\nReturned to baseline after about a half hour or so. \nWas reportedly confused for ~ 45 minutes afterwards (not\nresponding). Then returned to baseline. He was not treated for \nit\nor hospitalized. \n\n \nPast Medical History:\nNeuroacanthocytosis(dx with low chorine protein by Western Blot) \n\nPeriodic limb movements                                     \nSleep apnea                                                    \nSialorrhea                                                      \nPEG Tube\nAll teeth removed ___ recurrent injuries from biting             \n\n\n \nSocial History:\n___\nFamily History:\n- Father has ___ disease, onset at age ___. Mother has \ndiabetes.  \n- Father is from ___ and mother from ___.  \n- At a meeting, they met two other families from ___ who \nalso had chorea-acanthocytosis.\n- Served in active duty in the ___ Army. Received an \nhonorable discharge in ___. Later worked at ___.\n- Was an avid runner, and ran several marathons. Also an avid \nboxing fan.\n- Wrote an autobiography notable for determination not to let \nhis disease \"break him.\" An excerpt: \"Years ago I made a silent \npromise to myself denying choreacanthocytosis the chance to \ndefine my life and although it has laid claim to numerous small \nvictories, I am still here and willing to go into battle.\" \n \nPhysical Exam:\nAdmission Exam:\nGeneral: eyes closed, does not open to tactile or verbal\nstimulation. Some flutter of eye lids with sternal rub. Global\nexam improved over next ___ minutes\nHEENT: NC/AT, no scleral icterus noted, unable to assess oral\npharynx given resistance to opening mouth\nNeck: Supple, no nuchal rigidity\nCardiac: warm and well perfused\nExtremities: No cyanosis, clubbing or edema bilaterally\nSkin: profuse dry skin\n\nNeurologic:\n\n-Mental Status: eyes closed. eventually would briefly open eyes\nopen verbal request indicating understanding however unable to\nkeep them open longer than a few seconds. Intermittently would\nfall asleep with snoring but able to be aroused again. Was able\nto show left thumb. attempted to stick out tongue but could not\nopen mouth. non verbal at baseline. \n\n-Cranial Nerves:\nI: Olfaction not tested.\nII: PERRL 3 to 2mm and brisk. unable to assess vision\nIII, IV, VI: Unable to assess EOM given eyes closed and\nintermittently sleeping\nV: unable to assess Facial sensation\nVII: No facial droop, facial musculature symmetric. no teeth\ncausing dysmorphic appearing face.\nVIII: Hearing intact to voice given following verbal commands.\nUnclear each ear compared to the other\nIX, X: Unable to assess if palate elevates symmetrically.\nXI: ___ strength in trapezii and SCM bilaterally. Was able to\nfollow this command\nXII: unable to see tongue given inability to open mouth. Unsure\nif baseline. \n\n-Motor: Decreased bulk throughout. Despite intermittently \nfalling\nasleep and not opening eyes, he was able to participate in\nconfrontational strength testing. Full throughout though\nexamination was simplified in order to optimize effort. \nNo adventitious movements, such as tremor, noted at rest or with\nactivation. \n\n-Sensory: with draws to noxious stim on left lower foot but not\nright. Withdrew bilateral upper\n\n-DTRs:\n  Bi ___ Pat Ach\n\nL  2   2    2   1\n\nR  2   2    2   1\n-Coordination: unable to assess\n\n-Gait: deferred\n\nDischarge Exam:\n===============\n\nMS: Patient is alert awake, in no acute distress.  Able to speak \none word at a time (Yes, Hospital) but otherwise non-verbal. \nAnswers questions with nodding/shaking head or with ipad. Able \nto communicate by typing on his iPAD. Follows commands. Oriented \nto location and date and year. \n\n-Cranial Nerves:  PERRL 3\u003e2.  VFF to confrontation. Extraocular \nmovements are full without clear impairment in upgaze. Severe \nhypomimia. Severe dysphonia (mutters \"yes\" \"hospital\" ___ \nwith very soft voice.\" Mouth opening \u003c1-2 cm. He has an action \ntremor of his tongue with orolingual dyskinesias at rest. \nHearing is intact to conversation. \n\n-Motor: He has a moderate irregular resting tremor which \naccentuates with  movement. Dystonic flexor posturing of \nbilateral hands (right\u003eleft, pronounced at MCP joints). Tone is \nincreased in his upper extremities, slightly more pronounced on \nright and with augmentation. Bradykinetic in both upper \nextremities with finger opening/closing. Strength is as follows:\n   Delt Bic Tri WrE   FFl  IP Quad Ham TA \n L  5-    ___   ___    4+  5  \n R  5-    ___   ___    4+  5  \n\n-Sensory: Notes symmetric sensation bilaterally to light touch\n\n-DTRs:\n  Bi ___ Pat Ach\nL  2   2    2   1\n\nR  2   2    2   1\n\n-Coordination: No dysmetria but has fine intention tremors on \nfinger-nose testing\n\n-Gait: did not have his walker from home to evaluate baseline \ngait.\n\n \nPertinent Results:\n___ 06:40AM BLOOD WBC-5.5 RBC-4.18* Hgb-13.8 Hct-41.4 \nMCV-99* MCH-33.0* MCHC-33.3 RDW-14.6 RDWSD-53.1* Plt ___\n___ 11:07AM BLOOD Neuts-68.6 Lymphs-15.2* Monos-11.5 \nEos-3.5 Baso-0.6 Im ___ AbsNeut-3.17 AbsLymp-0.70* \nAbsMono-0.53 AbsEos-0.16 AbsBaso-0.03\n___ 06:40AM BLOOD Glucose-63* UreaN-13 Creat-0.8 Na-143 \nK-4.8 Cl-103 HCO3-30 AnGap-10\n___ 11:07AM BLOOD ALT-30 AST-43* AlkPhos-99 TotBili-0.4\n___ 06:40AM BLOOD Glucose-63* UreaN-13 Creat-0.8 Na-143 \nK-4.8 Cl-103 HCO3-30 AnGap-10\n___ 11:41AM BLOOD Lactate-1.4\n___ 11:19AM URINE Blood-NEG Nitrite-NEG Protein-30* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG\n___ 11:19AM URINE RBC-2 WBC-1 Bacteri-NONE Yeast-NONE \nEpi-\u003c1\n___ 11:19AM URINE CastHy-1*\n___ 11:19AM URINE Color-Yellow Appear-Clear Sp ___\n \nBrief Hospital Course:\nThis is a ___ yo man with chorea-acanthocytosis (known to Dr. \n___ and one possible prior event concerning for a \nseizure in ___ who was brought into ___ for evaluation of an \nepisode of stiffening concerning for seizure. His seizure event \nwas witnessed by his nurse (___) at ___. She describes the \nevent as follows: \"He woke after 8:00 am, was helped to the \nbathroom and returned to his bed. Soon\nafter she was called into the room and the patient was stiff in \nall extremities, eyes were open and his gaze was fixed straight. \nHe was not responsive to voice or tactile stimuli but was \nlocalizing to sternal rub. No jerking noted by her but the PCA \nnoticed some twitching prior to her arrival. He was turned to \nhis side\nand the episode lasted about 5 min. He closed his eyes and \ncontinued to be unresponsive for another 5 min until EMS arrived \nwhen he started to open eyes in response to his name. He had a \nsimilar episode on ___ but ___ his nurse was not present at \nthat time.\" In the ED he was initially drowsy and lethargic to \nresponse to commands, far from his baseline. He was given a 1mg \nKeppra load and started on 500mg BID dosing out of concern for \nseizure with post-ictal confusion. Impression was that his \npresenting episode may be a second episode of possible seizure \nwith a history of neurological disorder that predisposes him to \nepilepsy, warranting initiation of low dose AED. Within several \nhours, his mental status returned to baseline. He underwent \nroutine extended EEG which did not show any epileptiform \ndischarges (official read pending). His was not orthostatic \n(Lying SBP 121 \u003e standing 108, HR 84--\u003e71) He did not have any \nfurther clinical seizure-like activity but was noted to have two \nbrief oxygen desaturation events overnight, lasting less than a \nminute. Impression for his desaturation is likely related to \nrespiration/apnea vs nocturnal seizures. To facilitate event \ncapture, he was discharged with an ambulatory EEG to evaluate \nfor seizure activity overnight, which may warrant further \nuptitration of Keppra in the outpatient setting. Decision was \nmade to do this in the outpatient setting, as he expressed \nwishes to return to his home environment as soon as possible. \n\nTransitional issues:\n- Continue Keppra 500mg BID, may need uptitration pending \nresults of ambulatory EEG\n- Follow up results of ambulatory EEG, to be performed on ___ \novernight\n- Return to EEG lab at ___ ___) on ___ at 11 AM to \ndisconnect EEG\n- Follow-up with Dr. ___ next ___ months, we will call \nto schedule you an appointment, if you do not \n  hear from us, please call ___ to schedule an \nappointment\n- Continue all remaining home medications and PEG feeds as prior \nto admission\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amantadine 100 mg PO TID \n2. ClonazePAM 1 mg PO BID \n3. Levothyroxine Sodium 75 mcg PO DAILY \n4. Pramipexole 0.125 mg PO QHS \n5. ClonazePAM 2 mg PO QHS \n6. Venlafaxine XR 112.5 mg PO QHS \n7. TraZODone 50 mg PO QHS \n8. Gabapentin 200 mg PO BID \n9. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever \n10. Multivitamins 1 TAB PO DAILY \n11. Polyethylene Glycol 17 g PO DAILY \n12. Gabapentin 300 mg PO QHS \n13. Senna 8.6 mg PO BID \n14. Glycopyrrolate 1 mg PO Q8H:PRN secretions \n15. Carbidopa-Levodopa (___) 1 TAB PO TID \n16. Simethicone 80 mg PO TID \n\n \nDischarge Medications:\n1.  LevETIRAcetam 500 mg PO Q12H  \n2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  \n3.  Amantadine 100 mg PO TID  \n4.  Carbidopa-Levodopa (___) 1 TAB PO TID  \n5.  ClonazePAM 1 mg PO BID  \n6.  ClonazePAM 2 mg PO QHS  \n7.  Gabapentin 200 mg PO BID  \n8.  Gabapentin 300 mg PO QHS  \n9.  Glycopyrrolate 1 mg PO Q8H:PRN secretions  \n10.  Levothyroxine Sodium 75 mcg PO DAILY  \n11.  Multivitamins 1 TAB PO DAILY  \n12.  Polyethylene Glycol 17 g PO DAILY  \n13.  Pramipexole 0.125 mg PO QHS  \n14.  Senna 8.6 mg PO BID  \n15.  Simethicone 80 mg PO TID  \n16.  TraZODone 50 mg PO QHS  \n17.  Venlafaxine XR 112.5 mg PO QHS  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nSeizures\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the hospital for an episode of confusion \nwith possible stiffening of your extremities. This event \noccurred after you woke up but was not associated with \nstanding/sitting and as such was not clearly correlated to \nchanges in blood pressure. This is your second episode within 3 \nmonths, which raises concern for possible seizures. Your \ndisease, Choreoacanthocytosis, increases your risk for seizures. \nAs such, we started you on a seizure medication (KEPPRA).  We \nevaluated your brain activity on EEG for 60 minutes and saw \nNORMAL brain activity without signs of seizure activity. No \nfurther seizure-like activity was noted and your mental status \nreturned to baseline within a few hours.\n\nWe monitored you overnight and detected 2 very brief episodes of \nlow oxygen.  This could be related to your breathing during \nsleep or possibly (and less likely) due to short lasting \nseizures during sleep. To better characterize these spells, we \nordered a 24-hour ambulatory EEG monitoring so that we can see \nhow you sleep and how your brain functions during sleep while \nyou are in your home environment.  You will need to return to \nEEG lab for removal of leads on ___ at 11 AM.  Your home \nfacility ___ at ___ was notified to arrange \ntransportation.\n\nYour primary neurologist Dr. ___ has been notified of your \nhospitalization and medication changes. Please follow up with \nhim as scheduled below. \n\nYour sincerely,\n___ Neurology team\n \nFollowup Instructions:\n___\n"}
{"subject_id":"16073850","hadm_id":"22474026","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nNeuro Eval\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo RH woman with a PMH notable for Right ACA/MCA watershed\nstroke (with residual left leg weakness and numbness) ___\nwith tight right ICA stenosis on coumadin and aspirin,\n___-Danlos, L5-S1 disc surgery, asthma, obesity and \ndepression\np/w dizziness and drifting to the right while walking. Promptly,\nNext, Neurology was called.\n\nShe was admitted to neurology service in ___ after she came\nwith acute onset left leg weakness and was found to have R\nwatershed stroke sec to ICA stenosis on right. She was started \non\nasa and coumadin and vascular surg recs were obtained who\nsuggested medical treatment for now. She was sent home with home\n___ and recovered well but a little weakness and numbness in left\nleg.\n\nOver last ___ days she started noticing increasing dizzines\n(unsteady sensation like \"spinning\") and for last ___ days noted\nthat she was drifting to the right side while walking. Her niece\nwho is a phlobotomist was sharp to pick it up and promptly bring\nher to the ED for neuro eval. She thinks that her \"speech\" has\nbecome somewhat slower and her right arm is shaking\nintermittently. \n\nShe denies any falls/ any visual changes/ new weakness\n\nRest of ROS is negative. \n \nPast Medical History:\nstroke as mentioned. ___, L5-S1 disc surgery,\nasthma, obesity and depression. Duodenal ulcer.\n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\nGen: Lying in bed, NAD.\nHEENT: NC/AT, moist oral mucosa\nNeck: supple, no carotid or vertebral bruit\nBack: No point tenderness or erythema\nCV: Nl S1 and S2, no murmurs/gallops/rubs\nLung: Clear to auscultation bilaterally\nAbd: Soft, nontender, non-distended.  No masses or megalies.\nPercussion within normal limits. +BS. \nExt: no edema, no DVT data. Pulses ++ and symmetric.\n.\n\nMS:\nGeneral:  alert, awake, normal affect\nOrientation:  oriented to person, place, date, situation.\n___ backwards +: \nFollows simple axial and appendicular commands. memory: ___ and\nRecalls ___ . Speech/Language: fluent w/o paraphasic (phonemic \nor\nsemantic) errors; comprehension, repetition, naming (high and \nlow\nfrequency objects): normal. Prosody: normal. No apraxia/neglect. \n\n\nCN:\nI: not tested\nII,III:  VFF to confrontation, PERRL 3mm to 2mm,  fundus w/o\npapilledema. No red desaturation.  \nIII,IV,VI: EOMI, no ptosis. No pathological nystagmus. Normal\npursuit. \nV:  sensation intact V1-V3 to LT. PP\nVII:  Facial strength intact/symmetrical\nVIII:  hears finger rub bilaterally\nIX,X:  palate elevates symmetrically, uvula midline\nXI:  SCM/trapezeii ___ bilaterally\nXII:  tongue moves properly in both directions (no asymmetry\nseen), no dysarthria\n\nMotor:\nNormal bulk. \nTone: decreased on the left leg. No tremor, no asterixis or\nmyoclonus. No pronator drift:\n.\n       Delt;C5 bic:C6 Tri:C7 Wr ext:C6 Fing ext:C7\nLeft    5       5      5        5          5            \nRight   4+      5      4+       5          5            \n\nPower exam in ___ : normal in RLE. she has mild IP and Hamstring\n(4+) and moderate to severe DF (4) and TE(4-) weakness on the\nleft.\n.\nDeep tendon Reflexes:\n.\n       Bicip: Tric: Brachial: Patellar:  Achilles   Toes:\nRight   2        2         2          3      2   DOWNGOING\nLeft    2        2         2          3      2   UPGOING \n.\nSensation: loss of sensation below knee on left to pain and \ntouch\nconsistent with the exam mentioned in previous notes from old\nstroke \n\nCoordination:\n*Finger-nose-finger normal.\n*Rapid Arm Movements normal.\n*Fine finger tapping: normal.\n*Heal to shin: normal.\n\nRhomberg : neg\n\nGait :walks with cane, drifts to the right while walking.\n \nPertinent Results:\nLaboratory data:\n___ 04:00PM BLOOD WBC-11.9* RBC-4.79 Hgb-14.8 Hct-42.2 \nMCV-88 MCH-30.9 MCHC-35.0 RDW-13.8 Plt ___\n___ 06:15AM BLOOD WBC-9.8 RBC-4.56 Hgb-14.2 Hct-40.8 MCV-90 \nMCH-31.1 MCHC-34.7 RDW-13.9 Plt ___\n___ 04:00PM BLOOD Neuts-74.6* ___ Monos-2.2 Eos-2.4 \nBaso-1.2\n___ 04:00PM BLOOD ___ PTT-37.8* ___\n___ 06:15AM BLOOD ___ PTT-39.3* ___\n___ 04:00PM BLOOD Glucose-103* UreaN-14 Creat-1.0 Na-143 \nK-4.1 Cl-103 HCO3-31 AnGap-13\n___ 06:15AM BLOOD Glucose-93 UreaN-14 Creat-0.9 Na-141 \nK-3.7 Cl-105 HCO3-27 AnGap-13\n___ 04:00PM BLOOD Calcium-10.1 Phos-4.2 Mg-2.0\n___ 06:15AM BLOOD Calcium-9.1 Phos-4.6* Mg-2.0 Cholest-158\n___ 06:15AM BLOOD %HbA1c-5.5 eAG-111\n___ 06:15AM BLOOD Triglyc-100 HDL-51 CHOL/HD-3.1 LDLcalc-87\n___ 04:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 04:00PM URINE Color-Yellow Appear-Clear Sp ___\n___ 04:00PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR\n___ 04:00PM URINE RBC-1 WBC-8* Bacteri-MANY Yeast-NONE \nEpi-2\n.\nImaging:\n___   MR HEAD W/O CONTRAST: 1. No acute infarct, hemorrhage \nor mass. \n2. Chronic near occlusion of the right internal carotid artery, \nbetter \ndemonstrated on the recent CTA head and neck. \n            \n___   CTA HEAD/NECK ___ C \u0026 RECO: \n1. Near occlusion of the right internal carotid artery origin, \nwith a thin \ntrickle of trough of contrast seen in the more distal right \ncervical ICA, \nsimilar to prior, with intracranial reconstitution likely via \nthe ophthalmic and right PCom. \n2. No evidence of interval infarct, hemorrhage or mass.  \n              \n___   CT HEAD W/O CONTRAST: No acute intracranial process.  \n     \n \nBrief Hospital Course:\n___ yo RH woman with a PMH notable for old R ACA / MCA stroke, \nright ICA stenosis,  Ehlers-Danlos, L5-S1 disc surgery, asthma, \nobesity and depression presents with ___ days h/o vertigo and \nconsistently going to right while walking. Exam shows cervical\nspondylosis and mild weakness in right UE. She has vertigo on \nneck movements. labs show UTI. Most likely diagnosis is UTI with \ndehydration and /or peripheral vertigo. However given the h/o \nstroke and tight R ICA stenosis , concern of posterior \ncirculation stroke is raised. The chance is small, given INR of \n3.9 and CT is negative for bleed. Pt admitted to stroke service, \ntreat UTI and get MRI brain to rule out new stroke. \n\nNeuro: MRI negative for stroke. Physical exam consistent with \nperipheral vestibulopathy. Stroke risk factors checked upon \nadmission: LDL: 87; HbA1c: 5.5. We continued home asa and \nstatin. Due to elevated INR at time of admission, coumadin held, \nQOD ___ care set up prior to discharge to monitor INR. Pt \ninstructed to continue to hold coumadin until INR \u003c 3.0.\n\nDispo: pt discharged with home ___.\n\nID: Pt started on ceftriaxone for asymptomatic pyuria (avoid \nsulfa/ fluroquins given coumadin) at time of admission, \ntransitioned to PO cefpodoxime upon discharge.\n \nMedications on Admission:\ntizanidine 2 mg Tab\nTablet(s) by mouth \n   \nalendronate 70 mg Tab\n1 Tablet(s) by mouth qweek\n   \nsimvastatin 40 mg Tab\n1 Tablet(s) by mouth once a day\n   \nsertraline 100 mg Tab\n1 Tablet(s) by mouth once a day\n   \nwarfarin 1 mg Tab (takes 4 times a week and 2 mg three times a\nweek but will need adjustment now)\n   \nfluticasone 50 mcg/Actuation Nasal Spray, Susp\n1 spray twice a day\n   \nLidoderm 5 % (700 mg/patch) Adhesive Patch\n   \nOmega ___ -- Unknown Strength\n1 Capsule(s) Once Daily\n   \nglucosamine-chondroitin -- Unknown Strength\n1 Capsule(s) Once Daily\n   \nVitamin D 50,000 unit Cap Oral\n1 Capsule(s) once weekly\n\nASA 81/ day\n \nDischarge Medications:\n1. tizanidine 2 mg Tablet Sig: One (1) Tablet PO three times a \nday.  \n2. alendronate 70 mg Tablet Sig: One (1) Tablet PO once a week.  \n\n3. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1)  \nNasal twice a day.  \n4. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily).  \n5. sertraline 100 mg Tablet Sig: One (1) Tablet PO once a day.  \n6. simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n8. omega-3 fatty acids     Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n9. ergocalciferol (vitamin D2) 50,000 unit Capsule Sig: One (1) \nCapsule PO once a week.  \n10. cefpodoxime 100 mg Tablet Sig: One (1) Tablet PO twice a day \nfor 3 days.\nDisp:*6 Tablet(s)* Refills:*0*\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPeripheral vestibulopathy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n \nYou were admitted for changes in your gait.  An MRI of your \nbrain was done and you did not have a new stroke.  We continued \nyour aspirin but held your coumadin as your INR was 3.9.  Please \nbe sure to have your INR checked every other day; you should \ncontinue to hold your coumadin until the INR is below 3.0. \n\nYou were found to have a urinary tract infection; please be sure \nto complete a course of antibiotics as prescribed.\n\nYour stroke risk factors were checked.  You should not smoke.  \nYour LDL cholesterol was 87.  You were continued on your home \nsimvastatin; please discuss with your primary care doctor to \npossibly increase your  You were checked for blood glucose \ncontrol with a HgB A1c.  The level was 5.5.  You need to \ncontinue your blood pressure control.  \n \nYou should continue to eat a low fat healthy diet, and follow up \nwith your primary care physician and stroke ___.\n \nIt was a pleasure taking care of you.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11333292","hadm_id":"23205670","text":" \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nlisinopril / Aldactone / Betadine / spironolactone / fish oil / \natorvastatin / guanfacine\n \nAttending: ___.\n \nChief Complaint:\ndysuria, urinary frequency, subjective fevers\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMrs. ___ is a ___ year old female with history of IgA\nnephropathy w/ ESRD who is now POD16 from a pediatric en bloc\ndeceased donor renal transplant. Her course was complicated by\n___ hematoma requiring transfusion. She was\ndischarged ___ on a course of augmentin for enterococcus UTI\nand ciprofloxacin for donor positive pan sensitive pseudomonas\nblood culture.  She was recovering well at home and was seen \nthis\nweek in transplant clinic and was reportedly well, compliant \nwith\nmedications. She has complained of dysuria since surgery however\nstates it became worse this morning and was accompanied by low\ngrade temperature to 100.4 at home, increased void frequency, \nand\nminor chills. On presentation to the ED she is afebrile after\ntaking Tylenol at home. She denies fevers and chills now. She \nhad\ndiarrhea this week which stopped when she discontinued her bowel\nregimen. She otherwise feels well and denies hematuria, nausea,\nvomiting, SOB, CP, flank pain, back pain, abdominal pain. Her\ntacro dose was decreased to 2.5 BID this past week and she was\nstarted on sodium bicarbonate, otherwise she denies changes to\nher medications.\n\n \nPast Medical History:\nPast Medical History:  \n - IgA nephropathy resulting in end stage renal disease  \n - Hypertension  \n - Anemia  \n - Nephrolithiasis  \n - Hyperlipidemia  \n - Sciatica  \n - Thyroid nodules.  \n - Hx Hep B\n \n Past Surgical History:  \n-pediatric en bloc deceased donor renal transplant ___\n-L brachiobasilic AVF ___, superficialization ___, \n-TAH/BSO\n-PD catheter ___  \n \nSocial History:\n___\nFamily History:\nFamily History:\nNo known family history of diabetes or renal disease. Patient's \nmother with myocardial infarction.\n \nPhysical Exam:\nVitals: 98.6, 77, 109 / 72, 18, 98% RA \nGeneral: Alert, oriented, no acute distress\nHEENT: NO pallor. no icterus. conjuctiva and sclera clear\nCV: Regular rate and rhythm\nLungs: unlabored respirations on room air\nAbdomen: Soft, non-distended, tender in RLQ incision, staples \nhave been removed with steri strips in place, some underlying \nfirmness and tenderness in RLQ. No suprapubic tenderness. No \ncostovertebral tenderness. \nExt: no clubbing, cyanosis or edema;\nNeuro: No focal deficits. normal speech\nAccess: LUE AVF\n\n \nPertinent Results:\n=========================\nLABS\n\n___ 02:00PM BLOOD WBC-7.2 RBC-2.82* Hgb-9.2* Hct-27.8* \nMCV-99* MCH-32.6* MCHC-33.1 RDW-17.0* RDWSD-58.6* Plt ___\n___ 08:20AM BLOOD WBC-5.8 RBC-2.99* Hgb-9.6* Hct-29.7* \nMCV-99* MCH-32.1* MCHC-32.3 RDW-16.8* RDWSD-58.9* Plt ___\n\n___ 02:00PM BLOOD Glucose-126* UreaN-25* Creat-1.1 Na-139 \nK-4.7 Cl-107 HCO3-17* AnGap-20\n___ 08:20AM BLOOD Glucose-106* UreaN-19 Creat-1.0 Na-134 \nK-4.7 Cl-104 HCO3-24 AnGap-11\n\n___ 02:00PM BLOOD Calcium-9.2 Phos-2.0* Mg-1.5*\n___ 08:20AM BLOOD Calcium-9.4 Phos-1.7* Mg-1.8\n\n___ 08:20AM BLOOD tacroFK-7.6\n\n___ 02:50PM URINE Color-Straw Appear-Clear Sp ___\n___ 02:50PM URINE Blood-SM  Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-TR\n___ 02:50PM URINE RBC-1 WBC-3 Bacteri-NONE Yeast-NONE Epi-0 \nTransE-\u003c1\n\n___ 2:50 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n=========================\nIMAGING\n\nEXAMINATION:  RENAL TRANSPLANT U.S. \n  \nINDICATION:  ___ year old woman with recent en bloc renal \ntransplant presenting with fever.  Assess renal transplant. \n  \nTECHNIQUE:  Grey scale as well as color and spectral Doppler \nultrasound images of the renal transplant were obtained. \n  \nCOMPARISON:  Renal transplant ultrasound from ___ \n  \nFINDINGS:  \n  \nThe right iliac fossa en block transplant kidneys are \nidentified. \n  \nKidney 1: This kidney measures 7.8 cm.  There is unchanged mild \npelvocaliectasis.  Color flow and Doppler waveforms are normal \nthroughout the transplant kidney with resistive indices in the \nintrarenal arteries measuring 0.73-0.78. The main renal artery \nshows a normal waveform, with prompt systolic upstroke and \ncontinuous antegrade diastolic flow, with peak systolic velocity \nof 318 cm/sec.  Vascularity is symmetric throughout transplant. \nThe transplant renal vein is patent and shows normal waveform. \n  \nKidney 2: Kidney measures 6.3 cm.  There is no hydronephrosis.  \nColor flow and Doppler waveforms are also normal throughout the \nkidney with resistive indices measuring 0.68 throughout the \nintrarenal arteries.  The main renal artery shows a normal \nwaveform, with prompt systolic upstroke and continuous antegrade \ndiastolic flow, with peak systolic velocity of 92.7 cm/sec.  \nVascularity is symmetric throughout transplant. The transplant \nrenal vein is patent and shows normal waveform. \n  \nThere is a resolving pelvic hematoma which measures 9.8 x 3.3 x \n5.7 cm, \npreviously 12.4 x 8.4 x 7.6 cm, decreased in size.  The bladder \nis mildly \ndistended but overall unremarkable.  At least one ureteral stent \nis \nidentified. \n  \nIMPRESSION:  \n  \n1.  Symmetric vascularity throughout both transplant kidneys \nwith mildly \nelevated resistive indices in one of the kidneys, as before. \n  \n2.  Slightly decreased size of the resolving peritransplant \nhematoma now \nmeasuring 9.8 cm. \n\n \nBrief Hospital Course:\nMrs. ___ was re-admitted to the hospital for observation after \npresenting to the hospital with subjective fever at home to \n100.4 and worsened dysuria and urinary frequency 5 days after \ndischarge to home from her kidney transplant hospitalization. \nHer urinalysis was essentially normal and her urine culture did \nnot grow any organisms. Her WBC was normal, she made appropriate \nurine output, and she remained afebrile for \u003e 24hrs. Her kidney \ngraft function is excellent with Cr of 1.0. She has been \nadherent to her post-transplant regimen including a course of \naugmentin for an enterococcus urinary tract infection that has \nresolved from her original admission, and ciprofloxacin for \npseudomonal coverage due to her donor having pan-sensitive \npseudomonas bacteremia.  Her home medications were continued, \nincluding her immunosuppressive regimen and prophylactic \nmedications. Tacrolimus level was 7.6 and her 2.5q12hr dose was \nnot changed. She was tolerating a regular diet with stable \nsymptoms and expressed her desire to return home. With \nassistance of her daughter's interpretation the patient was \neducated about expected post-operative discomfort and frequent \nvoiding due to the re-expansion of the bladder. She is due for \nlabs the day after discharge and expressed her understanding of \nthis. She will have outpatient follow up with the transplant \ncenter this week. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amoxicillin-Clavulanic Acid ___ mg PO Q12H \n2. Carvedilol 25 mg PO BID \n3. Ciprofloxacin HCl 500 mg PO Q12H \n4. Gabapentin 100 mg PO QHS \n5. LaMIVudine 100 mg PO DAILY \n6. Mycophenolate Mofetil 1000 mg PO BID \n7. Nystatin Oral Suspension 5 mL PO QID \n8. Omeprazole 20 mg PO DAILY \n9. PredniSONE 5 mg PO DAILY \n10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY \n11. Tacrolimus 2.5 mg PO Q12H \n12. ValGANCIclovir 450 mg PO Q24H \n13. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild \n14. Sodium Bicarbonate 650 mg PO BID \n\n \nDischarge Medications:\n1.  Acetaminophen 325 mg PO Q6H:PRN Pain - Mild  \n2.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H \nEnd date ___  \n3.  Carvedilol 25 mg PO BID  \n4.  Ciprofloxacin HCl 500 mg PO Q12H \nEnd date ___  \n5.  Gabapentin 100 mg PO QHS  \n6.  LaMIVudine 100 mg PO DAILY  \n7.  Mycophenolate Mofetil 1000 mg PO BID  \n8.  Nystatin Oral Suspension 5 mL PO QID  \n9.  Omeprazole 20 mg PO DAILY  \n10.  PredniSONE 5 mg PO DAILY  \n11.  Sodium Bicarbonate 650 mg PO BID  \n12.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY  \n13.  Tacrolimus 2.5 mg PO Q12H  \n14.  ValGANCIclovir 450 mg PO Q24H  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ndysuria\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nPlease call the transplant clinic at ___ for fever \u003e \n101, chills, nausea, vomiting, diarrhea, constipation, inability \nto tolerate food, fluids or medications, yellowing of skin or \neyes, increased abdominal pain, incisional redness, drainage or \nbleeding, dizziness or weakness, decreased urine output or dark, \ncloudy urine, swelling of abdomen or ankles, or any other \nconcerning symptoms.\n\nBring your pill box and list of current medications to every \nclinic visit.\n\nYou will have labwork drawn every ___ and ___ as \narranged by the transplant clinic, with results to the \ntransplant clinic (Fax ___ . CBC, Chem 10, AST, T \nBili, Trough Tacro level, Urinalysis.\n\n*** On the days you have your labs drawn, do not take your Tacro \nuntil your labs are drawn. Bring your Tacro with you so you may \ntake your medication as soon as your labwork has been drawn.\n\nFollow your medication card, keep it updated with any dosage \nchanges, and always bring your card with you to any clinic or \nhospital visits.\n\nYou may shower. Allow the water to run over your incision and \npat area dry. No rubbing, no lotions or powder near the \nincision. You may leave the incision open to the air. The \nstaples are removed approximately 3 weeks following your \ntransplant.\n\nNo tub baths or swimming\n\nNo driving if taking narcotic pain medications\n\nAvoid direct sun exposure. Wear protective clothing and a hat, \nand always wear sunscreen with SPF 30 or higher when you go \noutdoors.\n\nDrink enough fluids to keep your urine light in color. Your \nappetite will return with time. Eat small frequent meals, and \nyou may supplement with things like carnation instant breakfast \nor Ensure.\n\nCheck your blood sugars and blood pressure at home. Report \nconsistently elevated values to the transplant clinic\n\nDo not increase, decrease, stop or start medications without \nconsultation with the transplant clinic at ___. There \nare significant drug interactions with anti-rejection \nmedications which must be considered in medication management \nfollowing transplant. Your medications were not changed, \ncontinue these as ordered. \n\nConsult transplant binder, and there is always someone on call \nat the transplant clinic with any questions that may arise.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12366560","hadm_id":"26653039","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: PSYCHIATRY\n \nAllergies: \namoxicillin / Bactrim\n \nAttending: ___.\n \nChief Complaint:\n\"I was just having bad thoughts\"\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nPer Dr. ___ ___ ED Psychiatry Initial Consultation \nnote:\n\n___ yo F history of bipolar I disorder, PTSD, childhood trauma, \ngeneralized anxiety disorder on prazosin, lamotrigine, buspar \nand abilify who presents on a ___ from ___ with \nher\naunt after reporting progressively worsening depression and \nsuicidality, also self-discontinuing her buspar and abilify a \nfew weeks ago because she felt that it was making her feel more \ndepressed and suicidal. \n\nOn initial evaluation, the patient is seen with her friend, \n___, and her Aunt, ___, who are at bedside. I \ninterviewed the patient privately before speaking with both \n___ and ___. \n\nShe explains that she has been having a few weeks of wanting to \ndie. She states she has had thoughts like this before, which \nhave led up to hospitalizations in the past. She denies having \nany active suicidal thoughts. She reports attending the ___ \n___ Partial for approximately one week. She previously \nattended this partial in the middle of ___ for two weeks, \nbut then went on vacation and was discharged. She explains that \nshe was referred to the program in the first place after \npresenting at ___ ED for worsening depression.\n\nShe also explains that she was recently seeing a psychiatrist \nnamed ___ at ___, who \"told me to stop \nseeing her after I told her that I stopped all my medications.\" \nShe has been resumed on some of her medications slowly at the \n___ program.  She also explains that she has been \nseeing her therapist ___, and last her in the beginning of \n___. In the meantime, she does not have a psychiatrist. \n\nShe explains that she feels the medications were making her feel \nworse and more depressed. She was on 4 medications with her \nformer psychiatrist: buspar, abilify, lamictal, and prazosin. \nWhen she enrolled in the partial program this week, the NP \nstarted her back on lamictal and prazosin only, which she has \nfound helpful only with her nightmares. \n\nI ask her a few questions regarding her future orientation. She \nstates she plans to go back to school and still enjoys going to \nthe beach, even in this weather. However, she states, \"I don't \nknow,\" when explaining what her outlook on life is. \n\nShe also endorses that she has been having worsening motivation \nto go shower, brush her teeth, and get out of bed in the \nmorning, which has been occurring for the past few weeks. She \nalso states that she feels about the same mood-wise and with \nregards to her thoughts about death before leading up to her \nprior psychiatric hospitalization in ___. \n\nShe explains that she has been attempting to use her distress \ntolerance skills but that they have not been effective for her, \nand she has no idea why. [Grounding tools, using Wise mind, \nTIPP]. \n\nIn the ED, patient was cooperative and did not have any \nbehavioral concerns that required physical or chemical \nrestraints. Patient was continued on Prazosin 1mg qHS and \nLamictal 25mg qHS. \n\nOn admission to the inpatient psychiatric unit, patient \ncorroborates the history as above. She reports coming to the \nhospital for her \"anxiety and depression\" and states that she \nwas having \"bad thoughts about hurting myself and wanting to \ndie.\" She reports stopping her medications three weeks ago while \nbecause she thought they were making her feel worse. She \nendorses depressed mood, decreased energy, anhedonia, and recent \nsuicidal ideation with a plan to overdose on medications. She \nreports feeling \"scared\" that she will feel alone in the \nhospital. She reports a history of cutting (last ___ years ago) \nand a previous suicide attempt by \"taking medications.\" She \ndenies current suicidal ideation and endorses feeling safe on \nthe unit. She says that if her suicidal thoughts return, she \nwill notify a nurse or other staff member on the floor. \n\nShe also reports a time in the ___ when she stopped sleeping, \nhad increased energy and \"I felt like I could do anything.\" She \ndenies risky behavior or being hospitalized at this time, and \nsays that she has only been hospitalized for depression. She \ndoes reports carrying a diagnosis of Bipolar disorder. \n\nPatient reports that her psychiatrist said she wanted to stop \nseeing the patient after patient self discontinued her \nmedications. She reports having a therapist named ___ at \n___ in ___ and says that ___ is \"helpful.\" \nPatient says that during previous hospitalizations, attending \ngroups has been the most helpful in making her feel better.\n \nPast Medical History:\nPast psychiatric history notable for two prior inpatient \nadmissions at ___ (in ___ for \"mania;\" \n___ for depressive symptoms). However, ___ aunt \nindicated that she had been hospitalized twice in ___ as well \nfor symptoms related to depression/suicidality. Therapist: \n___ in ___. Prescriber: ___ NP at \n___ \n\nMedication and ECT trials (per review of ___ Atrius) - \nMirtazapine 15mg, Buspar 10mg TID, Abilify up to 15mg, Lamictal \nup to 200mg, topamax 50-100mg (also for migraines), Doxepin \n25mg, Chlorpromazine 50mg, Quetiapine XR 50mg, Methylphenidate \n5mg BID/Methylphenidate ER 30 (stimulant trials beginning in \n___\n\nSelf-injury: Cutting. Last cut a year ago. Never needed \nstitches; no current urges.\nSuicide attempts: Denies, but per Aunt, has taken a few pills in \nthe past and required ED visit, but did not require medical \nevaluation\nHarm to others: Denies\n.\nDenies medical history.\nPCP: Dr. ___\n \nSocial History:\n-Born/Raised: in ___ \n-Relationship status/Children: Has boyfriend ___ years, no \nchildren\n-Primary Supports: boyfriend, grandparents, aunt \n-___: Lives in ___ with father, grandparent and \nbrothers, spends most of her time at boyfriend, ___ home\n-Education: Senior at ___ studying psychology, currently on \nmedical leave\n-Employment/Income: Worked at ___ at ___ History: ___\n-Access to weapons: denies\n.\nSUBSTANCE USE HISTORY:\n-Caffeine: 1 cup coffee/day, occasional energy drink\n-Tobacco: denies\n-___ drinks per week/Denies history of blackouts, \nalcohol withdrawal, DTs, seizures.\n-Marijuana: Denies\n-Heroin: Denies\n-Opiates: Denies\n-Benzos: Denies\n-Cocaine: Denies\n-Amphetamines/speed: Denies\n-LSD/PCP: ___: Denies\n-Other Drugs: Denies\n\n \nFamily History:\n-Psychiatric Diagnoses: Mother with reported anxiety, \ndepression, bipolar disorder, completed suicide\n-Substance Use Disorders: unknown\n-Suicide Attempts/Completed Suicides: Mother ___ by \nintentional OD\n \nPhysical Exam:\nGeneral:\n-HEENT: Normocephalic, atraumatic.  Moist mucous membranes,\noropharynx clear, supple neck.  No scleral icterus.\n-Cardiovascular: Regular rate and rhythm, no murmurs, rubs or\ngallops, distal pulses palpable\n-Pulmonary: No increased work of breathing.  Lungs clear to\nauscultation bilaterally.  No wheezes/rhonchi/rales.\n-Abdominal: Non-distended, bowel sounds normoactive.  No\ntenderness to palpation in all quadrants.  No guarding, no\nrebound tenderness.\n-Extremities: Warm and well-perfused.  No edema of the limbs.\n-Skin: No rashes or lesions noted.\n\nNeurological:\n-Cranial Nerves:\n---I: Olfaction not tested.\n---II: PERRL\n---III, IV, VI: EOMI without nystagmus\n---V: Facial sensation intact to light touch in all \ndistributions\n---VII: No facial droop, facial musculature symmetric and ___\nstrength in upper and lower distributions, bilaterally\n---VIII: Hearing intact to finger rub bilaterally\n---IX, X: Palate elevates symmetrically\n---XI: ___ strength in trapezii and SCM bilaterally\n---XII: Tongue protrudes in midline\n-Motor: Normal bulk and tone bilaterally. No abnormal movements,\nno tremor. Strength ___ throughout.\n-Sensory: No deficits to fine touch throughout\n-DTRs: not formally assessed\nCoordination: no intention tremor noted\n-Gait: Good initiation.  Narrow-based, normal stride and arm\nswing.  Able to walk in tandem without difficulty.  \n\nCognition (from ED consult note on ___: \nWakefulness/alertness: Alert and awake \n-Attention (digit span, MOYB): Grossly wnl \n-Orientation: ___ , ___ , ___\n-Executive function (go-no go, Luria, trails, FAS): not formally\nassessed\n-Memory:  ___ registration C/H/P; ___ short-term recall C/H/P\n-Fund of knowledge: ___\n-Calculations:   $1.75 = 7 quarters\n-Abstraction:  \"The grass is greener on the other side\" = \n\"Things\nare better in other places\" \n Visuospatial:  not assessed\n-Language: Native ___ speaker, no paraphasic errors,\nappropriate to conversation\n\nMental Status:\n-Appearance: female appearing younger than stated age, embracing\nstuffed animal, fair grooming and hygiene, wearing hospital \ngown,\nin no apparent distress\n-Behavior: cooperative, appropriate eye contact, no psychomotor\nagitation or retardation\n-Mood: \"scared\"\n-Affect: dysphoric, tearful at times, restricted range\n-Speech: Normal rate, volume, and tone\n-Thought process: Linear and logical, coherent, goal-oriented, \nno\nloose associations\n-Thought Content:\n---Safety: Denies current suicidal ideation, intent, or plan,\nendorses recent SI with plan to OD, denies HI\n---Delusions: No evidence of paranoid delusions, grandiose\ndelusions, persecutory delusions, delusions of reference, or\ndelusions of thought insertion, withdrawal, or broadcasting\n---Obsessions/Compulsions: No evidence based on current \nencounter\n---Hallucinations: Denies AVH, not appearing to be attending to\ninternal stimuli\n-Insight: fair\n-Judgment: Poor as evidenced by self discontinuing psychotropic\nmedications\n\n \nPertinent Results:\n___ 02:05PM BLOOD WBC-10.5* RBC-5.07 Hgb-14.3 Hct-41.4 \nMCV-82 MCH-28.2 MCHC-34.5 RDW-12.9 RDWSD-37.8 Plt ___\n___ 02:05PM BLOOD Glucose-82 UreaN-11 Creat-0.8 Na-136 \nK-4.0 Cl-101 HCO3-20* AnGap-15\n___ 06:53AM BLOOD ALT-30 AST-16 AlkPhos-55 TotBili-0.5\n___ 06:53AM BLOOD Cholest-249*\n___ 06:53AM BLOOD %HbA1c-5.0 eAG-97\n___ 06:53AM BLOOD Triglyc-102 HDL-49 CHOL/HD-5.1 \nLDLcalc-180*\n___ 06:53AM BLOOD TSH-1.7\n___ 02:05PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n \nBrief Hospital Course:\n1. LEGAL \u0026 SAFETY:  \nOn admission, the patient signed a conditional voluntary \nagreement (Section 10 \u0026 11) and remained on that level \nthroughout her admission.  She was also placed on 15 minute \nchecks status on admission and remained on that level of \nobservation throughout while being unit restricted.\n.\n2. PSYCHIATRIC:\n#) Bipolar Spectrum Disorder\nPatient is a ___ yo female with a history of bipolar disorder, \nPTSD, childhood trauma, and generalized anxiety disorder, \nmultiple psychiatric hospitalizations, and family history \nnotable for a mother who completed suicide, who presents on a \n___ from ___  after reporting progressively \nworsening depression and suicidality with a plan to overdose on \nmedications, in the context of recently self-discontinuing her \npsychotropic medications because she felt that it was making her \nmore depressed and suicidal. \n.\nOn admission, patient endorsed depressed mood, anhedonia, poor \nself esteem, fragmented sleep, and poor coping skills. MSE on \nadmission was notable for a tearful and dysphoric young female \nwho denies current suicidal ideation but feels \"scared\" about \nbeing alone and voices recent suicidal thoughts and plan. \n.\n___ presentation appeared most consistent with bipolar \nspectrum spectrum disorder (current episode depressed) verses \nMDD.  Bipolar spectrum disorder is most likely given ___ \nreported history of weeks with hypomanic symptoms (grandiosity, \nreduced need for sleep, elevated mood) and history of bipolar \ndisorder in a first degree relative.  Given ___ history of \nself injurious and impulsive behavior, affective instability, \npossible unstable relationships (reportedly psychiatrist \nrecently terminated w/ patient), and self reported diagnosis of \nborderline personality disorder, there is also concern for an \nunderlying personality disorder contributing to ___ \npresentation.\n.\nPatient was continued on Lamotrigine 25mg PO daily and Prazosin \n1mg qHS. Patient was additionally started on Aripriprazole, \ntitrated to 15mg PO daily ___ previous dose before self \ndiscontinuing medications) and clonidine 0.1mg qAM and at 1400 \nfor ___ physical symptoms of anxiety.\n.\nAfter a few days, patient reported improvement in mood and \nresolution of suicidal ideation and urges. Patient requested \nmultiple times to be discharged prior to the weekend despite the \nprimary team and family member's concerns for patient leaving \nprematurely if discharged prior to ___ with established \noutpatient follow up. Patient accepted distress tolerance \nworksheets to work through over the weekend. \nOn discharge, ___ mental status was notable for moderately \nimproved mood and affect, linear thought process, no evidence of \ninternal preoccupation and no voiced perceptual disturbances, \nand fair insight and judgment. At the time of discharge, patient \ndenied suicidal ideation, intent, or plan. \n .\n3. SUBSTANCE USE DISORDERS:\n#) None\n.\n4. MEDICAL\n#)None- Health maintenance labs as above.\n.\n5. PSYCHOSOCIAL\n#) GROUPS/MILIEU:  \nThe patient was encouraged to participate in the various groups \nand milieu therapy opportunities offered by the unit.  The \npatient often attended these groups that focused on teaching \npatients various coping skills.  Patient was visible, pleasant, \nand cooperative in the milieu. Patient did not present any \nsafety or behavioral concerns. \n.\n#) COLLATERAL INFORMATION AND  FAMILY INVOLVEMENT\n___ family was involved in her treatment and aftercare \nplanning. ___ aunt, grandparents, and boyfriend visited \npatient regularly in the evenings. Aunt ___, visited \npatient during the day and met with treatment team. ___ was \nvery supportive of the ___ treatment plan and aftercare. \n.\n___ explains that Ms. ___ is usually very help-seeking, \nand she reports being very close with her. She endorses that she \nhas been having approximately 1 month of worsening depressive \nsymptoms and thoughts of death. She also explained that the \npatient did not like the former psychiatrist and that ___ \nseemed overly medicated when she was on 4 medications. ___ \nalso is in agreement that the patient should be set up with more \nsuitable outpatient providers that would be able to work with \n___. She believes that ___ feels more depressed than \nusual because of a bad interaction she had with her father and \npsychiatrist last week. \n.\n___, ___ \nHas seen patient since ___. Reports patient has chronic \npassive suicidal ideation. Patient has a safety plan that she \nhas successfully accessed in the past. When ___ depressive \nand suicidal ideations symptoms worsen she has a history of \nreaching out and getting a higher level of care. Patient has \nself presented to the ER when she has felt suicidal in the past. \nReports that patient stopped her medications in ___, initially \ndid not experience any side effects and then felt a lot worse. \nShe also had increased nightmares and insomnia after self \ndiscontinuing prazosin. Patient had a lapse in insurance \ncoverage and was able to advocate for herself to obtain new \ninsurance coverage. Reports that patient feels triggered in her \nhome and prefers to spend time at her aunt's and her boyfriend's \nhomes.\n.\nSummary of Records from ___ -\n\nDischarge Summary ___ - ___\nHPI - Self presented to ED due to concerns about worsening \ndepression and frequent statements about suicidal ideation with \na plan either to overdose on ___ meds or cut her arm with a \nknife. Experiencing AH over 3 days prior to this presentation \nand was instructed to go to ER by outpatient psychiatrist. \nPatient currently on leave from college from ___ and living at \nhome with her father, grandfather and two brothers in ___ \nand reports having feelings of being overwhelmed and command AH \nto her psychiatrist at ___. She had been hospitalized at \n___ in ___, went to ___ when she \nwas ___ at ___. She is currently on Lamictal 200mg at bedtime, \nTopiramate BID, and was on a trial of luradisone 20mg at HS when \nshe became acutely depressed and suicidal and agitated and began \nto report AH. Latuda was discontinued after 2 weeks of a trial \nand the last dose was on ___. Patient reports downward \nspiral occurred in and around this trial of latuda. Reports \nexperiencing worsening depression over the past two weeks, \nsuicidal ideation and hearing voices telling her to kill \nherself. Her sleep would become disrupted, became anhedonic, and \nlacked motivation and was unable to safety contract for safety \nin the community and was admitted to our inpatient unit for \nfurther stabilization and evaluation. \n\n___ - Hospitalized at ___ in ___ (and ___. \nShe engaged in self-injurious behavior and cute herself \nrequiring stitches. She has had multiple medication trials in \nthe past. She\nis being seen on an outpatient basis through ___ and her \npsychiatrist is ___. Carries diagnosis of PTSD, \nbipolar disorder, major depression. \n\nMedications on admission were lamictal 200mg daily and \ntopiramate 50mg BID. \n\nHospital Course - Trial of Abilify; also felt that Vistaril was \nhelping with her anxiety. Noted that Abilify was helping with \nher AH, especially at night.\n\nDischarge meds - Abilify 5mg daily, Lamictal 200mg daily and \nTopamax 50mg BID. \n\nDischarge diagnosis - Bipolar Disorder, PTSD\n\nDischarge Summary ___ - ___\nHPI - admitted for worsening depression with suicidal thoughts \nand intentional overdose of 13 hydroxyzine. Identified worsening \ndepressive symptoms and strain of missing her own mother who \npassed away due to an overdose which was a suicide attempt that \nthe patient had witnessed. Patient reported being traumatized by \nthis and was a period of time that was difficult for the \npatient. Also reported having difficulty in school. As soon as \npatient took 13 hydroxyzine, she immediately regretted it and \ncalled her boyfriend right away who brought her to the hospital. \nShe was evaluated, treated, and brought to inpatient unit. \n\nMedications on admission -  Abilify 15mg daily, Lamictal 200mg \ndaily, Topamax 50mg QAM + 100mg QHS\n\nPPH - Stated that she has been depressed since she was ___ and in \ntreatment since she was ___. Has a psychiatrist at ___ and \ntherapist for the past ___ years. Medication trials included \nPaxil and Zoloft (in addition to current medications), but noted \nthat Paxil and Zoloft caused anxiety and mood swings. Bupropion \nwas also tried but had caused her to get hives. Has not previous \nsuicide attempts other than the current episode, no other \nepisodes of self-harm. \n\nHospital Course - Continued on Abilify 15mg daily, Lamictal \n200mg daily, Topamax 50mg QAM + 100mg QHS. Also started on \nprazosin for trauma and nightmares for racing thoughts. Reported \nimproved sleep with prazosin and feeling calmer with less racing \nthoughts with thorazine. \n\nDischarge Medications - Abilify 15mg daily, Lamictal 200mg \ndaily, Topamax 50mg QAM + 100mg QHS, Prazosin 1mg QHS, Thorazine \n50mg Q6hrs PRN for anxiety (not to exceed two doses per day)\n\nDischarge diagnosis - Major Depression, PTSD\n\nDischarge Summary ___ - ___\nHPI - Presented for increased depression and suicidal ideation. \nReported that she had been medication compliant since her last \ndischarge about a month prior to this admission. She did not act \non increasingly depressive symptoms or suicidal ideation. \nInstead she reports that she reached out for help. Her Abilify \nwas increased from 10 to 15mg by her outpatient psychiatrist. \nHowever, she continued to feel depressed and continued to feel \nsuicidal and she was brought in to the emergency room for \nfurther evaluation by her family. Her symptoms at time of \nadmission were ongoing suicidal thoughts. She doesn't want to \ndie. She denies any acute stressors. She reached out for help \nand was brought to the ED where she was evaluated and reports \nthat for about a week she had crashed and became acutely \ndepressed after a period of decreased need for sleep. \n\nMedications on admission - Abilify which was just changed in \ndose, Buspar 5mg TID, Lamictal 200mg daily, Topamax 50mg QAM + \n100mg QHS, Prazosin 1mg QHS, and Remeron 7.5mg at night.\n\nHospital Course - Patient attended the unit programs and able to \ngo to groups. She had demonstrated little insight into what was \ncausing her problems but changed since she was last here. She \ndid over time articulate what she thinks that the hope of the \nmedication working was actually more positive than her actually \nhaving received much benefit from it. She was able to reach out \nto people instead of acting on suicidal thoughts. She was \ntolerating increase in Abilify that had just been instated. \nUltimately she was anxious and intermittently dysphoric at time \nof discharge but in no acute distress. \n\nMedications on discharge - Continued on Abilify 15mg, Lamictal \n200mg daily, Topamax 50mg in the morning and 100mg at night, \nPrazosin 1mg at bedtime, Buspar 5mg TID and Remeron 7.5mg QHS\n\nDisposition - Patient was going to continue on with treatment \nand medication adjustments in the PHP where she would have her \nintake on ___ at ___'s program in ___. She \nwill follow up with their psychiatric nurse practitioner and \ntherapist. She was given an ___ worker through ___.\n\nDischarge Diagnosis - Major Depressive Disorder, PTSD, Bipolar \nDisorder, Schizoaffective Disorder Bipolar type.\n.\n#) INTERVENTIONS\n- Medications: Aripriprazole 15mg PO daily, lamotrigine 25mg PO \ndaily, prazosin 1mg PO qHS, clonidine 0.1mg PO BID (qAM and at \n14:00)\n- Psychotherapeutic Interventions: Individual, group, and milieu \ntherapy.\n- Coordination of aftercare: Patient has outpatient follow up \nwith PCP through ___, and therapist and nurse \npractitioner at ___.\n.\nINFORMED CONSENT: The team discussed the indications for, \nintended benefits of, and possible side effects and risks of \nstarting aripriprazole, and risks and benefits of possible \nalternatives, including not taking the medication, with this \npatient.  We discussed the ___ right to decide whether to \ntake this medication as well as the importance of the ___ \nactively participating in the treatment and discussing any \nquestions about medications with the treatment team.  The \npatient appeared able to understand and consented to begin the \nmedication.\n.\nRISK ASSESSMENT\nOn presentation, the patient was evaluated and felt to be at an \nincreased risk of harm to herself  based upon significant \nconcern from family members and outpatient providers for \n___ inability to maintain safety in outpatient partial \nprogram.  Her static factors noted at that time include history \nof suicide attempts, history of abuse, chronic mental illness, \nrecent discharge from an inpatient psychiatric unit, , marital \nstatus, and possible concurrent personality disorder.  The \nmodifiable risk factors including suicidal ideation with plan, \nmedication non-compliance, hopelessness, insomnia, and \nimpulsivity were also addressed at that time.  These modifiable \nrisk factors were addressed during her  admission via medication \ninitiation and adjustment, acute stabilization within a \ntherapeutic milieu, individual and group  therapy, and aftercare \nplanning. Finally, the patient is being discharged with many \nprotective risk factors including help seeking nature, future \noriented viewpoint, positive therapeutic relationship with \noutpatient therapist, lack of suicidal ideation, and no history \nof substance use disorder.  Overall, the patient is not at an \nacutely elevated risk of self-harm nor danger to others due to \nacutely decompensated psychiatric illness. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Prazosin 1 mg PO QHS \n2. LamoTRIgine 25 mg PO QHS \n\n \nDischarge Medications:\n1.  ARIPiprazole 15 mg PO DAILY \nRX *aripiprazole [Abilify] 15 mg 1 tablet(s) by mouth daily Disp \n#*14 Tablet Refills:*1 \n2.  CloNIDine 0.1 mg PO BID \nRX *clonidine HCl [Catapres] 0.1 mg 1 tablet(s) by mouth twice a \nday Disp #*28 Tablet Refills:*1 \n3.  LamoTRIgine 25 mg PO QHS \nRX *lamotrigine [Lamictal] 25 mg 1 tablet(s) by mouth daily Disp \n#*14 Tablet Refills:*1 \n4.  Prazosin 1 mg PO QHS \nRX *prazosin [Minipress] 1 mg 1 capsule(s) by mouth at bedtime \nDisp #*14 Capsule Refills:*1 \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nBipolar spectrum disorder\nr/o personality traits\nr/o PTSD\nr/o unspecified anxiety disorder\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n-Please follow up with all outpatient appointments as listed - \ntake this discharge paperwork to your appointments.\n-Unless a limited duration is specified in the prescription, \nplease continue all medications as directed until your \nprescriber tells you to stop or change.\n-Please avoid abusing alcohol and any drugs--whether \nprescription drugs or illegal drugs--as this can further worsen \nyour medical and psychiatric illnesses.\n-Please contact your outpatient psychiatrist or other providers \nif you have any concerns.\n-Please call ___ or go to your nearest emergency room if you \nfeel unsafe in any way and are unable to immediately reach your \nhealth care providers.\nIt was a pleasure to have worked with you, and we wish you the \nbest of health.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"12071059","hadm_id":"22462507","text":" \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\n___ year old male admitted for weight reduction surgery.\n \nMajor Surgical or Invasive Procedure:\nStatus Post Laparoscopic Gastric Bypass\n\n \nHistory of Present Illness:\n___ has class III morbid obesity with weight of 328.1 lbs as of\n___ (initial screen weight on ___ was 326.6 lbs), height\nof 67.5 inches and BMI of 51.4. Previous weight loss efforts \nhave\nincluded 6 months of HMR in ___ losing 30 pounds that he\nmaintained for 6 months, 3 months Nutrisystem in ___ losing 30\npounds that he also maintained for 6 months, as well as one week\na Weight Watchers, one week ___ without results and 6\nmonths of prescription weight loss medication Xenical without\nresults.  He also did ___ounseling again without \nany\nresults.  ___ participated in the ___ Luck\nAhead Study where his weight dropped to 280 pounds.  He has not\nused over-the-counter ephedra-containing appetite\nsuppressant/herbal supplements. His weight at age ___ was 200\npounds his lowest adult weight with his highest weight being his\ncurrent weight of 328 pounds.  His weight one year ago was 310\npounds.  He states he developed a significant weight problem at\nthe age of ___ especially when he quit smoking.  Factors\ncontributing to his excess weight include large portions, late\nnight eating, too many carbohydrates, stress, emotional, nervous\nand compulsive eating with occasional binging as well as lack of\nexercise although he likes to walk 20 to 30 minutes 3 times a\nweek. \n \nPast Medical History:\ntype 2 diabetes, dyslipidemia, obstructive sleep apnea on CPAP, \nosteoarthritis/DJD, history of gout (left big toe), fatty  \nliver, colonic polyps and hematuria.  \n\n \nSocial History:\n___\nFamily History:\n His family history is noted for\nfather deceased at age ___ of cancer and diabetes; mother living\nage ___ with arthritis and obesity. \n \nPhysical Exam:\nHis blood pressure was 123/75, pulse 82 and O2 sat 97% on room\nair.  On physical examination ___ was casually dressed, \npleasant\nand in no apparent distress. His skin is tanned, warm, dry with\nno rashes, there were multiple skin tags. Sclerae were \nanicteric,\nconjunctiva clear, pupils were equal round and reactive to \nlight,\nfundi with sharp optic disks and no evidence of retinopathy,\nmucous membranes were moist, tongue was pink and the oropharynx\nwas without exudates or hyperemia.  Trachea was in the midline\nand the neck was supple with full range of motion, no \nadenopathy,\nthyromegaly or carotid bruits.  Chest was symmetric and the \nlungs\nwere clear to auscultation bilaterally with good air movement. \nCardiac exam was noted for regular rate and rhythm, normal S1 \nand\nS2, no murmurs, rubs or gallops.  The abdomen was obese but soft\nand non-tender, non-distended with normal bowel sound activity\nand no appreciable masses, there was a well-healed right lower\nquadrant vertical incision scar, no hernias.  Spinal curvature\nwas normal with no spinal tenderness or flank pain.  Lower\nextremities were noted to trace edema of the left and mild \nvenous\ninsufficiency/varicosity, there was no clubbing.  There is no\nevidence of joint swelling or inflammation of the joints.  There\nwere no focal neurological deficits, gait was normal.\n\n \nPertinent Results:\n___ 06:52AM BLOOD WBC-7.8# RBC-4.25* Hgb-12.1* Hct-36.4* \nMCV-86 MCH-28.4 MCHC-33.1 RDW-15.0 Plt ___\n___ 02:23PM BLOOD Hct-37.0*\n___ 06:52AM BLOOD Glucose-133* UreaN-9 Creat-0.8 Na-137 \nK-4.1 Cl-102 HCO3-28 AnGap-11\n___ 06:52AM BLOOD CK(CPK)-1060*\n___ 06:52AM BLOOD CK-MB-9 cTropnT-\u003c0.01\n___ 06:52AM BLOOD Calcium-8.4 Phos-3.1 Mg-1.8\n\n___ Upper Gi Status post gastric bypass without evidence of \nleak or \nobstruction. Slow emptying into the jejunum likely represents \npostoperative edema. \n\n___ Chest X-ray\n\nLeft retrocardiac atelectasis is moderate, more prominent than \non the right side. There is no volume overload. The \ncardiomediastinal silhouette is enlarged, probably due to \nmediastinal lipomatosis. Lungs are otherwise clear and hilar \ncontours are normal. There is no pleural effusion. \n\n \nBrief Hospital Course:\nPatient underwent a laparoscopic gastric bypass without \ncomplications. Postoperatively he had chest pain that resolved \nquickly with no signs or symptoms of cardiac involvement. EKG \nand cardiac enzymes were negative for myocardial infarction. On \npostoperative day 2 some erythema noted around midabdominal port \nsites. Ancef started.\n\nPatient was supported by intravenous fluids and pain medication \nthroughout hospital course. He was progressed from a bariatric \nstage one to stage 3 diet without nausea or vomiting. Erythema \non abdominal wall looks like it is resolving.\n\nCurrently patient is doing very well. On a stage 3 diet with \nstable blood sugars and ambulating independently. We will \ndischarge home today.\n\nFollow up Plans:\n1. Resolving Cellulitis - will send home with keflex liquid ___ \nqid for 7 days. Will follow up with Dr. ___ in ___ \nclinic on ___.\n\n2. Diabetes - throughout hospital course blood sugars have been \nrelatively stable. Will have patient continue to check his blood \nsugars four times a day at home and log. Will give ___ of his \nmetformin dose and hold his glucotrol for now to avoid \nhypoglycemia. Will have patient follow up with his primary care \nin one week to adjust his diabetic regimen.\n\n3. Obstructive Sleep Apnea - Patient used his personal CPAP \nmachine in hospital. His oxygen saturations have been stable. \n \nMedications on Admission:\nLantus insulin 80 units at bedtime,  \nMetformin 1000 mg twice a day, Glucotrol 10 mg twice a day for  \ndiabetes; Cozaar 10 mg daily for renal prophylaxis; Lipitor 10 \nmg  \ndaily for hyperlipidemia; Ecotrin 325 mg for cardiac \nprophylaxis;  \nand nutritional supplements ascorbic acid, B complex vitamins,  \nvitamin B12, iron, coenzyme Q10, pyridoxine, vitamin E and  \nmultivitamin.  \n\n \nDischarge Medications:\n1. Actigall 300 mg Capsule Sig: One (1) Capsule PO twice a day: \nplease take for 6 months.\nDisp:*60 Capsule(s)* Refills:*5*\n2. Zantac 15 mg/mL Syrup Sig: Ten (10) ml PO twice a day: please \ntake for one month.\nDisp:*600 ml* Refills:*0*\n3. Roxicet ___ mg/5 mL Solution Sig: ___ ml PO every ___ \nhours as needed for constipation.\nDisp:*600 ml* Refills:*0*\n4. Colace 50 mg/5 mL Liquid Sig: Ten (10) ml PO twice a day as \nneeded for constipation.\nDisp:*500 ml* Refills:*0*\n5. Metformin 500 mg/5 mL Solution Sig: 500mg 5 ml PO twice a \nday.\nDisp:*300 ml* Refills:*2*\n6. Medications\nPlease take ___ of your metformin dose, do not take glucotrol, \necotrin, or vitamin E. Please monitor your fingerstick blood \nsugars four times a day and log. Make an appointment with your \nprimary care in one week and have him/her review this log and \nadjust your diabetic medications.\n7. medication\nKeflex ___ po/liquid qid  X  7 days. Script called in.\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis: Obesity\nSecondary Diagnoses: Type 2 diabetes, dyslipidemia, obstructive \nsleep apnea on CPAP, osteoarthritis/DJD, history of gout (left \nbig toe), fatty liver, colonic polyps \n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nDischarge Instructions: Please call your surgeon or return to \nthe emergency department if you develop a fever greater than \n101.5, chest pain, shortness of breath, severe abdominal pain, \npain unrelieved by your pain medication, severe nausea or \nvomiting, severe abdominal bloating, inability to eat or drink, \nfoul smelling or colorful drainage from your incisions, redness \nor swelling around your incisions, or any other symptoms which \nare concerning to you.\n\nDiet: Stay on Stage III diet until your follow up appointment. \nDo not self advance\ndiet, do not drink out of a straw or chew gum.\n\nMedication Instructions:\nResume your home medications, CRUSH ALL PILLS.\nYou will be starting some new medications:\n1.  You are being discharged on medications to treat the pain \nfrom your operation. These medications will make you drowsy and \nimpair your ability to drive a motor vehicle or operate \nmachinery safely. You MUST  refrain from such activities while \ntaking these medications.\n2. You should begin taking a Flintstones chewable complete \nmultivitamin. No gummy vitamins.\n3. You will be taking Zantac liquid ___ mg twice daily for one \nmonth. This medicine prevents gastric reflux.\n4. You will be taking Actigall 300 mg twice daily for 6 months. \nThis medicine prevents you from having problems with your \ngallbladder.\n5. You should take a stool softener, Colace, twice daily for \nconstipation as needed, or until you resume a normal bowel \npattern.\n\nActivity:\nNo heavy lifting of items ___ pounds for 6 weeks. You may \nresume moderate\nexercise at your discretion, no abdominal exercises.\n\nWound Care:\nYou may shower, no tub baths or swimming. \n\nIf there is clear drainage from your incisions, cover with \nclean, dry gauze. \nYour steri-strips will fall off on their own. Please remove any \nremaining strips ___ days after surgery.\nPlease call the doctor if you have increased pain, swelling, \nredness, or drainage from the incision sites.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"19320223","hadm_id":"22941495","text":"Name:  ___           ___ No:  ___\n\nAdmission Date: ___        Discharge Date: ___\n\nDate of Birth:  ___        Sex:  M\n\nService:  OME\n\n\nHISTORY OF PRESENT ILLNESS:  Mr. ___ is a ___\nmale with metastatic melanoma admitted today to begin cycle\n1, week 1, high-dose IL-2 therapy. His oncologic history\nbegan in the ___, when he underwent excisional\nbiopsy for 1.75-mm thick melanoma from his right flank. Right\naxillary and right inguinal sentinel lymph node biopsy showed\nno evidence of melanoma. He developed a soft tissue nodule on\nhis right anterior chest wall in ___ which was\nexcised with pathology showing melanoma. In ___ he\ndeveloped multiple cutaneous nodules surrounding the right\nbreast. PET CT scan showed increased uptake in the right\nbreast only. On ___, he underwent a right\nmastectomy with pathology showing multiple soft tissue nodule\ndeposits, melanoma and clean margins. An axillary node\ndissection was not performed. He received adjuvant interferon\nfrom ___ until ___. He was well until\n___ when he developed a right neck nodule. FNA was\nperformed revealing melanoma. PET scan showed widespread\nmetastatic disease including right submandibular, right\naxillary, retroperitoneal, right inguinal and pelvic\nlymphadenopathy, as well as buttock soft tissue nodules and\nlower extremity FTG uptake. Head CT was negative. Treatment\noptions were reviewed and high-dose IL-2 therapy was felt\nmost appropriate assuming atrial fibrillation could be\ncontrolled off beta blockade. He underwent Persantine stress\ntest without ischemic changes noted. He passed other\neligibility testing and presents today to begin cycle 1, week\n1, high-dose IL-2 therapy.\n\nPAST MEDICAL HISTORY:  Melanoma as above, type 2 diabetes,\natrial fib status post resection of a benign polyp status\npost bilateral inguinal hernia repair, status post right\nmastectomy.\n\nALLERGIES:  No known drug allergies.\n\nMEDICATIONS:  Digoxin 250 mcg p.o. daily, Coumadin on hold,\nLovenox 80 mg subcu b.i.d., metformin 750 mg b.i.d. Toprol XL\n25 mg daily on hold, simvastatin 40 mg daily, Cialis p.r.n.,\ntestosterone 300 mg IM monthly.\n\nPHYSICAL EXAMINATION:  GENERAL:  Well-appearing male in no\nacute distress. Performance status zero. VITAL SIGNS:  95.8,\n75, 20, 137/82, O2 sat 100% on percent on room air. HEENT:\nNormocephalic, atraumatic. Sclerae anicteric. Moist oral\nmucosa without lesions. NECK:  Reveals a right centimeter\nright submandibular node. Lymph nodes: No left cervical,\nsupraclavicular or bilateral axillary lymphadenopathy. HEART:\nIrregularly irregular. CHEST:  Clear bilaterally. Status post\nright mastectomy. ABDOMEN:  Round and soft, nontender.\nEXTREMITIES:  No lower extremity edema. NEUROLOGIC EXAM:\nAlert, oriented x3. Speech clear and fluent, nonfocal. SKIN:\nRight flank scar and right chest wall scar is intact.\n\nADMISSION LABS:  WBC 6.4, hemoglobin 14, hematocrit 40.7,\nplatelet count 206,000, INR 2.7, BUN 14, creatinine 0.8,\nsodium 138, potassium 4.2, chloride 101, CO2 27, ALT 20, AST\n21, CK 84, total bili 0.5, albumin 4.6, dig level 0.6.\n\nHOSPITAL COURSE:  Mr. ___ was admitted and underwent\ncentral line placement to begin therapy. His admission weight\nwas 85 kg and he received interleukin-2 600,000 international\nunits per kilo equalling 51.2 million units IV every 8 hours\nx14 potential doses. During this week he received ___ doses\nwith additional doses held due to atrial fibrillation with\nrapid ventricular response. He was maintained on telemetry\nthroughout this week. Upon admission he was given additional\ndigoxin to achieve a therapeutic digoxin level to assist with\nheart rate control. On treatment day #3, IL-2 dosing was\nchanged to b.i.d. given tachycardia to the 120-140 range with\nany activity. He remained completely asymptomatic with stable\nblood pressure throughout. On treatment day #4, he had\npersistent tachycardia to the 150-160 range and he received\none dose of IL-2 with his other two doses held. He was\ntreated with additional dose of IV digoxin with eventual\nimprovement in his heart rate control. At that time he had\nassociated dyspnea with his elevated heart rate. On treatment\nday five, his heart rate had improved into the ___ off IL-2\nfor 24 hours and he was given final dose of IL-2. His heart\nrate subsequently increased to the 150 range again. He\nremained asymptomatic without hypotension noted. He had no\ndyspnea noted. He did receive additional digoxin IV with\nimprovement in his heart rate control. Digoxin was decreased\nto 125 mcg p.o. daily given decreased renal clearance\nanticipated with IL-2 therapy. At the time of discharge his\nheart rate was in the 90-120 range with occasional PVCs and\nhe was planned to restart Toprol XL for the week that he was\nhome. He will discontinue that on the ___ before his\nadmission.\n\nOther side effects during this week included fatigue; rigors\nimproved with Demerol; and occasional dyspnea on exertion.\nHis glucoses were fairly well managed off metformin.\n\nDuring this week he had no evidence of acute renal failure.\nHe developed transaminitis with a peak ALT of 77 and a peak\nAST of 70, both improved at the time of discharge. He\ndeveloped hyperbilirubinemia with a peak bilirubin of 3.7. He\nhad no acidosis noted. He was anemic without need for packed\nred blood cell transfusion. He developed thrombocytopenia\nwith a platelet count low of 31,000 without evidence of\nbleeding. He had no myocarditis or significant coagulopathy\nnoted. He was maintained on Lovenox throughout this admission\ndue to history of atrial fibrillation. By ___, he had\nrecovered from side effects to allow for discharge to home.\n\nCONDITION ON DISCHARGE:  Alert, oriented and ambulatory.\n\nDISCHARGE STATUS:  To home with his wife.\n\nDISCHARGE DIAGNOSES:  ___ melanoma status post cycle\n1, week 1, high-dose IL-2 complicated by atrial fibrillation\nwith rapid ventricular response.\n\nDISCHARGE MEDICATIONS:  Lasix 20 mg p.o. daily times 5 days\nor until you reach pretreatment weight, Tylenol ___ mg\nq.i.d. p.r.n. pain, ranitidine 150 mg p.o. b.i.d. p.r.n.\nheartburn, lorazepam 0.5 mg t.i.d. p.r.n. nausea/vomiting,\nBenadryl ___ mg q.i.d. p.r.n. pruritus, prochlorperazine 10\nmg q.i.d. p.r.n. nausea/vomiting, Keflex 5 mg p.o. b.i.d.\ntimes 5 days, Lomotil 1 to 2 tabs q.i.d. p.r.n. diarrhea,\nEucerin cream topically, Sarna lotion topically, Lovenox 80\nmg subcu b.i.d., digoxin 125 mcg p.o. daily, metformin 750 mg\np.o. b.i.d. once eating well. He will resume Toprol XL 25 mg\ndaily upon discharge.\n\nFOLLOW-UP PLANS:  Mr. ___ will return in 1 week for week\nnumber 2 of therapy.\n\n\n\n                        ___, MD ___\n\nDictated By:  ___, NP\n\nMEDQUIST36\nD:  ___ 10:30:26\nT:  ___ 11:38:32\n___:  ___\n\ncc:  ___\n"}
{"subject_id":"16957321","hadm_id":"29166835","text":" \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nLeft leg weakness new frontal mass\n \nMajor Surgical or Invasive Procedure:\nS/P Cranitomy for tumor removal\n\n \nHistory of Present Illness:\n___ well known for long h/o metastatic ovarian cancer; has \nbeen undergoing numerous chemotherapies; also developed multiple \n\nmyeloma for which she has been treated with steroids. Over the \npast few weeks, she developed general weakness, clearly \nproeminent on her left side, involving both arm and leg; \nweakness \nhas been worsening to the point that she had multiple \"falls\" to \n\nthe ground. Steroids have been held to r/o steroid induced \nmyelopathy. Weakness has nonetheless been progressing and she \nwas \nreferred to the ED by her oncologist. Head CT shows large Right \nfrontal mass; MRI confirmed a large cystic mass in the right \npremotor region.\n\n \nPast Medical History:\nh/o metastatic ovarian cancer, with progression of \nretroperitoneal lymphadenopathies, possible new rib and lung \nmetastasis; myeloma;  \n\n \nSocial History:\n___\nFamily History:\nThere is breast cancer in the family. She has \nthree brothers and three sisters. \n\n \nPhysical Exam:\nPHYSICAL EXAMINATION: \nGENERAL: The patient is alert, very pleasant elderly lady in no \nacute distress. She is well developed, well nourished. \nVITAL SIGNS: Temperature 97.5, pulse of 92, blood pressure \n124/80, and respirations of 16. \nCARDIOVASCULAR: She had regular rate and rhythm, no murmurs, \ngallops, or rubs. \nRESPIRATORY: Lungs were clear to auscultation bilaterally. \nSKIN/HEME/LYMPH: No clubbing or cyanosis. Her left lower \nextremity is swollen, about 1+ compared to the right, which has \nnone. Peripheral pulses were good. There are no neurocutaneous \nmarkers. \nNEUROLOGIC: The patient was alert and oriented x3. On mini \nmental status, she scored ___ with one point taken off for \nrecall. HEENT: Head was normocephalic, atraumatic. Eyes:  \nPupils equal, round, reactive to light. Extraocular movements \nwere intact. Visual fields were full. There was no nystagmus.  \nMouth: Oral mucosa was pink and moist. Tongue was midline, \npalate elevated symmetrically. Neck: Carotids were without \nbruit. Neck movements were full range and nontender. Cranial \nnerves II through IV, VI as already stated above. Cranial nerve \nV: Sensation was intact to light touch over the face. Cranial \nnerve VII: The patient had a symmetric smile, no evidence of \nfacial motor weakness. Cranial nerve VIII: Hearing was intact \nto finger rub bilaterally. Cranial nerves IX through XII: No \ndysarthria. Sternocleidomastoids were ___. Shoulder shrug was \nstrong. On motor evaluation, on the right deltoid was about \n4+/5, right biceps was about 4+/5, and right triceps was 4+/5, \nright grip was about ___, left deltoid was about ___, biceps \nand \ntriceps were 4+/5, and grip was about ___, right iliopsoas was \nabout ___, leg extension and leg flexion was about ___, as was \ndorsiflexion and plantar flexion. On the left leg, the iliopsoas \n\nwas about ___, leg extension and leg flexion was about ___. She \n\nhad ___ for dorsiflexion in the left leg, although she could \nlift \nher left toe up and she had about ___ for plantar flexion.  \nReflexes showed 2+ reflexes throughout and she had upgoing toe \non \nthe left. Cerebellar: She had decreased amplitude and velocity \nof fine motor movements on the left arm as well as leg. She was \nunable to do foot tapping well on either foot. The right was \nbetter than the left. She had difficulty doing heel-knee-shin \nwith the left leg. With gait, she needed assistance to stand and \n\nused a cane to prop herself up. She could not stand with her \nfeet together. She did have very unsteady steps and just had to \nsit back down again. \n\nExam upon discharge:\nOriented x 3. PERRL. No drift. Tongue midline, face symmetric.\nLeft leg weakness. Right side full strenghth. Sensation \ndecreased slightly on the left. Left leg swelling has improved. \nIncision, clean, dry, intact.\n \nPertinent Results:\n___ 05:15AM BLOOD WBC-8.8 RBC-3.35* Hgb-10.9* Hct-31.6* \nMCV-95 MCH-32.6* MCHC-34.5 RDW-15.9* Plt ___\n___ 05:00PM BLOOD Neuts-81.7* Lymphs-11.3* Monos-4.4 \nEos-2.4 Baso-0.3\n___ 05:15AM BLOOD Plt ___\n___ 05:15AM BLOOD Glucose-104 UreaN-20 Creat-0.7 Na-139 \nK-4.1 Cl-101 HCO3-28 AnGap-14\n___ 05:00PM BLOOD ALT-29 AST-82* AlkPhos-136* TotBili-0.3\n___ 05:15AM BLOOD Albumin-3.8 Calcium-9.8 Phos-3.2 Mg-1.6\n___ 04:25PM BLOOD Hgb-10.9* calcHCT-33\n___ 04:25PM BLOOD freeCa-1.17\n\nMRI Brain ___:\nFINDINGS: Since the previous study, the patient has undergone \nresection of \nright posterior frontal lobe, parasagittal rim-enhancing mass. \nBlood products are seen in this region with surrounding edema. \nFollowing gadolinium, residual enhancement is identified at the \nanterior aspect of the blood products. Subtle meningeal \nenhancement is also identified in the adjacent sulci. Blood \nproducts are seen in this region. No new areas of enhancement \nare identified. No hydrocephalus or midline shift seen. There is \npneumocephalus identified with tiny extra-axial collection which \nappear \npostoperative in nature. \n  \nIMPRESSION: Status post resection of right posterior frontal \nlobe rim- \nenhancing lesion seen on the prior MRI of ___. Blood products \nare seen \nwith residual enhancement anteriorly. Edema is again identified \nwithout \nchange. No hydrocephalus. Pneumocephalus and other postoperative \nfindings. \n  \nEEG ___:\nFINDINGS:  \nABNORMALITY #1: Focal slow transients were seen involving the \nright \ntemporal region broadly throughout the tracing. \nABNORMALITY #2: Although at best, background frequencies in the \n9 Hz \nrange were seen, throughout the majority of the tracing, a \npoorly \nmodulated ___ Hz mixed theta and alpha frequency background was \nseen. \nBACKGROUND: As above. \nHYPERVENTILATION: Was contraindicated due to the patient's \nhistory of \nrecent brain surgery. \nINTERMITTENT PHOTIC STIMULATION: Could not be obtained as the \ntest was \nrequested as a portable study. \nSLEEP: No clear sleep or wake transitions were seen. \nCARDIAC MONITOR: Revealed a generally regular rhythm with \naverage rate \nof 72 bpm. \nIMPRESSION: This is an abnormal EEG due to the presence of focal \n\nslowing involving the right temporal region suggesting the \npresence of a \nsubcortical abnormality in this area. The slow and disorganized \nbackground is consistent with a mild to moderate encephalopathy \nof \ntoxic, metabolic, or anoxic etiologies. No evidence of ongoing \nepileptogenesis was seen at the time of this tracing. \n  \n\n \nBrief Hospital Course:\nMs ___ was admitted to the neurosurgery service. She had an \nMRI completed, was started on Decadron and had close \nneurological observation. On ___ she underwent a right sided \ncranitomy for tumor removal, post operatively she was noted to \nhave hand shacking which was felt to seizure related. An EEG on \n___ showed a presence of focal slowing involving the right \ntemporal region, no suggestion of ongoing epileptogenesis. A \npost op MRI showed possible residual enhancement otherwise it \nwas normal post op changes. \n\nWhile her immediate neurologic exam remained stable relative to \nthe pre-operative status, she had suffered two episodes of \nseizure which left the left upper extremity weaker to pre-op. \nThe neurology service was consulted.  Consequently, her Keppra \ndose was increased to 1500 mg bid. After the initiation of this \nregiment, the patient became seizure free. She was seizure free \nfor 2 days prior to discharge. She was seen by ___ and was found \nto need acute rehab.  The patient was discharged to rehab on \n___ in the afternoon. She will continue her carboplatin that \nwas prescribed by her outside oncologist.\n \nMedications on Admission:\n Calcium Carbonate 500 mg Tablet, MVI, and Pyridoxine \n \nDischarge Medications:\n1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).  \n2. Insulin Regular Human 100 unit/mL Solution Sig: One (1)  \nInjection ASDIR (AS DIRECTED).  \n3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n4. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed.  \n5. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO HS (at \nbedtime) as needed.  \n7. Alum-Mag Hydroxide-Simeth 200-200-20 mg/5 mL Suspension Sig: \n___ MLs PO QID (4 times a day) as needed.  \n8. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) \nTablet, Chewable PO QID (4 times a day) as needed.  \n9. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n10. Pyridoxine 50 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n11. Simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, \nChewable PO QID (4 times a day) as needed.  \n12. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed.  \n13. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q8H \n(every 8 hours) as needed.  \n14. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1)  \nInjection BID (2 times a day).  \n15. Levetiracetam 500 mg Tablet Sig: Three (3) Tablet PO BID (2 \ntimes a day).  \n16. Menthol-Cetylpyridinium 3 mg Lozenge Sig: One (1) Lozenge \nMucous membrane PRN (as needed) as needed for sore throat.  \n17. Dexamethasone 2 mg Tablet Sig: One (1) Tablet PO Q8H (every \n8 hours) for 3 days.  \n18. Dexamethasone 2 mg Tablet Sig: One (1) Tablet PO Q12H (every \n12 hours).  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nMetastic Brain Mass\n\n \nDischarge Condition:\nNeurologically stable\n\n \nDischarge Instructions:\nHave a friend/family member check your incision daily for \nsigns of infection.\nTake your pain medicine as prescribed.\nExercise should be limited to walking; no lifting, straining, \nor excessive bending.\nYou may wash your hair only after after your wound check with \nDr ___. Your sutures are dissolvable You may shower before \nthis time using a shower cap to cover your head.\nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nUnless directed by your doctor, do not take any \nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and \nIbuprofen etc. \nClearance to drive and return to work will be addressed at \nyour post-operative office visit.\nMake sure to continue to use your incentive spirometer while \nat home, unless you have been instructed not to. \n\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING\n\nNew onset of tremors or seizures.\nAny confusion or change in mental status. \nAny numbness, tingling, weakness in your extremities.\nPain or headache that is continually increasing, or not \nrelieved by pain medication.\nAny signs of infection at the wound site: redness, swelling, \ntenderness, or drainage.\nFever greater than or equal to 101 F.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"10543994","hadm_id":"26560621","text":" \nName:  ___                 ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \n___ Complaint:\nshortness of breath\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ h/o stage IIA pancreatic cancer (recently completed ___ \ncycle gemcitabine), severe AS (valve area \u003c1.0cm2), Afib (on \nxeralto) VVI pacemaker for AV block is transferred from ___ for decompensated heart failure related to severe AS and \nNSVT, plan for valvuloplasty.  \n \nRe his cardiac history he has severe AS and had been preparing \nfor aortic valve replacement. One month ago he fainted while \ndriving he was noted to have AV wenkebach 2:1 AV block and \nreceived a pacemaker. In ___ he was noted to be in Afib and he \nwas started on xeralto. He was readmitted ___ following a \nsyncopal event while sitting in a chair which was felt to be \nfrom severe AS.  \n\nHe was seen by Dr ___ cardiologist on ___ and the \npt's pacemaker was interrogated and it was noted he had ___ \nepisodes of NSVT daily longest episode 20 beats. He was \nconcerned the pt developed NSVT from myocardial strain due to \ncritical AS. Given his advancing dementia and metastatic \npancreatic cancer the decision was made to consider palliative \naortic valvuloplasty  \n\nHe presented to ___ ___ with SOB. He had noticed \nincreased ___ edema for the past week, productive cough. Per \nreport day of admission he was taking his medications and \naspirated on one of his pills, and he noted to desat to 70-80%. \nHe was brought to ___ and there Vitals 98 94 16 98% \n2L NC 124/60 CXR was suggestive of CHF, BNP 2544 and he was \nadmitted for decompensated CHF and aspiration PNA. He was given \nclinda IV for aspiration PNA . Speech and swallow evaluated pt \ngiven aspiration and recommended regular diet with thin liquids, \nmeds to be crushed in puree. He was requiring ___ NC on day \nof transfer. The pt remained afebrile and WBC was normal.  \n\nRe CHF he was given 20IV lasix BID. He was on tele during hosp \ncourse and continued to have episodes of NSVT. Dr ___ \nspoke with the pt's oncologist, Dr ___, and pt has \n60% one yr survival. After discussion with pt's wife decision \nwas made to transfer pt to ___ to pursue aortic valvuloplasty. \n \n\nOn the floor he understands why he is here in the hospital. He \ndenies CP  \n\nReview of Systems:  per HPI\n \nPast Medical History:\nONCOLOGIC HISTORY (per OMR):  \nmetastatic pancreatic cancer, presented ___, presumptive \nstage IIA (T3N0M0). treatment has included chemoradiation with \ngemcitabine and XRT On ___, he underwent ERCP with \nsphincterotomy and placement of a metal stent.  \nSevere Aortic Stenosis and mild Aortic insufficiency  \nMild to Moderate MR  \nLBBB and fluctuation PR intervals  \nType 2 DM  \nMild Dementia  \nFrequent urination  \nAbdominal Hernia  \nPre-cancerous skin cancer on ears  \nMild arthritis  \nsevere AS  \nAfib\n \nSocial History:\n___\nFamily History:\n1. Sister with CAD.  \n2. Sister who had a lump removed. There may or may not had been  \ncancer.  \n3. No family history of breast cancer, colon cancer, pancreatic \ncancer, or other malignancies. \n \nPhysical Exam:\nADMISSION PHYSICAL:\n=====================\nVitals - 98.4 115/86 96 77 94$ 3.5L NC  \nGENERAL: NAD appear slightly dyspneic  \nNECK: difficult to assess JVP bc of large neck  \nCARDIAC: iregular, grade ___ systolic ejection murmur  \nLUNG: crackles up to mid lungs b/l  \nABDOMEN: large abd girth  \nEXTREMITIES: ___ edema \n\nDISCHARGE PHYSICAL:\n=====================\nGeneral: resting in bed with high flow mask on\nCardiac: regular, S1S2\nPulm: in mild to moderate respiratory distress\n___: soft, non-tender\nExtremities: trace edema in ___\n\n \nPertinent Results:\nADMISSION LABS:\n=========================\n___ 07:32AM BLOOD WBC-9.1 RBC-2.84*# Hgb-9.1*# Hct-27.5*# \nMCV-97 MCH-31.9 MCHC-32.9 RDW-17.9* Plt ___\n___ 06:27AM BLOOD ___ PTT-31.0 ___\n___ 12:57AM BLOOD Glucose-152* UreaN-23* Creat-1.4* Na-131* \nK-4.0 Cl-93* HCO3-28 AnGap-14\n___ 07:32AM BLOOD proBNP-6491*\n___ 12:57AM BLOOD Calcium-8.4 Phos-3.7 Mg-2.1\n\nPERTINENT LABS:\n=========================\n___ 05:39AM BLOOD WBC-19.6* RBC-3.37* Hgb-10.4* Hct-31.7* \nMCV-94 MCH-30.9 MCHC-32.9 RDW-17.1* Plt ___\n___ 04:22AM BLOOD WBC-18.3* RBC-3.33* Hgb-10.2* Hct-32.2* \nMCV-97 MCH-30.8 MCHC-31.9 RDW-17.2* Plt ___\n___ 04:22AM BLOOD Neuts-94.8* Lymphs-2.5* Monos-2.3 Eos-0.3 \nBaso-0.1\n___ 03:10AM BLOOD LD(___)-423*\n___ 04:22AM BLOOD LD(LDH)-316*\n___ 05:39AM BLOOD LD(LDH)-317*\n___ 07:32AM BLOOD proBNP-6491*\n___ 03:10AM BLOOD ANCA-NEGATIVE B\n___ 03:10AM BLOOD ___\n___ 03:10AM BLOOD RheuFac-18*\n___ 05:14AM BLOOD Vanco-15.1\n___ 01:31AM BLOOD Type-ART Temp-36.7 O2 Flow-6 pO2-44* \npCO2-39 pH-7.50* calTCO2-31* Base XS-6 Intubat-NOT INTUBA \nComment-SIMPLE FAC\n___ 11:54PM BLOOD Type-ART pO2-73* pCO2-43 pH-7.48* \ncalTCO2-33* Base XS-7\n___ 05:39AM BLOOD ___ pO2-39* pCO2-64* pH-7.38 \ncalTCO2-39* Base XS-9\n___ 01:31AM BLOOD Lactate-2.2*\n\n \nTest                        \n----                       \nFungitell (tm) Assay for (1,3)-B-D-Glucans\n \nResults                                 Reference Ranges\n-------                                 ----------------\n\u003e500 pg/mL*                             Negative       Less than \n60 pg/mL\n                                        Indeterminate  60 - 79 \npg/mL\n                                        Positive       Greater \nthan or equal to\n                                                       80 pg/mL\n\nTest                          Result              Reference \nRange/Units\nACE, SERUM                    50                  ___ U/L\n \n\nTest                          Result              Reference \nRange/Units\nSJOGREN'S ANTIBODY (SS-A)     \u003c1.0 NEG            \u003c1.0 NEG AI\nSJOGREN'S ANTIBODY (SS-B)     \u003c1.0 NEG            \u003c1.0 NEG AI\n \n Test                          Result              Reference \nRange/Units\nSED RATE BY MODIFIED          \u003e130  H             \u003c OR = 20 mm/h\n___         \n\nDISCHARGE LABS:\n=========================\n\nSTUDIES:\n=========================\n___ (PORTABLE AP)\nInterval placement of a single lead left-sided pacing device \nwith the lead\nterminating over the expected location of the right ventricle. \nThe cardiac and\nmediastinal contours are stable with left ventricular \nprominence. Interval\nplacement of a right internal jugular Port-A-Cath with its tip \nin the distal\nSVC. No pneumothorax. Interval appearance of mild pulmonary \nedema.\n\n___  ImagingCHEST (PORTABLE AP)\nAs compared to ___ radiograph, cardiomegaly is \naccompanied by\npulmonary vascular congestion and worsening asymmetrical \ncombined alveolar and\ninterstitial pattern which remains more severe in the right lung \nthan the\nleft. Observed findings may reflect asymmetrical edema, but \nfollowup\nradiographs after diuresis may be helpful to exclude secondary \nsuperimposed\nprocess in the right lung such as infection. Small pleural \neffusions are\npresent bilaterally.\n\n___\nThe left atrium is mildly dilated. The right atrium is \nmoderately dilated. There is mild symmetric left ventricular \nhypertrophy. The left ventricular cavity size is normal. Overall \nleft ventricular systolic function is mildly depressed (LVEF= 45 \n%) secondary to pacing-induced dyssynchrony. Right ventricular \nchamber size and free wall motion are normal. The aortic root is \nmildly dilated at the sinus level. The ascending aorta is mildly \ndilated. The aortic arch is mildly dilated. There are focal \ncalcifications in the aortic arch. The aortic valve leaflets are \nseverely thickened/deformed. There is severe aortic valve \nstenosis (valve area = 1.0cm2). Indexed ___ = 0.5 cm2 per m2 \nBSA. The mitral valve leaflets are mildly thickened. Mild (1+) \nmitral regurgitation is seen. There is moderate pulmonary artery \nsystolic hypertension. There is no pericardial effusion. \n\nCompared with the prior study (images reviewed) of ___. \nThe findings are similar. \n \n \nBrief Hospital Course:\n___ h/o stage IIA pancreatic cancer (recently completed ___ \ncycle gemcitabine), severe AS (valve area \u003c1.0cm2), Afib (on \nxeralto) VVI pacemaker for AV block is transferred from ___ for decompensated heart failure related to severe AS and \nNSVT, plan for valvuloplasty.\n\n#Decompensated diastolic heart failure related to severe AS: On \nexam he appeared volume overloaded with crackles and 1+ ___ \nedema. OSH CXR suggesting CHF. He was given 20 IV lasix BID at \nOSH and he was requiring 5L facemask (at OSH 2.5L). His O2 \nrequirement here was worsening and he was transferred to the CCU \nwhen he had to be put on a non-rebreather. There was initial \nconcern that the patients heart failure may have acutely \nworsened due to his aortic stenosis. Repeat echo was performed \nand showed a valve area of \u003c1cm and a preserved ejection \nfraction of 45%. The patient initially had been planned to have \na palliative valvuloplasty however on reevaluation it was \nunlikely to provide the patient with much relief given the valve \narea and mean gradient. The patient was diuresed with a lasix \ndrip and IV lasix  bolus of 40mg to which he put out well too. \nHe was diuresed with caution given his aortic stenosis. The \npatient was 92kg on admission and 88kg on transfer from the CCU. \n\n\n#Hypoxemia- Patient had presented to the hospital with dyspnea \nhad a new oxygen requirement. It was thought to be \nmultifactorial. This included aspiration, possible pneumonia and \nheart failure. The patient was triggered during his hospital \nstay for acute desaturation into the ___ and required to be \nplaced on a rebreather. His physical exam was notable for severe \nanterior and posterior crackles. The patient was transferred to \nthe ICU. He was kept on the rebreather and was not intubated \ngiven his code status of DNR/DNI. The patient was diuresed as \nper above. He was treated initially for aspiration pneumonia \nwith broad spectrum antibiotics which was discontinued as it was \nthought he was suffering from aspiration pneumonitis.  His \namiodarone was discontinued as it may have been resulting in \nadditional pulmonary toxicity. Given his prolonged hypoxia with \nminor improvement with the above actions the decision was made \nto consult pulmonary. The suggested further work up and possible \ngemcitabine toxicity. The patient was started on IV solumedrol \nfor 5 days. The patients oxygen requirement went down from \nrebreather to FiO2 80% on facemask. His crackles resolved on \nphysical exam. The patients Beta Glucan came back positive. He \nwas started on treatment for PCP with bactrim for 21 days  (___). The patient had daily CXR and LDH. High resolution CT \nscan was not performed as it was unlikely to change managment \ngivne that patients chronic pancreatic cancer.  The patient was \ntransferred to the MICU. The patient was given bactrim and \ncontinued on steroids with the thought that his hypoxia could be \nsecondary to PJP, however after 3 days of treatment there was no \nimprovement seen in the patient's oxygenation status.  The \npatient was maintained on nasal canula oxygen and a combination \nof high flow/non-rebreater/shovel mask with goal O2 saturations \n\u003e80%.  On the day of discharge, the patient was made CMO and \ngiven small doses of morphine and ativan to help with air \nhunger.  Patient was satting between 80 and 96% on high flow \nface mask. \n\n#NSVT: Likely due to myocardial strain from severe AS. Pt had \nmultiple episodes of polymorphic SVT since arriving to the \ncardiology floor. On ___, triggered for 1 min run of VT with \nloss of consciousness before spontaneously converting (normal \nlytes). His pacer rate was initially increased to 91 but \nsubsequently decreased to 80 in the setting of a worsening O2 \nrequirement. He was loaded with amiodarone. After transfer to \nthe CCY his amiodarone was discontinued as the patient had no \nmore episodes of NSVT and there was concern that the amiodarone \nmay be leading to pulmonary toxicity. Given the short duration \nof dosing it was unlikely to be causing pulmonary toxicity \nhowever given his fragile pulmonary system it was deemed safer \nto discontinue it. He appeared to be stable with the pacing at \n80. The patient was monitored after the amiodarone was stopped \nand did well with no repeat episodes. \n\n#Aspiration PNA/Pneumonitis: Pt had a witnessed aspiration event \nbefore transfer to ___. Otherwise he had been afebrile, had a \nnormal white count, and CXR showed small area of increased \ndensity in the RLL, consolidation could not ruled out. He had \nbeen receiving IV clinda at OSH and was switched to levofloxacin \non arrival to ___. This was further switched to ceftriaxone. \nWhen the patient triggered on the floor for hypoxia, the acute \ndrop in his saturation was thought to be due to an aspiration \nevent. The patient appeared to desaturate in the setting of \nhaving just received his medications. His antibiotics were \nbroadened to vancomycin and cefepime and the patient was made \nNPO. Speech and swallow evaluated the patient and deemed him \nsafe to eat. The broad spectrum antibiotics were discontinued \nafter 72 hours given that he was afebrile and stable. \n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Aspirin 81 mg PO DAILY \n2. Cyanocobalamin ___ mcg PO DAILY \n3. Donepezil 5 mg PO DAILY \n4. Finasteride 5 mg PO DAILY \n5. FoLIC Acid 1 mg PO DAILY \n6. Tamsulosin 0.4 mg PO HS \n7. Simvastatin 20 mg PO DAILY \n8. Pantoprazole 40 mg PO Q24H \n9. Levothyroxine Sodium 50 mcg PO DAILY \n10. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 \nmg(1,500mg) -400 unit oral BID \n11. carboxymethylcellulose sodium 0.5 % ophthalmic 1 drop as \nneeded  for dry eyes \n12. glimepiride 4 mg ORAL BID \n13. Hydrochlorothiazide 12.5 mg PO DAILY \n14. Furosemide 40 mg PO DAILY \n15. Rivaroxaban 10 mg PO DAILY \n16. Sertraline 75 mg PO DAILY \n\n \nDischarge Medications:\nHYDROmorphone (Dilaudid) 0.25 mg IV Q30MIN: PRN dyspnea\nOLANZapine (Disintegrating Tablet) 5 mg PO TID:PRN agitated \ndelirium \nBisacodyl 10 mg PO DAILY:PRN constipation \nDocusate Sodium 100 mg PO/NG BID:PRN constipation \nHeparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line flush, \nFlush w/ 10ml Normal saline f/b 5ml of 10unit/ml Heparin. Flush \ndaily and after intermittent infusions, transfusions or blood \ndraw   \nHeparin Flush (100 units/ml) 5 mL IV PRN and PRN, line flush for \nde-accessing portacath  \n \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nhypoxemic respiratory failure\ncritical AS\nCHF\nAtrial Fibrillation\nHeart Block with pacer\nPancreatic CA\n \nDischarge Condition:\nFair\n \nDischarge Instructions:\nYou were admitted to the the hospital with shortness of breath.  \nYou were treated for heart failure with aggressive diuretic \ntherapy, but even after a lot of fluid was removed from your \nlungs, you still had significant trouble breathing.  You were \ntreated for infection in your lungs as well as with steroids to \nhelp decrease inflammation.  Despite these treatments, your \noxygen level was still low.  You did not wish to have aggressive \ninterventions performed.  Your wife and friend helped to make \nthe decision to focus your medical care on comfort, and you were \ntransferred to ___ hospital hospice to help manage your \nsymptoms.\n \nFollowup Instructions:\n___\n"}
{"subject_id":"11051865","hadm_id":"20213822","text":" \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \n___ Complaint:\nincarcerated parastomal hernia \n \nMajor Surgical or Invasive Procedure:\nLaparoscopic reduction of parastomal hernia and\ntranslocation of the ileostomy with mesh reinforcement.\n\n \nHistory of Present Illness:\nPer colorectal surgery note in the emergency department:\n\n___ PMHx of UC s/p total proctocolectomy with end ileostomy\n(___) with development of subsequent parastomal hernia who\npresents to the ED with significant abdominal pain, nausea, with\nCT concerning for incarcerated parastoma hernia. Patient states\nthat she first noticed a ___ bulge ___ years after her\ninitial operation. She only states that she experienced one\nlikely obstructive episode that self resolved with manual\nreduction. She previously saw Dr. ___ operative repair of\nhernia, but the ultimate decision per patient was to \nconservative\nobservation. However, Ms. ___ states that 24 hours ago she\nstarted to experience acute onset of abdominal pain, nausea, 1\nepisode of emesis. She presented to the ED where a CT scan with\nPO/IV contrast demonstrated dilated stomach, edema within\nparastomal hernia, as well as mesenteric stranding concerning \nfor\nincarceration. \n\n \nPast Medical History:\nUlcerative colitis vs. Crohn (steroid dependence, pseudopolyps \nin sigmoid colon), arthritis (prednisone, remicade)\n\nPSH: none\n\n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\nD/C PE\n\nGeneral: doing well, tolerating a regular diet, pain controlled, \nambulating\nVSS\nNeuro: A\u0026OX3\nCardio/Pulm: no chest pain or shortness of breath\nAbd: ilesotmy pink with output, surgical incisions intact \nwithout signs of infection\n \nPertinent Results:\n___ 06:40AM BLOOD WBC-7.7 RBC-3.97 Hgb-12.4 Hct-36.7 MCV-92 \nMCH-31.2 MCHC-33.8 RDW-12.9 RDWSD-43.8 Plt ___\n___ 07:16AM BLOOD WBC-7.3 RBC-3.37* Hgb-10.6* Hct-31.2* \nMCV-93 MCH-31.5 MCHC-34.0 RDW-13.3 RDWSD-45.2 Plt ___\n___ 06:45AM BLOOD WBC-12.6* RBC-3.80* Hgb-11.8 Hct-34.9 \nMCV-92 MCH-31.1 MCHC-33.8 RDW-13.4 RDWSD-45.4 Plt ___\n___ 05:53PM BLOOD WBC-21.6* RBC-4.33 Hgb-13.7 Hct-41.1 \nMCV-95 MCH-31.6 MCHC-33.3 RDW-13.3 RDWSD-46.6* Plt ___\n___ 07:00AM BLOOD WBC-14.2* RBC-3.95 Hgb-12.3 Hct-36.2 \nMCV-92 MCH-31.1 MCHC-34.0 RDW-13.2 RDWSD-44.8 Plt ___\n___ 08:48PM BLOOD WBC-9.9 RBC-4.43 Hgb-13.7 Hct-38.5 MCV-87 \nMCH-30.9 MCHC-35.6 RDW-13.1 RDWSD-41.0 Plt ___\n___ 06:40AM BLOOD Glucose-82 UreaN-6 Creat-0.6 Na-141 K-4.2 \nCl-105 HCO3-26 AnGap-10\n___ 07:00AM BLOOD Glucose-88 UreaN-5* Creat-0.6 Na-141 \nK-4.2 Cl-105 HCO3-26 AnGap-10\n___ 07:16AM BLOOD Glucose-91 UreaN-4* Creat-0.7 Na-141 \nK-3.6 Cl-107 HCO3-26 AnGap-8*\n___ 06:45AM BLOOD Glucose-113* UreaN-5* Creat-0.6 Na-138 \nK-4.1 Cl-104 HCO3-25 AnGap-9*\n___ 05:53PM BLOOD Glucose-131* UreaN-5* Creat-0.7 Na-139 \nK-3.8 Cl-103 HCO3-22 AnGap-14\n___ 07:00AM BLOOD Glucose-122* UreaN-9 Creat-0.6 Na-140 \nK-4.4 Cl-104 HCO3-24 AnGap-12\n___ 06:40AM BLOOD Calcium-8.4 Phos-3.5 Mg-2.0\n___ 07:00AM BLOOD Calcium-8.1* Phos-2.7 Mg-1.9\n___ 07:16AM BLOOD Calcium-7.7* Phos-2.2* Mg-2.1\n___ 06:45AM BLOOD Calcium-7.7* Phos-2.8 Mg-2.5\n___ 05:53PM BLOOD Calcium-7.8* Phos-3.3 Mg-2.3\n___ 07:00AM BLOOD Calcium-7.9* Phos-3.4 Mg-1.7\n___ 08:48PM BLOOD Albumin-4.3\n\n CT ABD \u0026 PELVIS WITH CONTRAST Study Date of ___ 11:41 ___\nIMPRESSION: \n  \n  \n1. Right parastomal hernia contains obstructed small bowel loops \nand \nsurrounding edema which should be correlated for \nincarceration/strangulation. \n2. Mildly dilated intrahepatic peripheral biliary ducts.  \nConsider nonemergent \nMRCP for further evaluation given history of ulcerative colitis. \n\n3. Right lower lobe pulmonary airspace disease may reflect \naspiration or \npneumonia. \n\n \nBrief Hospital Course:\nMrs. ___ presented to the Emergency Department with an \nincarcerated parastomal hernia She was seen by Dr. ___. On \n___ she was taken to the operating room for  Laparoscopic \nreduction of parastomal hernia and translocation of the \nileostomy with mesh reinforcement. Post-operatively she did \nwell. She had output from the ileostomy. She did well over the \nnext few days and voided after the foley catheter was removed. \nShe was followed by the wound ostomy nursing team. She was \ndischarged home meeting all discharge criteria. She was given \nappropriate discharge instruction. \n\n \nMedications on Admission:\n___:  \n Symbicort 160mcg-4.5mcg/2puffs daily PRN  \n Etanercept (hold)  \n Levothyroxine 125mg'  \n Loratidine  \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Moderate \ndo not take more than 3000mg of Tylenol in 24 hours or drink \nalcohol while taking \nRX *acetaminophen 325 mg 2 tablet(s) by mouth every six (6) \nhours Disp #*50 Tablet Refills:*0 \n2.  Enoxaparin Sodium 40 mg SC DAILY \ntake for 26 more days \nRX *enoxaparin 40 mg/0.4 mL 40 mg subcutaneous once a day Disp \n#*26 Syringe Refills:*0 \n3.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Mild \ndo not drink alcohol or drive a car while taking \nRX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours \nDisp #*10 Tablet Refills:*0 \n4.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation \ninhalation BID  \n5.  Ibuprofen 400-600 mg PO Q8H:PRN Pain - Moderate \ntake with food, do not take for more than ___ days  \n6.  Levothyroxine Sodium 125 mcg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nIncarcerated parastomal hernia with intestinal compromise.\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n___ have a new ileostomy. The most common complication from a \nnew ileostomy placement is dehydration. The output from the \nstoma is stool from the small intestine and the water content is \nvery high. The stool is no longer passing through the large \nintestine which is where the water from the stool is reabsorbed \ninto the body and the stool becomes formed. ___ must measure \nyour ileostomy output for the next few weeks. The output from \nthe stoma should not be more than 1200cc or less than 500cc. If \n___ find that your output has become too much or too little, \nplease call the office for advice. The office nurse or nurse \npractitioner can recommend medications to increase or slow the \nileostomy output. Keep yourself well hydrated, if ___ notice \nyour ileostomy output increasing, take in more electrolyte drink \nsuch as Gatorade. Please monitor yourself for signs and symptoms \nof dehydration including: dizziness (especially upon standing), \nweakness, dry mouth, headache, or fatigue. If ___ notice these \nsymptoms please call the office or return to the emergency room \nfor evaluation if these symptoms are severe. ___ may eat a \nregular diet with your new ileostomy. However it is a good idea \nto avoid fatty or spicy foods and follow diet suggestions made \nto ___ by the ostomy nurses.\n___ monitor the appearance of the ostomy and stoma and care \nfor it as instructed by the wound/ostomy nurses. ___ stoma \n(intestine that protrudes outside of your abdomen) should be \nbeefy red or pink, it may ooze small amounts of blood at times \nwhen touched and this should subside with time. The skin around \nthe ostomy site should be kept clean and intact. Monitor the \nskin around the stoma for bulging or signs of infection listed \nabove. Please care for the ostomy as ___ have been instructed by \nthe wound/ostomy nurses. ___ will be able to make an appointment \nwith the ostomy nurse in the clinic 7 days after surgery. ___ \nwill have a visiting nurse at home for the next few weeks \nhelping to monitor your ostomy until ___ are comfortable caring \nfor it on your own.\n\nIf ___ have any of the following symptoms please call the office \nfor advice ___:\nfever greater than 101.5\nincreasing abdominal distension\nincreasing abdominal pain\nnausea/vomiting\ninability to tolerate food or liquids\nprolonged loose stool\nextended constipation\ninability to urinate\n\n___ will be discharged home on Lovenox injections to prevent \nblood clots after surgery. ___ will take this for 30 days after \nyour surgery date. This will be given once daily. Please follow \nall nursing teaching instruction given by the nursing staff. \nPlease monitor for any signs of bleeding: fast heart rate, \nbloody bowel movements, abdominal pain, bruising, feeling faint \nor weak. If ___ have any of these symptoms please call our \noffice for advice or seek medical attention if there is an \nemergency. Avoid any contact activity while taking Lovenox. \nPlease take extra caution to avoid falling.\n\n \nFollowup Instructions:\n___\n"}
{"subject_id":"15006188","hadm_id":"28063257","text":" \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nGastrointestinal Bleeding after discharge from Laparoscopic \nRight Colectomy ___\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPer Colorectal Surgery Admit Note:\n\nHPI: Mr. ___ is a ___ year old male with history of DVT/PE\nduring admission for hip replacement ___ who was found to \nhave\na 3cm friable cecal adenocarcinoma after presenting with anemia\n___ (EGD at that time was normal). He underwent uncomplicated\nlaparoscopic right colectomy ___ by Dr. ___ was\ndischarged on coumadin and lovenox yesterday. He received only\none dose of lovenox yesterday prior to discharge, and did not\ntake his dose this morning.\n\nThis morning at 1am and 5am, he had two large bloody BMs and \nfelt\nweak, prompting him to present to the ED. Of note, his hct\npost-operatively was 20.3, from 22.7 preoperatively. He received\n2u pRBCs the next morning with appropriate hct rise to 28.8 \nprior\nto discharge. His hct is now down to 22.6. He remains\nhemodynamically stable and has two large bore IVs in place.\n \nPast Medical History:\nPMH: \nT2DM  \nAfib s/p DCCV in ___  \nHTN  \nHLD  \nBPH  \nRadiation exposure in ___ \n\nPSH: L hip replacement ___ at ___,\nright inguinal hernia repair\n \nSocial History:\n___\nFamily History:\nFather died in ___, mother died of old age at age ___. No known \nhistory of colon cancer.\n \nPhysical Exam:\nAt Discharge:\n\nGeneral: Patient appears well, ambulating without difficulty, \ntolerating regular diet, no pain, no bloody bowel movements.\nVSS\nNeuro: A\u0026oX3\nCardio/Pulm: RRR, no shortness of breath\nAbd: Lap sights intact without sign of infection, abdomen soft \nand nondistended\n___: no significant lower extremity edema\n \nPertinent Results:\n___ 06:49AM BLOOD Hct-27.6*\n___ 07:39AM BLOOD WBC-6.0 RBC-3.21* Hgb-9.0* Hct-26.7* \nMCV-83 MCH-27.9 MCHC-33.6 RDW-17.0* Plt ___\n___ 10:55AM BLOOD Hct-25.6*\n___ 06:10AM BLOOD WBC-7.4 RBC-3.01* Hgb-8.5* Hct-24.9* \nMCV-83 MCH-28.3 MCHC-34.2 RDW-17.0* Plt ___\n___ 09:15PM BLOOD WBC-7.3 RBC-3.11* Hgb-8.7* Hct-25.4* \nMCV-82 MCH-27.8 MCHC-34.0 RDW-16.9* Plt ___\n___ 02:52PM BLOOD WBC-7.9 RBC-2.68* Hgb-7.3* Hct-22.0* \nMCV-83 MCH-27.4 MCHC-33.2 RDW-16.9* Plt ___\n___ 07:35AM BLOOD WBC-7.1 RBC-2.64* Hgb-7.3* Hct-22.6* \nMCV-86 MCH-27.5 MCHC-32.2 RDW-17.2* Plt ___\n___ 10:55AM BLOOD Glucose-131* UreaN-22* Creat-0.9 Na-137 \nK-3.8 Cl-108 HCO3-24 AnGap-9\n___ 06:10AM BLOOD Glucose-84 UreaN-25* Creat-1.0 Na-138 \nK-4.1 Cl-108 HCO3-24 AnGap-10\n___ 07:35AM BLOOD Glucose-154* UreaN-28* Creat-1.4* Na-141 \nK-3.6 Cl-110* HCO3-18* AnGap-17\n___ 10:55AM BLOOD Calcium-8.3* Phos-1.8* Mg-1.7\n___ 06:10AM BLOOD Calcium-8.3* Phos-2.4*# Mg-1.8\n___ 07:50AM BLOOD Lactate-2.8*\n \nBrief Hospital Course:\nMr ___ was readmitted after discharge following a right \ncolectomy related to GI bleeding at the staple line caused by an \nmedication error on our teams part. The patient was sent home on \ncoumadin and prophylactic lovenox after very specific \ninstructions on what the anticoagulation plane would be which \nwas prophylactic lovenox only has he was no longer on warfarin \nand had been treated for a prior clotting event. We addressed \nthis with our team. He recieved 3 units of blood in total and \nwas monitored closely for continued bleeding. On ___ he had \none bowel movement with old clot and no bright red blood. He was \nmonitored closely. His diet was slowly advanced as his symptoms \ncontinued to improve. He was hemodynamically stable. There was \nno procedure to stop the bleeding, we waited and held \nanticoagulation and the bleeding subsided. On ___ he had \ntwo bowel movements that were old dark maroon blood. And on the \nday of discharge, he had a brown bowel movement and was stable \nand ready for discharge home on the appropriate anticoagulation \nplan. He was specifically told by this writer not to restart \nWarfarin at home. Dr. ___ explained to the patient in \n___ not to restart the warfarin. \n \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Enoxaparin Sodium 40 mg SC Q24H \nStart: ___, First Dose: Next Routine Administration Time \n2. Aspirin 81 mg PO DAILY \n3. Finasteride 5 mg PO DAILY \n4. Metoprolol Succinate XL 6.25 mg PO DAILY \n5. Hydrochlorothiazide 25 mg PO DAILY \n6. Acetaminophen 650 mg PO Q6H:PRN pain \nWarfaring-\u003e restarted in error at the time of previous \ndischarge.\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q6H:PRN pain \ndo not take more than 3000mg of tylenol in 24 hours or drink \nalcohol while taking \nRX *acetaminophen 325 mg 2 tablet(s) by mouth every six (6) \nhours Disp #*50 Tablet Refills:*0\n2. Finasteride 5 mg PO DAILY \n3. Hydrochlorothiazide 25 mg PO DAILY \n4. Metoprolol Succinate XL 6.25 mg PO DAILY \n5. Aspirin 81 mg PO DAILY \n6. Enoxaparin Sodium 40 mg SC Q24H \nStart: ___, First Dose: First Routine Administration Time \nPlease start on ___, take until ___ \nRX *enoxaparin 40 mg/0.4 mL 40 mg subcutaneous once a day Disp \n#*8 Syringe Refills:*0\n7. Pantoprazole 40 mg PO Q24H \nRX *pantoprazole [Protonix] 40 mg 1 tablet(s) by mouth once a \nday Disp #*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPost-Operative Anastomotic Bleed after starting anticoagulation \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were readmitted after surgery for bleeding from your \nprevious Right Colectomy. This was likely related to restarting \nyour blood thinning medication to prevent blood clots. You were \ngiven blood when you were admitted and now your blood counts are \nstable. You are stable to return home. You should continue to \nmonitor how you are feeling and for signs and symptoms of \nbleeding. Please call if you have any of the following symptoms: \npassing blood from your rectum or with bowel movements, \ndizziness, feeling faint, fast heart rate, weakness, bruising \nover your abdomen that has worsened, increased abdominal \ndistension, increased abdominal pain. Please call if you are \nexperiencing any concerning symptoms. You should restart the \nLovenox on ___ and you will take this medication for \na total of one month after surgery please call if there are any \nissues with the lovenox. \n\nYou have ___ laparoscopic surgical incisions on your abdomen \nwhich are closed with internal sutures and a skin glue called \nDermabond. These are healing well however it is important that \nyou monitor these areas for signs and symptoms of infection \nincluding: increasing redness of the incision lines, \nwhite/green/yellow/malodorous drainage, increased pain at the \nincision, increased warmth of the skin at the incision, or \nswelling of the area. Please call the office if you develop any \nof these symptoms or a fever. You may go to the emergency room \nif your symptoms are severe.  \nYou may shower; pat the incisions dry with a towel, do not rub. \nThe small incisions may be left open to the air. If closed with \nsteri-strips (little white adhesive strips) instead of \nDermabond, these will fall off over time, please do not remove \nthem. Please no baths or swimming for 6 weeks after surgery \nunless told otherwise by your surgical team.\n\nPlease monitor your bowel function closely. Some loose stool and \npassing of small amounts of dark, old appearing blood are \nexpected. However, if you notice that you are passing bright red \nblood with bowel movements or having loose stool without \nimprovement please call the office or go to the emergency room \nif the symptoms are severe. If you are taking narcotic pain \nmedications there is a risk that you will have some \nconstipation. Please take an over the counter stool softener \nsuch as Colace, and if the symptoms do not improve call the \noffice. If you have any of the following symptoms please call \nthe office for advice or go to the emergency room if severe: \nincreasing abdominal distension, increasing abdominal pain, \nnausea, vomiting, inability to tolerate food or liquids, \nprolonged loose stool, or extended constipation.  \n\nYou may take Tylenol as recommended for pain. Please do not take \nmore than 3000mg of Tylenol daily. Do not drink alcohol while \ntaking narcotic pain medication or Tylenol. Please do not drive \na car while taking narcotic pain medication. Please do not take \nany ibuprofen or other antiinflammatory medications, this can \ncontribute to bleeding. \n\nNo heavy lifting greater than 6 lbs for until your first \npost-operative visit after surgery. Please no strenuous activity \nuntil this time unless instructed otherwise by Dr. ___ Dr. \n___.  \n \nThank you for allowing us to participate in your care! Our hope \nis that you will have a quick return to your life and usual \nactivities.  \n \n \n\n \nFollowup Instructions:\n___\n"}
